data_2ijy_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2ijy _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.134 0.492 . . . . 73.24 110.092 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.31 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.34 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.41 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.463 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 26.5 m-70 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.51 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.588 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.33 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.01 109.468 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.31 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 143' ' ' SER . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.24 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.02 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.55 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 19' ' ' SER . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.05 110.397 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.34 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.11 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.34 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.23 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.13 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.13 110.185 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.523 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.51 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.45 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.32 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.13 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.691 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.32 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.41 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.12 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.33 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.23 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.23 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.24 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.51 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.11 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.43 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.02 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.523 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.13 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.33 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' HD13 ' A' ' 167' ' ' LEU . 19.0 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.1 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.23 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.635 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.34 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.41 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.04 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.42 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.22 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.11 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.01 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.11 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.11 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.12 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.24 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.21 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.33 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.14 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.32 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.24 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.33 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.12 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.31 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.13 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.2 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.21 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.02 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.31 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.42 110.337 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.459 ' HE1' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.04 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' HG11 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.43 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.51 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.13 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.33 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.21 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 132' ' ' MET . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.31 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.563 HG22 ' CE1' ' A' ' 120' ' ' PHE . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.21 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.523 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.04 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.32 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.32 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.521 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.3 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.12 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.32 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.11 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' HG22 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.02 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.521 ' HG3' ' CD1' ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.51 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.4 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.12 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' MET . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.33 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.03 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.45 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.35 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.14 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.45 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.44 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.11 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.4 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.14 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.35 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.45 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.45 ' HB2' ' HE1' ' A' ' 65' ' ' MET . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.43 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.31 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.51 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.33 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.55 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.14 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.524 ' CD1' ' HE1' ' A' ' 89' ' ' MET . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.15 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.3 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.4 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 105' ' ' GLU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.2 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.51 ' CD2' ' HE3' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.42 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.51 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.05 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.24 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.31 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.528 HG23 ' CE ' ' A' ' 119' ' ' LYS . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.14 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.24 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.578 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.22 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.11 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.528 ' CE ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.34 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 75' ' ' THR . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.24 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.24 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.33 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.34 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.34 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.35 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.21 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.513 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.13 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.34 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.13 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.34 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 71' ' ' LYS . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.44 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.14 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 132' ' ' MET . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.12 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.44 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.15 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.52 110.146 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' NE2' ' CD1' ' A' ' 136' ' ' PHE . 52.3 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.23 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.42 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.43 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.21 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.33 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.22 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 140' ' ' PHE . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.43 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.2 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.02 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.12 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.447 ' HB3' HD23 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.13 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.465 HG22 HD12 ' A' ' 40' ' ' ILE . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.4 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 25' ' ' PHE . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.33 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.34 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.464 ' HA ' HG11 ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.14 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HD2' ' CB ' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.44 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 180' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.33 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.524 HD23 ' CD2' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.4 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' A' ' 173' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.54 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.517 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 99.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.2 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.33 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.53 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.01 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.577 ' CB ' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.42 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.44 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.23 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.471 HD13 ' NE2' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.42 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.35 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.577 ' N ' ' CB ' ' A' ' 164' ' ' ALA . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.2 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.575 ' CE2' ' OD1' ' A' ' 175' ' ' ASN . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.33 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.04 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.516 ' CD2' HG12 ' A' ' 159' ' ' VAL . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.13 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.22 109.712 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.575 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.11 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.34 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.577 HD21 ' CG ' ' A' ' 9' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.12 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.22 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.4 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.13 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.425 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.05 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.76 -0.459 . . . . 73.24 109.76 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.31 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.34 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.41 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.471 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.51 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.33 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.01 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.31 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' THR . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.24 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.02 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.55 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.05 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.463 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.34 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.11 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.34 110.051 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.23 109.922 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.13 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.13 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.523 ' OE2' ' CG2' ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.51 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.45 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.518 ' HA ' ' CG2' ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.32 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.13 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.574 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.24 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.32 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.41 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.12 110.499 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.33 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.23 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.23 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.24 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.51 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.11 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.43 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.02 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.13 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.33 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 21.9 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.1 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 HD13 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.23 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.34 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.41 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.04 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' LEU . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.42 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.22 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.11 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.01 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 178' ' ' LEU . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.11 110.577 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.11 109.633 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.12 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.4 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.24 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.21 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 3.1 t-20 -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.33 109.802 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.14 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.32 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.24 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.33 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.12 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.578 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.31 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.13 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' MET . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.21 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.02 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.31 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.42 110.211 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.04 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.43 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.13 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.33 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.466 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.21 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.31 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.21 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.524 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.04 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.32 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.32 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.527 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.3 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.12 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.32 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.11 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.02 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.57 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.51 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.4 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.12 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 85' ' ' MET . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.33 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.03 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.45 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.8 t30 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.35 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.14 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.45 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.44 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.11 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.4 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.14 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.35 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.45 110.234 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.464 ' HB3' HD12 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.43 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.31 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.51 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.33 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.55 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.14 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.15 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.3 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.4 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.2 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.42 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.51 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.05 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HG3' ' SD ' ' A' ' 85' ' ' MET . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.24 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.31 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.14 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.475 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.24 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.22 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.11 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.34 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 75' ' ' THR . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.24 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.24 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.33 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.34 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.34 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.35 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.21 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.13 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.34 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.13 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.577 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.34 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.515 ' CG1' ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.44 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.14 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 132' ' ' MET . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.12 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.44 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.15 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.52 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.23 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.42 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.43 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.519 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.21 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.33 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.22 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.534 ' CD1' ' OG ' ' A' ' 143' ' ' SER . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.43 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.2 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.02 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.12 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.528 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.13 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.4 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.33 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.526 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.34 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' HG13 ' A' ' 152' ' ' VAL . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.14 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.518 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.44 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.33 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.4 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.519 HG12 ' CE1' ' A' ' 170' ' ' TYR . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.54 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.477 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 51.8 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.2 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.33 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.53 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.01 110.479 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.486 ' HB3' ' CB ' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.42 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.44 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.23 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.517 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.42 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.35 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 159' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.2 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.633 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.33 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.04 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.493 HD11 ' CD2' ' A' ' 9' ' ' TYR . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.13 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.22 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.573 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.11 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.34 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.574 HD23 ' CG ' ' A' ' 9' ' ' TYR . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.12 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.22 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.4 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.13 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.05 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.135 0.493 . . . . 73.24 109.945 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.31 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.34 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.41 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 10.8 m-70 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.51 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.33 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.01 109.536 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.567 HG23 ' CE2' ' A' ' 157' ' ' TYR . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.31 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 143' ' ' SER . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.24 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.02 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.55 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.05 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.34 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.11 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.34 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.512 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.23 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.13 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.13 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.466 ' OE1' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.51 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.45 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.32 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.13 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.24 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.32 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.41 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.12 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.33 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.23 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 28.8 t-20 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.23 110.367 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.24 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.51 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.517 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.11 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.43 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.02 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.13 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.33 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 20.7 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.1 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.23 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.34 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.41 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.1 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.04 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' LEU . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.42 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.22 110.069 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.11 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB2' HD22 ' A' ' 178' ' ' LEU . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.11 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.11 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.12 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.24 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.21 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.33 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.613 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 4.0 p-80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.14 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 148' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.32 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.467 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.24 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.33 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.12 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.31 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.13 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.2 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.527 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.21 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.02 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.31 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.42 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.04 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.566 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.43 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' CG ' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.13 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.33 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.21 110.019 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.31 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 120' ' ' PHE . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.21 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.508 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.04 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.32 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.528 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.32 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CB ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.3 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.12 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.524 HG13 ' CB ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.32 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.11 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 113' ' ' GLU . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.02 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.51 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.534 ' HB ' ' CD ' ' A' ' 87' ' ' PRO . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.4 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.12 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' MET . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.33 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.03 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.45 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.35 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.14 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' CD1' ' A' ' 29' ' ' TYR . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.45 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.44 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.11 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.4 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.14 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.35 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.45 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.528 ' CG ' HD11 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.43 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.31 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.51 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.33 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.55 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.14 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 HD11 ' CG ' ' A' ' 100' ' ' PRO . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.15 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.3 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.4 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.2 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.42 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.51 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.05 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.486 ' O ' ' NZ ' ' A' ' 84' ' ' LYS . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.24 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.31 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.14 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.48 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.24 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.22 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.11 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.34 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.687 ' CE1' ' CG ' ' A' ' 110' ' ' PHE . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.24 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.24 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.33 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 78' ' ' ALA . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.34 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.34 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.35 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.21 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.13 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.34 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.13 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.34 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.579 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.44 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.14 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.12 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.44 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.15 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.52 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.23 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.42 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.43 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.21 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 145' ' ' LEU . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.33 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.22 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.585 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.43 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.535 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.2 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.578 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.02 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.12 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.13 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.4 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 25' ' ' PHE . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.33 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.34 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.462 ' HA ' HG11 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.14 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.525 ' CD ' ' HB1' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.44 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.33 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.4 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.53 HG12 ' CE1' ' A' ' 170' ' ' TYR . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.54 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.509 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.8 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.2 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.33 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.53 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.01 110.485 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.42 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.44 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.23 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.49 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.42 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.502 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.35 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 159' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.2 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.33 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.04 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.13 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.22 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.7 m120 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.11 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.34 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.12 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.516 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.22 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.4 110.314 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.13 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.05 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.039 0.447 . . . . 73.24 109.931 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.578 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.31 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.41 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.552 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.51 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.33 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.01 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.31 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.24 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.02 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.55 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.05 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.34 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.11 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' CB ' HD23 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.34 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.23 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.13 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.13 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.471 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.51 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.45 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.32 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.526 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.13 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.688 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.24 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.32 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.027 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.41 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.12 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.33 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.027 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.23 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 60.7 t-20 -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.23 110.611 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.24 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.573 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.51 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.5 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.11 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.43 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HA ' ' HG3' ' A' ' 42' ' ' GLN . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.02 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.13 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.33 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.7 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.1 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.23 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.34 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.41 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.2 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.04 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.42 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.22 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.11 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.01 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.11 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.11 109.765 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.12 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.24 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.21 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.33 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.68 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.14 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 60' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.32 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.24 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.33 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.12 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.31 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.13 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.2 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.21 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.02 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.31 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.42 110.311 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.04 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.465 ' HB3' HG12 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.43 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.13 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.33 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.21 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.31 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 120' ' ' PHE . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.21 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.04 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.32 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.32 110.473 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.3 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.12 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.32 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.11 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.02 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.51 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.552 HG22 ' CE1' ' A' ' 73' ' ' TYR . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.4 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.12 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.33 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.522 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.03 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.45 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.35 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.14 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.565 HD13 ' CE1' ' A' ' 29' ' ' TYR . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.45 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 12.1 t-80 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.44 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.11 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.4 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.14 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.35 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.45 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.43 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.31 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.51 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.33 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.55 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.14 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.15 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.3 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.4 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.2 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.42 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.51 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.05 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.24 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.31 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.14 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.24 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.596 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.22 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.11 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.34 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 75' ' ' THR . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.24 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.24 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.33 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.493 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.34 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.34 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.35 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.21 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.13 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.34 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.13 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.34 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.44 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.14 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.12 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.44 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.15 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.52 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.508 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.23 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.42 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.43 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.21 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.33 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.22 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.639 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.43 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.2 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.02 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.12 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.13 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 158' ' ' LEU . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.4 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.33 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.34 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.447 ' HA ' HG12 ' A' ' 152' ' ' VAL . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.14 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.44 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CE2' HG22 ' A' ' 11' ' ' VAL . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.33 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.5 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.4 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.566 HG12 ' CE1' ' A' ' 170' ' ' TYR . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.54 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.2 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.33 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.53 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.01 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.42 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.44 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.23 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.425 HD22 ' CG2' ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.42 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.508 ' CB ' ' HB1' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.35 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.566 ' CE1' HG12 ' A' ' 159' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.2 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.33 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.04 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 9' ' ' TYR . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.13 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.22 109.89 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.11 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.559 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.34 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.12 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.525 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.22 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.4 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.13 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.05 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.099 0.476 . . . . 73.24 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.31 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.41 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.51 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.33 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.01 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.31 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.459 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.24 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.02 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.55 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.05 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.34 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.11 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.517 ' CB ' HD22 ' A' ' 178' ' ' LEU . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.34 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.23 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.13 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.13 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.51 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CB ' HG11 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.45 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.32 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.532 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.13 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.24 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.32 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.41 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.12 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.33 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.532 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.23 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.23 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.513 ' CG2' ' NE2' ' A' ' 94' ' ' HIS . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.24 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.51 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.527 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.11 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.43 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.515 ' CG2' HD23 ' A' ' 167' ' ' LEU . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.02 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.572 HD13 ' CE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.13 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.33 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.3 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.1 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.23 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.34 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.41 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.5 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.04 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.42 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HD2' HD21 ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.22 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.11 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.01 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.11 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.11 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.12 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.2 mm-40 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.24 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.21 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.33 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.14 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CD1' ' A' ' 140' ' ' PHE . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.32 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.24 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.33 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.12 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.31 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.13 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.2 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.21 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.02 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.31 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.42 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.04 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.43 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.13 110.395 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.33 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.21 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.31 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.57 HG23 ' CD1' ' A' ' 120' ' ' PHE . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.21 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.04 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.32 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.32 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.3 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.12 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.32 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.11 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.02 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.517 ' SD ' ' CD1' ' A' ' 115' ' ' ILE . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.51 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.548 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.4 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.12 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.526 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.33 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.493 ' CG ' ' HE1' ' A' ' 76' ' ' MET . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.03 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.45 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.35 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.14 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.45 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.44 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.11 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.4 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.14 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.35 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.45 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.52 ' CB ' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.43 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.31 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.51 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.33 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.55 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.14 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.15 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.3 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.4 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.2 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.575 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.42 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.51 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.05 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.24 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.31 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.14 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.24 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.22 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.11 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.34 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CD1' HG23 ' A' ' 75' ' ' THR . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.24 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.24 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.33 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.34 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.34 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.35 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.21 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.523 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.13 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.34 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.13 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.523 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.34 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.44 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.14 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.12 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.44 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.15 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.52 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 143' ' ' SER . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.23 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.609 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.42 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.43 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.21 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.528 ' CB ' HD11 ' A' ' 145' ' ' LEU . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.33 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.22 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.609 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.43 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.2 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 25' ' ' PHE . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.02 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.516 ' CA ' ' SG ' ' A' ' 33' ' ' CYS . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.12 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.13 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.534 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.4 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.489 HG23 ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.33 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.34 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.14 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.44 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.58 ' CD1' HG21 ' A' ' 11' ' ' VAL . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.33 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.4 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CD1' ' A' ' 177' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.54 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.2 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.33 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.53 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.01 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.42 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.44 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.23 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.515 HD23 ' CG2' ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.42 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.35 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.53 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.2 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.629 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.33 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.04 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.13 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.4 ' O ' HD11 ' A' ' 178' ' ' LEU . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.22 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.45 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.11 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.34 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.12 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 20' ' ' PRO . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.22 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.4 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.13 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.442 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.05 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mttt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.068 0.461 . . . . 73.24 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.31 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.34 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.41 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.524 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 15.6 m-70 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.51 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 5' ' ' GLU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.33 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.01 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.31 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.24 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.02 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.55 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.05 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.34 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.11 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.524 ' CB ' HD23 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.34 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.23 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.13 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.13 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.51 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.45 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.32 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.13 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.684 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.24 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.32 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.41 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.12 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.33 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.23 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.23 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.24 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.51 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.11 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.43 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.02 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.13 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.33 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' HD11 ' A' ' 167' ' ' LEU . 22.9 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.1 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.23 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.34 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.41 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.04 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.57 HD13 ' CD1' ' A' ' 53' ' ' PHE . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.42 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.22 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.11 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.01 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.11 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.11 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.12 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.24 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.21 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.33 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.14 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.32 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.24 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.33 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.12 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.31 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.13 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.2 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.21 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.02 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.31 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.42 110.309 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.04 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.43 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CG ' HG22 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.13 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.33 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.21 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.529 ' CB ' ' HE1' ' A' ' 132' ' ' MET . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.31 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.21 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.561 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.04 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.32 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.32 109.773 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.3 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.12 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.32 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.11 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.02 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.51 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.578 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.4 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.12 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.52 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.33 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.514 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.03 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.45 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.35 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.14 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.45 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 21.8 t-160 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.44 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.11 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.4 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.14 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.35 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.45 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.526 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.43 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.31 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.51 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.33 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.55 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.14 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.52 HD11 ' CG ' ' A' ' 100' ' ' PRO . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.15 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.3 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.4 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.513 HG23 ' NE ' ' A' ' 92' ' ' ARG . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.2 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.567 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.42 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.51 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.05 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.52 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.24 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.31 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.14 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.515 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.24 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.574 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.22 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.11 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.34 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.24 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.24 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.33 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 75' ' ' THR . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.34 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.513 ' N ' HG21 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.34 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.35 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.21 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.523 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.13 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.34 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.13 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HE1' ' CB ' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.34 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.574 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.44 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.14 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.12 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.44 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.15 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.52 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.23 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.637 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.42 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.43 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.505 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.21 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.33 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.22 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.43 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.2 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.02 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.12 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.13 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.467 HG23 HD12 ' A' ' 40' ' ' ILE . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.4 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 25' ' ' PHE . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.33 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.34 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.14 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 181' ' ' LYS . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.44 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.33 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.459 HD11 HG22 ' A' ' 152' ' ' VAL . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.4 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.54 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.2 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.33 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.53 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.01 110.412 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.472 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.42 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.44 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.23 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.51 HD11 ' NE2' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.42 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.472 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.35 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.636 ' CE1' ' CG1' ' A' ' 159' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.2 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.33 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.04 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.524 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.13 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.22 109.629 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.424 ' O ' HG22 ' A' ' 179' ' ' THR . 1.8 m-80 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.11 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.34 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.12 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.524 HD23 ' CB ' ' A' ' 20' ' ' PRO . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.22 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.4 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.13 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.05 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.656 -0.498 . . . . 73.24 109.656 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.31 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.34 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.41 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.58 ' NE2' ' CB ' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.51 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.572 ' CG ' HD23 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.33 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.513 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.01 109.516 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.31 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 143' ' ' SER . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.24 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.02 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.55 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.05 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.34 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.435 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.11 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.34 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.23 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.13 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.13 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HG3' ' CG2' ' A' ' 40' ' ' ILE . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.51 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.45 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.32 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.13 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.24 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.32 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.047 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.41 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.12 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.33 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.047 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.23 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.576 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.23 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.24 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.51 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.11 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.43 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.02 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.13 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' PRO . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.33 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.7 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.1 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.23 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.517 ' NZ ' ' HE2' ' A' ' 55' ' ' LYS . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.34 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.41 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.04 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.42 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' HD21 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.22 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.11 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.01 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.11 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.11 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.12 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.24 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.21 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.33 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.14 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.479 HG13 ' CG1' ' A' ' 148' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.32 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.456 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.24 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.33 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.58 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.12 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.31 109.884 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.13 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.2 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.463 ' HE3' HD21 ' A' ' 106' ' ' LEU . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.21 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.02 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.31 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.42 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.04 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.43 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' HG23 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.13 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.33 110.109 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.21 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.31 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.21 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.522 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.04 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.32 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.32 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.3 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.12 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.32 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.11 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.02 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 110' ' ' PHE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.51 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG22 ' CE2' ' A' ' 73' ' ' TYR . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.4 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.12 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' MET . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.33 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.519 ' CB ' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.03 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.45 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.524 ' OD1' ' CG2' ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.35 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.14 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.542 HD12 ' CE1' ' A' ' 29' ' ' TYR . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.45 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.44 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.11 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.4 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.14 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.35 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HB3' HD11 ' A' ' 93' ' ' ILE . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.45 110.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 109' ' ' ILE . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.43 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.31 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.51 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.33 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.55 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.14 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.15 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.3 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.4 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.2 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.575 ' CD2' ' HE1' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.42 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.51 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.05 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.24 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.31 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.14 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.24 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.578 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.22 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.11 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.34 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.574 ' CE1' HG23 ' A' ' 75' ' ' THR . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.24 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.24 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.33 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.522 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.34 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.34 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.35 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.21 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.13 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.34 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.13 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.34 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.44 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.14 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' A' ' 134' ' ' ARG . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.12 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.44 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.15 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.52 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.23 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.42 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.43 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.528 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.21 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.33 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.22 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.43 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.2 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.02 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.55 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.12 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.13 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.458 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.4 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.546 HG22 ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.33 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.34 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.14 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.496 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.44 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.33 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.4 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.54 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 97.5 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.2 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.33 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.53 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.58 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.01 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.42 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.44 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.23 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.42 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.35 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.56 ' N ' ' CB ' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.2 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 43' ' ' LEU . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.33 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.04 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 9' ' ' TYR . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.13 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.22 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.561 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.11 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.34 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.572 HD23 ' CG ' ' A' ' 9' ' ' TYR . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.12 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.22 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.4 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.13 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.456 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.05 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.408 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 67.7 mttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.203 0.525 . . . . 73.24 110.285 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.31 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.34 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.41 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 31.9 m-70 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.51 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.33 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.01 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.31 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.24 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.02 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.55 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.456 ' HB3' HG13 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.05 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.34 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.11 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' CB ' HD21 ' A' ' 178' ' ' LEU . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.34 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.23 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.13 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.13 110.057 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.51 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.45 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.32 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.13 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.24 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.32 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.41 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.12 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.33 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.23 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.23 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.24 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.51 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.11 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.43 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.02 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.526 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.13 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.529 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.33 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 20.1 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.1 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.23 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 53' ' ' PHE . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.34 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.41 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.4 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.04 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LEU . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.42 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.22 109.891 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.11 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.01 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.11 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.11 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.12 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.24 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.21 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.33 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.14 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.32 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.428 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.24 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.33 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.12 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.31 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.13 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.2 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.21 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.02 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.31 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.42 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.04 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.43 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HD3' ' CE1' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.13 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.33 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.21 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.31 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.522 HG23 ' CB ' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.21 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.52 ' CE ' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.04 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HG2' ' A' ' 82' ' ' GLU . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.32 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.32 109.524 172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.3 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.12 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.32 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.11 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.02 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' ' CD1' ' A' ' 110' ' ' PHE . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.51 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.4 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.12 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.525 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.33 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.494 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.03 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.45 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.35 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.14 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.45 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.44 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.11 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.4 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.14 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.35 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.45 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.524 ' CB ' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.43 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.31 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.51 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.33 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.55 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.14 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.15 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.3 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.4 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.2 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.42 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.51 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.05 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.525 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.24 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.31 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.14 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.24 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.593 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.22 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.11 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.34 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.24 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.24 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.33 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.34 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.34 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.35 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.21 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.534 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.13 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.34 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.13 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.34 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.44 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.14 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.12 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.44 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.15 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.52 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.23 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.42 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.43 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.21 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.528 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.33 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.22 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.43 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.2 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.02 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.12 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.13 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.514 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.4 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.33 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.2 m-80 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.34 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.14 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.44 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.33 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.4 108.989 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.505 HG23 ' CD1' ' A' ' 177' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.54 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.2 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 164' ' ' ALA . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.33 109.757 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.53 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.01 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.42 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.44 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.23 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.464 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.42 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.35 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.514 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.2 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.33 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.04 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.13 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.407 HG22 HD23 ' A' ' 43' ' ' LEU . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.22 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.11 110.736 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.34 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.534 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.12 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.502 HD21 ' CB ' ' A' ' 20' ' ' PRO . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.22 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.4 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.13 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.05 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.114 0.483 . . . . 73.24 109.929 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.31 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.34 109.211 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.41 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.509 ' NE2' ' OG ' ' A' ' 163' ' ' SER . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.51 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.33 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.01 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.31 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.24 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.02 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.55 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.05 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.34 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.11 109.626 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.517 ' CB ' HD23 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.34 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.23 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.13 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.13 110.031 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.493 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.51 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.45 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.32 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.535 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.13 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.683 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.24 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.32 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.41 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.12 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.33 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.23 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 27' ' ' SER . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.23 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.24 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.567 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.51 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.11 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 37' ' ' GLU . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.43 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' HD22 ' A' ' 167' ' ' LEU . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.02 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' A' ' 151' ' ' VAL . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.13 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.33 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 14.7 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.1 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.23 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.34 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.41 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 52.1 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.04 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' LEU . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.42 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' HD21 ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.22 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.11 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.01 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.11 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.11 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.12 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.24 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.21 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.33 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.14 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.32 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.24 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.33 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.12 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.31 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.13 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.21 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.02 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.31 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.42 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.516 ' CE ' ' HE3' ' A' ' 89' ' ' MET . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.04 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.43 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.13 110.218 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.33 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.21 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.31 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.575 HG23 ' CE1' ' A' ' 120' ' ' PHE . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.21 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.499 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.04 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.32 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.32 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.3 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.12 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.32 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.11 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.02 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.51 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.4 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.12 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.33 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.03 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.45 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.35 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.557 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.14 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 99' ' ' PRO . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.45 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 38.1 t-80 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.44 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.11 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.557 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.4 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.14 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.35 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.45 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.495 ' CB ' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.43 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.31 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.51 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.33 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.55 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.14 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.15 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.3 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.4 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.2 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.42 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.51 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.05 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CD ' ' CG2' ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.24 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.31 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.14 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.24 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.598 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.22 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.11 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.34 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CE1' HG23 ' A' ' 75' ' ' THR . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.24 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.24 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.33 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.34 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.34 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.35 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.21 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.427 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.13 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.34 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.496 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.13 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.34 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.594 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.44 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.14 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 134' ' ' ARG . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.12 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.44 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.15 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.52 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 56' ' ' ASN . 16.0 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.23 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.42 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.43 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.21 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.33 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.22 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.43 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.2 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.527 HG22 ' CE ' ' A' ' 61' ' ' MET . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.02 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.567 ' HG2' ' CG ' ' A' ' 36' ' ' PHE . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.12 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.522 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.13 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.505 ' CG2' HD12 ' A' ' 40' ' ' ILE . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.4 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.33 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.34 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.14 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.522 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.44 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.33 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.4 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG11 ' CE1' ' A' ' 170' ' ' TYR . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.54 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.2 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.33 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.53 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.01 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.42 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.44 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.23 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.42 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.465 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.35 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG11 ' A' ' 159' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.2 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.634 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.33 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 173' ' ' LEU . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.04 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.13 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.22 109.596 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.11 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.34 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.547 HD22 ' CG ' ' A' ' 157' ' ' TYR . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.12 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.22 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.4 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.584 ' CB ' ' CE2' ' A' ' 157' ' ' TYR . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.13 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.207 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.095 0.474 . . . . 73.24 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.463 ' OE2' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.31 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.34 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.471 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.41 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.51 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.33 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.512 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.01 109.407 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.31 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.24 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.02 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.55 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.05 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.34 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.11 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' CB ' HD21 ' A' ' 178' ' ' LEU . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.34 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.23 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.13 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.51 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.45 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.32 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.551 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.13 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.24 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.32 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.528 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.41 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.12 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.33 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.23 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.23 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.24 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.51 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.11 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.43 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.02 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.13 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.33 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.1 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.23 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.552 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.34 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.41 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.2 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.04 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.42 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.22 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.11 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.01 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 178' ' ' LEU . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.11 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.11 109.681 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.12 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.24 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.21 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.33 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.14 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.32 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.24 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.33 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.12 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.31 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.13 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.2 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.21 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.02 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.31 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.42 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.579 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.04 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.575 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.43 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' HG23 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.13 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.33 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.21 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.31 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.57 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.21 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.49 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.04 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.32 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.513 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.32 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.3 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.12 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.531 HG13 ' CB ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.32 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.11 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.47 ' O ' HG22 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.02 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.51 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 73' ' ' TYR . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.4 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.532 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.12 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.33 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.569 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.03 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.45 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.495 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.35 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.14 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.45 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.44 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.11 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.4 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.14 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.35 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.45 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.43 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.31 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.51 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.33 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.55 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.14 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.526 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.15 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.3 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.4 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.2 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CD2' ' HE1' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.42 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.51 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.05 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.24 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.31 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.14 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.24 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.22 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.11 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.34 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG21 ' A' ' 75' ' ' THR . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.24 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.24 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.33 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.513 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.34 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.503 ' N ' HG22 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.34 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.35 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.21 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 74' ' ' ALA . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.13 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.34 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.52 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.13 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.34 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.44 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.14 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.12 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.44 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.15 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.52 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.507 ' OE1' ' ND2' ' A' ' 56' ' ' ASN . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.23 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.42 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.43 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.21 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.33 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.22 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.61 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.43 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.2 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 25' ' ' PHE . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.02 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.516 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.12 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.13 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 40' ' ' ILE . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.4 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 25' ' ' PHE . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.33 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.34 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.14 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.44 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.33 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.4 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 177' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.54 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.512 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.7 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.2 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.33 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.53 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.01 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.42 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.44 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.23 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.42 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.35 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 164' ' ' ALA . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.2 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.599 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.33 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.04 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.464 ' O ' HD13 ' A' ' 173' ' ' LEU . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.13 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.22 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.446 ' HA ' HD11 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.11 110.585 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.34 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.52 HD11 ' CG2' ' A' ' 153' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.12 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 20' ' ' PRO . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.22 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.4 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.13 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.05 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.31 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.34 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.41 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.567 ' NE2' ' CB ' ' A' ' 163' ' ' SER . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.51 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.33 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.514 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.01 109.617 175.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.31 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 143' ' ' SER . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.24 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.02 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.55 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.05 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.34 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.454 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.11 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.521 ' CB ' HD21 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.23 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.13 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 152' ' ' VAL . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.13 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.454 ' OE2' HG13 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.51 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.45 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.32 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.13 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.24 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.32 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.41 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.12 110.033 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.33 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.23 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.23 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.24 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.51 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HB3' ' CD ' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.11 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 37' ' ' GLU . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.43 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.511 HD12 ' NE2' ' A' ' 42' ' ' GLN . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.02 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.13 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.33 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.511 ' NE2' HD12 ' A' ' 39' ' ' ILE . 40.9 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.1 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.23 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 53' ' ' PHE . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.34 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.41 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 44.8 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.04 110.306 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.42 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.22 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.11 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.01 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.11 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.11 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.12 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.504 ' HG3' ' CG2' ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.24 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.21 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.33 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.677 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.14 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 27' ' ' SER . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.32 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.24 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.33 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.563 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.12 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.31 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.13 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.2 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.21 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.02 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.31 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.42 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.544 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.04 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.567 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.43 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.13 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.33 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.21 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.31 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.547 HG23 ' CE1' ' A' ' 120' ' ' PHE . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.21 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.492 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.04 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.32 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.32 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CB ' HG12 ' A' ' 81' ' ' VAL . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.3 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.12 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.32 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.11 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.466 ' O ' HG21 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.02 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.51 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 73' ' ' TYR . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.4 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.12 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.33 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.03 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.45 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.35 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.14 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 29' ' ' TYR . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.45 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.44 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.11 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.4 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.14 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.35 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.45 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.43 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.31 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.51 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.33 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.55 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.14 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.15 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.3 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.4 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.2 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.42 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.51 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.05 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.24 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.31 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.14 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.24 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.22 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.11 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.524 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.34 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.679 ' CE1' ' CG ' ' A' ' 110' ' ' PHE . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.24 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.24 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.33 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.34 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.34 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.35 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.21 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.531 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.13 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.34 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.13 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.531 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.34 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.44 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.14 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.12 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.44 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.15 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.52 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.512 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.23 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.42 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.21 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.33 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.22 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.43 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.2 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.535 HG12 ' CB ' ' A' ' 25' ' ' PHE . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.02 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.52 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.12 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.13 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.452 HG23 ' OH ' ' A' ' 170' ' ' TYR . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.4 110.067 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.453 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.33 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.34 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.14 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.44 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.33 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.446 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.4 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.54 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.6 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.2 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.33 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.53 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.01 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.42 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.44 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.23 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.42 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.35 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.519 ' CE1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.2 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.33 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.04 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.13 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 171' ' ' PHE . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.22 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.11 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.34 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.564 HD22 ' CD2' ' A' ' 157' ' ' TYR . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.12 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.22 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.4 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.13 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.464 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.05 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.135 0.493 . . . . 73.24 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.31 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.34 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.41 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.578 ' NE2' ' CB ' ' A' ' 163' ' ' SER . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.51 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.33 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.01 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.31 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.24 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.02 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.55 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.453 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.05 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.34 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.11 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.34 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 21' ' ' VAL . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.23 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.13 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.13 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.578 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.51 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.45 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.32 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.13 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.24 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CD1' HD11 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.32 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.41 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.12 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.33 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.23 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.23 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.24 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.51 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.11 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.43 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.02 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.56 HD12 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.13 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.33 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.488 ' NE2' HD12 ' A' ' 167' ' ' LEU . 14.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.1 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.23 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.34 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.41 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.04 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.42 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.22 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.11 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.01 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.525 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.11 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.11 109.631 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.12 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.24 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.21 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.33 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.14 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.581 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.32 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.24 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.33 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.12 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.31 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.13 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.2 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.21 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.02 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.31 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.42 110.205 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.04 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.43 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.514 ' N ' HG22 ' A' ' 133' ' ' VAL . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.13 110.4 176.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.33 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CE1' ' OE2' ' A' ' 82' ' ' GLU . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.21 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.31 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 120' ' ' PHE . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.21 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.582 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.04 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.466 HG13 ' OE2' ' A' ' 82' ' ' GLU . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.32 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.32 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.528 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.3 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.12 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.32 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.11 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.02 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.521 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.51 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.4 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.12 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.33 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.486 ' O ' HG12 ' A' ' 93' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.03 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.45 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.501 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.35 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.14 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 29' ' ' TYR . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.45 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 85.5 t60 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.44 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.11 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.4 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.14 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.35 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.45 110.378 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 93' ' ' ILE . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.43 110.066 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.31 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.51 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.33 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.55 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.14 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.15 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.3 110.393 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.4 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.2 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.582 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.42 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.51 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.05 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.24 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.31 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.14 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.24 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.592 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.22 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.11 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.34 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CD1' HG22 ' A' ' 75' ' ' THR . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.24 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.24 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.33 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.34 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.34 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.35 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.21 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.13 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.34 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.499 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.13 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.34 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 71' ' ' LYS . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.44 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.14 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.12 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.44 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.15 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.52 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.23 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.42 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.43 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.21 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.532 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.33 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.22 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.639 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.43 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.2 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.02 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.54 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.12 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.13 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.4 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.33 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.34 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.523 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.14 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.44 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.33 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.4 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 170' ' ' TYR . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.54 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.2 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.33 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.53 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.01 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HB2' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.42 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.44 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.23 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.488 HD12 ' NE2' ' A' ' 42' ' ' GLN . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.42 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.35 110.564 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG13 ' A' ' 159' ' ' VAL . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.2 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.33 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.04 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.13 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.22 109.702 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.442 ' HA ' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.11 110.926 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.517 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.34 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.12 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.22 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.4 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 157' ' ' TYR . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.13 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.05 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 66.1 mttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.449 -0.574 . . . . 73.24 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.31 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.34 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.41 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.512 ' NE2' ' OG ' ' A' ' 163' ' ' SER . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.51 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.33 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.01 109.315 173.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.31 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.24 110.267 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.02 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.55 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.05 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.34 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.11 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.516 ' CB ' HD21 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.34 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.23 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.13 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.13 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.506 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.51 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CB ' HG13 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.45 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.32 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.13 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.24 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.32 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.41 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.12 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.33 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.526 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.23 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.23 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.24 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.446 ' HA ' HD12 ' A' ' 39' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.51 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.11 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.43 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.48 ' CG2' HD23 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.02 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.13 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.33 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.6 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.1 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.23 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.34 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.41 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.574 ' HG2' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.04 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' LEU . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.42 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.22 109.923 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.11 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.01 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.11 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.11 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.12 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.24 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.21 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.33 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.14 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.32 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.24 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.33 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.12 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.31 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.13 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.2 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.495 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.21 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.02 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.31 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.42 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.04 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.43 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.513 ' HG2' ' CG2' ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.13 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.33 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.461 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.21 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.31 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 120' ' ' PHE . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.21 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.04 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.511 HD13 ' CE ' ' A' ' 132' ' ' MET . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.32 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.32 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.3 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.12 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.32 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.11 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.02 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.51 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.4 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.12 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.33 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.529 ' CE ' HD12 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.03 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.45 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.503 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.35 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.14 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 89' ' ' MET . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.45 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.44 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.11 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.555 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.4 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.14 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.35 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.45 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.518 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.43 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.31 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.51 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.33 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.55 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.14 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.529 HD12 ' CE ' ' A' ' 89' ' ' MET . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.15 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.3 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.4 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.2 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.42 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.51 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.05 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 85' ' ' MET . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.24 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.31 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.14 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.24 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.22 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.11 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.34 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG22 ' A' ' 75' ' ' THR . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.24 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.24 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.33 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.34 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.512 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.34 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.35 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.21 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.531 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.13 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.34 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.13 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.525 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.34 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.44 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.529 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.14 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.12 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.44 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.15 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.52 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.52 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.23 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.42 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.43 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.21 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 145' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.33 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.574 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.43 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.2 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.02 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.12 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.514 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.13 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.457 ' O ' HD11 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.4 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.465 HG23 ' CE1' ' A' ' 25' ' ' PHE . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.33 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.518 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.34 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.14 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.44 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.33 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.461 HD23 HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.4 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.54 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.517 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.3 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.2 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.33 109.829 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.53 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.01 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.468 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.42 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.44 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.23 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.42 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.35 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.453 ' OH ' HG23 ' A' ' 151' ' ' VAL . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.2 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.579 ' CD1' HD12 ' A' ' 43' ' ' LEU . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.33 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.04 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.13 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.22 109.898 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 1.6 m120 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.11 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.563 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.34 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.12 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.22 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 175' ' ' ASN . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.4 110.611 -177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.13 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.05 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.218 0.532 . . . . 73.24 110.444 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.31 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.34 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.41 110.464 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 15.2 m-70 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.51 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.33 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.01 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.31 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.24 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.02 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.55 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.05 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.34 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.11 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.23 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.13 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.492 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.51 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.45 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.32 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.521 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.13 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.24 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.32 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.41 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.12 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.33 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.23 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.23 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.24 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.608 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.51 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.525 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.11 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.43 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD22 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.02 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.608 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.13 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.33 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.1 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.572 HD11 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.23 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.34 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.41 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.04 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.42 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.22 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.11 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.01 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 178' ' ' LEU . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.11 110.6 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.11 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.12 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.24 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.21 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.33 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.9 p-80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.14 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.32 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.24 110.758 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.33 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.12 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.31 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.13 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.2 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.21 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.02 109.81 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.31 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.42 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.04 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 57' ' ' HIS . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.43 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.517 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.13 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 69' ' ' MET . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.33 110.439 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.21 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.31 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 120' ' ' PHE . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.21 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.579 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.04 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.47 ' CG1' ' HG2' ' A' ' 82' ' ' GLU . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.32 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.439 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.32 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.3 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.12 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.32 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 86' ' ' VAL . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.11 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.02 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.568 ' HE1' ' CG ' ' A' ' 110' ' ' PHE . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.51 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.542 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.4 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.12 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.53 HG13 ' CG ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.33 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.475 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.03 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.45 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.35 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.477 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.14 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.45 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.44 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.11 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 95' ' ' THR . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.4 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.14 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.35 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.45 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.43 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.31 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.51 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.33 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.55 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.14 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.453 HD13 ' HE3' ' A' ' 89' ' ' MET . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.15 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' NH1' HD13 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.3 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.4 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.456 HG21 ' SD ' ' A' ' 89' ' ' MET . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.2 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.579 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.42 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.51 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.05 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.53 ' CG ' HG13 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.24 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.31 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.533 HG22 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.14 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.24 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.597 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.22 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.11 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.34 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG22 ' A' ' 75' ' ' THR . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.24 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.24 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.33 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.34 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.34 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.35 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.21 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.13 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.34 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.13 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.34 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.526 ' CG1' ' OG ' ' A' ' 70' ' ' SER . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.44 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.14 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 132' ' ' MET . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.12 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.44 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.15 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.52 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.23 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.42 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.43 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.21 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.484 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.33 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.22 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.581 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.43 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.2 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.02 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.545 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.12 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.525 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.13 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 40' ' ' ILE . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.4 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.33 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.493 ' CG2' HD11 ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.34 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.14 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.536 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.44 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.33 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.52 ' CD2' HD23 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.4 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 170' ' ' TYR . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.54 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 27.5 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.2 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.33 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.53 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.01 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.42 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.44 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.23 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.42 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.35 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.575 ' CE1' HG12 ' A' ' 159' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.2 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.572 ' CD2' HD11 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.33 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.04 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.522 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.13 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.22 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.453 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.11 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.34 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.12 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.503 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.22 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.4 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.13 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.05 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 92.9 mttt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.269 0.557 . . . . 73.24 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.31 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.34 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.41 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 27.4 m-70 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.51 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.33 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.01 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.31 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.24 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.02 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.55 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 19' ' ' SER . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.05 110.291 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.34 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.11 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.522 ' CB ' HD21 ' A' ' 178' ' ' LEU . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.34 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.23 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.13 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.13 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CD ' HG13 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.51 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CB ' HG11 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.45 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.32 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.478 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.13 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.24 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' ILE . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.32 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.41 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.12 110.403 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.33 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.23 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.23 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.24 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.633 ' CE2' ' CG1' ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.51 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.11 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.43 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' CD2' ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.02 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.633 ' CG1' ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.13 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.33 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.1 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.23 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.34 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.41 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 50.3 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.04 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD2' ' HD2' ' A' ' 48' ' ' PRO . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.42 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.22 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.11 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.01 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.11 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.11 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.12 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.24 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.21 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.33 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.14 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.32 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.45 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.24 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.582 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.33 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.12 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.31 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.13 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.2 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.461 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.21 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 62' ' ' GLY . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.02 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.31 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.42 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.04 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.43 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.13 110.035 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.33 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.21 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.529 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.31 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.21 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.528 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.04 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.32 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.515 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.32 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CB ' HG13 ' A' ' 81' ' ' VAL . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.3 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.12 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.32 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.11 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.02 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.532 ' CG ' ' CD1' ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.51 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.4 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.535 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.12 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.33 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.03 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.45 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.35 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.14 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.45 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 58.4 t-80 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.44 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.11 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.4 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.14 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.35 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.45 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.517 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.43 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.31 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' O ' ' HE1' ' A' ' 65' ' ' MET . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.51 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.33 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.55 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.14 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.15 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.3 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.4 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.2 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.528 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.42 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.51 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.05 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.24 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.31 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CD1' ' CG ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.14 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.24 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.58 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.22 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.11 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.524 ' HD3' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.34 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.576 ' CE1' HG22 ' A' ' 75' ' ' THR . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.24 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.24 109.711 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.33 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.34 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.34 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.35 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.21 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.13 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.34 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.13 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.529 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.34 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.588 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.44 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.14 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.12 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.44 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.15 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.52 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 12.8 mm100 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.23 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.42 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.43 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.21 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 145' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.33 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.606 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.43 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.2 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.02 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.544 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.12 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.534 ' CB ' ' CD2' ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.13 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.524 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.4 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.33 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.7 m-80 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.34 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.449 ' HA ' HG13 ' A' ' 152' ' ' VAL . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.14 110.916 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HD2' ' CB ' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.44 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.33 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.4 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG12 ' CE1' ' A' ' 170' ' ' TYR . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.54 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.2 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.33 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.53 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.01 110.247 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.42 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.44 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.464 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.23 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.42 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.35 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG12 ' A' ' 159' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.2 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.33 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.04 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.13 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' HD12 ' A' ' 178' ' ' LEU . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.22 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.11 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.34 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.529 HD21 ' CG ' ' A' ' 9' ' ' TYR . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.12 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.524 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.22 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.4 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.13 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.05 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.537 . . . . 73.24 110.42 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.31 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.34 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.41 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.456 ' O ' HD23 ' A' ' 173' ' ' LEU . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.51 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.33 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.01 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.31 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.24 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.02 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.55 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.05 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.34 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.11 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.34 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.506 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.23 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.13 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.13 109.621 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE2' HG23 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.51 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.45 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.32 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.13 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.24 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.32 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.41 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.12 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.33 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.23 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.23 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.24 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' GLU . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.51 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.11 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.43 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 36' ' ' PHE . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.02 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 24' ' ' GLU . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.13 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.33 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.1 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.568 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.23 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.581 ' HD3' ' CE2' ' A' ' 53' ' ' PHE . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.34 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.41 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.04 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' LEU . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.42 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.22 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.11 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.01 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.11 110.507 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.11 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.12 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.24 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.21 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.33 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.14 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.601 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.32 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.24 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.33 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.592 ' CE ' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.12 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.31 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.13 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.2 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.21 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.02 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.31 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.42 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.563 ' SD ' ' CD2' ' A' ' 29' ' ' TYR . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.04 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.43 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.13 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.33 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.21 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.31 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.571 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.21 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.569 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.04 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.32 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.32 109.703 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.3 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.12 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.32 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.11 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.02 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.558 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.51 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.562 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.4 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.12 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.53 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.33 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.579 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.03 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.45 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.495 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.35 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 98' ' ' LYS . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.14 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' A' ' 89' ' ' MET . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.45 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.44 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 97' ' ' ARG . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.11 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.4 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.14 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.35 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.45 110.396 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.43 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.31 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.51 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.33 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.55 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.14 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.15 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.3 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.4 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.2 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.569 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.42 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.51 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.05 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.53 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.31 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.14 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.24 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.22 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.11 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.34 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.571 ' CE1' HG22 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.24 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.24 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.33 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.34 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.34 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.35 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.21 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.524 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.13 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.34 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.13 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.538 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.34 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.44 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.14 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.12 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.44 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.15 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.52 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.23 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.42 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.43 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.21 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.33 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.22 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.578 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.43 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.2 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.592 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.02 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.12 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.518 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.13 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.469 HG22 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.4 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.33 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.34 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' HG11 ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.14 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.526 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.44 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.33 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.4 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.514 ' N ' HD12 ' A' ' 158' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.54 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.455 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.2 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.33 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.53 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.01 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.42 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.44 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.23 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.42 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.522 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.35 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.469 ' OH ' HG22 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.2 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.33 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.04 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.508 HD13 ' CD1' ' A' ' 177' ' ' LEU . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.13 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.22 109.766 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 171' ' ' PHE . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.11 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.34 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.558 HD23 ' CG ' ' A' ' 9' ' ' TYR . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.12 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.517 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.22 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.4 110.191 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.13 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.05 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.24 0.543 . . . . 73.24 110.124 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.31 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.34 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.41 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.465 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 25.7 m170 -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.51 109.949 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.33 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.01 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.31 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.24 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.02 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.55 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 19' ' ' SER . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.05 110.413 -177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.34 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.11 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.52 ' CB ' HD22 ' A' ' 178' ' ' LEU . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.34 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.23 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.13 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.13 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.455 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.51 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.45 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.32 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.13 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.24 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.468 ' OH ' ' HG3' ' A' ' 69' ' ' MET . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.32 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.41 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.12 110.059 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.33 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.23 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.23 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.478 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.24 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.51 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.11 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.43 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.448 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.02 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.13 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.33 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 15.3 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.1 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.629 ' CD1' ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.23 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.626 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.34 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.41 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.506 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 49.8 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.04 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' LEU . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.42 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.22 109.931 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.11 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.11 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.11 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.12 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.7 mm-40 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.24 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.21 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.33 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.657 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.14 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 60' ' ' PHE . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.32 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.464 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.24 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.33 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.12 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.31 109.895 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.13 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.2 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.515 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.21 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.02 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.31 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.42 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.468 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.04 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.43 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.13 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.33 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.657 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.21 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.31 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 120' ' ' PHE . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.21 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.58 ' HE1' ' CZ ' ' A' ' 110' ' ' PHE . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.04 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.32 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.32 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.523 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.3 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.12 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.32 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.11 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.02 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.523 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.51 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.536 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.4 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.12 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.33 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.519 ' HE3' ' CD1' ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.03 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.45 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.35 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.14 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.45 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.44 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.11 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.4 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.14 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.35 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.45 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.515 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.43 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.31 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.51 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.33 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.55 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.14 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.519 ' CD1' ' HE3' ' A' ' 89' ' ' MET . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.15 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.3 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.4 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.2 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.58 ' CZ ' ' HE1' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.42 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.51 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.05 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.24 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.31 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.14 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.24 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.22 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.11 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.34 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.572 ' CD2' ' HG3' ' A' ' 107' ' ' ARG . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.24 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.24 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.33 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' CG2' ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.34 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.572 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.34 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.35 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.21 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.532 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.13 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.34 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.13 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.532 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.34 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.44 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.14 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.12 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.44 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.15 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.52 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.23 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.42 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 26.6 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.43 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.21 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.33 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.22 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.632 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.43 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.02 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.12 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.13 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.4 110.151 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 155' ' ' ASN . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.33 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.34 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.14 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.516 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.44 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.33 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.453 ' CD2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.4 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 170' ' ' TYR . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.54 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.2 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.33 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.53 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.01 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.42 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.44 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.23 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.42 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.464 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.35 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.57 ' CE1' HG13 ' A' ' 159' ' ' VAL . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.2 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.629 ' CG ' ' CD1' ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.33 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.04 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.489 HD13 ' CD2' ' A' ' 9' ' ' TYR . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.13 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.454 ' O ' HD11 ' A' ' 178' ' ' LEU . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.22 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.11 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.34 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.575 HD23 ' CG ' ' A' ' 9' ' ' TYR . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.12 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.22 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.4 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.13 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.05 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.159 0.504 . . . . 73.24 109.755 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.31 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.447 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.34 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.41 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.51 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.574 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.33 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.01 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.31 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.24 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.02 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.485 ' CG2' ' C ' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.55 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.05 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.34 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.11 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.34 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.468 ' CG2' ' CD ' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.23 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 54' ' ' GLN . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.13 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.495 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.13 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.51 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.45 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.32 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.447 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.13 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.686 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.24 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.32 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.41 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.12 110.358 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.33 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.23 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.23 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.24 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 149' ' ' PRO . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.51 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.11 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.43 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.567 HD13 ' CD1' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.02 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.525 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.13 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.33 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.1 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.575 HD13 ' CG ' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.23 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.601 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.34 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.41 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 43.1 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.04 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 53' ' ' PHE . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.42 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' HD22 ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.22 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.11 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.01 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.11 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.11 109.578 174.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.12 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.24 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.21 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.33 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.14 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.511 HG11 ' CD1' ' A' ' 140' ' ' PHE . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.32 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.24 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.33 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.12 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.31 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.13 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.2 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 68' ' ' ALA . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.21 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.02 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.31 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB3' ' CE ' ' A' ' 65' ' ' MET . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.42 110.383 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.449 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.04 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.43 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.13 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.33 110.329 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 76' ' ' MET . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.21 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.525 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.31 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.62 ' CG2' ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.21 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.538 ' HE1' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.04 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.32 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.32 109.763 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.3 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.12 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.32 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.11 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.02 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.565 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.51 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.4 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.12 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG1' ' OE2' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.33 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.517 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.03 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.45 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.35 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.14 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.45 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.516 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 11.0 t-160 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.44 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.11 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.4 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.14 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.35 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.444 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.45 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.465 ' HB3' HD12 ' A' ' 109' ' ' ILE . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.43 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.31 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.51 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.33 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.55 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.14 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.15 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.3 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.4 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.2 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.573 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.42 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.51 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.05 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.524 ' OE2' ' CG1' ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.24 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.31 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.14 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.24 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.22 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.11 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.34 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.24 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.24 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.33 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.34 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.5 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.34 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.35 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.21 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.529 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.13 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.34 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.13 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.577 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.34 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 71' ' ' LYS . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.44 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.14 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.12 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.44 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.15 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.52 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.23 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.42 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.43 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.485 ' C ' ' CG2' ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.21 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.522 ' CB ' HD12 ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.33 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.22 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 140' ' ' PHE . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.43 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.2 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.02 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.593 ' CB ' ' CD2' ' A' ' 36' ' ' PHE . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.12 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.13 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.4 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.51 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.33 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.34 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.51 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.14 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.522 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.44 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.33 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.4 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.559 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.54 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.2 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.33 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.53 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.01 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.42 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.44 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.23 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.42 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.35 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.559 ' CE1' ' CG1' ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.2 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 167' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.33 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.04 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.13 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.22 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.11 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.499 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.34 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.574 HD21 ' CG ' ' A' ' 9' ' ' TYR . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.12 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.22 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.4 110.179 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.13 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.457 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.05 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.238 0.542 . . . . 73.24 110.286 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.31 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.34 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.41 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.458 ' HB3' HD21 ' A' ' 173' ' ' LEU . 5.0 m-70 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.51 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.576 ' CG ' HD23 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.33 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.01 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.31 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.24 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.02 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.55 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.05 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.34 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.11 109.513 174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.525 ' CB ' HD23 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.34 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.23 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.13 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.13 110.23 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.527 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.51 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CB ' HG12 ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.45 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.32 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.531 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.13 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.24 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 69' ' ' MET . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.32 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.41 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.12 109.999 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.33 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.23 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.429 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.23 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.24 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.51 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.11 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.43 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.02 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.13 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.33 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.5 ' NE2' HD12 ' A' ' 167' ' ' LEU . 15.8 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.1 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.23 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.34 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.41 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.04 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.42 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.22 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.11 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.01 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.11 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.11 109.641 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.12 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.24 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.561 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.21 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.33 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.14 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.517 HG13 ' CG1' ' A' ' 148' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.32 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.24 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.61 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.33 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.61 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.12 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.31 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.13 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.2 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.524 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.21 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.02 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.31 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.42 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.04 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.576 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.43 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG2' ' CG2' ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.13 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.33 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.21 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.31 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.21 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.511 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.04 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.32 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.516 ' CB ' ' HB2' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.32 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.3 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.12 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.32 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.11 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.02 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.565 ' HE3' ' CD2' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.51 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 73' ' ' TYR . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.4 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.532 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.12 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 84' ' ' LYS . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.33 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.515 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.03 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.45 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.35 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.541 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.14 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.496 ' CG1' ' O ' ' A' ' 89' ' ' MET . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.45 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.44 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.11 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.4 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.14 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.35 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.45 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.524 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.43 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.46 ' HG2' ' OE1' ' A' ' 105' ' ' GLU . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.31 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.51 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.33 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.55 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.46 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.14 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.468 ' CD1' ' HE3' ' A' ' 89' ' ' MET . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.15 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.3 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.6 mm100 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.4 110.615 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.2 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.42 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.51 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.05 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.24 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.31 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.14 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.527 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.24 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.569 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.22 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.11 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.34 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 75' ' ' THR . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.24 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.24 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.33 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.34 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.34 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.35 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.21 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.514 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.13 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.34 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.13 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE1' HD13 ' A' ' 77' ' ' ILE . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.34 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.586 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.44 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.517 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.14 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.517 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.12 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.44 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.15 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.52 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.484 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 9.6 mt-30 -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.23 110.611 -175.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.42 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.43 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.21 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.33 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.22 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.43 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.2 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.537 HG12 ' CB ' ' A' ' 25' ' ' PHE . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.02 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.536 ' CB ' ' CD2' ' A' ' 36' ' ' PHE . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.12 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.13 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.4 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.33 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.529 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.34 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.14 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.52 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.44 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.577 ' CE2' HG21 ' A' ' 11' ' ' VAL . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.33 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.522 ' CD2' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.4 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.54 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.2 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.33 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.53 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.01 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.42 109.715 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.44 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.23 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.5 HD12 ' NE2' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.42 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.35 110.587 177.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.407 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.2 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.581 ' CD1' HD13 ' A' ' 43' ' ' LEU . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.33 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.04 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 9' ' ' TYR . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.13 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.22 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.7 m120 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.11 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.34 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 9' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.12 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.529 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.22 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.4 110.677 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.13 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.05 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' N ' ' NE2' ' A' ' 8' ' ' HIS . 32.6 tttt . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.988 0.423 . . . . 73.24 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.31 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.34 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.41 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.655 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.51 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CD2' ' NE2' ' A' ' 8' ' ' HIS . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.33 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.01 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.31 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.24 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.02 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.55 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.05 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.34 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.11 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.427 ' CB ' HD21 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.34 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.23 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.13 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.13 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.498 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.51 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.45 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.32 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.13 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.24 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 99' ' ' PRO . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.32 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.41 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.12 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.33 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.23 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 94' ' ' HIS . 15.6 t-20 -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.23 110.365 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.24 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.51 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.11 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.43 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.46 ' CG2' HD22 ' A' ' 167' ' ' LEU . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.02 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.13 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.33 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 16.4 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.1 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.23 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.609 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.34 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.41 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.4 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.04 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.42 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.22 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.11 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.01 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 178' ' ' LEU . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.11 110.435 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.11 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.12 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.24 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.21 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.33 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.14 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.32 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.24 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.33 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.12 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.31 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.13 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.2 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.21 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.02 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.443 ' NE2' HG11 ' A' ' 133' ' ' VAL . 64.0 tp60 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.31 110.259 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.42 110.236 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.45 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.04 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.569 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.43 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.13 110.103 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.33 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.21 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.53 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.31 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 120' ' ' PHE . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.21 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.582 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.04 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.32 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.32 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.528 ' CB ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.3 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.12 109.944 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.32 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 76' ' ' MET . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.11 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.02 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.558 ' HE3' ' CD2' ' A' ' 110' ' ' PHE . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.51 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.574 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.4 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.12 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 ' CG1' ' OE2' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.33 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.482 ' HE3' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.03 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.45 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.35 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.14 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.45 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 34' ' ' ASN . 51.7 t-80 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.44 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.11 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.4 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.14 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.35 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.45 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.43 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.31 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.51 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.33 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.55 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.14 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 100' ' ' PRO . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.15 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.3 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.8 mm100 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.4 110.612 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.2 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.582 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.42 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.51 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.05 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.527 ' OE2' ' CG1' ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.24 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.31 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.14 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.48 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.24 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.22 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.11 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.34 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 75' ' ' THR . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.24 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.24 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.33 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.34 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.34 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.35 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.21 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.525 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.13 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.34 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.13 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.53 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.34 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.44 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.14 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.12 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.44 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.15 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.52 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.514 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.23 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.42 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.43 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.21 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.521 ' CB ' HD12 ' A' ' 145' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.33 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.22 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.631 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.43 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.02 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.12 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.524 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.13 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.4 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 25' ' ' PHE . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.33 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.493 ' CG2' HD12 ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.34 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.14 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.532 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.44 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.583 ' CE2' HG21 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.33 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.4 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 170' ' ' TYR . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.54 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.2 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.33 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.53 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.01 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.42 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.44 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.23 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.46 HD22 ' CG2' ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.42 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.526 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.35 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.56 ' CE1' HG12 ' A' ' 159' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.2 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.602 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.33 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.04 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.595 ' CD1' ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.13 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.22 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.455 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.11 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.34 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.12 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.492 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.22 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.4 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.13 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.05 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.465 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 53.5 mttt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.212 0.529 . . . . 73.24 110.586 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.574 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.31 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.34 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.41 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 13.1 m-70 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.51 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.574 ' CE2' ' HG2' ' A' ' 5' ' ' GLU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.33 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.01 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.31 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.24 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.02 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.55 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.05 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.34 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.11 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.515 ' CB ' HD23 ' A' ' 178' ' ' LEU . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.34 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 21' ' ' VAL . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.23 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLN . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.13 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.13 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.525 ' OE2' ' CG1' ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.51 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.45 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.32 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.527 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.13 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.684 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.24 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.32 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.41 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.12 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.33 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.23 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.23 110.369 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.24 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.51 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.11 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.43 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.02 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.13 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.33 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.1 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.23 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 41' ' ' ALA . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.34 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.41 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.04 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.42 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.22 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.11 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.01 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.11 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' SER . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.11 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.12 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.24 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.516 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.21 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.33 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.674 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.14 109.64 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 140' ' ' PHE . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.32 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.453 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.24 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.33 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.12 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.31 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.13 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.2 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.21 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.02 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.31 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.42 110.226 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.04 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.43 110.214 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.519 ' CA ' HG22 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.13 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.33 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 86' ' ' VAL . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.21 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.31 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.638 ' CG2' ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.21 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.58 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.04 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.32 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.32 109.758 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.3 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.12 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.32 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.11 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.02 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.521 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.51 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.577 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.4 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.12 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.33 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.515 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.03 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.45 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.35 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.14 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 99' ' ' PRO . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.45 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.44 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.11 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.4 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.14 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.35 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.521 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.45 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.516 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.43 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.31 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.51 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.33 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.55 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.14 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.15 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.3 110.32 176.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.2 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.42 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.51 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.05 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.521 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.24 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.31 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.521 HG21 ' CE ' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.14 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.24 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.576 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.22 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.11 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.34 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.24 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.24 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.33 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.503 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.34 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.34 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.35 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.21 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.13 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.34 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.13 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.575 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.34 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.519 HG22 ' CA ' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.44 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.14 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.12 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.674 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.44 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.15 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.52 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 6.8 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.23 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.42 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.43 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.21 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.33 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.22 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.43 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.2 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.02 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.12 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.13 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG1' ' OE2' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.4 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.33 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.34 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.14 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.512 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.44 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.578 ' CE1' HG23 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.33 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.4 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.54 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.2 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.33 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.53 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.01 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.42 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.44 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.23 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 39' ' ' ILE . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.42 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.35 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.409 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.2 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.33 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.04 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.13 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 178' ' ' LEU . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.22 109.861 -178.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . 0.451 ' O ' HG21 ' A' ' 179' ' ' THR . 1.7 m-80 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.11 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.34 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 9' ' ' TYR . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.12 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.22 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.4 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.13 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.05 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 9.5 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.2 0.524 . . . . 73.24 110.251 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.31 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.34 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.41 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 25.1 m-70 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.51 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.33 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.01 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.31 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.24 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.02 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.55 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.05 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.34 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.11 109.788 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' PRO . . . . . 0.523 ' CB ' HD21 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.34 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.23 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.13 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.13 110.188 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.51 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' HG12 ' A' ' 148' ' ' VAL . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.45 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.32 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.13 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.686 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.24 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.32 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.41 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.12 110.347 -176.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.33 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.23 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 90' ' ' PHE . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.23 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.24 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CB ' ' HG2' ' A' ' 149' ' ' PRO . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.51 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.11 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.43 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.02 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.483 ' CG2' ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.13 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.33 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.492 ' NE2' HD23 ' A' ' 167' ' ' LEU . 19.0 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.1 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.23 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.34 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.41 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.04 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HG ' ' HG ' ' A' ' 43' ' ' LEU . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.42 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.22 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.11 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.01 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.11 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.11 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.12 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.24 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.21 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.585 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.33 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' HIS . . . . . 0.691 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 3.0 p-80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.14 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.32 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.24 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.612 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.33 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' MET . . . . . 0.612 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.12 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.31 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.13 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.2 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.21 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.02 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.31 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.42 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.04 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.43 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.13 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.33 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.21 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.31 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.21 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' MET . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.04 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 82' ' ' GLU . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.32 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.32 109.55 172.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.3 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.12 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.32 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.11 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.02 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' MET . . . . . 0.567 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.51 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.4 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.12 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.33 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' MET . . . . . 0.624 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.03 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.45 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.35 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.14 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 89' ' ' MET . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.45 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.44 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.11 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.4 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.14 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.35 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.45 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.43 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.31 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.51 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.33 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.55 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.14 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.15 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.3 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.4 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.2 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.42 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.51 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.05 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.527 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.24 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.31 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.14 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.24 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.586 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.22 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.11 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.34 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.24 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.24 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.33 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.34 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' TYR . . . . . 0.568 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.34 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.35 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.21 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.13 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.34 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.13 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.51 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.34 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.44 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.14 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.12 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' PHE . . . . . 0.691 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.44 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.15 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.52 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 136' ' ' PHE . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.23 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.42 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.43 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 143' ' ' SER . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.21 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.516 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.33 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.22 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 140' ' ' PHE . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.43 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 147' ' ' GLY . . . . . 0.563 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.2 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.576 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.02 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.12 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.13 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 151' ' ' VAL . . . . . 0.517 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.4 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.33 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 153' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 154' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.34 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.14 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.522 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.44 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 157' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.33 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 158' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 151' ' ' VAL . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.4 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.498 HG11 ' CE1' ' A' ' 170' ' ' TYR . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.54 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 160' ' ' GLN . . . . . 0.474 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.2 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.33 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.53 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.01 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.42 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.44 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.23 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 167' ' ' LEU . . . . . 0.492 HD23 ' NE2' ' A' ' 42' ' ' GLN . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.42 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 169' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.35 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 170' ' ' TYR . . . . . 0.517 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.2 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.33 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 172' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.04 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 173' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.13 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.22 109.847 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.11 110.802 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.34 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.577 HD21 ' CG ' ' A' ' 9' ' ' TYR . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.12 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 178' ' ' LEU . . . . . 0.523 HD21 ' CB ' ' A' ' 20' ' ' PRO . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.22 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.4 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.13 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.463 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.205 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.258 0.551 . . . . 71.14 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.575 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.0 -32.56 69.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 70.15 110.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 58.7 m-85 -100.68 132.81 45.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.015 . . . . 73.02 110.684 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm -137.97 152.05 48.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.479 -0.763 . . . . 73.24 110.092 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.31 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.34 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.41 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.575 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 26.5 m-70 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.51 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.588 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.33 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.01 109.468 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.31 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 143' ' ' SER . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.24 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.472 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.02 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.55 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.515 ' CB ' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 19' ' ' SER . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.05 110.397 -179.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.34 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.11 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.464 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.34 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.23 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.13 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.13 110.185 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.51 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.45 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.32 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.13 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.691 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.32 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.41 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.465 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.12 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.33 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.23 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.23 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.24 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' CD2' ' HG2' ' A' ' 149' ' ' PRO . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.51 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.11 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.43 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.47 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.02 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.523 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.13 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.33 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.471 ' NE2' HD13 ' A' ' 167' ' ' LEU . 19.0 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.1 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.571 HD11 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.23 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.635 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.34 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.41 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.502 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.04 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' N ' ' O ' ' A' ' 43' ' ' LEU . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.42 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.403 ' HG2' ' HB3' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.22 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.11 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.01 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.441 ' HB1' HD23 ' A' ' 178' ' ' LEU . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.11 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.11 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.12 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.24 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.46 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.21 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.33 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.14 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.58 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.32 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.24 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.33 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.12 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.31 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.13 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.2 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASN . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.21 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.02 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.31 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.42 110.337 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.459 ' HE1' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.04 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.457 ' HB2' HG11 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.43 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.51 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.13 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.33 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.452 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.21 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' CB ' ' HE2' ' A' ' 132' ' ' MET . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.31 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.563 HG22 ' CE1' ' A' ' 120' ' ' PHE . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.21 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.523 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.04 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.482 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.32 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.517 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.32 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.521 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.3 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.12 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.523 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.32 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.543 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.11 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.452 ' O ' HG22 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.02 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.521 ' HG3' ' CD1' ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.51 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.4 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.12 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' MET . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.33 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.03 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.45 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.35 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.548 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.14 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.45 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.44 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.491 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.11 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.548 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.4 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.14 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.35 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.433 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.45 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.45 ' HB2' ' HE1' ' A' ' 65' ' ' MET . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.43 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.31 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.51 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.33 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.55 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.14 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.524 ' CD1' ' HE1' ' A' ' 89' ' ' MET . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.15 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.3 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.4 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 105' ' ' GLU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.2 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.51 ' CD2' ' HE3' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.42 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.51 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.05 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.456 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.24 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.31 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.528 HG23 ' CE ' ' A' ' 119' ' ' LYS . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.14 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.24 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.578 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.22 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.11 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.528 ' CE ' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.34 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.563 ' CE1' HG22 ' A' ' 75' ' ' THR . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.24 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.24 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.33 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.52 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.34 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.34 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.35 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.21 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.513 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.13 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.34 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.13 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.34 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.51 HG23 ' N ' ' A' ' 71' ' ' LYS . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.44 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.14 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 132' ' ' MET . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.12 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.44 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.15 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.52 110.146 176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' NE2' ' CD1' ' A' ' 136' ' ' PHE . 52.3 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.23 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.42 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.43 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.21 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.33 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.22 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.627 ' CB ' ' CE2' ' A' ' 140' ' ' PHE . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.43 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.2 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.02 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.514 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.12 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.447 ' HB3' HD23 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.13 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.465 HG22 HD12 ' A' ' 40' ' ' ILE . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.4 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.558 HG21 ' CE1' ' A' ' 25' ' ' PHE . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.33 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.491 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.34 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.464 ' HA ' HG11 ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.14 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.515 ' HD2' ' CB ' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.44 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.575 ' CE1' ' HB3' ' A' ' 180' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.33 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.524 HD23 ' CD2' ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.4 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.516 HG12 ' CD2' ' A' ' 173' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.54 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.517 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 99.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.2 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.33 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.53 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.01 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.577 ' CB ' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.42 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.44 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.23 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.471 HD13 ' NE2' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.42 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.35 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.577 ' N ' ' CB ' ' A' ' 164' ' ' ALA . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.2 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.575 ' CE2' ' OD1' ' A' ' 175' ' ' ASN . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.33 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.04 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.516 ' CD2' HG12 ' A' ' 159' ' ' VAL . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.13 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.22 109.712 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.575 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.11 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.34 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.577 HD21 ' CG ' ' A' ' 9' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.12 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.513 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.22 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.4 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.575 ' HB3' ' CE1' ' A' ' 157' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.13 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.425 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.05 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 71.14 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 55.5 mt-30 -58.95 -34.27 71.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 70.15 110.342 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -129.12 162.5 27.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.955 . . . . 73.02 110.449 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -170.99 149.99 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 73.24 109.76 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.31 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.34 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.41 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.51 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.33 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.01 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.568 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.31 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.408 ' HB3' HG21 ' A' ' 14' ' ' THR . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.24 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.02 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.519 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.55 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.518 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.05 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.463 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.34 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.11 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.34 110.051 -178.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . . . . . . . . . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.23 109.922 172.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.13 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.457 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.13 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.523 ' OE2' ' CG2' ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.51 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.645 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.45 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.518 ' HA ' ' CG2' ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.32 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.13 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.574 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.24 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.578 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.32 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 34' ' ' ASN . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.41 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.12 110.499 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.457 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.33 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.23 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.23 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.24 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.488 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.51 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.11 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.43 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.459 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.02 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.488 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.13 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.33 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.517 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 21.9 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.1 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 HD13 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.23 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.34 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.41 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.04 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.49 ' N ' ' O ' ' A' ' 43' ' ' LEU . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.42 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.22 110.102 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.11 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.01 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.44 ' HB1' HD22 ' A' ' 178' ' ' LEU . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.11 110.577 -177.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.11 109.633 174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.12 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.4 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.24 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.514 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.21 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.52 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 3.1 t-20 -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.33 109.802 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.14 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.32 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.24 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.57 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.33 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.12 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.578 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.31 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.13 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.46 ' HG2' ' O ' ' A' ' 65' ' ' MET . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.21 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.02 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.31 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.42 110.211 179.047 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.483 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.04 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.515 ' OG ' ' CG1' ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.43 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.47 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.13 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.462 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.33 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.466 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.21 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.31 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.21 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.524 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.04 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.472 ' HA ' ' OE2' ' A' ' 82' ' ' GLU . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.32 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.454 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.32 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.527 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.3 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.12 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.32 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.11 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.469 ' O ' HG21 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.02 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.57 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.51 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.532 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.4 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.529 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.12 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.478 ' HB ' ' O ' ' A' ' 85' ' ' MET . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.33 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.03 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.574 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.45 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.8 t30 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.35 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.527 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.14 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.569 HD11 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.45 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.44 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.517 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.11 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.4 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.14 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.5 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.35 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.45 110.234 -179.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.464 ' HB3' HD12 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.43 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.31 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.51 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.33 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.55 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.14 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.53 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.15 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.3 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.4 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.53 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.2 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.42 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.51 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.05 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.462 ' HG3' ' SD ' ' A' ' 85' ' ' MET . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.24 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.31 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.14 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.475 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.24 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.22 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.11 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.34 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.561 ' CE1' HG22 ' A' ' 75' ' ' THR . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.24 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.24 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.33 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB1' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.34 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.445 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.34 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.35 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.21 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.13 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.34 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.465 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.13 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.577 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.34 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.515 ' CG1' ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.44 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.14 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 132' ' ' MET . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.12 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.44 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.15 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.52 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.23 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.42 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.43 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.519 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.21 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.534 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.33 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.22 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.534 ' CD1' ' OG ' ' A' ' 143' ' ' SER . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.43 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.2 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.02 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.12 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.528 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.13 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.4 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.645 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.33 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.526 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.514 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.34 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' HG13 ' A' ' 152' ' ' VAL . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.14 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.518 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.44 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.33 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.457 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.4 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.519 HG12 ' CE1' ' A' ' 170' ' ' TYR . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.54 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.477 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 51.8 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.2 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.33 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.53 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.01 110.479 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.486 ' HB3' ' CB ' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.42 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.44 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.23 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.517 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.42 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.486 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.35 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.519 ' CE1' HG12 ' A' ' 159' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.2 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.633 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.33 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.04 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.493 HD11 ' CD2' ' A' ' 9' ' ' TYR . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.13 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.22 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.573 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.11 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.34 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 HD23 ' CG ' ' A' ' 9' ' ' TYR . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.12 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.526 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.22 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.454 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.4 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.13 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.463 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.05 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.247 0.546 . . . . 71.14 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.518 ' NE2' ' OE1' ' A' ' 169' ' ' GLU . 58.6 tt0 -56.76 -34.52 67.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 70.15 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 38.7 p90 -122.57 159.84 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 73.02 110.316 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp -172.2 162.01 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 73.24 109.945 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.31 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.34 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.41 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 10.8 m-70 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.51 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.33 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.509 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.01 109.536 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.567 HG23 ' CE2' ' A' ' 157' ' ' TYR . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.31 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 HD12 ' O ' ' A' ' 143' ' ' SER . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.24 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.02 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.55 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.525 ' HB1' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.05 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.454 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.34 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.443 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.11 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.443 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.34 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.512 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.23 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.13 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.13 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.466 ' OE1' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.51 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.536 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.45 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.32 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.13 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.24 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.32 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.41 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.12 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.33 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.495 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.23 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.508 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 28.8 t-20 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.23 110.367 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.24 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.506 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.51 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.517 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.11 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.517 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.43 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.461 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.02 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.13 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.33 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 20.7 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.1 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.574 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.23 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.63 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.34 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.41 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.1 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.04 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 43' ' ' LEU . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.42 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.22 110.069 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.11 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.457 ' HB2' HD22 ' A' ' 178' ' ' LEU . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.11 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.11 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.12 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.24 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.21 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.536 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.33 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.613 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 4.0 p-80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.14 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.442 HG21 HG21 ' A' ' 148' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.32 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.467 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.24 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.33 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.12 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.31 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.13 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.2 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.527 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.21 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.02 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.31 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.42 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.564 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.04 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.566 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.43 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' CG ' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.13 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.466 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.33 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.21 110.019 175.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.31 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.567 HG22 ' CE1' ' A' ' 120' ' ' PHE . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.21 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.508 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.04 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.32 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.528 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.32 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CB ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.3 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.12 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.524 HG13 ' CB ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.32 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.529 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.11 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' NZ ' ' O ' ' A' ' 113' ' ' GLU . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.02 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.51 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.534 ' HB ' ' CD ' ' A' ' 87' ' ' PRO . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.4 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.12 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 85' ' ' MET . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.33 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.03 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.45 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.35 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.14 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.528 HD13 ' CD1' ' A' ' 29' ' ' TYR . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.45 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.44 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.11 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.4 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.14 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.35 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.45 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.528 ' CG ' HD11 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.43 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.31 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.51 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.33 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.55 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.14 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 HD11 ' CG ' ' A' ' 100' ' ' PRO . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.15 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.3 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.4 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.2 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.42 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.51 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.05 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.486 ' O ' ' NZ ' ' A' ' 84' ' ' LYS . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.24 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.31 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.14 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.48 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.24 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.22 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.11 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.34 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.687 ' CE1' ' CG ' ' A' ' 110' ' ' PHE . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.24 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.24 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.33 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 78' ' ' ALA . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.34 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.34 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.35 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.21 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.13 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.34 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.13 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.34 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.579 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.44 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.14 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.12 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.44 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.15 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.52 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.464 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.23 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.585 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.42 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.43 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.21 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.516 ' CB ' HD12 ' A' ' 145' ' ' LEU . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.33 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.22 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.585 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.43 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.535 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.2 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.578 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.02 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.539 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.12 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.13 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.528 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.4 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.464 HG22 ' CE1' ' A' ' 25' ' ' PHE . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.33 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.487 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.34 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.462 ' HA ' HG11 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.14 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.525 ' CD ' ' HB1' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.44 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.33 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.4 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.53 HG12 ' CE1' ' A' ' 170' ' ' TYR . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.54 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.8 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.2 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.33 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.53 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.01 110.485 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.502 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.42 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.44 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.23 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.49 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.42 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.35 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.53 ' CE1' HG12 ' A' ' 159' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.2 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.33 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.04 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.524 HD11 ' CD1' ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.13 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.452 HG21 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.22 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.57 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.7 m120 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.11 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.34 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.529 HD22 ' CD2' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.12 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.516 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.22 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.4 110.314 -179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.13 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.05 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.247 0.546 . . . . 71.14 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.576 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.02 -33.59 70.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 70.15 110.291 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -127.19 161.15 29.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 73.02 110.405 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -163.51 146.25 9.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 73.24 109.931 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.578 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.31 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.41 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.576 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.51 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.33 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.01 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.31 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' CD1' ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.24 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.02 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.55 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.469 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.05 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.34 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.11 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' CB ' HD23 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.34 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.23 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.13 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.13 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.471 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.51 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.45 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.32 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.526 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.13 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.688 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.24 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.565 ' CE1' HD13 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.32 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.027 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.41 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.573 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.12 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.433 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.33 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.027 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.23 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 60.7 t-20 -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.23 110.611 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.475 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.24 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.573 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.51 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.5 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.11 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.43 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.44 ' HA ' ' HG3' ' A' ' 42' ' ' GLN . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.02 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.573 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.13 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.33 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.7 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.1 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.576 HD13 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.23 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.34 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.41 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.2 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.04 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.503 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.42 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.22 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.11 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.01 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.11 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.11 109.765 175.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.12 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.24 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.578 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.21 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.33 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.68 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.14 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 60' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.32 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.24 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.33 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.12 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.31 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.13 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.2 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.21 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.02 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.31 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.42 110.311 -179.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.04 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.465 ' HB3' HG12 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.43 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.514 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.13 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.33 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.578 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.21 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.31 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.573 HG21 ' CE1' ' A' ' 120' ' ' PHE . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.21 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.553 ' SD ' ' CZ ' ' A' ' 110' ' ' PHE . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.04 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.473 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.32 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.32 110.473 177.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.3 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.12 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.32 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.11 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.02 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.51 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG22 ' CE1' ' A' ' 73' ' ' TYR . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.4 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.12 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.509 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.33 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.522 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.03 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.45 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.35 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.14 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.565 HD13 ' CE1' ' A' ' 29' ' ' TYR . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.45 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 12.1 t-80 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.44 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.11 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.4 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.14 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.35 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.459 ' HB3' HD12 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.45 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.43 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.31 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.51 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.33 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.55 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.14 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.15 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.3 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.4 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.524 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.2 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.42 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.51 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.05 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.517 ' N ' ' OE1' ' A' ' 113' ' ' GLU . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.24 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.31 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.522 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.14 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.482 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.24 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.596 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.22 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.11 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.529 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.34 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CE1' HG21 ' A' ' 75' ' ' THR . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.24 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.24 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.33 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.493 ' CB ' HG22 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.34 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.34 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.35 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.21 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.13 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.483 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.34 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.13 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.34 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.44 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.14 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.468 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.12 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.44 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.15 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.52 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.508 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.23 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.42 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.462 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.43 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.21 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.33 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.22 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.639 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.43 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.2 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.02 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.12 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.13 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 158' ' ' LEU . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.4 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.33 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.526 ' CG2' HD11 ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.506 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.34 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.447 ' HA ' HG12 ' A' ' 152' ' ' VAL . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.14 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.469 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.44 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.572 ' CE2' HG22 ' A' ' 11' ' ' VAL . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.33 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.5 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.4 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.566 HG12 ' CE1' ' A' ' 170' ' ' TYR . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.54 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.459 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.2 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.33 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.53 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.01 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.508 ' HB1' ' CB ' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.42 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.44 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.23 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.425 HD22 ' CG2' ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.42 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.508 ' CB ' ' HB1' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.35 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.566 ' CE1' HG12 ' A' ' 159' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.2 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.62 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.33 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.04 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.586 ' CD1' ' CD1' ' A' ' 9' ' ' TYR . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.13 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.22 109.89 -178.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.11 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.34 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.527 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.12 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.525 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.22 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.4 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.563 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.13 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.05 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' O ' ' CE ' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.245 0.545 . . . . 71.14 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.3 tt0 -56.15 -36.87 68.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 70.15 110.295 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.582 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 92.8 m-85 -103.18 128.7 50.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 73.02 110.291 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt -140.71 153.93 46.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.419 -0.8 . . . . 73.24 110.393 -177.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.31 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.41 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.51 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.33 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.01 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.58 HG21 ' CD1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.31 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.459 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.24 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.02 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.55 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.514 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.05 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.34 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.44 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.11 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.517 ' CB ' HD22 ' A' ' 178' ' ' LEU . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.34 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.525 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.23 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.13 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.13 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.51 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CB ' HG11 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.45 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.32 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.532 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.13 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.24 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.572 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.32 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.532 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.41 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.12 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.33 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.532 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.23 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.23 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.513 ' CG2' ' NE2' ' A' ' 94' ' ' HIS . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.24 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.572 ' CE2' HD13 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.51 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.527 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.11 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.43 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.515 ' CG2' HD23 ' A' ' 167' ' ' LEU . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.02 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.572 HD13 ' CE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.13 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.33 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.3 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.1 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.58 HD13 ' CE1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.23 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.529 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.34 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.41 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.5 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.04 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.42 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.408 ' HD2' HD21 ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.22 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.11 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.01 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.463 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.11 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.11 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.12 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.2 mm-40 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.24 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.21 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.33 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.14 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.559 HG13 ' CD1' ' A' ' 140' ' ' PHE . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.32 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.436 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.24 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.33 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.12 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.538 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.31 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.13 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.2 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.21 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.436 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.02 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.31 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.42 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.572 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.04 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.43 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.13 110.395 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.33 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.483 ' CE1' HG21 ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.21 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.31 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.57 HG23 ' CD1' ' A' ' 120' ' ' PHE . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.21 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.575 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.04 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.32 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.498 ' CB ' ' HB3' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.32 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.3 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.423 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.12 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.32 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.11 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.02 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.517 ' SD ' ' CD1' ' A' ' 115' ' ' ILE . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.51 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.548 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.4 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.548 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.12 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.526 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.33 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.493 ' CG ' ' HE1' ' A' ' 76' ' ' MET . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.03 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.45 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.35 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.537 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.14 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.5 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.45 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.44 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.11 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.4 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.14 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.35 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.464 ' HB3' HD11 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.45 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.52 ' CB ' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.43 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.31 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.51 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.33 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.55 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.416 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.14 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.15 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.3 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.4 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.2 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.575 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.42 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.591 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.51 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.05 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.24 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.31 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.14 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.494 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.24 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.591 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.22 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.11 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.34 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CD1' HG23 ' A' ' 75' ' ' THR . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.24 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.24 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.33 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.517 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.34 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.34 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.35 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.21 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.523 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.13 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.34 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.13 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.523 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.34 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.44 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.14 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.463 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.12 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.44 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.15 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.52 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.467 ' O ' ' HB2' ' A' ' 143' ' ' SER . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.23 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.609 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.42 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.461 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.43 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.21 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.528 ' CB ' HD11 ' A' ' 145' ' ' LEU . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.33 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.22 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.609 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.43 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.571 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.2 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.529 HG11 ' CB ' ' A' ' 25' ' ' PHE . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.02 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.516 ' CA ' ' SG ' ' A' ' 33' ' ' CYS . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.12 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.521 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.13 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.534 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.4 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.489 HG23 ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.33 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.481 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.483 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.34 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.14 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.514 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.44 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.58 ' CD1' HG21 ' A' ' 11' ' ' VAL . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.33 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.4 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.522 HG23 ' CD1' ' A' ' 177' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.54 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.457 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.2 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.33 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.53 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.01 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.42 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.44 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.23 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.515 HD23 ' CG2' ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.42 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.35 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.53 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.2 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.629 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.33 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.04 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.582 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.13 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.4 ' O ' HD11 ' A' ' 178' ' ' LEU . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.22 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.45 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.11 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.34 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.532 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.12 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.517 HD22 ' CB ' ' A' ' 20' ' ' PRO . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.22 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.466 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.4 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.13 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.442 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.05 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.42 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.268 0.556 . . . . 71.14 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 38.3 mt-30 -58.6 -35.13 71.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 70.15 110.444 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 92.1 m-85 -96.75 129.66 44.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 73.02 110.74 -172.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' HE3' ' O ' ' A' ' 1' ' ' ALA . 39.2 mttt -138.48 155.4 48.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -0.802 . . . . 73.24 109.954 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' HA ' ' CE2' ' A' ' 9' ' ' TYR . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.31 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.34 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.41 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 15.6 m-70 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.51 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 5' ' ' GLU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.33 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.01 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.31 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.24 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.02 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.55 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.478 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.05 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.34 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.11 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.524 ' CB ' HD23 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.34 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.23 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.13 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.13 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.51 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.45 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.425 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.32 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.13 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.684 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.24 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.574 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.32 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.483 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.41 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.542 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.12 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.33 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 30' ' ' CYS . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.23 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.23 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.476 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.24 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.499 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.51 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.518 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.11 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.43 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.464 ' HB ' ' O ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.02 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.524 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.13 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.33 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.51 ' NE2' HD11 ' A' ' 167' ' ' LEU . 22.9 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.1 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.571 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.23 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.34 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.41 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.04 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.57 HD13 ' CD1' ' A' ' 53' ' ' PHE . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.42 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.22 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.11 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.01 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.455 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.11 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.11 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.12 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.24 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.21 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.33 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.14 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.32 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.463 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.24 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.33 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.574 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.12 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.574 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.31 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.13 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.2 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.21 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.02 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.31 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.42 110.309 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.04 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.43 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.408 ' CG ' HG22 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.13 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.43 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.33 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.21 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.529 ' CB ' ' HE1' ' A' ' 132' ' ' MET . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.31 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.57 HG23 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.21 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.561 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.04 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.32 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.32 109.773 173.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.529 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.3 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.12 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.521 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.32 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.11 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.02 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.51 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.578 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.4 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.12 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.52 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.33 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.514 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.03 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.45 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.35 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.14 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.526 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.45 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.542 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 21.8 t-160 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.44 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.11 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.4 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.14 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.35 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.487 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.45 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.526 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.43 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.31 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.51 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.33 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.55 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.14 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.52 HD11 ' CG ' ' A' ' 100' ' ' PRO . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.15 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.3 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.4 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.513 HG23 ' NE ' ' A' ' 92' ' ' ARG . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.2 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.567 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.42 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.51 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.05 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.52 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.24 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.31 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.536 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.14 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.515 ' N ' HG23 ' A' ' 115' ' ' ILE . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.24 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.574 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.22 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.11 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.34 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG23 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.24 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.24 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.33 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.508 ' CB ' HG21 ' A' ' 75' ' ' THR . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.34 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.513 ' N ' HG21 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.34 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.35 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.21 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.523 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.13 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.34 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.13 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HE1' ' CB ' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.34 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.574 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.44 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.14 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.462 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.12 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.44 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.15 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.52 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.473 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.23 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.637 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.42 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.43 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.505 ' O ' ' CG2' ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.21 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.521 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.33 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.22 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.637 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.43 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.2 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.02 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.541 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.12 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.527 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.13 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.467 HG23 HD12 ' A' ' 40' ' ' ILE . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.4 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.491 HG23 ' CE1' ' A' ' 25' ' ' PHE . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.33 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.508 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.34 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.14 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.465 ' NH1' ' O ' ' A' ' 181' ' ' LYS . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.44 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.639 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.33 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.459 HD11 HG22 ' A' ' 152' ' ' VAL . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.4 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.54 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.2 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.33 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.53 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.01 110.412 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.472 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.42 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.44 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.23 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.51 HD11 ' NE2' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.42 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.35 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.636 ' CE1' ' CG1' ' A' ' 159' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.2 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.571 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.33 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.578 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.04 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.575 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.13 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.22 109.629 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.424 ' O ' HG22 ' A' ' 179' ' ' THR . 1.8 m-80 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.11 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.34 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.12 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.524 HD23 ' CB ' ' A' ' 20' ' ' PRO . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.22 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.45 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.4 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.13 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.05 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.248 0.546 . . . . 71.14 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 56.3 mt-30 -59.06 -33.11 70.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 70.15 110.375 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.8 p90 -125.94 159.71 31.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 73.02 110.561 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -170.24 150.78 3.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 73.24 109.656 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.568 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.31 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.34 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.41 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' NE2' ' CB ' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.51 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.572 ' CG ' HD23 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.33 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.513 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.01 109.516 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.569 HG23 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.31 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 143' ' ' SER . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.24 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.02 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.528 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.55 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.496 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.05 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.34 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.435 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.11 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.34 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.519 HG22 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.23 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.582 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.13 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.13 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.524 ' HG3' ' CG2' ' A' ' 40' ' ' ILE . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.51 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.45 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.32 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.47 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.13 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.24 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.32 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.047 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.41 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.57 ' HA ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.12 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.33 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.047 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.23 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.576 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.23 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.465 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.24 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.617 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.51 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.11 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.43 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.413 HD11 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.02 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.617 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.13 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.461 ' HB2' ' O ' ' A' ' 38' ' ' PRO . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.33 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.7 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.1 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.579 HD11 ' CE1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.23 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.517 ' NZ ' ' HE2' ' A' ' 55' ' ' LYS . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.34 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.41 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.466 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.04 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.629 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.42 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.452 ' HD2' HD21 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.22 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.11 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.01 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.11 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.11 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.12 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.575 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.24 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.517 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.21 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.33 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.14 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.479 HG13 ' CG1' ' A' ' 148' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.32 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.456 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.24 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.33 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.58 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.12 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.31 109.884 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.13 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.2 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.463 ' HE3' HD21 ' A' ' 106' ' ' LEU . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.21 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.406 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.02 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.31 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.42 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.04 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.43 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' HG23 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.13 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.33 110.109 -178.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.21 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' HB2' ' CG2' ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.31 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.574 HG23 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.21 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.522 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.04 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.32 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.32 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.3 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.12 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.32 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.534 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.11 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.516 ' HG3' ' N ' ' A' ' 85' ' ' MET . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.02 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.575 ' HE1' ' CD2' ' A' ' 110' ' ' PHE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.51 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG22 ' CE2' ' A' ' 73' ' ' TYR . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.4 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.12 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.483 ' HB ' ' O ' ' A' ' 85' ' ' MET . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.33 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.519 ' CB ' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.03 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.45 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.524 ' OD1' ' CG2' ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.35 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.529 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.14 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.542 HD12 ' CE1' ' A' ' 29' ' ' TYR . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.45 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.44 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.524 ' CG2' ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.11 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.529 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.4 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.14 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.35 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.445 ' HB3' HD11 ' A' ' 93' ' ' ILE . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.45 110.485 -177.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.467 ' HB3' HD12 ' A' ' 109' ' ' ILE . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.43 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.31 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.51 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.33 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.55 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.464 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.14 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.15 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.3 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.4 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.519 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.2 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.575 ' CD2' ' HE1' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.42 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.578 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.51 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.05 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.48 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.24 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.31 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CD1' ' HG3' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.14 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.24 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.578 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.22 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.11 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.52 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.34 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.574 ' CE1' HG23 ' A' ' 75' ' ' THR . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.24 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.24 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.33 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.522 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.34 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.34 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.35 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.21 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.404 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.53 ' CG2' ' HB2' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.13 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.34 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.504 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.13 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.522 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.34 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.589 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.44 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.504 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.14 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.466 ' N ' ' CG ' ' A' ' 134' ' ' ARG . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.12 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.44 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.15 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.52 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.457 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.23 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.42 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.43 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.528 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.21 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.33 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.22 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.575 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.43 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.2 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.55 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.02 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.55 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.12 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.531 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.13 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.458 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.4 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.546 HG22 ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.33 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.518 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.34 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.14 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.496 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.44 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.577 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.33 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.403 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.4 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.457 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.54 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.513 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 97.5 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.2 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.33 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.53 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.58 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.01 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.56 ' CB ' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.42 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.44 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.467 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.23 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.42 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.35 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.56 ' N ' ' CB ' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.2 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.579 ' CE1' HD11 ' A' ' 43' ' ' LEU . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.33 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.04 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.466 HD11 ' CD2' ' A' ' 9' ' ' TYR . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.13 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.22 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.561 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.11 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.34 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.572 HD23 ' CG ' ' A' ' 9' ' ' TYR . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.12 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.22 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.44 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.4 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.577 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.13 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.456 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.05 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.445 ' O ' ' HE2' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.549 . . . . 71.14 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 61.1 tt0 -56.54 -37.68 70.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 70.15 110.337 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' HA ' ' CG ' ' A' ' 8' ' ' HIS . 59.6 m-85 -106.05 132.1 52.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 73.02 110.225 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.445 ' HE2' ' O ' ' A' ' 1' ' ' ALA . 67.7 mttm -138.52 153.59 48.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 73.24 110.285 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.572 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.31 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.34 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.41 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 31.9 m-70 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.51 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.572 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.33 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.01 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.567 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.31 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.24 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.02 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.55 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.48 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.456 ' HB3' HG13 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.05 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.34 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.11 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' CB ' HD21 ' A' ' 178' ' ' LEU . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.34 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.456 HG13 ' HB3' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.23 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.13 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.13 110.057 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.526 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.51 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.544 ' CB ' HG12 ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.45 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.444 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.32 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.13 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.24 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.32 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.442 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.41 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.12 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.33 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.23 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.23 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.24 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' O ' ' HB ' ' A' ' 39' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.51 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.11 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.43 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.466 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.02 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.526 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.13 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.529 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.33 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 20.1 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.1 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.23 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.569 ' HD3' ' CE2' ' A' ' 53' ' ' PHE . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.34 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.41 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.4 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.04 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.523 ' N ' ' O ' ' A' ' 43' ' ' LEU . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.42 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.22 109.891 178.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.11 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.01 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.464 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.11 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.11 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.12 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.24 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.21 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.33 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.14 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.32 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.428 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.24 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.33 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.12 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.31 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.13 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.2 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.465 ' HE3' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.21 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.428 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.02 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.31 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.42 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.04 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.43 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HD3' ' CE1' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.13 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.476 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.33 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.21 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.31 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.522 HG23 ' CB ' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.21 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.52 ' CE ' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.04 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.48 HG12 ' HG2' ' A' ' 82' ' ' GLU . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.32 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.32 109.524 172.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.3 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.12 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.522 ' CG2' ' HB3' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.32 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.11 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.02 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.564 ' HE1' ' CD1' ' A' ' 110' ' ' PHE . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.51 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.4 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.12 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.525 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.33 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.494 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.03 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.45 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.492 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.35 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.538 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.14 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.573 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.45 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.44 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.504 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.11 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.538 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.4 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.14 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.35 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.461 ' HB3' HD11 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.45 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.524 ' CB ' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.43 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.31 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.51 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.33 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.55 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.461 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.14 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.529 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.15 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.3 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.4 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.529 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.2 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.42 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.51 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.05 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.525 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.24 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.31 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.14 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.24 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.593 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.22 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.11 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.34 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.24 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.24 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.33 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.522 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.34 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.576 ' CE1' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.34 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.35 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.21 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.534 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.13 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.34 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.13 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.534 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.34 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.44 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.14 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.12 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.44 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.15 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.52 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.511 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.23 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.569 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.42 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.427 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.43 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.21 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.528 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.33 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.22 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.569 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.43 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.542 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.2 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.544 HG12 ' CB ' ' A' ' 25' ' ' PHE . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.02 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.12 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.13 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.514 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.4 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.485 HG23 ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.33 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.476 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.48 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.2 m-80 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.34 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.14 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.463 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.44 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.33 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.4 108.989 178.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.505 HG23 ' CD1' ' A' ' 177' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.54 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.461 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.2 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 164' ' ' ALA . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.33 109.757 177.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.53 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.01 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.463 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.42 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.44 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.23 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.464 ' CD1' ' NE2' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.42 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.463 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.35 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.514 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.2 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.33 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.572 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.04 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.515 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.13 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.407 HG22 HD23 ' A' ' 43' ' ' LEU . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.22 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.11 110.736 179.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.57 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.34 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.534 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.12 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.502 HD21 ' CB ' ' A' ' 20' ' ' PRO . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.22 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.4 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.13 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.05 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.281 0.562 . . . . 71.14 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.547 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 58.0 tt0 -56.67 -36.19 69.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 70.15 110.348 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.625 ' CD1' ' ND1' ' A' ' 8' ' ' HIS . 23.2 m-85 -103.97 128.08 51.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 73.02 110.317 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp -164.39 160.14 20.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 73.24 109.929 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.31 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.34 109.211 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.41 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' CD1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.51 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.33 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.01 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.31 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.24 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.02 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.55 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.05 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.34 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.11 109.626 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.517 ' CB ' HD23 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.34 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.41 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.23 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.13 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.13 110.031 -178.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.493 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.51 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CE1' HG21 ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.45 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.32 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.535 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.13 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.683 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.24 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.32 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.41 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.448 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.12 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.33 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.23 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.466 ' OD1' ' O ' ' A' ' 27' ' ' SER . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.23 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.24 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.567 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.51 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.11 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' CD ' ' HB3' ' A' ' 37' ' ' GLU . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.43 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.499 ' CG2' HD22 ' A' ' 167' ' ' LEU . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.02 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.505 HD12 ' CG2' ' A' ' 151' ' ' VAL . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.13 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.33 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 14.7 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.1 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.574 HD13 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.23 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.577 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.34 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.41 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 52.1 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.04 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.486 ' N ' ' O ' ' A' ' 43' ' ' LEU . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.42 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.449 ' HD2' HD21 ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.22 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.11 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.01 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.456 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.11 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.11 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.577 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.12 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.24 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.21 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.33 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.14 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.527 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.32 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.435 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.24 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.33 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.12 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.31 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.13 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.21 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.465 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.02 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.31 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.42 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.516 ' CE ' ' HE3' ' A' ' 89' ' ' MET . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.04 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.571 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.43 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.13 110.218 176.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.431 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.33 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.21 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.31 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.575 HG23 ' CE1' ' A' ' 120' ' ' PHE . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.21 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.499 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.04 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.515 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.32 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.528 ' CB ' ' HB2' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.32 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.3 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.12 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.32 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.11 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.472 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.02 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.571 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.51 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.4 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.526 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.12 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.33 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.03 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.45 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.502 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.35 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.557 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.14 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.472 ' CD1' ' HB3' ' A' ' 99' ' ' PRO . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.45 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.448 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 38.1 t-80 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.44 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.11 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.557 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.4 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.14 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.35 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.472 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.45 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.495 ' CB ' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.43 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.31 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.51 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.33 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.55 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.452 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.14 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.522 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.15 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.3 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.4 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.522 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.2 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.42 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.51 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.05 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.469 ' CD ' ' CG2' ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.24 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.31 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.14 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.476 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.24 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.598 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.22 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.11 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.531 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.34 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.575 ' CE1' HG23 ' A' ' 75' ' ' THR . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.24 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.24 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.33 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.528 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.34 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.34 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.35 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.21 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.427 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.13 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.34 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.496 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.13 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.523 ' HE2' ' CB ' ' A' ' 74' ' ' ALA . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.34 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.594 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.44 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.14 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.468 ' N ' ' CG ' ' A' ' 134' ' ' ARG . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.12 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.44 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.15 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.52 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 56' ' ' ASN . 16.0 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.23 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.42 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.43 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.21 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.525 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.33 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.22 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.574 ' HB2' ' CE1' ' A' ' 140' ' ' PHE . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.43 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.2 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.527 HG22 ' CE ' ' A' ' 61' ' ' MET . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.02 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.567 ' HG2' ' CG ' ' A' ' 36' ' ' PHE . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.12 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.522 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.13 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.505 ' CG2' HD12 ' A' ' 40' ' ' ILE . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.4 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.557 HG21 ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.33 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.45 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.34 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.14 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.522 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.44 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.33 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.435 ' CD2' HG23 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.4 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG11 ' CE1' ' A' ' 170' ' ' TYR . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.54 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.466 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.2 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.33 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.53 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.01 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.42 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.44 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.23 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.499 HD22 ' CG2' ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.42 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.519 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.35 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG11 ' A' ' 159' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.2 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.634 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.33 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.585 ' OD1' ' CE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.04 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.516 ' N ' ' OD1' ' A' ' 172' ' ' ASP . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.13 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.22 109.596 179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.528 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.11 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.34 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.547 HD22 ' CG ' ' A' ' 157' ' ' TYR . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.12 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.22 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.463 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.4 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.584 ' CB ' ' CE2' ' A' ' 157' ' ' TYR . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.13 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.207 179.883 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.246 0.546 . . . . 71.14 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.16 -32.93 70.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 70.15 110.319 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.518 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 79.6 m-85 -96.79 125.42 41.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 73.02 110.428 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.471 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp -150.98 149.1 29.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 73.24 110.158 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.463 ' OE2' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.31 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.34 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.471 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.41 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.51 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.567 ' CD1' ' N ' ' A' ' 9' ' ' TYR . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.33 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.512 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.01 109.407 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.31 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.463 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.24 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.02 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.521 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.55 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.05 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.34 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.405 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.11 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' CB ' HD21 ' A' ' 178' ' ' LEU . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.34 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 21' ' ' VAL . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.23 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.13 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.51 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.45 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.32 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.551 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.13 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.24 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.579 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.32 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.528 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.41 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.12 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.33 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.23 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.23 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.24 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.587 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.51 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.11 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.43 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.524 ' CG2' HD23 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.02 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.587 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.13 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.464 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.33 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 13.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.1 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.584 HD11 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.23 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.552 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.34 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.41 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.2 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.04 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.496 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.42 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.22 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.11 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.01 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.452 ' HB3' HD22 ' A' ' 178' ' ' LEU . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.11 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.11 109.681 175.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.552 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.12 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.24 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.4 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.21 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.33 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.14 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.524 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.32 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.24 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.33 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.567 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.12 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.521 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.31 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.13 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.2 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.21 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.02 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.31 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.42 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.579 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.04 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.575 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.43 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.52 ' CG ' HG23 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.13 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.33 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.21 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.529 ' HB3' ' CG2' ' A' ' 129' ' ' VAL . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.31 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.57 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.21 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.49 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.04 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.32 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.513 ' HB1' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.32 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.532 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.3 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.12 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.531 HG13 ' CB ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.32 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.542 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.11 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.47 ' O ' HG22 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.02 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.577 ' HE1' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.51 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.575 HG22 ' CE2' ' A' ' 73' ' ' TYR . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.4 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.532 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.12 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.478 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.33 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.569 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.03 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.45 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.495 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.35 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.528 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.14 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.45 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.44 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.495 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.11 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.528 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.4 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.14 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.35 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.512 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.45 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.433 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.43 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.31 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.456 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.51 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.33 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.55 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.462 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.14 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.526 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.15 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.3 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.4 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.526 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.2 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.577 ' CD2' ' HE1' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.42 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.51 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.05 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.24 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.31 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.14 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.24 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.22 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.11 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.532 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.34 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.57 ' CE1' HG21 ' A' ' 75' ' ' THR . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.24 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.24 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.33 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.513 ' CB ' ' HB1' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.34 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.503 ' N ' HG22 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.34 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.35 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.21 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 74' ' ' ALA . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.13 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.34 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.52 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.13 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.34 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.591 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.44 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.52 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.14 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.12 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.44 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.15 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.52 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.507 ' OE1' ' ND2' ' A' ' 56' ' ' ASN . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.23 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.42 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.43 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.21 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.33 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.22 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.61 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.43 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.2 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG1' ' O ' ' A' ' 25' ' ' PHE . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.02 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.516 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.12 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.13 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.461 HG21 HD12 ' A' ' 40' ' ' ILE . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.4 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.504 HG21 ' CE1' ' A' ' 25' ' ' PHE . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.33 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.52 ' CG2' HD11 ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.454 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.34 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.14 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.523 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.44 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.33 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.522 ' CD2' HD22 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.4 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.519 HG23 ' CD1' ' A' ' 177' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.54 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.512 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.7 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.2 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.33 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.53 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.01 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.467 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.42 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.44 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.23 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.42 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.467 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.35 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.457 ' HB2' ' HB2' ' A' ' 164' ' ' ALA . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.2 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.599 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.33 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.04 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.518 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.13 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.22 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.446 ' HA ' HD11 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.11 110.585 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.34 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.52 HD11 ' CG2' ' A' ' 153' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.12 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.527 HD21 ' CB ' ' A' ' 20' ' ' PRO . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.22 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.4 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.13 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.05 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.261 0.553 . . . . 71.14 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 37.7 mt-30 -58.78 -34.5 71.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 70.15 110.409 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CE1' ' CE2' ' A' ' 176' ' ' TYR . 54.4 p90 -129.75 163.11 26.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 73.02 110.669 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.418 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt -169.86 149.58 3.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 73.24 109.606 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.31 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.34 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.418 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.41 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.51 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.33 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.514 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.01 109.617 175.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.568 HG23 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.31 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.464 HD13 ' O ' ' A' ' 143' ' ' SER . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.24 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.02 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.526 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.55 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB2' ' CB ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.05 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.34 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.454 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.11 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.521 ' CB ' HD21 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.504 ' CG2' ' HG3' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.23 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.13 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.453 ' OG ' ' HB ' ' A' ' 152' ' ' VAL . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.13 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.454 ' OE2' HG13 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.51 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.56 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.45 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.451 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.32 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CG2' ' A' ' 58' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.13 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.24 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.577 ' CD1' HD11 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.32 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.522 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.41 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.12 110.033 -179.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.33 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.522 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.23 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.23 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.24 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.515 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.51 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' HB3' ' CD ' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.11 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 37' ' ' GLU . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.43 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.511 HD12 ' NE2' ' A' ' 42' ' ' GLN . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.02 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.515 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.13 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.33 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.511 ' NE2' HD12 ' A' ' 39' ' ' ILE . 40.9 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.1 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 ' HB2' ' CE1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.23 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HG2' ' CD2' ' A' ' 53' ' ' PHE . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.34 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.41 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 44.8 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.04 110.306 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 53' ' ' PHE . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.42 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.22 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.11 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.01 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.465 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.11 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.11 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.12 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.504 ' HG3' ' CG2' ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.24 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.21 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.33 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.677 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.14 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' CG2' ' OG ' ' A' ' 27' ' ' SER . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.32 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.42 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.24 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.563 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.33 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.563 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.12 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.515 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.31 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.13 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.2 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.523 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.21 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.02 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.31 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.42 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.544 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.04 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.567 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.43 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.576 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.13 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.459 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.33 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.21 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.31 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.547 HG23 ' CE1' ' A' ' 120' ' ' PHE . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.21 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.492 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.04 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.32 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.426 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.32 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.524 ' CB ' HG12 ' A' ' 81' ' ' VAL . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.3 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.12 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.524 HG12 ' CB ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.32 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.536 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.11 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.466 ' O ' HG21 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.02 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.576 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.51 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.572 HG22 ' CE2' ' A' ' 73' ' ' TYR . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.4 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.531 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.12 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.474 ' CG1' ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.33 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.578 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.03 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.45 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.496 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.35 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.14 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.577 HD11 ' CD1' ' A' ' 29' ' ' TYR . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.45 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.44 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.496 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.11 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.4 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.14 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.35 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.514 ' HA ' ' CD1' ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.45 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.523 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.43 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.461 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.31 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.51 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.33 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.55 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.14 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.15 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.3 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.4 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.2 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.42 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.51 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.05 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.51 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.24 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.31 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.524 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.14 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.489 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.24 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.22 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.11 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.524 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.34 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.679 ' CE1' ' CG ' ' A' ' 110' ' ' PHE . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.24 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.24 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.33 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.465 ' HB3' ' HA ' ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.34 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.34 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.35 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.21 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.531 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.13 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.34 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.13 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.531 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.34 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.44 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.14 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.48 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.12 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.44 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.15 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.52 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.512 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.23 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.42 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.526 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.21 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.519 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.33 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.22 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.577 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.43 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.2 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.535 HG12 ' CB ' ' A' ' 25' ' ' PHE . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.02 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.52 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.12 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.515 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.13 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.452 HG23 ' OH ' ' A' ' 170' ' ' TYR . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.4 110.067 -178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.453 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.33 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.527 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.34 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.14 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.503 ' CB ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.44 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.33 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.446 ' CD2' HG21 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.4 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.507 HG23 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.54 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.514 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.6 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.2 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.519 ' HA3' ' CE1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.33 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.53 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.01 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.42 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.44 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.465 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.23 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.57 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.42 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.35 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.519 ' CE1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.2 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.33 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.04 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.493 HD11 ' CD1' ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.13 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 171' ' ' PHE . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.22 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.11 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CE2' ' CE1' ' A' ' 3' ' ' PHE . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.34 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.564 HD22 ' CD2' ' A' ' 157' ' ' TYR . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.12 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.527 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.22 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.4 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.13 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.464 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.05 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.268 0.556 . . . . 71.14 110.246 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 54.5 mt-30 -59.11 -33.01 70.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 70.15 110.399 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.9 p90 -122.84 160.4 26.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 73.02 110.719 -174.72 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -169.61 154.15 5.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.523 -0.736 . . . . 73.24 109.688 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.31 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.34 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.41 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.578 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.51 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.33 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.01 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.31 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.24 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.02 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.55 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.453 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.05 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.34 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.11 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.469 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.34 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.401 ' O ' HG11 ' A' ' 21' ' ' VAL . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.23 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.13 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.463 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.13 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.578 ' OE2' ' CE1' ' A' ' 53' ' ' PHE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.51 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.45 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.457 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.32 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.13 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.24 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.571 ' CD1' HD11 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.32 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.41 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.12 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.33 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.23 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.23 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.24 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CE2' HD12 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.51 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.522 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.11 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.522 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.43 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.482 HD11 ' CD1' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.02 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.56 HD12 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.13 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.453 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.33 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.488 ' NE2' HD12 ' A' ' 167' ' ' LEU . 14.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.1 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.572 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.23 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' HE3' ' CE2' ' A' ' 53' ' ' PHE . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.34 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.41 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.04 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 53' ' ' PHE . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.42 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.525 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.22 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.11 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.01 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.525 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.11 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.11 109.631 175.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.638 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.12 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.24 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.458 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.21 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.33 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.495 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.14 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.581 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.32 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.411 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.24 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.33 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.581 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.12 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.31 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.13 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.2 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.459 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.21 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.411 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.02 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.31 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.42 110.205 179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.04 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.495 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.43 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.514 ' N ' HG22 ' A' ' 133' ' ' VAL . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.13 110.4 176.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.33 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.467 ' CE1' ' OE2' ' A' ' 82' ' ' GLU . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.21 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.31 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.573 HG22 ' CD1' ' A' ' 120' ' ' PHE . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.21 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.582 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.04 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.466 HG13 ' OE2' ' A' ' 82' ' ' GLU . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.32 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.32 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.3 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.12 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.526 HG12 ' CB ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.32 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.11 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.02 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.521 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.51 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.4 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.12 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.33 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.486 ' O ' HG12 ' A' ' 93' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.03 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.45 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.501 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.35 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.14 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.571 HD11 ' CD1' ' A' ' 29' ' ' TYR . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.45 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 85.5 t60 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.44 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.11 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.4 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.14 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.35 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.457 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.45 110.378 -178.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.458 ' HD2' HD12 ' A' ' 93' ' ' ILE . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.43 110.066 178.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.31 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.51 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.33 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.55 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.425 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.14 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.525 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.15 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.3 110.393 178.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.4 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.525 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.2 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.582 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.42 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.51 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.05 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.524 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.24 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.31 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.535 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.14 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.483 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.24 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.592 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.22 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.11 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.535 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.34 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.573 ' CD1' HG22 ' A' ' 75' ' ' THR . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.24 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.24 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.33 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.524 ' HB1' ' CG2' ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.34 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.34 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.35 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.21 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.13 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.34 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.499 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.13 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.526 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.34 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 71' ' ' LYS . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.44 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.499 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.14 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.485 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.12 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.44 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.15 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.52 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.23 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.639 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.42 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.43 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.21 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.532 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.33 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.22 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.639 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.43 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.2 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.02 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.54 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.12 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.519 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.13 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.4 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.523 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.33 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.34 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.523 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.14 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.535 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.44 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.33 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.519 ' CD1' ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.4 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG13 ' CE1' ' A' ' 170' ' ' TYR . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.54 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.2 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.33 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.53 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.01 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HB2' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.42 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.44 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.23 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.488 HD12 ' NE2' ' A' ' 42' ' ' GLN . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.42 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.35 110.564 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG13 ' A' ' 159' ' ' VAL . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.2 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.626 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.33 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.04 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.482 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.13 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.22 109.702 -178.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.442 ' HA ' HD13 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.11 110.926 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.34 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.531 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.12 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.22 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.4 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.576 ' HB3' ' CE1' ' A' ' 157' ' ' TYR . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.13 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.05 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.301 0.572 . . . . 71.14 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -58.91 -32.36 69.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.862 . . . . 70.15 110.345 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.5 p90 -121.65 149.73 42.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 73.02 110.65 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 66.1 mttm -156.68 158.66 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.424 -0.798 . . . . 73.24 109.449 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.31 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.34 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.41 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.578 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.51 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.33 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.517 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.01 109.315 173.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.31 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.24 110.267 -179.699 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.02 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.55 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' A' ' 154' ' ' ASN . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.05 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.34 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.11 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.516 ' CB ' HD21 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.34 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.513 HG23 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.23 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.13 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.13 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.506 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.51 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.469 ' CB ' HG13 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.45 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.472 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.32 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.13 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.68 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.24 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.32 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.41 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.439 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.12 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.33 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.526 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.23 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.23 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.479 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.24 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.446 ' HA ' HD12 ' A' ' 39' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.51 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.11 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.43 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.48 ' CG2' HD23 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.02 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.506 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.13 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.33 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.6 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.1 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.579 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.23 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.34 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.41 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.574 ' HG2' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.04 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' N ' ' O ' ' A' ' 43' ' ' LEU . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.42 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.22 109.923 179.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.11 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.01 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.11 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.11 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.12 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.545 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.24 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.461 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.21 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.515 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.33 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.14 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.32 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.467 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.24 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.33 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.12 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.523 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.31 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.13 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.2 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.495 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.21 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.467 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.02 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.31 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.42 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.04 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.578 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.43 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.513 ' HG2' ' CG2' ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.13 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.33 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.461 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.21 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.531 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.31 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 120' ' ' PHE . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.21 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.571 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.04 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.511 HD13 ' CE ' ' A' ' 132' ' ' MET . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.32 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.462 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.32 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.3 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.12 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.32 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.11 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.02 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.52 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.51 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.565 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.4 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.12 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.51 ' CG2' ' HA ' ' A' ' 85' ' ' MET . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.33 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.529 ' CE ' HD12 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.03 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.45 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.503 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.35 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.555 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.14 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 89' ' ' MET . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.45 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.44 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.505 HG21 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.11 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.555 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.4 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.14 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.35 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.45 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.518 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.43 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.31 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.51 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.33 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.55 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.435 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.14 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.529 HD12 ' CE ' ' A' ' 89' ' ' MET . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.15 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.3 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.4 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.455 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.2 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.42 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.59 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.51 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.05 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.475 ' HG3' ' HB2' ' A' ' 85' ' ' MET . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.24 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.31 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.531 HG21 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.14 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.24 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.59 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.22 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.11 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.34 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG22 ' A' ' 75' ' ' THR . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.24 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.24 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.33 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.34 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.512 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.34 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.35 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.21 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.531 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.13 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.34 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.13 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.525 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.34 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.44 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.529 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.14 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.486 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.12 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.44 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.15 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.52 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.52 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.23 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.42 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.43 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.21 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.464 ' OG ' HD12 ' A' ' 145' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.33 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.574 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.43 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.2 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.535 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.02 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.535 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.12 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.514 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.13 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.457 ' O ' HD11 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.4 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.465 HG23 ' CE1' ' A' ' 25' ' ' PHE . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.33 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.518 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.511 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.34 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.14 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.454 ' HD2' ' HB3' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.44 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.33 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.461 HD23 HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.4 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.45 HG23 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.54 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.517 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.3 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.2 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.33 109.829 177.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.53 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.01 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.468 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.42 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.44 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.23 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.483 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.42 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.468 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.35 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.453 ' OH ' HG23 ' A' ' 151' ' ' VAL . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.2 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.579 ' CD1' HD12 ' A' ' 43' ' ' LEU . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.33 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.04 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.48 HD11 ' CD1' ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.13 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.22 109.898 -178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 1.6 m120 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.11 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.34 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.519 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.12 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.518 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.22 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.454 HG23 ' O ' ' A' ' 175' ' ' ASN . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.4 110.611 -177.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.13 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.05 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.542 . . . . 71.14 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.572 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.8 tt0 -56.4 -37.75 70.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 70.15 110.192 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.579 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 84.2 m-85 -100.35 129.72 46.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 73.02 110.194 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -147.86 145.3 28.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 73.24 110.444 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.31 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.34 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.41 110.464 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.572 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 15.2 m-70 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.51 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.33 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.01 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.635 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.31 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.24 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.02 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.55 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' O ' ' CB ' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.536 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.05 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.34 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.11 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.46 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.23 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.569 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.13 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.492 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.51 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.45 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.574 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.32 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.521 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.13 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.24 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CD1' HD11 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.32 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.41 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.12 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.33 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.23 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.23 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.24 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.608 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.51 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.525 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.11 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.43 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.402 HG23 HD22 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.02 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.608 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.13 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.452 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.33 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.1 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.572 HD11 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.23 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.527 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.34 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.41 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.04 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD1' ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.42 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.464 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.22 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.11 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.01 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HB3' HD23 ' A' ' 178' ' ' LEU . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.11 110.6 -177.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.11 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.569 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.12 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.24 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.21 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.33 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.9 p-80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.14 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.598 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.32 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.24 110.758 176.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.33 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.532 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.12 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.31 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.13 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.2 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.458 ' O ' ' HG3' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.21 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.02 109.81 -175.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.31 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.42 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.04 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.53 ' HA ' ' CD2' ' A' ' 57' ' ' HIS . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.43 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.517 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.13 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 69' ' ' MET . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.33 110.439 -176.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.21 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.31 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.58 HG22 ' CE1' ' A' ' 120' ' ' PHE . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.21 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.579 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.04 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.47 ' CG1' ' HG2' ' A' ' 82' ' ' GLU . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.32 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.439 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.32 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.3 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.425 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.12 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.533 ' CG2' ' HB2' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.32 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' O ' HG21 ' A' ' 86' ' ' VAL . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.11 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.02 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.568 ' HE1' ' CG ' ' A' ' 110' ' ' PHE . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.51 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.542 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.4 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.12 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 HG13 ' CG ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.33 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.475 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.03 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.53 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.45 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.491 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.35 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.477 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.14 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.568 HD11 ' CD1' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.45 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.524 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.44 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.519 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.11 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.519 ' N ' HG22 ' A' ' 95' ' ' THR . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.4 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.14 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.35 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.446 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.45 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.43 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.31 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.51 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.33 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.55 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.14 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.453 HD13 ' HE3' ' A' ' 89' ' ' MET . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.15 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' NH1' HD13 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.3 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.4 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.456 HG21 ' SD ' ' A' ' 89' ' ' MET . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.2 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.42 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.597 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.51 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.05 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.53 ' CG ' HG13 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.24 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.31 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.533 HG22 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.14 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.24 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.597 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.22 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.11 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.34 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.58 ' CE1' HG22 ' A' ' 75' ' ' THR . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.24 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.24 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.33 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.521 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.34 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.516 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.34 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.35 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.21 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.522 ' CG1' ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.13 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.471 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.34 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.13 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.34 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.526 ' CG1' ' OG ' ' A' ' 70' ' ' SER . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.44 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.14 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.467 ' HB3' ' O ' ' A' ' 132' ' ' MET . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.12 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.44 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.15 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.411 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.52 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.465 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.23 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.42 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.43 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.52 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.21 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.484 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.33 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.22 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.581 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.43 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.2 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.02 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.545 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.12 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.525 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.13 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.454 HG23 HD13 ' A' ' 40' ' ' ILE . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.4 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.33 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.493 ' CG2' HD11 ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.34 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.14 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.536 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.44 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.635 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.33 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.52 ' CD2' HD23 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.4 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.575 HG12 ' CE1' ' A' ' 170' ' ' TYR . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.54 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 27.5 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.2 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.33 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.53 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.01 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.42 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.44 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.23 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.402 HD22 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.42 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.469 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.35 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.575 ' CE1' HG12 ' A' ' 159' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.2 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.572 ' CD2' HD11 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.33 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.04 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.579 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.13 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.417 HG13 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.22 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.453 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.11 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.34 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.12 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.503 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.22 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.4 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.583 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.13 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.462 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.05 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.428 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 71.14 110.186 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.5 tt0 -56.36 -37.77 70.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 70.15 110.179 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 89.6 m-85 -105.41 132.83 51.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 73.02 110.127 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.459 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 92.9 mttt -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 73.24 110.21 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.31 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.34 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.41 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.573 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 27.4 m-70 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.51 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.577 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.33 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.449 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.01 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.575 HG21 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.31 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.24 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.02 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.55 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.498 ' CB ' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.442 ' OG ' ' O ' ' A' ' 19' ' ' SER . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.05 110.291 -179.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.34 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.11 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.522 ' CB ' HD21 ' A' ' 178' ' ' LEU . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.34 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.23 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.13 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.13 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.433 ' CD ' HG13 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.51 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.527 ' CB ' HG11 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.45 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.32 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.478 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.13 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.24 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' ILE . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.32 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.481 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.41 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.12 110.403 -176.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.33 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.23 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.23 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.468 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.24 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.633 ' CE2' ' CG1' ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.51 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.11 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.43 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.518 HG21 ' CD2' ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.02 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.633 ' CG1' ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.13 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.47 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.33 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.1 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.577 ' HB2' ' CE1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.23 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.573 ' HD2' ' CE2' ' A' ' 53' ' ' PHE . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.34 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.41 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 50.3 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.04 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD2' ' HD2' ' A' ' 48' ' ' PRO . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.42 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.52 ' HD2' ' CD2' ' A' ' 47' ' ' LEU . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.22 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.11 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.01 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.11 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.11 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.12 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.24 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.455 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.21 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.33 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.14 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.582 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.32 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.45 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.24 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.582 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.33 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.12 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.452 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.31 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.13 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.2 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.461 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.21 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.452 ' HA2' ' HA3' ' A' ' 62' ' ' GLY . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.02 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.31 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.42 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HE1' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.04 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.583 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.43 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.13 110.035 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.409 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.33 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.21 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.529 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.31 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.576 HG22 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.21 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.528 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.04 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.468 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.32 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.515 ' CB ' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.32 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.526 ' CB ' HG13 ' A' ' 81' ' ' VAL . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.3 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.448 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.12 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.528 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.32 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.535 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.11 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.02 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.532 ' CG ' ' CD1' ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.51 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.4 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.535 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.12 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.33 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.509 ' O ' HG13 ' A' ' 93' ' ' ILE . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.03 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.45 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.48 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.35 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.551 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.14 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.45 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 58.4 t-80 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.44 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.11 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.551 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.4 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.473 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.14 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.35 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.45 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.517 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.43 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.31 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' O ' ' HE1' ' A' ' 65' ' ' MET . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.51 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.33 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.55 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.468 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.14 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.15 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.3 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.4 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.521 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.2 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.528 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.42 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.51 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.05 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.24 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.31 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CD1' ' CG ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.14 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.24 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.58 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.22 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.11 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.524 ' HD3' ' CD2' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.34 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.576 ' CE1' HG22 ' A' ' 75' ' ' THR . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.24 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.24 109.711 177.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.33 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.527 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.34 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.34 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.35 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.21 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.415 ' O ' ' OG ' ' A' ' 131' ' ' SER . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.527 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.13 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.34 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.13 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.529 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.34 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.588 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.44 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.14 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.12 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.44 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.15 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.52 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.467 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 12.8 mm100 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.23 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.42 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.43 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.21 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.529 ' CB ' HD13 ' A' ' 145' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.33 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.606 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.43 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.2 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.02 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.544 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.12 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.534 ' CB ' ' CD2' ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.13 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.524 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.4 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.503 HG21 ' CD2' ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.33 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.7 m-80 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.34 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.449 ' HA ' HG13 ' A' ' 152' ' ' VAL . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.14 110.916 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.498 ' HD2' ' CB ' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.44 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.33 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.504 HD11 ' N ' ' A' ' 159' ' ' VAL . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.4 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG12 ' CE1' ' A' ' 170' ' ' TYR . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.54 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.479 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.2 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.33 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.53 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.01 110.247 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.523 ' CB ' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.42 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.44 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.464 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.23 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.42 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.523 ' HB2' ' CB ' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.35 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.571 ' CE1' HG12 ' A' ' 159' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.2 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.577 ' CE1' ' HB2' ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.33 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.569 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.04 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.566 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.13 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.457 ' O ' HD12 ' A' ' 178' ' ' LEU . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.22 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.437 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.11 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.34 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.529 HD21 ' CG ' ' A' ' 9' ' ' TYR . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.12 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.524 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.22 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.4 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.13 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.424 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.05 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.266 0.555 . . . . 71.14 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.9 tt0 -56.34 -37.01 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 70.15 110.21 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.3 m-85 -105.15 129.77 53.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 73.02 110.22 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt -150.21 150.17 31.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 73.24 110.42 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.31 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.34 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.41 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.51 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.33 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.01 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.64 ' CG2' ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.31 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.24 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.02 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.55 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.526 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.05 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.34 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.517 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.11 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.517 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.34 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.506 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.23 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.13 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.13 109.621 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.469 ' OE2' HG23 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.51 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.45 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.32 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.13 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.24 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.32 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.41 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.12 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.33 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.23 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.446 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.23 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.24 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.42 ' O ' ' C ' ' A' ' 37' ' ' GLU . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.51 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.11 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.43 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.41 HD13 ' CD1' ' A' ' 36' ' ' PHE . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.02 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.459 HD11 ' OE2' ' A' ' 24' ' ' GLU . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.13 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' HA ' ' NZ ' ' A' ' 44' ' ' LYS . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.33 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.406 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.1 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.568 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.23 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.581 ' HD3' ' CE2' ' A' ' 53' ' ' PHE . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.34 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.41 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.04 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.516 ' N ' ' O ' ' A' ' 43' ' ' LEU . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.42 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.433 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.22 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.11 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.01 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.429 ' HB1' HD21 ' A' ' 178' ' ' LEU . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.11 110.507 -177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.11 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.581 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.12 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.565 ' N ' ' O ' ' A' ' 22' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.24 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.21 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.33 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.14 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.601 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.32 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.43 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.24 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.33 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.592 ' CE ' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.12 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.31 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.13 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.2 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.522 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.21 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.02 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.31 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.42 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.563 ' SD ' ' CD2' ' A' ' 29' ' ' TYR . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.04 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.519 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.43 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HA ' ' CG2' ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.13 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.467 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.33 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.465 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.21 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.523 ' HB3' ' CG1' ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.31 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.571 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.21 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.569 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.04 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.476 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.32 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.32 109.703 172.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.536 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.3 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.455 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.12 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.516 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.32 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.517 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.11 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.02 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.558 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.51 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.562 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.4 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.12 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.53 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.33 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.579 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.03 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.45 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.495 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.35 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.52 ' NE ' ' O ' ' A' ' 98' ' ' LYS . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.14 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.522 ' CG1' ' O ' ' A' ' 89' ' ' MET . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.45 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.44 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.506 ' O ' ' NH1' ' A' ' 97' ' ' ARG . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.11 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.4 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.14 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.35 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.45 110.396 -178.036 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.522 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.43 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.31 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.51 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.33 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.55 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.459 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.14 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.506 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.15 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.3 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.4 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.506 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.2 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.569 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.42 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.589 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.51 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.05 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.53 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.31 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.14 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.497 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.24 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.589 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.22 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.11 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.536 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.34 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.571 ' CE1' HG22 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.24 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.24 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.33 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.52 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.34 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.509 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.34 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.35 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.21 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.524 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.13 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.34 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.13 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.538 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.34 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.44 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.14 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.12 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.44 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.15 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.52 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.53 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.23 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.42 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.43 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.21 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.526 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.33 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.22 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.578 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.43 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.2 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.592 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.02 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.543 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.12 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.518 ' CB ' HD23 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.13 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.469 HG22 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.4 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.567 HG21 ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.33 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.517 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.34 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.465 ' HA ' HG11 ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.14 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.526 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.44 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.64 ' CE1' ' CG2' ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.33 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.514 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.4 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.514 ' N ' HD12 ' A' ' 158' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.54 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.455 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.2 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.33 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.53 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.01 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' CB ' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.42 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.44 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.23 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . . . . . . . . . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.42 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.522 ' CB ' ' HB3' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.35 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.469 ' OH ' HG22 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.2 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.568 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.33 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.04 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.58 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.13 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.22 109.766 -178.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.407 ' ND2' ' O ' ' A' ' 171' ' ' PHE . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.11 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.34 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.558 HD23 ' CG ' ' A' ' 9' ' ' TYR . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.12 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.517 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.22 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.4 110.191 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.13 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.05 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.225 0.536 . . . . 71.14 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.1 tt0 -56.38 -36.48 68.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 70.15 110.307 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.8 m-85 -104.19 132.74 50.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 73.02 110.272 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -132.22 153.65 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 73.24 110.124 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' HA ' ' CE1' ' A' ' 9' ' ' TYR . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.31 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.34 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.41 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 25.7 m170 -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.51 109.949 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.588 ' CE1' ' HA ' ' A' ' 5' ' ' GLU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.33 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.01 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.31 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.451 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.24 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.02 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.55 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.516 ' HB3' ' CB ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.465 ' OG ' ' O ' ' A' ' 19' ' ' SER . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.05 110.413 -177.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.34 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.465 ' O ' ' OG ' ' A' ' 17' ' ' SER . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.11 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.52 ' CB ' HD22 ' A' ' 178' ' ' LEU . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.34 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.23 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.13 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.13 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.455 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.51 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.45 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.32 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.13 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.685 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.24 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.468 ' OH ' ' HG3' ' A' ' 69' ' ' MET . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.32 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.41 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.12 110.059 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.33 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.23 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.23 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.478 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.24 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.638 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.51 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.11 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.43 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.448 ' CG2' ' CD2' ' A' ' 167' ' ' LEU . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.02 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.638 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.13 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.33 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 15.3 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.1 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.629 ' CD1' ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.23 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.626 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.34 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.506 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.41 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.506 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 49.8 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.04 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 43' ' ' LEU . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.42 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.22 109.931 179.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.11 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.11 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.11 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.12 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.7 mm-40 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.24 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.21 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.567 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.33 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.657 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.14 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HB ' ' CE2' ' A' ' 60' ' ' PHE . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.32 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.464 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.24 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.577 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.33 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.12 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.31 109.895 -178.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.13 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.2 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.515 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.21 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.02 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.31 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.42 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.468 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.04 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.57 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.43 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.13 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.33 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.657 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.21 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' CB ' ' CG1' ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.31 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.561 HG22 ' CE1' ' A' ' 120' ' ' PHE . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.21 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.58 ' HE1' ' CZ ' ' A' ' 110' ' ' PHE . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.04 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.517 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.32 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.448 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.32 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.523 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.3 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.464 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.12 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.52 HG11 ' CB ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.32 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.11 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.02 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.523 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.51 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.536 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.4 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.536 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.12 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.523 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.33 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.519 ' HE3' ' CD1' ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.03 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.45 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.506 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.35 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.14 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.523 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.45 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.44 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.506 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.11 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.53 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.4 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.14 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.509 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.35 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.45 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.515 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.43 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.31 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.51 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.33 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.55 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.14 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.519 ' CD1' ' HE3' ' A' ' 89' ' ' MET . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.15 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.572 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.3 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.4 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.502 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.2 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.58 ' CZ ' ' HE1' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.42 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.51 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.05 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.523 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.24 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.31 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.14 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.492 ' N ' HG22 ' A' ' 115' ' ' ILE . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.24 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.22 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.11 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HD2' ' CG2' ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.34 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.572 ' CD2' ' HG3' ' A' ' 107' ' ' ARG . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.24 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.24 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.33 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.529 ' HB2' ' CG2' ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.34 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.572 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.34 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.35 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.21 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.532 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.13 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.34 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.13 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.532 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.34 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.44 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.14 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.488 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.12 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.44 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.15 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.52 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.23 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.632 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.42 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.41 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 26.6 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.43 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.525 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.21 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.524 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.33 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.22 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.632 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.43 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.02 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.12 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.526 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.13 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.4 110.151 -178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 155' ' ' ASN . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.33 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.524 ' CG1' ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.523 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.34 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.459 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.14 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.516 ' CB ' ' HB3' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.44 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.33 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.453 ' CD2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.4 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.57 HG13 ' CE1' ' A' ' 170' ' ' TYR . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.54 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.465 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.2 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.425 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.33 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.44 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.53 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.01 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.464 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.42 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.44 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.23 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.575 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.42 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.481 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.35 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.57 ' CE1' HG13 ' A' ' 159' ' ' VAL . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.2 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.629 ' CG ' ' CD1' ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.33 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.579 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.04 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.571 ' HB2' ' CD2' ' A' ' 3' ' ' PHE . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.13 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.454 ' O ' HD11 ' A' ' 178' ' ' LEU . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.22 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.11 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.34 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.575 HD23 ' CG ' ' A' ' 9' ' ' TYR . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.12 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.22 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.446 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.4 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.13 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.05 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.226 0.536 . . . . 71.14 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.577 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 62.2 tp60 -56.47 -41.18 76.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 70.15 110.392 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 27.8 p90 -147.51 157.94 43.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 73.02 110.606 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt -155.95 -165.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 73.24 109.755 177.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.57 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.31 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.447 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.34 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.41 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.51 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.574 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.33 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.447 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.01 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.629 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.31 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.457 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.24 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.02 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.485 ' CG2' ' C ' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.55 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.05 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.34 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.11 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.454 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.34 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.468 ' CG2' ' CD ' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.23 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.54 ' O ' ' N ' ' A' ' 54' ' ' GLN . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.13 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.495 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.13 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.51 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.45 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.573 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.32 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.447 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.13 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.686 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.24 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.454 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.32 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.439 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.41 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.516 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.12 110.358 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.33 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.471 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.23 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.23 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.24 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.593 ' CD2' ' CB ' ' A' ' 149' ' ' PRO . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.51 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.11 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.43 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.567 HD13 ' CD1' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.02 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.525 ' CG2' ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.13 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.446 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.33 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.1 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.575 HD13 ' CG ' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.23 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.601 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.34 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.41 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 43.1 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.04 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.569 HD11 ' CD1' ' A' ' 53' ' ' PHE . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.42 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.45 ' HD2' HD22 ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.22 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.11 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.01 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.11 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.11 109.578 174.507 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.601 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.12 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.54 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.24 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.457 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.21 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.565 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.33 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.14 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.511 HG11 ' CD1' ' A' ' 140' ' ' PHE . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.32 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.24 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CE2' ' CZ ' ' A' ' 140' ' ' PHE . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.33 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.576 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.12 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.31 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.13 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.2 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.498 ' CE ' ' HB3' ' A' ' 68' ' ' ALA . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.21 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.02 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.31 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.498 ' HB3' ' CE ' ' A' ' 65' ' ' MET . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.42 110.383 178.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.449 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.04 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.513 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.43 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.521 ' N ' HG23 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.13 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.33 110.329 -176.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.475 ' O ' ' HB2' ' A' ' 76' ' ' MET . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.21 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.525 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.31 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.62 ' CG2' ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.21 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.538 ' HE1' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.04 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 ' HA ' ' CD ' ' A' ' 82' ' ' GLU . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.32 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.32 109.763 173.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.53 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.3 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.467 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.12 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.475 ' CG2' ' HA ' ' A' ' 76' ' ' MET . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.32 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.524 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.11 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.02 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.565 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.51 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.571 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.4 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.12 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.524 ' CG1' ' OE2' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.33 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.517 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.03 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.45 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.511 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.35 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.14 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.516 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.45 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.516 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 11.0 t-160 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.44 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.511 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.11 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.4 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.14 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.35 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.444 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.45 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.465 ' HB3' HD12 ' A' ' 109' ' ' ILE . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.43 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.31 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.51 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.33 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.55 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.14 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.516 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.15 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.3 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.4 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.516 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.2 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.573 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.42 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.51 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.05 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.524 ' OE2' ' CG1' ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.24 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.31 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.527 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.14 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.24 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.579 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.22 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.11 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.53 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.34 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.62 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.24 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.24 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.33 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.524 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.34 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.5 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.34 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.35 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.21 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.529 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.13 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.34 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.13 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.577 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.34 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.521 HG23 ' N ' ' A' ' 71' ' ' LYS . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.44 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.14 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.12 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.44 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.463 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.15 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.52 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.23 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.42 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.463 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.43 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.485 ' C ' ' CG2' ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.21 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.522 ' CB ' HD12 ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.33 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.22 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.581 ' HB3' ' CE1' ' A' ' 140' ' ' PHE . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.43 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.2 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.545 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.02 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.593 ' CB ' ' CD2' ' A' ' 36' ' ' PHE . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.12 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.52 ' HB3' ' CD2' ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.13 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.4 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.51 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.33 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.522 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.34 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.51 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.14 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.522 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.44 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.629 ' CE2' ' CG2' ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.33 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.512 HD21 ' CD2' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.4 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.559 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.54 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.458 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.2 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.33 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.53 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.01 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.451 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.42 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . 0.412 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.44 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.23 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.581 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.42 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.451 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.35 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.559 ' CE1' ' CG1' ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.2 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 167' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.33 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.04 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.468 HD22 ' HA ' ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.13 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.416 HG22 HG22 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.22 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.462 ' O ' ' HB2' ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.11 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.34 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 HD21 ' CG ' ' A' ' 9' ' ' TYR . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.12 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.522 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.22 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.461 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.4 110.179 179.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.13 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.457 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.05 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.238 0.542 . . . . 71.14 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' NE2' ' HG3' ' A' ' 169' ' ' GLU . 59.5 tt0 -56.38 -35.91 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 70.15 110.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 176' ' ' TYR . 52.0 p90 -130.51 164.07 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 73.02 110.178 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.462 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt -172.83 167.02 5.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 73.24 110.286 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.563 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.31 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.34 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.462 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.41 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 5.0 m-70 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.51 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.576 ' CG ' HD23 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.33 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.01 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.577 HG21 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.31 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.24 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.02 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.498 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.55 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.52 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.46 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.05 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.34 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.11 109.513 174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.525 ' CB ' HD23 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.34 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.23 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.13 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.13 110.23 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.527 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.51 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CB ' HG12 ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.45 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.561 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.32 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.531 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.13 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.24 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' OH ' ' HG3' ' A' ' 69' ' ' MET . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.32 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.41 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.12 109.999 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.33 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.109 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.23 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.429 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.23 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.24 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.51 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.11 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.43 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.401 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.02 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.13 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.33 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.5 ' NE2' HD12 ' A' ' 167' ' ' LEU . 15.8 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.1 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.581 HD13 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.23 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.57 ' HE2' ' CE2' ' A' ' 53' ' ' PHE . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.34 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.41 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.04 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.42 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.22 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.11 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.01 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.519 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.11 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.11 109.641 175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.57 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.12 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.24 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.561 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.21 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.33 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.14 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.517 HG13 ' CG1' ' A' ' 148' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.32 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.24 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.61 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.33 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.61 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.12 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.31 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.13 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.2 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.524 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.21 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.02 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.31 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.42 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.462 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.04 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.576 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.43 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG2' ' CG2' ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.13 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.33 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.21 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.514 ' HB1' ' CG1' ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.31 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.565 HG22 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.21 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.511 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.04 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.499 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.32 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.516 ' CB ' ' HB2' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.32 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.3 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.12 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.32 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.532 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.11 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.527 ' O ' ' CG2' ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.02 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.565 ' HE3' ' CD2' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.51 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.545 HG21 ' CE2' ' A' ' 73' ' ' TYR . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.4 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.532 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.12 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 84' ' ' LYS . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.33 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.515 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.03 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.45 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.35 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.541 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.14 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.496 ' CG1' ' O ' ' A' ' 89' ' ' MET . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.45 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.44 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.11 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.541 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.4 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.14 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.35 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.45 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.524 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.43 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.46 ' HG2' ' OE1' ' A' ' 105' ' ' GLU . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.31 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.51 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.33 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.55 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.46 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.14 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.468 ' CD1' ' HE3' ' A' ' 89' ' ' MET . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.15 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.3 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.6 mm100 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.4 110.615 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.466 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.2 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.565 ' CD2' ' HE3' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.42 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.51 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.05 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.519 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.24 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.31 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.14 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.527 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.24 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.569 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.22 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.11 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.527 ' HG2' ' CB ' ' A' ' 116' ' ' ASP . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.34 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.565 ' CE1' HG22 ' A' ' 75' ' ' THR . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.24 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.24 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.33 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.516 ' HB2' ' CB ' ' A' ' 78' ' ' ALA . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.34 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.34 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.35 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.21 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.514 ' CG1' ' HB1' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.13 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.34 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.436 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.13 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.463 ' HE1' HD13 ' A' ' 77' ' ' ILE . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.34 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.586 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.44 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.517 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.14 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.517 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.12 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.44 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.15 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.52 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.484 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 9.6 mt-30 -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.23 110.611 -175.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.42 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.43 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.498 ' O ' ' CG2' ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.21 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.527 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.33 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.22 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.43 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.2 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.537 HG12 ' CB ' ' A' ' 25' ' ' PHE . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.02 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.536 ' CB ' ' CD2' ' A' ' 36' ' ' PHE . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.12 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.52 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.13 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.4 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.525 HG22 ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.33 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.529 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.34 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.14 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.52 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.44 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.577 ' CE2' HG21 ' A' ' 11' ' ' VAL . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.33 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.522 ' CD2' HD23 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.4 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.451 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.54 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.467 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.2 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.33 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.53 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.01 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.42 109.715 176.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.44 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.23 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.5 HD12 ' NE2' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.42 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.515 ' HG3' ' NE2' ' A' ' 2' ' ' GLN . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.35 110.587 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.407 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.2 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.581 ' CD1' HD13 ' A' ' 43' ' ' LEU . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.33 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.04 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 9' ' ' TYR . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.13 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.22 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.7 m120 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.11 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 3' ' ' PHE . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.34 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.576 HD23 ' CG ' ' A' ' 9' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.12 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.529 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.22 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.4 110.677 -175.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.13 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.46 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.05 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 71.14 110.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.65 -35.73 68.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 70.15 110.266 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' CD2' ' CE2' ' A' ' 176' ' ' TYR . 22.9 m-85 -104.29 137.36 42.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 73.02 109.647 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' N ' ' NE2' ' A' ' 8' ' ' HIS . 32.6 tttt -162.56 133.24 4.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.009 -1.057 . . . . 73.24 110.943 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.31 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.34 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.41 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.655 ' NE2' ' CD2' ' A' ' 9' ' ' TYR . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.51 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CD2' ' NE2' ' A' ' 8' ' ' HIS . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.33 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.01 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.583 HG21 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.31 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.514 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.24 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.02 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.55 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.532 ' CB ' ' HB2' ' A' ' 156' ' ' ARG . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.05 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.34 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.11 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.427 ' CB ' HD21 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.34 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.23 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.457 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.13 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.13 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.498 ' OE1' ' CG2' ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.51 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.45 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.32 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.13 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.677 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.24 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.431 ' CE1' ' HB3' ' A' ' 99' ' ' PRO . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.32 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.41 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.12 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.33 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 1.063 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.23 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 94' ' ' HIS . 15.6 t-20 -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.23 110.365 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.24 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.636 ' CE2' ' CD1' ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.51 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.11 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.43 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.46 ' CG2' HD22 ' A' ' 167' ' ' LEU . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.02 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.636 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.13 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' O ' ' HB2' ' A' ' 44' ' ' LYS . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.33 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.469 ' O ' ' HG3' ' A' ' 46' ' ' GLN . 16.4 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.1 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.58 HD11 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.23 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.609 ' CE ' ' CE2' ' A' ' 53' ' ' PHE . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.34 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.512 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.41 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.4 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.04 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.483 ' N ' ' O ' ' A' ' 43' ' ' LEU . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.42 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.22 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.11 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.01 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.448 ' HB3' HD22 ' A' ' 178' ' ' LEU . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.11 110.435 -178.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.11 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.12 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.452 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.24 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.418 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.21 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.33 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.14 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.587 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.32 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.468 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.24 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.587 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.33 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.12 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.31 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.13 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.2 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.518 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.21 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.468 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.02 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.443 ' NE2' HG11 ' A' ' 133' ' ' VAL . 64.0 tp60 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.31 110.259 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.42 110.236 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.45 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.04 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.569 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.43 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.13 110.103 177.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.446 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.33 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.21 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.53 ' CB ' ' HE3' ' A' ' 132' ' ' MET . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.31 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 120' ' ' PHE . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.21 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.582 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.04 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.523 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.32 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.443 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.32 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.528 ' CB ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.3 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.12 109.944 -176.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.528 HG13 ' CB ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.32 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' HA ' ' HB3' ' A' ' 76' ' ' MET . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.11 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.02 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.558 ' HE3' ' CD2' ' A' ' 110' ' ' PHE . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.51 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.574 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.4 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.12 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 ' CG1' ' OE2' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.33 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.482 ' HE3' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.03 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.45 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.51 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.35 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.553 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.14 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG2' ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.45 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 34' ' ' ASN . 51.7 t-80 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.44 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.11 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.553 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.4 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.14 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.35 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.451 ' HB3' HD11 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.45 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.518 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.43 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.31 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.51 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.479 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.33 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.55 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.14 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 100' ' ' PRO . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.15 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.479 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.3 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . 0.506 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.8 mm100 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.4 110.612 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.465 ' O ' ' HG2' ' A' ' 113' ' ' GLU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.2 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.582 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.42 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.51 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.05 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.527 ' OE2' ' CG1' ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.24 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.31 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.14 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.48 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.24 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.556 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.22 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.11 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.523 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.34 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 75' ' ' THR . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.24 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.24 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.33 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.461 ' HB2' ' HA ' ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.34 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.34 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.35 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.21 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.525 ' HA ' ' CE ' ' A' ' 132' ' ' MET . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.13 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.34 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.13 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.53 ' HE3' ' CB ' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.34 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.58 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.44 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.53 ' HB3' ' CZ ' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.14 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.495 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.12 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.44 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.15 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.52 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.514 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.23 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.42 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.43 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.21 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.521 ' CB ' HD12 ' A' ' 145' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.33 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.22 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.631 ' CB ' ' CE1' ' A' ' 140' ' ' PHE . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.43 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.02 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.571 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.12 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.524 ' CB ' HD21 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.13 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.453 ' HB ' ' HB ' ' A' ' 159' ' ' VAL . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.4 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.505 HG23 ' CE1' ' A' ' 25' ' ' PHE . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.33 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.493 ' CG2' HD12 ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.492 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.34 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.14 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.532 ' HB2' ' CB ' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.44 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.583 ' CE2' HG21 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.33 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 9' ' ' TYR . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.4 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.56 HG12 ' CE1' ' A' ' 170' ' ' TYR . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.54 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.463 ' HB2' ' O ' ' A' ' 8' ' ' HIS . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.2 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.33 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.53 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.01 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.42 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.44 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.23 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.46 HD22 ' CG2' ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.42 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.526 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.35 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.56 ' CE1' HG12 ' A' ' 159' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.2 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.602 ' CE1' ' CB ' ' A' ' 46' ' ' GLN . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.33 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.04 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.595 ' CD1' ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.13 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.22 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.455 ' HA ' HD11 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.11 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.647 ' CE2' ' CD2' ' A' ' 3' ' ' PHE . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.34 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.641 ' CD2' ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.12 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.492 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.22 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.459 ' OG1' ' O ' ' A' ' 176' ' ' TYR . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.4 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.13 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.05 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.512 ' O ' ' CE ' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 71.14 110.153 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.2 tt0 -56.21 -37.35 69.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 70.15 110.259 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.54 ' HA ' ' CG ' ' A' ' 8' ' ' HIS . 48.6 m-85 -103.08 131.65 49.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 73.02 109.948 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.512 ' CE ' ' O ' ' A' ' 1' ' ' ALA . 53.5 mttt -144.69 167.21 23.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 73.24 110.586 -177.506 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.31 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.34 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.41 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 13.1 m-70 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.51 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.574 ' CE2' ' HG2' ' A' ' 5' ' ' GLU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.33 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.01 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.578 HG23 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.31 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.24 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.02 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.55 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.512 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.05 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.34 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.41 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.11 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.515 ' CB ' HD23 ' A' ' 178' ' ' LEU . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.34 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 21' ' ' VAL . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.23 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.501 ' O ' ' N ' ' A' ' 54' ' ' GLN . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.13 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.13 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.525 ' OE2' ' CG1' ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.51 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.45 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.482 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.32 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.527 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.13 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.684 ' CD2' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.24 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.573 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.32 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.41 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.12 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.33 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.96 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.23 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.23 110.369 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.24 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.568 ' CE2' HD13 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.51 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.11 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.43 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.548 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.02 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.568 HD13 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.13 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.33 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.527 ' HG3' ' O ' ' A' ' 39' ' ' ILE . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.1 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.57 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.23 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HD3' ' HA ' ' A' ' 41' ' ' ALA . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.34 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.41 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.04 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 43' ' ' LEU . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.42 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.22 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.11 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.01 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.466 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.11 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.41 ' NZ ' ' HB2' ' A' ' 19' ' ' SER . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.11 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.12 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.501 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.24 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.516 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.21 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.33 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.674 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.14 109.64 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.566 HG12 ' CD1' ' A' ' 140' ' ' PHE . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.32 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.453 ' HB2' ' HA3' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.24 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.33 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.12 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.31 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.13 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.2 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.463 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.21 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.02 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.31 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.42 110.226 179.838 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.04 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.43 110.214 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.519 ' CA ' HG22 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.13 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.33 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.557 ' CE2' HG21 ' A' ' 86' ' ' VAL . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.21 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.526 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.31 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.638 ' CG2' ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.21 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.58 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.04 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.5 ' CD1' ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.32 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.32 109.758 173.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CG ' ' HD3' ' A' ' 119' ' ' LYS . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.3 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.12 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.32 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.11 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.02 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.521 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.51 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.577 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.4 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.12 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.521 ' CG2' ' OE1' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.33 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.515 ' SD ' ' CE ' ' A' ' 76' ' ' MET . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.03 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.45 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.509 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.35 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.556 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.14 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 99' ' ' PRO . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.45 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.44 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.11 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.4 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.14 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.35 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.521 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.45 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.516 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.43 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.31 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.51 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.33 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.55 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.14 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.15 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.3 110.32 176.69 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.2 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.42 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.51 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.05 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.521 ' OE1' ' CG2' ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.24 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.31 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.521 HG21 ' CE ' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.14 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.24 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.576 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.22 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.11 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CG ' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.34 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.638 ' CE1' ' CG2' ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.24 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.24 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.33 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.503 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.34 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.517 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.34 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.35 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.21 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.526 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.13 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.34 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.13 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.575 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.34 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.519 HG22 ' CA ' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.44 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.14 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.12 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.674 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.44 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.15 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.52 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 6.8 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.23 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.42 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.43 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.21 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.517 ' OG ' ' CD1' ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.33 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.22 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.576 ' O ' ' CZ ' ' A' ' 140' ' ' PHE . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.43 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.2 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.02 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.53 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.12 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.524 ' HB1' ' CD2' ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.13 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG1' ' OE2' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.4 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.33 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.523 ' CG1' ' HG ' ' A' ' 178' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.512 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.34 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.14 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.512 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.44 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.578 ' CE1' HG23 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.33 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.453 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.4 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.454 ' HB ' ' HB ' ' A' ' 151' ' ' VAL . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.54 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.471 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.2 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . 0.409 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.33 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.53 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.01 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.455 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.42 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.44 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.23 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.454 HD22 HG22 ' A' ' 39' ' ' ILE . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.42 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.455 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.35 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.409 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.2 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.57 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.33 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.04 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.13 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . 0.42 ' O ' HD13 ' A' ' 178' ' ' LEU . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.22 109.861 -178.164 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . 0.451 ' O ' HG21 ' A' ' 179' ' ' THR . 1.7 m-80 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.11 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.34 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.574 HD22 ' CG ' ' A' ' 9' ' ' TYR . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.12 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.22 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.451 HG21 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.4 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.13 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.463 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.05 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' O ' ' CE ' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.337 0.589 . . . . 71.14 110.226 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 60.6 tt0 -58.36 -33.5 69.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 70.15 110.369 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PHE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 80.4 m-85 -100.22 131.53 46.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 73.02 110.242 -177.678 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' ALA . 9.5 mmtt -135.62 154.8 51.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 73.24 110.251 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.31 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.34 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.41 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 25.1 m-70 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.51 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.585 ' CZ ' ' CA ' ' A' ' 5' ' ' GLU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.33 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.01 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.31 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.518 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.24 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.02 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.518 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.55 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . 0.522 ' HB1' ' CB ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.05 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.34 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.11 109.788 177.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' PRO . . . . . 0.523 ' CB ' HD21 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.34 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.23 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.13 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.13 110.188 -179.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.483 ' CD ' ' CG2' ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.51 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.539 ' CB ' HG12 ' A' ' 148' ' ' VAL . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.45 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.32 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.13 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.686 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.24 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.32 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.428 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.41 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.12 110.347 -176.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.33 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.23 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.465 ' OD1' ' HB3' ' A' ' 90' ' ' PHE . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.23 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.24 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' CB ' ' HG2' ' A' ' 149' ' ' PRO . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.51 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.521 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.11 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.43 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.463 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.02 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.483 ' CG2' ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.13 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.33 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.492 ' NE2' HD23 ' A' ' 167' ' ' LEU . 19.0 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.1 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.573 HD11 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.23 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.578 ' HE2' ' CZ ' ' A' ' 53' ' ' PHE . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.34 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLN . . . . . 0.517 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.41 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.567 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.04 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.445 ' HG ' ' HG ' ' A' ' 43' ' ' LEU . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.42 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.22 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.11 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.01 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.11 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.11 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.578 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.12 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.24 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.21 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.585 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.33 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' HIS . . . . . 0.691 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 3.0 p-80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.14 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.522 ' CG2' ' HB2' ' A' ' 27' ' ' SER . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.32 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' SER . . . . . 0.415 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.24 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.612 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.33 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' MET . . . . . 0.612 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.12 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.31 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.13 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.2 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' MET . . . . . 0.467 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.21 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.415 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.02 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.31 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.42 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.04 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.574 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.43 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.568 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.13 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.33 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.46 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.21 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.525 ' HB2' ' CG1' ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.31 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.569 HG22 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.21 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' MET . . . . . 0.57 ' HE3' ' CZ ' ' A' ' 110' ' ' PHE . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.04 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.475 HG12 ' HG2' ' A' ' 82' ' ' GLU . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.32 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.32 109.55 172.211 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.534 ' CD1' ' HD3' ' A' ' 119' ' ' LYS . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.3 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.12 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.518 ' CG1' ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.32 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.516 ' O ' ' CG2' ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.11 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.02 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' MET . . . . . 0.567 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.51 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.4 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.12 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' VAL . . . . . 0.527 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.33 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' MET . . . . . 0.624 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.03 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.45 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASN . . . . . 0.484 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.35 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' HA ' ' CD1' ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.14 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 89' ' ' MET . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.45 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.509 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.44 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.484 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.11 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.531 ' CD1' ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.4 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . 0.474 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.14 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.35 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.45 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' PRO . . . . . 0.461 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.43 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.458 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.31 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.51 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.33 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.55 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' GLU . . . . . 0.423 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.14 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.528 ' HA ' ' CD1' ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.15 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.3 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.4 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.528 ' CD1' ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.2 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.57 ' CZ ' ' HE3' ' A' ' 76' ' ' MET . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.42 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.51 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.05 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.527 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.24 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.31 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.14 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.24 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.586 ' N ' ' CD2' ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.22 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.11 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.534 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.34 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' PHE . . . . . 0.569 ' CE1' HG22 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.24 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.24 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.33 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.515 ' CB ' HG23 ' A' ' 75' ' ' THR . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.34 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' TYR . . . . . 0.568 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.34 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.35 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.21 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' VAL . . . . . 0.525 ' CG1' ' HB2' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.13 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.34 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.13 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.51 ' CE ' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.34 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.44 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.14 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.478 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.12 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' PHE . . . . . 0.691 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.44 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.15 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.52 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.471 ' HB3' ' O ' ' A' ' 136' ' ' PHE . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.23 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.42 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.43 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 143' ' ' SER . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.21 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.516 ' N ' ' OD1' ' A' ' 142' ' ' ASP . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.33 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.22 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.574 ' O ' ' CE2' ' A' ' 140' ' ' PHE . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.43 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 147' ' ' GLY . . . . . 0.563 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.2 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.576 ' CG2' ' CE ' ' A' ' 61' ' ' MET . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.02 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.12 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 150' ' ' ALA . . . . . 0.45 ' HB3' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.13 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 151' ' ' VAL . . . . . 0.517 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.4 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.539 HG23 ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.33 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 153' ' ' VAL . . . . . 0.523 HG22 ' CD1' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 154' ' ' ASN . . . . . 0.51 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.34 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.14 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.522 ' CB ' ' HB1' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.44 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 157' ' ' TYR . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 180' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.33 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 158' ' ' LEU . . . . . 0.443 HD11 ' O ' ' A' ' 151' ' ' VAL . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.4 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.498 HG11 ' CE1' ' A' ' 170' ' ' TYR . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.54 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 160' ' ' GLN . . . . . 0.474 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.2 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.33 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.53 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.01 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.42 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.44 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.23 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 167' ' ' LEU . . . . . 0.492 HD23 ' NE2' ' A' ' 42' ' ' GLN . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.42 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 169' ' ' GLU . . . . . 0.521 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.35 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 170' ' ' TYR . . . . . 0.517 ' OH ' ' CG2' ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.2 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . 0.573 ' CD2' HD11 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.33 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 172' ' ' ASP . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.04 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.519 ' CD2' ' O ' ' A' ' 8' ' ' HIS . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.13 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.22 109.847 -179.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 175' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.11 110.802 179.528 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.659 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.34 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.577 HD21 ' CG ' ' A' ' 9' ' ' TYR . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.12 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 178' ' ' LEU . . . . . 0.523 HD21 ' CB ' ' A' ' 20' ' ' PRO . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.22 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 179' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.4 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.13 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.463 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.205 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.134 0.492 . . . . 73.239999999999995 110.092 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.310000000000002 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.340000000000003 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.608 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.409999999999997 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 30.6 m80 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.510000000000005 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CG ' HD21 ' A' ' 177' ' ' LEU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.329999999999998 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.010000000000005 109.468 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.310000000000002 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.905 HD11 HD23 ' A' ' 158' ' ' LEU . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.239999999999995 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.019999999999996 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.549999999999997 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.978 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.049999999999997 110.397 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.340000000000003 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.109999999999999 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.340000000000003 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.230000000000004 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.130000000000003 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.129999999999995 110.185 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.808 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.510000000000005 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.450000000000003 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.319999999999993 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.129999999999995 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.319999999999993 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.409999999999997 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.120000000000005 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.329999999999998 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.229999999999997 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.230000000000004 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.240000000000002 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.510000000000005 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.109999999999999 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.430000000000007 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.808 HG21 ' CD ' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.129999999999995 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.329999999999998 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' A' ' 167' ' ' LEU . 38.9 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.099999999999994 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.230000000000004 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.340000000000003 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.409999999999997 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.040000000000006 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' HA ' ' A' ' 44' ' ' LYS . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.420000000000002 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.219999999999999 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.109999999999999 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.010000000000005 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.109999999999999 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.109999999999999 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.120000000000005 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.239999999999995 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.209999999999994 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.329999999999998 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.140000000000001 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.319999999999993 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.240000000000002 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.329999999999998 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.120000000000005 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.593 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.310000000000002 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.130000000000003 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.200000000000003 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.209999999999994 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.019999999999996 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.420000000000002 110.337 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.697 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.040000000000006 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.871 ' CB ' HG13 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.430000000000007 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.130000000000003 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.329999999999998 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.210000000000001 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.310000000000002 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.787 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.210000000000001 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.548 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.040000000000006 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.319999999999993 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.319999999999993 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD13 ' CD ' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.299999999999997 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.120000000000005 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.319999999999993 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.109999999999999 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.019999999999996 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.561 ' CG ' HD11 ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.510000000000005 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.400000000000006 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.120000000000005 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 113' ' ' GLU . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.329999999999998 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.030000000000001 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.450000000000003 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.349999999999994 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.838 ' HA ' HD12 ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.140000000000001 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.450000000000003 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.439999999999998 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.109999999999999 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.400000000000006 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.140000000000001 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.349999999999994 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.450000000000003 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.52 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.430000000000007 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.310000000000002 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.510000000000005 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.329999999999998 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.549999999999997 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.140000000000001 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.149999999999999 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.299999999999997 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.400000000000006 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.200000000000003 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.548 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.420000000000002 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.510000000000005 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.049999999999997 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.239999999999995 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.310000000000002 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.561 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.140000000000001 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.239999999999995 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.219999999999999 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.109999999999999 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.919 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.340000000000003 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 79' ' ' LEU . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.239999999999995 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.329999999999998 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.340000000000003 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.340000000000003 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.349999999999994 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.209999999999994 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.129999999999995 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.340000000000003 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.129999999999995 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.764 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.340000000000003 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 70' ' ' SER . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.439999999999998 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.140000000000001 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.120000000000005 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.439999999999998 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.150000000000006 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 138' ' ' LYS . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.519999999999996 110.146 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 14.7 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.230000000000004 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.420000000000002 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.430000000000007 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.210000000000001 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.697 ' O ' HD13 ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.329999999999998 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.219999999999999 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 158' ' ' LEU . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.430000000000007 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.200000000000003 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.019999999999996 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.119999999999997 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.886 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.130000000000003 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.832 HG21 ' OH ' ' A' ' 170' ' ' TYR . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.399999999999999 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.543 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.329999999999998 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.340000000000003 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.140000000000001 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.978 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.439999999999998 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.822 ' HB3' HD22 ' A' ' 177' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.329999999999998 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.400000000000006 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 177' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.540000000000006 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.200000000000003 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.329999999999998 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.530000000000001 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.009999999999998 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.789 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.420000000000002 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.439999999999998 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.607 HD11 ' OE1' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.420000000000002 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.349999999999994 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.832 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.200000000000003 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.758 ' CD1' HD12 ' A' ' 43' ' ' LEU . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.329999999999998 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.039999999999999 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 177' ' ' LEU . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.129999999999995 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 159' ' ' VAL . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.219999999999999 109.712 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.74 HD22 ' HE2' ' A' ' 171' ' ' PHE . 38.1 m-20 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.109999999999999 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.807 ' O ' HD23 ' A' ' 180' ' ' LEU . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.340000000000003 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 157' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.120000000000005 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 175' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.219999999999999 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.400000000000006 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.129999999999995 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.049999999999997 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.76 -0.459 . . . . 73.239999999999995 109.76 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.736 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.310000000000002 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.340000000000003 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.409999999999997 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HB3' HD22 ' A' ' 173' ' ' LEU . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.510000000000005 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CG ' HD21 ' A' ' 177' ' ' LEU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.329999999999998 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.010000000000005 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.310000000000002 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 143' ' ' SER . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.239999999999995 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.019999999999996 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.549999999999997 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.016 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.049999999999997 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.340000000000003 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.109999999999999 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.401 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.340000000000003 110.051 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.230000000000004 109.922 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.130000000000003 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.129999999999995 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.947 ' OE2' HG22 ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.510000000000005 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE1' HG23 ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.450000000000003 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.746 ' HA ' HG21 ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.319999999999993 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.239999999999995 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.646 ' CD1' HD12 ' A' ' 93' ' ' ILE . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.319999999999993 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.409999999999997 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.705 ' O ' HG23 ' A' ' 35' ' ' THR . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.120000000000005 110.499 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.229999999999997 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.230000000000004 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 31' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.240000000000002 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.761 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.510000000000005 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.109999999999999 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.430000000000007 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.019999999999996 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.129999999999995 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.329999999999998 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.67 ' OE1' HD11 ' A' ' 167' ' ' LEU . 41.2 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.099999999999994 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.230000000000004 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.340000000000003 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.409999999999997 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.4 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.040000000000006 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.420000000000002 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.219999999999999 110.102 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.109999999999999 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.010000000000005 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.109999999999999 110.577 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.109999999999999 109.633 174.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.120000000000005 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 7.8 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.239999999999995 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.209999999999994 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.59 ' ND2' ' HB3' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.329999999999998 109.802 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.140000000000001 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.319999999999993 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.488 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.240000000000002 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.329999999999998 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.120000000000005 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.310000000000002 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.130000000000003 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.200000000000003 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.209999999999994 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.019999999999996 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.310000000000002 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.420000000000002 110.211 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.040000000000006 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.723 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.430000000000007 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.130000000000003 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.329999999999998 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.487 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.210000000000001 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.055 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.310000000000002 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.695 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.210000000000001 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.55 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.040000000000006 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.319999999999993 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.628 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.319999999999993 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 ' CD ' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.299999999999997 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.120000000000005 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.319999999999993 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.109999999999999 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.019999999999996 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.64 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.510000000000005 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.400000000000006 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.54 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.120000000000005 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.771 HG11 ' HG3' ' A' ' 113' ' ' GLU . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.329999999999998 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.030000000000001 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.450000000000003 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' THR . 12.3 t-20 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.349999999999994 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.140000000000001 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.450000000000003 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.439999999999998 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.109999999999999 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.400000000000006 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.140000000000001 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.349999999999994 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.450000000000003 110.234 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.602 ' CG ' HD13 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.430000000000007 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.310000000000002 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.510000000000005 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.329999999999998 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.549999999999997 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.140000000000001 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.149999999999999 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.299999999999997 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.400000000000006 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.200000000000003 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.64 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.420000000000002 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.510000000000005 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.049999999999997 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.771 ' HG3' HG11 ' A' ' 88' ' ' VAL . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.239999999999995 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.310000000000002 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.140000000000001 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.239999999999995 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.219999999999999 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.109999999999999 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.986 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.340000000000003 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.839 ' HA ' HD11 ' A' ' 79' ' ' LEU . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.239999999999995 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.239999999999995 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.329999999999998 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.340000000000003 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.340000000000003 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.349999999999994 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.209999999999994 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.129999999999995 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.340000000000003 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.129999999999995 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.340000000000003 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.723 HG13 ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.439999999999998 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HD3' ' HA ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.140000000000001 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.120000000000005 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.439999999999998 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.150000000000006 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.519999999999996 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.420000000000002 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.430000000000007 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.210000000000001 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.219999999999999 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 150' ' ' ALA . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.430000000000007 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.200000000000003 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 26' ' ' PHE . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.019999999999996 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.647 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.119999999999997 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.130000000000003 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.947 HG22 ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.399999999999999 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.329999999999998 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.5 m120 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.340000000000003 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.140000000000001 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.016 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.439999999999998 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.329999999999998 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.400000000000006 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 177' ' ' LEU . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.540000000000006 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 45.2 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.200000000000003 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.329999999999998 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.530000000000001 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.406 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.009999999999998 110.479 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.420000000000002 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.439999999999998 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.67 HD11 ' OE1' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.420000000000002 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.349999999999994 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.886 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.200000000000003 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.773 ' HE2' HD22 ' A' ' 175' ' ' ASN . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.329999999999998 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.039999999999999 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.668 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.129999999999995 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.219999999999999 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.773 HD22 ' HE2' ' A' ' 171' ' ' PHE . 37.8 m-20 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.109999999999999 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.340000000000003 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.120000000000005 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.535 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.219999999999999 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.400000000000006 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.129999999999995 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.049999999999997 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.135 0.493 . . . . 73.239999999999995 109.945 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.310000000000002 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.340000000000003 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.606 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.409999999999997 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.525 ' HB3' HD22 ' A' ' 173' ' ' LEU . 4.4 m80 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.510000000000005 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.329999999999998 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.010000000000005 109.536 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 5' ' ' GLU . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.310000000000002 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.239999999999995 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.019999999999996 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.549999999999997 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.049999999999997 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.493 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.340000000000003 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.109999999999999 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.340000000000003 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.230000000000004 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.130000000000003 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.129999999999995 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.779 ' OE2' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.510000000000005 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.450000000000003 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.319999999999993 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.129999999999995 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.239999999999995 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.319999999999993 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.409999999999997 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.120000000000005 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.329999999999998 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.229999999999997 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.230000000000004 110.367 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.240000000000002 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.510000000000005 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.109999999999999 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.430000000000007 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 167' ' ' LEU . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.019999999999996 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.759 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.129999999999995 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.329999999999998 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.677 ' OE1' HD11 ' A' ' 167' ' ' LEU . 42.2 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.099999999999994 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.230000000000004 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.340000000000003 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.409999999999997 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.3 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.040000000000006 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.420000000000002 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.219999999999999 110.069 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.109999999999999 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.010000000000005 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.109999999999999 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.109999999999999 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.120000000000005 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.239999999999995 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.209999999999994 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.329999999999998 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.793 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 10.1 p80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.140000000000001 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.319999999999993 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' HG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.240000000000002 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.329999999999998 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.120000000000005 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.310000000000002 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.130000000000003 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.200000000000003 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.55 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.209999999999994 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.019999999999996 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.310000000000002 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.420000000000002 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.040000000000006 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.694 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.430000000000007 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.919 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.130000000000003 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.329999999999998 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CE2' HD11 ' A' ' 77' ' ' ILE . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.210000000000001 110.019 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.310000000000002 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 123' ' ' ALA . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.210000000000001 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.040000000000006 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.982 HD12 ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.319999999999993 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.319999999999993 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.299999999999997 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.120000000000005 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.319999999999993 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.109999999999999 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.019999999999996 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.510000000000005 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.400000000000006 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.120000000000005 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 84' ' ' LYS . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.329999999999998 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.030000000000001 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.450000000000003 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.349999999999994 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.648 ' CA ' HD12 ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.140000000000001 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 99' ' ' PRO . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.450000000000003 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.439999999999998 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.109999999999999 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.648 HD12 ' CA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.400000000000006 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.140000000000001 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.349999999999994 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.450000000000003 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.732 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.430000000000007 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.310000000000002 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.510000000000005 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.329999999999998 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.549999999999997 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.140000000000001 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.149999999999999 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.299999999999997 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.400000000000006 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.019 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.200000000000003 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.420000000000002 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.510000000000005 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.049999999999997 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.239999999999995 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.310000000000002 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.140000000000001 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.239999999999995 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.219999999999999 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.109999999999999 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.829 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.340000000000003 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 79' ' ' LEU . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.239999999999995 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.239999999999995 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.329999999999998 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.777 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.340000000000003 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.349999999999994 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.209999999999994 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.129999999999995 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.340000000000003 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.129999999999995 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.528 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.340000000000003 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.919 HG21 ' HG2' ' A' ' 71' ' ' LYS . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.439999999999998 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.140000000000001 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.120000000000005 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.793 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.439999999999998 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.150000000000006 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.519999999999996 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.230000000000004 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' HD12 ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.420000000000002 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.430000000000007 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.210000000000001 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.601 ' HA ' HG21 ' A' ' 14' ' ' THR . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.329999999999998 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.219999999999999 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.866 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.430000000000007 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.200000000000003 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.606 HG23 ' HE1' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.019999999999996 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.119999999999997 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.866 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.130000000000003 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.058 HG21 ' OH ' ' A' ' 170' ' ' TYR . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.399999999999999 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 155' ' ' ASN . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.329999999999998 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.4 m120 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.340000000000003 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.140000000000001 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.993 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.439999999999998 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.978 ' HB3' HD22 ' A' ' 177' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.329999999999998 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.400000000000006 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.745 HG21 HG22 ' A' ' 174' ' ' VAL . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.540000000000006 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.0 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.200000000000003 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.329999999999998 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.530000000000001 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.009999999999998 110.485 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.506 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.420000000000002 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.439999999999998 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.677 HD11 ' OE1' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.420000000000002 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.349999999999994 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 1.058 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.200000000000003 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.329999999999998 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.039999999999999 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.129999999999995 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.745 HG22 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.219999999999999 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.698 ' HA ' HD12 ' A' ' 178' ' ' LEU . 39.7 m-20 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.109999999999999 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.340000000000003 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.120000000000005 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.219999999999999 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.400000000000006 110.314 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 177' ' ' LEU . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.129999999999995 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.049999999999997 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.039 0.447 . . . . 73.239999999999995 109.931 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.742 ' OE2' HG21 ' A' ' 11' ' ' VAL . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.310000000000002 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.340000000000003 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.409999999999997 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.823 ' HB3' HD22 ' A' ' 173' ' ' LEU . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.510000000000005 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.329999999999998 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.010000000000005 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.310000000000002 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.794 HD13 ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.239999999999995 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.019999999999996 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.549999999999997 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB2' ' HD3' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.049999999999997 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.340000000000003 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.109999999999999 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.712 ' HB2' HD22 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.340000000000003 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.230000000000004 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.130000000000003 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.129999999999995 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.897 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.510000000000005 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.450000000000003 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 58' ' ' VAL . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.319999999999993 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.129999999999995 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.239999999999995 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.681 ' HA ' HG21 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.319999999999993 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.409999999999997 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 35' ' ' THR . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.120000000000005 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' HIS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.329999999999998 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.63 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.230000000000004 110.611 -178.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 31' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.240000000000002 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.892 ' CE2' HD11 ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.510000000000005 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.109999999999999 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.430000000000007 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 167' ' ' LEU . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.019999999999996 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.897 HG21 ' OE1' ' A' ' 24' ' ' GLU . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.129999999999995 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.329999999999998 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 4.8 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.099999999999994 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.230000000000004 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.340000000000003 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.409999999999997 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.4 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.040000000000006 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.420000000000002 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.219999999999999 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.109999999999999 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.010000000000005 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.109999999999999 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.109999999999999 109.765 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.120000000000005 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.239999999999995 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.209999999999994 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.329999999999998 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.532 ' CD2' ' CE2' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.140000000000001 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 26' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.319999999999993 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.240000000000002 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.329999999999998 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.624 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.120000000000005 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.310000000000002 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.130000000000003 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.200000000000003 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.019999999999996 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.310000000000002 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.420000000000002 110.311 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.040000000000006 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.609 ' OG ' HG13 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.430000000000007 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.130000000000003 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.329999999999998 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.210000000000001 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.072 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.310000000000002 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 123' ' ' ALA . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.210000000000001 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.555 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.040000000000006 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.319999999999993 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.319999999999993 110.473 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.006 HD13 ' CD ' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.299999999999997 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.120000000000005 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.319999999999993 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.109999999999999 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.019999999999996 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.510000000000005 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.400000000000006 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.120000000000005 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG11 ' OE2' ' A' ' 113' ' ' GLU . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.329999999999998 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.450000000000003 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.349999999999994 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.140000000000001 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.450000000000003 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' PHE . 35.8 t60 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.439999999999998 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.109999999999999 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.400000000000006 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.140000000000001 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.349999999999994 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.450000000000003 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.430000000000007 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.310000000000002 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.329999999999998 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.549999999999997 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.140000000000001 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.997 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.149999999999999 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.299999999999997 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.400000000000006 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.997 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.200000000000003 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.420000000000002 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.510000000000005 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.049999999999997 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.78 ' OE2' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.239999999999995 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.310000000000002 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.140000000000001 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.239999999999995 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.219999999999999 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.109999999999999 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 1.006 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.340000000000003 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.901 ' HA ' HD11 ' A' ' 79' ' ' LEU . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.239999999999995 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.239999999999995 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.329999999999998 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.340000000000003 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.349999999999994 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.209999999999994 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.072 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.129999999999995 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.340000000000003 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.129999999999995 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.340000000000003 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.439999999999998 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.140000000000001 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.120000000000005 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.439999999999998 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.150000000000006 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.519999999999996 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.230000000000004 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.420000000000002 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.430000000000007 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.210000000000001 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.794 ' HA ' HD13 ' A' ' 12' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.219999999999999 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.943 HD22 ' CB ' ' A' ' 150' ' ' ALA . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.430000000000007 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.200000000000003 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 33' ' ' CYS . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.019999999999996 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.119999999999997 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.943 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.130000000000003 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.787 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.399999999999999 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.329999999999998 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.756 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.340000000000003 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 15' ' ' PRO . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.140000000000001 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.439999999999998 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.957 ' HB3' HD22 ' A' ' 177' ' ' LEU . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.329999999999998 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.817 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.400000000000006 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.540000000000006 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.200000000000003 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.329999999999998 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.530000000000001 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.009999999999998 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.420000000000002 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.439999999999998 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.230000000000004 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.420000000000002 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.349999999999994 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.787 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.200000000000003 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 43' ' ' LEU . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.329999999999998 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.039999999999999 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.129999999999995 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.219999999999999 109.89 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.109999999999999 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.559 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.340000000000003 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.988 HD23 HD12 ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.120000000000005 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.219999999999999 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.400000000000006 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.988 HD12 HD23 ' A' ' 177' ' ' LEU . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.129999999999995 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.049999999999997 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.099 0.476 . . . . 73.239999999999995 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.310000000000002 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.340000000000003 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.409999999999997 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.510000000000005 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.329999999999998 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.010000000000005 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.915 HG22 ' CE1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.310000000000002 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.239999999999995 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.019999999999996 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 143' ' ' SER . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.549999999999997 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.957 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.049999999999997 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.340000000000003 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.109999999999999 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.340000000000003 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.230000000000004 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.130000000000003 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.129999999999995 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.931 ' OE1' HG22 ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.510000000000005 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CB ' HG12 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.450000000000003 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.319999999999993 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.611 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.129999999999995 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.931 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.319999999999993 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.409999999999997 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.633 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.120000000000005 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.329999999999998 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.229999999999997 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.230000000000004 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 31' ' ' PRO . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.240000000000002 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.88 ' HE2' HD11 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.510000000000005 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.109999999999999 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.430000000000007 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 167' ' ' LEU . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.019999999999996 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.88 HD11 ' HE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.129999999999995 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.329999999999998 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 4.0 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.099999999999994 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.230000000000004 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 47' ' ' LEU . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.340000000000003 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.409999999999997 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 48.9 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.040000000000006 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.420000000000002 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.219999999999999 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.109999999999999 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.010000000000005 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.109999999999999 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.109999999999999 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.120000000000005 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.6 mm100 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.239999999999995 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.209999999999994 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.329999999999998 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.140000000000001 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.319999999999993 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.240000000000002 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.329999999999998 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.120000000000005 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.310000000000002 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.130000000000003 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.200000000000003 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.209999999999994 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.019999999999996 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.310000000000002 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.420000000000002 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.584 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.040000000000006 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.430000000000007 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.130000000000003 110.395 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.329999999999998 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.210000000000001 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.310000000000002 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 123' ' ' ALA . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.210000000000001 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.703 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.040000000000006 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.965 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.319999999999993 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.319999999999993 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.999 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.299999999999997 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.120000000000005 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 79' ' ' LEU . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.319999999999993 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.109999999999999 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.019999999999996 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.561 ' HA ' HG23 ' A' ' 88' ' ' VAL . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.510000000000005 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.400000000000006 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.120000000000005 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.796 HG21 ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.329999999999998 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.030000000000001 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.450000000000003 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.349999999999994 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.140000000000001 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.931 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.450000000000003 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.439999999999998 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.109999999999999 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.400000000000006 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.140000000000001 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.349999999999994 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.450000000000003 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.693 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.430000000000007 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.310000000000002 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.510000000000005 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.329999999999998 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.549999999999997 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.140000000000001 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.149999999999999 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.299999999999997 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.400000000000006 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.200000000000003 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.703 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.420000000000002 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.845 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.510000000000005 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.049999999999997 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.796 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.239999999999995 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.310000000000002 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.140000000000001 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.545 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.239999999999995 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.845 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.219999999999999 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.109999999999999 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.999 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.340000000000003 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 79' ' ' LEU . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.239999999999995 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.239999999999995 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.329999999999998 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.340000000000003 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.349999999999994 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.209999999999994 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.129999999999995 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.340000000000003 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.129999999999995 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.662 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.340000000000003 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.791 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.439999999999998 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.140000000000001 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 132' ' ' MET . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.120000000000005 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.439999999999998 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.150000000000006 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.519999999999996 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.230000000000004 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' HD12 ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.420000000000002 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.430000000000007 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.210000000000001 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 14' ' ' THR . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.329999999999998 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.219999999999999 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.952 HD22 ' HB1' ' A' ' 150' ' ' ALA . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.430000000000007 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.593 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.200000000000003 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' C ' ' A' ' 149' ' ' PRO . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.019999999999996 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 148' ' ' VAL . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.119999999999997 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.130000000000003 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.054 HG21 ' OH ' ' A' ' 170' ' ' TYR . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.399999999999999 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.329999999999998 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.895 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.340000000000003 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.140000000000001 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.439999999999998 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.925 ' HB3' HD22 ' A' ' 177' ' ' LEU . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.329999999999998 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.400000000000006 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.84 HG13 HD23 ' A' ' 173' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.540000000000006 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.200000000000003 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.329999999999998 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.530000000000001 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.009999999999998 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 170' ' ' TYR . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.420000000000002 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.439999999999998 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.230000000000004 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.420000000000002 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.349999999999994 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 1.054 ' OH ' HG21 ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.200000000000003 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.329999999999998 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.039999999999999 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 159' ' ' VAL . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.129999999999995 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 159' ' ' VAL . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.219999999999999 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.1 m120 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.109999999999999 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.340000000000003 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.120000000000005 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.400000000000006 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 177' ' ' LEU . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.129999999999995 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.459 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.049999999999997 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mttt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.068 0.461 . . . . 73.239999999999995 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.621 ' CD ' HG11 ' A' ' 11' ' ' VAL . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.310000000000002 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.340000000000003 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.409999999999997 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.524 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 10.6 m80 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.510000000000005 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.649 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.329999999999998 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.010000000000005 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.310000000000002 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.239999999999995 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.019999999999996 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.549999999999997 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.049999999999997 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.340000000000003 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.109999999999999 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.340000000000003 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.230000000000004 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.130000000000003 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.129999999999995 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.786 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.510000000000005 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.450000000000003 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.319999999999993 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.129999999999995 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.917 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.239999999999995 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.612 ' HA ' HG21 ' A' ' 93' ' ' ILE . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.319999999999993 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.409999999999997 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.120000000000005 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.329999999999998 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 149' ' ' PRO . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.229999999999997 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.230000000000004 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.240000000000002 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.772 ' CE2' HD11 ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.510000000000005 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.109999999999999 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.430000000000007 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.019999999999996 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.786 HG21 ' CD ' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.129999999999995 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.329999999999998 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.67 ' OE1' HD11 ' A' ' 167' ' ' LEU . 41.3 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.099999999999994 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.230000000000004 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.896 ' HA ' HD12 ' A' ' 47' ' ' LEU . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.340000000000003 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.409999999999997 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.040000000000006 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.420000000000002 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.219999999999999 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.109999999999999 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.010000000000005 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.109999999999999 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.109999999999999 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.76 ' CD1' HD11 ' A' ' 47' ' ' LEU . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.120000000000005 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.239999999999995 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.209999999999994 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.329999999999998 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.140000000000001 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.319999999999993 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.240000000000002 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.329999999999998 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.672 ' SD ' HG22 ' A' ' 148' ' ' VAL . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.120000000000005 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.591 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.310000000000002 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.130000000000003 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.200000000000003 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.209999999999994 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.019999999999996 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.310000000000002 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.420000000000002 110.309 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.040000000000006 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.430000000000007 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.904 ' HG2' HG21 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.130000000000003 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.329999999999998 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.210000000000001 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.310000000000002 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.709 HG21 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.210000000000001 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.603 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.040000000000006 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.918 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.319999999999993 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.319999999999993 109.773 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.009 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.299999999999997 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.120000000000005 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 79' ' ' LEU . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.319999999999993 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.109999999999999 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.019999999999996 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.510000000000005 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.400000000000006 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.120000000000005 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.938 HG21 ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.329999999999998 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 106' ' ' LEU . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.030000000000001 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.450000000000003 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.349999999999994 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.997 ' NH2' HG21 ' A' ' 109' ' ' ILE . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.917 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.450000000000003 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 90' ' ' PHE . 1.9 t60 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.439999999999998 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.109999999999999 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.400000000000006 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.140000000000001 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.349999999999994 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.450000000000003 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.657 ' CG ' HD13 ' A' ' 106' ' ' LEU . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.430000000000007 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.310000000000002 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.510000000000005 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.329999999999998 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.549999999999997 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.140000000000001 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.011 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.149999999999999 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.299999999999997 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.400000000000006 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.200000000000003 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.603 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.420000000000002 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.510000000000005 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.049999999999997 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.938 ' OE1' HG21 ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.239999999999995 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.310000000000002 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.688 HG23 ' HE3' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.140000000000001 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.239999999999995 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.219999999999999 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.109999999999999 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.688 ' HE3' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.340000000000003 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.709 ' CE1' HG21 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.239999999999995 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.239999999999995 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.329999999999998 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.340000000000003 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.340000000000003 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.349999999999994 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.209999999999994 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.129999999999995 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.340000000000003 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.129999999999995 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.841 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.340000000000003 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.904 HG21 ' HG2' ' A' ' 71' ' ' LYS . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.439999999999998 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.140000000000001 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.120000000000005 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.439999999999998 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.150000000000006 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.519999999999996 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.230000000000004 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' HD12 ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.420000000000002 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.430000000000007 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.677 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.210000000000001 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 145' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.329999999999998 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.219999999999999 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 158' ' ' LEU . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.430000000000007 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.200000000000003 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.672 HG22 ' SD ' ' A' ' 61' ' ' MET . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.019999999999996 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.119999999999997 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.917 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.130000000000003 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.724 HG21 ' OH ' ' A' ' 170' ' ' TYR . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.399999999999999 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.329999999999998 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 4.2 m120 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.340000000000003 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.140000000000001 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.838 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.439999999999998 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.895 ' HB3' HD22 ' A' ' 177' ' ' LEU . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.329999999999998 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 145' ' ' LEU . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.400000000000006 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.540000000000006 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.200000000000003 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.329999999999998 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.530000000000001 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.401 ' HG ' ' CD2' ' A' ' 8' ' ' HIS . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.009999999999998 110.412 179.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.420000000000002 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.439999999999998 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.230000000000004 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.67 HD11 ' OE1' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.420000000000002 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.349999999999994 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.724 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.200000000000003 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.794 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.329999999999998 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.039999999999999 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.528 HD23 HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.129999999999995 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 159' ' ' VAL . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 109.629 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.626 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.109999999999999 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.340000000000003 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.120000000000005 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.219999999999999 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.400000000000006 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.129999999999995 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.049999999999997 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.656 -0.498 . . . . 73.239999999999995 109.656 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.310000000000002 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.340000000000003 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.583 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.409999999999997 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.510000000000005 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.58 ' CG ' HD21 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.329999999999998 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.010000000000005 109.516 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.815 HG22 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.310000000000002 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HD23 ' A' ' 158' ' ' LEU . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.239999999999995 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.019999999999996 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.549999999999997 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.972 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.049999999999997 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.340000000000003 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.109999999999999 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.340000000000003 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.603 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.230000000000004 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.626 ' CG2' HD21 ' A' ' 178' ' ' LEU . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.130000000000003 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.129999999999995 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.831 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.510000000000005 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.450000000000003 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.319999999999993 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.129999999999995 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.239999999999995 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.752 ' HA ' HG21 ' A' ' 93' ' ' ILE . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.319999999999993 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.409999999999997 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.54 ' N ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.120000000000005 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.329999999999998 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.230000000000004 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.240000000000002 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD11 ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.510000000000005 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.109999999999999 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.430000000000007 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.019999999999996 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.913 HD11 ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.129999999999995 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.329999999999998 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 4.6 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.099999999999994 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.673 HD12 ' CD1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 47' ' ' LEU . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.340000000000003 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.409999999999997 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.040000000000006 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.420000000000002 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.219999999999999 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.109999999999999 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.010000000000005 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.109999999999999 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.109999999999999 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.120000000000005 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.239999999999995 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.209999999999994 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.329999999999998 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.585 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.140000000000001 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.319999999999993 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.240000000000002 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.329999999999998 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.120000000000005 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.310000000000002 109.884 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.130000000000003 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.200000000000003 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.209999999999994 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.019999999999996 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.310000000000002 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.420000000000002 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.040000000000006 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.430000000000007 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.06 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.130000000000003 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.329999999999998 110.109 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 76' ' ' MET . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.210000000000001 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.991 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.310000000000002 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.763 HG21 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.210000000000001 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.040000000000006 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.319999999999993 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.319999999999993 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.299999999999997 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.120000000000005 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.813 HG12 ' HE3' ' A' ' 84' ' ' LYS . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.109999999999999 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.813 ' HE3' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.019999999999996 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.61 ' CG ' HD11 ' A' ' 115' ' ' ILE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.510000000000005 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.400000000000006 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.120000000000005 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.847 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.329999999999998 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.030000000000001 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.450000000000003 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.753 ' OD1' HG21 ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.349999999999994 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.822 ' HA ' HD12 ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.140000000000001 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.450000000000003 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.439999999999998 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.753 HG21 ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.109999999999999 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.822 HD12 ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.400000000000006 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.140000000000001 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.349999999999994 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.450000000000003 110.485 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.430000000000007 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.310000000000002 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.510000000000005 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.329999999999998 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.549999999999997 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.140000000000001 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.072 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.149999999999999 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.299999999999997 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.400000000000006 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.072 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.200000000000003 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.420000000000002 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.510000000000005 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.049999999999997 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.847 ' HG3' HG11 ' A' ' 88' ' ' VAL . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.239999999999995 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.310000000000002 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.140000000000001 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.239999999999995 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.219999999999999 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.109999999999999 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.974 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.340000000000003 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.927 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.239999999999995 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.239999999999995 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.329999999999998 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.340000000000003 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.340000000000003 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.349999999999994 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.209999999999994 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.991 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.129999999999995 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.340000000000003 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.535 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.129999999999995 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.894 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.340000000000003 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.06 HG21 ' HG2' ' A' ' 71' ' ' LYS . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.439999999999998 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.140000000000001 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.120000000000005 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.439999999999998 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.150000000000006 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.519999999999996 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.230000000000004 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HA ' HD12 ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.420000000000002 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.430000000000007 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.210000000000001 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.58 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.329999999999998 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.219999999999999 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.9 HD22 ' HB1' ' A' ' 150' ' ' ALA . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.430000000000007 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.200000000000003 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.019999999999996 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.119999999999997 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.9 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.130000000000003 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.831 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.399999999999999 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.329999999999998 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 177' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.340000000000003 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.140000000000001 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.972 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.439999999999998 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.815 ' CE1' HG22 ' A' ' 11' ' ' VAL . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.329999999999998 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.762 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.400000000000006 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.723 HG22 ' CD1' ' A' ' 177' ' ' LEU . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.540000000000006 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 26.6 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.200000000000003 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.329999999999998 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.530000000000001 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.599 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.009999999999998 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.420000000000002 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.439999999999998 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.230000000000004 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 167' ' ' LEU . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.420000000000002 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.349999999999994 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.762 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.200000000000003 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.74 ' HE2' HD22 ' A' ' 175' ' ' ASN . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.329999999999998 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.039999999999999 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.129999999999995 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.219999999999999 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.74 HD22 ' HE2' ' A' ' 171' ' ' PHE . 37.9 m-20 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.109999999999999 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.340000000000003 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.120000000000005 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.626 HD21 ' CG2' ' A' ' 22' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.219999999999999 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 175' ' ' ASN . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.400000000000006 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.129999999999995 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.049999999999997 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.203 0.525 . . . . 73.239999999999995 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.574 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.310000000000002 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.340000000000003 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.409999999999997 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 39.0 m80 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.510000000000005 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.329999999999998 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.010000000000005 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.310000000000002 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 158' ' ' LEU . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.239999999999995 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.019999999999996 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.848 HG22 ' HB2' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.549999999999997 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.049999999999997 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.340000000000003 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.109999999999999 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.340000000000003 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG11 ' OG ' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.230000000000004 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.130000000000003 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.506 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.129999999999995 110.057 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.815 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.510000000000005 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.450000000000003 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.319999999999993 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.129999999999995 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.239999999999995 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.319999999999993 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.409999999999997 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.120000000000005 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.329999999999998 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.229999999999997 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.230000000000004 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.240000000000002 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 40' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.510000000000005 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.109999999999999 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.430000000000007 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 36' ' ' PHE . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.019999999999996 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' CD ' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.129999999999995 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.329999999999998 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.621 ' OE1' HD11 ' A' ' 167' ' ' LEU . 40.3 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.099999999999994 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.230000000000004 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.340000000000003 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.409999999999997 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 45.5 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.040000000000006 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.420000000000002 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.219999999999999 109.891 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.109999999999999 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.010000000000005 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.109999999999999 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.109999999999999 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.582 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.120000000000005 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.239999999999995 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.209999999999994 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.329999999999998 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.140000000000001 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 61' ' ' MET . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.319999999999993 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.240000000000002 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.329999999999998 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.120000000000005 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.310000000000002 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.130000000000003 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.200000000000003 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.464 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.209999999999994 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.019999999999996 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.310000000000002 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.420000000000002 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.595 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.040000000000006 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.430000000000007 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.130000000000003 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.329999999999998 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.210000000000001 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.310000000000002 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.605 HG23 ' HB3' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.210000000000001 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.823 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.040000000000006 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.944 HD12 ' HA ' ' A' ' 74' ' ' ALA . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.319999999999993 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.319999999999993 109.524 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.028 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.299999999999997 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.120000000000005 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.319999999999993 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.109999999999999 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.019999999999996 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.823 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.510000000000005 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.400000000000006 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.120000000000005 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.759 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.329999999999998 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.559 ' HE1' HD11 ' A' ' 106' ' ' LEU . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.030000000000001 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.450000000000003 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.349999999999994 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.86 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.140000000000001 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.450000000000003 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.439999999999998 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.109999999999999 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.400000000000006 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.349999999999994 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.450000000000003 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.430000000000007 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.310000000000002 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.510000000000005 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.329999999999998 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.549999999999997 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.140000000000001 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.008 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.149999999999999 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.299999999999997 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.400000000000006 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.200000000000003 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.420000000000002 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.855 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.510000000000005 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.049999999999997 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.759 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.239999999999995 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.310000000000002 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.140000000000001 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.239999999999995 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.855 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.219999999999999 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.109999999999999 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.340000000000003 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.239999999999995 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.239999999999995 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.329999999999998 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.340000000000003 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.340000000000003 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.349999999999994 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.209999999999994 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.129999999999995 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.340000000000003 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.129999999999995 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.802 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.340000000000003 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.439999999999998 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 132' ' ' MET . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.120000000000005 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.439999999999998 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.150000000000006 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.519999999999996 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.528 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.230000000000004 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.430000000000007 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.848 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.210000000000001 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.329999999999998 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.219999999999999 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.897 HD22 ' HB1' ' A' ' 150' ' ' ALA . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.430000000000007 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.200000000000003 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.019999999999996 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.119999999999997 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.897 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.130000000000003 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.981 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.399999999999999 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.415 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.329999999999998 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.9 m120 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.340000000000003 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.140000000000001 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.439999999999998 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.788 ' HB3' HD22 ' A' ' 177' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.329999999999998 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.754 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.400000000000006 108.989 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.524 HG13 HD23 ' A' ' 173' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.540000000000006 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.200000000000003 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.329999999999998 109.757 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.530000000000001 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.009999999999998 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.420000000000002 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.439999999999998 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.230000000000004 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.621 HD11 ' OE1' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.420000000000002 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.349999999999994 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.981 ' OH ' HG21 ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.200000000000003 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.769 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.329999999999998 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.039999999999999 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 159' ' ' VAL . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.129999999999995 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.219999999999999 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.109999999999999 110.736 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.709 ' O ' HG22 ' A' ' 179' ' ' THR . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.340000000000003 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.967 HD23 HD12 ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.120000000000005 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.219999999999999 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.400000000000006 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.967 HD12 HD23 ' A' ' 177' ' ' LEU . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.049999999999997 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.114 0.483 . . . . 73.239999999999995 109.929 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.310000000000002 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.340000000000003 109.211 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.409999999999997 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.518 ' HB3' HD22 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.510000000000005 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.329999999999998 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.010000000000005 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.002 HG22 ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.310000000000002 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.239999999999995 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.019999999999996 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.549999999999997 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.049999999999997 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.340000000000003 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.402 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.109999999999999 109.626 175.876 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.340000000000003 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.230000000000004 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 HD21 ' A' ' 47' ' ' LEU . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.130000000000003 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.129999999999995 110.031 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.809 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.510000000000005 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.450000000000003 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.319999999999993 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.129999999999995 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.696 ' O ' HG21 ' A' ' 93' ' ' ILE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.239999999999995 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.319999999999993 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.409999999999997 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.120000000000005 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.329999999999998 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.229999999999997 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.230000000000004 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.240000000000002 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.510000000000005 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.109999999999999 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.430000000000007 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.019999999999996 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 24' ' ' GLU . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.129999999999995 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.329999999999998 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 5.0 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.099999999999994 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.230000000000004 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.752 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.340000000000003 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.409999999999997 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 45.3 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.040000000000006 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 44' ' ' LYS . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.420000000000002 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.219999999999999 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.109999999999999 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.010000000000005 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.109999999999999 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.109999999999999 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.120000000000005 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.239999999999995 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.209999999999994 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 136' ' ' PHE . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.329999999999998 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.140000000000001 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 58' ' ' VAL . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.319999999999993 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.240000000000002 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.329999999999998 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.120000000000005 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.310000000000002 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.130000000000003 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.200000000000003 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.209999999999994 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.019999999999996 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.310000000000002 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.420000000000002 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.040000000000006 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.564 ' OG ' ' CD2' ' A' ' 57' ' ' HIS . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.430000000000007 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HG2' HG21 ' A' ' 133' ' ' VAL . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.130000000000003 110.218 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.329999999999998 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.210000000000001 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.310000000000002 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.210000000000001 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.040000000000006 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.319999999999993 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.319999999999993 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.973 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.299999999999997 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.120000000000005 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.319999999999993 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.109999999999999 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.019999999999996 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.510000000000005 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.400000000000006 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.120000000000005 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.329999999999998 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.030000000000001 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.450000000000003 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.526 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.349999999999994 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.824 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.140000000000001 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.450000000000003 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 78.9 t60 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.439999999999998 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.109999999999999 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.400000000000006 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.140000000000001 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.349999999999994 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.450000000000003 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.430000000000007 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.310000000000002 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HE1' ' A' ' 65' ' ' MET . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.510000000000005 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.329999999999998 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.549999999999997 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.140000000000001 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.149999999999999 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.299999999999997 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.400000000000006 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.200000000000003 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.420000000000002 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.835 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.510000000000005 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.049999999999997 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.239999999999995 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.310000000000002 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 85' ' ' MET . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.140000000000001 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.239999999999995 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.835 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.219999999999999 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.109999999999999 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.973 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.340000000000003 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 79' ' ' LEU . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.239999999999995 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.239999999999995 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.329999999999998 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.340000000000003 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.340000000000003 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.349999999999994 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.209999999999994 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.129999999999995 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.340000000000003 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.527 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.129999999999995 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.846 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.340000000000003 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.714 HG21 ' HG2' ' A' ' 71' ' ' LYS . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.439999999999998 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.140000000000001 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.120000000000005 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.439999999999998 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.150000000000006 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.519999999999996 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 3.3 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.230000000000004 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.420000000000002 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.430000000000007 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.662 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.210000000000001 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.567 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.329999999999998 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.219999999999999 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 158' ' ' LEU . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.430000000000007 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.200000000000003 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.019999999999996 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.119999999999997 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.823 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.130000000000003 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.661 HG21 ' OH ' ' A' ' 170' ' ' TYR . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.399999999999999 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.329999999999998 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' HB2' ' A' ' 177' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.340000000000003 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.140000000000001 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.683 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.439999999999998 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 1.002 ' CE1' HG22 ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.329999999999998 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.400000000000006 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.540000000000006 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.200000000000003 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.329999999999998 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.530000000000001 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.009999999999998 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.420000000000002 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.439999999999998 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.230000000000004 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.479 HD21 HG23 ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.420000000000002 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.516 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.349999999999994 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.661 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.200000000000003 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.787 ' HE2' HD22 ' A' ' 175' ' ' ASN . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.329999999999998 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD2' ' HA ' ' A' ' 169' ' ' GLU . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.039999999999999 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.129999999999995 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 159' ' ' VAL . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.596 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.787 HD22 ' HE2' ' A' ' 171' ' ' PHE . 36.1 m-20 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.109999999999999 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.340000000000003 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.004 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.120000000000005 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.219999999999999 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.400000000000006 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.004 HD12 ' HA ' ' A' ' 177' ' ' LEU . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.129999999999995 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.049999999999997 110.207 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.095 0.474 . . . . 73.239999999999995 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.663 ' CD ' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.310000000000002 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.340000000000003 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.609 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.409999999999997 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.510000000000005 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CG ' HD21 ' A' ' 177' ' ' LEU . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.329999999999998 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.010000000000005 109.407 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.310000000000002 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.239999999999995 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.019999999999996 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.549999999999997 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.049999999999997 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.340000000000003 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.109999999999999 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.340000000000003 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.230000000000004 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.130000000000003 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.129999999999995 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.909 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.510000000000005 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.450000000000003 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.319999999999993 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.622 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.129999999999995 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.239999999999995 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.319999999999993 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.409999999999997 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.120000000000005 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.329999999999998 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.229999999999997 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.230000000000004 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.240000000000002 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.887 ' CE2' HD11 ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.510000000000005 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.109999999999999 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.430000000000007 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.019999999999996 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 ' OE1' ' A' ' 24' ' ' GLU . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.129999999999995 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.329999999999998 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 4.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.099999999999994 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.340000000000003 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.409999999999997 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.6 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.040000000000006 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.420000000000002 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.219999999999999 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.109999999999999 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.010000000000005 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.109999999999999 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.109999999999999 109.681 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.120000000000005 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.239999999999995 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.209999999999994 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.329999999999998 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.797 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.140000000000001 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 58' ' ' VAL . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.319999999999993 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.240000000000002 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.329999999999998 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.120000000000005 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.310000000000002 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.130000000000003 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.200000000000003 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.209999999999994 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.019999999999996 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.310000000000002 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.420000000000002 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.596 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.040000000000006 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.561 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.430000000000007 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.99 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.130000000000003 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.329999999999998 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.797 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.210000000000001 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.310000000000002 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.210000000000001 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.040000000000006 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.937 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.319999999999993 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.319999999999993 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 81' ' ' VAL . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.299999999999997 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.120000000000005 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.319999999999993 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.109999999999999 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.019999999999996 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.510000000000005 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.400000000000006 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.120000000000005 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.665 HG11 ' HG3' ' A' ' 113' ' ' GLU . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.329999999999998 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.594 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.030000000000001 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.450000000000003 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.349999999999994 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.140000000000001 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.450000000000003 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.439999999999998 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.109999999999999 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.400000000000006 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.140000000000001 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.349999999999994 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.450000000000003 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.430000000000007 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.310000000000002 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.493 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.329999999999998 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.549999999999997 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.140000000000001 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.023 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.149999999999999 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.299999999999997 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.400000000000006 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.200000000000003 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.420000000000002 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.510000000000005 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.049999999999997 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.239999999999995 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.310000000000002 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.140000000000001 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.239999999999995 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.886 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.219999999999999 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.109999999999999 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.340000000000003 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.239999999999995 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.239999999999995 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.329999999999998 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.779 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.340000000000003 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.340000000000003 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.349999999999994 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.209999999999994 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.959 ' HA ' ' HE3' ' A' ' 132' ' ' MET . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.129999999999995 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.340000000000003 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.548 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.129999999999995 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.340000000000003 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.99 HG21 ' HG2' ' A' ' 71' ' ' LYS . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.439999999999998 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.140000000000001 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.120000000000005 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.439999999999998 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.150000000000006 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.519999999999996 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.52 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.230000000000004 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.420000000000002 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.430000000000007 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.575 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.210000000000001 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.647 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.329999999999998 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.219999999999999 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.055 HD22 ' HB1' ' A' ' 150' ' ' ALA . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.430000000000007 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.200000000000003 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.019999999999996 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.119999999999997 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 1.055 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.130000000000003 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.902 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.399999999999999 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.568 HG22 HD22 ' A' ' 158' ' ' LEU . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.329999999999998 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.340000000000003 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.140000000000001 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.439999999999998 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.94 ' CE2' HG22 ' A' ' 11' ' ' VAL . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.329999999999998 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.993 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.400000000000006 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 173' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.540000000000006 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.609 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.2 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.200000000000003 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.329999999999998 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.530000000000001 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.009999999999998 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.420000000000002 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.439999999999998 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.230000000000004 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.420000000000002 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.349999999999994 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.902 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.200000000000003 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.329999999999998 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.039999999999999 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.129999999999995 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.219999999999999 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.565 ' HA ' HD12 ' A' ' 178' ' ' LEU . 5.5 m-20 -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.109999999999999 110.585 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.340000000000003 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.878 ' CD1' HG22 ' A' ' 159' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.120000000000005 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 175' ' ' ASN . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.219999999999999 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.400000000000006 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.129999999999995 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.049999999999997 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.606 -0.516 . . . . 73.239999999999995 109.606 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.310000000000002 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.340000000000003 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.409999999999997 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.647 ' HB3' HD22 ' A' ' 173' ' ' LEU . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.510000000000005 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.329999999999998 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.010000000000005 109.617 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.564 HG22 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.310000000000002 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.239999999999995 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.019999999999996 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.549999999999997 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.925 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.049999999999997 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.340000000000003 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.109999999999999 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.491 ' HB2' HD22 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.340000000000003 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.641 HG21 ' CD ' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.230000000000004 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.130000000000003 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.129999999999995 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.510000000000005 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CB ' HG12 ' A' ' 148' ' ' VAL . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.450000000000003 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.45 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.319999999999993 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.62 ' OG ' HG21 ' A' ' 148' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.129999999999995 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.856 ' O ' HG21 ' A' ' 93' ' ' ILE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.239999999999995 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HA ' HG21 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.319999999999993 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.7 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.409999999999997 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.120000000000005 110.033 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.329999999999998 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.229999999999997 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.230000000000004 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.240000000000002 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.510000000000005 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.109999999999999 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.430000000000007 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 36' ' ' PHE . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.818 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.129999999999995 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.329999999999998 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' A' ' 167' ' ' LEU . 8.2 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.099999999999994 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.230000000000004 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.340000000000003 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.409999999999997 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.040000000000006 110.306 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.420000000000002 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.873 ' HD2' HD23 ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.219999999999999 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.109999999999999 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.010000000000005 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.109999999999999 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.109999999999999 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.120000000000005 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.641 ' CD ' HG21 ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.239999999999995 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.209999999999994 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.329999999999998 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.812 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.140000000000001 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 58' ' ' VAL . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.319999999999993 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.240000000000002 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.598 ' HE1' HG21 ' A' ' 58' ' ' VAL . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.329999999999998 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.7 ' HE3' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.120000000000005 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.310000000000002 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.130000000000003 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.200000000000003 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.209999999999994 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.019999999999996 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.310000000000002 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.420000000000002 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.556 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.040000000000006 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.430000000000007 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.130000000000003 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.329999999999998 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.812 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.210000000000001 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.019 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.310000000000002 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.210000000000001 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.504 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.040000000000006 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.319999999999993 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.319999999999993 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.917 HD13 ' CD ' ' A' ' 119' ' ' LYS . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.299999999999997 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.120000000000005 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.319999999999993 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.109999999999999 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.019999999999996 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.595 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.510000000000005 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.400000000000006 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.120000000000005 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.911 HG11 ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.329999999999998 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.030000000000001 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.450000000000003 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.349999999999994 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.844 ' HA ' HD12 ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.140000000000001 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.856 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.450000000000003 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.439999999999998 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.109999999999999 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.400000000000006 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.140000000000001 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.349999999999994 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.61 ' HA ' HD13 ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.450000000000003 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 106' ' ' LEU . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.430000000000007 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.310000000000002 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.510000000000005 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.329999999999998 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.549999999999997 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.140000000000001 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.033 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.149999999999999 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.299999999999997 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.400000000000006 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.033 HD12 ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.200000000000003 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.420000000000002 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.879 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.510000000000005 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.049999999999997 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.911 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.310000000000002 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.140000000000001 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.239999999999995 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.879 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.219999999999999 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.109999999999999 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.917 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.340000000000003 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.239999999999995 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.329999999999998 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.340000000000003 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.340000000000003 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.349999999999994 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.019 HG13 ' HB3' ' A' ' 74' ' ' ALA . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.129999999999995 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.340000000000003 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.129999999999995 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.745 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.340000000000003 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.439999999999998 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.140000000000001 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.120000000000005 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.439999999999998 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.150000000000006 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.519999999999996 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.53 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.230000000000004 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.420000000000002 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.430000000000007 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.210000000000001 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.591 ' OG ' HD12 ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.329999999999998 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.219999999999999 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.057 HD22 ' HB1' ' A' ' 150' ' ' ALA . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.430000000000007 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.200000000000003 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.62 HG21 ' OG ' ' A' ' 27' ' ' SER . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.019999999999996 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.554 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.119999999999997 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 1.057 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.130000000000003 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.399999999999999 110.067 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.461 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.329999999999998 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.8 m120 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.340000000000003 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.140000000000001 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.925 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.439999999999998 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.804 ' HB3' HD22 ' A' ' 177' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.329999999999998 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.903 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.400000000000006 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.540000000000006 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 26.7 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.200000000000003 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.329999999999998 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.530000000000001 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.009999999999998 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.420000000000002 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.439999999999998 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.494 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.420000000000002 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.349999999999994 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.538 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.200000000000003 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.85 ' CD1' HD13 ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.329999999999998 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.039999999999999 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.129999999999995 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.8 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.109999999999999 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.340000000000003 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.120000000000005 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.219999999999999 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.400000000000006 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.049999999999997 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.135 0.493 . . . . 73.239999999999995 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.310000000000002 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.340000000000003 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.409999999999997 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.67 ' HB3' HD22 ' A' ' 173' ' ' LEU . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.510000000000005 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.329999999999998 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.010000000000005 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.310000000000002 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.239999999999995 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.019999999999996 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.549999999999997 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.049999999999997 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.340000000000003 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.109999999999999 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.340000000000003 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.230000000000004 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.130000000000003 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.129999999999995 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HG2' HD12 ' A' ' 40' ' ' ILE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.510000000000005 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.450000000000003 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 58' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.319999999999993 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.129999999999995 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.955 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.239999999999995 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CD1' HD12 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.319999999999993 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.409999999999997 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.120000000000005 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.329999999999998 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.229999999999997 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.230000000000004 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.240000000000002 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.510000000000005 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.109999999999999 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.430000000000007 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.019999999999996 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.917 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.129999999999995 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.329999999999998 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 4.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.099999999999994 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.948 ' HA ' HD12 ' A' ' 47' ' ' LEU . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.340000000000003 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.409999999999997 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.040000000000006 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.420000000000002 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.219999999999999 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.109999999999999 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.010000000000005 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.109999999999999 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.109999999999999 109.631 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.935 ' CD1' HD11 ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.120000000000005 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.209999999999994 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.329999999999998 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.140000000000001 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.319999999999993 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.240000000000002 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.329999999999998 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.120000000000005 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.310000000000002 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.130000000000003 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.200000000000003 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.465 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.209999999999994 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.019999999999996 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.310000000000002 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.420000000000002 110.205 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.040000000000006 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.742 ' CB ' HG13 ' A' ' 133' ' ' VAL . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.430000000000007 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.130000000000003 110.4 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.329999999999998 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.210000000000001 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.310000000000002 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 123' ' ' ALA . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.210000000000001 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.040000000000006 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 74' ' ' ALA . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.319999999999993 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.319999999999993 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.99 HD13 ' CD ' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.299999999999997 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.120000000000005 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.319999999999993 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.109999999999999 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.019999999999996 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.510000000000005 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.400000000000006 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.120000000000005 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.704 HG21 ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.329999999999998 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.756 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.030000000000001 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.349999999999994 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.140000000000001 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.955 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.450000000000003 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t-80 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.439999999999998 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.109999999999999 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.400000000000006 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' THR . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.140000000000001 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.349999999999994 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.450000000000003 110.378 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.430000000000007 110.066 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.310000000000002 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.510000000000005 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.329999999999998 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.549999999999997 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.140000000000001 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.149999999999999 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.459 HH21 ' HB1' ' A' ' 117' ' ' ALA . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.299999999999997 110.393 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.400000000000006 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.200000000000003 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.420000000000002 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.851 HD21 ' CA ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.510000000000005 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.049999999999997 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.704 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.239999999999995 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.310000000000002 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.140000000000001 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.239999999999995 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.851 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.219999999999999 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.109999999999999 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.99 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.340000000000003 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.84 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.239999999999995 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.239999999999995 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.329999999999998 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.340000000000003 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.340000000000003 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.349999999999994 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.209999999999994 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.129999999999995 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.340000000000003 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.129999999999995 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.678 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.340000000000003 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.742 HG13 ' CB ' ' A' ' 70' ' ' SER . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.439999999999998 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.140000000000001 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.120000000000005 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.439999999999998 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.150000000000006 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.519999999999996 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.230000000000004 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.420000000000002 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.430000000000007 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.210000000000001 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HD12 ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.219999999999999 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.936 HD22 ' CB ' ' A' ' 150' ' ' ALA . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.430000000000007 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.200000000000003 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.019999999999996 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.568 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.119999999999997 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.936 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.130000000000003 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.978 ' O ' HD13 ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.399999999999999 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 HD21 ' A' ' 158' ' ' LEU . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.329999999999998 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.140000000000001 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.644 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.439999999999998 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.942 ' HB3' HD22 ' A' ' 177' ' ' LEU . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.329999999999998 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.978 HD13 ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.400000000000006 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 174' ' ' VAL . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.540000000000006 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.200000000000003 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.329999999999998 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.530000000000001 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.009999999999998 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.439999999999998 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.230000000000004 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 39' ' ' ILE . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.420000000000002 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.349999999999994 110.564 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.618 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.200000000000003 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.75 ' CD1' HD12 ' A' ' 43' ' ' LEU . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.329999999999998 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.039999999999999 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.129999999999995 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 159' ' ' VAL . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.219999999999999 109.702 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.667 ' HA ' HD12 ' A' ' 178' ' ' LEU . 6.1 m-20 -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.109999999999999 110.926 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.517 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.340000000000003 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.120000000000005 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.219999999999999 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.400000000000006 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 177' ' ' LEU . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.129999999999995 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.049999999999997 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 66.1 mttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.449 -0.574 . . . . 73.239999999999995 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.310000000000002 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.340000000000003 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.601 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.409999999999997 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' HD22 ' A' ' 173' ' ' LEU . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.510000000000005 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.329999999999998 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.010000000000005 109.315 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG22 ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.310000000000002 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD23 ' A' ' 158' ' ' LEU . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.239999999999995 110.267 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.019999999999996 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.549999999999997 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.884 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.049999999999997 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.340000000000003 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.109999999999999 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.340000000000003 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.612 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.230000000000004 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.130000000000003 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.129999999999995 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.821 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.510000000000005 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' HG12 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.450000000000003 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.319999999999993 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.129999999999995 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.239999999999995 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.319999999999993 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.409999999999997 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.120000000000005 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.329999999999998 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.229999999999997 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.230000000000004 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 40' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.510000000000005 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.109999999999999 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.430000000000007 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.019999999999996 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.821 HG21 ' CD ' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.129999999999995 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.329999999999998 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' A' ' 167' ' ' LEU . 39.4 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.099999999999994 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.230000000000004 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' A' ' 47' ' ' LEU . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.340000000000003 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.409999999999997 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.559 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.040000000000006 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.759 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.420000000000002 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.219999999999999 109.923 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.109999999999999 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.010000000000005 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.109999999999999 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.109999999999999 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.120000000000005 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.209999999999994 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.329999999999998 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.140000000000001 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 61' ' ' MET . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.319999999999993 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.240000000000002 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.329999999999998 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.638 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.120000000000005 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.310000000000002 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.130000000000003 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.200000000000003 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.516 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.209999999999994 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.019999999999996 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.310000000000002 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.420000000000002 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.040000000000006 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.430000000000007 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.018 ' HG2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.130000000000003 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.329999999999998 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.210000000000001 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.024 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.310000000000002 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.746 HG23 ' HB3' ' A' ' 123' ' ' ALA . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.210000000000001 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.592 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.040000000000006 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.319999999999993 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.319999999999993 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.904 HD22 ' HG2' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.299999999999997 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.120000000000005 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 79' ' ' LEU . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.319999999999993 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.109999999999999 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.019999999999996 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.668 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.510000000000005 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.400000000000006 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.120000000000005 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.737 HG21 ' OE1' ' A' ' 113' ' ' GLU . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.329999999999998 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.030000000000001 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.450000000000003 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.349999999999994 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.140000000000001 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.695 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.450000000000003 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.109999999999999 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.400000000000006 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 95' ' ' THR . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.140000000000001 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.349999999999994 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.450000000000003 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.541 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.430000000000007 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.310000000000002 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.510000000000005 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.329999999999998 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.549999999999997 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.140000000000001 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.934 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.149999999999999 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.299999999999997 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.400000000000006 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.934 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.200000000000003 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.420000000000002 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.859 HD21 ' CA ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.510000000000005 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.049999999999997 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.737 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.239999999999995 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.310000000000002 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.75 HG23 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.140000000000001 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.239999999999995 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.859 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.219999999999999 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.109999999999999 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.904 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.340000000000003 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.239999999999995 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.239999999999995 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.329999999999998 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.476 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.340000000000003 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.349999999999994 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.209999999999994 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.024 HG13 ' HB3' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.129999999999995 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.340000000000003 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.129999999999995 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.688 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.340000000000003 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.018 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.439999999999998 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.140000000000001 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.120000000000005 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.439999999999998 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.150000000000006 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.519999999999996 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.230000000000004 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.420000000000002 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.430000000000007 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.210000000000001 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 12' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.329999999999998 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.219999999999999 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' HB1' ' A' ' 150' ' ' ALA . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.430000000000007 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.200000000000003 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.019999999999996 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.119999999999997 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.926 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.130000000000003 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.399999999999999 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.329999999999998 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.340000000000003 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.140000000000001 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.884 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.439999999999998 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.973 ' CE1' HG22 ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.329999999999998 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.867 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.400000000000006 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.708 HG22 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.540000000000006 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.5 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.200000000000003 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.329999999999998 109.829 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.530000000000001 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.009999999999998 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.420000000000002 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.439999999999998 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.701 HD11 ' OE1' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.420000000000002 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.349999999999994 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.41 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.200000000000003 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.783 ' HE2' HD22 ' A' ' 175' ' ' ASN . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.329999999999998 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.039999999999999 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.129999999999995 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.219999999999999 109.898 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.783 HD22 ' HE2' ' A' ' 171' ' ' PHE . 18.2 m-20 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.109999999999999 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.563 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.340000000000003 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.120000000000005 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.219999999999999 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.400000000000006 110.611 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 177' ' ' LEU . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.129999999999995 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.049999999999997 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.218 0.532 . . . . 73.239999999999995 110.444 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.310000000000002 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.340000000000003 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.409999999999997 110.464 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 8.9 m80 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.510000000000005 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.329999999999998 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.010000000000005 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.310000000000002 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 143' ' ' SER . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.239999999999995 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.019999999999996 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.549999999999997 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.049999999999997 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.340000000000003 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.109999999999999 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.340000000000003 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.230000000000004 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.130000000000003 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.129999999999995 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.85 ' CD ' HG21 ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.510000000000005 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.450000000000003 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.319999999999993 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.129999999999995 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.239999999999995 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' HA ' HG21 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.319999999999993 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.409999999999997 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.120000000000005 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.329999999999998 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.230000000000004 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.240000000000002 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.864 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.510000000000005 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.109999999999999 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.430000000000007 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.629 HG23 HD21 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.019999999999996 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.864 HD11 ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.129999999999995 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.329999999999998 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.099999999999994 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.793 HD12 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.230000000000004 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.84 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.340000000000003 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.409999999999997 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.040000000000006 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.420000000000002 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.219999999999999 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.109999999999999 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.010000000000005 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.109999999999999 110.6 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.109999999999999 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.120000000000005 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.239999999999995 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.209999999999994 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.329999999999998 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.717 ' CE1' ' HB2' ' A' ' 70' ' ' SER . 14.1 p80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.140000000000001 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.319999999999993 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.240000000000002 110.758 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.329999999999998 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.63 ' HG3' HG21 ' A' ' 58' ' ' VAL . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.120000000000005 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.310000000000002 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.130000000000003 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.200000000000003 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.209999999999994 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.019999999999996 109.81 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.310000000000002 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.420000000000002 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.040000000000006 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.806 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.430000000000007 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.130000000000003 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.329999999999998 110.439 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.210000000000001 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.310000000000002 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' ALA . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.210000000000001 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.809 ' SD ' HG23 ' A' ' 86' ' ' VAL . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.040000000000006 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 74' ' ' ALA . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.319999999999993 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.319999999999993 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.975 ' O ' HG13 ' A' ' 81' ' ' VAL . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.299999999999997 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.120000000000005 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.319999999999993 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 77' ' ' ILE . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.109999999999999 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.019999999999996 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.691 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.510000000000005 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.809 HG23 ' SD ' ' A' ' 76' ' ' MET . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.400000000000006 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.120000000000005 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.329999999999998 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 106' ' ' LEU . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.030000000000001 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.450000000000003 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.349999999999994 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.140000000000001 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.450000000000003 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.439999999999998 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.109999999999999 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 96' ' ' LEU . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.400000000000006 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.140000000000001 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.349999999999994 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.450000000000003 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.430000000000007 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.310000000000002 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.510000000000005 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.329999999999998 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.549999999999997 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.140000000000001 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.149999999999999 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.752 ' NH1' HD11 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.299999999999997 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.400000000000006 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.200000000000003 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CD2' ' CD1' ' A' ' 120' ' ' PHE . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.420000000000002 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.863 HD21 ' CA ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.510000000000005 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.049999999999997 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.743 ' CD ' HG21 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.310000000000002 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.746 HG23 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.140000000000001 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.239999999999995 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.863 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.219999999999999 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.109999999999999 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.902 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.340000000000003 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.879 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.239999999999995 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.239999999999995 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.329999999999998 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.340000000000003 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.340000000000003 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.349999999999994 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.209999999999994 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.129999999999995 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.340000000000003 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.129999999999995 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.340000000000003 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.821 HG21 ' HG2' ' A' ' 71' ' ' LYS . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.439999999999998 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.140000000000001 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.120000000000005 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.439999999999998 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.150000000000006 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.519999999999996 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 5.0 mm-40 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.230000000000004 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.420000000000002 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.430000000000007 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.210000000000001 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 12' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.329999999999998 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.219999999999999 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.992 HD22 ' HB1' ' A' ' 150' ' ' ALA . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.430000000000007 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.200000000000003 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.019999999999996 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.587 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.119999999999997 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.992 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.130000000000003 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' OH ' ' A' ' 170' ' ' TYR . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.399999999999999 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.329999999999998 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.340000000000003 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.140000000000001 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.632 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.439999999999998 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 1.012 ' CE2' HG22 ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.329999999999998 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.400000000000006 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 177' ' ' LEU . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.540000000000006 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 85.7 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.200000000000003 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.329999999999998 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.530000000000001 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.009999999999998 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.420000000000002 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.439999999999998 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.230000000000004 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.420000000000002 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.349999999999994 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.466 ' OH ' HG21 ' A' ' 151' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.200000000000003 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.793 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.329999999999998 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.039999999999999 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 177' ' ' LEU . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.129999999999995 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.219999999999999 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.109999999999999 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.340000000000003 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.120000000000005 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.219999999999999 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.400000000000006 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.013 HD12 ' HA ' ' A' ' 177' ' ' LEU . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.129999999999995 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.049999999999997 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 92.9 mttt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.269 0.557 . . . . 73.239999999999995 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.310000000000002 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.340000000000003 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.409999999999997 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.528 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 32.3 m80 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.510000000000005 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CG ' HD21 ' A' ' 177' ' ' LEU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.329999999999998 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.010000000000005 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.310000000000002 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 1.052 HD13 ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.239999999999995 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.019999999999996 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.549999999999997 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.049999999999997 110.291 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.340000000000003 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.403 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.109999999999999 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.340000000000003 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.230000000000004 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.130000000000003 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.129999999999995 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.510000000000005 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CB ' HG12 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.450000000000003 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.319999999999993 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.129999999999995 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.239999999999995 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.319999999999993 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.409999999999997 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.120000000000005 110.403 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.329999999999998 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.229999999999997 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.230000000000004 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.240000000000002 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.510000000000005 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.109999999999999 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.430000000000007 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.937 HG23 HD21 ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.019999999999996 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.129999999999995 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.329999999999998 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.099999999999994 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.230000000000004 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.852 ' HA ' HD12 ' A' ' 47' ' ' LEU . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.340000000000003 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.409999999999997 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 40.5 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.040000000000006 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.420000000000002 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.219999999999999 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.109999999999999 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.010000000000005 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.109999999999999 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.109999999999999 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.120000000000005 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.239999999999995 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.209999999999994 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.329999999999998 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.140000000000001 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.319999999999993 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.240000000000002 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.329999999999998 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.685 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.120000000000005 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.310000000000002 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.130000000000003 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.200000000000003 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 100' ' ' PRO . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.209999999999994 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.019999999999996 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.310000000000002 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.420000000000002 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.633 ' HE2' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.040000000000006 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.430000000000007 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.843 ' HG2' HG21 ' A' ' 133' ' ' VAL . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.130000000000003 110.035 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.329999999999998 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.210000000000001 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.079 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.310000000000002 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.83 HG21 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.210000000000001 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.549 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.040000000000006 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.319999999999993 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.319999999999993 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.881 HD11 ' HA ' ' A' ' 120' ' ' PHE . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.299999999999997 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.120000000000005 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.319999999999993 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.109999999999999 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.019999999999996 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HD12 ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.510000000000005 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.400000000000006 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.120000000000005 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.329999999999998 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.593 ' CE ' HD11 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.030000000000001 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.349999999999994 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.846 ' HA ' HD12 ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.140000000000001 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.450000000000003 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 63.6 t60 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.439999999999998 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.109999999999999 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.400000000000006 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.140000000000001 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.349999999999994 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.450000000000003 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.747 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.430000000000007 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.310000000000002 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.510000000000005 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.329999999999998 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.549999999999997 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.140000000000001 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.06 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.149999999999999 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.299999999999997 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.400000000000006 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.06 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.200000000000003 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.523 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.420000000000002 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.510000000000005 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.049999999999997 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.239999999999995 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.310000000000002 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.559 HD12 ' SD ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.140000000000001 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.239999999999995 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.96 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.219999999999999 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.109999999999999 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.764 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.340000000000003 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.239999999999995 109.711 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.329999999999998 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.340000000000003 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.340000000000003 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.349999999999994 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.209999999999994 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.079 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.129999999999995 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.340000000000003 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.129999999999995 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.774 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.340000000000003 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.843 HG21 ' HG2' ' A' ' 71' ' ' LYS . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.439999999999998 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.140000000000001 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.120000000000005 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.439999999999998 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.150000000000006 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.519999999999996 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 155' ' ' ASN . 6.8 mm-40 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.230000000000004 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.420000000000002 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.430000000000007 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.210000000000001 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 1.052 ' HA ' HD13 ' A' ' 12' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.329999999999998 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.219999999999999 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' CB ' ' A' ' 150' ' ' ALA . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.430000000000007 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.200000000000003 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.019999999999996 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.119999999999997 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.926 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.130000000000003 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.582 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.399999999999999 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.329999999999998 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m120 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.340000000000003 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.527 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.140000000000001 110.916 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.93 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.439999999999998 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.76 ' CE2' HG22 ' A' ' 11' ' ' VAL . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.329999999999998 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.400000000000006 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 HD23 ' A' ' 173' ' ' LEU . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.540000000000006 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.200000000000003 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.329999999999998 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.530000000000001 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.009999999999998 110.247 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.420000000000002 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.439999999999998 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.230000000000004 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG23 ' A' ' 39' ' ' ILE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.420000000000002 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.74 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.349999999999994 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.582 ' OH ' HG21 ' A' ' 151' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.200000000000003 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.934 ' CD1' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.329999999999998 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.039999999999999 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.791 HD23 HG13 ' A' ' 159' ' ' VAL . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.129999999999995 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 159' ' ' VAL . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.219999999999999 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.792 ' HA ' HD12 ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.109999999999999 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.340000000000003 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.071 HD23 HD12 ' A' ' 180' ' ' LEU . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.120000000000005 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.219999999999999 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.400000000000006 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.071 HD12 HD23 ' A' ' 177' ' ' LEU . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.129999999999995 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.049999999999997 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.537 . . . . 73.239999999999995 110.42 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.310000000000002 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.340000000000003 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.409999999999997 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.510000000000005 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.329999999999998 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.010000000000005 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG22 ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.310000000000002 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.239999999999995 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.019999999999996 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.549999999999997 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 1.009 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.049999999999997 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.340000000000003 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.525 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.109999999999999 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.340000000000003 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.130000000000003 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.129999999999995 109.621 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.787 ' OE2' HG22 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.510000000000005 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.450000000000003 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.319999999999993 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.129999999999995 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.239999999999995 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.319999999999993 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.409999999999997 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.120000000000005 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.329999999999998 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.229999999999997 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.230000000000004 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.240000000000002 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.689 ' HE2' HD11 ' A' ' 40' ' ' ILE . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.510000000000005 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.109999999999999 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.430000000000007 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 167' ' ' LEU . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.019999999999996 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.689 HD11 ' HE2' ' A' ' 36' ' ' PHE . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.129999999999995 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.329999999999998 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 5.2 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.099999999999994 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.230000000000004 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.863 ' HA ' HD12 ' A' ' 47' ' ' LEU . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.340000000000003 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.409999999999997 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.040000000000006 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.420000000000002 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD23 ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.219999999999999 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.109999999999999 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.010000000000005 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.109999999999999 110.507 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.109999999999999 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.120000000000005 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.239999999999995 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.209999999999994 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.329999999999998 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.140000000000001 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.319999999999993 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.240000000000002 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.329999999999998 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.642 ' HE1' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.120000000000005 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.310000000000002 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.130000000000003 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.200000000000003 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.209999999999994 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.019999999999996 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.310000000000002 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.420000000000002 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.040000000000006 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.511 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.430000000000007 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.879 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.130000000000003 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.329999999999998 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.210000000000001 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.011 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.310000000000002 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.641 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.210000000000001 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.040000000000006 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.319999999999993 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.319999999999993 109.703 172.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.017 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.299999999999997 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.120000000000005 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.017 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.109999999999999 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.019999999999996 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.572 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.510000000000005 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.400000000000006 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.120000000000005 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.77 HG21 ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.329999999999998 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.583 ' CE ' HD11 ' A' ' 106' ' ' LEU . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.030000000000001 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.450000000000003 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.349999999999994 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.868 ' HA ' HD12 ' A' ' 96' ' ' LEU . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.140000000000001 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.450000000000003 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.439999999999998 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.109999999999999 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.400000000000006 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.349999999999994 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.450000000000003 110.396 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.742 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.430000000000007 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.310000000000002 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.510000000000005 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.329999999999998 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.549999999999997 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.140000000000001 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.014 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.149999999999999 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.299999999999997 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.400000000000006 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.014 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.200000000000003 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.420000000000002 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.510000000000005 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.049999999999997 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.77 ' OE1' HG21 ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.310000000000002 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.140000000000001 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.239999999999995 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.833 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.219999999999999 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.109999999999999 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.340000000000003 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.239999999999995 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.239999999999995 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.329999999999998 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.340000000000003 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.340000000000003 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.349999999999994 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.209999999999994 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.129999999999995 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.340000000000003 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.129999999999995 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.567 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.340000000000003 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.879 HG21 ' HG2' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.439999999999998 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.140000000000001 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.120000000000005 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.439999999999998 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.150000000000006 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.519999999999996 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.230000000000004 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.430000000000007 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.210000000000001 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.579 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.329999999999998 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.219999999999999 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 158' ' ' LEU . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.430000000000007 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.200000000000003 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.642 ' CG2' ' HE1' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.019999999999996 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.119999999999997 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.903 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.130000000000003 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.399999999999999 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.329999999999998 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.340000000000003 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.140000000000001 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.009 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.439999999999998 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.984 ' CE1' HG22 ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.329999999999998 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.400000000000006 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 173' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.540000000000006 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.200000000000003 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.329999999999998 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.530000000000001 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.009999999999998 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.420000000000002 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.439999999999998 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.230000000000004 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 39' ' ' ILE . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.420000000000002 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.349999999999994 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.200000000000003 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.757 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.329999999999998 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.039999999999999 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.712 HD23 HG13 ' A' ' 159' ' ' VAL . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.129999999999995 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 43' ' ' LEU . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.219999999999999 109.766 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 178' ' ' LEU . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.109999999999999 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.340000000000003 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.006 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.120000000000005 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.219999999999999 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.400000000000006 110.191 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 177' ' ' LEU . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.129999999999995 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.049999999999997 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.24 0.543 . . . . 73.239999999999995 110.124 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 11' ' ' VAL . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.310000000000002 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.340000000000003 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.409999999999997 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 0.6 OUTLIER -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.510000000000005 109.949 179.649 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.7 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.329999999999998 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.010000000000005 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.310000000000002 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 158' ' ' LEU . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.239999999999995 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.019999999999996 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.549999999999997 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.979 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.049999999999997 110.413 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.340000000000003 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.109999999999999 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 51' ' ' ALA . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.340000000000003 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.230000000000004 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.130000000000003 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.129999999999995 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.712 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.510000000000005 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.450000000000003 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.319999999999993 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.129999999999995 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.926 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.239999999999995 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HA ' HG21 ' A' ' 93' ' ' ILE . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.319999999999993 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.409999999999997 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 35' ' ' THR . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.120000000000005 110.059 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.329999999999998 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.229999999999997 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.230000000000004 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.510000000000005 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.109999999999999 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.430000000000007 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 36' ' ' PHE . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.019999999999996 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.129999999999995 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.329999999999998 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.6 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.099999999999994 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.975 HD13 ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.230000000000004 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.340000000000003 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.409999999999997 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 40.3 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.040000000000006 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.420000000000002 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.219999999999999 109.931 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.109999999999999 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.010000000000005 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.109999999999999 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.109999999999999 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.120000000000005 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.6 mm100 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.239999999999995 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.209999999999994 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.329999999999998 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.815 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.140000000000001 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG21 ' HG3' ' A' ' 61' ' ' MET . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.319999999999993 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.469 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.240000000000002 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.329999999999998 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.656 ' HG3' HG21 ' A' ' 58' ' ' VAL . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.120000000000005 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.310000000000002 109.895 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.130000000000003 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.200000000000003 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.209999999999994 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.019999999999996 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.310000000000002 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.420000000000002 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.040000000000006 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.430000000000007 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.130000000000003 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.329999999999998 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.815 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.210000000000001 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.075 ' CB ' HG13 ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.310000000000002 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.863 HG23 ' HB3' ' A' ' 123' ' ' ALA . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.210000000000001 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.040000000000006 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.975 HD12 ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.319999999999993 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.496 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.319999999999993 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.958 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.299999999999997 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.120000000000005 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.319999999999993 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.109999999999999 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.019999999999996 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.674 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.510000000000005 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.400000000000006 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.120000000000005 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.329999999999998 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.030000000000001 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.450000000000003 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.349999999999994 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.140000000000001 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.926 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.450000000000003 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.439999999999998 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.109999999999999 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.400000000000006 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 95' ' ' THR . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.140000000000001 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.349999999999994 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.450000000000003 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.649 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.430000000000007 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.310000000000002 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.510000000000005 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.329999999999998 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.549999999999997 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.140000000000001 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.988 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.149999999999999 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.299999999999997 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.400000000000006 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.988 HD12 ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.200000000000003 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.420000000000002 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.510000000000005 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.049999999999997 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.71 ' CD ' HG11 ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.239999999999995 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.310000000000002 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' CE ' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.140000000000001 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.239999999999995 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.219999999999999 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.109999999999999 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.958 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.340000000000003 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.239999999999995 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.239999999999995 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.329999999999998 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.863 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.340000000000003 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.340000000000003 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.349999999999994 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.209999999999994 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.075 HG13 ' CB ' ' A' ' 74' ' ' ALA . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.129999999999995 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.340000000000003 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.129999999999995 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.741 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.340000000000003 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.439999999999998 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.140000000000001 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.120000000000005 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.439999999999998 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.150000000000006 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.519999999999996 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm-40 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.230000000000004 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.643 ' HA ' HD12 ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.420000000000002 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 84.8 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.430000000000007 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.936 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.210000000000001 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.566 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.329999999999998 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.219999999999999 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.945 HD22 ' CB ' ' A' ' 150' ' ' ALA . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.430000000000007 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.200000000000003 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.019999999999996 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.119999999999997 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.945 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.130000000000003 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.454 ' O ' HD13 ' A' ' 158' ' ' LEU . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.399999999999999 110.151 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.329999999999998 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.340000000000003 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.140000000000001 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.979 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.439999999999998 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.873 ' HB3' HD22 ' A' ' 177' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.329999999999998 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.400000000000006 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.718 HG13 HD23 ' A' ' 173' ' ' LEU . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.540000000000006 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.200000000000003 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.329999999999998 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.530000000000001 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.009999999999998 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.420000000000002 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.439999999999998 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.230000000000004 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.420000000000002 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.349999999999994 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.200000000000003 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.975 ' CG ' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.329999999999998 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.039999999999999 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.718 HD23 HG13 ' A' ' 159' ' ' VAL . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.129999999999995 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.584 HG22 HG21 ' A' ' 159' ' ' VAL . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.219999999999999 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.109999999999999 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.340000000000003 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.120000000000005 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.219999999999999 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.400000000000006 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.129999999999995 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.049999999999997 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.159 0.504 . . . . 73.239999999999995 109.755 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.589 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.310000000000002 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.340000000000003 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.409999999999997 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.510000000000005 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.329999999999998 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLN . . . . . 0.462 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.010000000000005 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 1.056 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.310000000000002 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.239999999999995 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.019999999999996 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.549999999999997 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.049999999999997 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.340000000000003 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.109999999999999 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.340000000000003 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG21 ' OE1' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.230000000000004 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HD21 ' A' ' 178' ' ' LEU . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.130000000000003 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.129999999999995 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.905 ' OE1' HG21 ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.510000000000005 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' C ' HG11 ' A' ' 148' ' ' VAL . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.450000000000003 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.319999999999993 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.129999999999995 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.927 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.239999999999995 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.6 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.319999999999993 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.409999999999997 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.120000000000005 110.358 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.329999999999998 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.229999999999997 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.230000000000004 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.240000000000002 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.78 ' HE2' HD11 ' A' ' 40' ' ' ILE . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.510000000000005 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.109999999999999 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.430000000000007 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.019999999999996 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.129999999999995 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.329999999999998 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.099999999999994 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.917 HD13 ' CD1' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.230000000000004 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.340000000000003 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.409999999999997 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.9 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.040000000000006 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.420000000000002 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.219999999999999 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.109999999999999 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.010000000000005 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.109999999999999 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.109999999999999 109.578 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.776 ' CD1' HD11 ' A' ' 47' ' ' LEU . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.120000000000005 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.618 ' OE1' HG21 ' A' ' 21' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.239999999999995 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.209999999999994 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.329999999999998 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.140000000000001 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' A' ' 61' ' ' MET . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.319999999999993 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.240000000000002 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.329999999999998 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.120000000000005 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.310000000000002 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.130000000000003 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.200000000000003 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 65' ' ' MET . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.209999999999994 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.019999999999996 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.310000000000002 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.420000000000002 110.383 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.47 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.040000000000006 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.885 ' CB ' HG13 ' A' ' 133' ' ' VAL . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.430000000000007 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.130000000000003 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' A' ' 106' ' ' LEU . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.329999999999998 110.329 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 55' ' ' LYS . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.210000000000001 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.310000000000002 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.210000000000001 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.648 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.040000000000006 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.319999999999993 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.319999999999993 109.763 173.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.971 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.299999999999997 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.120000000000005 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.971 HG13 ' O ' ' A' ' 79' ' ' LEU . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.319999999999993 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.109999999999999 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.019999999999996 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.631 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.510000000000005 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.400000000000006 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.120000000000005 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.805 HG21 ' OE1' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.329999999999998 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.731 ' HE1' HD11 ' A' ' 106' ' ' LEU . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.030000000000001 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.349999999999994 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.865 ' HA ' HD12 ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.140000000000001 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.450000000000003 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' PHE . 7.5 t60 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.439999999999998 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.109999999999999 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.140000000000001 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.349999999999994 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.450000000000003 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.430000000000007 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.310000000000002 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.510000000000005 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.329999999999998 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.549999999999997 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.140000000000001 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.071 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.149999999999999 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.299999999999997 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.400000000000006 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.071 HD12 ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.200000000000003 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.648 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.420000000000002 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.510000000000005 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.049999999999997 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.805 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.239999999999995 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.310000000000002 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.140000000000001 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.239999999999995 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.219999999999999 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.109999999999999 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.67 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.340000000000003 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CE1' HG21 ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.239999999999995 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.239999999999995 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.329999999999998 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.588 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.340000000000003 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.677 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.340000000000003 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.349999999999994 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.129999999999995 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.340000000000003 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.129999999999995 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.340000000000003 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.885 HG13 ' CB ' ' A' ' 70' ' ' SER . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.439999999999998 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.140000000000001 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.120000000000005 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.439999999999998 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.150000000000006 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.519999999999996 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.230000000000004 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.832 ' HA ' HD12 ' A' ' 145' ' ' LEU . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.420000000000002 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.430000000000007 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.897 ' HB3' HG22 ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.210000000000001 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.329999999999998 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.219999999999999 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 158' ' ' LEU . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.430000000000007 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.200000000000003 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.61 HG11 ' C ' ' A' ' 25' ' ' PHE . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.019999999999996 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.119999999999997 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.130000000000003 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.399999999999999 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.329999999999998 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.8 m120 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.340000000000003 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.140000000000001 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.994 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.439999999999998 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 1.056 ' CE2' HG22 ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.329999999999998 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.400000000000006 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.789 HG21 HG22 ' A' ' 174' ' ' VAL . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.540000000000006 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.200000000000003 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.329999999999998 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.530000000000001 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.009999999999998 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.439999999999998 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.230000000000004 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.420000000000002 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.349999999999994 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.634 ' CE1' HG12 ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.200000000000003 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.917 ' CD1' HD13 ' A' ' 43' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.329999999999998 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.039999999999999 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.713 HD23 HG13 ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.129999999999995 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.988 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.109999999999999 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.499 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.340000000000003 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 180' ' ' LEU . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.120000000000005 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.988 HD12 ' HA ' ' A' ' 175' ' ' ASN . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.400000000000006 110.179 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 177' ' ' LEU . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.129999999999995 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.458 ' OXT' ' HG2' ' A' ' 181' ' ' LYS . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.049999999999997 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.238 0.542 . . . . 73.239999999999995 110.286 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.310000000000002 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.340000000000003 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.409999999999997 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB3' HD22 ' A' ' 173' ' ' LEU . 2.5 m80 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.510000000000005 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.693 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.329999999999998 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.010000000000005 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.906 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.310000000000002 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.667 HD11 HD23 ' A' ' 158' ' ' LEU . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.239999999999995 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.019999999999996 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.549999999999997 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.971 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.049999999999997 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.340000000000003 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.109999999999999 109.513 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.529 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.340000000000003 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.230000000000004 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.130000000000003 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.129999999999995 110.23 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.804 ' OE1' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.510000000000005 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.450000000000003 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.319999999999993 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.544 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.129999999999995 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.239999999999995 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.505 ' HA ' HG21 ' A' ' 93' ' ' ILE . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.319999999999993 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.409999999999997 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.120000000000005 109.999 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.329999999999998 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.229999999999997 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.44 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.230000000000004 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.240000000000002 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.985 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.510000000000005 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.109999999999999 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.430000000000007 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.019999999999996 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.985 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.129999999999995 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.329999999999998 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.49 ' OE1' HD11 ' A' ' 167' ' ' LEU . 24.1 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.099999999999994 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' HD12 ' A' ' 47' ' ' LEU . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.340000000000003 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.409999999999997 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.040000000000006 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 44' ' ' LYS . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.420000000000002 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.219999999999999 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.109999999999999 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.010000000000005 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.109999999999999 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.109999999999999 109.641 175.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.120000000000005 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.239999999999995 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.209999999999994 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.329999999999998 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.766 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.140000000000001 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.319999999999993 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.458 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.240000000000002 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.62 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.329999999999998 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.62 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.120000000000005 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.310000000000002 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.130000000000003 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.200000000000003 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.209999999999994 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.019999999999996 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.420000000000002 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.040000000000006 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.430000000000007 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 1.039 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.130000000000003 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.329999999999998 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.210000000000001 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.052 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.310000000000002 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 123' ' ' ALA . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.210000000000001 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.535 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.040000000000006 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.976 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.319999999999993 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.319999999999993 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.866 ' O ' HG13 ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.299999999999997 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.120000000000005 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.319999999999993 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.109999999999999 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.019999999999996 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.717 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.510000000000005 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.400000000000006 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.120000000000005 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.329999999999998 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.651 ' HE1' HD11 ' A' ' 106' ' ' LEU . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.030000000000001 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.450000000000003 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.349999999999994 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.855 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.140000000000001 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.450000000000003 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.439999999999998 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.109999999999999 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.400000000000006 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.140000000000001 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.349999999999994 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.450000000000003 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.430000000000007 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.310000000000002 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.510000000000005 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.329999999999998 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.549999999999997 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.140000000000001 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.882 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.149999999999999 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.299999999999997 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.400000000000006 110.615 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.200000000000003 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.717 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.420000000000002 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.510000000000005 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.049999999999997 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.698 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.239999999999995 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.310000000000002 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.140000000000001 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.557 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.239999999999995 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.219999999999999 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.109999999999999 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.817 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.340000000000003 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.775 ' HA ' HD11 ' A' ' 79' ' ' LEU . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.239999999999995 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.239999999999995 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.329999999999998 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.340000000000003 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.340000000000003 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.349999999999994 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.209999999999994 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.052 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.129999999999995 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.340000000000003 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.129999999999995 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.340000000000003 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 71' ' ' LYS . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.439999999999998 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.140000000000001 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.120000000000005 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.439999999999998 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.150000000000006 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.519999999999996 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.230000000000004 110.611 -175.604 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.689 ' HA ' HD12 ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.420000000000002 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.430000000000007 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.210000000000001 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.329999999999998 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.219999999999999 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.430000000000007 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.200000000000003 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.019999999999996 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.119999999999997 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.130000000000003 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.868 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.399999999999999 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.329999999999998 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 177' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.340000000000003 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.140000000000001 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.971 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.439999999999998 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 177' ' ' LEU . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.329999999999998 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.957 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.400000000000006 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.493 HG13 HD23 ' A' ' 173' ' ' LEU . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.540000000000006 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.508 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.200000000000003 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.329999999999998 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.530000000000001 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.009999999999998 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 169' ' ' GLU . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.420000000000002 109.715 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.439999999999998 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.49 HD11 ' OE1' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.420000000000002 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.349999999999994 110.587 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.868 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.200000000000003 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.828 ' HE2' HD22 ' A' ' 175' ' ' ASN . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.329999999999998 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.039999999999999 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 8' ' ' HIS . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.129999999999995 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.219999999999999 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.828 HD22 ' HE2' ' A' ' 171' ' ' PHE . 38.5 m-20 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.109999999999999 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.340000000000003 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 157' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.120000000000005 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.219999999999999 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.400000000000006 110.677 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 177' ' ' LEU . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.129999999999995 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.049999999999997 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' N ' ' NE2' ' A' ' 8' ' ' HIS . 32.6 tttt . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.988 0.423 . . . . 73.239999999999995 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.310000000000002 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.340000000000003 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.409999999999997 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 1.135 ' ND1' HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.510000000000005 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 1.122 ' CD2' HD21 ' A' ' 177' ' ' LEU . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.329999999999998 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.010000000000005 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.310000000000002 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' SER . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.239999999999995 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.019999999999996 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.549999999999997 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.049999999999997 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.340000000000003 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.109999999999999 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.340000000000003 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.230000000000004 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.130000000000003 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.129999999999995 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.799 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.510000000000005 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.450000000000003 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 58' ' ' VAL . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.319999999999993 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.129999999999995 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.958 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.239999999999995 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' HG21 ' A' ' 93' ' ' ILE . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.319999999999993 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.409999999999997 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.120000000000005 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.329999999999998 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.229999999999997 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.427 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 0.9 OUTLIER -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.230000000000004 110.365 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.240000000000002 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.973 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.510000000000005 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.109999999999999 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.430000000000007 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.973 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.129999999999995 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.329999999999998 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 5.2 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.099999999999994 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.230000000000004 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.692 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.340000000000003 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.409999999999997 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.6 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.040000000000006 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.420000000000002 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.219999999999999 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.109999999999999 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.010000000000005 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.109999999999999 110.435 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.109999999999999 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.120000000000005 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.239999999999995 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.209999999999994 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.329999999999998 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.140000000000001 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.647 HG21 ' HG3' ' A' ' 61' ' ' MET . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.319999999999993 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.240000000000002 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.329999999999998 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.120000000000005 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.310000000000002 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.130000000000003 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.200000000000003 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.55 ' HE2' HD22 ' A' ' 106' ' ' LEU . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.209999999999994 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.019999999999996 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.310000000000002 110.259 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.420000000000002 110.236 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.459 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.040000000000006 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.430000000000007 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.832 ' HG2' HG21 ' A' ' 133' ' ' VAL . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.130000000000003 110.103 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.329999999999998 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.210000000000001 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.058 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.310000000000002 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 123' ' ' ALA . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.210000000000001 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.639 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.040000000000006 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.319999999999993 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.319999999999993 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.981 ' O ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.299999999999997 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.120000000000005 109.944 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.319999999999993 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' VAL . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.109999999999999 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.019999999999996 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.639 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.510000000000005 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.400000000000006 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.120000000000005 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.329999999999998 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HE1' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.030000000000001 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.450000000000003 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.532 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.349999999999994 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.867 ' HA ' HD12 ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.140000000000001 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.958 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.450000000000003 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.427 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 79.8 t60 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.439999999999998 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.109999999999999 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.400000000000006 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' THR . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.140000000000001 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.349999999999994 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.467 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.450000000000003 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.701 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.430000000000007 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.310000000000002 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.510000000000005 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.329999999999998 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.549999999999997 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.140000000000001 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.957 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.149999999999999 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.299999999999997 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.400000000000006 110.612 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.200000000000003 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' O ' HG12 ' A' ' 115' ' ' ILE . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.420000000000002 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' CA ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.510000000000005 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.049999999999997 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.310000000000002 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.140000000000001 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.239999999999995 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.219999999999999 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.109999999999999 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.340000000000003 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.239999999999995 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.239999999999995 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.329999999999998 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.797 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.340000000000003 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.349999999999994 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.058 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.129999999999995 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.340000000000003 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.129999999999995 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.340000000000003 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.832 HG21 ' HG2' ' A' ' 71' ' ' LYS . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.439999999999998 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.140000000000001 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.120000000000005 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.439999999999998 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.150000000000006 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.519999999999996 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.531 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.230000000000004 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.420000000000002 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.430000000000007 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.210000000000001 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.708 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.329999999999998 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.219999999999999 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 158' ' ' LEU . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.430000000000007 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.200000000000003 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.019999999999996 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.119999999999997 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.130000000000003 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 0.808 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.399999999999999 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.329999999999998 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.340000000000003 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.52 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.140000000000001 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.439999999999998 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.329999999999998 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.400000000000006 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 177' ' ' LEU . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.540000000000006 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.200000000000003 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.329999999999998 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.530000000000001 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.009999999999998 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.420000000000002 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.439999999999998 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.230000000000004 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.420000000000002 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.349999999999994 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.808 ' OH ' HG21 ' A' ' 151' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.200000000000003 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.716 ' CD1' HD12 ' A' ' 43' ' ' LEU . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.329999999999998 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.039999999999999 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 1.135 HD13 ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.129999999999995 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.219999999999999 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.109999999999999 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.340000000000003 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 1.122 HD21 ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.120000000000005 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.219999999999999 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.400000000000006 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.129999999999995 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.049999999999997 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 53.5 mttt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.212 0.529 . . . . 73.239999999999995 110.586 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.587 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.310000000000002 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.340000000000003 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.409999999999997 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 6.0 m80 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.510000000000005 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.639 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.329999999999998 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.010000000000005 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG22 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.310000000000002 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.239999999999995 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.019999999999996 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.549999999999997 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.049999999999997 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.340000000000003 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.428 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.109999999999999 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.340000000000003 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.230000000000004 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 178' ' ' LEU . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.130000000000003 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.129999999999995 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 1.037 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.510000000000005 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.450000000000003 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.319999999999993 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.552 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.129999999999995 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.737 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.239999999999995 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.497 ' HA ' HG21 ' A' ' 93' ' ' ILE . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.319999999999993 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.409999999999997 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.120000000000005 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.329999999999998 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.229999999999997 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.621 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.230000000000004 110.369 179.745 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.240000000000002 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.809 ' CE2' HD11 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.510000000000005 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.109999999999999 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.430000000000007 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.7 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.019999999999996 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.809 HD11 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.129999999999995 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.329999999999998 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.684 ' CD ' HD13 ' A' ' 167' ' ' LEU . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.099999999999994 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.230000000000004 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' LEU . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.340000000000003 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.409999999999997 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.040000000000006 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' LYS . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.420000000000002 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.219999999999999 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.109999999999999 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.010000000000005 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.109999999999999 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.109999999999999 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.120000000000005 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.239999999999995 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.209999999999994 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.329999999999998 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 m-70 -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.140000000000001 109.64 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.319999999999993 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.240000000000002 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.329999999999998 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.120000000000005 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.310000000000002 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.130000000000003 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.200000000000003 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.469 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.209999999999994 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.019999999999996 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.420000000000002 110.226 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.040000000000006 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 133' ' ' VAL . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.430000000000007 110.214 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.130000000000003 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.329999999999998 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.210000000000001 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.077 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.310000000000002 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.746 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.210000000000001 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.633 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.040000000000006 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.953 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.319999999999993 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.319999999999993 109.758 173.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.035 ' O ' HG13 ' A' ' 81' ' ' VAL . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.299999999999997 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.120000000000005 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.109999999999999 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.019999999999996 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.702 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.510000000000005 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.400000000000006 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.120000000000005 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.731 HG11 ' CD ' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.329999999999998 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.799 ' HE1' HD11 ' A' ' 106' ' ' LEU . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.030000000000001 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.450000000000003 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.349999999999994 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.140000000000001 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 28' ' ' PHE . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.450000000000003 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.439999999999998 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.109999999999999 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.400000000000006 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.140000000000001 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.349999999999994 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.450000000000003 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.477 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.430000000000007 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.310000000000002 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.510000000000005 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.329999999999998 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.549999999999997 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.140000000000001 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.017 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.149999999999999 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.724 ' NH2' ' HB1' ' A' ' 117' ' ' ALA . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.299999999999997 110.32 176.69 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.400000000000006 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.200000000000003 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.420000000000002 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.510000000000005 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.049999999999997 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.731 ' CD ' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.239999999999995 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.310000000000002 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.140000000000001 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.239999999999995 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.219999999999999 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.109999999999999 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.681 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.340000000000003 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.239999999999995 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.239999999999995 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.329999999999998 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.340000000000003 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.667 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.340000000000003 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.349999999999994 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.209999999999994 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.077 HG13 ' HB3' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.129999999999995 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.340000000000003 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.129999999999995 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.895 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.340000000000003 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.777 HG21 ' HG2' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.439999999999998 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.140000000000001 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.120000000000005 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 132' ' ' MET . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.439999999999998 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.150000000000006 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.519999999999996 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.2 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.230000000000004 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.420000000000002 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.430000000000007 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.210000000000001 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.602 ' OG ' HD12 ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.329999999999998 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.219999999999999 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 158' ' ' LEU . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.430000000000007 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.200000000000003 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.019999999999996 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.119999999999997 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.964 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.130000000000003 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.037 HG22 ' OE1' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.399999999999999 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.329999999999998 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.95 HG11 ' HB2' ' A' ' 177' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.340000000000003 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.140000000000001 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.951 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.439999999999998 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.908 ' CE1' HG22 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.329999999999998 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.400000000000006 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.540000000000006 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.200000000000003 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 161' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.329999999999998 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.530000000000001 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.009999999999998 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.420000000000002 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.439999999999998 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.230000000000004 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.684 HD13 ' CD ' ' A' ' 42' ' ' GLN . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.420000000000002 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.349999999999994 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' A' ' 151' ' ' VAL . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.200000000000003 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.329999999999998 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.039999999999999 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.642 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.129999999999995 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.219999999999999 109.861 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.1 m120 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.109999999999999 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.340000000000003 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.955 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.120000000000005 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.219999999999999 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.400000000000006 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 177' ' ' LEU . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.129999999999995 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.049999999999997 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 9.5 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.2 0.524 . . . . 73.239999999999995 110.251 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.310000000000002 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.340000000000003 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.409999999999997 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 27.8 m80 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.510000000000005 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 177' ' ' LEU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.329999999999998 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.010000000000005 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.310000000000002 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.239999999999995 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.019999999999996 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.549999999999997 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.874 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.049999999999997 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.340000000000003 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.109999999999999 109.788 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.340000000000003 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.230000000000004 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.130000000000003 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.129999999999995 110.188 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.858 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.510000000000005 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 56' ' ' ASN . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.450000000000003 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.319999999999993 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.129999999999995 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.239999999999995 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.319999999999993 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.409999999999997 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.120000000000005 110.347 -176.833 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.329999999999998 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.229999999999997 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.230000000000004 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.748 ' HE2' HD11 ' A' ' 40' ' ' ILE . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.510000000000005 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.109999999999999 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.430000000000007 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.019999999999996 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.858 HG21 ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.129999999999995 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.329999999999998 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 37.8 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.099999999999994 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.230000000000004 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 47' ' ' LEU . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.340000000000003 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.409999999999997 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.040000000000006 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.420000000000002 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.219999999999999 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.109999999999999 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.010000000000005 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.109999999999999 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.109999999999999 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.120000000000005 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.239999999999995 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.209999999999994 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.329999999999998 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 57' ' ' HIS . . . . . 0.547 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 9.0 p80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.140000000000001 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.319999999999993 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.240000000000002 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.329999999999998 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 61' ' ' MET . . . . . 0.619 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.120000000000005 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.310000000000002 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.130000000000003 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.200000000000003 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.209999999999994 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.019999999999996 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.310000000000002 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.420000000000002 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.040000000000006 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.430000000000007 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.130000000000003 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.329999999999998 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.210000000000001 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.043 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.310000000000002 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.682 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.210000000000001 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' MET . . . . . 0.61 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.040000000000006 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.319999999999993 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.319999999999993 109.55 172.211 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 1.018 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.299999999999997 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.120000000000005 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.319999999999993 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.109999999999999 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.019999999999996 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' MET . . . . . 0.686 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.510000000000005 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.400000000000006 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.120000000000005 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.329999999999998 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' MET . . . . . 0.647 ' CE ' HD11 ' A' ' 106' ' ' LEU . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.030000000000001 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.450000000000003 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.349999999999994 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.857 ' HA ' HD12 ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.140000000000001 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.450000000000003 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.439999999999998 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.109999999999999 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.400000000000006 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.140000000000001 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.349999999999994 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.450000000000003 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' PRO . . . . . 0.736 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.430000000000007 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.310000000000002 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.510000000000005 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.329999999999998 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.549999999999997 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.140000000000001 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.149999999999999 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.299999999999997 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.400000000000006 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.200000000000003 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.557 ' CD2' ' CE1' ' A' ' 120' ' ' PHE . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.420000000000002 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.510000000000005 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.049999999999997 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.774 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.239999999999995 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.310000000000002 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.140000000000001 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.239999999999995 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.832 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.219999999999999 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.109999999999999 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.340000000000003 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 120' ' ' PHE . . . . . 0.682 ' CE1' HG21 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.239999999999995 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.239999999999995 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.329999999999998 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.340000000000003 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 124' ' ' TYR . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.340000000000003 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.349999999999994 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.209999999999994 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' VAL . . . . . 1.043 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.129999999999995 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.340000000000003 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.129999999999995 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.439999999999998 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.140000000000001 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.120000000000005 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.439999999999998 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.150000000000006 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.519999999999996 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.230000000000004 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.420000000000002 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.430000000000007 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.210000000000001 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.614 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.329999999999998 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.219999999999999 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 158' ' ' LEU . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.430000000000007 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 147' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.200000000000003 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.019999999999996 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.119999999999997 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 150' ' ' ALA . . . . . 0.892 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.130000000000003 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.399999999999999 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.329999999999998 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 153' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m120 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.340000000000003 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.140000000000001 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.874 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.439999999999998 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 157' ' ' TYR . . . . . 0.782 ' HB3' HD22 ' A' ' 177' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.329999999999998 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.400000000000006 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 173' ' ' LEU . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.540000000000006 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.200000000000003 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.329999999999998 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.530000000000001 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.009999999999998 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.420000000000002 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.439999999999998 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.230000000000004 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.420000000000002 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 169' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.349999999999994 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.200000000000003 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.329999999999998 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 172' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.039999999999999 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 159' ' ' VAL . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.129999999999995 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 159' ' ' VAL . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.219999999999999 109.847 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 175' ' ' ASN . . . . . 0.856 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.109999999999999 110.802 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.340000000000003 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.120000000000005 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 178' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.219999999999999 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 179' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.400000000000006 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.96 HD12 ' HA ' ' A' ' 177' ' ' LEU . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.129999999999995 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.481 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.049999999999997 110.205 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.258 0.551 . . . . 71.140000000000001 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.575 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 81.5 mt-30 -59.0 -32.56 69.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 70.150000000000006 110.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 58.7 m-85 -100.68 132.81 45.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.015 . . . . 73.019999999999996 110.684 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm -137.97 152.05 48.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.479 -0.763 . . . . 73.239999999999995 110.092 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.310000000000002 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.340000000000003 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.608 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.409999999999997 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 26.5 m-70 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.510000000000005 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CG ' HD21 ' A' ' 177' ' ' LEU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.329999999999998 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.010000000000005 109.468 174.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.310000000000002 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.905 HD11 HD23 ' A' ' 158' ' ' LEU . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.239999999999995 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.019999999999996 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.549999999999997 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.978 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.049999999999997 110.397 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.340000000000003 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.109999999999999 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.340000000000003 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.230000000000004 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.130000000000003 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.129999999999995 110.185 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.808 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.510000000000005 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.450000000000003 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.319999999999993 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.129999999999995 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.319999999999993 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.409999999999997 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.120000000000005 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.329999999999998 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.229999999999997 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.230000000000004 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.240000000000002 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.510000000000005 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.109999999999999 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.430000000000007 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.808 HG21 ' CD ' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.129999999999995 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.329999999999998 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.607 ' OE1' HD11 ' A' ' 167' ' ' LEU . 38.9 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.099999999999994 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.230000000000004 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.340000000000003 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.409999999999997 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.040000000000006 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' HA ' ' A' ' 44' ' ' LYS . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.420000000000002 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.219999999999999 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.109999999999999 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.010000000000005 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.109999999999999 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.109999999999999 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.120000000000005 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.239999999999995 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.209999999999994 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.329999999999998 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.140000000000001 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.319999999999993 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.240000000000002 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.329999999999998 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.120000000000005 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.593 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.310000000000002 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.130000000000003 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.200000000000003 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.209999999999994 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.019999999999996 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.420000000000002 110.337 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.697 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.040000000000006 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.871 ' CB ' HG13 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.430000000000007 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.130000000000003 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.329999999999998 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.210000000000001 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.310000000000002 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.787 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.210000000000001 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.548 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.040000000000006 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.319999999999993 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.319999999999993 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD13 ' CD ' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.299999999999997 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.120000000000005 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.319999999999993 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.109999999999999 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.019999999999996 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.561 ' CG ' HD11 ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.510000000000005 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.400000000000006 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.120000000000005 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 113' ' ' GLU . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.329999999999998 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.030000000000001 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.450000000000003 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.349999999999994 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.838 ' HA ' HD12 ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.140000000000001 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.450000000000003 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.439999999999998 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.109999999999999 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.400000000000006 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.140000000000001 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.349999999999994 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.450000000000003 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.52 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.430000000000007 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.310000000000002 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.510000000000005 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.329999999999998 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.549999999999997 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.140000000000001 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.149999999999999 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.299999999999997 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.400000000000006 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.200000000000003 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.548 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.420000000000002 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.510000000000005 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.049999999999997 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.239999999999995 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.310000000000002 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.561 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.140000000000001 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.239999999999995 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.219999999999999 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.109999999999999 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.919 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.340000000000003 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 79' ' ' LEU . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.239999999999995 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.329999999999998 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.340000000000003 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.340000000000003 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.349999999999994 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.209999999999994 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.129999999999995 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.340000000000003 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.129999999999995 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.764 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.340000000000003 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 70' ' ' SER . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.439999999999998 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.140000000000001 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.120000000000005 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.439999999999998 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.150000000000006 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 138' ' ' LYS . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.519999999999996 110.146 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.494 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 14.7 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.230000000000004 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.420000000000002 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.430000000000007 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.210000000000001 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.697 ' O ' HD13 ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.329999999999998 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.219999999999999 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 158' ' ' LEU . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.430000000000007 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.200000000000003 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.019999999999996 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.119999999999997 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.886 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.130000000000003 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.832 HG21 ' OH ' ' A' ' 170' ' ' TYR . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.399999999999999 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.543 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.329999999999998 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.514 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.340000000000003 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.140000000000001 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.978 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.439999999999998 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.822 ' HB3' HD22 ' A' ' 177' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.329999999999998 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.400000000000006 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 177' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.540000000000006 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.608 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.200000000000003 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.329999999999998 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.530000000000001 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.009999999999998 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.789 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.420000000000002 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.439999999999998 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.230000000000004 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.607 HD11 ' OE1' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.420000000000002 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.349999999999994 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.832 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.200000000000003 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.758 ' CD1' HD12 ' A' ' 43' ' ' LEU . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.329999999999998 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.039999999999999 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 177' ' ' LEU . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.129999999999995 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 159' ' ' VAL . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.219999999999999 109.712 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.74 HD22 ' HE2' ' A' ' 171' ' ' PHE . 38.1 m-20 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.109999999999999 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.807 ' O ' HD23 ' A' ' 180' ' ' LEU . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.340000000000003 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 157' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.120000000000005 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 175' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.219999999999999 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.400000000000006 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.129999999999995 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.049999999999997 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 71.140000000000001 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 55.5 mt-30 -58.95 -34.27 71.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 70.150000000000006 110.342 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -129.12 162.5 27.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.955 . . . . 73.019999999999996 110.449 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -170.99 149.99 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 73.239999999999995 109.76 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.736 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.310000000000002 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.340000000000003 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.409999999999997 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.56 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.510000000000005 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CG ' HD21 ' A' ' 177' ' ' LEU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.329999999999998 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.010000000000005 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.310000000000002 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 143' ' ' SER . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.239999999999995 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.019999999999996 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.549999999999997 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.016 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.049999999999997 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.340000000000003 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.109999999999999 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.401 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.340000000000003 110.051 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.230000000000004 109.922 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.130000000000003 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.129999999999995 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.947 ' OE2' HG22 ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.510000000000005 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE1' HG23 ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.450000000000003 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.746 ' HA ' HG21 ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.319999999999993 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.239999999999995 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.646 ' CD1' HD12 ' A' ' 93' ' ' ILE . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.319999999999993 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.409999999999997 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.705 ' O ' HG23 ' A' ' 35' ' ' THR . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.120000000000005 110.499 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.329999999999998 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.229999999999997 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.230000000000004 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 31' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.240000000000002 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.761 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.510000000000005 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.109999999999999 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.430000000000007 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.019999999999996 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.129999999999995 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.329999999999998 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.67 ' OE1' HD11 ' A' ' 167' ' ' LEU . 41.2 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.099999999999994 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.230000000000004 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.340000000000003 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.409999999999997 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.4 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.040000000000006 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.420000000000002 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.219999999999999 110.102 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.109999999999999 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.010000000000005 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.109999999999999 110.577 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.109999999999999 109.633 174.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.120000000000005 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 7.8 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.239999999999995 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.209999999999994 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.59 ' ND2' ' HB3' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.329999999999998 109.802 -177.211 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.140000000000001 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.319999999999993 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.488 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.240000000000002 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.329999999999998 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.120000000000005 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.310000000000002 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.130000000000003 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.200000000000003 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.209999999999994 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.019999999999996 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.310000000000002 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.420000000000002 110.211 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.040000000000006 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.723 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.430000000000007 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.130000000000003 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.329999999999998 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.487 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.210000000000001 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.055 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.310000000000002 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.695 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.210000000000001 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.55 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.040000000000006 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.319999999999993 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.628 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.319999999999993 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 ' CD ' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.299999999999997 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.120000000000005 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.319999999999993 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.109999999999999 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.019999999999996 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.64 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.510000000000005 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.400000000000006 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.54 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.120000000000005 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.771 HG11 ' HG3' ' A' ' 113' ' ' GLU . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.329999999999998 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.030000000000001 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.450000000000003 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' THR . 12.3 t-20 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.349999999999994 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.140000000000001 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.450000000000003 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.439999999999998 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.109999999999999 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.400000000000006 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.140000000000001 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.349999999999994 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.450000000000003 110.234 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.602 ' CG ' HD13 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.430000000000007 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.310000000000002 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.510000000000005 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.329999999999998 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.549999999999997 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.140000000000001 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.149999999999999 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.299999999999997 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.400000000000006 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.200000000000003 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.64 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.420000000000002 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.510000000000005 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.049999999999997 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.771 ' HG3' HG11 ' A' ' 88' ' ' VAL . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.239999999999995 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.310000000000002 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.140000000000001 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.239999999999995 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.219999999999999 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.109999999999999 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.986 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.340000000000003 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.839 ' HA ' HD11 ' A' ' 79' ' ' LEU . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.239999999999995 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.239999999999995 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.329999999999998 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.340000000000003 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.340000000000003 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.349999999999994 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.209999999999994 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.129999999999995 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.340000000000003 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.129999999999995 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.340000000000003 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.723 HG13 ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.439999999999998 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HD3' ' HA ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.140000000000001 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.120000000000005 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.439999999999998 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.150000000000006 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.519999999999996 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.230000000000004 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.420000000000002 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.430000000000007 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.210000000000001 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.219999999999999 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 150' ' ' ALA . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.430000000000007 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.200000000000003 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 26' ' ' PHE . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.019999999999996 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.647 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.119999999999997 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.130000000000003 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.947 HG22 ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.399999999999999 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.329999999999998 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.5 m120 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.340000000000003 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.140000000000001 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.016 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.439999999999998 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.329999999999998 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.400000000000006 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 177' ' ' LEU . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.540000000000006 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 45.2 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.200000000000003 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.329999999999998 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.530000000000001 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.406 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.009999999999998 110.479 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.420000000000002 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.439999999999998 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.230000000000004 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.67 HD11 ' OE1' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.420000000000002 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.349999999999994 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.886 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.200000000000003 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.773 ' HE2' HD22 ' A' ' 175' ' ' ASN . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.329999999999998 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.039999999999999 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.668 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.129999999999995 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.219999999999999 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.773 HD22 ' HE2' ' A' ' 171' ' ' PHE . 37.8 m-20 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.109999999999999 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.340000000000003 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.120000000000005 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.535 ' HG ' ' CG1' ' A' ' 153' ' ' VAL . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.219999999999999 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.400000000000006 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.129999999999995 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.049999999999997 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.247 0.546 . . . . 71.140000000000001 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.594 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 7.5 tt0 -56.76 -34.52 67.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 70.150000000000006 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.739 ' HB3' ' CD2' ' A' ' 8' ' ' HIS . 38.7 p90 -122.57 159.84 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 73.019999999999996 110.316 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp -172.2 162.01 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 73.239999999999995 109.945 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.310000000000002 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.340000000000003 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.606 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.409999999999997 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.739 ' CD2' ' HB3' ' A' ' 3' ' ' PHE . 4.4 m80 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.510000000000005 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.329999999999998 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.010000000000005 109.536 174.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 5' ' ' GLU . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.310000000000002 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.239999999999995 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.019999999999996 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.549999999999997 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.049999999999997 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.340000000000003 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.109999999999999 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.340000000000003 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.230000000000004 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.130000000000003 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.129999999999995 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.779 ' OE2' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.510000000000005 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.450000000000003 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.319999999999993 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.129999999999995 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.239999999999995 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.319999999999993 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.409999999999997 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.120000000000005 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.329999999999998 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.229999999999997 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 16.8 t30 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.230000000000004 110.367 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.240000000000002 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.510000000000005 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.109999999999999 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.430000000000007 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 167' ' ' LEU . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.019999999999996 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.759 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.129999999999995 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.329999999999998 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.677 ' OE1' HD11 ' A' ' 167' ' ' LEU . 42.2 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.099999999999994 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.230000000000004 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.340000000000003 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.409999999999997 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.3 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.040000000000006 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.420000000000002 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.219999999999999 110.069 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.109999999999999 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.010000000000005 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.109999999999999 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.109999999999999 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.120000000000005 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.239999999999995 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.209999999999994 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.329999999999998 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.793 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 10.1 p80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.140000000000001 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.319999999999993 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' HG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.240000000000002 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.329999999999998 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.120000000000005 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.310000000000002 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.130000000000003 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.200000000000003 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.55 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.209999999999994 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.019999999999996 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.310000000000002 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.420000000000002 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.040000000000006 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.694 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.430000000000007 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.919 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.130000000000003 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.329999999999998 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CE2' HD11 ' A' ' 77' ' ' ILE . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.210000000000001 110.019 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.310000000000002 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 123' ' ' ALA . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.210000000000001 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.040000000000006 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.982 HD12 ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.319999999999993 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.319999999999993 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.299999999999997 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.120000000000005 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.319999999999993 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.109999999999999 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.019999999999996 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.510000000000005 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.400000000000006 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.120000000000005 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 84' ' ' LYS . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.329999999999998 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.030000000000001 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.450000000000003 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.349999999999994 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.648 ' CA ' HD12 ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.140000000000001 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 99' ' ' PRO . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.450000000000003 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.439999999999998 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.109999999999999 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.648 HD12 ' CA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.400000000000006 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.140000000000001 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.349999999999994 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.450000000000003 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.732 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.430000000000007 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.310000000000002 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.510000000000005 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.329999999999998 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.549999999999997 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.140000000000001 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.149999999999999 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.299999999999997 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.400000000000006 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.019 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.200000000000003 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.420000000000002 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.510000000000005 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.049999999999997 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.239999999999995 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.310000000000002 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.140000000000001 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.239999999999995 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.219999999999999 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.109999999999999 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.829 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.340000000000003 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 79' ' ' LEU . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.239999999999995 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.239999999999995 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.329999999999998 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.777 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.340000000000003 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.340000000000003 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.349999999999994 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.209999999999994 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.129999999999995 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.340000000000003 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.129999999999995 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.528 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.340000000000003 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.919 HG21 ' HG2' ' A' ' 71' ' ' LYS . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.439999999999998 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.140000000000001 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.120000000000005 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.793 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.439999999999998 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.150000000000006 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.519999999999996 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.230000000000004 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' HD12 ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.420000000000002 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.430000000000007 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.210000000000001 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.601 ' HA ' HG21 ' A' ' 14' ' ' THR . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.329999999999998 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.219999999999999 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.866 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.430000000000007 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.200000000000003 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.606 HG23 ' HE1' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.019999999999996 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.119999999999997 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.866 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.130000000000003 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.058 HG21 ' OH ' ' A' ' 170' ' ' TYR . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.399999999999999 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 155' ' ' ASN . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.329999999999998 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.4 m120 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.340000000000003 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.140000000000001 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.993 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.439999999999998 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.978 ' HB3' HD22 ' A' ' 177' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.329999999999998 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.400000000000006 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.745 HG21 HG22 ' A' ' 174' ' ' VAL . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.540000000000006 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.606 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.0 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.200000000000003 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.329999999999998 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.530000000000001 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.009999999999998 110.485 -178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.506 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.420000000000002 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.439999999999998 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.230000000000004 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.677 HD11 ' OE1' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.420000000000002 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.349999999999994 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 1.058 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.200000000000003 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.329999999999998 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.039999999999999 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.129999999999995 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.745 HG22 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.219999999999999 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.698 ' HA ' HD12 ' A' ' 178' ' ' LEU . 39.7 m-20 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.109999999999999 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.340000000000003 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.120000000000005 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.219999999999999 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.400000000000006 110.314 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 177' ' ' LEU . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.129999999999995 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.049999999999997 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.247 0.546 . . . . 71.140000000000001 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.576 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 82.1 mt-30 -59.02 -33.59 70.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 70.150000000000006 110.291 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -127.19 161.15 29.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 73.019999999999996 110.405 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -163.51 146.25 9.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 73.239999999999995 109.931 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.742 ' OE2' HG21 ' A' ' 11' ' ' VAL . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.310000000000002 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.340000000000003 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.409999999999997 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.823 ' HB3' HD22 ' A' ' 173' ' ' LEU . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.510000000000005 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.329999999999998 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.010000000000005 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.310000000000002 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.794 HD13 ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.239999999999995 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.019999999999996 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.549999999999997 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB2' ' HD3' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.049999999999997 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.340000000000003 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.109999999999999 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.712 ' HB2' HD22 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.340000000000003 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.230000000000004 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.130000000000003 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.129999999999995 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.897 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.510000000000005 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.450000000000003 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 58' ' ' VAL . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.319999999999993 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.129999999999995 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.239999999999995 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.681 ' HA ' HG21 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.319999999999993 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.409999999999997 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 35' ' ' THR . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.120000000000005 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.329999999999998 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.63 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.230000000000004 110.611 -178.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 31' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.240000000000002 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.892 ' CE2' HD11 ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.510000000000005 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.109999999999999 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.430000000000007 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 167' ' ' LEU . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.019999999999996 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.897 HG21 ' OE1' ' A' ' 24' ' ' GLU . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.129999999999995 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.329999999999998 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 4.8 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.099999999999994 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.230000000000004 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.340000000000003 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.409999999999997 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.4 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.040000000000006 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.420000000000002 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.219999999999999 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.109999999999999 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.010000000000005 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.109999999999999 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.109999999999999 109.765 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.120000000000005 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.239999999999995 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.209999999999994 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.329999999999998 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.532 ' CD2' ' CE2' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.140000000000001 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 26' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.319999999999993 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.240000000000002 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.329999999999998 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.624 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.120000000000005 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.310000000000002 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.130000000000003 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.200000000000003 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.209999999999994 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.019999999999996 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.310000000000002 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.420000000000002 110.311 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.040000000000006 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.609 ' OG ' HG13 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.430000000000007 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.130000000000003 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.329999999999998 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.210000000000001 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.072 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.310000000000002 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 123' ' ' ALA . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.210000000000001 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.555 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.040000000000006 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.319999999999993 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.319999999999993 110.473 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.006 HD13 ' CD ' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.299999999999997 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.120000000000005 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.319999999999993 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.109999999999999 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.019999999999996 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.510000000000005 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.400000000000006 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.120000000000005 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG11 ' OE2' ' A' ' 113' ' ' GLU . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.329999999999998 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.030000000000001 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.450000000000003 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.349999999999994 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.140000000000001 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.450000000000003 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.468 ' N ' ' O ' ' A' ' 90' ' ' PHE . 35.8 t60 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.439999999999998 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.109999999999999 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.400000000000006 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.140000000000001 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.349999999999994 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.450000000000003 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.430000000000007 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.310000000000002 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.329999999999998 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.549999999999997 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.140000000000001 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.997 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.149999999999999 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.299999999999997 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.400000000000006 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.997 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.200000000000003 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.420000000000002 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.510000000000005 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.049999999999997 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.78 ' OE2' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.239999999999995 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.310000000000002 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.140000000000001 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.239999999999995 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.219999999999999 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.109999999999999 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 1.006 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.340000000000003 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.901 ' HA ' HD11 ' A' ' 79' ' ' LEU . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.239999999999995 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.239999999999995 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.329999999999998 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.340000000000003 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.340000000000003 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.349999999999994 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.209999999999994 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.072 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.129999999999995 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.340000000000003 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.129999999999995 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.340000000000003 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.439999999999998 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.140000000000001 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.120000000000005 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.589 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.439999999999998 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.150000000000006 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.519999999999996 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.230000000000004 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.420000000000002 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.430000000000007 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.210000000000001 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.794 ' HA ' HD13 ' A' ' 12' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.219999999999999 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.943 HD22 ' CB ' ' A' ' 150' ' ' ALA . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.430000000000007 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.200000000000003 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 33' ' ' CYS . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.019999999999996 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.119999999999997 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.943 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.130000000000003 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.787 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.399999999999999 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.329999999999998 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.756 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.340000000000003 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 15' ' ' PRO . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.140000000000001 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.439999999999998 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.957 ' HB3' HD22 ' A' ' 177' ' ' LEU . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.329999999999998 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.817 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.400000000000006 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.540000000000006 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.200000000000003 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.329999999999998 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.530000000000001 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.009999999999998 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.420000000000002 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.439999999999998 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.230000000000004 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.420000000000002 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.349999999999994 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.787 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.200000000000003 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 43' ' ' LEU . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.329999999999998 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.039999999999999 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.129999999999995 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.219999999999999 109.89 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.109999999999999 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.340000000000003 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.988 HD23 HD12 ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.120000000000005 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.219999999999999 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.400000000000006 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.988 HD12 HD23 ' A' ' 177' ' ' LEU . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.129999999999995 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.049999999999997 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.245 0.545 . . . . 71.140000000000001 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.3 tt0 -56.15 -36.87 68.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 70.150000000000006 110.295 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 92.8 m-85 -103.18 128.7 50.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 73.019999999999996 110.291 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt -140.71 153.93 46.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.419 -0.8 . . . . 73.239999999999995 110.393 -177.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.310000000000002 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.340000000000003 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.409999999999997 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.510000000000005 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.329999999999998 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.010000000000005 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.915 HG22 ' CE1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.310000000000002 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.239999999999995 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.019999999999996 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 143' ' ' SER . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.549999999999997 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.957 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.049999999999997 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.340000000000003 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.109999999999999 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.340000000000003 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.230000000000004 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.130000000000003 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.129999999999995 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.931 ' OE1' HG22 ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.510000000000005 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CB ' HG12 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.450000000000003 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.319999999999993 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.611 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.129999999999995 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.931 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.239999999999995 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.319999999999993 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.409999999999997 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.633 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.120000000000005 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.329999999999998 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.229999999999997 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.230000000000004 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 31' ' ' PRO . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.240000000000002 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.88 ' HE2' HD11 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.510000000000005 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.109999999999999 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.430000000000007 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.511 HG23 HD21 ' A' ' 167' ' ' LEU . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.019999999999996 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.88 HD11 ' HE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.129999999999995 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.329999999999998 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.459 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 4.0 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.099999999999994 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.230000000000004 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 47' ' ' LEU . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.340000000000003 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.409999999999997 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 48.9 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.040000000000006 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.420000000000002 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.219999999999999 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.109999999999999 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.010000000000005 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.109999999999999 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.109999999999999 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.120000000000005 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.6 mm100 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.239999999999995 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.209999999999994 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.329999999999998 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.140000000000001 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.319999999999993 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.240000000000002 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.329999999999998 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.120000000000005 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.310000000000002 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.130000000000003 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.200000000000003 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.209999999999994 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.019999999999996 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.310000000000002 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.420000000000002 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.584 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.040000000000006 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.430000000000007 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.130000000000003 110.395 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.329999999999998 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.210000000000001 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.310000000000002 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 123' ' ' ALA . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.210000000000001 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.703 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.040000000000006 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.965 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.319999999999993 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.319999999999993 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.999 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.299999999999997 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.120000000000005 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 79' ' ' LEU . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.319999999999993 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.109999999999999 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.019999999999996 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.561 ' HA ' HG23 ' A' ' 88' ' ' VAL . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.510000000000005 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.400000000000006 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.120000000000005 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.796 HG21 ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.329999999999998 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.030000000000001 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.450000000000003 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.349999999999994 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.140000000000001 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.931 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.450000000000003 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.439999999999998 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.109999999999999 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.400000000000006 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.140000000000001 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.349999999999994 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.450000000000003 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.693 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.430000000000007 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.310000000000002 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.510000000000005 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.329999999999998 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.549999999999997 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.140000000000001 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.149999999999999 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.299999999999997 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.400000000000006 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.200000000000003 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.703 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.420000000000002 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.845 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.510000000000005 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.049999999999997 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.796 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.239999999999995 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.310000000000002 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.140000000000001 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.545 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.239999999999995 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.845 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.219999999999999 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.109999999999999 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.999 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.340000000000003 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 79' ' ' LEU . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.239999999999995 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.239999999999995 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.329999999999998 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.340000000000003 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.349999999999994 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.209999999999994 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.129999999999995 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.340000000000003 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.129999999999995 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.662 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.340000000000003 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.791 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.439999999999998 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.140000000000001 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 132' ' ' MET . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.120000000000005 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.439999999999998 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.150000000000006 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.519999999999996 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.230000000000004 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' HD12 ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.420000000000002 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.430000000000007 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.210000000000001 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 14' ' ' THR . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.329999999999998 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.219999999999999 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.952 HD22 ' HB1' ' A' ' 150' ' ' ALA . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.430000000000007 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.593 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.200000000000003 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' C ' ' A' ' 149' ' ' PRO . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.019999999999996 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 148' ' ' VAL . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.119999999999997 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.130000000000003 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.054 HG21 ' OH ' ' A' ' 170' ' ' TYR . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.399999999999999 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.329999999999998 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.895 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.340000000000003 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.140000000000001 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.439999999999998 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.925 ' HB3' HD22 ' A' ' 177' ' ' LEU . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.329999999999998 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.400000000000006 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.84 HG13 HD23 ' A' ' 173' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.540000000000006 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.200000000000003 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.329999999999998 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.530000000000001 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.009999999999998 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 170' ' ' TYR . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.420000000000002 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.439999999999998 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.230000000000004 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.420000000000002 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.349999999999994 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 1.054 ' OH ' HG21 ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.200000000000003 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.329999999999998 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.039999999999999 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 159' ' ' VAL . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.129999999999995 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 159' ' ' VAL . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.219999999999999 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.1 m120 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.109999999999999 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.340000000000003 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.120000000000005 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.219999999999999 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.400000000000006 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 177' ' ' LEU . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.129999999999995 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.459 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.049999999999997 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.268 0.556 . . . . 71.140000000000001 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 38.3 mt-30 -58.6 -35.13 71.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 70.150000000000006 110.444 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 92.1 m-85 -96.75 129.66 44.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 73.019999999999996 110.74 -172.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 1' ' ' ALA . 39.2 mttt -138.48 155.4 48.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -0.802 . . . . 73.239999999999995 109.954 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.621 ' CD ' HG11 ' A' ' 11' ' ' VAL . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.310000000000002 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.340000000000003 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.409999999999997 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 15.6 m-70 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.510000000000005 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.649 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.329999999999998 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.010000000000005 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.310000000000002 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.239999999999995 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.019999999999996 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.549999999999997 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.049999999999997 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.340000000000003 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.109999999999999 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.340000000000003 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.230000000000004 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.130000000000003 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.129999999999995 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.786 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.510000000000005 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.450000000000003 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.319999999999993 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.129999999999995 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.917 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.239999999999995 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.612 ' HA ' HG21 ' A' ' 93' ' ' ILE . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.319999999999993 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.409999999999997 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.120000000000005 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.329999999999998 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 149' ' ' PRO . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.229999999999997 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.230000000000004 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.240000000000002 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.772 ' CE2' HD11 ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.510000000000005 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.109999999999999 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.430000000000007 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.019999999999996 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.786 HG21 ' CD ' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.129999999999995 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.329999999999998 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.67 ' OE1' HD11 ' A' ' 167' ' ' LEU . 41.3 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.099999999999994 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.230000000000004 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.896 ' HA ' HD12 ' A' ' 47' ' ' LEU . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.340000000000003 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.409999999999997 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.040000000000006 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.420000000000002 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.219999999999999 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.109999999999999 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.010000000000005 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.109999999999999 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.109999999999999 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.76 ' CD1' HD11 ' A' ' 47' ' ' LEU . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.120000000000005 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.239999999999995 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.209999999999994 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.329999999999998 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.140000000000001 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.319999999999993 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.240000000000002 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.329999999999998 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.672 ' SD ' HG22 ' A' ' 148' ' ' VAL . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.120000000000005 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.591 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.310000000000002 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.130000000000003 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.200000000000003 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.209999999999994 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.019999999999996 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.310000000000002 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.420000000000002 110.309 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.040000000000006 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.430000000000007 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.904 ' HG2' HG21 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.130000000000003 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.329999999999998 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.210000000000001 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.310000000000002 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.709 HG21 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.210000000000001 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.603 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.040000000000006 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.918 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.319999999999993 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.319999999999993 109.773 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.009 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.299999999999997 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.120000000000005 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 79' ' ' LEU . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.319999999999993 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.109999999999999 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.019999999999996 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.510000000000005 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.400000000000006 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.120000000000005 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.938 HG21 ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.329999999999998 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 106' ' ' LEU . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.030000000000001 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.450000000000003 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.349999999999994 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.997 ' NH2' HG21 ' A' ' 109' ' ' ILE . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.140000000000001 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.917 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.450000000000003 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.48 ' N ' ' O ' ' A' ' 90' ' ' PHE . 1.9 t60 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.439999999999998 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.109999999999999 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.400000000000006 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.140000000000001 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.349999999999994 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.450000000000003 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.657 ' CG ' HD13 ' A' ' 106' ' ' LEU . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.430000000000007 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.310000000000002 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.510000000000005 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.329999999999998 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.549999999999997 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.140000000000001 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.011 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.149999999999999 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.299999999999997 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.400000000000006 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.200000000000003 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.603 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.420000000000002 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.510000000000005 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.049999999999997 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.938 ' OE1' HG21 ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.239999999999995 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.310000000000002 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.688 HG23 ' HE3' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.140000000000001 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.239999999999995 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.219999999999999 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.109999999999999 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.688 ' HE3' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.340000000000003 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.709 ' CE1' HG21 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.239999999999995 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.239999999999995 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.329999999999998 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.340000000000003 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.340000000000003 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.349999999999994 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.209999999999994 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.129999999999995 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.340000000000003 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.129999999999995 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.841 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.340000000000003 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.904 HG21 ' HG2' ' A' ' 71' ' ' LYS . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.439999999999998 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.140000000000001 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.120000000000005 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.439999999999998 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.150000000000006 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.519999999999996 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.230000000000004 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' HD12 ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.420000000000002 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.430000000000007 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.677 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.210000000000001 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 145' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.329999999999998 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.219999999999999 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 158' ' ' LEU . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.430000000000007 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.200000000000003 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.672 HG22 ' SD ' ' A' ' 61' ' ' MET . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.019999999999996 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.119999999999997 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.917 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.130000000000003 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.724 HG21 ' OH ' ' A' ' 170' ' ' TYR . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.399999999999999 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.329999999999998 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.501 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 4.2 m120 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.340000000000003 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.140000000000001 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.838 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.439999999999998 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.895 ' HB3' HD22 ' A' ' 177' ' ' LEU . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.329999999999998 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 145' ' ' LEU . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.400000000000006 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.540000000000006 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.200000000000003 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.329999999999998 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.530000000000001 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.009999999999998 110.412 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.420000000000002 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.439999999999998 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.230000000000004 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.67 HD11 ' OE1' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.420000000000002 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.349999999999994 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.724 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.200000000000003 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.794 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.329999999999998 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.039999999999999 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.129999999999995 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 159' ' ' VAL . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.219999999999999 109.629 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.626 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.109999999999999 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.340000000000003 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.120000000000005 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.219999999999999 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.400000000000006 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.129999999999995 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.049999999999997 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.248 0.546 . . . . 71.140000000000001 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 56.3 mt-30 -59.06 -33.11 70.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 70.150000000000006 110.375 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.8 p90 -125.94 159.71 31.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 73.019999999999996 110.561 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -170.24 150.78 3.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 73.239999999999995 109.656 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.310000000000002 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.340000000000003 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.583 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.409999999999997 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.510000000000005 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.58 ' CG ' HD21 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.329999999999998 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.010000000000005 109.516 175.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.815 HG22 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.310000000000002 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HD23 ' A' ' 158' ' ' LEU . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.239999999999995 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.019999999999996 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.549999999999997 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.972 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.049999999999997 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.340000000000003 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.109999999999999 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.340000000000003 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.603 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.230000000000004 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.626 ' CG2' HD21 ' A' ' 178' ' ' LEU . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.130000000000003 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.129999999999995 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.831 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.510000000000005 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.450000000000003 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.479 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.319999999999993 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.129999999999995 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.239999999999995 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.752 ' HA ' HG21 ' A' ' 93' ' ' ILE . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.319999999999993 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.409999999999997 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.54 ' N ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.120000000000005 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.329999999999998 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.230000000000004 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.240000000000002 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD11 ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.510000000000005 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.109999999999999 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.430000000000007 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.019999999999996 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.913 HD11 ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.129999999999995 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.329999999999998 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 4.6 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.099999999999994 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.673 HD12 ' CD1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.230000000000004 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 47' ' ' LEU . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.340000000000003 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.409999999999997 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.040000000000006 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.420000000000002 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.219999999999999 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.109999999999999 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.010000000000005 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.109999999999999 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.109999999999999 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.120000000000005 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.239999999999995 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.209999999999994 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.329999999999998 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.585 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.2 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.140000000000001 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.319999999999993 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.240000000000002 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.329999999999998 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.120000000000005 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.310000000000002 109.884 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.130000000000003 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.200000000000003 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.209999999999994 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.019999999999996 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.310000000000002 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.420000000000002 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.040000000000006 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.430000000000007 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.06 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.130000000000003 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.329999999999998 110.109 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.463 ' O ' ' HB2' ' A' ' 76' ' ' MET . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.210000000000001 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.991 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.310000000000002 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.763 HG21 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.210000000000001 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.040000000000006 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.319999999999993 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.319999999999993 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.299999999999997 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.120000000000005 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.813 HG12 ' HE3' ' A' ' 84' ' ' LYS . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.319999999999993 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.109999999999999 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.813 ' HE3' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.019999999999996 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.61 ' CG ' HD11 ' A' ' 115' ' ' ILE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.510000000000005 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.400000000000006 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.120000000000005 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.847 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.329999999999998 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.030000000000001 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.450000000000003 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.753 ' OD1' HG21 ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.349999999999994 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.822 ' HA ' HD12 ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.140000000000001 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.450000000000003 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.439999999999998 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.753 HG21 ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.109999999999999 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.822 HD12 ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.400000000000006 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.140000000000001 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.349999999999994 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.450000000000003 110.485 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.430000000000007 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.310000000000002 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.510000000000005 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.329999999999998 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.549999999999997 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.140000000000001 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.072 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.149999999999999 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.299999999999997 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.400000000000006 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.072 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.200000000000003 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.420000000000002 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.510000000000005 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.049999999999997 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.847 ' HG3' HG11 ' A' ' 88' ' ' VAL . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.239999999999995 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.310000000000002 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.140000000000001 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.239999999999995 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.219999999999999 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.109999999999999 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.974 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.340000000000003 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.927 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.239999999999995 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.239999999999995 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.329999999999998 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.340000000000003 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.340000000000003 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.349999999999994 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.209999999999994 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.991 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.129999999999995 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.340000000000003 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.535 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.129999999999995 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.894 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.340000000000003 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.06 HG21 ' HG2' ' A' ' 71' ' ' LYS . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.439999999999998 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.140000000000001 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.120000000000005 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.439999999999998 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.150000000000006 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.519999999999996 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.230000000000004 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HA ' HD12 ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.420000000000002 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.430000000000007 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.210000000000001 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.58 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.329999999999998 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.219999999999999 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.9 HD22 ' HB1' ' A' ' 150' ' ' ALA . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.430000000000007 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.200000000000003 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.019999999999996 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.119999999999997 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.9 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.130000000000003 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.831 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.399999999999999 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.329999999999998 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 177' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.340000000000003 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.140000000000001 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.972 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.439999999999998 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.815 ' CE1' HG22 ' A' ' 11' ' ' VAL . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.329999999999998 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.762 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.400000000000006 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.723 HG22 ' CD1' ' A' ' 177' ' ' LEU . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.540000000000006 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.583 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 26.6 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.200000000000003 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.329999999999998 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.530000000000001 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.599 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.009999999999998 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.420000000000002 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.439999999999998 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.230000000000004 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 167' ' ' LEU . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.420000000000002 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.349999999999994 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.762 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.200000000000003 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.74 ' HE2' HD22 ' A' ' 175' ' ' ASN . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.329999999999998 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.039999999999999 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.129999999999995 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.219999999999999 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.74 HD22 ' HE2' ' A' ' 171' ' ' PHE . 37.9 m-20 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.109999999999999 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.340000000000003 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.120000000000005 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.626 HD21 ' CG2' ' A' ' 22' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.219999999999999 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 175' ' ' ASN . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.400000000000006 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.129999999999995 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.049999999999997 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.549 . . . . 71.140000000000001 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 61.1 tt0 -56.54 -37.68 70.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 70.150000000000006 110.337 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 59.6 m-85 -106.05 132.1 52.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 73.019999999999996 110.225 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 1' ' ' ALA . 67.7 mttm -138.52 153.59 48.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 73.239999999999995 110.285 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.310000000000002 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.340000000000003 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.409999999999997 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 31.9 m-70 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.510000000000005 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.329999999999998 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.010000000000005 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.310000000000002 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 158' ' ' LEU . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.239999999999995 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.019999999999996 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.848 HG22 ' HB2' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.549999999999997 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.049999999999997 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.340000000000003 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.109999999999999 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.340000000000003 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG11 ' OG ' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.230000000000004 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.130000000000003 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.506 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.129999999999995 110.057 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.815 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.510000000000005 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.450000000000003 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.319999999999993 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.129999999999995 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.239999999999995 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.319999999999993 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.409999999999997 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.120000000000005 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.329999999999998 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.229999999999997 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.230000000000004 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.240000000000002 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 40' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.510000000000005 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.109999999999999 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.430000000000007 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 36' ' ' PHE . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.019999999999996 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' CD ' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.129999999999995 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.329999999999998 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.621 ' OE1' HD11 ' A' ' 167' ' ' LEU . 40.3 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.099999999999994 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.230000000000004 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.340000000000003 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.409999999999997 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 45.5 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.040000000000006 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.420000000000002 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.219999999999999 109.891 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.109999999999999 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.010000000000005 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.109999999999999 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.109999999999999 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.582 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.120000000000005 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.239999999999995 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.209999999999994 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.329999999999998 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.140000000000001 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 61' ' ' MET . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.319999999999993 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.240000000000002 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.329999999999998 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.120000000000005 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.310000000000002 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.130000000000003 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.200000000000003 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.464 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.209999999999994 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.019999999999996 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.310000000000002 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.420000000000002 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.595 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.040000000000006 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.430000000000007 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.130000000000003 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.329999999999998 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.210000000000001 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.310000000000002 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.605 HG23 ' HB3' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.210000000000001 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.823 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.040000000000006 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.944 HD12 ' HA ' ' A' ' 74' ' ' ALA . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.319999999999993 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.319999999999993 109.524 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.028 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.299999999999997 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.120000000000005 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.319999999999993 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.109999999999999 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.019999999999996 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.823 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.510000000000005 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.400000000000006 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.120000000000005 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.759 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.329999999999998 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.559 ' HE1' HD11 ' A' ' 106' ' ' LEU . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.030000000000001 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.450000000000003 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.349999999999994 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.86 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.140000000000001 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.450000000000003 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.439999999999998 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.109999999999999 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.400000000000006 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.140000000000001 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.349999999999994 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.450000000000003 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.430000000000007 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.310000000000002 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.510000000000005 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.329999999999998 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.549999999999997 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.140000000000001 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.008 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.149999999999999 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.299999999999997 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.400000000000006 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.200000000000003 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.420000000000002 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.855 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.510000000000005 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.049999999999997 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.759 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.239999999999995 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.310000000000002 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.140000000000001 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.239999999999995 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.855 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.219999999999999 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.109999999999999 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.340000000000003 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.239999999999995 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.239999999999995 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.329999999999998 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.340000000000003 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.340000000000003 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.349999999999994 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.209999999999994 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.129999999999995 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.340000000000003 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.129999999999995 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.802 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.340000000000003 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.439999999999998 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.140000000000001 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 132' ' ' MET . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.120000000000005 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.439999999999998 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.150000000000006 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.519999999999996 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.528 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.230000000000004 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.420000000000002 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.430000000000007 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.848 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.210000000000001 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.329999999999998 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.219999999999999 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.897 HD22 ' HB1' ' A' ' 150' ' ' ALA . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.430000000000007 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.200000000000003 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.019999999999996 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.119999999999997 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.897 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.130000000000003 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.981 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.399999999999999 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.415 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.329999999999998 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.9 m120 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.340000000000003 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.140000000000001 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.439999999999998 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.788 ' HB3' HD22 ' A' ' 177' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.329999999999998 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.754 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.400000000000006 108.989 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.524 HG13 HD23 ' A' ' 173' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.540000000000006 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.200000000000003 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.329999999999998 109.757 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.530000000000001 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.009999999999998 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.420000000000002 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.439999999999998 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.230000000000004 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.621 HD11 ' OE1' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.420000000000002 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.349999999999994 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.981 ' OH ' HG21 ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.200000000000003 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.769 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.329999999999998 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.039999999999999 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 159' ' ' VAL . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.129999999999995 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.219999999999999 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.109999999999999 110.736 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.709 ' O ' HG22 ' A' ' 179' ' ' THR . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.340000000000003 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.967 HD23 HD12 ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.120000000000005 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.219999999999999 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.400000000000006 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.967 HD12 HD23 ' A' ' 177' ' ' LEU . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.129999999999995 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.049999999999997 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.281 0.562 . . . . 71.140000000000001 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 58.0 tt0 -56.67 -36.19 69.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 70.150000000000006 110.348 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.625 ' CD1' ' ND1' ' A' ' 8' ' ' HIS . 23.2 m-85 -103.97 128.08 51.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 73.019999999999996 110.317 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp -164.39 160.14 20.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 73.239999999999995 109.929 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.310000000000002 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.340000000000003 109.211 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.409999999999997 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' CD1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.510000000000005 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.329999999999998 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.010000000000005 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.002 HG22 ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.310000000000002 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.239999999999995 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.019999999999996 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.549999999999997 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.049999999999997 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.340000000000003 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.402 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.109999999999999 109.626 175.876 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.340000000000003 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.230000000000004 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 HD21 ' A' ' 47' ' ' LEU . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.130000000000003 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.129999999999995 110.031 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.809 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.510000000000005 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.450000000000003 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.319999999999993 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.129999999999995 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.696 ' O ' HG21 ' A' ' 93' ' ' ILE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.239999999999995 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.319999999999993 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.409999999999997 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.120000000000005 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.329999999999998 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.229999999999997 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.230000000000004 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.240000000000002 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.510000000000005 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.109999999999999 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.430000000000007 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.019999999999996 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 24' ' ' GLU . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.129999999999995 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.329999999999998 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 5.0 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.099999999999994 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.230000000000004 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.752 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.340000000000003 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.409999999999997 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 45.3 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.040000000000006 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 44' ' ' LYS . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.420000000000002 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.219999999999999 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.109999999999999 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.010000000000005 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.109999999999999 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.109999999999999 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.120000000000005 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.239999999999995 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.209999999999994 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 136' ' ' PHE . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.329999999999998 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.140000000000001 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 58' ' ' VAL . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.319999999999993 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.240000000000002 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.329999999999998 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.120000000000005 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.310000000000002 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.130000000000003 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 42.9 m-20 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.200000000000003 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.209999999999994 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.019999999999996 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.310000000000002 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.420000000000002 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.040000000000006 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.564 ' OG ' ' CD2' ' A' ' 57' ' ' HIS . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.430000000000007 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HG2' HG21 ' A' ' 133' ' ' VAL . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.130000000000003 110.218 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.329999999999998 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.210000000000001 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.310000000000002 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.210000000000001 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.040000000000006 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.319999999999993 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.319999999999993 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.973 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.299999999999997 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.120000000000005 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.319999999999993 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.109999999999999 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.019999999999996 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.510000000000005 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.400000000000006 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.120000000000005 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.329999999999998 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.030000000000001 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.450000000000003 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.526 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.349999999999994 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.824 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.140000000000001 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.450000000000003 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 78.9 t60 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.439999999999998 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.109999999999999 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.400000000000006 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.140000000000001 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.349999999999994 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.450000000000003 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.430000000000007 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.310000000000002 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HE1' ' A' ' 65' ' ' MET . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.510000000000005 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.329999999999998 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.549999999999997 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.140000000000001 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.149999999999999 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.299999999999997 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.400000000000006 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.200000000000003 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.420000000000002 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.835 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.510000000000005 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.049999999999997 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.239999999999995 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.310000000000002 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 85' ' ' MET . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.140000000000001 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.239999999999995 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.835 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.219999999999999 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.109999999999999 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.973 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.340000000000003 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 79' ' ' LEU . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.239999999999995 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.239999999999995 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.329999999999998 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.340000000000003 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.340000000000003 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.349999999999994 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.209999999999994 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.129999999999995 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.340000000000003 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.527 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.129999999999995 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.846 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.340000000000003 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.714 HG21 ' HG2' ' A' ' 71' ' ' LYS . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.439999999999998 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.140000000000001 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.120000000000005 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.439999999999998 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.150000000000006 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.519999999999996 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 3.3 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.230000000000004 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.420000000000002 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.430000000000007 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.662 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.210000000000001 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.567 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.329999999999998 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.219999999999999 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 158' ' ' LEU . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.430000000000007 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.200000000000003 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.019999999999996 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.119999999999997 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.823 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.130000000000003 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.661 HG21 ' OH ' ' A' ' 170' ' ' TYR . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.399999999999999 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.329999999999998 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' HB2' ' A' ' 177' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.340000000000003 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.140000000000001 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.683 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.439999999999998 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 1.002 ' CE1' HG22 ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.329999999999998 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.400000000000006 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.540000000000006 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.200000000000003 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.329999999999998 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.530000000000001 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.009999999999998 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.420000000000002 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.439999999999998 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.230000000000004 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.479 HD21 HG23 ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.420000000000002 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.519 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.349999999999994 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.661 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.200000000000003 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.787 ' HE2' HD22 ' A' ' 175' ' ' ASN . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.329999999999998 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.585 ' OD1' ' CE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.039999999999999 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.129999999999995 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 159' ' ' VAL . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.219999999999999 109.596 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.787 HD22 ' HE2' ' A' ' 171' ' ' PHE . 36.1 m-20 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.109999999999999 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.340000000000003 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.004 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.120000000000005 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.219999999999999 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.400000000000006 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.004 HD12 ' HA ' ' A' ' 177' ' ' LEU . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.129999999999995 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.049999999999997 110.207 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.246 0.546 . . . . 71.140000000000001 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 81.8 mt-30 -59.16 -32.93 70.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 70.150000000000006 110.319 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' HB2' ' A' ' 173' ' ' LEU . 79.6 m-85 -96.79 125.42 41.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 73.019999999999996 110.428 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp -150.98 149.1 29.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 73.239999999999995 110.158 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.663 ' CD ' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.310000000000002 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.340000000000003 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.609 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.409999999999997 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.510000000000005 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CG ' HD21 ' A' ' 177' ' ' LEU . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.329999999999998 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.010000000000005 109.407 172.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.310000000000002 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.239999999999995 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.019999999999996 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.549999999999997 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.049999999999997 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.340000000000003 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.109999999999999 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.340000000000003 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.230000000000004 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.130000000000003 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.129999999999995 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.909 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.510000000000005 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.450000000000003 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.319999999999993 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.622 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.129999999999995 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.239999999999995 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.319999999999993 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.409999999999997 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.120000000000005 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.329999999999998 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.229999999999997 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.230000000000004 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.240000000000002 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.887 ' CE2' HD11 ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.510000000000005 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.109999999999999 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.430000000000007 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.019999999999996 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 ' OE1' ' A' ' 24' ' ' GLU . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.129999999999995 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.329999999999998 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.483 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 4.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.099999999999994 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.340000000000003 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.409999999999997 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.6 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.040000000000006 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.420000000000002 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.219999999999999 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.109999999999999 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.010000000000005 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.109999999999999 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.109999999999999 109.681 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.120000000000005 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.239999999999995 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.209999999999994 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.329999999999998 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.797 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.140000000000001 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 58' ' ' VAL . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.319999999999993 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.240000000000002 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.329999999999998 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.120000000000005 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.310000000000002 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.130000000000003 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.200000000000003 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.209999999999994 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.019999999999996 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.310000000000002 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.420000000000002 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.596 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.040000000000006 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.561 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.430000000000007 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.99 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.130000000000003 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.329999999999998 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.797 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.210000000000001 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.310000000000002 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.210000000000001 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.040000000000006 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.937 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.319999999999993 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.319999999999993 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 81' ' ' VAL . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.299999999999997 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.120000000000005 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.319999999999993 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.109999999999999 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.019999999999996 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.510000000000005 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.400000000000006 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.120000000000005 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.665 HG11 ' HG3' ' A' ' 113' ' ' GLU . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.329999999999998 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.594 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.030000000000001 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.450000000000003 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.349999999999994 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.140000000000001 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.450000000000003 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.439999999999998 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.109999999999999 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.400000000000006 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.140000000000001 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.349999999999994 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.450000000000003 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.430000000000007 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.310000000000002 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.510000000000005 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.329999999999998 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.549999999999997 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.140000000000001 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.023 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.149999999999999 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.299999999999997 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.400000000000006 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.200000000000003 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.420000000000002 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.510000000000005 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.049999999999997 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.239999999999995 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.310000000000002 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.140000000000001 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.239999999999995 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.886 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.219999999999999 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.109999999999999 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.340000000000003 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.239999999999995 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.239999999999995 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.329999999999998 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.779 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.340000000000003 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.340000000000003 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.349999999999994 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.209999999999994 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.959 ' HA ' ' HE3' ' A' ' 132' ' ' MET . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.129999999999995 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.340000000000003 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.548 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.129999999999995 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.340000000000003 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.99 HG21 ' HG2' ' A' ' 71' ' ' LYS . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.439999999999998 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.140000000000001 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.120000000000005 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.439999999999998 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.150000000000006 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.519999999999996 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.52 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.230000000000004 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.420000000000002 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.430000000000007 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.575 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.210000000000001 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.647 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.329999999999998 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.219999999999999 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.055 HD22 ' HB1' ' A' ' 150' ' ' ALA . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.430000000000007 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.200000000000003 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.019999999999996 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.119999999999997 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 1.055 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.130000000000003 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.902 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.399999999999999 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.568 HG22 HD22 ' A' ' 158' ' ' LEU . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.329999999999998 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.340000000000003 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.140000000000001 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.439999999999998 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.94 ' CE2' HG22 ' A' ' 11' ' ' VAL . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.329999999999998 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.993 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.400000000000006 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 173' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.540000000000006 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.609 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.2 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.200000000000003 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.329999999999998 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.530000000000001 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.009999999999998 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.420000000000002 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.439999999999998 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.230000000000004 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.420000000000002 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.349999999999994 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.902 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.200000000000003 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.329999999999998 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.039999999999999 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.129999999999995 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.219999999999999 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.565 ' HA ' HD12 ' A' ' 178' ' ' LEU . 5.5 m-20 -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.109999999999999 110.585 179.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.340000000000003 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.878 ' CD1' HG22 ' A' ' 159' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.120000000000005 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 175' ' ' ASN . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.219999999999999 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.400000000000006 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.129999999999995 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.049999999999997 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.261 0.553 . . . . 71.140000000000001 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 37.7 mt-30 -58.78 -34.5 71.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 70.150000000000006 110.409 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 54.4 p90 -129.75 163.11 26.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 73.019999999999996 110.669 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt -169.86 149.58 3.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 73.239999999999995 109.606 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.310000000000002 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.340000000000003 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.502 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.409999999999997 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.647 ' HB3' HD22 ' A' ' 173' ' ' LEU . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.510000000000005 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.329999999999998 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.010000000000005 109.617 175.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.564 HG22 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.310000000000002 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.239999999999995 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.019999999999996 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.549999999999997 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.925 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.049999999999997 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.340000000000003 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.109999999999999 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.491 ' HB2' HD22 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.340000000000003 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.641 HG21 ' CD ' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.230000000000004 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.130000000000003 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.129999999999995 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.510000000000005 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CB ' HG12 ' A' ' 148' ' ' VAL . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.450000000000003 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.45 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.319999999999993 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.62 ' OG ' HG21 ' A' ' 148' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.129999999999995 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.856 ' O ' HG21 ' A' ' 93' ' ' ILE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.239999999999995 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HA ' HG21 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.319999999999993 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.7 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.409999999999997 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.120000000000005 110.033 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.329999999999998 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.229999999999997 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.230000000000004 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.240000000000002 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.510000000000005 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.109999999999999 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.430000000000007 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.478 ' HB ' ' O ' ' A' ' 36' ' ' PHE . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.818 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.129999999999995 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.329999999999998 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.497 ' NE2' HD12 ' A' ' 167' ' ' LEU . 8.2 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.099999999999994 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.230000000000004 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.340000000000003 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.409999999999997 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 43.4 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.040000000000006 110.306 -179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.420000000000002 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.873 ' HD2' HD23 ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.219999999999999 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.109999999999999 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.010000000000005 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.109999999999999 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.109999999999999 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.120000000000005 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.641 ' CD ' HG21 ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.239999999999995 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.209999999999994 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.329999999999998 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.812 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.2 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.140000000000001 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 58' ' ' VAL . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.319999999999993 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.240000000000002 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.598 ' HE1' HG21 ' A' ' 58' ' ' VAL . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.329999999999998 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.7 ' HE3' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.120000000000005 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.310000000000002 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.130000000000003 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.200000000000003 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.209999999999994 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.019999999999996 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.310000000000002 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.420000000000002 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.556 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.040000000000006 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.430000000000007 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.130000000000003 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.329999999999998 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.812 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.210000000000001 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.019 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.310000000000002 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.210000000000001 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.504 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.040000000000006 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.319999999999993 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.319999999999993 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.917 HD13 ' CD ' ' A' ' 119' ' ' LYS . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.299999999999997 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.120000000000005 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.319999999999993 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.109999999999999 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.019999999999996 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.595 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.510000000000005 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.400000000000006 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.120000000000005 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.911 HG11 ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.329999999999998 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.030000000000001 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.450000000000003 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.349999999999994 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.844 ' HA ' HD12 ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.140000000000001 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.856 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.450000000000003 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.439999999999998 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.109999999999999 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.400000000000006 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.140000000000001 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.349999999999994 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.61 ' HA ' HD13 ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.450000000000003 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 106' ' ' LEU . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.430000000000007 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.310000000000002 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.510000000000005 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.329999999999998 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.549999999999997 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.140000000000001 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.033 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.149999999999999 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.299999999999997 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.400000000000006 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.033 HD12 ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.200000000000003 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.420000000000002 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.879 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.510000000000005 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.049999999999997 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.911 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.239999999999995 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.310000000000002 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.140000000000001 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.239999999999995 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.879 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.219999999999999 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.109999999999999 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.917 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.340000000000003 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.239999999999995 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.329999999999998 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.340000000000003 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.340000000000003 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.349999999999994 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.019 HG13 ' HB3' ' A' ' 74' ' ' ALA . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.129999999999995 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.340000000000003 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.129999999999995 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.745 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.340000000000003 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.439999999999998 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.140000000000001 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.120000000000005 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.439999999999998 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.150000000000006 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.519999999999996 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.53 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.230000000000004 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.420000000000002 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.430000000000007 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.210000000000001 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.591 ' OG ' HD12 ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.329999999999998 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.219999999999999 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.057 HD22 ' HB1' ' A' ' 150' ' ' ALA . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.430000000000007 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.200000000000003 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.62 HG21 ' OG ' ' A' ' 27' ' ' SER . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.019999999999996 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.554 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.119999999999997 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 1.057 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.130000000000003 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.399999999999999 110.067 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.461 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.329999999999998 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.8 m120 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.340000000000003 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.140000000000001 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.925 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.439999999999998 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.804 ' HB3' HD22 ' A' ' 177' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.329999999999998 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.903 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.400000000000006 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.540000000000006 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 26.7 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.200000000000003 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.329999999999998 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.530000000000001 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.009999999999998 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.420000000000002 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.439999999999998 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.494 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.230000000000004 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.420000000000002 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.349999999999994 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.538 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.200000000000003 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.85 ' CD1' HD13 ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.329999999999998 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.039999999999999 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.129999999999995 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.8 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.109999999999999 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.340000000000003 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.120000000000005 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.219999999999999 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.400000000000006 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.129999999999995 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.049999999999997 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.268 0.556 . . . . 71.140000000000001 110.246 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 54.5 mt-30 -59.11 -33.01 70.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 70.150000000000006 110.399 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.9 p90 -122.84 160.4 26.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 73.019999999999996 110.719 -174.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -169.61 154.15 5.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.523 -0.736 . . . . 73.239999999999995 109.688 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.310000000000002 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.340000000000003 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.409999999999997 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.67 ' HB3' HD22 ' A' ' 173' ' ' LEU . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.510000000000005 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.329999999999998 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.010000000000005 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.310000000000002 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.239999999999995 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.019999999999996 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.549999999999997 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.049999999999997 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.340000000000003 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.109999999999999 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.340000000000003 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.230000000000004 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.130000000000003 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.129999999999995 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HG2' HD12 ' A' ' 40' ' ' ILE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.510000000000005 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.450000000000003 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 58' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.319999999999993 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.129999999999995 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.955 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.239999999999995 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CD1' HD12 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.319999999999993 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.409999999999997 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.120000000000005 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.329999999999998 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.229999999999997 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.230000000000004 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.240000000000002 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.510000000000005 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.109999999999999 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.430000000000007 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.019999999999996 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.917 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.129999999999995 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.329999999999998 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.4 ' HB2' ' O ' ' A' ' 39' ' ' ILE . 4.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.099999999999994 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.230000000000004 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.948 ' HA ' HD12 ' A' ' 47' ' ' LEU . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.340000000000003 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.409999999999997 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.040000000000006 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.420000000000002 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.219999999999999 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.109999999999999 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.010000000000005 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.109999999999999 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.109999999999999 109.631 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.935 ' CD1' HD11 ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.120000000000005 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.239999999999995 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.209999999999994 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.329999999999998 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.140000000000001 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.319999999999993 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.240000000000002 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.329999999999998 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.120000000000005 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.310000000000002 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.130000000000003 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.200000000000003 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.465 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.209999999999994 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.019999999999996 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.310000000000002 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.420000000000002 110.205 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.040000000000006 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.742 ' CB ' HG13 ' A' ' 133' ' ' VAL . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.430000000000007 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.130000000000003 110.4 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.329999999999998 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.210000000000001 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.310000000000002 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 123' ' ' ALA . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.210000000000001 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.040000000000006 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 74' ' ' ALA . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.319999999999993 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.319999999999993 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.99 HD13 ' CD ' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.299999999999997 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.120000000000005 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.319999999999993 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.109999999999999 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.019999999999996 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.510000000000005 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.400000000000006 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.120000000000005 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.704 HG21 ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.329999999999998 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.756 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.030000000000001 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.349999999999994 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.140000000000001 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.955 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.450000000000003 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 38.7 t-80 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.439999999999998 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.109999999999999 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.400000000000006 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' THR . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.140000000000001 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.349999999999994 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.450000000000003 110.378 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.430000000000007 110.066 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.310000000000002 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.510000000000005 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.329999999999998 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.549999999999997 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.140000000000001 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.149999999999999 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.459 HH21 ' HB1' ' A' ' 117' ' ' ALA . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.299999999999997 110.393 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.400000000000006 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.200000000000003 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.420000000000002 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD21 ' CA ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.510000000000005 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.049999999999997 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.704 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.239999999999995 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.310000000000002 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.140000000000001 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.239999999999995 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.851 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.219999999999999 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.109999999999999 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.99 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.340000000000003 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.84 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.239999999999995 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.239999999999995 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.329999999999998 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.340000000000003 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.340000000000003 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.349999999999994 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.209999999999994 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.129999999999995 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.340000000000003 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.129999999999995 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.678 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.340000000000003 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.742 HG13 ' CB ' ' A' ' 70' ' ' SER . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.439999999999998 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.140000000000001 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.120000000000005 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.439999999999998 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.150000000000006 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.519999999999996 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.230000000000004 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.420000000000002 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.430000000000007 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.210000000000001 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HD12 ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.329999999999998 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.219999999999999 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.936 HD22 ' CB ' ' A' ' 150' ' ' ALA . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.430000000000007 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.200000000000003 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.019999999999996 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.568 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.119999999999997 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.936 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.130000000000003 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.978 ' O ' HD13 ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.399999999999999 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 HD21 ' A' ' 158' ' ' LEU . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.329999999999998 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.340000000000003 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.140000000000001 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.644 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.439999999999998 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.942 ' HB3' HD22 ' A' ' 177' ' ' LEU . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.329999999999998 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.978 HD13 ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.400000000000006 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 174' ' ' VAL . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.540000000000006 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.200000000000003 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.329999999999998 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.530000000000001 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.009999999999998 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.420000000000002 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.439999999999998 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.230000000000004 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.46 HD21 HG23 ' A' ' 39' ' ' ILE . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.420000000000002 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.349999999999994 110.564 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.618 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.200000000000003 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.75 ' CD1' HD12 ' A' ' 43' ' ' LEU . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.329999999999998 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.039999999999999 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.129999999999995 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 159' ' ' VAL . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.219999999999999 109.702 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.667 ' HA ' HD12 ' A' ' 178' ' ' LEU . 6.1 m-20 -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.109999999999999 110.926 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.340000000000003 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.120000000000005 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.219999999999999 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.400000000000006 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 177' ' ' LEU . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.129999999999995 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.049999999999997 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.301 0.572 . . . . 71.140000000000001 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 81.4 mt-30 -58.91 -32.36 69.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.862 . . . . 70.150000000000006 110.345 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.5 p90 -121.65 149.73 42.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 73.019999999999996 110.65 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 66.1 mttm -156.68 158.66 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.424 -0.798 . . . . 73.239999999999995 109.449 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.310000000000002 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.340000000000003 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.601 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.409999999999997 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' HD22 ' A' ' 173' ' ' LEU . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.510000000000005 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.329999999999998 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.010000000000005 109.315 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG22 ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.310000000000002 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD23 ' A' ' 158' ' ' LEU . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.239999999999995 110.267 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.019999999999996 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.549999999999997 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.884 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.049999999999997 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.340000000000003 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.109999999999999 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.340000000000003 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.612 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.230000000000004 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.130000000000003 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.129999999999995 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.821 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.510000000000005 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' HG12 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.450000000000003 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.319999999999993 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.129999999999995 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.239999999999995 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.319999999999993 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.409999999999997 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.120000000000005 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.329999999999998 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.229999999999997 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.230000000000004 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 40' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.510000000000005 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.109999999999999 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.430000000000007 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.019999999999996 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.821 HG21 ' CD ' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.129999999999995 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.329999999999998 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.701 ' OE1' HD11 ' A' ' 167' ' ' LEU . 39.4 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.099999999999994 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.230000000000004 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' A' ' 47' ' ' LEU . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.340000000000003 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.409999999999997 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.559 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.040000000000006 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.759 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.420000000000002 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.219999999999999 109.923 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.109999999999999 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.010000000000005 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.109999999999999 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.109999999999999 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.120000000000005 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.239999999999995 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.209999999999994 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.329999999999998 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.140000000000001 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 61' ' ' MET . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.319999999999993 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.240000000000002 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.329999999999998 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.638 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.120000000000005 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.310000000000002 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.130000000000003 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.200000000000003 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.516 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.209999999999994 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.019999999999996 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.310000000000002 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.420000000000002 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.040000000000006 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.430000000000007 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.018 ' HG2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.130000000000003 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.329999999999998 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.210000000000001 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.024 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.310000000000002 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.746 HG23 ' HB3' ' A' ' 123' ' ' ALA . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.210000000000001 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.592 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.040000000000006 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.319999999999993 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.319999999999993 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.904 HD22 ' HG2' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.299999999999997 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.120000000000005 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 79' ' ' LEU . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.319999999999993 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.109999999999999 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.019999999999996 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.668 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.510000000000005 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.400000000000006 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.120000000000005 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.737 HG21 ' OE1' ' A' ' 113' ' ' GLU . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.329999999999998 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.030000000000001 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.450000000000003 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.349999999999994 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.140000000000001 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.695 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.450000000000003 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.439999999999998 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.109999999999999 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.400000000000006 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 95' ' ' THR . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.140000000000001 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.349999999999994 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.450000000000003 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.541 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.430000000000007 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.310000000000002 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.510000000000005 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.329999999999998 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.549999999999997 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.140000000000001 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.934 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.149999999999999 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.299999999999997 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.400000000000006 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.934 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.200000000000003 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.420000000000002 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.859 HD21 ' CA ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.510000000000005 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.049999999999997 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.737 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.239999999999995 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.310000000000002 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.75 HG23 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.140000000000001 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.239999999999995 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.859 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.219999999999999 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.109999999999999 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.904 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.340000000000003 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.239999999999995 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.239999999999995 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.329999999999998 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.476 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.340000000000003 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.349999999999994 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.209999999999994 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.024 HG13 ' HB3' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.129999999999995 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.340000000000003 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.129999999999995 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.688 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.340000000000003 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.018 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.439999999999998 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.140000000000001 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.120000000000005 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.439999999999998 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.150000000000006 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.519999999999996 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.230000000000004 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.420000000000002 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.430000000000007 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.210000000000001 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 12' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.329999999999998 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.219999999999999 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' HB1' ' A' ' 150' ' ' ALA . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.430000000000007 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.200000000000003 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.019999999999996 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.119999999999997 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.926 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.130000000000003 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.399999999999999 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.329999999999998 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.503 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.340000000000003 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.140000000000001 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.884 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.439999999999998 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.973 ' CE1' HG22 ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.329999999999998 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.867 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.400000000000006 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.708 HG22 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.540000000000006 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.601 ' NE2' ' O ' ' A' ' 7' ' ' GLU . 27.5 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.200000000000003 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.329999999999998 109.829 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.530000000000001 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.009999999999998 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.420000000000002 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.439999999999998 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.230000000000004 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.701 HD11 ' OE1' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.420000000000002 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.349999999999994 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.41 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.200000000000003 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.783 ' HE2' HD22 ' A' ' 175' ' ' ASN . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.329999999999998 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.039999999999999 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.129999999999995 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.219999999999999 109.898 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.783 HD22 ' HE2' ' A' ' 171' ' ' PHE . 18.2 m-20 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.109999999999999 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.340000000000003 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.120000000000005 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.219999999999999 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.400000000000006 110.611 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 177' ' ' LEU . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.129999999999995 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.049999999999997 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.542 . . . . 71.140000000000001 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.572 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.8 tt0 -56.4 -37.75 70.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 70.150000000000006 110.192 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 84.2 m-85 -100.35 129.72 46.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 73.019999999999996 110.194 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -147.86 145.3 28.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 73.239999999999995 110.444 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.310000000000002 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.340000000000003 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.409999999999997 110.464 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 15.2 m-70 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.510000000000005 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.329999999999998 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.010000000000005 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.310000000000002 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 143' ' ' SER . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.239999999999995 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.019999999999996 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.549999999999997 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.049999999999997 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.340000000000003 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.109999999999999 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.340000000000003 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.230000000000004 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.130000000000003 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.129999999999995 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.85 ' CD ' HG21 ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.510000000000005 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.450000000000003 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.319999999999993 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.129999999999995 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.239999999999995 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' HA ' HG21 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.319999999999993 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.409999999999997 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.120000000000005 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.329999999999998 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.229999999999997 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.230000000000004 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.240000000000002 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.864 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.510000000000005 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.109999999999999 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.430000000000007 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.629 HG23 HD21 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.019999999999996 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.864 HD11 ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.129999999999995 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.329999999999998 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.099999999999994 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.793 HD12 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.230000000000004 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.84 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.340000000000003 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.409999999999997 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.040000000000006 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.420000000000002 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.219999999999999 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.109999999999999 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.010000000000005 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.109999999999999 110.6 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.109999999999999 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.120000000000005 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.239999999999995 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.209999999999994 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.329999999999998 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.717 ' CE1' ' HB2' ' A' ' 70' ' ' SER . 14.1 p80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.140000000000001 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.319999999999993 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.240000000000002 110.758 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.329999999999998 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.63 ' HG3' HG21 ' A' ' 58' ' ' VAL . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.120000000000005 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.310000000000002 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.130000000000003 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.200000000000003 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.209999999999994 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.019999999999996 109.81 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.310000000000002 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.420000000000002 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.040000000000006 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.806 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.430000000000007 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.130000000000003 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.329999999999998 110.439 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.210000000000001 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.310000000000002 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' ALA . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.210000000000001 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.809 ' SD ' HG23 ' A' ' 86' ' ' VAL . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.040000000000006 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 74' ' ' ALA . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.319999999999993 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.319999999999993 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.975 ' O ' HG13 ' A' ' 81' ' ' VAL . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.299999999999997 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.120000000000005 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.319999999999993 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 77' ' ' ILE . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.109999999999999 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.019999999999996 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.691 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.510000000000005 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.809 HG23 ' SD ' ' A' ' 76' ' ' MET . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.400000000000006 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.542 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.120000000000005 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.329999999999998 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 106' ' ' LEU . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.030000000000001 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.450000000000003 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.349999999999994 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.140000000000001 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.450000000000003 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.439999999999998 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.109999999999999 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.619 ' H ' HD12 ' A' ' 96' ' ' LEU . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.400000000000006 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.140000000000001 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.349999999999994 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.450000000000003 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.430000000000007 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.310000000000002 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.510000000000005 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.329999999999998 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.549999999999997 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.140000000000001 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.149999999999999 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.752 ' NH1' HD11 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.299999999999997 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.400000000000006 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.200000000000003 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CD2' ' CD1' ' A' ' 120' ' ' PHE . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.420000000000002 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.863 HD21 ' CA ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.510000000000005 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.049999999999997 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.743 ' CD ' HG21 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.239999999999995 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.310000000000002 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.746 HG23 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.140000000000001 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.239999999999995 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.863 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.219999999999999 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.109999999999999 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.902 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.340000000000003 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.879 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.239999999999995 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.239999999999995 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.329999999999998 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.340000000000003 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.340000000000003 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.349999999999994 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.209999999999994 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.129999999999995 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.340000000000003 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.129999999999995 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.340000000000003 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.821 HG21 ' HG2' ' A' ' 71' ' ' LYS . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.439999999999998 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.140000000000001 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.120000000000005 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.583 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.439999999999998 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.150000000000006 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.519999999999996 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 5.0 mm-40 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.230000000000004 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.420000000000002 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.430000000000007 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.210000000000001 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 12' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.329999999999998 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.219999999999999 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.992 HD22 ' HB1' ' A' ' 150' ' ' ALA . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.430000000000007 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.200000000000003 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.019999999999996 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.587 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.119999999999997 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.992 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.130000000000003 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' OH ' ' A' ' 170' ' ' TYR . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.399999999999999 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.329999999999998 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.340000000000003 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.140000000000001 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.632 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.439999999999998 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 1.012 ' CE2' HG22 ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.329999999999998 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.400000000000006 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 177' ' ' LEU . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.540000000000006 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 85.7 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.200000000000003 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.329999999999998 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.530000000000001 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.009999999999998 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.420000000000002 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.439999999999998 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.230000000000004 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.420000000000002 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.349999999999994 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.466 ' OH ' HG21 ' A' ' 151' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.200000000000003 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.793 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.329999999999998 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.039999999999999 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 177' ' ' LEU . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.129999999999995 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.219999999999999 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.109999999999999 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.340000000000003 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.120000000000005 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.219999999999999 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.400000000000006 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.013 HD12 ' HA ' ' A' ' 177' ' ' LEU . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.129999999999995 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.049999999999997 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 71.140000000000001 110.186 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.495 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.5 tt0 -56.36 -37.77 70.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 70.150000000000006 110.179 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 89.6 m-85 -105.41 132.83 51.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 73.019999999999996 110.127 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 1' ' ' ALA . 92.9 mttt -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 73.239999999999995 110.21 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.310000000000002 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.340000000000003 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.409999999999997 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 32.3 m80 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.510000000000005 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CG ' HD21 ' A' ' 177' ' ' LEU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.329999999999998 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.010000000000005 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.310000000000002 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 1.052 HD13 ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.239999999999995 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.019999999999996 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.549999999999997 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.049999999999997 110.291 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.340000000000003 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.403 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.109999999999999 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.340000000000003 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.230000000000004 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.130000000000003 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.129999999999995 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.510000000000005 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CB ' HG12 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.450000000000003 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.319999999999993 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.129999999999995 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.239999999999995 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE2' ' HE2' ' A' ' 69' ' ' MET . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.319999999999993 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.409999999999997 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.120000000000005 110.403 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.329999999999998 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.229999999999997 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.230000000000004 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.240000000000002 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.510000000000005 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.109999999999999 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.430000000000007 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.937 HG23 HD21 ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.019999999999996 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.129999999999995 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.329999999999998 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.099999999999994 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.230000000000004 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.852 ' HA ' HD12 ' A' ' 47' ' ' LEU . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.340000000000003 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.409999999999997 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 40.5 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.040000000000006 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.420000000000002 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.219999999999999 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.109999999999999 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.010000000000005 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.109999999999999 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.109999999999999 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.120000000000005 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.239999999999995 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.209999999999994 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.329999999999998 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.140000000000001 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.319999999999993 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.240000000000002 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.329999999999998 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.685 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.120000000000005 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.310000000000002 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.130000000000003 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.200000000000003 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 100' ' ' PRO . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.209999999999994 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.019999999999996 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.310000000000002 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.420000000000002 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.633 ' HE2' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.040000000000006 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.430000000000007 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.843 ' HG2' HG21 ' A' ' 133' ' ' VAL . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.130000000000003 110.035 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.329999999999998 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.210000000000001 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.079 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.310000000000002 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.83 HG21 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.210000000000001 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.549 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.040000000000006 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.319999999999993 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.319999999999993 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.881 HD11 ' HA ' ' A' ' 120' ' ' PHE . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.299999999999997 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.120000000000005 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.319999999999993 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.109999999999999 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.019999999999996 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HD12 ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.510000000000005 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.400000000000006 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.120000000000005 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.329999999999998 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.593 ' CE ' HD11 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.030000000000001 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.349999999999994 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.846 ' HA ' HD12 ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.140000000000001 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.450000000000003 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 63.6 t60 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.439999999999998 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.109999999999999 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.400000000000006 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.140000000000001 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.349999999999994 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.450000000000003 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.747 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.430000000000007 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.310000000000002 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.510000000000005 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.329999999999998 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.549999999999997 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.140000000000001 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.06 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.149999999999999 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.299999999999997 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.400000000000006 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.06 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.200000000000003 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.523 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.420000000000002 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.510000000000005 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.049999999999997 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.239999999999995 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.310000000000002 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.559 HD12 ' SD ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.140000000000001 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.239999999999995 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.96 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.219999999999999 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.109999999999999 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.764 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.340000000000003 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.239999999999995 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.239999999999995 109.711 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.329999999999998 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.340000000000003 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.340000000000003 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.349999999999994 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.209999999999994 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.079 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.129999999999995 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.340000000000003 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.129999999999995 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.774 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.340000000000003 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.843 HG21 ' HG2' ' A' ' 71' ' ' LYS . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.439999999999998 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.140000000000001 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.120000000000005 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.439999999999998 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.150000000000006 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.519999999999996 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' NE2' ' OD1' ' A' ' 155' ' ' ASN . 6.8 mm-40 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.230000000000004 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.420000000000002 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.430000000000007 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.210000000000001 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 1.052 ' HA ' HD13 ' A' ' 12' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.329999999999998 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.219999999999999 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' CB ' ' A' ' 150' ' ' ALA . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.430000000000007 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.200000000000003 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.019999999999996 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.119999999999997 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.926 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.130000000000003 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.582 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.399999999999999 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.329999999999998 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m120 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.340000000000003 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.527 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.140000000000001 110.916 175.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.93 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.439999999999998 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.76 ' CE2' HG22 ' A' ' 11' ' ' VAL . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.329999999999998 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.400000000000006 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 HD23 ' A' ' 173' ' ' LEU . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.540000000000006 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.200000000000003 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.329999999999998 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.530000000000001 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.009999999999998 110.247 178.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.420000000000002 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.439999999999998 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.230000000000004 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG23 ' A' ' 39' ' ' ILE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.420000000000002 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.74 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.349999999999994 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.582 ' OH ' HG21 ' A' ' 151' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.200000000000003 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.934 ' CD1' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.329999999999998 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.039999999999999 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.791 HD23 HG13 ' A' ' 159' ' ' VAL . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.129999999999995 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 159' ' ' VAL . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.219999999999999 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.792 ' HA ' HD12 ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.109999999999999 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.340000000000003 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.071 HD23 HD12 ' A' ' 180' ' ' LEU . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.120000000000005 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.219999999999999 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.400000000000006 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.071 HD12 HD23 ' A' ' 177' ' ' LEU . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.129999999999995 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.049999999999997 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.266 0.555 . . . . 71.140000000000001 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.9 tt0 -56.34 -37.01 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 70.150000000000006 110.21 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.3 m-85 -105.15 129.77 53.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 73.019999999999996 110.22 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt -150.21 150.17 31.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 73.239999999999995 110.42 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.310000000000002 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.340000000000003 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.409999999999997 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.510000000000005 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.329999999999998 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.010000000000005 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG22 ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.310000000000002 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.239999999999995 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.019999999999996 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.549999999999997 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 1.009 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.049999999999997 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.340000000000003 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.525 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.109999999999999 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.340000000000003 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.230000000000004 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.130000000000003 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.129999999999995 109.621 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.787 ' OE2' HG22 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.510000000000005 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.450000000000003 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.319999999999993 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.129999999999995 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.239999999999995 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.319999999999993 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.409999999999997 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.120000000000005 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.329999999999998 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.229999999999997 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.230000000000004 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.240000000000002 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.689 ' HE2' HD11 ' A' ' 40' ' ' ILE . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.510000000000005 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.109999999999999 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.430000000000007 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 167' ' ' LEU . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.019999999999996 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.689 HD11 ' HE2' ' A' ' 36' ' ' PHE . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.129999999999995 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.329999999999998 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 5.2 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.099999999999994 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.230000000000004 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.863 ' HA ' HD12 ' A' ' 47' ' ' LEU . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.340000000000003 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.409999999999997 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.040000000000006 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.420000000000002 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD23 ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.219999999999999 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.109999999999999 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.010000000000005 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.109999999999999 110.507 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.109999999999999 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.120000000000005 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.239999999999995 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.209999999999994 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.329999999999998 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.140000000000001 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.319999999999993 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.240000000000002 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.329999999999998 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.642 ' HE1' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.120000000000005 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.310000000000002 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.130000000000003 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.200000000000003 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.209999999999994 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.019999999999996 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.310000000000002 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.420000000000002 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.040000000000006 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.511 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.430000000000007 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.879 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.130000000000003 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.329999999999998 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.210000000000001 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.011 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.310000000000002 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.641 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.210000000000001 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.040000000000006 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.319999999999993 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.319999999999993 109.703 172.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.017 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.299999999999997 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.120000000000005 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.017 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.319999999999993 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.109999999999999 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.019999999999996 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.572 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.510000000000005 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.400000000000006 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.120000000000005 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.77 HG21 ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.329999999999998 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.583 ' CE ' HD11 ' A' ' 106' ' ' LEU . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.030000000000001 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.450000000000003 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.349999999999994 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.868 ' HA ' HD12 ' A' ' 96' ' ' LEU . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.140000000000001 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.450000000000003 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.439999999999998 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.109999999999999 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.400000000000006 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.140000000000001 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.349999999999994 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.450000000000003 110.396 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.742 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.430000000000007 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.310000000000002 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.510000000000005 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.329999999999998 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.549999999999997 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.140000000000001 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.014 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.149999999999999 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.299999999999997 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.400000000000006 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.014 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.200000000000003 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.420000000000002 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.510000000000005 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.049999999999997 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.77 ' OE1' HG21 ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.310000000000002 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.140000000000001 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.239999999999995 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.833 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.219999999999999 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.109999999999999 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.340000000000003 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.239999999999995 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.239999999999995 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.329999999999998 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.340000000000003 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.340000000000003 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.349999999999994 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.209999999999994 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.129999999999995 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.340000000000003 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.129999999999995 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.567 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.340000000000003 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.879 HG21 ' HG2' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.439999999999998 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.140000000000001 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.120000000000005 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.439999999999998 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.150000000000006 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.519999999999996 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.230000000000004 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.420000000000002 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.430000000000007 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.210000000000001 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.579 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.329999999999998 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.219999999999999 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 158' ' ' LEU . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.430000000000007 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.200000000000003 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.642 ' CG2' ' HE1' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.019999999999996 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.119999999999997 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.903 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.130000000000003 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.399999999999999 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.329999999999998 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.52 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.340000000000003 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.140000000000001 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.009 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.439999999999998 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.984 ' CE1' HG22 ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.329999999999998 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.400000000000006 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 173' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.540000000000006 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.200000000000003 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.329999999999998 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.530000000000001 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.009999999999998 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.420000000000002 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.439999999999998 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.230000000000004 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 39' ' ' ILE . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.420000000000002 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.349999999999994 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.200000000000003 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.757 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.329999999999998 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.039999999999999 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.712 HD23 HG13 ' A' ' 159' ' ' VAL . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.129999999999995 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 43' ' ' LEU . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.219999999999999 109.766 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 178' ' ' LEU . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.109999999999999 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.340000000000003 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.006 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.120000000000005 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.529 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.219999999999999 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.400000000000006 110.191 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 177' ' ' LEU . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.129999999999995 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.049999999999997 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.225 0.536 . . . . 71.140000000000001 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.1 tt0 -56.38 -36.48 68.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 70.150000000000006 110.307 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.8 m-85 -104.19 132.74 50.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 73.019999999999996 110.272 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -132.22 153.65 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 73.239999999999995 110.124 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 11' ' ' VAL . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.310000000000002 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.340000000000003 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.409999999999997 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 25.7 m170 -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.510000000000005 109.949 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.7 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.329999999999998 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.010000000000005 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.310000000000002 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 158' ' ' LEU . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.239999999999995 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.019999999999996 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.549999999999997 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.979 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.049999999999997 110.413 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.340000000000003 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.109999999999999 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 51' ' ' ALA . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.340000000000003 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.230000000000004 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.130000000000003 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.129999999999995 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.712 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.510000000000005 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.450000000000003 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.319999999999993 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.129999999999995 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.926 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.239999999999995 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HA ' HG21 ' A' ' 93' ' ' ILE . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.319999999999993 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.409999999999997 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 35' ' ' THR . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.120000000000005 110.059 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.329999999999998 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.229999999999997 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.230000000000004 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.240000000000002 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.510000000000005 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.109999999999999 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.430000000000007 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 36' ' ' PHE . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.019999999999996 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.129999999999995 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.329999999999998 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.504 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.6 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.099999999999994 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.975 HD13 ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.230000000000004 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.340000000000003 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.409999999999997 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 40.3 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.040000000000006 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.420000000000002 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.219999999999999 109.931 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.109999999999999 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.010000000000005 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.109999999999999 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.109999999999999 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.120000000000005 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 26.6 mm100 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.239999999999995 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.209999999999994 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.329999999999998 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.815 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.140000000000001 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG21 ' HG3' ' A' ' 61' ' ' MET . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.319999999999993 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.469 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.240000000000002 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.329999999999998 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.656 ' HG3' HG21 ' A' ' 58' ' ' VAL . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.120000000000005 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.310000000000002 109.895 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.130000000000003 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.200000000000003 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.209999999999994 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.019999999999996 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.310000000000002 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.420000000000002 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.040000000000006 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.430000000000007 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.130000000000003 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.329999999999998 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.815 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.210000000000001 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.075 ' CB ' HG13 ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.310000000000002 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.863 HG23 ' HB3' ' A' ' 123' ' ' ALA . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.210000000000001 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.040000000000006 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.975 HD12 ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.319999999999993 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.496 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.319999999999993 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.958 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.299999999999997 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.120000000000005 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.319999999999993 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.109999999999999 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.019999999999996 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.674 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.510000000000005 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.400000000000006 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.120000000000005 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.329999999999998 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.030000000000001 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.450000000000003 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.349999999999994 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.140000000000001 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.926 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.450000000000003 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.439999999999998 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.109999999999999 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.400000000000006 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 95' ' ' THR . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.140000000000001 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.349999999999994 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.450000000000003 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.649 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.430000000000007 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.310000000000002 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.510000000000005 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.329999999999998 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.549999999999997 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.140000000000001 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.988 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.149999999999999 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.299999999999997 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.400000000000006 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.988 HD12 ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.200000000000003 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.420000000000002 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.510000000000005 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.049999999999997 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.71 ' CD ' HG11 ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.239999999999995 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.310000000000002 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' CE ' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.140000000000001 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.239999999999995 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.219999999999999 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.109999999999999 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.958 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.340000000000003 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.239999999999995 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.239999999999995 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.329999999999998 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.863 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.340000000000003 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.340000000000003 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.349999999999994 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.209999999999994 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.075 HG13 ' CB ' ' A' ' 74' ' ' ALA . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.129999999999995 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.340000000000003 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.129999999999995 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.741 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.340000000000003 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.439999999999998 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.140000000000001 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.120000000000005 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.439999999999998 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.150000000000006 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.519999999999996 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm-40 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.230000000000004 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.643 ' HA ' HD12 ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.420000000000002 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 84.8 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.430000000000007 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.936 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.210000000000001 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.566 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.329999999999998 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.219999999999999 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.945 HD22 ' CB ' ' A' ' 150' ' ' ALA . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.430000000000007 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.200000000000003 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.019999999999996 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.119999999999997 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.945 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.130000000000003 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.454 ' O ' HD13 ' A' ' 158' ' ' LEU . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.399999999999999 110.151 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.329999999999998 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.2 m120 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.340000000000003 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.140000000000001 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.979 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.439999999999998 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.873 ' HB3' HD22 ' A' ' 177' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.329999999999998 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.400000000000006 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.718 HG13 HD23 ' A' ' 173' ' ' LEU . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.540000000000006 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.200000000000003 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.329999999999998 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.530000000000001 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.009999999999998 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.420000000000002 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.439999999999998 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.230000000000004 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.420000000000002 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.349999999999994 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.200000000000003 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.975 ' CG ' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.329999999999998 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.039999999999999 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.718 HD23 HG13 ' A' ' 159' ' ' VAL . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.129999999999995 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.584 HG22 HG21 ' A' ' 159' ' ' VAL . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.219999999999999 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.109999999999999 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.340000000000003 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.120000000000005 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.219999999999999 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.400000000000006 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.129999999999995 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.049999999999997 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.226 0.536 . . . . 71.140000000000001 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.577 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 62.2 tp60 -56.47 -41.18 76.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 70.150000000000006 110.392 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 27.8 p90 -147.51 157.94 43.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 73.019999999999996 110.606 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt -155.95 -165.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 73.239999999999995 109.755 177.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.589 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.310000000000002 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.340000000000003 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.409999999999997 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.510000000000005 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.329999999999998 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.462 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.010000000000005 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 1.056 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.310000000000002 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.239999999999995 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.019999999999996 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.549999999999997 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.049999999999997 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.340000000000003 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.109999999999999 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.340000000000003 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG21 ' OE1' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.230000000000004 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HD21 ' A' ' 178' ' ' LEU . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.130000000000003 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.129999999999995 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.905 ' OE1' HG21 ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.510000000000005 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' C ' HG11 ' A' ' 148' ' ' VAL . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.450000000000003 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.319999999999993 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.129999999999995 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.927 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.239999999999995 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.6 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.319999999999993 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.409999999999997 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.120000000000005 110.358 -177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.329999999999998 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.229999999999997 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.230000000000004 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.240000000000002 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.78 ' HE2' HD11 ' A' ' 40' ' ' ILE . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.510000000000005 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.109999999999999 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.430000000000007 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.019999999999996 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.129999999999995 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.329999999999998 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.099999999999994 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.917 HD13 ' CD1' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.230000000000004 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.340000000000003 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.409999999999997 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.42 ' HG3' ' O ' ' A' ' 42' ' ' GLN . 43.9 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.040000000000006 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.420000000000002 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.219999999999999 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.109999999999999 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.010000000000005 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.109999999999999 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.109999999999999 109.578 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.776 ' CD1' HD11 ' A' ' 47' ' ' LEU . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.120000000000005 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.618 ' OE1' HG21 ' A' ' 21' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.239999999999995 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.209999999999994 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.329999999999998 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.140000000000001 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' A' ' 61' ' ' MET . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.319999999999993 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.240000000000002 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.329999999999998 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.120000000000005 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.310000000000002 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.130000000000003 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.200000000000003 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.456 ' HG3' ' O ' ' A' ' 65' ' ' MET . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.209999999999994 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.019999999999996 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.310000000000002 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.420000000000002 110.383 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.47 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.040000000000006 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.885 ' CB ' HG13 ' A' ' 133' ' ' VAL . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.430000000000007 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.130000000000003 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' A' ' 106' ' ' LEU . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.329999999999998 110.329 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 55' ' ' LYS . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.210000000000001 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.310000000000002 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.210000000000001 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.648 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.040000000000006 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.319999999999993 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.319999999999993 109.763 173.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.971 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.299999999999997 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.120000000000005 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.971 HG13 ' O ' ' A' ' 79' ' ' LEU . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.319999999999993 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.109999999999999 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.019999999999996 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.631 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.510000000000005 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.400000000000006 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.120000000000005 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.805 HG21 ' OE1' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.329999999999998 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.731 ' HE1' HD11 ' A' ' 106' ' ' LEU . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.030000000000001 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.450000000000003 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.349999999999994 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.865 ' HA ' HD12 ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.140000000000001 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.450000000000003 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.505 ' N ' ' O ' ' A' ' 90' ' ' PHE . 7.5 t60 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.439999999999998 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.109999999999999 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.400000000000006 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.140000000000001 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.349999999999994 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.450000000000003 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.430000000000007 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.310000000000002 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.510000000000005 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.329999999999998 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.549999999999997 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.140000000000001 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.071 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.149999999999999 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.299999999999997 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.400000000000006 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.071 HD12 ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.200000000000003 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.648 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.420000000000002 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.510000000000005 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.049999999999997 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.805 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.239999999999995 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.310000000000002 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.140000000000001 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.239999999999995 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.219999999999999 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.109999999999999 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.67 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.340000000000003 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CE1' HG21 ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.239999999999995 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.239999999999995 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.329999999999998 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.588 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.340000000000003 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.677 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.340000000000003 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.349999999999994 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.129999999999995 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.340000000000003 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.129999999999995 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.340000000000003 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.885 HG13 ' CB ' ' A' ' 70' ' ' SER . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.439999999999998 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.140000000000001 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.120000000000005 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.439999999999998 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.150000000000006 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.519999999999996 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.230000000000004 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.832 ' HA ' HD12 ' A' ' 145' ' ' LEU . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.420000000000002 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.430000000000007 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.897 ' HB3' HG22 ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.210000000000001 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.329999999999998 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.219999999999999 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 158' ' ' LEU . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.430000000000007 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.200000000000003 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.61 HG11 ' C ' ' A' ' 25' ' ' PHE . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.019999999999996 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.119999999999997 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.130000000000003 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.399999999999999 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.329999999999998 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 3.8 m120 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.340000000000003 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.140000000000001 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.994 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.439999999999998 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 1.056 ' CE2' HG22 ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.329999999999998 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.400000000000006 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.789 HG21 HG22 ' A' ' 174' ' ' VAL . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.540000000000006 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.200000000000003 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.329999999999998 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.530000000000001 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.009999999999998 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.420000000000002 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.439999999999998 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.230000000000004 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.420000000000002 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.349999999999994 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.634 ' CE1' HG12 ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.200000000000003 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.917 ' CD1' HD13 ' A' ' 43' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.329999999999998 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.039999999999999 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.713 HD23 HG13 ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.129999999999995 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.219999999999999 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.988 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.109999999999999 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.340000000000003 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 180' ' ' LEU . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.120000000000005 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.988 HD12 ' HA ' ' A' ' 175' ' ' ASN . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.219999999999999 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.400000000000006 110.179 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 177' ' ' LEU . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.129999999999995 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.458 ' OXT' ' HG2' ' A' ' 181' ' ' LYS . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.049999999999997 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.238 0.542 . . . . 71.140000000000001 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' NE2' ' HG3' ' A' ' 169' ' ' GLU . 59.5 tt0 -56.38 -35.91 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 70.150000000000006 110.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 176' ' ' TYR . 52.0 p90 -130.51 164.07 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 73.019999999999996 110.178 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt -172.83 167.02 5.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 73.239999999999995 110.286 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.310000000000002 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.340000000000003 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.409999999999997 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB3' HD22 ' A' ' 173' ' ' LEU . 5.0 m-70 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.510000000000005 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.693 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.329999999999998 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.010000000000005 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.906 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.310000000000002 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.667 HD11 HD23 ' A' ' 158' ' ' LEU . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.239999999999995 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.019999999999996 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.549999999999997 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.971 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.049999999999997 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.340000000000003 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.109999999999999 109.513 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.529 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.340000000000003 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.230000000000004 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.130000000000003 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.129999999999995 110.23 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.804 ' OE1' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.510000000000005 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.450000000000003 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.319999999999993 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.544 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.129999999999995 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.239999999999995 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.505 ' HA ' HG21 ' A' ' 93' ' ' ILE . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.319999999999993 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.409999999999997 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.120000000000005 109.999 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.329999999999998 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.229999999999997 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.230000000000004 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.240000000000002 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.985 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.510000000000005 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.109999999999999 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.430000000000007 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.019999999999996 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.985 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.129999999999995 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.329999999999998 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.49 ' OE1' HD11 ' A' ' 167' ' ' LEU . 24.1 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.099999999999994 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.230000000000004 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' HD12 ' A' ' 47' ' ' LEU . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.340000000000003 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.409999999999997 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.040000000000006 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 44' ' ' LYS . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.420000000000002 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.219999999999999 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.109999999999999 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.010000000000005 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.109999999999999 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.109999999999999 109.641 175.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.120000000000005 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.239999999999995 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.209999999999994 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.329999999999998 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.766 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.140000000000001 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.319999999999993 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.458 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.240000000000002 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.62 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.329999999999998 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.62 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.120000000000005 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.310000000000002 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.130000000000003 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.200000000000003 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.209999999999994 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.019999999999996 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.420000000000002 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.040000000000006 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.430000000000007 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 1.039 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.130000000000003 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.329999999999998 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.766 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.210000000000001 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.052 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.310000000000002 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 123' ' ' ALA . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.210000000000001 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.535 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.040000000000006 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.976 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.319999999999993 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.319999999999993 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.866 ' O ' HG13 ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.299999999999997 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.120000000000005 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.319999999999993 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.109999999999999 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.019999999999996 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.717 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.510000000000005 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.400000000000006 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.120000000000005 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.329999999999998 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.651 ' HE1' HD11 ' A' ' 106' ' ' LEU . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.030000000000001 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.450000000000003 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.349999999999994 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.855 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.140000000000001 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.450000000000003 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.439999999999998 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.109999999999999 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.400000000000006 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.140000000000001 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.349999999999994 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.450000000000003 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.430000000000007 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.310000000000002 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.510000000000005 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.329999999999998 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.549999999999997 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.140000000000001 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.882 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.149999999999999 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.299999999999997 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 45.9 mm-40 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.400000000000006 110.615 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.200000000000003 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.717 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.420000000000002 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.510000000000005 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.049999999999997 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.698 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.239999999999995 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.310000000000002 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.140000000000001 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.557 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.239999999999995 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.219999999999999 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.109999999999999 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.817 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.340000000000003 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.775 ' HA ' HD11 ' A' ' 79' ' ' LEU . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.239999999999995 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.239999999999995 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.329999999999998 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.340000000000003 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.340000000000003 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.349999999999994 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.209999999999994 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.052 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.129999999999995 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.340000000000003 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.129999999999995 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.340000000000003 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 71' ' ' LYS . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.439999999999998 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.140000000000001 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.120000000000005 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.439999999999998 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.150000000000006 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.519999999999996 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 0.9 OUTLIER -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.230000000000004 110.611 -175.604 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.689 ' HA ' HD12 ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.420000000000002 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.430000000000007 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.210000000000001 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.329999999999998 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.219999999999999 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.430000000000007 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.200000000000003 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.019999999999996 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.119999999999997 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.130000000000003 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.868 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.399999999999999 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.329999999999998 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 177' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.504 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.340000000000003 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.140000000000001 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.971 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.439999999999998 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 177' ' ' LEU . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.329999999999998 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.957 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.400000000000006 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.493 HG13 HD23 ' A' ' 173' ' ' LEU . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.540000000000006 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.508 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.200000000000003 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.329999999999998 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.530000000000001 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.009999999999998 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 169' ' ' GLU . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.420000000000002 109.715 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.439999999999998 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.230000000000004 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.49 HD11 ' OE1' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.420000000000002 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.349999999999994 110.587 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.868 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.200000000000003 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.828 ' HE2' HD22 ' A' ' 175' ' ' ASN . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.329999999999998 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.039999999999999 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 8' ' ' HIS . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.129999999999995 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.219999999999999 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.828 HD22 ' HE2' ' A' ' 171' ' ' PHE . 38.5 m-20 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.109999999999999 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 3' ' ' PHE . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.340000000000003 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 157' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.120000000000005 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.219999999999999 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.400000000000006 110.677 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 177' ' ' LEU . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.129999999999995 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.049999999999997 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 71.140000000000001 110.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.65 -35.73 68.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 70.150000000000006 110.266 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' CD2' ' CE2' ' A' ' 176' ' ' TYR . 22.9 m-85 -104.29 137.36 42.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 73.019999999999996 109.647 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.576 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 32.6 tttt -162.56 133.24 4.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.009 -1.057 . . . . 73.239999999999995 110.943 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.310000000000002 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.340000000000003 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.409999999999997 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 1.135 ' ND1' HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.510000000000005 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 1.122 ' CD2' HD21 ' A' ' 177' ' ' LEU . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.329999999999998 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.010000000000005 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.310000000000002 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' SER . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.239999999999995 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.019999999999996 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.549999999999997 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.049999999999997 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.340000000000003 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.109999999999999 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.340000000000003 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.230000000000004 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.130000000000003 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.129999999999995 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.799 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.510000000000005 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.450000000000003 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 58' ' ' VAL . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.319999999999993 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.129999999999995 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.958 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.239999999999995 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' HG21 ' A' ' 93' ' ' ILE . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.319999999999993 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.409999999999997 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.120000000000005 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.329999999999998 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.229999999999997 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.427 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 0.9 OUTLIER -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.230000000000004 110.365 -179.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.240000000000002 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.973 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.510000000000005 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.109999999999999 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.430000000000007 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.019999999999996 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.973 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.129999999999995 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.329999999999998 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 5.2 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.099999999999994 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.230000000000004 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.692 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.340000000000003 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.409999999999997 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.6 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.040000000000006 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.420000000000002 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.219999999999999 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.109999999999999 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.010000000000005 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.109999999999999 110.435 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.109999999999999 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.120000000000005 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.239999999999995 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.209999999999994 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.329999999999998 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.140000000000001 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.647 HG21 ' HG3' ' A' ' 61' ' ' MET . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.319999999999993 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.240000000000002 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.329999999999998 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.120000000000005 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.310000000000002 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.130000000000003 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.200000000000003 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.55 ' HE2' HD22 ' A' ' 106' ' ' LEU . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.209999999999994 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.019999999999996 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 tp-100 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.310000000000002 110.259 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.420000000000002 110.236 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.459 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.040000000000006 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.430000000000007 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.832 ' HG2' HG21 ' A' ' 133' ' ' VAL . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.130000000000003 110.103 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.329999999999998 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.210000000000001 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.058 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.310000000000002 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 123' ' ' ALA . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.210000000000001 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.639 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.040000000000006 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.319999999999993 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.319999999999993 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.981 ' O ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.299999999999997 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.120000000000005 109.944 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.319999999999993 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' VAL . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.109999999999999 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.019999999999996 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.639 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.510000000000005 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.400000000000006 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.120000000000005 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.329999999999998 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HE1' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.030000000000001 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.450000000000003 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.532 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.349999999999994 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.867 ' HA ' HD12 ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.140000000000001 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.958 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.450000000000003 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.427 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 79.8 t60 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.439999999999998 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.109999999999999 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.400000000000006 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' THR . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.140000000000001 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.349999999999994 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.467 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.450000000000003 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.701 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.430000000000007 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.310000000000002 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.510000000000005 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.329999999999998 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.549999999999997 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.140000000000001 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.957 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.149999999999999 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.299999999999997 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 49.0 mm-40 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.400000000000006 110.612 -179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.200000000000003 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' O ' HG12 ' A' ' 115' ' ' ILE . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.420000000000002 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' CA ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.510000000000005 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.049999999999997 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.239999999999995 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.310000000000002 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.140000000000001 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.239999999999995 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.219999999999999 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.109999999999999 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.340000000000003 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.239999999999995 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.239999999999995 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.329999999999998 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.797 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.340000000000003 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.340000000000003 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.349999999999994 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.209999999999994 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.058 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.129999999999995 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.340000000000003 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.129999999999995 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.340000000000003 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.832 HG21 ' HG2' ' A' ' 71' ' ' LYS . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.439999999999998 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.140000000000001 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.120000000000005 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.439999999999998 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.150000000000006 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.519999999999996 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.531 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.230000000000004 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.420000000000002 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.430000000000007 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.210000000000001 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.708 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.329999999999998 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.219999999999999 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 158' ' ' LEU . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.430000000000007 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.200000000000003 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.019999999999996 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.119999999999997 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.130000000000003 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 0.808 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.399999999999999 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.329999999999998 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.340000000000003 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.52 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.140000000000001 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.439999999999998 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.329999999999998 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.400000000000006 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 177' ' ' LEU . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.540000000000006 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.200000000000003 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.329999999999998 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.530000000000001 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.009999999999998 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.420000000000002 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.439999999999998 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.230000000000004 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.420000000000002 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.349999999999994 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.808 ' OH ' HG21 ' A' ' 151' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.200000000000003 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.716 ' CD1' HD12 ' A' ' 43' ' ' LEU . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.329999999999998 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.039999999999999 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 1.135 HD13 ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.129999999999995 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.219999999999999 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.109999999999999 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.647 ' CE2' ' CD2' ' A' ' 3' ' ' PHE . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.340000000000003 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 1.122 HD21 ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.120000000000005 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.219999999999999 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.400000000000006 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.129999999999995 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.049999999999997 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB1' ' HE2' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 71.140000000000001 110.153 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.2 tt0 -56.21 -37.35 69.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 70.150000000000006 110.259 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 8' ' ' HIS . 48.6 m-85 -103.08 131.65 49.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 73.019999999999996 109.948 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.686 ' HE2' ' HB1' ' A' ' 1' ' ' ALA . 53.5 mttt -144.69 167.21 23.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 73.239999999999995 110.586 -177.506 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.587 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.310000000000002 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.340000000000003 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.409999999999997 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 13.1 m-70 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.510000000000005 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.639 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.329999999999998 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.010000000000005 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG22 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.310000000000002 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.239999999999995 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.019999999999996 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.549999999999997 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.049999999999997 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.340000000000003 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.428 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.109999999999999 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.340000000000003 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.230000000000004 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 178' ' ' LEU . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.130000000000003 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.129999999999995 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 1.037 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.510000000000005 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.450000000000003 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.319999999999993 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.552 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.129999999999995 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.737 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.239999999999995 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.497 ' HA ' HG21 ' A' ' 93' ' ' ILE . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.319999999999993 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.409999999999997 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.120000000000005 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.329999999999998 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.229999999999997 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.621 ' C ' HD21 ' A' ' 34' ' ' ASN . 0.2 OUTLIER -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.230000000000004 110.369 179.745 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.240000000000002 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.809 ' CE2' HD11 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.510000000000005 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.109999999999999 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.430000000000007 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.7 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.019999999999996 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.809 HD11 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.129999999999995 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.329999999999998 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.684 ' CD ' HD13 ' A' ' 167' ' ' LEU . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.099999999999994 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.230000000000004 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' LEU . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.340000000000003 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.409999999999997 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.040000000000006 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' LYS . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.420000000000002 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.219999999999999 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.109999999999999 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.010000000000005 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.109999999999999 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.109999999999999 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.120000000000005 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.239999999999995 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.209999999999994 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.329999999999998 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.514 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 1.7 m-70 -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.140000000000001 109.64 -179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.319999999999993 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.240000000000002 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.329999999999998 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.120000000000005 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.310000000000002 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.130000000000003 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.200000000000003 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.469 ' O ' ' HG2' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.209999999999994 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.019999999999996 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.310000000000002 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.420000000000002 110.226 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.040000000000006 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 133' ' ' VAL . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.430000000000007 110.214 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.130000000000003 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.329999999999998 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.474 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.210000000000001 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.077 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.310000000000002 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.746 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.210000000000001 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.633 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.040000000000006 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.953 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.319999999999993 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.319999999999993 109.758 173.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.035 ' O ' HG13 ' A' ' 81' ' ' VAL . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.299999999999997 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.120000000000005 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.319999999999993 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.109999999999999 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.019999999999996 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.702 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.510000000000005 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.400000000000006 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.120000000000005 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.731 HG11 ' CD ' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.329999999999998 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.799 ' HE1' HD11 ' A' ' 106' ' ' LEU . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.030000000000001 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.450000000000003 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.349999999999994 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.140000000000001 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 28' ' ' PHE . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.450000000000003 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.439999999999998 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.109999999999999 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.400000000000006 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.140000000000001 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.349999999999994 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.450000000000003 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.477 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.430000000000007 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.310000000000002 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.510000000000005 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.329999999999998 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.549999999999997 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.140000000000001 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.017 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.149999999999999 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.724 ' NH2' ' HB1' ' A' ' 117' ' ' ALA . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.299999999999997 110.32 176.69 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.400000000000006 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.200000000000003 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.420000000000002 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.510000000000005 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.049999999999997 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.731 ' CD ' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.239999999999995 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.310000000000002 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.140000000000001 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.239999999999995 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.219999999999999 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.109999999999999 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.681 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.340000000000003 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.239999999999995 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.239999999999995 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.329999999999998 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.340000000000003 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.667 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.340000000000003 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.349999999999994 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.209999999999994 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.077 HG13 ' HB3' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.129999999999995 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.340000000000003 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.129999999999995 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.895 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.340000000000003 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.777 HG21 ' HG2' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.439999999999998 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.140000000000001 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.120000000000005 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.575 ' CD2' ' O ' ' A' ' 132' ' ' MET . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.439999999999998 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.150000000000006 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.519999999999996 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.2 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.230000000000004 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.420000000000002 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.430000000000007 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.210000000000001 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.602 ' OG ' HD12 ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.329999999999998 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.219999999999999 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 158' ' ' LEU . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.430000000000007 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.200000000000003 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.019999999999996 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.119999999999997 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.964 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.130000000000003 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.037 HG22 ' OE1' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.399999999999999 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.329999999999998 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.95 HG11 ' HB2' ' A' ' 177' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.340000000000003 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.140000000000001 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.951 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.439999999999998 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.908 ' CE1' HG22 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.329999999999998 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.400000000000006 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.540000000000006 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.200000000000003 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 161' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.329999999999998 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.530000000000001 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.009999999999998 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.420000000000002 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.439999999999998 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.230000000000004 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.684 HD13 ' CD ' ' A' ' 42' ' ' GLN . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.420000000000002 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.349999999999994 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' A' ' 151' ' ' VAL . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.200000000000003 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.329999999999998 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.039999999999999 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.642 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.129999999999995 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.219999999999999 109.861 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.1 m120 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.109999999999999 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.340000000000003 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.955 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.120000000000005 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.219999999999999 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.400000000000006 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 177' ' ' LEU . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.129999999999995 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.049999999999997 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' O ' ' CE ' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.337 0.589 . . . . 71.140000000000001 110.226 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 60.6 tt0 -58.36 -33.5 69.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 70.150000000000006 110.369 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PHE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 80.4 m-85 -100.22 131.53 46.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 73.019999999999996 110.242 -177.678 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' ALA . 9.5 mmtt -135.62 154.8 51.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 73.239999999999995 110.251 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.310000000000002 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.340000000000003 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.409999999999997 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.583 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 25.1 m-70 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.510000000000005 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 177' ' ' LEU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.329999999999998 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.010000000000005 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.310000000000002 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.239999999999995 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.019999999999996 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.549999999999997 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.874 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.049999999999997 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.340000000000003 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.109999999999999 109.788 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.340000000000003 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.230000000000004 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.130000000000003 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.129999999999995 110.188 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.858 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.510000000000005 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 56' ' ' ASN . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.450000000000003 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.319999999999993 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.129999999999995 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.239999999999995 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.319999999999993 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.409999999999997 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.120000000000005 110.347 -176.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.329999999999998 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.229999999999997 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.230000000000004 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.240000000000002 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.748 ' HE2' HD11 ' A' ' 40' ' ' ILE . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.510000000000005 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.109999999999999 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.430000000000007 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.019999999999996 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.858 HG21 ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.129999999999995 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.329999999999998 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 37.8 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.099999999999994 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.230000000000004 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 47' ' ' LEU . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.340000000000003 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.409999999999997 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.040000000000006 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.420000000000002 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.219999999999999 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.109999999999999 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.010000000000005 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.109999999999999 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.109999999999999 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.120000000000005 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.239999999999995 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.209999999999994 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.329999999999998 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 57' ' ' HIS . . . . . 0.547 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 9.0 p80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.140000000000001 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.319999999999993 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.240000000000002 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.329999999999998 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 61' ' ' MET . . . . . 0.619 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.120000000000005 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.310000000000002 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.130000000000003 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.200000000000003 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' MET . . . . . 0.475 ' O ' ' HG2' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.209999999999994 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.019999999999996 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.310000000000002 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.420000000000002 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.040000000000006 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.479 ' HB3' ' CE1' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.430000000000007 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.130000000000003 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.329999999999998 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.210000000000001 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.043 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.310000000000002 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.682 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.210000000000001 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' MET . . . . . 0.61 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.040000000000006 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.319999999999993 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.319999999999993 109.55 172.211 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 1.018 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.299999999999997 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.120000000000005 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.319999999999993 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.109999999999999 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.019999999999996 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' MET . . . . . 0.686 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.510000000000005 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.400000000000006 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.120000000000005 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.329999999999998 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' MET . . . . . 0.647 ' CE ' HD11 ' A' ' 106' ' ' LEU . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.030000000000001 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.450000000000003 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.349999999999994 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.857 ' HA ' HD12 ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.140000000000001 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.450000000000003 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.439999999999998 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.109999999999999 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.400000000000006 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.140000000000001 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.349999999999994 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.450000000000003 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' PRO . . . . . 0.736 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.430000000000007 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.310000000000002 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.510000000000005 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.329999999999998 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.549999999999997 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.140000000000001 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.149999999999999 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.299999999999997 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.400000000000006 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.200000000000003 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.557 ' CD2' ' CE1' ' A' ' 120' ' ' PHE . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.420000000000002 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.510000000000005 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.049999999999997 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.774 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.239999999999995 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.310000000000002 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.140000000000001 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.239999999999995 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.832 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.219999999999999 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.109999999999999 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.340000000000003 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 120' ' ' PHE . . . . . 0.682 ' CE1' HG21 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.239999999999995 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.239999999999995 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.329999999999998 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.340000000000003 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' TYR . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.340000000000003 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.349999999999994 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.209999999999994 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' VAL . . . . . 1.043 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.129999999999995 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.340000000000003 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.129999999999995 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.340000000000003 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.439999999999998 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.140000000000001 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.120000000000005 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' PHE . . . . . 0.576 ' CD1' ' HA ' ' A' ' 56' ' ' ASN . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.439999999999998 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.150000000000006 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.519999999999996 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.230000000000004 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.420000000000002 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.430000000000007 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.210000000000001 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.614 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.329999999999998 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.219999999999999 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 158' ' ' LEU . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.430000000000007 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 147' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.200000000000003 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.019999999999996 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.119999999999997 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 150' ' ' ALA . . . . . 0.892 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.130000000000003 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.399999999999999 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.329999999999998 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 153' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.5 m120 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.340000000000003 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.140000000000001 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.874 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.439999999999998 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 157' ' ' TYR . . . . . 0.782 ' HB3' HD22 ' A' ' 177' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.329999999999998 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.400000000000006 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 173' ' ' LEU . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.540000000000006 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.200000000000003 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.329999999999998 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.530000000000001 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.009999999999998 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.420000000000002 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.439999999999998 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.230000000000004 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.420000000000002 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 169' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.349999999999994 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.200000000000003 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.329999999999998 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 172' ' ' ASP . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.039999999999999 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 159' ' ' VAL . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.129999999999995 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 159' ' ' VAL . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.219999999999999 109.847 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 175' ' ' ASN . . . . . 0.856 ' HA ' HD12 ' A' ' 178' ' ' LEU . 3.2 m120 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.109999999999999 110.802 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.659 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.340000000000003 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.120000000000005 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 178' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.219999999999999 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 179' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.400000000000006 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.96 HD12 ' HA ' ' A' ' 177' ' ' LEU . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.129999999999995 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.481 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.049999999999997 110.205 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.134 0.492 . . . . 73.24 110.092 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.31 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.34 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.41 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 26.5 m-70 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.51 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CG ' HD21 ' A' ' 177' ' ' LEU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.33 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.01 109.468 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.31 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.905 HD11 HD23 ' A' ' 158' ' ' LEU . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.24 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.02 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.55 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.978 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.05 110.397 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.34 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.11 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.34 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.23 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.13 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.13 110.185 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.808 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.51 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.45 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.32 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.13 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.32 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.41 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.12 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.33 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.23 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.23 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.24 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.51 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.11 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.43 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.02 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.808 HG21 ' CD ' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.13 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.33 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.757 ' NE2' HD11 ' A' ' 167' ' ' LEU . 19.0 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.1 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.23 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.34 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.41 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.04 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' HA ' ' A' ' 44' ' ' LYS . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.42 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.22 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.11 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.01 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.11 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.11 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.12 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.24 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.21 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.33 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.14 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.32 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.24 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.33 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.12 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.593 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.31 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.13 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.2 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.21 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.02 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.31 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.42 110.337 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.697 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.04 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.871 ' CB ' HG13 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.43 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.13 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.33 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.21 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.31 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.787 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.21 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.548 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.04 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.32 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.32 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.919 HD13 ' CD ' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.3 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.12 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.32 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.11 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.02 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.561 ' CG ' HD11 ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.51 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.4 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.12 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 113' ' ' GLU . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.33 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.03 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.45 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.35 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.838 ' HA ' HD12 ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.14 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.45 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.44 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.11 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.4 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.14 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.35 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.45 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.52 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.43 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.31 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.51 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.33 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.55 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.14 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.15 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.3 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.4 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.2 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.548 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.42 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.51 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.05 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.24 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.31 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.561 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.14 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.24 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.22 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.11 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.919 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.34 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 79' ' ' LEU . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.24 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.24 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.33 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.34 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.34 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.35 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.21 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.13 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.34 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.13 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.764 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.34 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 70' ' ' SER . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.44 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.14 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.12 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.44 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.15 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 138' ' ' LYS . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.52 110.146 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' NE2' ' CD1' ' A' ' 136' ' ' PHE . 52.3 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.23 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.42 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.43 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.21 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.697 ' O ' HD13 ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.33 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.22 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 158' ' ' LEU . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.43 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.2 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.02 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.12 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.886 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.13 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.832 HG21 ' OH ' ' A' ' 170' ' ' TYR . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.4 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.543 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.33 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.34 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.439 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.14 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.978 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.44 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.822 ' HB3' HD22 ' A' ' 177' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.33 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.4 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 177' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.54 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 99.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.2 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.33 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.53 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.01 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.789 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.42 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.44 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.23 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.42 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.35 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.832 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.2 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.758 ' CD1' HD12 ' A' ' 43' ' ' LEU . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.33 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.04 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 177' ' ' LEU . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.13 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 159' ' ' VAL . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.22 109.712 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.635 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.6 m120 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.11 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.807 ' O ' HD23 ' A' ' 180' ' ' LEU . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.34 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 157' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.12 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 175' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.22 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.4 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.13 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.05 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm . . . . . 0 N--CA 1.491 1.596 0 N-CA-C 109.76 -0.459 . . . . 73.24 109.76 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.736 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.31 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.34 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.41 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.547 ' HB3' HD22 ' A' ' 173' ' ' LEU . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.51 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CG ' HD21 ' A' ' 177' ' ' LEU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.33 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.01 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.31 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 143' ' ' SER . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.24 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.02 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.55 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.016 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.05 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.34 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.11 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.401 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.34 110.051 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.23 109.922 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.13 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.13 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.947 ' OE2' HG22 ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.51 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE1' HG23 ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.45 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.746 ' HA ' HG21 ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.32 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.13 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.24 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.646 ' CD1' HD12 ' A' ' 93' ' ' ILE . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.32 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.41 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.705 ' O ' HG23 ' A' ' 35' ' ' THR . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.12 110.499 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.33 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.23 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.23 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 31' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.24 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.761 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.51 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.11 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.43 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.02 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.13 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.33 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.82 ' NE2' HD11 ' A' ' 167' ' ' LEU . 21.9 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.1 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.23 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.34 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.41 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.04 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.42 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.22 110.102 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.11 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.01 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.11 110.577 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.11 109.633 174.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.12 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.4 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.24 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.21 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 3.1 t-20 -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.33 109.802 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.14 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.32 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.488 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.24 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.33 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.12 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.31 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.13 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.21 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.02 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.31 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.42 110.211 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.04 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.723 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.43 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.13 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.33 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.487 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.21 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.055 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.31 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.695 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.21 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.55 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.04 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.32 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.628 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.32 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 ' CD ' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.3 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.12 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.32 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.11 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.02 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.64 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.51 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.4 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.54 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.12 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.771 HG11 ' HG3' ' A' ' 113' ' ' GLU . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.33 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.03 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.45 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.8 t30 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.35 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.14 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.45 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.44 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.11 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.4 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.14 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.35 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.45 110.234 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.602 ' CG ' HD13 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.43 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.31 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.51 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.33 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.55 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.14 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.15 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.3 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.4 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.2 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.64 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.42 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.51 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.05 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.771 ' HG3' HG11 ' A' ' 88' ' ' VAL . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.24 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.31 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.14 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.24 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.22 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.11 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.986 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.34 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.839 ' HA ' HD11 ' A' ' 79' ' ' LEU . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.24 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.24 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.33 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.34 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.34 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.35 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.21 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.13 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.34 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.13 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.34 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.723 HG13 ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.44 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HD3' ' HA ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.14 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.12 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.44 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.15 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.52 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.23 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.42 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.43 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.21 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.33 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.22 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 150' ' ' ALA . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.43 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.2 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 26' ' ' PHE . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.02 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.647 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.12 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.13 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.947 HG22 ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.4 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.33 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.34 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.14 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.016 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.44 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.33 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.4 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 177' ' ' LEU . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.54 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 51.8 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.2 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.33 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.53 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.406 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.01 110.479 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.42 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.44 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.23 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.82 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.42 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.35 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.886 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.2 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.756 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.33 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.04 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.668 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.13 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.22 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.573 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.11 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.576 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.34 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.12 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.549 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.22 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.4 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.13 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.05 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.135 0.493 . . . . 73.24 109.945 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.31 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.34 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.41 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 10.8 m-70 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.51 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.33 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.01 109.536 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 5' ' ' GLU . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.31 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.24 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.02 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.55 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.05 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.493 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.34 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.11 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.34 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.23 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.13 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.13 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.779 ' OE2' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.51 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.45 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.32 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.13 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.24 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.32 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.41 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.12 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.33 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.23 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 28.8 t-20 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.23 110.367 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.24 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.51 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.11 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.43 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 167' ' ' LEU . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.02 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.759 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.13 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.33 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.7 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.1 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.23 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.34 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.41 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.1 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.04 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.42 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.22 110.069 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.11 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.11 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.11 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.12 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.24 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.21 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.33 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.613 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 4.0 p-80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.14 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.32 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' HG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.24 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.33 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.12 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.31 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.13 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.2 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.55 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.21 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.02 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.31 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.42 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.04 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.58 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.43 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.919 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.13 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.33 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CE2' HD11 ' A' ' 77' ' ' ILE . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.21 110.019 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.31 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 123' ' ' ALA . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.21 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.04 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.982 HD12 ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.32 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.32 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.3 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.12 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.32 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.11 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.02 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.51 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.4 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.12 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 84' ' ' LYS . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.33 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.03 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.45 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.35 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.648 ' CA ' HD12 ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.14 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 99' ' ' PRO . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.45 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.44 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.11 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.648 HD12 ' CA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.4 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.14 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.35 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.45 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.732 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.43 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.31 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.51 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.33 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.55 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.14 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.15 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.3 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.4 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.019 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.2 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.42 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.51 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.05 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.24 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.31 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.14 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.24 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.22 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.11 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.829 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.34 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 79' ' ' LEU . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.24 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.24 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.33 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.777 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.34 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.34 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.35 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.21 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.13 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.34 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.13 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.528 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.34 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.919 HG21 ' HG2' ' A' ' 71' ' ' LYS . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.44 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.14 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.12 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.44 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.15 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.52 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.23 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' HD12 ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.42 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.43 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.21 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.601 ' HA ' HG21 ' A' ' 14' ' ' THR . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.33 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.22 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.866 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.43 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.2 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.606 HG23 ' HE1' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.02 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.12 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.866 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.13 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.058 HG21 ' OH ' ' A' ' 170' ' ' TYR . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.4 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 155' ' ' ASN . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.33 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.34 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.14 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.993 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.44 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.978 ' HB3' HD22 ' A' ' 177' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.33 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.4 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.745 HG21 HG22 ' A' ' 174' ' ' VAL . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.54 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.524 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.8 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.2 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.33 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.53 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.01 110.485 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.506 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.42 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.44 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.23 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 ' NE2' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.42 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.506 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.35 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 1.058 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.2 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.33 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.04 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.13 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.745 HG22 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.22 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.698 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.7 m120 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.11 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.34 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.12 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.22 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.4 110.314 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 177' ' ' LEU . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.13 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.05 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.039 0.447 . . . . 73.24 109.931 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.742 ' OE2' HG21 ' A' ' 11' ' ' VAL . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.31 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.41 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.823 ' HB3' HD22 ' A' ' 173' ' ' LEU . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.51 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.33 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.01 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.31 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.794 HD13 ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.24 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.02 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.55 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB2' ' HD3' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.05 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.34 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.11 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.712 ' HB2' HD22 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.34 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.23 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.13 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.13 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.897 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.51 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.45 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 58' ' ' VAL . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.32 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.13 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.24 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.681 ' HA ' HG21 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.32 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.41 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 35' ' ' THR . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.12 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.33 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.23 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 60.7 t-20 -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.23 110.611 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 31' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.24 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.892 ' CE2' HD11 ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.51 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.11 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.43 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 167' ' ' LEU . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.02 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.897 HG21 ' OE1' ' A' ' 24' ' ' GLU . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.13 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.33 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 13.7 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.1 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.23 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.34 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.41 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.2 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.04 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.42 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.22 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.11 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.01 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.11 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.11 109.765 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.12 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.24 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.21 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.33 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.68 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.14 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 26' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.32 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.24 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.33 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.624 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.12 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.31 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.13 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.2 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.21 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.02 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.31 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.42 110.311 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.04 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.609 ' OG ' HG13 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.43 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.13 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.33 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.21 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.072 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.31 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 123' ' ' ALA . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.21 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.555 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.04 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.32 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.32 110.473 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.006 HD13 ' CD ' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.3 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.12 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.32 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.11 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.02 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.51 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.4 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.12 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.78 HG11 ' OE2' ' A' ' 113' ' ' GLU . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.33 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.03 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.45 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.35 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.14 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.45 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 12.1 t-80 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.44 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.11 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.4 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.14 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.35 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.45 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.43 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.31 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.51 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.33 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.55 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.14 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.997 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.15 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.3 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.4 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.997 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.2 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.42 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.51 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.05 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.78 ' OE2' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.24 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.31 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.14 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.24 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.864 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.22 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.11 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 1.006 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.34 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.901 ' HA ' HD11 ' A' ' 79' ' ' LEU . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.24 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.24 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.33 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.34 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.34 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.35 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.21 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.072 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.13 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.34 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.13 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.34 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.44 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.14 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.12 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.44 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.15 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.52 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.23 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.42 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.43 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.21 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.794 ' HA ' HD13 ' A' ' 12' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.33 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.22 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.943 HD22 ' CB ' ' A' ' 150' ' ' ALA . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.43 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.2 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 33' ' ' CYS . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.02 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.12 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.943 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.13 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.787 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.4 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.33 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.756 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.34 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 15' ' ' PRO . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.14 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.671 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.44 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.957 ' HB3' HD22 ' A' ' 177' ' ' LEU . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.33 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.817 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.4 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.54 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.2 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.33 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.53 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.01 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.42 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.44 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.23 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.42 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.35 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.787 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.2 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 43' ' ' LEU . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.33 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.04 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.13 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.22 109.89 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.11 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.559 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.34 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.988 HD23 HD12 ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.12 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.22 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.4 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.988 HD12 HD23 ' A' ' 177' ' ' LEU . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.13 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.05 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 121.099 0.476 . . . . 73.24 110.393 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.31 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.41 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.526 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.51 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.33 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.01 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.915 HG22 ' CE1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.31 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.24 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.02 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 143' ' ' SER . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.55 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.957 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.05 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.34 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.11 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.34 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.23 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.13 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.13 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.931 ' OE1' HG22 ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.51 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CB ' HG12 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.45 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.32 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.611 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.13 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.931 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.24 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.32 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.41 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.633 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.12 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.33 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.23 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.23 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 31' ' ' PRO . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.24 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.88 ' HE2' HD11 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.51 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.11 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.43 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.607 HD13 HE21 ' A' ' 42' ' ' GLN . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.02 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.88 HD11 ' HE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.13 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.33 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.607 HE21 HD13 ' A' ' 39' ' ' ILE . 13.3 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.1 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.23 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 47' ' ' LEU . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.34 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.41 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.5 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.04 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.42 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.22 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.11 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.01 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.11 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.11 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.12 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.2 mm-40 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.24 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.21 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.33 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.14 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.32 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.24 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.33 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.12 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.31 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.13 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.2 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.21 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.02 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.31 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.42 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.584 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.04 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.43 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.13 110.395 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.33 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.21 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.31 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 123' ' ' ALA . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.21 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.703 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.04 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.965 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.32 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.32 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.999 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.3 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.12 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 79' ' ' LEU . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.32 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.11 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.02 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.561 ' HA ' HG23 ' A' ' 88' ' ' VAL . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.51 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.4 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.12 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.796 HG21 ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.33 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.03 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.45 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.35 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.14 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.931 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.45 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.44 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.11 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.4 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.14 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.35 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.45 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.693 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.43 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.31 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.51 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.33 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.55 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.14 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.15 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.3 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.4 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.2 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.703 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.42 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.845 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.51 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.05 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.796 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.24 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.31 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.14 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.545 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.24 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.845 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.22 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.11 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.999 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.34 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 79' ' ' LEU . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.24 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.24 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.33 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.34 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.34 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.35 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.21 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.13 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.34 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.13 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.662 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.34 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.791 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.44 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.14 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 132' ' ' MET . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.12 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.44 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.15 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.52 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.23 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' HD12 ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.42 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.43 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.21 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 14' ' ' THR . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.33 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.22 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.952 HD22 ' HB1' ' A' ' 150' ' ' ALA . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.43 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.593 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.2 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' C ' ' A' ' 149' ' ' PRO . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.02 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 148' ' ' VAL . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.12 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.13 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.054 HG21 ' OH ' ' A' ' 170' ' ' TYR . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.4 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.33 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.895 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.34 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.14 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.44 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.925 ' HB3' HD22 ' A' ' 177' ' ' LEU . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.33 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.4 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.84 HG13 HD23 ' A' ' 173' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.54 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.2 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.33 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.53 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.01 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 170' ' ' TYR . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.42 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.44 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.23 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.42 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.35 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 1.054 ' OH ' HG21 ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.2 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.33 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.04 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 159' ' ' VAL . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.13 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 159' ' ' VAL . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.22 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.11 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.34 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.12 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.22 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.4 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 177' ' ' LEU . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.13 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.459 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.05 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 39.2 mttt . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.068 0.461 . . . . 73.24 109.954 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.621 ' CD ' HG11 ' A' ' 11' ' ' VAL . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.31 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.34 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.41 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.524 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 15.6 m-70 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.51 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.649 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.33 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.01 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.31 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.24 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.02 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.55 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.05 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.34 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.11 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.34 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.23 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.13 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.13 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.786 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.51 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.45 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.32 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.13 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.917 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.24 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.612 ' HA ' HG21 ' A' ' 93' ' ' ILE . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.32 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.41 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.12 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.33 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 149' ' ' PRO . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.23 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.23 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.24 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.772 ' CE2' HD11 ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.51 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.11 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.43 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.02 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.786 HG21 ' CD ' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.13 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.33 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 167' ' ' LEU . 22.9 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.1 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.23 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.896 ' HA ' HD12 ' A' ' 47' ' ' LEU . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.34 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.41 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.04 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.42 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.22 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.11 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.01 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.11 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.11 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.76 ' CD1' HD11 ' A' ' 47' ' ' LEU . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.12 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.24 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.21 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.33 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.14 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.32 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.24 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.33 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.672 ' SD ' HG22 ' A' ' 148' ' ' VAL . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.12 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.591 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.31 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.13 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.2 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.21 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.02 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.31 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.42 110.309 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.04 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.43 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.904 ' HG2' HG21 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.13 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.33 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.21 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.31 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.709 HG21 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.21 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.603 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.04 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.918 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.32 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.32 109.773 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.009 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.3 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.12 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 79' ' ' LEU . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.32 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.11 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.02 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.51 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.4 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.12 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.938 HG21 ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.33 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 106' ' ' LEU . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.03 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.45 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.35 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.997 ' NH2' HG21 ' A' ' 109' ' ' ILE . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.14 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.917 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.45 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 21.8 t-160 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.44 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.11 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.4 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.14 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.35 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.45 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.657 ' CG ' HD13 ' A' ' 106' ' ' LEU . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.43 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.31 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.51 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.33 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.55 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.14 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.011 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.15 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.3 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.4 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.2 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.603 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.42 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.51 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.05 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.938 ' OE1' HG21 ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.24 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.31 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.688 HG23 ' HE3' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.14 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.24 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.22 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.11 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.688 ' HE3' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.34 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.709 ' CE1' HG21 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.24 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.24 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.33 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.34 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.34 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.35 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.21 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.13 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.34 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.13 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.841 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.34 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.904 HG21 ' HG2' ' A' ' 71' ' ' LYS . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.44 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.14 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.12 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.44 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.15 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.52 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.23 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' HD12 ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.42 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.43 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.677 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.21 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 145' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.33 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.22 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 158' ' ' LEU . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.43 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.2 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.672 HG22 ' SD ' ' A' ' 61' ' ' MET . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.02 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.12 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.917 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.13 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.724 HG21 ' OH ' ' A' ' 170' ' ' TYR . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.4 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.33 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.34 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.14 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.838 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.44 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.895 ' HB3' HD22 ' A' ' 177' ' ' LEU . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.33 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 145' ' ' LEU . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.4 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.54 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.2 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.33 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.53 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.01 110.412 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.42 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.44 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.23 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' NE2' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.42 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.35 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.724 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.2 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.794 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.33 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.04 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.528 HD23 HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.13 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 159' ' ' VAL . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.22 109.629 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.626 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.11 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.545 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.34 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.12 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.22 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.4 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.13 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.05 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt . . . . . 0 N--CA 1.491 1.599 0 N-CA-C 109.656 -0.498 . . . . 73.24 109.656 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.672 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.31 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.34 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.41 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.51 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.58 ' CG ' HD21 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.33 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.01 109.516 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.815 HG22 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.31 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HD23 ' A' ' 158' ' ' LEU . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.24 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.02 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.55 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.972 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.05 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.34 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.11 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.34 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.603 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.23 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.626 ' CG2' HD21 ' A' ' 178' ' ' LEU . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.13 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.13 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.831 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.51 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.45 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.32 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.13 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.24 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.752 ' HA ' HG21 ' A' ' 93' ' ' ILE . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.32 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.41 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.54 ' N ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.12 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.33 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.23 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.23 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.24 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD11 ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.51 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.11 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.43 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.02 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.913 HD11 ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.13 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.33 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.7 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.1 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.673 HD12 ' CD1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.23 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 47' ' ' LEU . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.34 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.41 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.04 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.42 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.22 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.11 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.01 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.11 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.11 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.12 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.24 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.21 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.33 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.14 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.32 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.24 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.33 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.12 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.31 109.884 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.13 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.2 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.21 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.02 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.31 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.42 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.04 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.43 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.06 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.13 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.33 110.109 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.21 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.991 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.31 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.763 HG21 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.21 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.04 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.32 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.32 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.3 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.12 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.813 HG12 ' HE3' ' A' ' 84' ' ' LYS . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.32 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.11 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.813 ' HE3' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.02 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.61 ' CG ' HD11 ' A' ' 115' ' ' ILE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.51 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.4 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.12 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.847 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.33 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.03 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.45 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.753 ' OD1' HG21 ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.35 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.822 ' HA ' HD12 ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.14 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.45 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.44 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.753 HG21 ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.11 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.822 HD12 ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.4 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.14 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.35 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.45 110.485 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.43 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.31 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.51 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.33 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.55 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.14 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.072 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.15 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.3 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.4 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.072 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.2 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.42 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.51 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.05 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.847 ' HG3' HG11 ' A' ' 88' ' ' VAL . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.24 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.31 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.14 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.24 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.22 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.11 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.974 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.34 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.927 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.24 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.24 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.33 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.34 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.34 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.35 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.21 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.991 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.13 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.34 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.535 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.13 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.894 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.34 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.06 HG21 ' HG2' ' A' ' 71' ' ' LYS . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.44 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.14 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.12 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.44 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.15 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.52 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.23 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HA ' HD12 ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.42 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.43 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.21 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.58 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.33 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.22 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.9 HD22 ' HB1' ' A' ' 150' ' ' ALA . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.43 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.2 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.02 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.12 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.9 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.13 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.831 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.4 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.33 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 177' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.34 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.14 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.972 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.44 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.815 ' CE1' HG22 ' A' ' 11' ' ' VAL . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.33 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.762 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.4 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.723 HG22 ' CD1' ' A' ' 177' ' ' LEU . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.54 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.525 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 97.5 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.2 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.33 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.53 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.599 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.01 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.42 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.44 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.23 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 167' ' ' LEU . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.42 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.35 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.762 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.2 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 43' ' ' LEU . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.33 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.04 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.13 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.22 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 179' ' ' THR . 2.6 m120 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.11 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.532 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.34 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.12 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.626 HD21 ' CG2' ' A' ' 22' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.22 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 175' ' ' ASN . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.4 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.13 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.05 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 67.7 mttm . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.203 0.525 . . . . 73.24 110.285 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.574 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.31 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.34 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.41 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.515 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 31.9 m-70 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.51 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.33 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.01 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.31 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 158' ' ' LEU . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.24 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.02 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.848 HG22 ' HB2' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.55 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.05 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.34 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.11 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.34 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.466 HG11 ' OG ' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.23 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.13 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.506 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.13 110.057 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.815 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.51 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.45 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.32 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.13 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.24 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.32 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.41 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.12 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.33 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.23 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.23 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.24 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 40' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.51 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.11 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.43 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 36' ' ' PHE . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.02 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' CD ' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.13 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.33 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.771 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.1 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.1 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.23 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.34 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.41 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.4 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.04 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.42 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.22 109.891 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.11 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.01 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.11 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.11 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.582 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.12 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.24 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.21 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.33 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.14 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 61' ' ' MET . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.32 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.24 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.33 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.12 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.31 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.13 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.2 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.21 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.02 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.31 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.42 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.595 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.04 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.43 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.13 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.33 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.21 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.31 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.605 HG23 ' HB3' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.21 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.823 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.04 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.944 HD12 ' HA ' ' A' ' 74' ' ' ALA . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.32 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.32 109.524 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.028 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.3 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.12 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.32 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.11 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.02 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.823 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.51 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.4 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.12 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.759 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.33 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.559 ' HE1' HD11 ' A' ' 106' ' ' LEU . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.03 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.45 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.35 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.86 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.14 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.45 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.44 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.11 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.4 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.14 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.35 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.45 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.43 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.31 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.51 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.33 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.55 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.14 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.008 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.15 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.3 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.4 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.2 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.42 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.855 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.51 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.05 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.759 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.24 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.31 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.14 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.24 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.855 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.22 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.11 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.34 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.24 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.24 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.33 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.34 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.34 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.35 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.21 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.13 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.34 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.13 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.802 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.34 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.44 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.14 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 132' ' ' MET . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.12 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.44 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.15 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.52 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.528 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.23 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.42 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.43 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.848 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.21 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.33 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.22 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.897 HD22 ' HB1' ' A' ' 150' ' ' ALA . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.43 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.2 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.02 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.12 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.897 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.13 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.981 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.4 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.415 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.33 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.2 m-80 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.34 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.14 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.44 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.788 ' HB3' HD22 ' A' ' 177' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.33 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.754 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.4 108.989 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.524 HG13 HD23 ' A' ' 173' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.54 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.2 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.33 109.757 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.53 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.01 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.42 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.44 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.23 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.771 HD11 ' NE2' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.42 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.35 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.981 ' OH ' HG21 ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.2 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.769 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.33 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.04 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 159' ' ' VAL . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.13 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.22 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.11 110.736 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.709 ' O ' HG22 ' A' ' 179' ' ' THR . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.34 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.967 HD23 HD12 ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.12 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.508 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.22 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.4 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.967 HD12 HD23 ' A' ' 177' ' ' LEU . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.13 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.05 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.114 0.483 . . . . 73.24 109.929 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.31 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.34 109.211 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.41 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.518 ' HB3' HD22 ' A' ' 173' ' ' LEU . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.51 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.33 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.01 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.002 HG22 ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.31 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.24 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.02 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.55 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.05 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.34 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.402 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.11 109.626 175.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.34 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.23 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 HD21 ' A' ' 47' ' ' LEU . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.13 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.13 110.031 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.809 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.51 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.45 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.32 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.13 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.696 ' O ' HG21 ' A' ' 93' ' ' ILE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.24 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.32 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.513 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.41 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.12 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.33 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.23 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.23 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.24 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.51 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.11 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.43 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.02 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 24' ' ' GLU . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.13 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.33 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.1 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.23 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.752 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.34 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.41 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 52.1 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.04 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 44' ' ' LYS . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.42 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.22 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.11 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.01 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.11 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.11 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.12 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.24 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.21 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.33 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.14 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 58' ' ' VAL . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.32 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.24 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.33 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.12 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.31 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.13 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.21 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.02 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.31 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.42 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.04 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.564 ' OG ' ' CD2' ' A' ' 57' ' ' HIS . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.43 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HG2' HG21 ' A' ' 133' ' ' VAL . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.13 110.218 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.33 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.21 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.31 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.21 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.04 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.32 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.32 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.973 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.3 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.12 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.32 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.11 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.02 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.51 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.4 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.12 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.33 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.03 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.45 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.526 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.35 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.824 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.14 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.45 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 38.1 t-80 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.44 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.11 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.4 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.14 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.35 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.45 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.43 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.31 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HE1' ' A' ' 65' ' ' MET . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.51 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.33 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.55 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.14 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.15 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.3 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.4 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.2 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.42 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.835 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.51 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.05 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.24 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.31 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 85' ' ' MET . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.14 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.24 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.835 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.22 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.11 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.973 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.34 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 79' ' ' LEU . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.24 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.24 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.33 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.34 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.34 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.35 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.21 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.13 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.34 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.527 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.13 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.846 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.34 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.714 HG21 ' HG2' ' A' ' 71' ' ' LYS . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.44 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.14 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.12 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.44 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.15 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.52 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 56' ' ' ASN . 16.0 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.23 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.42 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.43 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.662 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.21 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.567 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.33 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.22 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 158' ' ' LEU . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.43 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.2 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.02 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.12 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.823 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.13 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.661 HG21 ' OH ' ' A' ' 170' ' ' TYR . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.4 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.33 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' HB2' ' A' ' 177' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.34 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.14 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.683 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.44 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 1.002 ' CE1' HG22 ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.33 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.4 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.54 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.2 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.33 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.53 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.01 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.42 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.44 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.23 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.479 HD21 HG23 ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.42 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.516 ' HA ' ' OD2' ' A' ' 172' ' ' ASP . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.35 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.661 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.2 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.33 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 173' ' ' LEU . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.04 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.13 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 159' ' ' VAL . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.22 109.596 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.554 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.6 m120 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.11 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.34 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.004 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.12 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.22 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.4 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.004 HD12 ' HA ' ' A' ' 177' ' ' LEU . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.13 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.207 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.095 0.474 . . . . 73.24 110.158 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.663 ' CD ' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.31 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.34 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.41 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.452 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.51 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CG ' HD21 ' A' ' 177' ' ' LEU . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.33 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.01 109.407 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.31 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.24 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.02 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.55 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.05 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.34 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.11 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.34 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.23 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.13 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.909 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.51 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.45 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.32 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.622 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.13 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.24 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.32 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.41 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.12 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.33 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.23 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.23 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.24 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.887 ' CE2' HD11 ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.51 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.11 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.43 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.02 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 ' OE1' ' A' ' 24' ' ' GLU . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.13 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.33 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.586 HE21 HD13 ' A' ' 39' ' ' ILE . 13.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.1 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.23 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.34 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.41 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.2 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.04 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.42 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.22 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.11 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.01 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.11 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.11 109.681 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.12 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.24 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.21 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.33 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.14 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 58' ' ' VAL . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.32 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.24 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.33 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.12 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.31 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.13 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.2 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.21 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.02 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.31 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.42 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.596 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.04 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.561 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.43 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.99 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.13 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.33 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.21 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.31 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.21 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.04 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.937 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.32 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.32 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 81' ' ' VAL . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.3 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.12 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.32 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.11 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.02 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.51 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.4 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.12 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.665 HG11 ' HG3' ' A' ' 113' ' ' GLU . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.33 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.594 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.03 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.45 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.35 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.14 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.45 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.44 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.11 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.4 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.14 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.35 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.45 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.43 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.31 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.493 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.51 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.33 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.55 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.14 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.023 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.15 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.3 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.4 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.2 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.42 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.51 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.05 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.24 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.31 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.14 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.24 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.886 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.22 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.11 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.871 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.34 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.24 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.24 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.33 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.779 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.34 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.34 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.35 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.21 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.959 ' HA ' ' HE3' ' A' ' 132' ' ' MET . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.13 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.34 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.548 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.13 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.34 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.99 HG21 ' HG2' ' A' ' 71' ' ' LYS . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.44 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.14 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.12 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.44 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.15 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.52 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.52 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.23 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.42 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.43 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.575 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.21 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.647 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.33 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.22 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.055 HD22 ' HB1' ' A' ' 150' ' ' ALA . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.43 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.2 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.02 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.12 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 1.055 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.13 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.902 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.4 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.568 HG22 HD22 ' A' ' 158' ' ' LEU . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.33 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.34 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.14 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.44 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.94 ' CE2' HG22 ' A' ' 11' ' ' VAL . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.33 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.993 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.4 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 173' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.54 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.527 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.7 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.2 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.33 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.53 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.01 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.42 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.44 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.23 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.42 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.35 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.902 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.2 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.33 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.04 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.13 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.22 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.565 ' HA ' HD12 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.11 110.585 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.34 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.878 ' CD1' HG22 ' A' ' 159' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.12 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 175' ' ' ASN . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.22 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.4 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.13 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.05 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.606 -0.516 . . . . 73.24 109.606 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.31 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.34 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.41 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.647 ' HB3' HD22 ' A' ' 173' ' ' LEU . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.51 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.33 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.522 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.01 109.617 175.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.564 HG22 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.31 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.24 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.02 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.55 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.925 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.05 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.34 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.11 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.491 ' HB2' HD22 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.641 HG21 ' CD ' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.23 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.13 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.13 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.51 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CB ' HG12 ' A' ' 148' ' ' VAL . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.45 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.45 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.32 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.62 ' OG ' HG21 ' A' ' 148' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.13 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.856 ' O ' HG21 ' A' ' 93' ' ' ILE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.24 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HA ' HG21 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.32 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.7 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.41 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.12 110.033 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.33 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.23 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.23 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.24 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.51 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.11 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.43 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.769 HD13 HE21 ' A' ' 42' ' ' GLN . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.02 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.818 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.13 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.33 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.769 HE21 HD13 ' A' ' 39' ' ' ILE . 40.9 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.1 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.23 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.34 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.41 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 44.8 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.04 110.306 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.873 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.42 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.873 ' HD2' HD23 ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.22 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.11 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.01 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.11 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.11 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.12 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.641 ' CD ' HG21 ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.24 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.21 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.33 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.677 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.14 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 58' ' ' VAL . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.32 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.24 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.598 ' HE1' HG21 ' A' ' 58' ' ' VAL . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.33 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.7 ' HE3' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.12 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.31 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.13 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.2 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.21 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.02 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.31 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.42 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.556 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.04 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.43 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.13 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.33 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.21 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.019 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.31 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.21 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.504 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.04 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.32 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.32 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.917 HD13 ' CD ' ' A' ' 119' ' ' LYS . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.3 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.12 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.32 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.11 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.02 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.595 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.51 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.4 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.12 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.911 HG11 ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.33 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.03 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.45 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.35 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.844 ' HA ' HD12 ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.14 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.856 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.45 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.44 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.11 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.4 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.14 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.35 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.61 ' HA ' HD13 ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.45 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 106' ' ' LEU . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.43 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.31 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.51 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.33 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.55 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.14 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.033 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.15 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.3 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.4 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.033 HD12 ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.2 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.42 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.879 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.51 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.05 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.911 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.24 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.31 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.14 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.24 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.879 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.22 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.11 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.917 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.34 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.24 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.24 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.33 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.34 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.34 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.35 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.21 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.019 HG13 ' HB3' ' A' ' 74' ' ' ALA . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.13 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.34 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.13 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.745 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.34 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.44 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.14 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.12 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.44 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.15 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.52 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.53 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.23 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.42 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.21 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.591 ' OG ' HD12 ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.33 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.22 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.057 HD22 ' HB1' ' A' ' 150' ' ' ALA . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.43 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.2 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.62 HG21 ' OG ' ' A' ' 27' ' ' SER . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.02 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.554 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.12 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 1.057 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.13 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.4 110.067 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.461 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.33 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.547 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.34 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.14 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.925 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.44 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.804 ' HB3' HD22 ' A' ' 177' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.33 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.903 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.4 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.54 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.522 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.6 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.2 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.33 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.53 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.01 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.42 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.44 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.494 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.23 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.42 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.35 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.538 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.2 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.85 ' CD1' HD13 ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.33 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.04 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.13 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.22 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.8 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.11 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.571 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.34 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.12 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.22 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.4 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.13 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.05 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.135 0.493 . . . . 73.24 109.688 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.31 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.34 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.41 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.67 ' HB3' HD22 ' A' ' 173' ' ' LEU . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.51 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.33 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.01 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.31 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.24 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.02 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.55 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.05 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.34 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.11 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.34 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.23 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.13 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.13 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HG2' HD12 ' A' ' 40' ' ' ILE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.51 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.45 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 58' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.32 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.13 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.955 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.24 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CD1' HD12 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.32 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.41 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.12 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.33 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.23 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.23 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.24 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.51 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.11 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.43 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.02 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.917 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.13 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.33 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' HD11 ' A' ' 167' ' ' LEU . 14.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.1 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.23 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.948 ' HA ' HD12 ' A' ' 47' ' ' LEU . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.34 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.41 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.04 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.42 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.22 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.11 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.01 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.11 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.11 109.631 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.935 ' CD1' HD11 ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.12 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.24 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.21 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.33 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.14 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.637 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.32 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.24 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.33 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.12 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.31 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.13 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.2 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.21 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.02 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.31 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.42 110.205 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.04 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.742 ' CB ' HG13 ' A' ' 133' ' ' VAL . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.43 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.13 110.4 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.33 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.21 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.31 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 123' ' ' ALA . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.21 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.04 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 74' ' ' ALA . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.32 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.32 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.99 HD13 ' CD ' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.3 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.12 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.32 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.11 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.02 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.51 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.4 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.12 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.704 HG21 ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.33 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.756 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.03 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.45 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.35 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.14 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.955 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.45 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 85.5 t60 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.44 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.11 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.4 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' THR . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.14 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.35 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.45 110.378 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.43 110.066 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.31 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.51 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.33 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.55 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.14 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.15 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.459 HH21 ' HB1' ' A' ' 117' ' ' ALA . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.3 110.393 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.4 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.2 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.42 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.851 HD21 ' CA ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.51 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.05 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.704 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.24 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.31 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.14 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.24 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.851 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.22 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.11 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.99 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.34 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.84 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.24 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.24 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.33 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.34 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.34 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.35 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.21 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.13 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.34 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.13 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.678 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.34 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.742 HG13 ' CB ' ' A' ' 70' ' ' SER . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.44 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.14 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.12 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.44 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.15 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.52 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.23 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.42 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.43 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.21 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HD12 ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.33 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.22 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.936 HD22 ' CB ' ' A' ' 150' ' ' ALA . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.43 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.2 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.02 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.568 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.12 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.936 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.13 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.978 ' O ' HD13 ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.4 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 HD21 ' A' ' 158' ' ' LEU . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.33 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.34 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.14 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.644 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.44 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.942 ' HB3' HD22 ' A' ' 177' ' ' LEU . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.33 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.978 HD13 ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.4 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 174' ' ' VAL . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.54 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.2 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.33 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.53 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.01 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.42 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.44 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.23 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.519 HD11 ' NE2' ' A' ' 42' ' ' GLN . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.42 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . . . . . . . . . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.35 110.564 178.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.618 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.2 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.75 ' CD1' HD12 ' A' ' 43' ' ' LEU . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.33 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.04 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.13 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 159' ' ' VAL . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.22 109.702 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.667 ' HA ' HD12 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.11 110.926 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.517 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.34 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.12 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.22 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.4 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 177' ' ' LEU . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.13 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.05 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.452 ' O ' ' OE1' ' A' ' 7' ' ' GLU . 66.1 mttm . . . . . 0 N--CA 1.492 1.65 0 N-CA-C 109.449 -0.574 . . . . 73.24 109.449 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.31 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.34 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.41 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' HD22 ' A' ' 173' ' ' LEU . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.51 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.33 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.01 109.315 173.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.973 HG22 ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.31 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD23 ' A' ' 158' ' ' LEU . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.24 110.267 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.02 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.55 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.884 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.05 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.34 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.11 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.34 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.612 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.23 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.13 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.13 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.821 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.51 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' HG12 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.45 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.32 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.13 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.695 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.24 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.32 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.41 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.12 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.33 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.23 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.23 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.24 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 40' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.51 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.11 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.43 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.02 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.821 HG21 ' CD ' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.13 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.33 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.857 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.6 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.1 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.23 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' A' ' 47' ' ' LEU . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.34 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.41 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.559 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.04 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.759 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.42 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.22 109.923 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.11 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.01 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.11 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.11 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.12 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.612 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.24 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.21 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.33 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.14 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 61' ' ' MET . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.32 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.24 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.33 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.638 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.12 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.31 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.13 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.2 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.516 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.21 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.02 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.31 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.42 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.04 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.43 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.018 ' HG2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.13 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.33 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.472 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.21 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.024 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.31 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.746 HG23 ' HB3' ' A' ' 123' ' ' ALA . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.21 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.592 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.04 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.32 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.32 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.904 HD22 ' HG2' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.3 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.12 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 79' ' ' LEU . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.32 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.11 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.02 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.668 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.51 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.4 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.12 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.737 HG21 ' OE1' ' A' ' 113' ' ' GLU . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.33 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.03 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.45 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.35 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.14 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.695 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.45 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.44 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.11 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.4 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 95' ' ' THR . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.14 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.35 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.45 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.541 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.43 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.31 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.51 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.33 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.55 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.14 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.934 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.15 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.3 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.4 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.934 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.2 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.42 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.859 HD21 ' CA ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.51 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.05 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.737 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.24 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.31 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.75 HG23 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.14 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.24 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.859 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.22 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.11 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.904 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.34 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.24 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.24 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.33 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.34 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.476 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.34 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.35 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.21 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.024 HG13 ' HB3' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.13 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.34 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.13 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.688 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.34 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.018 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.44 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.14 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.12 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.44 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.15 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.52 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.23 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.42 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.43 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.21 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 12' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.33 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' HB1' ' A' ' 150' ' ' ALA . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.43 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.2 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.02 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.12 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.926 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.13 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.4 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.33 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.34 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.14 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.884 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.44 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.973 ' CE1' HG22 ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.33 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.867 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.4 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.708 HG22 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.54 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.526 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.3 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.2 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.33 109.829 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.53 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.01 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.42 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.44 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.23 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.857 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.42 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.35 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.41 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.2 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.714 ' CD1' HD12 ' A' ' 43' ' ' LEU . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.33 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.04 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.13 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.22 109.898 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.67 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.6 m120 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.11 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.563 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.34 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.12 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.22 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.4 110.611 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 177' ' ' LEU . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.13 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.05 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.218 0.532 . . . . 73.24 110.444 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.31 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.34 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.41 110.464 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.522 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 15.2 m-70 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.51 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.33 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.01 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.31 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 143' ' ' SER . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.24 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.02 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.55 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.05 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.34 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.11 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.23 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.13 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.85 ' CD ' HG21 ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.51 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.45 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.32 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.13 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.24 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.533 ' HA ' HG21 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.32 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.41 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.12 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.33 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.23 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.23 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.24 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.864 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.51 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.537 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.11 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.43 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.629 HG23 HD21 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.02 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.864 HD11 ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.13 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.33 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.1 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.793 HD12 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.23 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.84 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.34 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.41 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.04 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.42 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.22 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.11 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.01 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.11 110.6 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.11 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.12 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.24 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.21 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.33 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.9 p-80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.14 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.32 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.24 110.758 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.33 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.63 ' HG3' HG21 ' A' ' 58' ' ' VAL . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.12 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.31 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.13 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.2 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.21 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.02 109.81 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.31 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.42 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.04 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.806 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.43 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.13 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.33 110.439 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.21 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.31 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' ALA . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.21 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.809 ' SD ' HG23 ' A' ' 86' ' ' VAL . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.04 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 74' ' ' ALA . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.32 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.32 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.975 ' O ' HG13 ' A' ' 81' ' ' VAL . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.3 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.12 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.32 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 77' ' ' ILE . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.11 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.02 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.691 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.51 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.809 HG23 ' SD ' ' A' ' 76' ' ' MET . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.4 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.12 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.33 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 106' ' ' LEU . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.03 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.45 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.35 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.14 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.45 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.44 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.11 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 96' ' ' LEU . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.4 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.14 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.35 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.45 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.43 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.31 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.51 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.33 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.55 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.14 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.15 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.752 ' NH1' HD11 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.3 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.4 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.2 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CD2' ' CD1' ' A' ' 120' ' ' PHE . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.42 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.863 HD21 ' CA ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.51 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.05 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.743 ' CD ' HG21 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.24 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.31 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.746 HG23 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.14 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.24 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.863 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.22 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.11 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.902 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.34 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.879 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.24 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.24 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.33 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.34 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.34 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.35 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.21 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.13 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.34 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.13 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.34 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.821 HG21 ' HG2' ' A' ' 71' ' ' LYS . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.44 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.14 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.12 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.44 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.15 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.52 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.23 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.42 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.43 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.21 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 12' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.33 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.22 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.992 HD22 ' HB1' ' A' ' 150' ' ' ALA . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.43 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.2 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.02 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.587 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.12 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.992 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.13 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' OH ' ' A' ' 170' ' ' TYR . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.4 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.33 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.34 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.14 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.632 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.44 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 1.012 ' CE2' HG22 ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.33 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.4 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 177' ' ' LEU . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.54 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 27.5 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.2 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.33 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.53 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.01 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.42 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.44 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.23 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.42 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.35 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.466 ' OH ' HG21 ' A' ' 151' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.2 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.793 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.33 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.541 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.04 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 177' ' ' LEU . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.13 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.22 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.11 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.34 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.12 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.22 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.4 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.013 HD12 ' HA ' ' A' ' 177' ' ' LEU . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.13 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.05 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.459 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 92.9 mttt . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.269 0.557 . . . . 73.24 110.21 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.31 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.34 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.41 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.573 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 27.4 m-70 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.51 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CG ' HD21 ' A' ' 177' ' ' LEU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.33 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.01 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.31 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 1.052 HD13 ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.24 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.02 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.55 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.05 110.291 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.34 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.403 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.11 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.34 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.23 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.13 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.13 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.655 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.51 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CB ' HG12 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.45 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.32 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.13 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.24 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' ILE . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.32 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.41 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.12 110.403 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.33 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.23 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.23 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.24 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.51 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.11 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.43 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.937 HG23 HD21 ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.02 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.13 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.33 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.1 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.23 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.852 ' HA ' HD12 ' A' ' 47' ' ' LEU . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.34 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.41 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 50.3 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.04 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.42 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.22 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.11 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.01 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.11 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.11 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.12 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.24 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.21 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.33 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.14 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.32 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.24 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.33 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.685 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.12 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.31 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.13 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.2 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 100' ' ' PRO . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.21 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.02 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.31 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.42 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.633 ' HE2' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.04 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.43 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.843 ' HG2' HG21 ' A' ' 133' ' ' VAL . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.13 110.035 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.33 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.21 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.079 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.31 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.83 HG21 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.21 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.549 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.04 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.32 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.653 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.32 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.881 HD11 ' HA ' ' A' ' 120' ' ' PHE . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.3 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.12 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.32 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.11 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.02 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HD12 ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.51 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.4 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.12 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.33 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.593 ' CE ' HD11 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.03 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.45 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.35 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.846 ' HA ' HD12 ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.14 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.45 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 58.4 t-80 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.44 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.11 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.4 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.14 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.35 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.45 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.747 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.43 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.31 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.51 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.33 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.55 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.14 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.06 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.15 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.3 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.4 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.06 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.2 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.523 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.42 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.51 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.05 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.24 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.31 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.559 HD12 ' SD ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.14 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.24 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.96 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.22 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.11 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.764 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.34 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.24 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.24 109.711 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.33 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.34 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.34 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.35 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.21 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.079 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.13 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.34 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.13 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.774 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.34 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.843 HG21 ' HG2' ' A' ' 71' ' ' LYS . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.44 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.14 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.12 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.44 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.15 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.52 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 12.8 mm100 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.23 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.42 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.43 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.21 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 1.052 ' HA ' HD13 ' A' ' 12' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.33 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' CB ' ' A' ' 150' ' ' ALA . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.43 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.2 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.02 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.12 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.926 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.13 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.582 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.4 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.33 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.7 m-80 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.34 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.14 110.916 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.93 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.44 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.76 ' CE2' HG22 ' A' ' 11' ' ' VAL . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.33 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.4 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 HD23 ' A' ' 173' ' ' LEU . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.54 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.2 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.33 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.53 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.01 110.247 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.42 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.44 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.23 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG23 ' A' ' 39' ' ' ILE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.42 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.74 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.35 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.582 ' OH ' HG21 ' A' ' 151' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.2 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.934 ' CD1' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.33 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.04 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.791 HD23 HG13 ' A' ' 159' ' ' VAL . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.13 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 159' ' ' VAL . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.22 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.792 ' HA ' HD12 ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.11 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.556 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.34 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.071 HD23 HD12 ' A' ' 180' ' ' LEU . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.12 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.22 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.4 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.071 HD12 HD23 ' A' ' 177' ' ' LEU . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.13 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.05 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt . . . . . 0 N--CA 1.492 1.628 0 CA-C-O 121.229 0.537 . . . . 73.24 110.42 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.31 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.34 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.41 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.439 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.51 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.33 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.01 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.984 HG22 ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.31 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.24 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.02 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.55 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 1.009 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.05 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.34 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.525 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.11 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.34 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.23 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.13 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.13 109.621 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.787 ' OE2' HG22 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.51 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.45 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.32 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.13 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.24 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.32 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.41 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.12 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.33 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.23 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.23 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.24 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.689 ' HE2' HD11 ' A' ' 40' ' ' ILE . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.51 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.11 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.43 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 167' ' ' LEU . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.02 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.689 HD11 ' HE2' ' A' ' 36' ' ' PHE . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.13 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.33 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.1 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.23 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.863 ' HA ' HD12 ' A' ' 47' ' ' LEU . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.34 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.41 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.04 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.42 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD23 ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.22 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.11 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.01 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.11 110.507 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.11 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.12 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.24 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.21 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.33 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.14 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.32 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.24 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.33 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.642 ' HE1' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.12 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.31 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.13 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.2 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.21 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.02 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.31 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.42 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.04 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.511 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.43 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.879 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.13 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.33 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.21 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.011 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.31 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.641 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.21 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.04 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.32 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.32 109.703 172.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.017 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.3 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.12 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.017 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.32 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.11 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.02 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.572 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.51 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.4 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.12 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.77 HG21 ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.33 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.583 ' CE ' HD11 ' A' ' 106' ' ' LEU . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.03 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.45 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.35 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.868 ' HA ' HD12 ' A' ' 96' ' ' LEU . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.14 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.45 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.44 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.11 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.4 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.14 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.35 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.45 110.396 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.742 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.43 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.31 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.51 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.33 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.55 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.14 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.014 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.15 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.3 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.4 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.014 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.2 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.42 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.51 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.05 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.77 ' OE1' HG21 ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.31 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.14 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.24 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.833 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.22 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.11 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.34 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.24 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.24 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.33 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.34 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.34 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.35 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.21 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.13 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.34 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.13 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.567 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.34 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.879 HG21 ' HG2' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.44 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.14 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.12 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.44 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.15 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.52 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.23 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.42 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.43 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.21 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.579 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.33 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.22 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 158' ' ' LEU . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.43 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.2 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.642 ' CG2' ' HE1' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.02 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.12 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.903 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.13 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.4 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.33 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.34 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.438 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.14 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.009 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.44 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.984 ' CE1' HG22 ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.33 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.4 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 173' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.54 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.2 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.33 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.53 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.01 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.42 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.44 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.23 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 39' ' ' ILE . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.42 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.35 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.2 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.757 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.33 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.04 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.712 HD23 HG13 ' A' ' 159' ' ' VAL . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.13 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 43' ' ' LEU . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.22 109.766 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 178' ' ' LEU . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.11 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.52 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.34 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.006 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.12 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.545 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.22 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.4 110.191 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 177' ' ' LEU . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.13 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.05 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.24 0.543 . . . . 73.24 110.124 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 11' ' ' VAL . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.31 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.34 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.41 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 160' ' ' GLN . 25.7 m170 -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.51 109.949 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.7 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.33 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.01 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.31 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 158' ' ' LEU . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.24 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.02 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.55 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.979 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.05 110.413 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.34 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.11 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 51' ' ' ALA . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.34 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.23 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.13 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.13 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.712 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.51 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.45 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.32 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.13 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.926 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.24 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HA ' HG21 ' A' ' 93' ' ' ILE . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.32 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.41 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 35' ' ' THR . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.12 110.059 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.33 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.23 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.23 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.24 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.51 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.11 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.43 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 36' ' ' PHE . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.02 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.13 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.33 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.563 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 15.3 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.1 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.975 HD13 ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.23 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.34 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.41 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 49.8 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.04 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.42 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.22 109.931 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.11 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.11 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.11 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.12 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.7 mm-40 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.24 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.21 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.33 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.657 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.14 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG21 ' HG3' ' A' ' 61' ' ' MET . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.32 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.469 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.24 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.33 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.656 ' HG3' HG21 ' A' ' 58' ' ' VAL . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.12 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.31 109.895 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.13 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.2 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.21 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.02 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.31 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.42 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.04 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.43 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.13 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.33 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.657 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.21 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.075 ' CB ' HG13 ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.31 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.863 HG23 ' HB3' ' A' ' 123' ' ' ALA . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.21 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.04 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.975 HD12 ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.32 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.496 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.32 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.958 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.3 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.12 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.32 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.11 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.02 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.674 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.51 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.4 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.12 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.33 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.03 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.45 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.527 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.35 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.14 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.926 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.45 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.44 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.11 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.4 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 95' ' ' THR . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.14 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.35 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.45 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.649 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.43 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.31 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.51 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.33 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.55 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.14 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.988 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.15 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.3 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.4 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.988 HD12 ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.2 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.42 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.51 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.05 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.71 ' CD ' HG11 ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.24 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.31 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' CE ' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.14 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.24 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.22 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.11 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.958 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.34 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.24 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.24 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.33 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.863 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.34 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.34 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.35 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.21 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.075 HG13 ' CB ' ' A' ' 74' ' ' ALA . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.13 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.34 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.13 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.741 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.34 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.44 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.14 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.12 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.44 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.15 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.52 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.23 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.643 ' HA ' HD12 ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.42 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 26.6 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.43 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.936 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.21 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.566 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.33 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.22 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.945 HD22 ' CB ' ' A' ' 150' ' ' ALA . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.43 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.02 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.12 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.945 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.13 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.454 ' O ' HD13 ' A' ' 158' ' ' LEU . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.4 110.151 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.33 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.34 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.14 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.979 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.44 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.873 ' HB3' HD22 ' A' ' 177' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.33 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.4 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.718 HG13 HD23 ' A' ' 173' ' ' LEU . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.54 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.2 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.33 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.53 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.01 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.42 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.44 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.23 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.42 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.35 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.2 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.975 ' CG ' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.33 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.04 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.718 HD23 HG13 ' A' ' 159' ' ' VAL . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.13 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.584 HG22 HG21 ' A' ' 159' ' ' VAL . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.22 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.11 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.34 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.12 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.22 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.4 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.13 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.05 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.159 0.504 . . . . 73.24 109.755 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.589 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.31 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.34 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.41 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.575 ' CD2' ' OG ' ' A' ' 163' ' ' SER . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.51 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.33 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . 0.462 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.01 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 1.056 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.31 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.24 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.02 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.55 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.05 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.34 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.11 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.34 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.618 HG21 ' OE1' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.23 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HD21 ' A' ' 178' ' ' LEU . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.13 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.13 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.905 ' OE1' HG21 ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.51 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.61 ' C ' HG11 ' A' ' 148' ' ' VAL . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.45 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.32 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.13 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.927 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.24 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.6 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.32 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.41 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.524 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.12 110.358 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.33 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.23 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.23 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.24 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.78 ' HE2' HD11 ' A' ' 40' ' ' ILE . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.51 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.11 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.43 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.02 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.13 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.33 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.1 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.917 HD13 ' CD1' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.23 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.34 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.41 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 43.1 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.04 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.42 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.22 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.11 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.01 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.11 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.11 109.578 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.776 ' CD1' HD11 ' A' ' 47' ' ' LEU . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.12 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.618 ' OE1' HG21 ' A' ' 21' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.24 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.21 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.33 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.14 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' A' ' 61' ' ' MET . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.32 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.24 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.33 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.12 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.31 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.13 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.2 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.456 ' O ' ' HG3' ' A' ' 65' ' ' MET . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.21 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.02 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.31 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.42 110.383 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.47 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.04 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.885 ' CB ' HG13 ' A' ' 133' ' ' VAL . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.43 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.13 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' A' ' 106' ' ' LEU . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.33 110.329 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 55' ' ' LYS . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.21 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.31 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.21 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.648 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.04 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.32 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.32 109.763 173.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.971 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.3 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.12 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.971 HG13 ' O ' ' A' ' 79' ' ' LEU . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.32 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.11 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.02 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.631 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.51 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.4 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.12 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.805 HG21 ' OE1' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.33 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.731 ' HE1' HD11 ' A' ' 106' ' ' LEU . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.03 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.45 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.35 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.865 ' HA ' HD12 ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.14 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.45 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 11.0 t-160 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.44 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.11 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.4 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.14 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.35 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.501 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.45 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.43 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.31 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.51 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.33 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.55 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.14 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.071 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.15 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.3 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.4 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.071 HD12 ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.2 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.648 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.42 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.51 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.05 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.805 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.24 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.31 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.14 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.24 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.22 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.11 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.67 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.34 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CE1' HG21 ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.24 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.24 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.33 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.588 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.34 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.677 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.34 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.35 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.21 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.13 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.34 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.13 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.34 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.885 HG13 ' CB ' ' A' ' 70' ' ' SER . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.44 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.14 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.12 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.44 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.15 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.52 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.23 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.832 ' HA ' HD12 ' A' ' 145' ' ' LEU . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.42 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.43 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.897 ' HB3' HG22 ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.21 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.33 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.22 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 158' ' ' LEU . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.43 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.2 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.61 HG11 ' C ' ' A' ' 25' ' ' PHE . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.02 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.12 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.13 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.4 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.33 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.34 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.14 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.994 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.44 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 1.056 ' CE2' HG22 ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.33 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.4 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.789 HG21 HG22 ' A' ' 174' ' ' VAL . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.54 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.2 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.33 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.53 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.01 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.42 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.44 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.23 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.42 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.35 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.634 ' CE1' HG12 ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.2 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.917 ' CD1' HD13 ' A' ' 43' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.33 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.04 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.713 HD23 HG13 ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.13 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.22 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.988 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.11 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.499 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.34 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 180' ' ' LEU . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.12 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.988 HD12 ' HA ' ' A' ' 175' ' ' ASN . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.22 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.4 110.179 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 177' ' ' LEU . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.13 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.458 ' HG2' ' OXT' ' A' ' 181' ' ' LYS . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.05 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.238 0.542 . . . . 73.24 110.286 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.31 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.34 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.41 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB3' HD22 ' A' ' 173' ' ' LEU . 5.0 m-70 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.51 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.693 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.33 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.01 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.906 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.31 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.667 HD11 HD23 ' A' ' 158' ' ' LEU . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.24 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.02 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.55 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.971 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.05 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.34 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.11 109.513 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.529 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.34 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.23 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.13 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.13 110.23 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.804 ' OE1' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.51 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.45 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.32 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.544 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.13 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.24 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.505 ' HA ' HG21 ' A' ' 93' ' ' ILE . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.32 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.41 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.12 109.999 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.33 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.23 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.44 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.23 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.24 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.985 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.51 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.11 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.43 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.02 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.985 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.13 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.33 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.646 ' NE2' HD11 ' A' ' 167' ' ' LEU . 15.8 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.1 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.23 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' HD12 ' A' ' 47' ' ' LEU . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.34 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.41 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.04 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 44' ' ' LYS . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.42 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.22 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.11 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.01 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.11 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.11 109.641 175.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.12 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.24 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.21 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.33 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.14 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.32 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.458 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.24 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.62 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.33 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.62 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.12 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.31 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.13 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.2 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.21 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.02 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.31 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.42 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.04 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.43 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 1.039 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.13 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.33 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.21 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.052 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.31 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 123' ' ' ALA . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.21 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.535 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.04 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.976 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.32 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.32 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.866 ' O ' HG13 ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.3 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.12 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.32 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.11 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.02 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.717 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.51 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.4 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.12 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.33 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.651 ' HE1' HD11 ' A' ' 106' ' ' LEU . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.03 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.45 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.35 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.855 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.14 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.45 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.44 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.11 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.4 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.14 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.35 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.45 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.43 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.31 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.51 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.33 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.55 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.14 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.882 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.15 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.3 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.51 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.6 mm100 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.4 110.615 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.2 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.717 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.42 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.51 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.05 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.698 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.24 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.31 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.14 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.557 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.24 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.22 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.11 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.817 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.34 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.775 ' HA ' HD11 ' A' ' 79' ' ' LEU . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.24 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.24 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.33 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.34 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.34 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.35 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.21 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.052 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.13 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.34 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.13 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.34 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 71' ' ' LYS . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.44 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.14 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.12 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.44 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.15 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.52 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 9.6 mt-30 -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.23 110.611 -175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.689 ' HA ' HD12 ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.42 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.43 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.21 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.33 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.22 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.43 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.2 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.02 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.12 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.13 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.868 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.4 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.33 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 177' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.34 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.14 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.971 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.44 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 177' ' ' LEU . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.33 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.957 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.4 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.493 HG13 HD23 ' A' ' 173' ' ' LEU . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.54 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.508 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.2 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.33 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.53 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.01 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 169' ' ' GLU . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.42 109.715 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.44 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.23 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.646 HD11 ' NE2' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.42 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.35 110.587 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.868 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.2 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' A' ' 43' ' ' LEU . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.33 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.04 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 8' ' ' HIS . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.13 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.22 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.7 m120 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.11 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.533 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.34 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 157' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.12 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.22 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.4 110.677 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 177' ' ' LEU . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.13 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.05 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.478 ' N ' ' NE2' ' A' ' 8' ' ' HIS . 32.6 tttt . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 120.988 0.423 . . . . 73.24 110.943 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.31 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.34 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.41 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 1.135 ' ND1' HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.51 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 1.122 ' CD2' HD21 ' A' ' 177' ' ' LEU . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.33 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.01 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.31 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' SER . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.24 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.02 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.55 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.05 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.34 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.11 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.34 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.23 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.13 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.13 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.799 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.51 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.45 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 58' ' ' VAL . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.32 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.13 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.958 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.24 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' HG21 ' A' ' 93' ' ' ILE . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.32 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.41 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.12 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.33 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.23 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 94' ' ' HIS . 15.6 t-20 -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.23 110.365 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.24 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.973 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.51 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.11 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.43 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.02 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.973 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.13 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.33 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 16.4 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.1 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.23 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.692 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.34 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.41 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.4 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.04 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.42 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.22 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.11 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.01 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.11 110.435 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.11 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.12 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.24 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.21 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.33 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.14 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.647 HG21 ' HG3' ' A' ' 61' ' ' MET . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.32 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.24 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.33 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.12 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.31 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.13 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.2 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.55 ' HE2' HD22 ' A' ' 106' ' ' LEU . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.21 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.02 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.446 HE21 HG11 ' A' ' 133' ' ' VAL . 64.0 tp60 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.31 110.259 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.42 110.236 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.459 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.04 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.43 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.832 ' HG2' HG21 ' A' ' 133' ' ' VAL . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.13 110.103 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.33 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.21 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.058 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.31 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 123' ' ' ALA . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.21 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.639 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.04 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.32 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.32 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.981 ' O ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.3 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.12 109.944 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.32 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' VAL . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.11 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.02 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.639 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.51 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.4 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.12 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.33 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.533 ' HE1' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.03 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.45 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.532 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.35 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.867 ' HA ' HD12 ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.14 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.958 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.45 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 34' ' ' ASN . 51.7 t-80 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.44 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.11 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.4 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' THR . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.14 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.35 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.467 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.45 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.701 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.43 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.31 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.51 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.33 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.55 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.14 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.957 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.15 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.3 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.8 mm100 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.4 110.612 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.2 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.481 ' O ' HG12 ' A' ' 115' ' ' ILE . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.42 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' CA ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.51 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.05 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.24 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.31 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.14 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.24 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.558 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.22 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.11 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.34 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.24 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.24 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.33 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.797 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.34 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.34 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.35 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.21 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.058 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.13 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.34 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.13 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.34 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.832 HG21 ' HG2' ' A' ' 71' ' ' LYS . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.44 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.14 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.12 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.44 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.15 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.52 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.531 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.23 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.42 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.43 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.21 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.708 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.33 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.22 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 158' ' ' LEU . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.43 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.02 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.12 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.13 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 0.808 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.4 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.33 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.34 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.52 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.14 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.44 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.33 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.4 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 177' ' ' LEU . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.54 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.2 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.33 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.53 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.01 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.42 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.44 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.23 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.42 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.35 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.808 ' OH ' HG21 ' A' ' 151' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.2 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.716 ' CD1' HD12 ' A' ' 43' ' ' LEU . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.33 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.04 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 1.135 HD13 ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.13 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.22 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.11 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.575 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.34 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 1.122 HD21 ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.12 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.22 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.4 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.13 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.05 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HD2' ' OE1' ' A' ' 7' ' ' GLU . 53.5 mttt . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 121.212 0.529 . . . . 73.24 110.586 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.587 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.31 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.34 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.41 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 13.1 m-70 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.51 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.639 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.33 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.01 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.908 HG22 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.31 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.24 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.02 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.55 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.05 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.34 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.428 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.11 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.34 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.23 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 178' ' ' LEU . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.13 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.13 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 1.037 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.51 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.45 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.32 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.552 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.13 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.737 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.24 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.497 ' HA ' HG21 ' A' ' 93' ' ' ILE . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.32 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.41 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.12 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.33 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.23 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.23 110.369 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.24 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.809 ' CE2' HD11 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.51 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.11 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.43 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.7 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.02 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.809 HD11 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.13 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.33 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.684 ' CD ' HD13 ' A' ' 167' ' ' LEU . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.1 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.657 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.23 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' LEU . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.34 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.41 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.04 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' LYS . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.42 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.22 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.11 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.01 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.11 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.11 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.12 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.24 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.21 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.33 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.674 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.14 109.64 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.32 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.24 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.33 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.12 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.31 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.13 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.2 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.21 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.02 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.31 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.42 110.226 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.04 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 133' ' ' VAL . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.43 110.214 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.13 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.33 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.547 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.21 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.077 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.31 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.746 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.21 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.633 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.04 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.953 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.32 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.32 109.758 173.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.035 ' O ' HG13 ' A' ' 81' ' ' VAL . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.3 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.12 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.32 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.11 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.02 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.702 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.51 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.4 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.12 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.731 HG11 ' CD ' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.33 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.799 ' HE1' HD11 ' A' ' 106' ' ' LEU . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.03 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.45 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.35 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.14 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 28' ' ' PHE . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.45 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.44 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.11 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.4 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.14 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.35 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.45 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.477 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.43 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.31 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.51 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.33 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.55 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.14 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.017 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.15 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.724 ' NH2' ' HB1' ' A' ' 117' ' ' ALA . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.3 110.32 176.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.2 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.42 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.51 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.05 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.731 ' CD ' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.24 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.31 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.14 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.24 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.22 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.11 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.681 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.34 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.24 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.24 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.33 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.34 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.667 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.34 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.35 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.21 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.077 HG13 ' HB3' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.13 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.34 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.13 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.895 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.34 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.777 HG21 ' HG2' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.44 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.14 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.12 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.674 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.44 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.15 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.52 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 6.8 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.23 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.42 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.43 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.21 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.602 ' OG ' HD12 ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.33 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.22 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 158' ' ' LEU . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.43 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.2 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.02 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.12 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.964 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.13 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.037 HG22 ' OE1' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.4 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.33 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.95 HG11 ' HB2' ' A' ' 177' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.34 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.14 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.951 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.44 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.908 ' CE1' HG22 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.33 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.4 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.54 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.2 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.33 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.53 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.01 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.42 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.44 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.23 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.684 HD13 ' CD ' ' A' ' 42' ' ' GLN . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.42 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.35 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' A' ' 151' ' ' VAL . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.2 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.33 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.04 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.642 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.13 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.22 109.861 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.7 m-80 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.11 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.34 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.955 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.12 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.22 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.4 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 177' ' ' LEU . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.13 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.05 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.49 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 9.5 mmtt . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.2 0.524 . . . . 73.24 110.251 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.31 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.34 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.41 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.519 ' O ' ' CD2' ' A' ' 173' ' ' LEU . 25.1 m-70 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.51 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 177' ' ' LEU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.33 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.01 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.31 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.24 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.02 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.55 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.874 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.05 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.34 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.11 109.788 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.34 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.23 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.13 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.13 110.188 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.858 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.51 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 56' ' ' ASN . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.45 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.32 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.13 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.765 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.24 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.32 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.41 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.12 110.347 -176.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.33 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.23 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.23 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.24 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.748 ' HE2' HD11 ' A' ' 40' ' ' ILE . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.51 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.11 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.43 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.02 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.858 HG21 ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.13 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.33 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 19.0 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.1 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.23 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 47' ' ' LEU . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.34 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.41 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.04 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.42 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.22 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.11 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.01 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.11 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.11 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.12 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.24 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.21 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.33 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' HIS . . . . . 0.691 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 3.0 p-80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.14 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.32 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.24 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.33 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' MET . . . . . 0.619 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.12 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.31 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.13 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.2 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.21 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.02 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.31 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.42 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.04 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.573 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.43 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.13 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.33 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.21 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.043 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.31 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.682 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.21 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' MET . . . . . 0.61 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.04 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.32 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.32 109.55 172.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 1.018 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.3 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.12 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.32 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.11 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.02 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . 0.686 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.51 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.4 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.12 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.33 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' MET . . . . . 0.647 ' CE ' HD11 ' A' ' 106' ' ' LEU . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.03 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.45 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.35 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.857 ' HA ' HD12 ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.14 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.45 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.44 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.11 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.4 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.14 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.35 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.45 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' PRO . . . . . 0.736 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.43 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.31 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.51 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.33 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.55 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.14 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.15 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.3 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.4 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.2 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.557 ' CD2' ' CE1' ' A' ' 120' ' ' PHE . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.42 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.51 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.05 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.774 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.24 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.31 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.14 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.24 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.832 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.22 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.11 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.34 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' PHE . . . . . 0.682 ' CE1' HG21 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.24 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.24 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.33 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.34 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' TYR . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.34 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.35 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.21 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' VAL . . . . . 1.043 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.13 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.34 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.13 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.34 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.44 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.14 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.12 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' PHE . . . . . 0.691 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.44 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.15 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.52 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.23 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.42 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.43 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.21 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.614 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.33 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.22 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 158' ' ' LEU . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.43 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 147' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.2 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.02 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.12 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 150' ' ' ALA . . . . . 0.892 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.13 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.4 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.33 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 153' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.34 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.14 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.874 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.44 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 157' ' ' TYR . . . . . 0.782 ' HB3' HD22 ' A' ' 177' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.33 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.4 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 173' ' ' LEU . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.54 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.2 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.33 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.53 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.01 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.42 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.44 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.23 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.42 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 169' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.35 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.2 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.33 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 172' ' ' ASP . . . . . 0.547 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.04 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 159' ' ' VAL . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.13 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 159' ' ' VAL . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.22 109.847 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 175' ' ' ASN . . . . . 0.856 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.11 110.802 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.34 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.12 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 178' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.22 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 179' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.4 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.96 HD12 ' HA ' ' A' ' 177' ' ' LEU . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.13 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.481 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.205 -179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.258 0.551 . . . . 71.14 110.206 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.575 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.0 -32.56 69.82 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.27 -0.894 . . . . 70.15 110.411 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.613 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 58.7 m-85 -100.68 132.81 45.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.015 . . . . 73.02 110.684 -172.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.421 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 31.5 mttm -137.97 152.05 48.55 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.479 -0.763 . . . . 73.24 110.092 179.183 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.588 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 81.8 tt0 -67.52 135.4 52.95 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 63.31 110.139 177.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.35 -9.5 67.17 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.481 -1.447 . . . . 64.34 109.481 -179.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.458 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.3 mt-10 -128.65 -54.05 1.24 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -1.162 . . . . 75.41 110.334 179.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.595 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 26.5 m-70 -93.89 -19.69 20.73 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.24 -0.912 . . . . 74.51 109.825 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CG ' HD21 ' A' ' 177' ' ' LEU . 52.7 p90 -158.41 172.81 17.66 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.627 -0.671 . . . . 52.33 110.395 176.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -128.83 158.26 39.22 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.518 -0.739 . . . . 73.01 109.468 174.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.523 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 87.0 t -102.03 123.19 55.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 120.88 -1.137 . . . . 73.31 110.626 -179.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.905 HD11 HD23 ' A' ' 158' ' ' LEU . 80.0 mt -77.55 -19.1 56.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.724 -0.61 . . . . 74.24 110.386 177.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.479 ' HB3' ' O ' ' A' ' 12' ' ' LEU . 22.5 tptm 62.64 14.68 7.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.352 -0.843 . . . . 72.02 109.542 -171.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.5 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.3 OUTLIER -67.82 165.8 28.4 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.497 -0.752 . . . . 74.55 110.076 177.916 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -56.05 93.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.98 1.516 . . . . 45.32 110.141 178.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.978 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -66.68 153.67 42.59 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.202 -0.936 . . . . 62.43 110.295 -178.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 88.8 p -85.3 151.01 24.37 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 61.05 110.397 -179.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -65.3 -29.59 70.36 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.255 -0.903 . . . . 74.34 110.235 179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -116.83 174.3 2.57 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.283 -0.886 . . . . 74.11 109.751 178.843 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 19' ' ' SER . 57.9 Cg_endo -71.69 122.45 8.56 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 123.812 1.427 . . . . 73.34 109.957 -179.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.2 p -144.49 138.25 23.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.858 -1.151 . . . . 74.23 110.125 173.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.4 t -119.79 126.58 75.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.213 -0.929 . . . . 63.13 109.705 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.403 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 85.9 p -117.86 136.86 53.17 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.998 -1.064 . . . . 65.13 110.185 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.808 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.6 tt0 -105.64 129.66 53.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.332 -0.855 . . . . 74.51 110.371 178.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 58.0 m-85 -102.96 124.49 48.57 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -0.902 . . . . 73.45 109.899 177.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.467 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 47.0 p90 -144.13 165.49 27.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.532 -0.73 . . . . 70.32 111.388 -176.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.6 t -132.17 132.5 43.23 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.425 -0.797 . . . . 72.13 110.397 178.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.697 ' HB2' ' HE2' ' A' ' 69' ' ' MET . 96.8 m-85 -60.89 -13.86 18.49 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 110.706 179.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.593 ' CD2' ' HA2' ' A' ' 62' ' ' GLY . 4.0 m-85 -96.15 11.82 32.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.928 -1.107 . . . . 74.32 111.638 -170.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.3 m -126.69 108.17 22.89 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 120.612 -1.305 . . . . 34.41 110.437 178.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.471 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.1 Cg_endo -58.62 -45.24 30.89 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 124.007 1.53 . . . . 74.12 110.198 -179.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.569 ' CD2' ' SG ' ' A' ' 33' ' ' CYS . 45.5 p-80 -65.01 -44.55 88.84 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.002 -1.061 . . . . 75.33 110.244 177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.569 ' SG ' ' CD2' ' A' ' 32' ' ' HIS . 100.0 m -60.74 -46.51 90.14 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.77 -1.206 . . . . 63.23 109.943 175.675 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.493 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 38.0 m-20 -58.37 -36.99 74.32 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.191 -0.943 . . . . 64.23 110.194 -179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.572 ' OG1' ' CE1' ' A' ' 94' ' ' HIS . 43.0 m -62.65 -41.65 99.17 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.165 -0.96 . . . . 63.24 110.185 178.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.681 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.4 t80 -63.44 -38.86 92.78 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.367 -0.833 . . . . 71.51 110.231 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.18 -56.47 4.22 Favored Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.23 -0.919 . . . . 62.11 110.45 -177.391 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 53.2 Cg_exo -41.92 -50.58 5.04 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.674 1.355 . . . . 75.43 110.462 176.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.521 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.7 -45.87 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.855 -1.153 . . . . 74.02 110.097 178.197 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.808 HG21 ' CD ' ' A' ' 24' ' ' GLU . 23.9 mm -55.43 -41.2 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.812 -1.18 . . . . 72.13 109.976 176.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.6 -38.2 74.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.965 -1.084 . . . . 51.33 109.527 175.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.757 ' NE2' HD11 ' A' ' 167' ' ' LEU . 19.0 mt-30 -59.16 -40.83 86.83 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.243 -0.911 . . . . 70.1 109.401 176.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.758 HD12 ' CD1' ' A' ' 171' ' ' PHE . 40.4 tp -61.87 -39.85 93.33 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.285 -0.884 . . . . 74.23 110.218 176.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.734 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.9 mttt -55.97 -51.17 68.65 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.374 -0.829 . . . . 73.34 110.207 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.0 mt-30 -63.86 -36.97 85.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.439 -0.788 . . . . 62.41 109.382 179.267 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.526 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 26.9 mt-30 -75.7 -31.33 59.64 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.685 -0.635 . . . . 72.04 110.395 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.734 HD12 ' HA ' ' A' ' 44' ' ' LYS . 11.1 mt -51.81 146.93 12.89 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.283 -0.886 . . . . 64.42 110.323 -177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 17.9 Cg_endo -65.3 143.3 76.47 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.084 1.571 . . . . 71.22 110.087 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.07 -34.69 66.18 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 75.11 109.844 178.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.82 -39.15 96.42 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.807 -1.317 . . . . 71.01 109.807 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.506 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -73.15 141.68 47.43 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.037 -1.273 . . . . 72.11 110.515 -177.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.3 mttp -97.78 154.68 17.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.499 -0.751 . . . . 74.11 109.537 174.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.635 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 49.0 t80 -123.18 160.06 27.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.714 -1.241 . . . . 64.12 110.695 177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.538 ' N ' ' O ' ' A' ' 22' ' ' VAL . 69.4 tp60 -146.84 161.08 41.43 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.745 . . . . 74.24 110.134 -176.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.446 ' N ' ' HG3' ' A' ' 54' ' ' GLN . 42.9 mttt -125.33 143.36 51.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.16 -0.963 . . . . 74.21 110.625 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 7.1 t30 -136.99 135.36 37.56 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.388 -0.82 . . . . 65.33 109.994 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.689 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 5.9 p-80 -115.04 132.23 56.67 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.734 -1.229 . . . . 75.14 110.138 175.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.593 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 26.9 m -98.53 140.2 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 O-C-N 121.242 -0.911 . . . . 64.32 110.783 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.484 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.15 -15.55 25.87 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.386 -0.821 . . . . 63.24 110.662 177.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.598 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 12.8 p90 -72.45 -30.69 64.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.649 -1.282 . . . . 61.33 110.017 -177.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.598 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 58.2 mmm -64.15 -38.1 89.84 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.088 -1.008 . . . . 73.12 110.052 172.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.593 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -62.98 -44.93 96.66 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.829 -1.309 . . . . 64.31 109.829 -178.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -137.11 13.21 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.405 -1.478 . . . . 34.13 109.405 -177.537 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 65' ' ' MET . 33.6 p-10 -55.39 -33.88 63.86 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.005 -1.291 . . . . 73.2 110.871 -179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.557 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 24.7 ttt -99.91 12.63 36.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.042 -1.036 . . . . 71.21 110.448 -178.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.04 -41.32 94.42 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.58 -1.408 . . . . 72.02 109.58 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -59.77 -39.52 85.17 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.092 -1.24 . . . . 62.31 110.249 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.557 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.34 -46.76 82.05 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.052 -1.03 . . . . 45.42 110.337 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.697 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 94.2 mmm -60.32 -42.69 96.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.032 -1.043 . . . . 73.04 110.468 -177.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.871 ' CB ' HG13 ' A' ' 133' ' ' VAL . 20.8 m -60.57 -48.24 82.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.0 -1.062 . . . . 75.43 110.115 179.154 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.572 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.8 mttt -59.8 -34.25 72.8 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.073 -1.017 . . . . 63.13 110.444 177.261 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.8 -47.42 80.93 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.002 -1.061 . . . . 61.33 110.284 -176.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' O ' ' HB2' ' A' ' 76' ' ' MET . 88.6 t80 -58.15 -44.08 87.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 120.824 -1.172 . . . . 54.21 109.828 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.77 -39.56 92.09 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.953 -1.092 . . . . 72.31 109.888 176.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.787 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.2 m -58.04 -42.94 86.46 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.146 -0.972 . . . . 62.21 109.675 177.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.548 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 54.0 mtt -53.45 -42.66 67.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.102 -0.999 . . . . 71.04 109.05 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.8 mt -60.82 -43.45 95.5 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.563 -0.711 . . . . 73.32 110.355 -177.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.54 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.08 -37.99 72.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.006 -1.059 . . . . 75.32 110.319 175.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.919 HD13 ' CD ' ' A' ' 119' ' ' LYS . 16.5 mt -91.54 5.5 49.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.128 -0.983 . . . . 54.3 110.946 -176.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.8 30.49 19.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.971 -1.081 . . . . 73.12 109.882 -177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.2 m -118.23 20.6 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 73.32 110.897 -176.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.592 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.37 -56.38 22.82 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 120.842 -1.161 . . . . 71.25 110.055 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -50.09 -43.21 51.38 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.008 -1.057 . . . . 73.11 110.747 -178.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.607 ' O ' HG23 ' A' ' 88' ' ' VAL . 84.8 tttt -74.33 -57.81 3.7 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.259 -0.9 . . . . 73.02 111.016 -175.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.561 ' CG ' HD11 ' A' ' 115' ' ' ILE . 91.8 mmm -73.86 -31.67 63.28 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.389 -0.819 . . . . 64.51 111.103 -174.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.592 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.6 t -46.11 -57.94 7.33 Favored Pre-proline 0 C--N 1.296 -1.746 0 O-C-N 120.848 -1.157 . . . . 74.4 109.578 -177.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.544 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.6 Cg_endo -64.49 -24.73 63.41 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.271 1.143 . . . . 74.12 111.129 177.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.741 HG11 ' HG3' ' A' ' 113' ' ' GLU . 94.4 t -62.83 -41.77 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 120.707 -1.246 . . . . 63.33 109.369 177.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.546 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -62.46 -43.78 97.98 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.314 -0.866 . . . . 74.03 109.855 177.447 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.691 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.9 m-85 -69.71 -40.51 76.24 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.829 -1.169 . . . . 75.45 110.675 179.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 59.2 t30 -57.68 -59.29 5.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.047 -1.033 . . . . 74.35 109.671 174.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.838 ' HA ' HD12 ' A' ' 96' ' ' LEU . 51.4 ttt85 -51.49 -35.43 40.1 Favored 'General case' 0 C--N 1.295 -1.776 0 O-C-N 121.362 -0.836 . . . . 75.14 110.016 -177.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.527 ' CG1' ' O ' ' A' ' 89' ' ' MET . 2.4 mm -81.2 -63.72 1.11 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.211 -0.931 . . . . 72.45 110.619 176.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CE1' ' OG1' ' A' ' 35' ' ' THR . 83.9 t60 -70.45 -16.05 62.89 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.204 -0.935 . . . . 72.44 111.25 -172.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.2 m -121.47 -69.15 0.85 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.898 -1.126 . . . . 71.11 110.406 -175.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.838 HD12 ' HA ' ' A' ' 92' ' ' ARG . 37.1 mt -60.24 -25.21 65.48 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.964 -1.085 . . . . 74.4 109.602 178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 81.9 mtp180 58.1 33.58 23.31 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.525 -0.734 . . . . 74.14 110.028 -177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.513 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 3.3 tppt? -126.04 71.93 69.82 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.317 -0.864 . . . . 74.35 110.116 177.413 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 19.2 Cg_exo -61.54 146.38 97.01 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.968 1.509 . . . . 71.45 110.205 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.52 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.8 Cg_endo -61.89 130.81 32.43 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.034 1.544 . . . . 74.43 110.121 -179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 55.2 pttt -94.03 -25.64 17.13 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.2 -0.937 . . . . 72.31 110.235 -179.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 68.4 m-20 -142.78 171.61 13.82 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.304 -0.872 . . . . 74.51 109.484 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.2 -29.39 63.68 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.947 -1.096 . . . . 71.33 109.47 173.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.9 mt-30 -67.12 -52.22 44.41 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.048 -1.033 . . . . 74.55 111.12 -176.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.467 ' OE1' ' N ' ' A' ' 101' ' ' LYS . 85.1 tt0 -60.41 -37.06 79.66 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.895 -1.128 . . . . 65.14 109.059 175.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.0 tp -59.43 -42.72 92.54 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.577 -0.702 . . . . 54.15 110.079 178.161 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 81.0 mtp180 -61.13 -44.57 97.13 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.776 -1.202 . . . . 71.3 110.524 177.523 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.06 -40.27 84.61 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.009 -1.057 . . . . 71.4 110.35 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.96 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.3 mt -55.12 -50.64 62.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -0.973 . . . . 73.2 110.117 -179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.548 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 32.0 m-85 -58.93 -47.68 84.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.044 -1.035 . . . . 53.42 110.662 179.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.675 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.5 mt -65.19 -37.18 86.54 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.882 -1.136 . . . . 73.51 110.434 -177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.2 -38.12 73.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.918 -1.114 . . . . 73.05 109.982 175.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.741 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.9 mm-40 -76.62 6.7 5.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.874 . . . . 73.24 111.218 -175.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.95 11.5 46.15 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.134 -1.186 . . . . 72.31 110.134 176.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.561 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.5 mt -99.92 158.51 3.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.037 -1.272 . . . . 54.14 110.469 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.522 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -93.28 141.74 28.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.059 -1.026 . . . . 71.24 110.616 -174.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.675 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -32.73 74.54 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.986 -1.072 . . . . 52.22 109.724 174.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.48 -51.85 65.84 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.267 -0.896 . . . . 63.11 110.752 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.919 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.35 -37.86 63.4 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.873 -1.142 . . . . 72.34 110.666 -176.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.842 ' HA ' HD11 ' A' ' 79' ' ' LEU . 68.3 t80 -60.12 -40.87 91.25 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 120.894 -1.129 . . . . 70.24 110.121 175.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.424 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -62.61 -41.86 99.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 64.24 109.804 177.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.47 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.35 -33.64 72.71 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.22 -0.925 . . . . 73.33 109.806 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.787 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -80.58 -45.49 17.27 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.234 -0.916 . . . . 73.34 110.932 -176.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -59.59 -31.93 69.92 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.211 -0.93 . . . . 72.34 110.082 -179.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.47 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.2 p-10 -99.23 8.53 44.7 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.193 -0.942 . . . . 74.35 110.077 -178.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.88 133.51 17.2 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.554 -1.418 . . . . 43.32 109.554 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -56.67 -34.33 67.27 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.123 -1.222 . . . . 74.21 109.666 177.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.02 -46.82 88.23 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.217 -0.927 . . . . 33.5 110.483 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 21.8 t -56.84 -51.16 71.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 120.814 -1.179 . . . . 73.13 109.972 179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.79 -40.93 76.79 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.112 -0.992 . . . . 70.34 109.897 -176.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.74 -36.79 79.77 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.219 -0.926 . . . . 71.13 110.347 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.764 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.5 mtm -74.21 -36.27 63.97 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.917 -1.114 . . . . 73.34 110.621 -175.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.871 HG13 ' CB ' ' A' ' 70' ' ' SER . 98.4 t -58.93 -45.89 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.759 0 O-C-N 121.138 -0.976 . . . . 63.44 109.547 177.078 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 86.2 mtt180 -61.86 -44.1 97.51 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.255 -0.903 . . . . 75.14 109.631 176.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 43.3 ttt180 -51.35 -63.6 1.08 Allowed 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.654 -0.654 . . . . 74.12 111.132 -179.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.689 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 72.0 m-85 -59.1 -42.35 90.28 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.92 -1.112 . . . . 65.44 110.832 -175.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -54.25 -44.22 71.6 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.812 -1.18 . . . . 73.15 109.737 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.434 ' HB3' ' HE3' ' A' ' 138' ' ' LYS . 20.8 ttpp -59.92 -39.88 86.97 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.175 -0.953 . . . . 71.52 110.146 176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' NE2' ' CD1' ' A' ' 136' ' ' PHE . 52.3 mt-30 -55.58 -46.59 77.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.956 -1.09 . . . . 72.23 110.01 -177.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.627 ' CE2' ' CB ' ' A' ' 145' ' ' LEU . 56.5 t80 -64.5 -40.28 95.36 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.379 -0.825 . . . . 75.42 110.301 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -62.68 -50.95 69.14 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 119.789 -0.764 . . . . 74.43 110.367 -178.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.5 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.4 m-20 -63.09 -37.13 85.97 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.163 -0.961 . . . . 62.21 110.189 178.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.697 ' O ' HD13 ' A' ' 12' ' ' LEU . 72.8 p -66.67 -18.13 65.21 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.485 -0.76 . . . . 73.33 110.654 -176.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.77 29.54 71.05 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 109.013 -1.635 . . . . 73.22 109.013 -177.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 158' ' ' LEU . 89.0 mt -78.26 141.38 38.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -1.138 . . . . 72.43 110.338 -178.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 3.4 t -114.77 -1.28 13.28 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.345 -0.847 . . . . 51.32 110.274 -178.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.06 124.04 0.83 Allowed Glycine 0 N--CA 1.49 2.237 0 C-N-CA 119.693 -1.241 . . . . 51.2 110.062 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.0 m -84.74 163.83 44.91 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 121.28 -1.129 . . . . 72.02 109.489 173.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.548 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 3.8 Cg_exo -71.65 128.45 14.38 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.554 -1.852 . . . . 63.12 111.352 3.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.886 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -117.66 141.01 48.88 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.352 -0.843 . . . . 41.13 109.415 172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.832 HG21 ' OH ' ' A' ' 170' ' ' TYR . 26.2 t -113.49 127.57 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.947 -1.095 . . . . 63.4 110.075 -179.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.543 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.8 t -114.26 131.8 65.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.196 -0.94 . . . . 64.33 110.28 -179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 177' ' ' LEU . 7.0 t -109.65 133.73 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.488 -0.758 . . . . 43.32 109.605 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.33 26.95 2.47 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.097 -1.002 . . . . 75.34 109.886 -175.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.439 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.2 t30 48.21 30.98 2.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.172 -0.955 . . . . 72.14 110.779 176.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.978 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -148.3 -29.93 0.29 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.868 -1.145 . . . . 73.44 111.118 -178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.822 ' HB3' HD22 ' A' ' 177' ' ' LEU . 16.4 m-85 -106.52 141.13 38.31 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.578 -1.327 . . . . 62.33 110.001 174.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.939 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.21 128.14 55.82 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.367 -0.833 . . . . 64.4 109.286 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.731 HG22 HD12 ' A' ' 177' ' ' LEU . 53.9 t -82.09 114.98 23.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.419 -0.801 . . . . 73.54 110.549 -174.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 99.0 mt-30 -75.3 -50.25 16.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.176 -0.953 . . . . 65.2 109.372 171.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.89 6.69 38.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 110.084 -1.206 . . . . 73.33 110.084 174.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -62.08 -42.9 99.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.996 -1.297 . . . . 73.53 110.151 -179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.5 m -64.67 -33.43 75.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.314 -0.866 . . . . 60.01 110.487 179.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.789 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -79.4 88.97 4.98 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.141 -0.975 . . . . 74.42 110.743 -174.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -63.24 -25.9 68.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 52.44 110.162 174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.6 t -122.61 149.33 44.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.238 -0.914 . . . . 74.23 109.997 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 42' ' ' GLN . 57.1 mt -52.06 -29.06 19.64 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.121 -0.987 . . . . 62.32 111.145 -176.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.49 -41.14 80.13 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 120.592 -1.318 . . . . 63.42 110.459 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.487 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 97.8 mt-10 -80.49 -42.34 22.72 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.878 -1.139 . . . . 70.35 110.631 177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.832 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -62.04 -44.88 95.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.104 -0.998 . . . . 75.2 110.002 178.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.758 ' CD1' HD12 ' A' ' 43' ' ' LEU . 66.3 t80 -59.4 -46.56 88.36 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.335 -0.853 . . . . 73.33 110.148 175.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.613 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 86.6 m-20 -56.47 -44.64 80.79 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.047 -1.033 . . . . 62.04 110.745 -177.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.773 HD11 HD11 ' A' ' 177' ' ' LEU . 6.0 tp -54.53 -51.88 63.78 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.588 -1.32 . . . . 73.13 109.719 174.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.41 HG22 HG21 ' A' ' 159' ' ' VAL . 55.4 t -52.54 -42.43 39.73 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.087 -1.008 . . . . 74.22 109.712 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.635 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.6 m120 -60.24 -42.86 96.14 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.252 -0.905 . . . . 73.11 110.733 -178.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.807 ' O ' HD23 ' A' ' 180' ' ' LEU . 72.1 m-85 -68.75 -43.31 76.09 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.003 -1.061 . . . . 71.34 109.893 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.822 HD22 ' HB3' ' A' ' 157' ' ' TYR . 84.6 mt -59.14 -35.97 74.42 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.418 -0.801 . . . . 71.12 109.956 178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 175' ' ' ASN . 7.3 mt -57.16 -30.79 64.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.092 -1.005 . . . . 74.22 109.833 175.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 66.3 p -101.67 10.57 39.99 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.325 -0.859 . . . . 72.4 110.216 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.807 HD23 ' O ' ' A' ' 176' ' ' TYR . 1.0 OUTLIER -88.99 141.86 28.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.21 -0.931 . . . . 72.13 110.223 -179.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 180' ' ' LEU . 64.8 mttm . . . . . 0 N--CA 1.491 1.581 0 CA-C-O 118.043 -0.979 . . . . 62.05 110.197 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.33 0.586 . . . . 71.14 110.16 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.52 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 55.5 mt-30 -58.95 -34.27 71.57 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.177 -0.952 . . . . 70.15 110.342 -179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.692 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -129.12 162.5 27.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.955 . . . . 73.02 110.449 -177.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 42.7 tttm -170.99 149.99 3.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.358 -0.839 . . . . 73.24 109.76 177.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.736 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -56.82 133.82 54.69 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.017 -1.052 . . . . 63.31 109.907 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.62 2.41 76.03 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.415 -1.474 . . . . 64.34 109.415 -175.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -137.45 -56.27 0.69 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.134 -1.216 . . . . 75.41 110.47 -179.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.56 ' CD2' ' HA ' ' A' ' 3' ' ' PHE . 3.8 m170 -98.77 -14.54 19.68 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.163 -0.961 . . . . 74.51 109.952 179.061 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.605 ' CG ' HD21 ' A' ' 177' ' ' LEU . 48.0 p90 -157.28 170.56 22.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.385 -0.822 . . . . 52.33 110.523 173.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -126.23 155.74 41.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.482 -0.761 . . . . 73.01 109.58 175.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.847 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.4 t -104.45 133.27 49.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 120.906 -1.121 . . . . 73.31 110.665 -177.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.463 HD13 ' HA ' ' A' ' 143' ' ' SER . 63.4 mt -103.69 144.46 31.42 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.634 -0.666 . . . . 74.24 110.265 -177.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -57.23 -18.48 16.22 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.111 -0.993 . . . . 72.02 109.659 173.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.635 HG22 ' HB3' ' A' ' 142' ' ' ASP . 46.9 p -46.06 151.94 0.84 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.4 -0.813 . . . . 74.55 110.529 -177.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_endo -62.77 140.62 81.3 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.179 1.62 . . . . 45.32 110.339 178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.016 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.08 155.89 18.07 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.156 -0.965 . . . . 62.43 110.161 178.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -83.52 140.98 31.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 61.05 110.462 -177.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.51 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 86.1 p -61.3 -29.61 69.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.247 -0.908 . . . . 74.34 109.928 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -113.79 171.9 4.01 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.35 -0.843 . . . . 74.11 109.614 176.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.401 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.4 Cg_endo -71.73 123.77 9.67 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.873 1.459 . . . . 73.34 110.051 -178.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.0 p -145.16 137.68 21.19 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 120.83 -1.169 . . . . 74.23 109.922 172.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.567 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.52 132.29 68.83 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 O-C-N 121.182 -0.949 . . . . 63.13 109.407 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.436 ' OG ' ' CE1' ' A' ' 25' ' ' PHE . 83.3 p -122.99 129.88 52.09 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 120.873 -1.142 . . . . 65.13 109.626 -179.431 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.947 ' OE2' HG22 ' A' ' 151' ' ' VAL . 34.9 tp10 -105.77 134.68 48.49 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.148 -0.97 . . . . 74.51 110.072 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CE1' HG23 ' A' ' 152' ' ' VAL . 33.6 m-85 -108.58 132.47 53.83 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.431 -0.793 . . . . 73.45 109.894 -175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.746 ' HA ' HG21 ' A' ' 148' ' ' VAL . 51.7 p90 -148.25 170.82 17.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.419 -0.801 . . . . 70.32 111.209 -174.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.52 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 44.7 t -128.62 131.89 48.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.361 -0.837 . . . . 72.13 110.54 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.569 ' HA ' ' CE1' ' A' ' 90' ' ' PHE . 90.5 m-85 -60.33 -22.62 63.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.108 -0.995 . . . . 73.24 110.798 177.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.646 ' CD1' HD12 ' A' ' 93' ' ' ILE . 40.9 m-85 -106.46 24.43 12.59 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -0.998 . . . . 74.32 110.799 -175.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.549 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 49.2 t -122.66 91.67 49.42 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.88 -1.138 . . . . 34.41 110.123 -177.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.705 ' O ' HG23 ' A' ' 35' ' ' THR . 32.4 Cg_exo -52.39 -47.61 26.08 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.045 1.55 . . . . 74.12 110.499 -176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.429 ' O ' ' OG1' ' A' ' 35' ' ' THR . 85.0 t60 -58.74 -47.53 84.32 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.101 -0.999 . . . . 75.33 110.013 177.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.476 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 22.1 m -64.14 -42.76 96.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.049 -1.032 . . . . 63.23 110.106 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 9.2 m-20 -56.93 -37.91 72.16 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.096 -1.002 . . . . 64.23 110.188 -178.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 31' ' ' PRO . 57.6 p -67.66 -39.06 84.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.055 -1.028 . . . . 63.24 110.177 177.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.761 ' CE2' HD11 ' A' ' 40' ' ' ILE . 76.1 t80 -61.61 -34.84 76.34 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.153 -0.967 . . . . 71.51 110.26 178.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.532 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.26 -61.23 1.02 Allowed Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.201 -0.937 . . . . 62.11 111.256 -175.17 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.1 Cg_endo -49.16 -44.05 34.72 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.359 1.189 . . . . 75.43 110.631 -176.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.472 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.7 mt -53.61 -48.59 59.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.777 -1.202 . . . . 74.02 110.062 176.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.761 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.3 mm -55.98 -39.69 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 120.891 -1.13 . . . . 72.13 109.973 176.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.72 -37.96 74.45 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.96 -1.087 . . . . 51.33 109.619 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.82 ' NE2' HD11 ' A' ' 167' ' ' LEU . 21.9 mt-30 -59.09 -42.04 89.49 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.169 -0.957 . . . . 70.1 109.333 176.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -59.97 -40.67 89.9 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.809 . . . . 74.23 110.261 176.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.793 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.1 mttt -56.58 -51.3 69.16 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.379 -0.825 . . . . 73.34 110.166 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -63.45 -36.57 84.17 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.503 -0.748 . . . . 62.41 109.495 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.633 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -76.88 -32.15 57.27 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.626 -0.672 . . . . 72.04 110.321 179.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.793 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -50.31 142.91 13.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.197 -0.94 . . . . 64.42 110.225 -176.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.4 Cg_exo -60.68 142.79 98.79 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.994 1.523 . . . . 71.22 110.102 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.86 -35.3 66.3 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.151 -0.968 . . . . 75.11 109.817 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.18 -38.06 94.99 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.794 -1.322 . . . . 71.01 109.794 178.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.44 138.71 45.35 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.099 -1.236 . . . . 72.11 110.577 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 39.8 mttm -95.78 155.76 16.61 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.406 -0.809 . . . . 74.11 109.633 174.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.571 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 47.3 t80 -124.0 160.65 27.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.748 -1.22 . . . . 64.12 110.625 178.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.567 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.4 tt0 -147.69 161.65 40.76 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.387 -0.821 . . . . 74.24 110.238 -174.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.546 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 23.2 mttp -124.6 145.65 49.49 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.169 -0.957 . . . . 74.21 110.78 -177.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.511 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 3.1 t-20 -143.69 140.14 29.88 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.361 -0.837 . . . . 65.33 109.802 -177.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.683 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.2 p-80 -130.87 139.53 50.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 120.398 -1.438 . . . . 75.14 111.483 179.525 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.654 ' CG1' ' CZ ' ' A' ' 140' ' ' PHE . 30.4 m -79.94 137.22 21.97 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 O-C-N 121.437 -0.79 . . . . 64.32 110.778 178.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.488 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 58.9 p -93.6 -12.34 29.69 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.036 -1.04 . . . . 63.24 110.142 170.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 1.2 p90 -70.5 -37.04 74.14 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.683 -1.26 . . . . 61.33 110.306 -175.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.571 ' HG2' ' CZ ' ' A' ' 60' ' ' PHE . 87.8 mmm -59.46 -37.51 78.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.239 -0.913 . . . . 73.12 109.979 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.59 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.41 -45.86 92.12 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.69 -1.364 . . . . 64.31 109.69 178.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.56 -135.49 12.29 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.358 -1.497 . . . . 34.13 109.358 -178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -54.13 -38.0 64.97 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 110.651 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.488 ' HG2' ' HB3' ' A' ' 68' ' ' ALA . 26.0 ttt -94.33 8.93 40.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.142 -0.974 . . . . 71.21 110.527 -177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -57.01 -40.4 91.19 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.545 -1.422 . . . . 72.02 109.545 -179.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.59 -38.28 80.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.163 -1.198 . . . . 62.31 110.19 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.488 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.1 -46.75 82.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.097 -1.002 . . . . 45.42 110.211 179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.498 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.2 mmm -60.03 -42.88 95.35 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.07 -1.019 . . . . 73.04 110.612 -178.307 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.723 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.6 p -62.31 -46.83 86.96 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.876 -1.14 . . . . 75.43 110.187 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.537 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.5 mtpt -60.37 -34.73 74.29 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.112 -0.993 . . . . 63.13 110.262 177.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.469 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.69 -48.12 75.86 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.129 -0.982 . . . . 61.33 110.398 -177.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.487 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 73.5 t80 -55.81 -44.88 78.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.812 -1.18 . . . . 54.21 109.73 176.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.055 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.47 -38.21 88.95 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.978 -1.076 . . . . 72.31 109.798 176.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.695 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.6 m -56.84 -43.01 80.69 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.16 -0.963 . . . . 62.21 109.682 177.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.55 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 50.5 mtt -53.83 -43.09 69.13 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.102 -0.999 . . . . 71.04 109.131 176.081 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.926 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.5 mt -60.43 -43.08 93.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 C-N-CA 119.732 -0.787 . . . . 73.32 110.322 -177.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.628 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.19 -38.47 73.71 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.891 -1.13 . . . . 75.32 110.379 175.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.986 HD13 ' CD ' ' A' ' 119' ' ' LYS . 14.8 mt -91.99 6.63 45.6 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.105 -0.997 . . . . 54.3 111.008 -175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.2 tt0 57.01 30.4 18.1 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.828 -1.17 . . . . 73.12 109.818 -177.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.805 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.9 m -117.62 21.74 6.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.31 -0.869 . . . . 73.32 110.768 -177.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.566 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.58 -53.25 60.2 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.916 -1.115 . . . . 71.25 109.994 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -51.52 -42.4 61.71 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 73.11 110.563 -177.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.647 ' O ' HG23 ' A' ' 88' ' ' VAL . 36.9 tttp -76.52 -58.24 3.4 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.306 -0.871 . . . . 73.02 111.004 -175.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.64 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 92.2 mmm -72.29 -32.46 66.61 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.351 -0.843 . . . . 64.51 111.264 -174.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.566 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -46.75 -57.24 9.33 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 120.79 -1.194 . . . . 74.4 109.489 -176.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.54 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.3 Cg_endo -64.71 -26.99 60.47 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 123.289 1.152 . . . . 74.12 111.085 176.322 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.771 HG11 ' HG3' ' A' ' 113' ' ' GLU . 73.6 t -61.18 -40.58 86.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 120.784 -1.197 . . . . 63.33 109.522 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.526 ' O ' ' CG1' ' A' ' 93' ' ' ILE . 40.8 mmm -65.23 -42.87 92.97 Favored 'General case' 0 C--N 1.298 -1.639 0 C-N-CA 119.238 -0.985 . . . . 74.03 109.332 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 56.7 m-85 -67.74 -41.64 83.08 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.777 -1.202 . . . . 75.45 110.588 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.529 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.8 t30 -59.82 -51.58 69.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.036 -1.04 . . . . 74.35 109.897 176.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.731 ' HA ' HD13 ' A' ' 96' ' ' LEU . 17.3 tpt180 -51.13 -35.53 36.13 Favored 'General case' 0 C--N 1.294 -1.838 0 O-C-N 121.175 -0.953 . . . . 75.14 109.667 175.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.646 HD12 ' CD1' ' A' ' 29' ' ' TYR . 1.2 mm -88.13 -67.63 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.339 -0.85 . . . . 72.45 110.718 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.499 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -66.1 -19.13 65.75 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.329 -0.857 . . . . 72.44 111.066 -172.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.578 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.54 -71.17 0.76 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.971 -1.08 . . . . 71.11 110.219 -176.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.731 HD13 ' HA ' ' A' ' 92' ' ' ARG . 2.2 mp -59.83 -27.94 67.05 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.115 -0.991 . . . . 74.4 109.956 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.475 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.4 ttm180 61.41 36.94 17.12 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.426 -0.797 . . . . 74.14 110.113 -178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.51 ' HB3' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -127.89 76.49 77.41 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.375 -0.828 . . . . 74.35 110.032 178.299 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.404 ' HA ' ' HD3' ' A' ' 100' ' ' PRO . 30.1 Cg_exo -56.26 144.21 82.63 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.884 1.465 . . . . 71.45 110.234 -179.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.602 ' CG ' HD13 ' A' ' 106' ' ' LEU . 39.5 Cg_exo -50.98 113.7 1.2 Allowed 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.918 1.483 . . . . 74.43 110.353 -179.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.489 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 8.8 tptt -60.54 -46.91 88.43 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.385 -0.822 . . . . 72.31 110.288 178.144 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.469 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.5 m-20 -144.42 -176.94 5.23 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.44 -0.787 . . . . 74.51 109.51 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.56 -30.21 66.97 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 120.826 -1.171 . . . . 71.33 109.574 171.194 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 -69.33 -52.16 30.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.92 . . . . 74.55 111.231 -176.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.489 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.1 mm-40 -62.02 -36.38 81.39 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.692 -1.255 . . . . 65.14 109.098 177.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.9 tp -59.44 -44.27 92.96 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.57 -0.707 . . . . 54.15 110.086 176.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.512 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 75.5 ttt180 -58.37 -45.14 88.82 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.961 -1.087 . . . . 71.3 110.372 178.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.62 -40.45 83.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.086 -1.009 . . . . 71.4 110.205 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -54.68 -49.52 67.19 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.192 -0.942 . . . . 73.2 110.182 -178.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.64 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 38.9 m-85 -58.91 -48.38 81.65 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.975 -1.078 . . . . 53.42 110.485 178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' HA ' ' A' ' 117' ' ' ALA . 87.2 mt -61.36 -41.21 96.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.999 -1.063 . . . . 73.51 110.184 -177.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.09 -37.73 77.82 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.188 -0.945 . . . . 73.05 110.299 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.771 ' HG3' HG11 ' A' ' 88' ' ' VAL . 73.6 mm-40 -72.38 2.23 6.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.278 -0.889 . . . . 73.24 111.21 -175.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.03 12.01 30.74 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.908 -1.277 . . . . 72.31 109.908 177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.623 HD11 ' CG ' ' A' ' 85' ' ' MET . 92.3 mt -99.82 151.7 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.022 -1.281 . . . . 54.14 110.325 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.77 142.74 28.75 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.09 -1.006 . . . . 71.24 110.513 -174.453 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -65.77 -33.63 76.3 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.168 -0.958 . . . . 52.22 109.533 176.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.25 -49.94 72.12 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.391 -0.818 . . . . 63.11 110.799 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.986 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.15 -36.81 61.53 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.858 -1.151 . . . . 72.34 110.578 -176.41 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.839 ' HA ' HD11 ' A' ' 79' ' ' LEU . 84.5 t80 -61.26 -41.7 97.38 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.873 -1.142 . . . . 70.24 110.07 175.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.512 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.4 m-20 -61.21 -42.21 98.21 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.268 -0.895 . . . . 64.24 109.798 178.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.16 -37.67 86.11 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.18 -0.95 . . . . 73.33 110.018 178.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.695 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.87 -45.59 57.48 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.231 -0.918 . . . . 73.34 110.824 -176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.437 ' CZ ' ' HE2' ' A' ' 71' ' ' LYS . 61.8 t80 -58.79 -33.55 70.46 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.15 -0.969 . . . . 72.34 109.452 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -90.73 2.18 56.21 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.449 -0.782 . . . . 74.35 110.174 179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -69.02 130.27 24.54 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.687 -1.365 . . . . 43.32 109.687 -177.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.414 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 50.9 p90 -58.49 -33.83 70.25 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.123 -1.222 . . . . 74.21 109.607 176.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.414 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -60.69 -45.13 95.38 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.252 -0.905 . . . . 33.5 110.278 178.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.055 HG13 ' HB3' ' A' ' 74' ' ' ALA . 31.7 t -57.76 -49.05 82.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 120.89 -1.131 . . . . 73.13 110.081 179.151 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -56.97 -41.31 78.12 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.072 -1.018 . . . . 70.34 109.982 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.505 ' HA ' ' HD3' ' A' ' 134' ' ' ARG . 23.3 m -62.33 -34.8 77.34 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.294 -0.878 . . . . 71.13 110.682 179.335 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.765 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.0 mtm -74.54 -37.43 63.01 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.813 -1.18 . . . . 73.34 110.347 -177.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.723 HG13 ' OG ' ' A' ' 70' ' ' SER . 77.6 t -62.71 -48.57 87.53 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 121.246 -0.908 . . . . 63.44 110.234 178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.505 ' HD3' ' HA ' ' A' ' 131' ' ' SER . 9.3 ptm180 -65.62 -38.27 88.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.056 . . . . 75.14 109.6 176.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.49 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 55.1 ttt85 -52.17 -51.35 58.57 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.528 -0.733 . . . . 74.12 110.673 178.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.683 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 24.8 m-85 -60.55 -48.77 80.31 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.993 -1.067 . . . . 65.44 110.591 -178.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.46 -44.93 72.97 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.028 -1.045 . . . . 73.15 110.424 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 17.4 tttp -60.97 -41.49 96.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.911 -1.118 . . . . 71.52 110.158 177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.49 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 5.2 mt-30 -57.54 -42.02 82.12 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.031 -1.043 . . . . 72.23 110.103 -179.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.654 ' CZ ' ' CG1' ' A' ' 58' ' ' VAL . 54.0 m-85 -60.62 -44.77 95.93 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.106 -0.996 . . . . 75.42 110.018 176.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.4 mt-30 -59.12 -51.16 71.21 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.744 -0.597 . . . . 74.43 110.529 -177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.635 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.04 -37.24 84.21 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.194 -0.941 . . . . 62.21 110.26 178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.656 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.3 p -71.43 -16.69 62.4 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.462 -0.774 . . . . 73.33 110.858 -175.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.47 26.1 74.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 108.967 -1.653 . . . . 73.22 108.967 -174.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.67 HD22 ' HB2' ' A' ' 150' ' ' ALA . 65.5 mt -83.14 130.01 35.07 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.303 -1.116 . . . . 72.43 110.419 -178.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 70.0 p -110.64 5.8 21.26 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.35 -0.844 . . . . 51.32 109.906 175.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 174.77 128.83 1.13 Allowed Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.792 -1.323 . . . . 51.2 109.792 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.746 HG21 ' HA ' ' A' ' 26' ' ' PHE . 1.8 m -84.42 173.5 7.15 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.409 -1.054 . . . . 72.02 108.545 176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.647 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 13.4 Cg_exo -67.26 143.57 67.35 Favored 'Cis proline' 0 N--CA 1.49 1.316 0 C-N-CA 122.886 -1.714 . . . . 63.12 111.45 5.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.67 ' HB2' HD22 ' A' ' 145' ' ' LEU . . . -129.86 145.85 51.59 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.989 -1.07 . . . . 41.13 109.116 168.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.947 HG22 ' OE2' ' A' ' 24' ' ' GLU . 25.8 t -123.14 123.82 68.7 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 120.873 -1.142 . . . . 63.4 109.655 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.664 HG23 ' CE1' ' A' ' 25' ' ' PHE . 12.6 t -117.93 132.15 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.157 -0.964 . . . . 64.33 110.349 -178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.743 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.3 t -112.59 134.5 54.96 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.495 -0.753 . . . . 43.32 109.583 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.549 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 49.79 27.88 2.48 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.115 -0.991 . . . . 75.34 110.044 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.428 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.6 t30 47.65 30.71 1.84 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.181 -0.949 . . . . 72.14 110.909 176.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.016 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.1 ttt-85 -152.15 -23.51 0.18 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.782 -1.199 . . . . 73.44 111.271 -176.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.847 ' CE2' HG22 ' A' ' 11' ' ' VAL . 63.9 m-85 -108.73 138.2 45.44 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.453 -1.404 . . . . 62.33 109.806 171.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.594 HD13 ' N ' ' A' ' 159' ' ' VAL . 0.2 OUTLIER -108.55 125.66 52.08 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.389 -0.82 . . . . 64.4 109.055 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.707 HG22 ' CD1' ' A' ' 177' ' ' LEU . 97.9 t -80.9 117.3 26.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 O-C-N 121.38 -0.825 . . . . 73.54 110.311 -173.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.501 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 51.8 mt-30 -81.5 -55.42 4.69 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.26 -0.9 . . . . 65.2 109.491 173.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.01 7.53 37.56 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 110.108 -1.197 . . . . 73.33 110.108 174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 50.2 tt0 -61.12 -42.21 98.11 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.01 -1.289 . . . . 73.53 110.187 -179.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.406 ' HB2' ' NE2' ' A' ' 8' ' ' HIS . 23.9 m -64.11 -33.64 76.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.273 -0.892 . . . . 60.01 110.479 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.537 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -82.78 113.73 20.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.153 -0.967 . . . . 74.42 110.787 -174.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 46.9 pttt -91.33 -7.58 50.59 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.273 -0.892 . . . . 52.44 110.058 175.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 28.8 t -127.48 144.88 51.0 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.296 -0.877 . . . . 74.23 109.999 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.82 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.0 mt -52.87 -28.13 21.63 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.079 -1.013 . . . . 62.32 111.11 -177.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.416 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.4 m-20 -57.96 -40.83 81.55 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.682 -1.261 . . . . 63.42 110.525 -179.313 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.537 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 96.3 mt-10 -81.51 -40.67 22.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.921 -1.112 . . . . 70.35 110.582 178.579 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.886 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.3 t80 -62.78 -45.08 94.33 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.008 -1.058 . . . . 75.2 109.872 177.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.756 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -60.6 -46.69 89.3 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.438 -0.789 . . . . 73.33 110.275 176.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.2 m-20 -56.74 -47.75 79.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.029 -1.045 . . . . 62.04 110.466 -177.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.668 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.86 -55.53 16.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.732 -1.23 . . . . 73.13 109.886 174.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 54.3 t -50.99 -42.28 23.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.09 -1.006 . . . . 74.22 109.771 -178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.573 ' OD1' ' CE2' ' A' ' 171' ' ' PHE . 2.6 m120 -58.93 -42.93 90.9 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.213 -0.93 . . . . 73.11 110.669 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.692 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 75.9 m-85 -69.93 -38.77 76.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.034 -1.041 . . . . 71.34 110.139 -179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -61.42 -37.63 84.22 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.118 -0.988 . . . . 71.12 109.529 176.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.549 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 11.5 mt -59.81 -32.29 70.49 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.113 -0.992 . . . . 74.22 109.543 172.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.464 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 38.4 m -73.93 -27.07 60.84 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.365 -0.834 . . . . 72.4 109.872 177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 9.1 mt -87.79 143.14 27.3 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.427 -0.795 . . . . 72.13 110.314 -176.338 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 18' ' ' SER . 4.5 ttpm? . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 117.969 -1.015 . . . . 62.05 110.175 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.247 0.546 . . . . 71.14 110.222 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.518 ' NE2' ' OE1' ' A' ' 169' ' ' GLU . 58.6 tt0 -56.76 -34.52 67.66 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.24 -0.913 . . . . 70.15 110.16 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 38.7 p90 -122.57 159.84 26.93 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.182 -0.949 . . . . 73.02 110.316 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.466 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 50.6 tttp -172.2 162.01 5.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.364 -0.835 . . . . 73.24 109.945 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 80.9 tt0 -60.48 135.23 57.69 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.124 -0.985 . . . . 63.31 110.209 178.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.66 0.75 78.44 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.591 -1.404 . . . . 64.34 109.591 -178.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.456 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -134.52 -63.87 0.7 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.114 -1.227 . . . . 75.41 110.437 -179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CE1' ' OG ' ' A' ' 163' ' ' SER . 10.8 m-70 -95.28 -15.79 22.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.217 -0.927 . . . . 74.51 109.87 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.0 p90 -156.7 171.33 20.55 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.459 -0.776 . . . . 52.33 110.593 175.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.524 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 94.7 mt-30 -123.33 157.16 33.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.56 -0.713 . . . . 73.01 109.536 174.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 5' ' ' GLU . 98.7 t -106.04 132.32 53.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.892 -1.13 . . . . 73.31 110.297 177.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.461 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 68.6 mt -106.99 145.05 32.74 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.519 -0.738 . . . . 74.24 110.456 -174.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.5 tptm -54.96 -20.86 10.01 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.153 -0.967 . . . . 72.02 109.653 173.329 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 22.3 p -44.31 143.84 1.84 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.393 -0.817 . . . . 74.55 110.441 -177.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.4 Cg_exo -58.4 140.8 95.95 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.149 1.604 . . . . 45.32 110.247 178.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.993 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.43 154.35 19.17 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 62.43 110.31 179.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.5 t -88.62 139.38 30.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.267 -0.895 . . . . 61.05 110.336 -178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.493 ' HA ' ' HD2' ' A' ' 181' ' ' LYS . 22.6 m -58.18 -35.68 71.95 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.202 -0.936 . . . . 74.34 110.129 179.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -105.33 170.7 5.64 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.334 -0.854 . . . . 74.11 109.85 177.736 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.463 ' HD2' ' HB3' ' A' ' 19' ' ' SER . 57.2 Cg_endo -71.65 125.35 11.05 Favored 'Trans proline' 0 C--N 1.303 -1.847 0 O-C-N 123.933 1.491 . . . . 73.34 110.063 -178.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.574 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -146.28 136.83 18.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 O-C-N 120.817 -1.177 . . . . 74.23 109.976 172.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.615 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.7 t -121.87 129.75 75.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 O-C-N 121.236 -0.915 . . . . 63.13 109.789 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 9.4 t -125.99 136.8 53.4 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.952 -1.093 . . . . 65.13 110.263 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.779 ' OE2' HG22 ' A' ' 151' ' ' VAL . 37.3 tp10 -106.19 131.96 52.82 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.238 -0.914 . . . . 74.51 110.466 178.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.55 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 85.2 m-85 -100.08 125.38 46.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.299 -0.876 . . . . 73.45 109.816 177.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 39.5 p90 -143.95 167.12 23.1 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.513 -0.742 . . . . 70.32 110.684 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.579 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 36.0 t -135.25 136.23 41.54 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.276 -0.89 . . . . 72.13 110.489 178.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.692 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.2 m-85 -58.4 -21.07 49.25 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.208 -0.932 . . . . 73.24 110.717 178.213 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.576 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 20.2 m-85 -97.94 15.43 23.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.002 -1.062 . . . . 74.32 111.406 -172.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CE ' ' A' ' 61' ' ' MET . 1.2 m -116.84 107.76 45.67 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.867 -1.146 . . . . 34.41 110.24 -179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.497 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.64 -42.81 50.35 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.91 1.479 . . . . 74.12 109.822 178.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 -59.12 -47.28 85.87 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.066 -1.021 . . . . 75.33 109.836 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.492 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 95.6 m -64.95 -40.21 94.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.113 -0.992 . . . . 63.23 110.292 177.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 28.8 t-20 -54.31 -42.63 70.35 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.171 -0.956 . . . . 64.23 110.367 179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 47.4 m -70.47 -41.19 73.06 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.182 -0.949 . . . . 63.24 110.602 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.759 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.7 t80 -66.23 -36.75 83.83 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.328 -0.857 . . . . 71.51 110.946 -175.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -41.5 -56.14 4.87 Favored Pre-proline 0 N--CA 1.494 1.758 0 O-C-N 121.004 -1.06 . . . . 62.11 110.705 -173.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 50.4 Cg_exo -45.75 -50.35 9.67 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.675 1.355 . . . . 75.43 110.499 178.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.52 HG23 HD21 ' A' ' 167' ' ' LEU . 89.1 mt -53.44 -47.49 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.943 -1.098 . . . . 74.02 110.255 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.759 HD11 ' CE2' ' A' ' 36' ' ' PHE . 23.7 mm -55.69 -40.71 61.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 120.886 -1.134 . . . . 72.13 110.191 177.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -59.06 -36.66 75.43 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.887 -1.133 . . . . 51.33 109.698 176.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.827 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.7 mt-30 -59.01 -42.0 89.05 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 70.1 109.307 176.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.739 HD12 ' CD1' ' A' ' 171' ' ' PHE . 41.7 tp -60.24 -40.51 90.5 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.357 -0.839 . . . . 74.23 110.345 176.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.778 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttt -55.89 -50.76 69.76 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.339 -0.85 . . . . 73.34 110.141 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 53.9 mt-30 -62.94 -36.78 84.58 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.446 -0.784 . . . . 62.41 109.529 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.1 mt-30 -77.27 -31.05 54.63 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.673 -0.642 . . . . 72.04 110.408 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.778 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -52.94 139.35 43.27 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.236 -0.915 . . . . 64.42 110.24 -176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 21.6 Cg_exo -60.66 142.48 97.94 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.004 1.528 . . . . 71.22 110.069 -179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.31 -34.54 66.62 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.204 -0.935 . . . . 75.11 109.858 178.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.25 -39.01 95.42 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.414 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.34 141.04 47.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.1 -1.235 . . . . 72.11 110.46 -178.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.463 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.6 mttt -96.27 154.26 17.35 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.52 -0.738 . . . . 74.11 109.471 175.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.63 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 48.8 t80 -123.47 159.9 28.07 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.827 -1.171 . . . . 64.12 110.676 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.615 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.3 mt-30 -143.85 161.86 37.56 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 121.751 0.786 . . . . 74.24 110.519 -176.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 36.4 mttt -129.03 140.46 51.61 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.291 -0.881 . . . . 74.21 110.139 178.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.55 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 1.2 m-20 -138.99 136.4 35.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.355 -0.841 . . . . 65.33 110.145 -178.68 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.613 ' CD2' ' CD2' ' A' ' 136' ' ' PHE . 4.0 p-80 -112.65 133.38 54.71 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.998 -1.064 . . . . 75.14 109.939 177.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.7 m -99.89 132.08 46.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.097 -1.002 . . . . 64.32 110.597 -176.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.459 ' HG ' ' HG ' ' A' ' 70' ' ' SER . 71.8 m -93.61 -8.42 41.17 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.333 -0.855 . . . . 63.24 110.129 175.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.636 ' CE2' ' CG ' ' A' ' 61' ' ' MET . 0.1 OUTLIER -63.0 -38.34 90.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.977 -1.077 . . . . 61.33 110.306 -174.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.636 ' CG ' ' CE2' ' A' ' 60' ' ' PHE . 34.1 mtm -73.61 -35.36 65.36 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.791 -1.193 . . . . 73.12 110.11 173.062 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.88 -40.07 80.01 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.926 -1.27 . . . . 64.31 109.926 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.14 -147.04 18.46 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.293 -1.523 . . . . 34.13 109.293 -177.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.25 -36.5 63.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.05 -1.265 . . . . 73.2 111.005 -177.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.55 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.7 ttt -92.96 5.82 50.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.906 -1.121 . . . . 71.21 110.715 -176.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' O ' ' OG ' ' A' ' 59' ' ' SER . . . -57.29 -42.9 93.77 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.216 -1.554 . . . . 72.02 109.216 179.344 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -57.43 -39.52 76.41 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.203 -1.175 . . . . 62.31 110.219 178.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.12 -44.95 94.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.111 -0.993 . . . . 45.42 110.295 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.576 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 95.5 mmm -59.55 -43.44 93.52 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.025 -1.047 . . . . 73.04 110.497 -178.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.58 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 54.1 m -61.27 -47.85 84.1 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.989 -1.07 . . . . 75.43 110.224 178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.919 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.0 mttt -59.45 -34.07 72.06 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.061 -1.024 . . . . 63.13 110.26 177.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.49 -50.14 73.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.028 -1.045 . . . . 61.33 110.202 -178.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.45 ' CE2' HD11 ' A' ' 77' ' ' ILE . 84.6 t80 -56.7 -44.41 81.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.936 -1.102 . . . . 54.21 110.019 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.007 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.93 -39.24 91.35 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.991 -1.068 . . . . 72.31 109.994 178.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.777 HG23 ' HB3' ' A' ' 123' ' ' ALA . 34.7 m -58.14 -43.27 87.2 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.196 -0.94 . . . . 62.21 109.772 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.546 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 46.1 mtt -55.49 -41.99 73.79 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.018 -1.052 . . . . 71.04 108.837 177.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.982 HD12 ' HA ' ' A' ' 74' ' ' ALA . 85.6 mt -58.32 -45.53 89.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.472 -0.768 . . . . 73.32 110.208 -178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.483 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.26 -37.2 74.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.031 -1.043 . . . . 75.32 110.45 177.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.927 ' O ' HG13 ' A' ' 81' ' ' VAL . 18.8 mt -89.27 7.4 35.71 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.064 -1.023 . . . . 54.3 110.908 -176.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 56.34 29.57 15.31 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.934 -1.104 . . . . 73.12 109.866 -176.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.927 HG13 ' O ' ' A' ' 79' ' ' LEU . 12.8 m -119.63 21.48 5.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.522 -0.736 . . . . 73.32 110.895 -176.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 8.2 mp0 -56.17 -53.47 56.72 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.756 -1.215 . . . . 71.25 110.161 -177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . 0.469 ' O ' ' CD ' ' A' ' 87' ' ' PRO . 92.2 m-20 -54.95 -42.09 71.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 73.11 110.537 -178.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.754 ' O ' HG23 ' A' ' 88' ' ' VAL . 47.2 tttm -70.35 -49.37 49.96 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.235 -0.916 . . . . 73.02 111.291 -175.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.572 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -85.59 -28.51 24.78 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.166 -0.959 . . . . 64.51 110.932 -174.317 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.1 t -52.87 -57.36 16.42 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 120.948 -1.095 . . . . 74.4 109.743 -175.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.3 Cg_endo -64.88 -25.8 59.82 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.345 1.181 . . . . 74.12 111.189 176.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.754 HG23 ' O ' ' A' ' 84' ' ' LYS . 58.4 t -60.77 -42.91 94.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.711 -1.243 . . . . 63.33 109.538 177.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.626 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 80.3 mmm -66.21 -43.96 85.24 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.305 -0.872 . . . . 74.03 109.86 178.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.692 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.9 m-85 -69.21 -36.09 76.89 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.871 -1.143 . . . . 75.45 110.521 178.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.543 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.9 t30 -60.24 -64.0 1.1 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.166 -0.959 . . . . 74.35 109.591 173.255 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.648 ' CA ' HD12 ' A' ' 96' ' ' LEU . 55.7 ttm-85 -49.32 -36.45 21.17 Favored 'General case' 0 C--N 1.294 -1.837 0 O-C-N 121.461 -0.774 . . . . 75.14 110.734 -172.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.539 HD13 ' HB3' ' A' ' 99' ' ' PRO . 5.0 mm -68.83 -58.76 4.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.977 -1.077 . . . . 72.45 110.924 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -82.89 -11.2 58.39 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.27 -0.894 . . . . 72.44 110.119 -176.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.543 ' N ' ' O ' ' A' ' 91' ' ' ASN . 7.1 m -114.36 -65.52 1.18 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.479 -0.763 . . . . 71.11 109.988 -175.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.648 HD12 ' CA ' ' A' ' 92' ' ' ARG . 16.6 mt -77.22 -2.09 32.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.363 -0.836 . . . . 74.4 109.972 177.072 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.527 ' N ' ' O ' ' A' ' 92' ' ' ARG . 47.1 ptt85 36.15 30.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.398 0.618 . . . . 74.14 110.646 -176.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.504 ' N ' ' O ' ' A' ' 96' ' ' LEU . 0.0 OUTLIER -123.14 74.78 50.04 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.398 -0.814 . . . . 74.35 110.045 179.384 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.2 Cg_endo -63.0 148.5 93.42 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.008 1.531 . . . . 71.45 110.262 -179.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.732 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.7 Cg_exo -52.94 112.48 0.93 Allowed 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.993 1.522 . . . . 74.43 110.324 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.512 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 23.2 tptm -60.58 -46.58 89.69 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.402 -0.811 . . . . 72.31 110.275 178.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.459 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -143.93 -173.36 3.97 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.5 -0.75 . . . . 74.51 109.491 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.92 -30.98 68.25 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 120.95 -1.094 . . . . 71.33 109.652 171.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 93.1 mt-30 -69.57 -52.86 22.31 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.133 -0.979 . . . . 74.55 111.348 -176.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.512 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 74.1 mm-40 -61.5 -36.37 80.31 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.672 -1.268 . . . . 65.14 109.121 177.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.019 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.9 tp -60.03 -43.25 95.44 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.474 -0.766 . . . . 54.15 110.139 176.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 56.0 ttp180 -59.95 -44.97 94.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.935 -1.103 . . . . 71.3 110.402 178.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -59.15 -40.5 85.73 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.113 -0.992 . . . . 71.4 110.194 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.019 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.6 mt -54.39 -47.78 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.095 -1.003 . . . . 73.2 109.72 179.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.687 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 10.6 m-85 -57.51 -52.72 64.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.131 -0.981 . . . . 53.42 110.613 178.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.881 HD21 ' HA ' ' A' ' 117' ' ' ALA . 93.6 mt -58.73 -41.05 85.53 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.992 -1.068 . . . . 73.51 110.208 -178.455 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.05 -38.78 76.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.916 -1.115 . . . . 73.05 110.558 177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.481 ' HG2' ' O ' ' A' ' 109' ' ' ILE . 75.8 mm-40 -69.22 -1.61 8.41 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.206 -0.934 . . . . 73.24 111.202 -176.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.27 6.7 44.56 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.465 -1.454 . . . . 72.31 109.465 -177.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.532 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 27.8 mm -81.72 147.86 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.21 -1.17 . . . . 54.14 109.765 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.526 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.42 141.08 30.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.118 -0.989 . . . . 71.24 109.723 177.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.881 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -63.38 -32.96 74.53 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.931 -1.106 . . . . 52.22 109.446 177.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.66 -50.27 69.95 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.419 -0.801 . . . . 63.11 111.022 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.829 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.54 -36.04 60.55 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.895 -1.128 . . . . 72.34 110.561 -175.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.746 ' HA ' HD11 ' A' ' 79' ' ' LEU . 86.6 t80 -61.34 -41.46 97.09 Favored 'General case' 0 C--N 1.303 -1.419 0 O-C-N 120.931 -1.106 . . . . 70.24 109.997 175.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.423 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.1 m-20 -61.42 -42.42 98.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.306 -0.871 . . . . 64.24 109.738 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.54 -37.62 86.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.203 -0.936 . . . . 73.33 110.191 178.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.777 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.48 -45.36 54.53 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.198 -0.939 . . . . 73.34 110.84 -175.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 57.1 t80 -61.22 -31.87 71.65 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.255 -0.903 . . . . 72.34 109.539 178.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -92.63 4.54 53.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 74.35 110.201 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -76.72 130.26 10.46 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.659 -1.376 . . . . 43.32 109.659 -178.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.61 -30.07 65.03 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.06 -1.259 . . . . 74.21 109.764 176.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.454 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.12 -52.05 67.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.128 -0.983 . . . . 33.5 110.045 178.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.007 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.0 t -55.44 -46.28 78.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 120.796 -1.19 . . . . 73.13 109.728 175.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.474 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.6 m-20 -55.31 -41.41 72.35 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.317 -0.864 . . . . 70.34 110.261 -178.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -61.03 -36.91 80.79 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.159 -0.963 . . . . 71.13 110.308 179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.528 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.9 mpp? -74.52 -34.73 63.1 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.023 -1.048 . . . . 73.34 110.796 -176.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.919 HG21 ' HG2' ' A' ' 71' ' ' LYS . 11.9 t -61.44 -44.97 99.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 O-C-N 120.897 -1.127 . . . . 63.44 109.289 177.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 87.3 mtt180 -62.34 -41.02 98.24 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 120.872 -1.142 . . . . 75.14 109.448 173.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 70.4 ttt180 -54.23 -52.83 60.08 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.754 -0.591 . . . . 74.12 111.234 -175.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.7 p90 -67.46 -41.35 84.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.739 -1.226 . . . . 65.44 110.466 -177.309 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.4 t0 -57.99 -47.46 82.94 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.893 -1.129 . . . . 73.15 110.343 -177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 44.6 tttm -62.04 -42.1 98.81 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.082 -1.012 . . . . 71.52 110.329 178.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.488 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 8.3 mm100 -58.28 -47.48 83.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.978 -1.077 . . . . 72.23 110.458 -176.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.753 ' HA ' HD12 ' A' ' 145' ' ' LEU . 51.5 t80 -65.37 -40.61 93.76 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.291 -0.881 . . . . 75.42 109.952 -178.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.1 mt-30 -62.62 -51.09 68.67 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 120.382 -0.527 . . . . 74.43 110.584 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.7 m-20 -62.55 -38.26 89.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.195 -0.941 . . . . 62.21 109.725 177.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.601 ' HA ' HG21 ' A' ' 14' ' ' THR . 3.9 t -59.57 -26.2 65.19 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.622 -0.674 . . . . 73.33 110.498 -179.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.2 20.73 76.82 Favored Glycine 0 N--CA 1.483 1.78 0 N-CA-C 108.771 -1.732 . . . . 73.22 108.771 -171.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.866 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.3 mt -64.23 128.77 37.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.163 -1.198 . . . . 72.43 110.612 -177.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 48.3 m -69.12 -36.37 77.43 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.128 -0.983 . . . . 51.32 109.587 172.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.556 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . -179.19 -173.93 44.86 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.895 -1.282 . . . . 51.2 109.895 179.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.606 HG23 ' HE1' ' A' ' 61' ' ' MET . 4.3 m -110.96 165.7 12.18 Favored Pre-proline 0 N--CA 1.495 1.775 0 O-C-N 121.418 -1.048 . . . . 72.02 109.444 178.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.4 Cg_exo -70.35 130.9 18.38 Favored 'Cis proline' 0 N--CA 1.491 1.358 0 C-N-CA 122.767 -1.764 . . . . 63.12 111.524 5.393 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.866 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -122.76 131.44 53.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.382 -0.824 . . . . 41.13 109.499 173.059 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.058 HG21 ' OH ' ' A' ' 170' ' ' TYR . 16.5 t -110.42 122.05 64.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.949 -1.094 . . . . 63.4 109.757 -179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.405 HG12 ' HA ' ' A' ' 155' ' ' ASN . 15.4 t -111.78 132.05 61.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.091 -1.006 . . . . 64.33 110.258 -179.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.806 HG11 ' HB2' ' A' ' 177' ' ' LEU . 6.0 t -111.13 135.22 50.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.444 -0.785 . . . . 43.32 109.577 178.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.553 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 49.63 25.68 1.54 Allowed 'General case' 0 C--N 1.299 -1.596 0 O-C-N 120.964 -1.085 . . . . 75.34 109.947 -175.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.405 ' HA ' HG12 ' A' ' 152' ' ' VAL . 3.8 t30 48.17 31.47 2.58 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.239 -0.913 . . . . 72.14 110.778 177.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.993 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 68.5 ttt180 -154.87 -23.86 0.12 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.893 -1.13 . . . . 73.44 111.11 -178.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.978 ' HB3' HD22 ' A' ' 177' ' ' LEU . 25.5 m-85 -107.39 138.71 43.1 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.488 -1.382 . . . . 62.33 109.588 170.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 151' ' ' VAL . 2.0 tp -114.52 127.9 56.05 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.102 -0.999 . . . . 64.4 109.555 -177.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.745 HG21 HG22 ' A' ' 174' ' ' VAL . 44.3 t -81.85 112.76 20.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 119.829 -0.748 . . . . 73.54 110.474 -173.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.524 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.8 mt-30 -74.89 -49.82 19.06 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.239 -0.913 . . . . 65.2 109.508 172.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 63.96 10.12 37.85 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.822 -1.311 . . . . 73.33 109.822 177.571 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -62.57 -37.26 85.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.128 -1.219 . . . . 73.53 110.361 -178.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.577 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 57.2 p -86.72 -1.89 58.09 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.258 -0.901 . . . . 60.01 110.485 -178.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.506 ' HA ' ' CB ' ' A' ' 169' ' ' GLU . . . -80.03 100.42 8.15 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.239 -0.913 . . . . 74.42 110.308 -178.201 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 83.8 mttt -61.54 -31.11 71.12 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.85 . . . . 52.44 110.228 178.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.1 p -147.05 170.34 17.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.237 -0.914 . . . . 74.23 109.806 -178.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.827 HD11 ' NE2' ' A' ' 42' ' ' GLN . 50.4 mt -52.53 -27.11 15.21 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.069 -1.019 . . . . 62.32 110.772 -178.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -58.31 -41.4 84.42 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 120.709 -1.245 . . . . 63.42 110.381 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.518 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 74.0 mm-40 -78.99 -43.29 24.69 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.821 -1.174 . . . . 70.35 110.514 178.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 1.058 ' OH ' HG21 ' A' ' 151' ' ' VAL . 86.1 t80 -62.45 -44.88 95.35 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.192 -0.942 . . . . 75.2 109.95 178.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.739 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.3 t80 -61.08 -45.64 93.9 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.455 -0.778 . . . . 73.33 110.292 176.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.556 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -57.32 -50.84 71.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 62.04 110.494 -177.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.652 HD11 HD11 ' A' ' 177' ' ' LEU . 4.8 tp -50.12 -55.9 13.13 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.786 -1.196 . . . . 73.13 109.956 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.745 HG22 HG21 ' A' ' 159' ' ' VAL . 54.7 t -50.65 -42.48 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.011 -1.055 . . . . 74.22 109.774 -178.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.698 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.7 m120 -58.73 -42.77 89.53 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.196 -0.94 . . . . 73.11 110.761 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 77.1 m-85 -71.23 -39.61 71.57 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 71.34 110.148 -179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.978 HD22 ' HB3' ' A' ' 157' ' ' TYR . 80.6 mt -58.62 -36.7 74.47 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.105 -0.997 . . . . 71.12 109.435 175.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -58.39 -30.05 66.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.233 -0.917 . . . . 74.22 109.942 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -93.02 -1.8 56.29 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.281 -0.887 . . . . 72.4 110.314 -179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.968 HD12 ' HA ' ' A' ' 177' ' ' LEU . 36.5 mt -97.03 139.41 33.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.213 -0.93 . . . . 72.13 110.275 179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.515 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 36.2 ttpt . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 118.022 -0.989 . . . . 62.05 110.224 -179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.247 0.546 . . . . 71.14 110.194 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.576 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.02 -33.59 70.92 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.287 -0.883 . . . . 70.15 110.291 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.5 p90 -127.19 161.15 29.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -0.951 . . . . 73.02 110.405 -178.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 21.7 tttm -163.51 146.25 9.97 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 73.24 109.931 179.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.742 ' OE2' HG21 ' A' ' 11' ' ' VAL . 81.2 tt0 -57.47 134.93 56.5 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.029 -1.045 . . . . 63.31 109.944 179.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.48 1.98 77.16 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -176.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -137.67 -50.94 0.62 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -1.196 . . . . 75.41 110.381 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.823 ' HB3' HD22 ' A' ' 173' ' ' LEU . 7.4 m-70 -100.1 -17.17 17.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.245 -0.909 . . . . 74.51 109.811 177.562 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.586 ' CD1' ' CD1' ' A' ' 173' ' ' LEU . 37.4 p90 -155.88 169.97 23.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.369 -0.832 . . . . 52.33 110.508 174.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -124.45 150.16 46.0 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.637 -0.664 . . . . 73.01 109.446 175.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.827 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.7 t -97.66 133.08 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 120.923 -1.111 . . . . 73.31 110.716 -176.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.794 HD13 ' HA ' ' A' ' 143' ' ' SER . 55.5 mt -99.81 149.6 23.2 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.759 -0.588 . . . . 74.24 110.44 -178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 31.0 mmtt -76.66 1.04 18.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.2 -0.938 . . . . 72.02 109.743 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.523 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 69.4 p -63.5 159.59 49.88 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.307 -0.87 . . . . 74.55 110.37 -179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' O ' ' O ' ' A' ' 155' ' ' ASN . 16.3 Cg_endo -62.38 141.16 86.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.07 1.563 . . . . 45.32 110.442 179.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.671 ' HB2' ' HD3' ' A' ' 156' ' ' ARG . . . -101.99 159.19 15.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.89 . . . . 62.43 110.055 177.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 31.5 t -89.18 141.67 28.31 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 61.05 110.263 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.5 p -59.41 -29.53 67.81 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 74.34 109.843 179.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.423 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.4 OUTLIER -116.56 172.16 4.1 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.353 -0.842 . . . . 74.11 109.52 175.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.712 ' HB2' HD22 ' A' ' 178' ' ' LEU . 56.1 Cg_endo -69.98 128.53 15.96 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 123.846 1.445 . . . . 73.34 109.939 -179.473 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.52 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.9 p -149.33 135.77 12.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 120.802 -1.186 . . . . 74.23 109.796 171.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.574 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.7 t -118.86 129.45 75.04 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 120.925 -1.109 . . . . 63.13 109.952 -176.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 89.6 p -117.24 134.37 54.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.05 -1.031 . . . . 65.13 110.183 -179.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.897 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -103.68 130.16 51.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.868 . . . . 74.51 110.119 176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.624 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 24.7 m-85 -102.81 124.03 47.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.306 -0.871 . . . . 73.45 109.843 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.634 ' O ' HG22 ' A' ' 58' ' ' VAL . 50.8 p90 -141.5 167.09 22.99 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.5 -0.75 . . . . 70.32 111.353 -177.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.54 ' HB3' HG21 ' A' ' 58' ' ' VAL . 55.2 p -135.42 140.99 45.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.585 -0.697 . . . . 72.13 110.34 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.5 m-85 -58.99 -24.11 62.44 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.224 -0.923 . . . . 73.24 110.49 175.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.681 ' HA ' HG21 ' A' ' 93' ' ' ILE . 68.0 m-85 -100.35 19.64 16.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.195 -0.941 . . . . 74.32 111.072 -171.142 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 48.3 t -127.46 94.71 37.48 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 120.983 -1.073 . . . . 34.41 110.191 -178.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.686 ' O ' HG23 ' A' ' 35' ' ' THR . 39.9 Cg_exo -51.2 -33.73 45.68 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.033 1.544 . . . . 74.12 109.905 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.437 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 66.1 m170 -59.48 -47.28 86.11 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.075 -1.015 . . . . 75.33 109.959 175.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.9 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 22.6 m -66.42 -43.6 85.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.125 -0.984 . . . . 63.23 110.139 178.555 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.455 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 60.7 t-20 -55.96 -39.22 71.45 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.208 -0.933 . . . . 64.23 110.611 -178.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.686 HG23 ' O ' ' A' ' 31' ' ' PRO . 44.6 p -76.11 -37.09 58.52 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.028 -1.045 . . . . 63.24 110.499 -179.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.892 ' CE2' HD11 ' A' ' 40' ' ' ILE . 66.2 t80 -67.91 -35.08 77.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.342 -0.849 . . . . 71.51 110.671 -177.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.51 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.05 -55.84 4.56 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.056 -1.027 . . . . 62.11 110.732 -174.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -43.88 -53.24 4.72 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.751 1.395 . . . . 75.43 110.646 179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.525 HG23 HD21 ' A' ' 167' ' ' LEU . 88.8 mt -54.26 -46.54 68.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 120.945 -1.097 . . . . 74.02 110.16 179.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.897 HG21 ' OE1' ' A' ' 24' ' ' GLU . 37.7 mm -56.01 -39.84 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.002 -1.061 . . . . 72.13 110.052 176.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.53 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.42 -39.12 75.52 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.067 -1.02 . . . . 51.33 109.495 176.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.464 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 13.7 mt-30 -59.27 -42.12 90.48 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.134 -0.979 . . . . 70.1 109.523 176.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.697 HD12 ' CD1' ' A' ' 171' ' ' PHE . 55.4 tp -61.37 -40.52 94.6 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.329 -0.857 . . . . 74.23 110.276 177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.785 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.3 mttt -57.79 -50.8 72.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.382 -0.824 . . . . 73.34 110.16 -179.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -63.09 -36.28 83.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.645 0.736 . . . . 62.41 109.473 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.62 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 47.2 mt-30 -79.36 -27.91 41.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.603 -0.686 . . . . 72.04 110.236 179.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.785 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.1 mt -49.66 142.98 11.48 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.221 -0.924 . . . . 64.42 110.093 -177.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.8 Cg_exo -61.92 142.12 91.99 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.01 1.531 . . . . 71.22 110.097 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -55.75 -35.6 66.36 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 75.11 109.619 177.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.52 -36.86 93.22 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.643 -1.383 . . . . 71.01 109.643 177.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.49 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -74.49 135.34 42.24 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.26 . . . . 72.11 110.496 -177.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 79.9 mttt -95.23 159.19 15.13 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.541 -0.724 . . . . 74.11 109.765 175.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.576 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 43.3 t80 -125.42 159.19 32.49 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.792 -1.192 . . . . 64.12 110.762 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.574 ' N ' ' O ' ' A' ' 22' ' ' VAL . 95.6 mt-30 -142.58 161.6 37.64 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 74.24 110.731 -175.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.566 ' HE3' ' CE1' ' A' ' 73' ' ' TYR . 4.8 ttpt -124.89 135.53 52.95 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.358 -0.839 . . . . 74.21 110.503 178.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 11.9 t-20 -127.39 135.43 50.46 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 65.33 110.578 -177.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.68 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -107.68 121.68 45.17 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.981 -1.074 . . . . 75.14 109.591 175.798 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.634 HG22 ' O ' ' A' ' 26' ' ' PHE . 35.5 m -78.91 132.27 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.883 -1.136 . . . . 64.32 110.286 177.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 58.4 p -93.51 -11.52 31.76 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.19 -0.944 . . . . 63.24 110.413 175.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.591 ' CE2' ' HB ' ' A' ' 58' ' ' VAL . 15.2 p90 -77.56 -29.91 52.38 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.659 -1.276 . . . . 61.33 110.131 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.624 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.0 mmm -64.67 -38.99 92.89 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.203 -0.936 . . . . 73.12 110.18 174.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -66.15 -44.81 90.38 Favored Glycine 0 N--CA 1.489 2.204 0 N-CA-C 109.75 -1.34 . . . . 64.31 109.75 -179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.57 -139.84 14.65 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.257 -1.537 . . . . 34.13 109.257 -177.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 46.8 t-20 -54.19 -37.76 64.88 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.038 -1.272 . . . . 73.2 110.645 179.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -93.38 8.0 42.2 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.097 -1.002 . . . . 71.21 110.597 -177.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -57.2 -41.76 92.99 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.559 -1.416 . . . . 72.02 109.559 -179.308 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.29 -41.44 84.42 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.151 -1.205 . . . . 62.31 110.257 179.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.405 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.79 -47.3 81.47 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.171 -0.956 . . . . 45.42 110.311 -179.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 95.4 mmm -59.77 -41.5 91.19 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.097 -1.002 . . . . 73.04 110.554 -178.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.609 ' OG ' HG13 ' A' ' 133' ' ' VAL . 21.2 t -60.05 -49.66 76.78 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.1 -1.0 . . . . 75.43 110.155 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.752 ' HG2' HG21 ' A' ' 133' ' ' VAL . 30.9 mtpt -58.78 -34.44 71.45 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.013 -1.054 . . . . 63.13 110.234 177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.452 ' O ' ' SD ' ' A' ' 76' ' ' MET . . . -63.47 -52.69 60.29 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.074 -1.016 . . . . 61.33 110.372 -177.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.566 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 0.3 OUTLIER -53.71 -44.75 70.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.938 -1.101 . . . . 54.21 109.378 178.048 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.072 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.32 -38.66 90.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.926 -1.109 . . . . 72.31 110.077 176.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.681 HG23 ' HB3' ' A' ' 123' ' ' ALA . 33.5 m -57.38 -43.47 83.61 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.164 -0.96 . . . . 62.21 109.764 177.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.555 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 0.6 OUTLIER -56.87 -43.02 80.83 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.122 -0.986 . . . . 71.04 109.379 175.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 98.6 mt -57.01 -45.14 83.77 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 C-N-CA 119.828 -0.749 . . . . 73.32 110.08 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.436 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.7 -38.4 78.2 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.106 -0.996 . . . . 75.32 110.473 177.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.006 HD13 ' CD ' ' A' ' 119' ' ' LYS . 19.6 mt -87.31 8.13 25.67 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.126 -0.983 . . . . 54.3 110.847 -176.334 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.471 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.8 tt0 57.82 28.84 16.58 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.876 -1.14 . . . . 73.12 109.712 -177.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.836 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -118.89 14.96 6.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.346 -0.846 . . . . 73.32 110.932 -177.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.598 ' O ' HG23 ' A' ' 86' ' ' VAL . 9.6 mt-10 -42.65 -77.12 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.075 -1.016 . . . . 71.25 110.231 177.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -53.38 -35.01 59.87 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.149 -0.969 . . . . 73.11 110.664 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.2 tttp -56.93 -43.01 81.05 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.965 -1.084 . . . . 73.02 111.183 -171.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.4 ppp? -126.16 -3.8 6.88 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.994 -1.066 . . . . 64.51 110.721 -177.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -52.61 -45.81 96.03 Favored Pre-proline 0 C--N 1.297 -1.688 0 O-C-N 120.731 -1.231 . . . . 74.4 109.276 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.54 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.72 -28.12 85.97 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.294 1.155 . . . . 74.12 110.485 174.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.78 HG11 ' OE2' ' A' ' 113' ' ' GLU . 44.7 t -64.77 -41.01 91.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.905 -1.122 . . . . 63.33 109.613 179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 82.6 mmm -59.21 -42.25 90.52 Favored 'General case' 0 C--N 1.299 -1.629 0 C-N-CA 119.202 -0.999 . . . . 74.03 109.465 176.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.688 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -70.64 -47.87 57.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.805 -1.185 . . . . 75.45 110.751 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.52 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.6 t30 -56.75 -42.59 79.58 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.217 -0.927 . . . . 74.35 109.813 177.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 22.1 tpt180 -57.61 -37.29 73.0 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.305 -0.872 . . . . 75.14 109.424 175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -89.5 -70.05 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.456 -0.777 . . . . 72.45 110.871 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.566 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 12.1 t-80 -66.97 -17.03 64.73 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.145 -0.972 . . . . 72.44 110.989 -172.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.628 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -116.56 -70.99 0.76 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.088 -1.008 . . . . 71.11 110.159 -175.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 86.1 mt -58.37 -25.6 62.22 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.233 -0.917 . . . . 74.4 109.981 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 58.9 ttt180 61.69 31.44 18.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.377 -0.827 . . . . 74.14 109.996 -178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.2 OUTLIER -125.04 73.44 65.68 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.354 -0.841 . . . . 74.35 110.028 178.034 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.416 ' HB3' HD13 ' A' ' 93' ' ' ILE . 15.9 Cg_endo -62.71 143.44 92.21 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.906 1.477 . . . . 71.45 110.26 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.544 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 38.8 Cg_exo -55.01 133.08 56.13 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 123.913 1.481 . . . . 74.43 110.165 -178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 0.9 OUTLIER -100.42 -25.89 14.06 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.212 -0.93 . . . . 72.31 110.331 -178.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.468 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 67.4 m-20 -142.85 168.65 19.22 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.161 -0.962 . . . . 74.51 109.561 179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.473 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.8 mt-10 -57.37 -29.79 64.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 120.891 -1.13 . . . . 71.33 109.381 173.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -67.15 -51.07 58.29 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 74.55 111.094 -176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.487 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -61.89 -36.25 80.73 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.856 -1.153 . . . . 65.14 109.139 176.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.997 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.1 tp -60.69 -42.84 97.95 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.504 -0.748 . . . . 54.15 110.035 177.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 73.8 mtp180 -59.19 -44.72 92.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.878 -1.139 . . . . 71.3 110.468 176.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -59.81 -39.73 86.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.175 -0.953 . . . . 71.4 110.383 -179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.997 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.7 mt -55.2 -50.03 67.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.134 -0.978 . . . . 73.2 110.075 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' CZ ' ' SD ' ' A' ' 76' ' ' MET . 33.5 m-85 -59.93 -50.66 72.88 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.107 -0.996 . . . . 53.42 110.578 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.864 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -62.17 -39.97 94.44 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 120.993 -1.067 . . . . 73.51 110.335 -175.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -59.11 -40.13 84.44 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.063 -1.023 . . . . 73.05 110.399 178.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.78 ' OE2' HG11 ' A' ' 88' ' ' VAL . 0.1 OUTLIER -67.01 -4.4 9.62 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.386 -0.821 . . . . 73.24 111.133 -176.716 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 105.85 11.74 27.65 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.692 -1.363 . . . . 72.31 109.692 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 75.5 mt -96.11 151.96 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.106 -1.231 . . . . 54.14 110.188 178.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.521 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -86.82 142.72 27.88 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.02 -1.05 . . . . 71.24 110.238 -176.147 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.864 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.29 -32.75 74.34 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.105 -0.997 . . . . 52.22 109.39 177.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.1 -48.97 74.07 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.474 -0.766 . . . . 63.11 110.823 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 1.006 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.97 -35.81 59.49 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.816 -1.178 . . . . 72.34 110.375 -176.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.901 ' HA ' HD11 ' A' ' 79' ' ' LEU . 79.9 t80 -60.07 -42.84 95.43 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 120.887 -1.133 . . . . 70.24 110.103 174.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.42 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 90.9 m-20 -61.04 -42.58 98.74 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.213 -0.929 . . . . 64.24 109.615 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.465 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.52 -35.14 75.26 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.221 -0.924 . . . . 73.33 110.212 177.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.681 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -79.57 -44.1 21.72 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.026 -1.046 . . . . 73.34 110.895 -175.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 75.0 t80 -58.54 -33.56 70.03 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.17 -0.956 . . . . 72.34 109.716 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.465 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 31.6 p-10 -101.95 10.54 39.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.335 -0.853 . . . . 74.35 109.865 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 135.84 22.74 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.399 -1.481 . . . . 43.32 109.399 178.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.01 -39.3 68.94 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.229 -1.159 . . . . 74.21 110.079 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.07 75.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.098 -1.001 . . . . 33.5 110.691 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.072 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.7 t -58.51 -49.86 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 120.717 -1.239 . . . . 73.13 110.144 -178.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.49 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 20.5 t70 -56.81 -40.93 76.89 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.083 -1.011 . . . . 70.34 109.724 -177.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 21.8 m -59.9 -37.43 79.39 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.203 -0.936 . . . . 71.13 110.355 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.34 -37.67 66.02 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.914 -1.117 . . . . 73.34 110.643 -175.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.752 HG21 ' HG2' ' A' ' 71' ' ' LYS . 89.5 t -59.85 -43.96 93.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.788 0 O-C-N 121.112 -0.992 . . . . 63.44 109.808 178.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.2 mtm180 -62.39 -45.06 94.85 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.058 -1.026 . . . . 75.14 109.682 176.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.496 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.9 ttt180 -51.33 -48.87 62.28 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.706 -0.621 . . . . 74.12 110.82 178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.68 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.1 m-85 -62.93 -49.58 74.22 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.138 -0.976 . . . . 65.44 110.759 -176.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.45 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 91.4 m-20 -57.54 -44.56 85.27 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.927 -1.108 . . . . 73.15 110.33 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 55.4 tttt -61.66 -42.9 99.55 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.051 -1.031 . . . . 71.52 110.434 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.527 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 4.0 mm-40 -58.93 -46.01 89.0 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.962 -1.086 . . . . 72.23 110.364 -177.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.732 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.1 t80 -65.59 -39.51 91.67 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.867 . . . . 75.42 110.224 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 93.7 mt-30 -62.56 -51.82 65.84 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.541 -0.724 . . . . 74.43 110.413 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.523 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.8 m-20 -63.47 -38.19 90.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.224 -0.923 . . . . 62.21 110.162 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.794 ' HA ' HD13 ' A' ' 12' ' ' LEU . 77.8 p -64.11 -19.57 65.36 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.462 -0.774 . . . . 73.33 110.608 -177.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.35 31.74 74.7 Favored Glycine 0 N--CA 1.487 2.077 0 N-CA-C 108.85 -1.7 . . . . 73.22 108.85 -176.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.943 HD22 ' CB ' ' A' ' 150' ' ' ALA . 58.4 mt -78.64 135.59 37.26 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.284 -1.127 . . . . 72.43 110.316 -178.275 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 60.7 p -108.07 3.41 23.91 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.235 -0.915 . . . . 51.32 110.139 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.94 131.13 1.36 Allowed Glycine 0 N--CA 1.489 2.224 0 C-N-CA 119.632 -1.271 . . . . 51.2 110.228 179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.61 HG23 ' SG ' ' A' ' 33' ' ' CYS . 6.0 m -84.49 165.31 38.76 Favored Pre-proline 0 N--CA 1.498 1.934 0 O-C-N 121.335 -1.097 . . . . 72.02 109.238 172.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.57 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.5 Cg_endo -71.48 133.73 29.6 Favored 'Cis proline' 0 N--CA 1.489 1.242 0 C-N-CA 122.4 -1.917 . . . . 63.12 111.343 2.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.943 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -124.62 143.27 50.81 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.271 -0.893 . . . . 41.13 109.402 171.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.787 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.3 t -115.68 127.57 73.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 120.894 -1.129 . . . . 63.4 110.114 -178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.624 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 15.2 t -116.17 133.29 63.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.115 -0.99 . . . . 64.33 110.07 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.756 HG11 ' HB2' ' A' ' 177' ' ' LEU . 12.5 t -108.29 131.85 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.434 -0.791 . . . . 43.32 109.924 -179.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 33.5 m-20 46.57 31.1 1.25 Allowed 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.267 -0.896 . . . . 75.34 110.456 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.441 ' O ' ' O ' ' A' ' 15' ' ' PRO . 1.6 t30 47.16 32.57 2.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.209 -0.932 . . . . 72.14 110.104 175.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.671 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 16.8 tpt180 -144.81 -35.57 0.33 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.212 -0.93 . . . . 73.44 110.475 -176.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.957 ' HB3' HD22 ' A' ' 177' ' ' LEU . 29.8 m-85 -111.27 143.43 42.06 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.787 -1.196 . . . . 62.33 110.162 176.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.817 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -111.75 127.13 55.7 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 64.4 109.219 -179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.743 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.5 t -81.59 118.06 28.69 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.284 -0.885 . . . . 73.54 110.224 -175.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.491 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 96.3 mt-30 -80.83 -54.45 5.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.192 -0.942 . . . . 65.2 109.581 173.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.83 5.49 46.42 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.911 -1.276 . . . . 73.33 109.911 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.92 -40.2 96.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.111 -1.229 . . . . 73.53 110.271 -179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.552 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 85.1 p -74.56 -23.19 58.74 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 60.01 110.382 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.473 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -87.84 108.87 19.37 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.162 -0.961 . . . . 74.42 110.44 -176.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -91.91 -5.09 53.85 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.27 -0.894 . . . . 52.44 110.14 176.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 51.1 m -128.29 145.28 51.1 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.245 -0.91 . . . . 74.23 109.925 178.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.525 HD21 HG23 ' A' ' 39' ' ' ILE . 46.4 mt -54.2 -28.04 38.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.013 -1.054 . . . . 62.32 110.916 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -57.52 -41.34 80.68 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.764 -1.21 . . . . 63.42 110.45 -179.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.473 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 96.5 mt-10 -80.58 -41.81 23.4 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.887 -1.133 . . . . 70.35 110.732 179.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.787 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.4 t80 -63.55 -44.56 93.83 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.072 -1.018 . . . . 75.2 109.861 178.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.697 ' CD1' HD12 ' A' ' 43' ' ' LEU . 74.0 t80 -59.91 -46.9 87.87 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.555 -0.715 . . . . 73.33 110.256 176.436 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.559 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.3 m-20 -57.62 -48.96 77.99 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.029 -1.044 . . . . 62.04 110.556 -177.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.823 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.7 tp -52.37 -55.03 24.37 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.917 -1.114 . . . . 73.13 110.32 176.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.625 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -51.35 -43.54 29.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.98 -1.075 . . . . 74.22 109.89 -178.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 7.9 m-80 -58.93 -42.01 88.7 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.256 -0.903 . . . . 73.11 110.929 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 68.7 m-85 -68.73 -41.29 79.18 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.033 -1.042 . . . . 71.34 110.3 179.219 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.988 HD23 HD12 ' A' ' 180' ' ' LEU . 82.0 mt -57.48 -37.07 72.33 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.203 -0.936 . . . . 71.12 109.576 176.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.7 mt -59.55 -29.52 67.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.245 -0.909 . . . . 74.22 110.108 175.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 43.7 m -97.36 -12.54 22.68 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 72.4 110.209 -178.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.988 HD12 HD23 ' A' ' 177' ' ' LEU . 55.1 mt -73.15 -36.98 66.74 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.225 -0.922 . . . . 72.13 110.518 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.482 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 17.0 tttt . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 118.063 -0.97 . . . . 62.05 110.543 178.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.493 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.245 0.545 . . . . 71.14 110.222 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.3 tt0 -56.15 -36.87 68.76 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.251 -0.906 . . . . 70.15 110.295 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.574 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 92.8 m-85 -103.18 128.7 50.05 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.236 -0.915 . . . . 73.02 110.291 -177.578 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.535 ' C ' ' CE2' ' A' ' 9' ' ' TYR . 86.0 mttt -140.71 153.93 46.14 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.419 -0.8 . . . . 73.24 110.393 -177.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.617 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.8 tt0 -64.72 131.89 48.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.151 -0.968 . . . . 63.31 110.166 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 87.79 2.04 81.99 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.46 -1.456 . . . . 64.34 109.46 -179.158 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -129.94 -68.5 0.71 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.173 -1.192 . . . . 75.41 110.262 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 39.2 m170 -98.34 -15.74 19.61 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.173 -0.955 . . . . 74.51 109.639 177.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.617 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 54.0 p90 -153.65 167.09 30.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.349 -0.844 . . . . 52.33 110.642 172.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -122.35 151.09 41.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.551 -0.718 . . . . 73.01 109.156 172.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.915 HG22 ' CE1' ' A' ' 157' ' ' TYR . 97.6 t -98.96 133.42 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.777 -1.202 . . . . 73.31 110.573 -178.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.49 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.5 mt -99.9 145.52 27.71 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.638 -0.664 . . . . 74.24 110.59 -176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 6.6 ttpm? -55.24 -20.52 11.13 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.127 -0.983 . . . . 72.02 109.653 172.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.736 HG21 ' HA ' ' A' ' 143' ' ' SER . 12.1 p -47.08 142.48 5.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.384 -0.822 . . . . 74.55 110.381 -177.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.57 132.08 34.1 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.091 1.574 . . . . 45.32 110.041 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.957 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -79.8 174.49 11.53 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.108 -0.995 . . . . 62.43 110.129 179.047 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.8 m -104.28 144.6 31.4 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.176 -0.953 . . . . 61.05 110.231 -179.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 m -57.48 -35.94 70.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.156 -0.965 . . . . 74.34 109.949 179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.414 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 1.7 m -114.37 169.77 6.21 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.418 -0.801 . . . . 74.11 109.687 176.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.495 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 47.1 Cg_endo -69.34 125.74 12.73 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.841 1.443 . . . . 73.34 110.063 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.528 HG22 ' CG ' ' A' ' 54' ' ' GLN . 9.8 p -144.82 134.12 18.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 O-C-N 120.878 -1.139 . . . . 74.23 109.681 171.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.586 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -118.74 127.62 75.67 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.643 0 O-C-N 121.061 -1.024 . . . . 63.13 109.788 -177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 21.3 t -122.83 135.21 54.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.966 -1.084 . . . . 65.13 110.422 -179.259 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.931 ' OE1' HG22 ' A' ' 151' ' ' VAL . 59.8 mm-40 -105.2 130.73 53.29 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.403 -0.811 . . . . 74.51 110.176 178.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CB ' HG12 ' A' ' 148' ' ' VAL . 73.4 m-85 -102.46 126.43 49.5 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.313 -0.867 . . . . 73.45 109.918 179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.519 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 50.8 p90 -136.12 165.71 25.08 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.539 -0.726 . . . . 70.32 110.777 -178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.611 ' CB ' ' HE2' ' A' ' 61' ' ' MET . 30.5 t -134.85 135.76 41.94 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.34 -0.85 . . . . 72.13 110.297 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.931 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -57.23 -26.09 60.17 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.011 -1.055 . . . . 73.24 110.458 177.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.584 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 29.1 m-85 -94.96 19.73 9.92 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.241 -0.912 . . . . 74.32 111.05 -174.587 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 3.2 t -120.77 101.39 45.62 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 120.883 -1.135 . . . . 34.41 110.231 -178.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.633 ' O ' HG23 ' A' ' 35' ' ' THR . 9.7 Cg_endo -57.3 -47.49 22.04 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.895 1.471 . . . . 74.12 110.16 -178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -59.03 -47.99 83.2 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.007 -1.058 . . . . 75.33 110.025 176.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.537 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -63.18 -47.19 83.65 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.085 -1.009 . . . . 63.23 110.452 178.427 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.431 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 12.0 m-20 -54.8 -37.92 66.69 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.053 -1.03 . . . . 64.23 110.212 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 31' ' ' PRO . 53.5 p -71.52 -35.04 70.58 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.081 -1.012 . . . . 63.24 110.091 176.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.88 ' HE2' HD11 ' A' ' 40' ' ' ILE . 47.2 t80 -62.18 -32.09 72.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.338 -0.851 . . . . 71.51 110.246 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.53 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -37.6 -60.21 0.95 Allowed Pre-proline 0 N--CA 1.497 1.885 0 O-C-N 121.31 -0.869 . . . . 62.11 111.262 -175.389 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.53 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 2.6 Cg_endo -50.42 -41.49 51.58 Favored 'Trans proline' 0 C--N 1.304 -1.805 0 O-C-N 123.326 1.171 . . . . 75.43 110.576 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.607 HD13 HE21 ' A' ' 42' ' ' GLN . 22.2 mm -55.58 -45.83 78.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.788 -1.195 . . . . 74.02 109.701 176.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.88 HD11 ' HE2' ' A' ' 36' ' ' PHE . 27.0 mm -55.62 -45.09 78.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.059 -1.026 . . . . 72.13 110.206 177.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -55.96 -38.49 70.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.076 -1.015 . . . . 51.33 109.316 178.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.607 HE21 HD13 ' A' ' 39' ' ' ILE . 13.3 mt-30 -60.35 -41.15 93.02 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.228 -0.92 . . . . 70.1 109.726 176.423 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD1' ' A' ' 171' ' ' PHE . 58.4 tp -62.57 -39.95 95.33 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.25 -0.906 . . . . 74.23 110.268 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.658 ' HA ' HD12 ' A' ' 47' ' ' LEU . 23.9 mttm -57.18 -51.47 69.18 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.352 -0.843 . . . . 73.34 110.242 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.6 mt-30 -63.22 -36.42 83.6 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.421 -0.799 . . . . 62.41 109.574 -179.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.629 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.5 mt-30 -78.36 -31.55 48.58 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.596 -0.69 . . . . 72.04 110.394 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.658 HD12 ' HA ' ' A' ' 44' ' ' LYS . 3.9 mt -52.39 139.42 37.39 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.22 -0.925 . . . . 64.42 110.263 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.2 Cg_exo -61.38 141.3 91.98 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.922 1.485 . . . . 71.22 110.143 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -57.75 -35.43 70.72 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.097 -1.002 . . . . 75.11 109.821 177.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.02 -40.39 98.42 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.78 -1.328 . . . . 71.01 109.78 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.495 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.07 144.1 47.19 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.126 -1.22 . . . . 72.11 110.412 -178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 31.9 mttt -95.96 154.6 17.15 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.416 -0.802 . . . . 74.11 109.516 175.468 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 51.4 t80 -124.4 156.41 37.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.758 -1.214 . . . . 64.12 110.71 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.586 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.2 mm-40 -141.63 161.04 38.91 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-O 121.594 0.711 . . . . 74.24 110.287 -176.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.463 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 39.0 tttp -133.92 136.51 44.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.098 -1.001 . . . . 74.21 110.39 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.481 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -141.17 147.54 38.58 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.263 -0.898 . . . . 65.33 110.37 -176.491 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 5.7 p-80 -121.6 142.94 49.61 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.934 -1.103 . . . . 75.14 110.094 176.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.489 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.4 m -104.5 132.5 50.98 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.227 -0.921 . . . . 64.32 110.751 -176.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.464 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 90.9 p -93.56 -8.51 41.1 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.365 -0.834 . . . . 63.24 110.459 175.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -61.79 -39.53 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.922 -1.111 . . . . 61.33 110.345 -173.263 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.632 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 6.6 mtm -67.17 -36.69 82.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.923 -1.111 . . . . 73.12 110.199 174.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.556 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.78 -42.48 91.66 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.826 -1.31 . . . . 64.31 109.826 -176.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.26 -141.7 15.71 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.517 -1.433 . . . . 34.13 109.517 -179.085 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.7 m-20 -54.1 -37.82 64.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.007 -1.29 . . . . 73.2 111.003 -177.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.1 ttt -92.94 6.51 47.57 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.925 -1.109 . . . . 71.21 110.557 -177.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.464 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.5 -42.69 94.07 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.393 -1.483 . . . . 72.02 109.393 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.92 -38.68 83.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.204 -1.174 . . . . 62.31 110.313 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.22 -46.92 81.71 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.067 -1.02 . . . . 45.42 110.301 179.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.584 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 96.6 mmm -59.82 -42.61 93.9 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.011 -1.056 . . . . 73.04 110.411 -178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.592 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 39.1 m -60.38 -48.2 82.77 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.027 -1.046 . . . . 75.43 110.217 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.791 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.8 mttt -59.67 -34.72 73.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.144 -0.972 . . . . 63.13 110.395 176.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.26 -48.91 79.25 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.982 -1.074 . . . . 61.33 110.196 -177.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.473 ' CE1' ' CG2' ' A' ' 86' ' ' VAL . 64.3 t80 -59.95 -42.85 94.96 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.863 -1.148 . . . . 54.21 109.826 177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.94 -39.74 90.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.944 -1.097 . . . . 72.31 109.779 177.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.888 HG23 ' HB3' ' A' ' 123' ' ' ALA . 42.2 m -57.51 -43.17 84.04 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.064 -1.022 . . . . 62.21 109.602 175.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.703 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.7 mtt -54.15 -42.09 69.2 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.134 -0.979 . . . . 71.04 109.016 177.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.965 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.9 mt -59.7 -45.01 94.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.515 -0.741 . . . . 73.32 110.194 -178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.434 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.31 -38.3 73.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.055 -1.028 . . . . 75.32 110.521 176.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.999 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -91.05 9.18 31.88 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.135 -0.978 . . . . 54.3 110.776 -176.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 54.65 33.67 19.81 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.009 -1.057 . . . . 73.12 110.222 -177.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.813 HG13 ' O ' ' A' ' 79' ' ' LEU . 25.2 m -119.13 9.02 6.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.342 -0.849 . . . . 73.32 111.144 -177.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.58 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -45.25 -72.53 0.06 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.782 -1.199 . . . . 71.25 109.795 -178.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 46.9 t0 -53.03 -37.87 61.89 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.805 -1.184 . . . . 73.11 110.701 179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -59.0 -43.47 91.48 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.181 -0.95 . . . . 73.02 111.362 -171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.561 ' HA ' HG23 ' A' ' 88' ' ' VAL . 1.8 ptm -126.52 0.29 6.89 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.998 -1.064 . . . . 64.51 110.996 -174.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -56.99 -45.89 99.92 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 120.685 -1.26 . . . . 74.4 109.393 178.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.34 -26.76 83.44 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.273 1.144 . . . . 74.12 110.329 176.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.796 HG21 ' OE1' ' A' ' 113' ' ' GLU . 47.8 t -64.25 -43.57 97.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.001 -1.062 . . . . 63.33 109.565 178.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.519 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -58.62 -42.67 88.78 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 119.099 -1.04 . . . . 74.03 109.554 177.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.5 m-85 -70.63 -43.15 69.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.749 -1.219 . . . . 75.45 110.735 179.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.535 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.8 t30 -57.26 -49.06 77.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.041 -1.037 . . . . 74.35 109.8 176.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.843 ' HA ' HD12 ' A' ' 96' ' ' LEU . 8.7 ttm180 -53.5 -37.06 62.4 Favored 'General case' 0 C--N 1.293 -1.866 0 O-C-N 121.114 -0.991 . . . . 75.14 109.61 176.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.931 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.1 mm -86.64 -67.81 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.467 0 O-C-N 121.35 -0.844 . . . . 72.45 110.648 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.513 ' NE2' ' CG2' ' A' ' 35' ' ' THR . 44.8 t-80 -65.65 -18.56 65.42 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.242 -0.911 . . . . 72.44 111.116 -172.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.556 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.62 -70.65 0.78 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 120.869 -1.144 . . . . 71.11 110.398 -175.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.843 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.8 mt -59.49 -26.82 65.59 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.195 -0.941 . . . . 74.4 110.028 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 32.8 ttm180 62.08 33.01 17.34 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.448 -0.783 . . . . 74.14 109.77 -175.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.8 tttp -126.64 73.14 74.59 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.445 -0.785 . . . . 74.35 109.969 178.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.1 Cg_endo -64.45 147.56 90.57 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.985 1.518 . . . . 71.45 110.377 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.693 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -58.79 132.51 48.24 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.014 1.534 . . . . 74.43 110.033 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 33.9 pttt -95.61 -28.17 14.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.125 -0.985 . . . . 72.31 110.511 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.8 m-20 -142.82 173.16 11.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.117 -0.989 . . . . 74.51 109.916 -179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -57.84 -30.56 65.87 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.996 -1.065 . . . . 71.33 109.332 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.6 tt0 -61.27 -55.34 32.97 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.341 -0.85 . . . . 74.55 111.143 179.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.412 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.5 tp10 -65.24 -39.52 92.82 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.967 -1.083 . . . . 65.14 110.01 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.9 tp -59.8 -41.95 92.35 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.347 -0.846 . . . . 54.15 109.94 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttp180 -61.35 -45.61 93.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.986 -1.071 . . . . 71.3 110.352 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -57.65 -40.48 79.39 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.034 -1.041 . . . . 71.4 110.217 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.1 mt -54.79 -48.98 72.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.101 -1.0 . . . . 73.2 109.954 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.703 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 25.4 m-85 -56.61 -49.96 73.39 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.013 -1.054 . . . . 53.42 110.32 177.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.845 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.7 mt -60.68 -40.79 93.44 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.057 -1.027 . . . . 73.51 110.259 -177.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -58.33 -38.2 76.67 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.116 -0.99 . . . . 73.05 110.445 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.796 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.4 mm-40 -70.04 -0.97 8.53 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.289 -0.882 . . . . 73.24 111.181 -176.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.96 11.39 32.4 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.696 -1.362 . . . . 72.31 109.696 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 81.8 mt -96.38 151.33 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.124 -1.221 . . . . 54.14 110.251 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.545 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -85.96 142.74 28.58 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.1 -1.0 . . . . 71.24 110.451 -176.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.845 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.64 -33.47 75.98 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.217 -0.927 . . . . 52.22 109.461 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.89 -49.43 72.72 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.458 -0.776 . . . . 63.11 110.859 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.999 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.24 -36.01 61.35 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.891 -1.131 . . . . 72.34 110.383 -176.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.887 ' HA ' HD11 ' A' ' 79' ' ' LEU . 83.5 t80 -60.39 -42.46 95.94 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.89 -1.131 . . . . 70.24 110.128 174.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.1 t0 -60.54 -42.63 96.92 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.162 -0.961 . . . . 64.24 109.642 178.43 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.23 -37.89 87.13 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.232 -0.917 . . . . 73.33 110.165 178.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.888 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.14 -44.75 59.64 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.167 -0.958 . . . . 73.34 110.87 -175.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -59.82 -32.84 71.02 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.103 -0.998 . . . . 72.34 109.525 178.647 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -90.38 5.56 46.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.414 -0.804 . . . . 74.35 110.178 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.72 128.54 8.51 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.778 -1.329 . . . . 43.32 109.778 -177.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.23 -28.16 64.61 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.033 -1.275 . . . . 74.21 109.725 175.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.1 -49.87 75.44 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.163 -0.961 . . . . 33.5 110.067 178.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.9 t -58.19 -47.16 88.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.773 -1.204 . . . . 73.13 109.816 175.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.472 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 92.7 m-20 -56.04 -39.98 72.8 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.35 -0.844 . . . . 70.34 110.408 -177.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 m -62.9 -37.17 85.86 Favored 'General case' 0 C--N 1.298 -1.64 0 O-C-N 121.217 -0.927 . . . . 71.13 110.168 178.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.662 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.2 mtm -73.02 -35.44 66.79 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.076 -1.015 . . . . 73.34 110.403 -177.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.791 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.8 t -59.7 -45.49 94.39 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 O-C-N 121.395 -0.815 . . . . 63.44 109.659 177.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 39.9 mtp180 -59.98 -40.92 90.76 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.849 -1.157 . . . . 75.14 108.959 173.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' HB2' ' HA ' ' A' ' 132' ' ' MET . 28.9 ttp85 -47.4 -66.01 0.47 Allowed 'General case' 0 C--N 1.302 -1.498 0 CA-C-O 121.299 0.571 . . . . 74.12 110.799 -179.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.625 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 5.0 p90 -61.51 -41.58 97.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.904 -1.122 . . . . 65.44 110.752 -172.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.625 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -55.53 -47.87 75.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.894 -1.129 . . . . 73.15 110.304 -175.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.466 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 91.4 mttt -62.46 -39.77 94.48 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.863 -1.148 . . . . 71.52 110.622 176.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 14.1 mm100 -56.94 -48.74 77.58 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.014 -1.054 . . . . 72.23 110.542 -176.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.76 ' HA ' HD12 ' A' ' 145' ' ' LEU . 54.1 t80 -68.81 -39.39 80.1 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.23 -0.919 . . . . 75.42 110.305 -178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.448 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.0 mt-30 -64.63 -50.5 66.89 Favored 'General case' 0 C--N 1.303 -1.432 0 C-N-CA 119.976 -0.69 . . . . 74.43 110.492 -177.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 2.2 p30 -63.91 -36.0 82.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.041 -1.037 . . . . 62.21 109.764 177.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 14' ' ' THR . 4.5 t -59.47 -26.84 65.58 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.516 -0.74 . . . . 73.33 110.4 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.61 20.98 77.64 Favored Glycine 0 N--CA 1.482 1.762 0 N-CA-C 108.683 -1.767 . . . . 73.22 108.683 -171.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.952 HD22 ' HB1' ' A' ' 150' ' ' ALA . 33.9 mt -64.34 131.7 48.01 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.037 -1.272 . . . . 72.43 110.457 -178.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.3 m -69.59 -37.02 76.75 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.218 -0.926 . . . . 51.32 109.622 173.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.593 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.72 -175.89 47.17 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.632 -1.387 . . . . 51.2 109.632 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.533 ' HA ' ' C ' ' A' ' 149' ' ' PRO . 3.8 m -109.97 165.42 12.69 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.355 -1.086 . . . . 72.02 109.75 178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.533 ' C ' ' HA ' ' A' ' 148' ' ' VAL . 31.5 Cg_endo -70.06 132.45 22.73 Favored 'Cis proline' 0 N--CA 1.492 1.438 0 C-N-CA 122.387 -1.922 . . . . 63.12 111.545 2.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -128.9 134.87 48.41 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.349 -0.844 . . . . 41.13 109.321 173.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.054 HG21 ' OH ' ' A' ' 170' ' ' TYR . 24.1 t -113.69 126.09 71.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.898 -1.126 . . . . 63.4 110.012 -176.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.9 t -113.96 131.08 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.166 -0.959 . . . . 64.33 110.004 -178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.895 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.9 t -109.81 133.04 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.349 -0.844 . . . . 43.32 109.802 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.513 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 16.6 m-20 46.21 31.35 1.18 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.25 -0.906 . . . . 75.34 110.274 -175.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.0 t30 50.71 29.36 4.16 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.202 -0.936 . . . . 72.14 111.015 173.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.957 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.8 ttt180 -152.0 -25.78 0.18 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.82 -1.175 . . . . 73.44 111.226 -179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.925 ' HB3' HD22 ' A' ' 177' ' ' LEU . 56.9 m-85 -108.39 139.93 42.41 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.531 -1.355 . . . . 62.33 109.992 173.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.636 HD12 ' N ' ' A' ' 159' ' ' VAL . 0.9 OUTLIER -114.04 126.37 55.04 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.184 -0.948 . . . . 64.4 109.619 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.84 HG13 HD23 ' A' ' 173' ' ' LEU . 78.1 t -79.1 115.36 21.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.923 -0.711 . . . . 73.54 110.382 -173.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.48 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.5 mt-30 -78.17 -49.5 13.71 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.207 -0.933 . . . . 65.2 109.539 173.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 59.87 14.07 28.78 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.798 -1.321 . . . . 73.33 109.798 176.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.1 tt0 -59.28 -38.76 80.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.186 -1.185 . . . . 73.53 110.278 -179.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 52.1 p -87.1 -0.48 56.73 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.2 -0.937 . . . . 60.01 110.472 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HB1' ' HB2' ' A' ' 170' ' ' TYR . . . -80.63 87.24 5.79 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.146 -0.971 . . . . 74.42 110.446 -177.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -61.33 -26.81 68.06 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 52.44 110.077 176.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.3 t -137.98 154.68 49.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 74.23 110.127 -177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.511 HD21 HG23 ' A' ' 39' ' ' ILE . 35.1 mt -52.28 -26.2 11.4 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.005 -1.059 . . . . 62.32 110.864 -177.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.425 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.7 m-20 -57.83 -41.93 83.32 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.699 -1.251 . . . . 63.42 110.383 -179.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.478 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 85.8 tt0 -79.5 -42.85 24.32 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.915 -1.116 . . . . 70.35 110.493 177.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 1.054 ' OH ' HG21 ' A' ' 151' ' ' VAL . 78.4 t80 -61.44 -46.92 88.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.084 -1.01 . . . . 75.2 110.145 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD1' HD12 ' A' ' 43' ' ' LEU . 69.2 t80 -59.67 -45.79 91.0 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.303 -0.873 . . . . 73.33 110.21 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.522 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.9 m-20 -55.8 -44.25 77.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.173 -0.955 . . . . 62.04 110.41 -178.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.84 HD23 HG13 ' A' ' 159' ' ' VAL . 4.8 tp -52.73 -54.25 36.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.714 -1.241 . . . . 73.13 110.036 175.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.639 HG22 HG21 ' A' ' 159' ' ' VAL . 55.7 t -52.68 -43.81 45.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.077 -1.014 . . . . 74.22 109.856 -177.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.661 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -58.88 -41.6 87.49 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.208 -0.932 . . . . 73.11 110.894 179.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.522 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 63.0 m-85 -68.55 -41.46 79.77 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.881 -1.137 . . . . 71.34 110.186 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.028 HD23 HD12 ' A' ' 180' ' ' LEU . 80.0 mt -59.42 -37.46 78.11 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.197 -0.94 . . . . 71.12 109.666 177.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.1 mt -59.98 -30.59 69.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.222 -0.924 . . . . 74.22 109.91 175.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 37.4 p -89.5 -19.09 25.48 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.24 -0.912 . . . . 72.4 109.875 177.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.028 HD12 HD23 ' A' ' 177' ' ' LEU . 59.4 mt -73.37 -33.65 65.16 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.343 -0.848 . . . . 72.13 110.298 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.459 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 37.9 tttm . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.952 -1.023 . . . . 62.05 110.236 179.667 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.436 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.268 0.556 . . . . 71.14 110.227 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 38.3 mt-30 -58.6 -35.13 71.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.261 -0.9 . . . . 70.15 110.444 179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.609 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 92.1 m-85 -96.75 129.66 44.13 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.112 -0.993 . . . . 73.02 110.74 -172.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.436 ' HE3' ' O ' ' A' ' 1' ' ' ALA . 39.2 mttt -138.48 155.4 48.47 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.416 -0.802 . . . . 73.24 109.954 178.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.621 ' CD ' HG11 ' A' ' 11' ' ' VAL . 34.5 tt0 -73.75 132.8 43.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.1 -1.0 . . . . 63.31 109.959 178.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.1 -2.73 69.13 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.422 -1.471 . . . . 64.34 109.422 -175.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -130.26 -70.37 0.63 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.127 -1.219 . . . . 75.41 110.348 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.58 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 15.6 m-70 -82.69 -20.73 35.57 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.197 -0.939 . . . . 74.51 110.036 179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.649 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.4 p90 -151.22 165.85 32.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.187 -0.946 . . . . 52.33 110.585 173.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -117.83 148.09 42.43 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.571 -0.9 . . . . 73.01 108.571 169.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.639 ' CG2' ' CE2' ' A' ' 157' ' ' TYR . 11.7 p -120.17 139.24 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.431 -1.418 . . . . 73.31 110.855 -174.689 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.526 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 87.8 mt -103.97 146.16 29.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.667 -0.646 . . . . 74.24 110.55 -172.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 58.5 mttm -59.44 -17.23 29.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.146 -0.972 . . . . 72.02 109.808 173.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.677 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.1 OUTLIER -44.93 158.34 0.29 Allowed Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.288 -0.883 . . . . 74.55 110.407 -177.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_endo -62.38 136.18 57.98 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.151 1.606 . . . . 45.32 110.467 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.838 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.91 156.56 18.23 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.185 -0.947 . . . . 62.43 109.974 177.195 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 26.9 t -81.27 140.55 34.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.197 -0.94 . . . . 61.05 110.387 -177.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.437 ' HA ' ' HE3' ' A' ' 181' ' ' LYS . 22.6 m -58.06 -35.83 71.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.223 -0.923 . . . . 74.34 110.06 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.42 169.79 6.48 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.283 -0.885 . . . . 74.11 109.706 177.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.48 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.5 Cg_endo -70.91 126.98 13.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.89 1.468 . . . . 73.34 110.1 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.7 p -147.12 137.85 17.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.829 -1.17 . . . . 74.23 109.957 172.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.536 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -120.15 127.35 75.89 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.091 -1.006 . . . . 63.13 109.822 -179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.5 p -118.12 135.34 54.27 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.958 -1.089 . . . . 65.13 110.037 -179.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.786 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.4 tt0 -104.19 125.85 50.82 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 74.51 110.207 177.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 80.7 m-85 -100.54 124.99 46.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.337 -0.852 . . . . 73.45 109.747 177.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.434 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 52.0 p90 -140.07 168.22 20.3 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.785 -0.572 . . . . 70.32 110.445 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.513 ' HB2' ' CG2' ' A' ' 58' ' ' VAL . 38.4 t -135.15 134.46 40.22 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 72.13 110.634 179.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.917 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.2 m-85 -57.82 -24.88 59.45 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.165 -0.959 . . . . 73.24 110.47 176.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.612 ' HA ' HG21 ' A' ' 93' ' ' ILE . 92.6 m-85 -94.85 18.04 12.56 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.189 -0.945 . . . . 74.32 111.055 -173.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.49 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 36.5 t -126.91 91.44 47.03 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 34.41 110.105 -178.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.572 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 9.5 Cg_endo -55.5 -46.53 31.53 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.082 1.569 . . . . 74.12 110.399 -176.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.0 m-70 -58.76 -47.02 86.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.004 -1.06 . . . . 75.33 110.06 176.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.472 ' SG ' ' HD3' ' A' ' 149' ' ' PRO . 19.1 m -64.9 -43.1 93.95 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.134 -0.979 . . . . 63.23 109.984 177.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 34.1 m-20 -56.01 -38.61 70.73 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.068 -1.02 . . . . 64.23 109.973 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.485 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.5 m -63.18 -41.96 99.29 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.116 -0.99 . . . . 63.24 110.155 176.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.772 ' CE2' HD11 ' A' ' 40' ' ' ILE . 77.2 t80 -60.95 -35.36 76.55 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.293 -0.879 . . . . 71.51 110.35 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.524 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.71 -60.63 1.28 Allowed Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.126 -0.984 . . . . 62.11 111.201 -174.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.61 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 1.9 Cg_endo -50.27 -40.93 51.96 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.396 1.209 . . . . 75.43 110.644 -177.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.616 HD12 ' HA ' ' A' ' 36' ' ' PHE . 98.0 mt -54.44 -48.21 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.739 -1.226 . . . . 74.02 109.94 176.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.786 HG21 ' CD ' ' A' ' 24' ' ' GLU . 29.1 mm -55.76 -40.53 61.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 120.853 -1.154 . . . . 72.13 109.747 175.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.76 -37.22 70.75 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.079 -1.013 . . . . 51.33 109.67 176.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.832 ' NE2' HD11 ' A' ' 167' ' ' LEU . 22.9 mt-30 -59.25 -42.39 91.02 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.056 -1.027 . . . . 70.1 109.325 176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.794 HD12 ' CD2' ' A' ' 171' ' ' PHE . 42.9 tp -59.09 -40.63 85.9 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.251 -0.906 . . . . 74.23 110.088 175.312 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.896 ' HA ' HD12 ' A' ' 47' ' ' LEU . 37.0 mttt -56.6 -49.35 75.18 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.274 -0.892 . . . . 73.34 110.093 -179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 77.5 mt-30 -61.21 -34.08 74.51 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 62.41 109.378 178.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.527 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 46.4 mt-30 -88.88 -12.79 40.82 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.584 -0.697 . . . . 72.04 110.427 -178.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.9 mt -56.15 137.65 73.94 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.165 -0.96 . . . . 64.42 110.323 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.9 Cg_exo -62.31 145.0 96.05 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.858 1.452 . . . . 71.22 109.838 178.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.46 -34.41 72.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.199 -0.938 . . . . 75.11 109.697 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.43 -38.94 97.14 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.801 -1.32 . . . . 71.01 109.801 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.454 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -77.74 139.69 39.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.093 -1.239 . . . . 72.11 110.634 -177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 60.6 mttt -97.18 156.21 16.5 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.51 -0.744 . . . . 74.11 109.522 174.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.76 ' CD1' HD11 ' A' ' 47' ' ' LEU . 53.2 t80 -123.14 160.15 27.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.822 -1.174 . . . . 64.12 110.673 178.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.7 tt0 -146.78 160.98 41.58 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.436 -0.79 . . . . 74.24 110.326 -175.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.507 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 87.6 mttt -122.49 143.27 49.81 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.148 -0.97 . . . . 74.21 110.484 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -144.58 135.48 24.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.372 -0.83 . . . . 65.33 110.164 -179.823 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 11.1 p-80 -119.67 135.7 54.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.895 -1.128 . . . . 75.14 110.115 178.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.599 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 34.3 m -87.95 132.67 32.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.119 -0.988 . . . . 64.32 110.685 -177.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.7 p -93.47 -11.32 32.33 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.343 -0.848 . . . . 63.24 110.58 175.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.599 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 8.3 p90 -74.17 -33.6 63.52 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.628 -1.295 . . . . 61.33 110.164 -176.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.672 ' SD ' HG22 ' A' ' 148' ' ' VAL . 84.5 mtp -65.45 -36.18 83.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.904 -1.123 . . . . 73.12 109.955 171.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.591 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -59.93 -44.39 97.19 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.698 -1.361 . . . . 64.31 109.698 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -144.83 16.91 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.373 -1.491 . . . . 34.13 109.373 -178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.3 m120 -54.54 -35.96 63.77 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.01 -1.288 . . . . 73.2 110.754 -179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.6 ttt -94.35 6.8 47.58 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.087 -1.008 . . . . 71.21 110.548 -177.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -56.89 -40.85 90.98 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.519 -1.432 . . . . 72.02 109.519 -179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -60.28 -38.9 85.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -1.213 . . . . 62.31 110.354 179.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -64.47 -46.88 81.16 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.06 -1.025 . . . . 45.42 110.309 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.479 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.9 mmm -59.85 -42.52 93.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.022 -1.049 . . . . 73.04 110.489 -179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.04 -49.03 79.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.04 -1.038 . . . . 75.43 110.242 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.904 ' HG2' HG21 ' A' ' 133' ' ' VAL . 57.8 mtpt -60.07 -34.24 73.17 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.01 -1.056 . . . . 63.13 110.086 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.432 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.7 -48.04 80.99 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.11 -0.994 . . . . 61.33 110.283 -177.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' O ' ' HB2' ' A' ' 76' ' ' MET . 83.7 t80 -58.23 -43.47 87.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.852 -1.155 . . . . 54.21 109.745 176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.038 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.17 -39.84 94.0 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.929 -1.107 . . . . 72.31 109.936 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.709 HG21 ' CE1' ' A' ' 120' ' ' PHE . 29.2 m -58.2 -43.25 87.51 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.164 -0.96 . . . . 62.21 109.613 176.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.603 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 62.5 mtt -53.07 -42.48 65.89 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.212 -0.93 . . . . 71.04 109.091 176.362 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.918 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.0 mt -61.75 -47.2 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.505 -0.747 . . . . 73.32 110.408 -177.3 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.486 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.83 -30.2 69.95 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.822 -1.174 . . . . 75.32 109.773 173.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.009 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -95.3 10.85 34.65 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.449 -0.782 . . . . 54.3 110.644 -175.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 48.44 36.35 7.12 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.101 -1.0 . . . . 73.12 110.518 179.031 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.009 HG13 ' O ' ' A' ' 79' ' ' LEU . 32.7 m -126.95 9.89 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.274 -0.891 . . . . 73.32 111.075 -179.046 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.585 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.1 mp0 -44.83 -74.44 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.757 -1.214 . . . . 71.25 109.858 -179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.31 -36.01 60.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.774 -1.204 . . . . 73.11 110.738 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -57.34 -44.67 84.46 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.059 -1.025 . . . . 73.02 111.329 -170.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.567 ' SD ' ' CD2' ' A' ' 110' ' ' PHE . 6.1 ptm -126.84 -2.32 6.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.048 -1.033 . . . . 64.51 110.993 -175.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.37 -44.81 98.26 Favored Pre-proline 0 C--N 1.299 -1.603 0 O-C-N 120.69 -1.256 . . . . 74.4 109.354 -179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.578 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.6 Cg_exo -61.51 -25.33 79.45 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.397 1.209 . . . . 74.12 110.497 176.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.938 HG21 ' OE1' ' A' ' 113' ' ' GLU . 63.1 t -64.84 -42.87 96.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 120.822 -1.174 . . . . 63.33 109.403 177.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.539 ' CE ' HD11 ' A' ' 106' ' ' LEU . 20.0 mtp -60.6 -41.68 95.22 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.094 -1.042 . . . . 74.03 109.811 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 28.0 m-85 -72.11 -42.88 65.58 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.639 -1.288 . . . . 75.45 110.652 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 54.4 t30 -56.68 -49.2 75.81 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.022 -1.049 . . . . 74.35 109.452 174.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.997 ' NH2' HG21 ' A' ' 109' ' ' ILE . 5.7 ttp85 -52.96 -37.55 61.22 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.29 -0.881 . . . . 75.14 109.798 177.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.917 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -67.65 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.429 -0.795 . . . . 72.45 110.454 179.381 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.572 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 21.8 t-160 -61.84 -21.73 64.9 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.271 -0.893 . . . . 72.44 110.99 -173.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -116.86 -70.47 0.79 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.031 -1.043 . . . . 71.11 110.379 -175.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 56.6 mt -60.53 -27.07 67.34 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.144 -0.973 . . . . 74.4 110.002 -179.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.0 mtt-85 58.77 34.59 23.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.449 -0.782 . . . . 74.14 110.166 -176.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -125.09 73.82 66.34 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.237 -0.915 . . . . 74.35 110.055 177.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HB3' HD13 ' A' ' 93' ' ' ILE . 18.4 Cg_endo -65.1 151.44 85.64 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.989 1.52 . . . . 71.45 110.389 -178.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.657 ' CG ' HD13 ' A' ' 106' ' ' LEU . 24.4 Cg_exo -58.72 137.06 77.93 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.969 1.51 . . . . 74.43 110.143 179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 47.8 pttt -94.99 -30.5 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -0.911 . . . . 72.31 110.21 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.6 m-20 -143.55 173.43 11.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.205 -0.934 . . . . 74.51 109.951 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.49 -30.79 67.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.005 -1.059 . . . . 71.33 109.34 172.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -60.58 -55.21 36.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 74.55 111.214 179.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.444 ' OE1' ' HG2' ' A' ' 101' ' ' LYS . 84.3 tt0 -64.96 -39.6 93.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.869 -1.145 . . . . 65.14 109.904 -178.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.011 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.13 -42.51 85.96 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.462 -0.774 . . . . 54.15 109.909 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 62.1 ttp180 -61.87 -45.92 91.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.006 -1.058 . . . . 71.3 110.448 177.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.448 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.7 tm0? -56.77 -40.88 76.67 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.984 -1.073 . . . . 71.4 110.038 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.011 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.8 mt -54.95 -50.64 60.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.085 -1.01 . . . . 73.2 110.218 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.603 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.0 m-85 -55.89 -45.39 78.6 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.066 -1.021 . . . . 53.42 110.314 179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 117' ' ' ALA . 57.5 mt -64.21 -37.19 86.59 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.942 -1.099 . . . . 73.51 110.401 -178.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.448 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -57.39 -38.0 73.58 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.939 -1.101 . . . . 73.05 110.021 174.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.938 ' OE1' HG21 ' A' ' 88' ' ' VAL . 69.6 mm-40 -68.99 -2.57 10.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.356 -0.84 . . . . 73.24 111.154 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.88 9.9 38.74 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.705 -1.358 . . . . 72.31 109.705 -178.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.688 HG23 ' HE3' ' A' ' 119' ' ' LYS . 80.4 mt -95.55 157.46 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.304 -1.115 . . . . 54.14 110.157 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.504 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.2 OUTLIER -95.66 144.06 26.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.945 -1.097 . . . . 71.24 110.152 -178.436 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.603 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.56 -33.36 75.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.913 -1.117 . . . . 52.22 109.686 175.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.84 -51.84 65.46 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.312 -0.868 . . . . 63.11 110.838 179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.688 ' HE3' HG23 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -73.84 -37.31 64.87 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.834 -1.166 . . . . 72.34 110.589 -176.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.709 ' CE1' HG21 ' A' ' 75' ' ' THR . 80.2 t80 -63.03 -40.44 97.74 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.836 -1.165 . . . . 70.24 109.899 176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.429 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 93.0 m-20 -58.92 -41.84 88.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.174 -0.954 . . . . 64.24 109.63 177.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.27 -40.02 92.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.018 -1.051 . . . . 73.33 110.045 177.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.43 -45.94 57.32 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.308 -0.87 . . . . 73.34 110.958 -176.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.607 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -58.79 -32.76 69.61 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.09 -1.006 . . . . 72.34 109.571 178.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -89.5 6.12 42.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.415 -0.803 . . . . 74.35 110.037 178.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.97 130.88 20.2 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.773 -1.331 . . . . 43.32 109.773 -177.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -55.67 -37.87 68.85 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.256 . . . . 74.21 109.672 175.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -45.31 87.35 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.282 -0.886 . . . . 33.5 110.57 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.038 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.4 t -58.32 -49.69 81.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 120.797 -1.189 . . . . 73.13 110.046 179.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.42 -40.61 78.71 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.096 -1.003 . . . . 70.34 109.945 -177.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.9 m -60.32 -37.65 81.25 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.308 -0.87 . . . . 71.13 110.294 178.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.841 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.2 mtm -71.97 -36.91 69.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.819 -1.176 . . . . 73.34 110.514 -177.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.904 HG21 ' HG2' ' A' ' 71' ' ' LYS . 57.5 t -58.09 -44.98 88.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.217 -0.927 . . . . 63.44 109.463 176.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.473 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 93.7 mtt180 -59.46 -43.15 93.25 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.085 -1.009 . . . . 75.14 109.784 175.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 5.8 mtp180 -53.07 -59.61 4.33 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.388 -0.82 . . . . 74.12 110.888 -176.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.632 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -60.8 -41.69 96.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.853 -1.154 . . . . 65.44 110.534 -173.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.632 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.7 t0 -57.54 -48.24 79.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.931 -1.106 . . . . 73.15 110.305 -177.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.454 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 49.6 tttt -62.51 -41.13 98.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.975 -1.078 . . . . 71.52 110.296 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HA ' ' OD1' ' A' ' 142' ' ' ASP . 10.9 mm100 -57.66 -46.11 84.65 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.179 -0.95 . . . . 72.23 110.595 -176.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.755 ' HA ' HD12 ' A' ' 145' ' ' LEU . 55.1 t80 -67.51 -39.37 85.13 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.17 -0.957 . . . . 75.42 110.13 -179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.26 -51.35 68.06 Favored 'General case' 0 C--N 1.3 -1.556 0 C-N-CA 120.11 -0.636 . . . . 74.43 110.747 -177.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.677 ' HB2' HG22 ' A' ' 14' ' ' THR . 4.2 p-10 -66.18 -35.63 80.97 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.061 -1.024 . . . . 62.21 110.149 179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.574 ' OG ' HD12 ' A' ' 145' ' ' LEU . 96.5 p -65.2 -20.35 66.4 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.574 -0.704 . . . . 73.33 110.54 -178.241 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.43 30.77 75.51 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 108.922 -1.671 . . . . 73.22 108.922 -175.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.918 HD21 HD11 ' A' ' 158' ' ' LEU . 39.7 mt -74.5 138.13 42.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -1.161 . . . . 72.43 110.124 -179.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.0 p -106.91 2.83 25.6 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.211 -0.931 . . . . 51.32 110.226 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 163.93 139.11 2.56 Favored Glycine 0 N--CA 1.489 2.205 0 C-N-CA 119.604 -1.284 . . . . 51.2 110.171 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.672 HG22 ' SD ' ' A' ' 61' ' ' MET . 10.0 m -84.64 164.32 43.03 Favored Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 121.395 -1.062 . . . . 72.02 109.351 173.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.574 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.4 Cg_endo -71.76 128.33 14.24 Favored 'Cis proline' 0 N--CA 1.49 1.292 0 C-N-CA 122.52 -1.867 . . . . 63.12 111.448 4.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.917 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -119.67 131.99 55.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.269 -0.894 . . . . 41.13 109.402 171.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.724 HG21 ' OH ' ' A' ' 170' ' ' TYR . 43.2 t -110.17 125.34 67.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.92 -1.112 . . . . 63.4 109.832 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.517 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 25.4 t -115.24 129.97 70.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.567 -0.853 . . . . 64.33 110.348 -178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.668 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -110.27 135.07 50.45 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.494 -0.754 . . . . 43.32 109.403 176.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.538 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 50.44 27.98 3.09 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.107 -0.996 . . . . 75.34 110.122 -174.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.8 t30 49.02 29.26 2.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.006 -1.059 . . . . 72.14 110.936 175.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.838 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 67.5 ttt180 -150.2 -24.54 0.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.854 -1.154 . . . . 73.44 111.01 -177.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.895 ' HB3' HD22 ' A' ' 177' ' ' LEU . 71.5 m-85 -109.15 143.02 39.09 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.456 -1.402 . . . . 62.33 110.212 173.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.918 HD11 HD21 ' A' ' 145' ' ' LEU . 2.6 mm? -111.75 124.28 52.01 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.333 -0.855 . . . . 64.4 109.443 178.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.636 ' CG1' ' CE1' ' A' ' 170' ' ' TYR . 24.5 t -74.03 113.07 11.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 O-C-N 121.544 -0.722 . . . . 73.54 110.151 -178.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.512 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.7 mm-40 -82.24 -52.15 7.23 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.244 -0.91 . . . . 65.2 109.835 175.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.55 8.77 67.78 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.745 -1.342 . . . . 73.33 109.745 176.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.0 -41.14 82.43 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.194 -1.18 . . . . 73.53 110.175 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 82.5 p -78.29 -18.9 54.65 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.227 -0.921 . . . . 60.01 110.412 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -89.73 109.81 20.77 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.153 -0.967 . . . . 74.42 110.588 -176.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 60.9 mttt -92.34 -8.87 43.82 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.249 -0.907 . . . . 52.44 110.028 176.561 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.7 m -129.79 148.69 51.69 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.363 -0.836 . . . . 74.23 109.875 179.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.832 HD11 ' NE2' ' A' ' 42' ' ' GLN . 47.8 mt -53.16 -28.5 26.58 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.079 -1.013 . . . . 62.32 110.886 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.67 -40.93 80.52 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 120.771 -1.206 . . . . 63.42 110.425 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' O ' ' CE2' ' A' ' 3' ' ' PHE . 97.0 mt-10 -81.68 -41.34 21.5 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 120.806 -1.184 . . . . 70.35 110.695 178.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.724 ' OH ' HG21 ' A' ' 151' ' ' VAL . 79.8 t80 -61.89 -45.27 94.47 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.942 -1.099 . . . . 75.2 109.929 177.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.794 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -58.6 -47.69 83.47 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.333 -0.855 . . . . 73.33 110.148 175.414 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.609 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.6 m-20 -56.27 -42.04 76.82 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.112 -0.993 . . . . 62.04 110.633 -179.126 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.582 ' HB2' ' CE2' ' A' ' 3' ' ' PHE . 5.7 tp -54.65 -50.51 67.99 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.759 -1.213 . . . . 73.13 110.107 176.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.592 HG22 HG21 ' A' ' 159' ' ' VAL . 55.0 t -53.09 -41.95 43.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.049 -1.032 . . . . 74.22 109.629 179.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.626 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.5 -41.98 91.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.171 -0.955 . . . . 73.11 110.866 179.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.547 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 75.5 m-85 -68.29 -41.21 81.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.947 -1.095 . . . . 71.34 110.103 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 70.7 mt -63.08 -36.47 83.7 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.295 -0.878 . . . . 71.12 109.76 177.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.626 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.8 mt -59.79 -30.87 69.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.171 -0.956 . . . . 74.22 109.811 174.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.625 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.4 p -90.15 -4.88 57.02 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.27 -0.894 . . . . 72.4 110.194 -179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 27.1 mt -94.45 142.98 26.8 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 72.13 110.255 179.063 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.465 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 86.8 tttt . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.033 -0.984 . . . . 62.05 110.192 179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.248 0.546 . . . . 71.14 110.164 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 56.3 mt-30 -59.06 -33.11 70.4 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.255 -0.903 . . . . 70.15 110.375 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 51.8 p90 -125.94 159.71 31.9 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.099 -1.001 . . . . 73.02 110.561 -177.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.8 tttt -170.24 150.78 3.7 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.47 -0.769 . . . . 73.24 109.656 178.117 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.672 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.3 tt0 -57.15 134.74 56.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.06 -1.025 . . . . 63.31 110.016 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.98 0.55 71.32 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.535 -1.426 . . . . 64.34 109.535 -176.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.427 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -138.06 -54.73 0.65 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.156 -1.202 . . . . 75.41 110.393 -179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.599 ' CE1' ' HB2' ' A' ' 163' ' ' SER . 5.2 m-70 -97.45 -14.89 20.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.22 -0.925 . . . . 74.51 110.0 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.58 ' CG ' HD21 ' A' ' 177' ' ' LEU . 49.2 p90 -159.01 172.43 18.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.443 -0.786 . . . . 52.33 110.453 174.116 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.525 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.7 mt-30 -127.45 158.03 38.45 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.52 -0.738 . . . . 73.01 109.516 175.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.815 HG22 ' CE1' ' A' ' 157' ' ' TYR . 46.9 t -107.45 132.56 54.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.907 -1.121 . . . . 73.31 110.793 -177.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.534 HD11 HD23 ' A' ' 158' ' ' LEU . 67.5 mt -98.85 151.99 20.23 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.768 -0.582 . . . . 74.24 110.248 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 24.7 pttt -71.91 -3.5 22.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.107 -0.996 . . . . 72.02 109.917 175.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.629 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.7 OUTLIER -61.49 155.12 60.81 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.251 -0.906 . . . . 74.55 110.303 179.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 14.9 Cg_endo -62.11 141.24 87.91 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.12 1.59 . . . . 45.32 110.481 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.972 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -102.19 153.7 19.71 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.172 -0.955 . . . . 62.43 110.129 177.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 75.4 m -75.66 144.8 41.45 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.173 -0.954 . . . . 61.05 110.37 -178.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -64.03 -29.36 70.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.289 -0.882 . . . . 74.34 109.891 177.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.448 ' OG ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -117.0 175.02 2.14 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.348 -0.845 . . . . 74.11 109.597 176.799 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.448 ' HD2' ' OG ' ' A' ' 19' ' ' SER . 56.5 Cg_endo -70.98 124.01 10.2 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.802 1.422 . . . . 73.34 110.104 -178.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.603 HG21 ' NE2' ' A' ' 54' ' ' GLN . 9.8 p -146.0 137.25 19.23 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 O-C-N 120.799 -1.188 . . . . 74.23 109.838 172.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.626 ' CG2' HD21 ' A' ' 178' ' ' LEU . 14.8 t -122.01 132.18 71.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 O-C-N 121.143 -0.973 . . . . 63.13 109.705 -178.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.2 p -122.98 137.5 54.94 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.027 -1.045 . . . . 65.13 109.894 -178.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.831 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.9 mm-40 -109.96 127.38 54.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.289 -0.882 . . . . 74.51 110.438 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.577 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 62.0 m-85 -101.54 125.08 48.13 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.313 -0.867 . . . . 73.45 109.738 177.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 57' ' ' HIS . 51.9 p90 -139.61 169.05 18.45 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.618 -0.676 . . . . 70.32 110.605 179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.472 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 28.5 t -134.33 133.18 40.38 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.308 -0.87 . . . . 72.13 110.638 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.835 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.7 m-85 -58.13 -22.72 52.2 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.891 . . . . 73.24 110.592 176.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.752 ' HA ' HG21 ' A' ' 93' ' ' ILE . 93.3 m-85 -101.69 21.56 14.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.34 -0.85 . . . . 74.32 110.857 -174.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 11.3 t -126.3 93.37 43.38 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.981 -1.074 . . . . 34.41 110.162 -178.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.54 ' N ' ' CD2' ' A' ' 94' ' ' HIS . 32.1 Cg_exo -52.25 -35.98 65.85 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.863 1.454 . . . . 74.12 109.971 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.6 t-80 -60.94 -48.3 82.45 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.958 -1.089 . . . . 75.33 109.963 174.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 1.045 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.1 m -63.96 -44.08 93.86 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.984 . . . . 63.23 110.2 178.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.587 ' HB2' ' CE1' ' A' ' 94' ' ' HIS . 52.5 t30 -53.59 -41.49 66.64 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.106 -0.997 . . . . 64.23 110.432 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.472 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.6 m -65.69 -42.91 90.65 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.042 -1.036 . . . . 63.24 110.306 178.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE2' HD11 ' A' ' 40' ' ' ILE . 61.7 t80 -61.4 -33.48 73.75 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.447 -0.783 . . . . 71.51 110.471 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.533 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 12.6 mm-40 -38.6 -61.19 0.92 Allowed Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.294 -0.879 . . . . 62.11 111.286 -175.205 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 3.1 Cg_endo -50.69 -44.26 41.6 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.415 1.219 . . . . 75.43 110.619 -178.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.596 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.9 mt -54.58 -47.28 72.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 120.858 -1.151 . . . . 74.02 109.846 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.913 HD11 ' CE2' ' A' ' 36' ' ' PHE . 27.8 mm -55.25 -44.04 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 120.991 -1.068 . . . . 72.13 110.194 176.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.428 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -56.33 -37.58 70.16 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.98 -1.075 . . . . 51.33 109.496 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 13.7 mt-30 -60.8 -39.37 88.69 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.927 . . . . 70.1 109.641 176.146 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.673 HD12 ' CD1' ' A' ' 171' ' ' PHE . 67.2 tp -66.05 -38.77 89.18 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.229 -0.919 . . . . 74.23 110.222 177.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.638 ' HA ' HD12 ' A' ' 47' ' ' LEU . 24.5 mttt -59.3 -51.95 67.74 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.375 -0.828 . . . . 73.34 110.647 -178.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 42' ' ' GLN . 14.1 pt20 -67.82 -36.09 79.77 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.378 -0.826 . . . . 62.41 109.593 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.488 ' HB3' ' CE1' ' A' ' 171' ' ' PHE . 27.8 mt-30 -72.7 -30.89 64.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.564 -0.71 . . . . 72.04 110.373 176.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.638 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.4 mt -51.45 144.57 16.55 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.373 -0.829 . . . . 64.42 110.367 -176.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.537 ' HD2' HD23 ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.02 143.33 90.69 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 71.22 109.93 178.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.81 -34.43 74.52 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.118 -0.989 . . . . 75.11 109.808 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.48 -38.32 95.59 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.836 -1.306 . . . . 71.01 109.836 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -69.82 141.66 53.26 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.08 -1.247 . . . . 72.11 110.488 -177.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 41.0 mttt -95.73 151.95 18.9 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.374 -0.829 . . . . 74.11 109.531 174.883 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.629 ' CD1' ' CD1' ' A' ' 47' ' ' LEU . 25.0 t80 -125.98 157.96 36.51 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.785 -1.197 . . . . 64.12 110.59 -178.037 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.603 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.5 mt-30 -143.83 160.99 39.78 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.283 -0.886 . . . . 74.24 110.824 -174.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.52 ' HE2' ' NZ ' ' A' ' 44' ' ' LYS . 81.3 mttt -124.49 144.39 50.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.247 -0.908 . . . . 74.21 110.285 177.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.577 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.2 OUTLIER -143.3 132.03 22.6 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.242 -0.911 . . . . 65.33 110.348 -178.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.606 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.7 124.27 51.97 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.056 -1.027 . . . . 75.14 109.463 -179.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.553 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.2 m -76.74 131.45 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.793 0 O-C-N 120.801 -1.187 . . . . 64.32 110.363 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.427 ' OG ' ' OG ' ' A' ' 70' ' ' SER . 4.4 m -94.44 -11.34 29.95 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.337 -0.852 . . . . 63.24 110.375 174.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 2.9 p90 -74.83 -35.53 62.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.713 -1.242 . . . . 61.33 110.312 -174.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.652 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 90.3 mtp -65.3 -36.46 84.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.943 -1.098 . . . . 73.12 110.105 171.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.417 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -60.65 -45.98 95.32 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.884 -1.286 . . . . 64.31 109.884 -177.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 91.36 -135.34 12.75 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.411 -1.476 . . . . 34.13 109.411 -178.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -54.36 -38.62 66.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.075 -1.25 . . . . 73.2 110.676 -179.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.482 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 83.5 mmm -96.68 11.69 34.53 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.121 -0.987 . . . . 71.21 110.542 -178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.42 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -63.1 -53.13 42.41 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.791 -1.324 . . . . 72.02 109.791 -178.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -59.93 -39.09 84.31 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.138 -1.213 . . . . 62.31 110.255 -179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.16 -45.72 90.52 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.088 -1.008 . . . . 45.42 110.356 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.63 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 24.1 tpp -60.05 -43.76 95.16 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.963 -1.086 . . . . 73.04 110.448 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 27.0 m -59.25 -47.69 84.43 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.936 -1.103 . . . . 75.43 110.067 179.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.06 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.5 mttt -59.68 -33.16 71.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.015 -1.053 . . . . 63.13 110.201 175.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.478 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.87 -46.23 90.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.09 -1.006 . . . . 61.33 110.109 -178.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.606 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 31.5 t80 -57.55 -45.25 85.36 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.907 -1.12 . . . . 54.21 109.632 175.6 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.991 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.86 -38.49 88.48 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.04 -1.038 . . . . 72.31 109.917 177.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.763 HG21 ' CE1' ' A' ' 120' ' ' PHE . 19.5 m -58.69 -42.74 89.25 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.175 -0.953 . . . . 62.21 109.672 176.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.545 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 52.1 mtt -53.19 -42.67 66.47 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.061 -1.024 . . . . 71.04 109.05 175.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.927 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -59.85 -44.55 94.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 119.821 -0.752 . . . . 73.32 110.229 -177.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.713 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -56.75 -38.61 72.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.999 -1.063 . . . . 75.32 110.436 176.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.974 HD13 ' CD ' ' A' ' 119' ' ' LYS . 15.0 mt -93.1 8.36 40.4 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.111 -0.993 . . . . 54.3 110.927 -176.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.8 mt-10 56.75 31.06 18.75 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 120.97 -1.081 . . . . 73.12 110.138 -177.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.813 HG12 ' HE3' ' A' ' 84' ' ' LYS . 21.8 m -118.58 23.44 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.384 -0.823 . . . . 73.32 110.996 -179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.554 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.7 mp0 -59.1 -53.32 59.73 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.623 -1.298 . . . . 71.25 109.535 177.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -51.81 -39.2 58.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.174 -0.954 . . . . 73.11 111.024 -177.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.813 ' HE3' HG12 ' A' ' 81' ' ' VAL . 0.2 OUTLIER -87.72 -47.56 8.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.943 -1.098 . . . . 73.02 111.156 -172.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.61 ' CG ' HD11 ' A' ' 115' ' ' ILE . 85.8 mmm -77.02 -33.25 57.47 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.908 -1.12 . . . . 64.51 111.147 -178.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 82' ' ' GLU . 4.0 t -45.93 -57.03 8.81 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.827 -1.17 . . . . 74.4 109.623 -176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.7 Cg_endo -65.1 -26.54 57.69 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.262 1.138 . . . . 74.12 111.158 176.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.847 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.4 t -60.85 -41.42 88.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 120.586 -1.321 . . . . 63.33 109.369 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.524 ' HB2' ' CD2' ' A' ' 28' ' ' PHE . 48.0 mmm -65.69 -41.69 92.09 Favored 'General case' 0 C--N 1.298 -1.646 0 C-N-CA 119.578 -0.849 . . . . 74.03 109.578 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 20.2 m-85 -69.11 -40.61 78.23 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.699 -1.251 . . . . 75.45 110.446 176.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.753 ' OD1' HG21 ' A' ' 95' ' ' THR . 57.1 t30 -59.0 -45.79 89.79 Favored 'General case' 0 N--CA 1.494 1.753 0 CA-C-O 121.911 0.862 . . . . 74.35 110.061 177.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.822 ' HA ' HD12 ' A' ' 96' ' ' LEU . 4.3 ttt180 -61.58 -34.93 76.46 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.242 -0.911 . . . . 75.14 109.797 178.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.835 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.4 mm -89.68 -68.39 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.409 -0.807 . . . . 72.45 110.962 -177.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.587 ' CE1' ' HB2' ' A' ' 34' ' ' ASN . 37.7 m80 -74.95 -11.17 60.06 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.168 -0.958 . . . . 72.44 110.659 -170.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.753 HG21 ' OD1' ' A' ' 91' ' ' ASN . 1.1 m -117.9 -68.81 0.89 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.068 -1.02 . . . . 71.11 109.918 -178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.822 HD12 ' HA ' ' A' ' 92' ' ' ARG . 84.1 mt -60.22 -24.67 65.03 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.267 -0.896 . . . . 74.4 109.993 178.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 66.1 mtp85 58.26 32.94 22.66 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.392 -0.818 . . . . 74.14 110.057 -176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 36.5 mtpt -125.97 73.06 70.68 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 74.35 109.906 177.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -64.86 140.5 67.14 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.017 1.535 . . . . 71.45 110.485 -177.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.408 ' HG3' HD13 ' A' ' 106' ' ' LEU . 12.7 Cg_endo -61.78 140.7 87.16 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 124.033 1.544 . . . . 74.43 109.903 177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 52.4 pttt -103.03 -20.22 14.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.177 -0.952 . . . . 72.31 110.218 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.482 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 76.3 m-20 -142.82 169.22 17.98 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.243 -0.911 . . . . 74.51 109.646 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.474 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.7 mt-10 -57.31 -27.59 62.32 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.004 -1.06 . . . . 71.33 109.408 173.007 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -66.92 -52.49 42.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.123 -0.986 . . . . 74.55 111.215 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.457 ' O ' HG13 ' A' ' 109' ' ' ILE . 92.6 mt-10 -63.24 -35.9 81.86 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.872 -1.143 . . . . 65.14 108.977 175.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.072 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.99 -43.4 91.45 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.568 -0.707 . . . . 54.15 110.351 177.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.474 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 75.5 mtm180 -62.59 -43.37 98.98 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.768 -1.208 . . . . 71.3 110.432 177.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 3.9 tm0? -57.86 -40.57 80.47 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.955 -1.091 . . . . 71.4 110.107 179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.072 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.4 mt -54.97 -51.23 55.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.153 -0.967 . . . . 73.2 110.177 -179.714 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.545 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.0 m-85 -58.38 -45.91 87.4 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.02 -1.05 . . . . 53.42 110.606 179.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.748 HD11 ' HB2' ' A' ' 117' ' ' ALA . 38.9 mt -65.0 -36.7 85.27 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.872 -1.142 . . . . 73.51 110.361 -177.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.79 -37.94 74.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.93 -1.107 . . . . 73.05 109.923 175.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.847 ' HG3' HG11 ' A' ' 88' ' ' VAL . 70.7 mm-40 -75.94 6.36 5.25 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.377 -0.827 . . . . 73.24 111.267 -175.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.36 11.54 44.68 Favored Glycine 0 N--CA 1.492 2.376 0 C-N-CA 119.741 -1.219 . . . . 72.31 110.132 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.61 HD11 ' CG ' ' A' ' 85' ' ' MET . 90.5 mt -101.11 158.84 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.082 -1.246 . . . . 54.14 110.39 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.5 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -94.43 141.89 28.06 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.009 -1.057 . . . . 71.24 110.565 -175.375 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.748 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.61 -32.57 74.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.96 -1.088 . . . . 52.22 109.652 174.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.15 -51.29 67.05 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 63.11 110.789 -179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.974 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.08 -37.92 64.07 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.891 -1.131 . . . . 72.34 110.629 -176.736 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.927 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.43 -41.61 97.45 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 120.926 -1.108 . . . . 70.24 110.119 175.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.431 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.5 m-20 -61.05 -42.02 97.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.099 -1.001 . . . . 64.24 109.831 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.84 -38.27 84.93 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.113 -0.992 . . . . 73.33 110.071 177.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.12 -45.28 57.84 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.275 -0.89 . . . . 73.34 110.842 -176.661 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -57.97 -33.38 68.81 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.143 -0.973 . . . . 72.34 109.549 178.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -88.95 4.6 47.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.369 -0.832 . . . . 74.35 110.094 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.2 130.97 10.79 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.749 -1.341 . . . . 43.32 109.749 -178.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.5 t80 -56.06 -35.18 66.65 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.076 -1.249 . . . . 74.21 109.932 176.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -55.5 -48.52 74.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.055 -1.028 . . . . 33.5 110.107 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.991 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.1 t -57.44 -46.5 85.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 120.784 -1.197 . . . . 73.13 109.7 174.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -56.08 -39.85 72.71 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.393 -0.817 . . . . 70.34 110.486 -177.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.535 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.9 p -67.53 -32.37 73.11 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.234 -0.916 . . . . 71.13 110.456 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.894 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 69.3 mtm -73.69 -39.07 64.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.996 -1.065 . . . . 73.34 110.198 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.06 HG21 ' HG2' ' A' ' 71' ' ' LYS . 48.4 t -65.94 -47.04 86.69 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 121.452 -0.78 . . . . 63.44 110.414 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.535 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 37.1 ptt180 -65.14 -38.42 90.55 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 120.636 -1.29 . . . . 75.14 109.297 175.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.482 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 73.5 ttt180 -51.93 -56.29 15.07 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.649 -0.657 . . . . 74.12 111.176 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -65.77 -40.82 92.42 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.733 -1.229 . . . . 65.44 110.387 -176.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.9 t0 -54.67 -47.92 73.02 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.973 -1.079 . . . . 73.15 110.086 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 46.2 tttp -61.62 -41.48 97.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.015 -1.053 . . . . 71.52 110.306 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.482 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 9.9 mm100 -57.99 -47.8 81.92 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.993 -1.067 . . . . 72.23 110.585 -177.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.605 ' HA ' HD12 ' A' ' 145' ' ' LEU . 48.5 t80 -66.11 -38.9 89.35 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.34 -0.85 . . . . 75.42 110.055 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -62.79 -51.9 65.27 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.702 -0.624 . . . . 74.43 110.529 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.629 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -62.12 -38.12 87.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.169 -0.957 . . . . 62.21 110.221 179.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.58 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.7 p -64.98 -21.29 66.82 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.463 -0.773 . . . . 73.33 110.545 -177.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 68.22 31.1 74.08 Favored Glycine 0 N--CA 1.486 2.01 0 N-CA-C 108.936 -1.666 . . . . 73.22 108.936 -175.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.9 HD22 ' HB1' ' A' ' 150' ' ' ALA . 44.9 mt -77.0 128.42 34.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.243 -1.151 . . . . 72.43 110.45 -177.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.7 m -69.06 -35.39 76.5 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.121 -0.987 . . . . 51.32 109.475 172.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.432 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -179.81 -169.51 40.18 Favored Glycine 0 N--CA 1.487 2.041 0 N-CA-C 109.919 -1.272 . . . . 51.2 109.919 179.144 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.578 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 7.8 m -116.0 166.17 13.01 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.589 -0.947 . . . . 72.02 109.643 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.578 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 37.9 Cg_endo -71.26 131.46 21.08 Favored 'Cis proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.54 -1.859 . . . . 63.12 111.599 4.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.9 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -124.9 132.09 53.34 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.157 -0.964 . . . . 41.13 109.33 170.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.831 HG22 ' OE1' ' A' ' 24' ' ' GLU . 44.1 t -111.81 127.75 68.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.017 -1.052 . . . . 63.4 109.933 -178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.468 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 12.7 t -116.38 130.98 70.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.29 -0.881 . . . . 64.33 110.207 -178.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.747 HG11 ' HB2' ' A' ' 177' ' ' LEU . 19.7 t -112.66 135.05 53.29 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.447 -0.783 . . . . 43.32 109.635 178.431 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.559 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.4 m-80 48.96 28.01 1.84 Allowed 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.171 -0.956 . . . . 75.34 110.077 -174.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.5 t30 48.6 31.34 2.89 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.204 -0.935 . . . . 72.14 110.805 175.403 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.972 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 70.2 ttt180 -153.67 -23.88 0.14 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.863 -1.148 . . . . 73.44 111.212 -177.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.815 ' CE1' HG22 ' A' ' 11' ' ' VAL . 68.1 m-85 -107.27 138.55 43.26 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.381 -1.449 . . . . 62.33 109.712 171.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.762 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.68 125.5 51.45 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.337 -0.852 . . . . 64.4 108.95 178.455 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.723 HG22 ' CD1' ' A' ' 177' ' ' LEU . 99.5 t -81.15 117.32 26.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.27 -0.894 . . . . 73.54 110.492 -173.208 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.525 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 97.5 mt-30 -80.44 -53.85 6.22 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.214 -0.929 . . . . 65.2 109.38 172.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 68.47 5.37 43.21 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.152 -1.179 . . . . 73.33 110.152 174.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -61.27 -42.86 99.36 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.015 -1.285 . . . . 73.53 110.236 -179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.599 ' HB2' ' CE1' ' A' ' 8' ' ' HIS . 28.7 m -64.62 -34.04 77.35 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.4 -0.812 . . . . 60.01 110.522 179.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.762 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -72.02 87.96 1.06 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.194 -0.941 . . . . 74.42 110.541 -175.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.4 mttp -61.52 -26.63 68.05 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.301 -0.874 . . . . 52.44 110.123 175.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.46 ' HB3' ' OD1' ' A' ' 168' ' ' ASP . 42.1 t -126.57 150.67 48.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.251 -0.905 . . . . 74.23 109.978 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.441 ' HA ' HD23 ' A' ' 167' ' ' LEU . 54.0 mt -52.02 -27.15 12.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.043 -1.036 . . . . 62.32 111.189 -175.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 26.9 p-10 -60.63 -39.25 87.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.548 -1.345 . . . . 63.42 110.481 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.517 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 74.9 mm-40 -79.93 -42.42 24.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.817 -1.177 . . . . 70.35 110.404 177.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.762 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 69.4 t80 -62.58 -45.7 91.7 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.201 -0.937 . . . . 75.2 110.046 178.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.673 ' CD1' HD12 ' A' ' 43' ' ' LEU . 68.3 t80 -60.58 -45.53 93.61 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.358 -0.839 . . . . 73.33 110.217 176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.532 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.3 m-20 -56.35 -47.98 77.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.084 -1.01 . . . . 62.04 110.478 -178.066 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.683 HD11 HD11 ' A' ' 177' ' ' LEU . 4.7 tp -50.08 -55.69 13.86 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.801 -1.187 . . . . 73.13 109.973 174.388 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.5 t -52.14 -42.55 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.147 -0.971 . . . . 74.22 109.805 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.616 ' O ' HG23 ' A' ' 179' ' ' THR . 2.6 m120 -58.97 -42.43 89.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.245 -0.909 . . . . 73.11 110.671 -179.241 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 71.8 m-85 -70.18 -40.47 74.63 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.048 -1.032 . . . . 71.34 110.234 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.015 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.2 mt -58.24 -37.8 75.6 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.136 -0.977 . . . . 71.12 109.433 175.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.626 HD21 ' CG2' ' A' ' 22' ' ' VAL . 9.0 mt -61.43 -29.63 70.07 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.163 -0.961 . . . . 74.22 109.969 173.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 175' ' ' ASN . 54.4 p -93.69 -13.97 26.89 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.322 -0.862 . . . . 72.4 110.205 -178.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.015 HD12 ' HA ' ' A' ' 177' ' ' LEU . 46.4 mt -74.82 -35.04 62.45 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.29 -0.881 . . . . 72.13 110.415 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.1 mttt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 117.941 -1.028 . . . . 62.05 110.382 178.207 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HE2' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.609 0 CA-C-O 121.252 0.549 . . . . 71.14 110.218 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 61.1 tt0 -56.54 -37.68 70.83 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.19 -0.944 . . . . 70.15 110.337 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 172' ' ' ASP . 59.6 m-85 -106.05 132.1 52.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.142 -0.974 . . . . 73.02 110.225 -176.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.43 ' HE2' ' O ' ' A' ' 1' ' ' ALA . 67.7 mttm -138.52 153.59 48.76 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.333 -0.854 . . . . 73.24 110.285 -178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.574 ' OE2' HG21 ' A' ' 11' ' ' VAL . 84.4 tt0 -69.51 137.35 52.46 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.273 -0.892 . . . . 63.31 110.097 177.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 96.6 -11.09 66.78 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.25 -1.54 . . . . 64.34 109.25 -177.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -128.69 -62.15 1.03 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.248 -1.148 . . . . 75.41 110.381 179.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.593 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 31.9 m-70 -84.97 -21.33 29.58 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 74.51 110.237 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.603 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.3 p90 -155.21 170.49 21.73 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.191 -0.943 . . . . 52.33 110.812 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.6 tt0 -125.71 157.47 37.28 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.625 -0.672 . . . . 73.01 109.453 174.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.765 HG22 ' CE1' ' A' ' 157' ' ' TYR . 60.2 t -106.73 134.8 47.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 120.854 -1.154 . . . . 73.31 110.866 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 HD11 HD23 ' A' ' 158' ' ' LEU . 61.0 mt -100.41 144.18 29.72 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.708 -0.62 . . . . 74.24 110.229 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 70.2 mmtt -57.83 -17.48 16.43 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.045 -1.034 . . . . 72.02 109.599 174.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.848 HG22 ' HB2' ' A' ' 142' ' ' ASP . 3.4 p -48.94 152.47 1.81 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 74.55 110.656 -177.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.515 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.9 Cg_endo -64.98 133.08 34.37 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.176 1.619 . . . . 45.32 110.336 178.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -74.76 166.21 23.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.046 -1.034 . . . . 62.43 110.015 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.466 ' OG ' HG11 ' A' ' 21' ' ' VAL . 29.7 t -103.29 143.59 32.46 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.062 -1.024 . . . . 61.05 110.23 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 19' ' ' SER . 29.3 t -59.3 143.21 50.0 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.224 -0.922 . . . . 74.34 109.803 179.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' O ' ' A' ' 18' ' ' SER . 0.6 OUTLIER 52.28 174.78 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.158 -0.964 . . . . 74.11 109.769 -175.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 59.9 Cg_endo -72.37 127.8 13.0 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 123.911 1.48 . . . . 73.34 110.4 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.466 HG11 ' OG ' ' A' ' 17' ' ' SER . 8.7 p -145.71 139.14 21.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 120.717 -1.24 . . . . 74.23 109.966 170.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.56 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.6 t -121.1 131.88 71.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.157 -0.965 . . . . 63.13 109.728 -179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.506 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 94.3 p -119.37 134.38 55.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.97 -1.081 . . . . 65.13 110.057 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.815 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -104.94 129.05 53.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.33 -0.856 . . . . 74.51 110.043 176.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' HB3' ' CG1' ' A' ' 148' ' ' VAL . 79.7 m-85 -101.01 125.43 47.63 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -0.975 . . . . 73.45 109.896 177.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.456 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 51.8 p90 -144.03 168.49 19.86 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.814 -0.554 . . . . 70.32 110.436 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.591 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 29.1 t -135.11 135.5 41.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.137 -0.977 . . . . 72.13 110.457 178.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.674 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 98.4 m-85 -58.64 -23.56 59.32 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.121 -0.987 . . . . 73.24 110.637 178.352 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.595 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 25.5 m-85 -95.85 17.56 14.97 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.232 -0.917 . . . . 74.32 111.162 -174.437 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 23.6 t -122.51 91.53 49.35 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.834 -1.167 . . . . 34.41 110.165 -177.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 8.0 Cg_endo -54.68 -50.76 12.25 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 124.027 1.541 . . . . 74.12 110.505 -176.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -57.72 -47.44 82.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.019 -1.051 . . . . 75.33 110.103 178.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.524 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 21.7 m -64.73 -41.73 95.75 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.962 -1.086 . . . . 63.23 110.158 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.474 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.5 m-20 -56.61 -39.23 73.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.1 -1.0 . . . . 64.23 110.064 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 74.5 m -62.56 -41.53 98.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.154 -0.966 . . . . 63.24 109.973 176.117 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.707 ' CE2' HD11 ' A' ' 40' ' ' ILE . 73.4 t80 -61.84 -37.73 85.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.353 -0.842 . . . . 71.51 110.369 178.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.553 ' OE2' ' CE2' ' A' ' 90' ' ' PHE . 0.1 OUTLIER -41.49 -57.41 3.79 Favored Pre-proline 0 N--CA 1.493 1.7 0 O-C-N 121.198 -0.939 . . . . 62.11 110.394 -176.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 51.3 Cg_exo -40.55 -50.35 3.83 Favored 'Trans proline' 0 C--N 1.304 -1.81 0 O-C-N 123.738 1.388 . . . . 75.43 110.528 175.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.526 HD12 ' HA ' ' A' ' 36' ' ' PHE . 90.3 mt -53.9 -47.37 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 120.863 -1.148 . . . . 74.02 110.159 178.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.815 HG21 ' CD ' ' A' ' 24' ' ' GLU . 24.8 mm -56.64 -39.26 61.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 120.89 -1.131 . . . . 72.13 109.947 177.127 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.538 ' HA ' ' CE ' ' A' ' 44' ' ' LYS . . . -58.35 -38.04 76.39 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 120.933 -1.105 . . . . 51.33 109.508 175.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.771 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.1 mt-30 -59.1 -41.49 88.22 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.23 -0.919 . . . . 70.1 109.357 176.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.769 HD12 ' CD1' ' A' ' 171' ' ' PHE . 53.5 tp -59.34 -42.0 90.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 74.23 110.452 177.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.764 ' HA ' HD12 ' A' ' 47' ' ' LEU . 34.2 mtmt -59.25 -48.75 80.44 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.248 -0.908 . . . . 73.34 110.461 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -60.7 -36.45 78.83 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.288 -0.882 . . . . 62.41 109.273 178.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.631 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 51.4 mt-30 -78.69 -27.5 45.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.514 -0.741 . . . . 72.04 110.205 177.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.6 mt -54.56 143.43 48.26 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.304 -0.872 . . . . 64.42 110.39 -176.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.5 Cg_exo -62.35 145.52 95.87 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.047 1.551 . . . . 71.22 109.891 178.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.97 -33.5 70.74 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.165 -0.96 . . . . 75.11 109.747 178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.23 -38.53 95.8 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.82 -1.312 . . . . 71.01 109.82 179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.502 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.23 138.64 45.72 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.12 -1.223 . . . . 72.11 110.619 -177.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.461 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 65.7 mttm -97.07 155.18 16.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.516 -0.74 . . . . 74.11 109.533 174.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.582 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 50.2 t80 -123.84 160.53 27.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.841 -1.162 . . . . 64.12 110.595 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.56 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.9 tt0 -146.23 161.28 40.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.479 -0.763 . . . . 74.24 110.047 -175.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.484 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 88.8 mttt -128.77 144.18 51.1 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.059 -1.026 . . . . 74.21 110.776 -178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.528 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 9.2 t-20 -135.8 138.44 42.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.347 -0.846 . . . . 65.33 110.161 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.619 ' NE2' ' CD2' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -113.09 122.09 46.52 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.045 -1.034 . . . . 75.14 109.525 176.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.543 HG21 ' HE2' ' A' ' 61' ' ' MET . 34.0 m -87.85 131.7 34.85 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.139 -0.976 . . . . 64.32 110.605 -178.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.457 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 83.9 p -94.17 -9.69 35.56 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.318 -0.864 . . . . 63.24 110.382 174.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.624 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.4 OUTLIER -65.13 -39.47 93.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.792 -1.192 . . . . 61.33 110.53 -172.138 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.624 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 57.1 mtm -72.24 -34.1 68.03 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.743 -1.223 . . . . 73.12 110.041 171.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.95 -41.18 83.95 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.052 -1.219 . . . . 64.31 110.052 -175.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.21 -151.87 20.06 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.464 -1.454 . . . . 34.13 109.464 -177.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.04 -37.4 64.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.029 -1.277 . . . . 73.2 111.01 -177.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.464 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.65 3.64 53.63 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.933 -1.104 . . . . 71.21 110.639 -176.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.457 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.72 -41.55 95.89 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.459 -1.456 . . . . 72.02 109.459 -179.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -59.59 -39.21 83.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.239 -1.153 . . . . 62.31 110.279 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.97 -46.75 80.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.083 -1.011 . . . . 45.42 110.407 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.595 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -60.43 -44.09 96.13 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.04 -1.038 . . . . 73.04 110.606 -177.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.594 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 44.6 m -61.21 -44.38 97.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.908 -1.12 . . . . 75.43 109.979 177.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.588 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 16.7 tttm -60.15 -34.31 73.38 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.095 -1.003 . . . . 63.13 109.825 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.485 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.41 -46.03 88.26 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.154 -0.966 . . . . 61.33 110.283 -179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.619 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 59.1 t80 -57.35 -42.97 83.01 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.817 -1.177 . . . . 54.21 109.553 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.7 -39.53 91.8 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.989 -1.069 . . . . 72.31 109.855 176.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.605 HG23 ' HB3' ' A' ' 123' ' ' ALA . 46.9 m -56.27 -43.82 79.16 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.009 -1.057 . . . . 62.21 109.644 175.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.823 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 60.1 mtt -53.57 -42.7 67.83 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.231 -0.918 . . . . 71.04 109.19 177.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.944 HD12 ' HA ' ' A' ' 74' ' ' ALA . 75.6 mt -61.6 -46.39 96.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 C-N-CA 119.791 -0.764 . . . . 73.32 110.285 -176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -62.23 -28.96 70.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 75.32 109.524 172.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.028 ' O ' HG13 ' A' ' 81' ' ' VAL . 2.5 tp -89.11 3.26 52.39 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.62 -0.675 . . . . 54.3 110.458 -177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.92 30.59 9.48 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.119 -0.988 . . . . 73.12 110.36 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.028 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.4 m -125.97 11.72 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.167 -0.958 . . . . 73.32 111.199 -177.186 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.579 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.6 mp0 -43.36 -72.55 0.06 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.985 -1.072 . . . . 71.25 110.074 -177.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.04 -37.17 61.32 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.877 -1.139 . . . . 73.11 110.9 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 26.7 tttp -59.69 -44.1 93.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.054 -1.029 . . . . 73.02 111.479 -169.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.823 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 5.3 ppp? -126.19 -0.77 7.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.952 -1.092 . . . . 64.51 110.938 -175.812 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.58 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.1 t -51.46 -44.57 89.42 Favored Pre-proline 0 N--CA 1.49 1.547 0 O-C-N 120.565 -1.334 . . . . 74.4 109.081 176.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.58 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.0 Cg_exo -61.96 -24.14 76.58 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.337 1.178 . . . . 74.12 110.639 175.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.759 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.0 t -65.52 -41.64 91.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.808 -1.183 . . . . 63.33 109.523 178.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.559 ' HE1' HD11 ' A' ' 106' ' ' LEU . 77.1 mmm -61.59 -43.08 99.52 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.092 -1.043 . . . . 74.03 109.417 178.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.674 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.0 m-85 -70.26 -44.11 69.12 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.828 -1.17 . . . . 75.45 110.709 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 66.5 t30 -56.16 -53.38 57.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.155 -0.965 . . . . 74.35 109.69 176.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.86 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.8 ttt85 -52.22 -36.35 52.03 Favored 'General case' 0 C--N 1.294 -1.812 0 O-C-N 121.301 -0.874 . . . . 75.14 109.742 -179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.582 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.5 mm -82.91 -66.0 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.235 -0.916 . . . . 72.45 110.381 175.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.476 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.7 t60 -63.36 -20.66 65.71 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.315 -0.866 . . . . 72.44 111.303 -173.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.515 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -121.05 -69.46 0.84 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.865 -1.147 . . . . 71.11 110.634 -173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.6 mt -59.05 -26.54 64.69 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.119 -0.988 . . . . 74.4 109.723 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 57.8 ttm-85 61.71 32.7 18.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.479 -0.763 . . . . 74.14 109.754 -176.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.516 ' O ' ' CZ ' ' A' ' 92' ' ' ARG . 0.6 OUTLIER -124.66 73.47 62.35 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.364 -0.835 . . . . 74.35 110.027 178.373 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HB3' HD13 ' A' ' 93' ' ' ILE . 19.8 Cg_endo -63.84 141.95 80.35 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.958 1.504 . . . . 71.45 110.272 -179.039 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.5 Cg_endo -59.36 133.74 54.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.994 1.523 . . . . 74.43 110.097 179.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 3.7 pttm -99.0 -28.44 13.41 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 72.31 110.431 -177.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.76 172.79 12.22 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.129 -0.982 . . . . 74.51 109.892 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -57.96 -30.64 66.15 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.006 -1.059 . . . . 71.33 109.369 173.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.8 tt0 -61.46 -55.04 35.6 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.388 -0.82 . . . . 74.55 111.148 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.483 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.1 mm-40 -66.87 -38.62 86.67 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.942 -1.099 . . . . 65.14 110.004 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.008 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.5 tp -58.91 -43.58 91.1 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.324 -0.86 . . . . 54.15 109.793 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 69.9 ttt180 -60.52 -45.8 92.49 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.046 -1.034 . . . . 71.3 110.419 177.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -56.6 -40.32 75.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.087 -1.008 . . . . 71.4 110.048 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.008 HD12 ' HA ' ' A' ' 106' ' ' LEU . 65.0 mt -55.28 -48.76 76.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.167 -0.958 . . . . 73.2 110.108 179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.599 ' CD2' ' CZ ' ' A' ' 120' ' ' PHE . 46.4 m-85 -56.47 -50.13 72.64 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.016 -1.052 . . . . 53.42 110.36 178.296 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.855 HD21 ' CA ' ' A' ' 117' ' ' ALA . 89.6 mt -60.01 -39.77 86.97 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.082 -1.011 . . . . 73.51 110.249 -178.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.95 -38.46 76.01 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.993 -1.067 . . . . 73.05 110.412 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.759 ' CG ' HG11 ' A' ' 88' ' ' VAL . 71.4 mm-40 -72.08 1.51 7.29 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.189 -0.944 . . . . 73.24 111.263 -175.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.14 6.3 51.73 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.45 -1.46 . . . . 72.31 109.45 -177.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.5 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 27.2 mm -79.42 148.44 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.248 -1.148 . . . . 54.14 109.602 176.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.555 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -87.77 139.37 30.59 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.015 -1.053 . . . . 71.24 109.756 175.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.855 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.8 -32.72 73.96 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.825 -1.172 . . . . 52.22 109.292 178.523 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.09 -49.76 70.99 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.499 -0.751 . . . . 63.11 111.03 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.666 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.56 -34.99 58.47 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.797 -1.189 . . . . 72.34 110.499 -175.456 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.599 ' CZ ' ' CD2' ' A' ' 110' ' ' PHE . 87.3 t80 -62.83 -41.44 99.32 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.936 -1.102 . . . . 70.24 109.774 175.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -59.59 -42.77 93.31 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.185 -0.947 . . . . 64.24 109.625 178.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.11 -38.73 90.03 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.12 -0.987 . . . . 73.33 110.212 178.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.629 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.99 -45.39 58.2 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.225 -0.922 . . . . 73.34 110.868 -175.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.588 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 65.0 t80 -61.57 -31.07 71.09 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.084 -1.01 . . . . 72.34 109.454 179.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -91.4 7.12 42.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.424 -0.798 . . . . 74.35 110.113 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.44 128.88 13.66 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.764 -1.334 . . . . 43.32 109.764 -177.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -55.99 -38.56 70.62 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.105 -1.232 . . . . 74.21 109.661 175.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.35 -44.8 88.94 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.255 -0.903 . . . . 33.5 110.474 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 41.1 t -58.88 -49.04 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.733 -1.23 . . . . 73.13 110.094 179.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.3 t0 -57.38 -40.2 77.67 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.033 -1.042 . . . . 70.34 110.039 -178.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -60.67 -37.37 81.35 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.19 -0.943 . . . . 71.13 110.252 178.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.802 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.1 mtm -72.82 -33.96 66.54 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.899 -1.125 . . . . 73.34 110.374 -178.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.578 ' O ' ' CE2' ' A' ' 136' ' ' PHE . 90.4 t -59.94 -46.78 93.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 O-C-N 121.246 -0.909 . . . . 63.44 109.589 176.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 66.5 mtp180 -59.6 -40.29 87.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.889 -1.132 . . . . 75.14 109.1 173.527 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.494 ' HB3' ' O ' ' A' ' 132' ' ' MET . 37.1 ttt85 -51.96 -70.42 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.747 -0.596 . . . . 74.12 110.694 -178.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.636 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.2 p90 -51.23 -41.76 60.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.97 -1.081 . . . . 65.44 110.88 -175.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.636 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.3 t0 -53.9 -48.0 70.57 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.816 -1.177 . . . . 73.15 109.778 -177.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.465 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 28.5 tttt -60.81 -40.05 91.24 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.029 -1.044 . . . . 71.52 110.284 175.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.528 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 89.0 mt-30 -56.85 -48.15 78.75 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.065 -1.022 . . . . 72.23 110.528 -175.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.592 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 53.0 t80 -68.7 -37.35 79.45 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.288 -0.882 . . . . 75.42 110.089 -177.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.416 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.2 mt-30 -62.42 -51.47 67.39 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 120.018 -0.673 . . . . 74.43 110.54 -178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.848 ' HB2' HG22 ' A' ' 14' ' ' THR . 3.6 p30 -65.08 -37.06 86.29 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.122 -0.986 . . . . 62.21 110.064 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 89.6 p -62.3 -21.19 65.05 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.375 -0.828 . . . . 73.33 110.306 -178.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 67.15 30.7 76.04 Favored Glycine 0 N--CA 1.487 2.038 0 N-CA-C 108.74 -1.744 . . . . 73.22 108.74 -176.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.897 HD22 ' HB1' ' A' ' 150' ' ' ALA . 48.3 mt -78.71 132.32 36.94 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.353 -1.086 . . . . 72.43 110.298 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 54.1 p -79.5 -20.03 48.24 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.281 -0.887 . . . . 51.32 109.677 175.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.566 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . 173.96 -177.63 46.15 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.908 -1.277 . . . . 51.2 109.908 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 3.7 m -116.67 165.66 14.66 Favored Pre-proline 0 N--CA 1.493 1.701 0 O-C-N 121.618 -0.93 . . . . 72.02 109.527 -179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.566 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.4 Cg_endo -72.3 137.16 47.0 Favored 'Cis proline' 0 N--CA 1.491 1.336 0 C-N-CA 122.492 -1.878 . . . . 63.12 111.632 4.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.897 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.26 139.92 50.73 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.293 -0.88 . . . . 41.13 109.288 171.167 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.981 HG21 ' OH ' ' A' ' 170' ' ' TYR . 38.2 t -113.45 127.24 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.923 -1.11 . . . . 63.4 110.088 -177.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.415 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.8 t -116.68 131.52 69.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.29 -0.881 . . . . 64.33 109.998 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.903 HG11 ' HB2' ' A' ' 177' ' ' LEU . 24.9 t -110.73 135.78 48.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.418 -0.801 . . . . 43.32 109.751 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.527 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.2 m-80 49.08 26.72 1.49 Allowed 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.223 -0.923 . . . . 75.34 110.13 -175.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 2.2 t30 49.97 29.99 3.76 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.185 -0.947 . . . . 72.14 110.832 175.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.685 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 64.9 ttt180 -153.43 -20.05 0.14 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.768 -1.207 . . . . 73.44 111.005 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.788 ' HB3' HD22 ' A' ' 177' ' ' LEU . 80.7 m-85 -111.28 137.94 48.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.596 -1.315 . . . . 62.33 109.804 172.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.754 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -107.66 125.67 51.64 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.22 -0.925 . . . . 64.4 108.989 178.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.524 HG13 HD23 ' A' ' 173' ' ' LEU . 46.3 t -77.62 111.34 14.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.414 -0.804 . . . . 73.54 110.312 -174.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.502 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -76.97 -47.51 20.62 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -0.928 . . . . 65.2 109.741 174.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 54.15 18.4 9.31 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.757 -1.337 . . . . 73.33 109.757 177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 62.9 tt0 -59.32 -38.67 80.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.2 -1.177 . . . . 73.53 110.196 -179.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.463 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 52.1 p -86.96 -0.91 57.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 60.01 110.497 -178.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.482 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -74.38 90.27 2.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.15 -0.969 . . . . 74.42 110.537 -177.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -59.66 -30.33 68.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.328 -0.857 . . . . 52.44 110.066 176.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.3 p -145.14 164.94 29.73 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 74.23 110.019 -178.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.771 HD11 ' NE2' ' A' ' 42' ' ' GLN . 54.1 mt -53.03 -26.9 17.19 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.109 -0.994 . . . . 62.32 110.943 -177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -57.43 -41.52 80.6 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.636 -1.29 . . . . 63.42 110.433 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.482 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.3 tt0 -81.53 -42.44 20.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.83 -1.169 . . . . 70.35 110.603 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.981 ' OH ' HG21 ' A' ' 151' ' ' VAL . 85.8 t80 -61.8 -44.66 96.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.062 -1.024 . . . . 75.2 109.966 178.058 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.769 ' CD1' HD12 ' A' ' 43' ' ' LEU . 65.6 t80 -59.31 -47.11 86.64 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.405 -0.81 . . . . 73.33 110.284 175.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.5 m-20 -56.68 -44.57 81.57 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.028 -1.045 . . . . 62.04 110.644 -177.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.524 HD23 HG13 ' A' ' 159' ' ' VAL . 6.2 tp -55.44 -51.34 67.23 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 120.675 -1.265 . . . . 73.13 110.132 176.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.432 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.38 -42.96 39.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 120.972 -1.08 . . . . 74.22 109.89 179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.502 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.5 -42.61 92.57 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.128 -0.983 . . . . 73.11 110.736 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.709 ' O ' HG22 ' A' ' 179' ' ' THR . 68.3 m-85 -66.52 -42.15 87.71 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.06 -1.025 . . . . 71.34 110.172 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.967 HD23 HD12 ' A' ' 180' ' ' LEU . 75.8 mt -61.12 -37.64 83.51 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.317 -0.865 . . . . 71.12 109.888 178.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.508 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 8.4 mt -60.13 -27.93 67.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.384 -0.823 . . . . 74.22 110.203 177.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.709 HG22 ' O ' ' A' ' 176' ' ' TYR . 9.7 t -101.97 -8.35 21.6 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.259 -0.9 . . . . 72.4 110.113 -179.422 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.967 HD12 HD23 ' A' ' 177' ' ' LEU . 30.1 mt -73.03 -33.58 65.81 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.263 -0.898 . . . . 72.13 110.31 177.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.413 ' OXT' ' O ' ' A' ' 180' ' ' LEU . 74.0 tttt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.989 -1.005 . . . . 62.05 110.179 179.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.281 0.562 . . . . 71.14 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' HB3' ' CE2' ' A' ' 3' ' ' PHE . 58.0 tt0 -56.67 -36.19 69.3 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.246 -0.909 . . . . 70.15 110.348 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.625 ' CD1' ' ND1' ' A' ' 8' ' ' HIS . 23.2 m-85 -103.97 128.08 51.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.074 -1.016 . . . . 73.02 110.317 -174.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.539 ' C ' ' CZ ' ' A' ' 9' ' ' TYR . 42.7 tttp -164.39 160.14 20.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.359 -0.838 . . . . 73.24 109.929 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.599 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.9 tt0 -61.93 130.88 47.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.114 -0.991 . . . . 63.31 110.284 178.763 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.417 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 98.29 -18.87 56.4 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.211 -1.556 . . . . 64.34 109.211 -179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.6 mm-40 -107.95 -72.96 0.7 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.327 -1.102 . . . . 75.41 110.485 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.625 ' ND1' ' CD1' ' A' ' 3' ' ' PHE . 0.1 OUTLIER -90.85 -17.71 26.08 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.359 -0.838 . . . . 74.51 110.113 -179.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.599 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.8 p90 -157.98 175.68 13.52 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.52 -0.737 . . . . 52.33 110.58 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 -125.66 155.68 40.45 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.5 -0.75 . . . . 73.01 109.438 172.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.002 HG22 ' CE1' ' A' ' 157' ' ' TYR . 90.7 t -104.84 135.34 43.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.882 -1.137 . . . . 73.31 110.525 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.515 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 61.8 mt -102.67 142.23 34.17 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.582 -0.699 . . . . 74.24 110.582 -174.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -58.76 -16.53 17.24 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.128 -0.983 . . . . 72.02 109.516 172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.662 HG22 ' HB3' ' A' ' 142' ' ' ASP . 1.1 p -53.13 151.55 9.05 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.397 -0.814 . . . . 74.55 110.397 -177.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.513 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.6 Cg_endo -64.1 140.01 69.74 Favored 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 124.093 1.575 . . . . 45.32 110.476 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.683 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -99.31 148.74 23.85 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.181 -0.949 . . . . 62.43 110.012 176.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 28.6 t -72.85 146.03 46.52 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.127 -0.983 . . . . 61.05 110.207 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -59.92 -29.37 68.33 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.166 -0.958 . . . . 74.34 109.857 178.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.402 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.4 OUTLIER -115.76 172.61 3.58 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.356 -0.84 . . . . 74.11 109.626 175.876 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.527 ' HB2' HD22 ' A' ' 178' ' ' LEU . 58.0 Cg_endo -71.42 124.08 10.07 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 123.787 1.414 . . . . 73.34 109.985 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.4 ' O ' HG13 ' A' ' 21' ' ' VAL . 7.6 p -143.13 134.83 23.97 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 O-C-N 120.903 -1.123 . . . . 74.23 109.922 172.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.57 HG21 HD21 ' A' ' 47' ' ' LEU . 13.0 t -114.42 130.23 69.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.575 0 O-C-N 121.045 -1.034 . . . . 63.13 109.729 -178.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.491 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 96.6 p -118.98 134.16 55.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.992 -1.068 . . . . 65.13 110.031 -178.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.809 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.7 tt0 -100.85 126.72 47.46 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.415 -0.803 . . . . 74.51 110.266 177.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.492 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 77.5 m-85 -101.48 124.58 47.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.231 -0.918 . . . . 73.45 109.605 175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.468 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 52.2 p90 -143.8 164.48 30.38 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.529 -0.732 . . . . 70.32 110.623 -177.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.562 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 12.9 t -135.42 126.8 28.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.219 -0.926 . . . . 72.13 110.563 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.696 ' O ' HG21 ' A' ' 93' ' ' ILE . 98.1 m-85 -56.65 -25.25 53.0 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.125 -0.984 . . . . 73.24 110.429 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.629 ' CE2' ' CA ' ' A' ' 62' ' ' GLY . 28.9 m-85 -72.13 -3.68 24.68 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.179 -0.95 . . . . 74.32 111.615 -170.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.513 ' CB ' ' HB2' ' A' ' 33' ' ' CYS . 5.3 m -124.31 113.47 27.75 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.432 -1.417 . . . . 34.41 110.888 -172.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 10.4 Cg_endo -59.41 -47.83 15.52 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.839 1.442 . . . . 74.12 110.073 177.279 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -61.6 -49.45 76.58 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.047 -1.033 . . . . 75.33 110.237 177.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.513 ' HB2' ' CB ' ' A' ' 30' ' ' CYS . 80.9 m -62.29 -44.29 96.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.937 -1.102 . . . . 63.23 110.219 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 73.1 m-20 -57.83 -38.28 75.32 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.037 -1.039 . . . . 64.23 110.194 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.466 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 42.3 m -62.49 -41.18 98.62 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.176 -0.952 . . . . 63.24 110.177 177.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.576 ' CG ' ' HG2' ' A' ' 149' ' ' PRO . 72.8 t80 -60.98 -39.06 88.17 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.278 -0.888 . . . . 71.51 110.219 179.168 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' OE1' ' CE2' ' A' ' 90' ' ' PHE . 24.1 tt0 -42.43 -55.74 6.45 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.009 -1.057 . . . . 62.11 110.207 -176.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 51.8 Cg_exo -40.71 -50.29 3.97 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.364 1.192 . . . . 75.43 110.603 174.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.536 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.6 mt -53.34 -46.19 57.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 120.854 -1.154 . . . . 74.02 109.97 179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.809 HG21 ' CD ' ' A' ' 24' ' ' GLU . 37.0 mm -55.98 -39.3 56.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.888 -1.132 . . . . 72.13 109.868 175.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.618 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.81 -39.46 74.2 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.996 -1.065 . . . . 51.33 109.534 176.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.472 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.6 -41.57 90.61 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.128 -0.982 . . . . 70.1 109.452 176.483 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.765 HD12 ' CD1' ' A' ' 171' ' ' PHE . 46.6 tp -60.1 -40.11 88.5 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.338 -0.851 . . . . 74.23 110.21 176.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.752 ' HA ' HD12 ' A' ' 47' ' ' LEU . 29.5 mttt -56.29 -51.15 69.25 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 73.34 110.19 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -62.76 -36.68 83.86 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 119.762 -0.775 . . . . 62.41 109.457 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.634 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 52.1 mt-30 -76.8 -32.12 57.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.655 -0.653 . . . . 72.04 110.385 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.752 HD12 ' HA ' ' A' ' 44' ' ' LYS . 1.1 mt -49.86 139.99 16.11 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.255 -0.903 . . . . 64.42 110.168 -176.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 19.4 Cg_exo -61.34 142.83 97.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.964 1.507 . . . . 71.22 110.11 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -57.04 -35.07 68.86 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.184 -0.947 . . . . 75.11 109.816 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.08 -40.44 98.52 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.784 -1.326 . . . . 71.01 109.784 179.449 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.477 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -73.87 143.54 45.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.163 -1.198 . . . . 72.11 110.48 -178.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 24.9 mttm -96.69 157.78 15.74 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.51 -0.744 . . . . 74.11 109.633 176.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.573 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 49.1 t80 -125.01 161.44 26.72 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.833 -1.167 . . . . 64.12 110.744 178.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.555 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -148.07 161.19 41.9 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.512 -0.743 . . . . 74.24 110.053 -176.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.495 ' HE3' ' NZ ' ' A' ' 44' ' ' LYS . 17.3 mttp -125.93 144.96 50.47 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 74.21 110.57 -179.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.512 ' OD1' ' NE2' ' A' ' 139' ' ' GLN . 4.8 t30 -145.39 142.1 29.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.885 . . . . 65.33 110.11 179.693 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 5.2 p-80 -123.04 136.08 54.69 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.854 -1.154 . . . . 75.14 110.378 178.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.563 HG23 ' O ' ' A' ' 58' ' ' VAL . 32.5 m -93.5 131.9 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.13 -0.981 . . . . 64.32 110.837 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.461 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 91.8 p -94.07 -10.55 33.03 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.303 -0.873 . . . . 63.24 110.334 173.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.627 ' CZ ' ' CG ' ' A' ' 61' ' ' MET . 0.2 OUTLIER -60.81 -42.45 97.69 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.844 -1.16 . . . . 61.33 110.476 -172.234 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.627 ' CG ' ' CZ ' ' A' ' 60' ' ' PHE . 36.8 mtm -64.89 -34.76 79.16 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.91 -1.119 . . . . 73.12 110.258 174.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.629 ' CA ' ' CE2' ' A' ' 29' ' ' TYR . . . -57.02 -43.9 93.07 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.919 -1.272 . . . . 64.31 109.919 -177.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 92.92 -141.99 15.78 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.414 -1.474 . . . . 34.13 109.414 -178.055 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -54.09 -37.59 64.42 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.099 -1.236 . . . . 73.2 111.05 -177.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 102' ' ' ASP . 24.7 ttt -92.47 6.31 47.57 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.915 -1.116 . . . . 71.21 110.625 -176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.466 ' HA2' ' OH ' ' A' ' 29' ' ' TYR . . . -57.67 -43.18 94.49 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.513 -1.435 . . . . 72.02 109.513 -179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -59.91 -38.75 83.2 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.143 -1.21 . . . . 62.31 110.235 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.19 -49.18 73.03 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.021 -1.049 . . . . 45.42 110.445 -179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.48 ' HB2' ' OH ' ' A' ' 29' ' ' TYR . 97.4 mmm -60.81 -40.85 94.25 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.983 -1.073 . . . . 73.04 110.584 -178.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.564 ' OG ' ' CD2' ' A' ' 57' ' ' HIS . 20.8 t -59.43 -48.8 80.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.929 -1.107 . . . . 75.43 109.962 178.104 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.714 ' HG2' HG21 ' A' ' 133' ' ' VAL . 20.2 mttt -58.47 -34.02 70.41 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.06 -1.025 . . . . 63.13 110.218 176.384 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.442 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.38 -48.47 81.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.026 -1.046 . . . . 61.33 110.295 -178.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 86.6 t80 -57.97 -44.63 87.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.959 -1.088 . . . . 54.21 109.904 175.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.034 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.48 -38.34 86.93 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.968 -1.082 . . . . 72.31 109.84 177.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.0 m -59.36 -43.13 92.89 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.064 -1.023 . . . . 62.21 109.682 177.085 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.525 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 40.3 mtt -53.59 -41.98 67.14 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.04 -1.038 . . . . 71.04 108.91 176.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.981 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.8 mt -59.73 -44.46 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.491 -0.756 . . . . 73.32 110.363 -178.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.15 -37.18 71.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.994 -1.066 . . . . 75.32 110.243 176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.973 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.2 mt -90.8 6.18 45.34 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.099 -1.001 . . . . 54.3 111.028 -176.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.7 mt-10 56.4 29.84 15.91 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.926 -1.109 . . . . 73.12 109.907 -176.307 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.857 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.6 m -118.19 20.85 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.395 -0.816 . . . . 73.32 111.038 -176.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.628 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.4 mp0 -57.59 -54.34 47.91 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.598 -1.314 . . . . 71.25 109.988 -178.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -52.01 -42.47 63.03 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.946 -1.096 . . . . 73.11 110.551 -178.094 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.712 ' O ' HG23 ' A' ' 88' ' ' VAL . 16.2 tttp -70.94 -52.73 18.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.173 -0.954 . . . . 73.02 111.121 -175.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.702 ' HG3' HD11 ' A' ' 115' ' ' ILE . 0.0 OUTLIER -80.55 -30.67 37.05 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.274 -0.891 . . . . 64.51 111.098 -174.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.9 t -49.32 -57.17 12.52 Favored Pre-proline 0 C--N 1.296 -1.748 0 O-C-N 120.96 -1.088 . . . . 74.4 109.761 -174.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.538 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 19.5 Cg_endo -64.77 -26.25 60.39 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.3 1.158 . . . . 74.12 111.103 176.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.712 HG23 ' O ' ' A' ' 84' ' ' LYS . 88.3 t -61.86 -41.92 92.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 120.758 -1.214 . . . . 63.33 109.631 178.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.6 ' CB ' ' CD1' ' A' ' 28' ' ' PHE . 10.3 mtp -65.36 -42.21 93.04 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.166 -0.959 . . . . 74.03 109.932 177.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.683 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 26.8 m-85 -69.39 -40.55 77.32 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.757 -1.214 . . . . 75.45 110.417 178.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.526 ' O ' ' HB ' ' A' ' 95' ' ' THR . 62.9 t30 -57.14 -56.58 19.89 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.098 -1.001 . . . . 74.35 109.489 174.201 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.824 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.1 ttm-85 -52.09 -35.92 49.23 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.328 -0.858 . . . . 75.14 110.23 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.696 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -81.3 -60.27 2.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.162 -0.961 . . . . 72.45 110.591 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.452 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 38.1 t-80 -76.07 -11.55 59.96 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.218 -0.926 . . . . 72.44 111.215 -171.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.526 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -125.43 -66.1 0.97 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.849 -1.157 . . . . 71.11 110.47 -176.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.824 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.5 mt -62.94 -25.17 68.22 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.979 -1.076 . . . . 74.4 109.678 178.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 88.2 mtt180 58.2 33.15 22.87 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.428 -0.795 . . . . 74.14 109.823 -175.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -130.71 71.77 82.19 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.383 -0.823 . . . . 74.35 110.019 178.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 23.4 Cg_exo -59.36 153.96 50.34 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.017 1.535 . . . . 71.45 110.124 179.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -56.43 111.83 0.9 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.923 1.486 . . . . 74.43 110.046 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 39.0 tptt -58.8 -44.95 90.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.447 -0.783 . . . . 72.31 110.483 -179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.48 ' O ' ' HE1' ' A' ' 65' ' ' MET . 76.9 m-20 -144.02 -172.07 3.68 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.511 -0.743 . . . . 74.51 109.411 -179.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.18 -33.39 70.89 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.822 -1.174 . . . . 71.33 109.503 170.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -68.11 -51.4 46.79 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.002 -1.061 . . . . 74.55 111.205 -176.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.449 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -60.0 -36.4 77.13 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 120.67 -1.269 . . . . 65.14 108.879 176.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.005 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.8 tp -60.94 -42.71 98.73 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.578 -0.701 . . . . 54.15 110.255 178.304 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 78.8 mtp180 -60.4 -43.08 97.03 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.829 -1.169 . . . . 71.3 110.329 177.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.7 tp60 -60.16 -40.28 89.34 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.049 -1.032 . . . . 71.4 110.286 179.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.005 HD12 ' HA ' ' A' ' 106' ' ' LEU . 71.2 mt -54.84 -46.85 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.087 -1.008 . . . . 73.2 109.855 179.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.571 ' CD2' ' SD ' ' A' ' 85' ' ' MET . 24.6 m-85 -61.51 -51.38 68.86 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.161 -0.962 . . . . 53.42 110.845 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.835 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -63.03 -41.64 99.57 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 120.813 -1.179 . . . . 73.51 110.138 -176.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 58.1 t0 -60.18 -37.95 81.75 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.052 -1.03 . . . . 73.05 110.363 177.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.672 ' CD ' HG21 ' A' ' 88' ' ' VAL . 39.5 tp10 -66.3 -5.57 11.02 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.362 -0.837 . . . . 73.24 110.912 -175.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 107.22 14.23 19.07 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.664 -1.374 . . . . 72.31 109.664 179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.702 HD11 ' HG3' ' A' ' 85' ' ' MET . 73.0 mt -106.02 154.6 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.154 -1.204 . . . . 54.14 110.559 -178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.53 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -88.05 143.57 27.01 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.137 -0.977 . . . . 71.24 110.438 -174.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.835 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -66.64 -33.96 76.81 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.178 -0.951 . . . . 52.22 109.431 176.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.98 -48.38 79.08 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.481 -0.762 . . . . 63.11 110.749 -179.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.973 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.79 -36.91 56.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.827 -1.171 . . . . 72.34 110.501 -176.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.81 ' HA ' HD11 ' A' ' 79' ' ' LEU . 77.8 t80 -59.46 -41.73 90.37 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 120.808 -1.183 . . . . 70.24 110.095 174.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 90.2 m-20 -61.94 -43.12 99.51 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.157 -0.964 . . . . 64.24 109.743 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -59.53 -33.34 71.25 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.317 -0.865 . . . . 73.33 110.165 178.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.718 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -81.23 -43.28 19.46 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.071 -1.018 . . . . 73.34 110.877 -176.351 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -59.36 -32.31 70.0 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.18 -0.95 . . . . 72.34 110.152 -178.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.1 p-10 -95.91 9.4 40.75 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.226 -0.922 . . . . 74.35 110.343 -176.671 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -78.51 132.64 11.84 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.79 -1.324 . . . . 43.32 109.79 -179.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -58.05 -29.97 65.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.014 -1.286 . . . . 74.21 109.845 176.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.7 -48.11 80.48 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 33.5 109.983 178.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.034 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.3 t -57.55 -46.2 86.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 120.813 -1.179 . . . . 73.13 109.71 174.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -55.92 -39.42 71.63 Favored 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.42 -0.8 . . . . 70.34 110.499 -178.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.527 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 85.0 p -67.96 -31.59 71.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.225 -0.922 . . . . 71.13 110.479 -179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.846 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 75.7 mtm -75.23 -36.53 61.33 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.035 -1.041 . . . . 73.34 110.151 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.714 HG21 ' HG2' ' A' ' 71' ' ' LYS . 37.5 t -64.07 -48.33 86.32 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 O-C-N 121.4 -0.812 . . . . 63.44 110.284 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.527 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.3 ptt180 -65.01 -40.46 94.92 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.442 -1.411 . . . . 75.14 109.554 175.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 37.6 ttm-85 -48.97 -63.6 1.05 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.565 -0.71 . . . . 74.12 111.12 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.627 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 0.5 OUTLIER -55.1 -45.74 75.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.717 -1.239 . . . . 65.44 110.418 -175.258 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.627 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -50.51 -47.44 57.4 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.867 -1.146 . . . . 73.15 109.913 -174.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 58.0 mttp -62.77 -39.15 93.3 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.988 -1.07 . . . . 71.52 110.809 175.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.512 ' NE2' ' OD1' ' A' ' 56' ' ' ASN . 16.0 mt-30 -58.65 -45.8 88.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.808 -1.183 . . . . 72.23 110.367 -176.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.599 ' CE1' ' HB2' ' A' ' 145' ' ' LEU . 63.9 t80 -68.19 -39.62 82.42 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.167 -0.958 . . . . 75.42 110.432 179.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -64.2 -52.08 60.59 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.783 -0.767 . . . . 74.43 110.318 -179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.662 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.4 m-20 -59.86 -38.76 83.06 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.256 -0.903 . . . . 62.21 110.256 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.567 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.3 p -64.76 -21.95 66.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.442 -0.786 . . . . 73.33 110.678 -177.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.22 27.87 69.23 Favored Glycine 0 N--CA 1.487 2.087 0 N-CA-C 109.027 -1.629 . . . . 73.22 109.027 -176.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 158' ' ' LEU . 42.3 mt -79.94 136.98 36.76 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.217 -1.167 . . . . 72.43 110.165 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 44.6 p -111.18 5.29 19.91 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.363 -0.836 . . . . 51.32 110.21 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 169.31 122.15 0.61 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.754 -1.338 . . . . 51.2 109.754 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.602 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 1.1 m -84.77 172.73 8.35 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.311 -1.111 . . . . 72.02 108.784 177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.602 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 12.4 Cg_exo -67.19 142.44 62.11 Favored 'Cis proline' 0 C--N 1.315 -1.211 0 C-N-CA 122.707 -1.789 . . . . 63.12 111.329 4.616 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.823 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -135.61 138.97 43.46 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.273 -0.892 . . . . 41.13 109.424 172.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.661 HG21 ' OH ' ' A' ' 170' ' ' TYR . 42.6 t -112.85 128.47 69.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.921 -1.112 . . . . 63.4 109.913 -178.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.492 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.9 t -115.72 131.92 66.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.213 -0.929 . . . . 64.33 110.037 179.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.825 HG11 ' HB2' ' A' ' 177' ' ' LEU . 30.4 t -106.53 130.31 58.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 O-C-N 121.35 -0.844 . . . . 43.32 109.776 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.51 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 21.7 m-20 47.73 33.29 3.03 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.361 -0.837 . . . . 75.34 110.431 -177.658 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.513 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.3 t30 45.16 30.76 0.67 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.25 -0.906 . . . . 72.14 110.462 174.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.683 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.2 tpt180 -143.08 -30.61 0.51 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.08 -1.012 . . . . 73.44 110.487 -178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 1.002 ' CE1' HG22 ' A' ' 11' ' ' VAL . 69.1 m-85 -112.13 140.99 46.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.819 -1.176 . . . . 62.33 110.291 175.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.9 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.35 125.96 52.31 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.292 -0.88 . . . . 64.4 108.973 177.576 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.769 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.9 t -81.7 119.49 31.39 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 C-N-CA 119.67 -0.812 . . . . 73.54 110.4 -173.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.515 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -89.72 -56.89 3.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.372 -0.83 . . . . 65.2 109.926 175.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 69.6 18.35 73.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.721 -1.351 . . . . 73.33 109.721 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.46 -39.37 79.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.159 -1.2 . . . . 73.53 110.402 -178.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.509 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 48.0 p -87.72 -0.24 56.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.212 -0.93 . . . . 60.01 110.485 -178.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -81.09 115.88 20.75 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.082 -1.011 . . . . 74.42 110.322 -178.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.7 pttp -88.5 -11.08 46.83 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 52.44 110.431 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.4 p -149.95 159.46 44.37 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.157 -0.965 . . . . 74.23 109.989 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.479 HD21 HG23 ' A' ' 39' ' ' ILE . 44.5 mt -53.72 -29.74 40.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.041 -1.037 . . . . 62.32 110.863 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -56.83 -40.47 76.12 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 120.717 -1.24 . . . . 63.42 110.332 -179.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.519 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 41.1 tp10 -80.19 -43.31 21.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.844 -1.16 . . . . 70.35 110.479 178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.661 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.4 t80 -59.43 -43.31 93.1 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.963 -1.085 . . . . 75.2 109.57 177.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.765 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.7 t80 -59.94 -46.39 89.57 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.37 -0.831 . . . . 73.33 110.221 175.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.585 ' OD1' ' CE1' ' A' ' 3' ' ' PHE . 0.0 OUTLIER -56.86 -46.43 81.81 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 120.957 -1.09 . . . . 62.04 109.949 -175.768 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.518 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.8 tp -53.85 -52.11 61.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.025 -1.047 . . . . 73.13 109.859 176.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.654 HG22 HG21 ' A' ' 159' ' ' VAL . 55.5 t -51.52 -42.2 28.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.139 -0.976 . . . . 74.22 109.596 179.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.554 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.6 m120 -59.56 -43.25 93.62 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.936 . . . . 73.11 110.573 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.498 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 74.3 m-85 -67.3 -40.28 86.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.11 -0.994 . . . . 71.34 110.164 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.004 ' HA ' HD12 ' A' ' 180' ' ' LEU . 76.7 mt -60.71 -38.39 84.91 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.294 -0.878 . . . . 71.12 109.558 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.554 HD12 ' HA ' ' A' ' 175' ' ' ASN . 11.8 mt -59.14 -32.34 69.77 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.175 -0.953 . . . . 74.22 109.48 172.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.471 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 36.4 m -74.06 -27.42 60.9 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.385 -0.822 . . . . 72.4 109.977 177.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.004 HD12 ' HA ' ' A' ' 177' ' ' LEU . 8.8 mt -88.06 142.39 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.42 -0.8 . . . . 72.13 110.241 -176.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.403 ' O ' ' HG2' ' A' ' 181' ' ' LYS . 57.6 tttm . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.207 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.246 0.546 . . . . 71.14 110.184 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 26.1 mt-30 -59.16 -32.93 70.33 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.315 -0.866 . . . . 70.15 110.319 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.521 ' CE2' ' HB2' ' A' ' 173' ' ' LEU . 79.6 m-85 -96.79 125.42 41.23 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.151 -0.968 . . . . 73.02 110.428 -174.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 22.5 tptp -150.98 149.1 29.18 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 73.24 110.158 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.663 ' CD ' HG21 ' A' ' 11' ' ' VAL . 98.6 mt-10 -60.42 131.72 51.66 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.287 -0.883 . . . . 63.31 110.45 -179.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.11 -11.51 60.31 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 108.927 -1.669 . . . . 64.34 108.927 -176.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.497 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 87.7 mt-10 -109.02 -69.04 0.88 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.179 -1.189 . . . . 75.41 110.812 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 10.7 m170 -97.6 -13.83 21.36 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.184 -0.947 . . . . 74.51 109.75 179.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.583 ' CG ' HD21 ' A' ' 177' ' ' LEU . 8.0 p90 -157.71 170.7 21.79 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 52.33 110.057 172.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.527 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.6 mt-30 -122.11 141.81 51.03 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.291 -0.881 . . . . 73.01 109.407 172.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.94 HG22 ' CE2' ' A' ' 157' ' ' TYR . 37.9 t -91.0 132.15 36.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 120.97 -1.082 . . . . 73.31 110.408 -177.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB3' ' OG1' ' A' ' 14' ' ' THR . 67.2 mt -99.79 148.09 24.78 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.568 -0.708 . . . . 74.24 110.433 -176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 33.2 pttt -76.28 -0.28 21.84 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.174 -0.954 . . . . 72.02 109.903 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.575 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.25 158.88 53.45 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.257 -0.902 . . . . 74.55 110.203 -179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.3 Cg_endo -63.75 136.11 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 124.023 1.538 . . . . 45.32 110.466 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.677 ' HB2' ' HB2' ' A' ' 156' ' ' ARG . . . -98.94 150.98 21.38 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.24 -0.912 . . . . 62.43 109.895 176.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.3 t -72.98 144.44 47.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.15 -0.969 . . . . 61.05 110.265 -179.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.2 m -55.89 -35.1 66.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.169 -0.957 . . . . 74.34 109.76 178.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.409 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.1 OUTLIER -112.4 172.26 3.68 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.345 -0.847 . . . . 74.11 109.679 175.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.502 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 42.5 Cg_endo -68.88 127.56 15.49 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.863 1.454 . . . . 73.34 110.029 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.2 p -145.73 135.56 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.806 -1.184 . . . . 74.23 110.084 172.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.523 ' O ' ' N ' ' A' ' 54' ' ' GLN . 13.5 t -115.26 129.53 71.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.532 0 O-C-N 121.009 -1.057 . . . . 63.13 109.827 -178.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 88.4 p -118.51 133.99 55.44 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.136 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.909 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.2 tt0 -103.1 125.44 49.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.443 -0.785 . . . . 74.51 110.198 177.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.526 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 89.4 m-85 -102.44 122.0 43.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.302 -0.874 . . . . 73.45 109.739 177.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.458 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.6 p90 -141.32 166.88 23.55 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.491 -0.755 . . . . 70.32 110.662 -178.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.622 ' HB3' ' HE1' ' A' ' 61' ' ' MET . 21.9 t -130.95 134.5 46.79 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.346 -0.846 . . . . 72.13 110.279 178.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.594 ' CD1' ' HB3' ' A' ' 89' ' ' MET . 87.6 m-85 -60.42 -12.64 10.01 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.262 -0.899 . . . . 73.24 110.567 179.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.596 ' CE2' ' HG3' ' A' ' 69' ' ' MET . 67.8 m-85 -104.71 18.51 22.13 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.237 -0.914 . . . . 74.32 111.106 -176.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.533 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 4.9 t -122.55 99.36 42.47 Favored Pre-proline 0 N--CA 1.49 1.532 0 O-C-N 120.702 -1.249 . . . . 34.41 110.431 -175.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.38 -44.9 45.14 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.979 1.515 . . . . 74.12 110.068 179.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.66 -49.3 78.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.138 -0.976 . . . . 75.33 110.089 176.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.533 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 1.1 t -63.34 -46.75 85.14 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.065 -1.022 . . . . 63.23 110.288 178.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 7.1 m-20 -55.51 -38.35 69.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.078 -1.014 . . . . 64.23 110.188 -177.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -66.32 -42.4 88.26 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.123 -0.986 . . . . 63.24 110.354 178.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.887 ' CE2' HD11 ' A' ' 40' ' ' ILE . 63.1 t80 -63.69 -33.09 74.86 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.279 -0.888 . . . . 71.51 110.508 -179.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 22.9 tp10 -39.09 -57.96 1.96 Allowed Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 121.23 -0.919 . . . . 62.11 111.222 -175.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.0 Cg_endo -52.05 -40.76 67.37 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.187 1.098 . . . . 75.43 110.562 -179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.621 HG23 HD21 ' A' ' 167' ' ' LEU . 20.8 mm -55.3 -48.42 76.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 120.782 -1.199 . . . . 74.02 109.914 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.909 HG21 ' OE1' ' A' ' 24' ' ' GLU . 34.5 mm -57.2 -41.26 77.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.016 -1.053 . . . . 72.13 110.155 177.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -56.09 -39.93 72.89 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.07 -1.019 . . . . 51.33 109.482 176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.586 HE21 HD13 ' A' ' 39' ' ' ILE . 13.5 mt-30 -60.66 -41.55 95.25 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 70.1 109.57 176.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.733 HD12 ' CD1' ' A' ' 171' ' ' PHE . 60.2 tp -60.47 -41.86 95.04 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.359 -0.838 . . . . 74.23 110.503 178.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.0 mtpp -60.08 -48.76 80.36 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.371 -0.831 . . . . 73.34 110.533 -178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.9 mt-30 -62.26 -37.72 86.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 62.41 109.41 178.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.599 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 49.2 mt-30 -75.96 -30.28 58.58 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.697 -0.627 . . . . 72.04 110.403 178.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -51.24 146.45 11.54 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 64.42 110.397 -175.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.565 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.0 Cg_endo -66.09 142.68 68.78 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.019 1.536 . . . . 71.22 110.07 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -56.6 -34.57 67.32 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.093 -1.004 . . . . 75.11 109.855 178.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.96 -39.66 97.34 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.821 -1.312 . . . . 71.01 109.821 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.481 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -75.05 141.75 43.83 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.131 -1.217 . . . . 72.11 110.525 -177.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.412 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 83.9 mttt -96.97 158.69 15.3 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.552 -0.717 . . . . 74.11 109.681 175.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.543 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 54.2 t80 -126.45 159.84 32.21 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.692 -1.255 . . . . 64.12 110.991 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.523 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.6 tt0 -149.66 161.16 42.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.542 -0.724 . . . . 74.24 110.089 -177.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.407 ' N ' ' HG2' ' A' ' 54' ' ' GLN . 39.9 mttm -128.73 148.94 50.88 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.988 -1.07 . . . . 74.21 110.562 -179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.507 ' ND2' ' OE1' ' A' ' 139' ' ' GLN . 0.6 OUTLIER -144.65 141.96 29.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.321 -0.862 . . . . 65.33 110.464 -177.702 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.1 OUTLIER -111.86 133.46 54.05 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.01 -1.056 . . . . 75.14 109.526 178.683 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 58' ' ' VAL . 23.5 m -100.2 131.16 48.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 120.95 -1.094 . . . . 64.32 110.675 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 55.0 p -94.73 -9.66 34.01 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.114 -0.991 . . . . 63.24 110.127 171.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 61' ' ' MET . 1.2 p90 -54.67 -30.08 54.48 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.933 . . . . 61.33 110.52 -172.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.622 ' HE1' ' HB3' ' A' ' 27' ' ' SER . 0.9 OUTLIER -106.32 -16.57 14.53 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.119 -0.988 . . . . 73.12 109.979 176.779 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.54 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -58.03 -38.24 88.55 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.552 -1.419 . . . . 64.31 109.552 178.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 89.81 -148.96 20.17 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.505 -1.438 . . . . 34.13 109.505 -179.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 48.2 t-20 -53.53 -37.62 63.01 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.057 -1.261 . . . . 73.2 110.824 -178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.493 ' SD ' ' HA ' ' A' ' 102' ' ' ASP . 73.0 mmm -91.53 6.19 46.59 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.018 -1.051 . . . . 71.21 110.865 -177.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.93 -50.44 65.66 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.725 -1.35 . . . . 72.02 109.725 -179.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -60.17 -39.85 87.87 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.059 -1.26 . . . . 62.31 110.307 -179.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.36 -45.99 88.62 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.047 -1.033 . . . . 45.42 110.427 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.596 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 98.3 mmm -60.83 -41.31 95.53 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.079 . . . . 73.04 110.589 -178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.561 ' OG ' ' CE2' ' A' ' 136' ' ' PHE . 22.9 t -58.77 -48.62 80.59 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.902 -1.123 . . . . 75.43 109.801 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.99 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.9 mttt -58.85 -33.51 70.54 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.955 -1.091 . . . . 63.13 110.127 174.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.503 ' HB3' ' O ' ' A' ' 69' ' ' MET . . . -61.45 -47.04 87.53 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.058 -1.026 . . . . 61.33 110.305 -177.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 48.3 t80 -58.44 -44.82 89.31 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.863 -1.148 . . . . 54.21 109.58 175.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.937 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -61.36 -38.18 86.02 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.121 -0.987 . . . . 72.31 109.822 176.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 123' ' ' ALA . 30.2 m -58.99 -44.0 91.54 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.175 -0.953 . . . . 62.21 109.681 176.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.505 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 60.3 mtt -53.27 -42.16 66.25 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.067 -1.021 . . . . 71.04 109.166 176.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.937 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.1 mt -59.35 -44.36 92.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.735 -0.786 . . . . 73.32 110.101 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.779 ' HB3' ' CB ' ' A' ' 123' ' ' ALA . . . -58.2 -35.79 72.15 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.0 -1.062 . . . . 75.32 110.215 174.024 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.917 ' O ' HG13 ' A' ' 81' ' ' VAL . 47.7 mt -88.93 3.17 52.36 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.201 -0.937 . . . . 54.3 110.872 -176.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 56.2 28.84 13.76 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.885 -1.134 . . . . 73.12 109.958 -175.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.917 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -119.12 20.75 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.245 -0.909 . . . . 73.32 111.141 -176.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.581 ' O ' HG23 ' A' ' 86' ' ' VAL . 4.8 mp0 -56.8 -56.82 16.67 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.668 -1.27 . . . . 71.25 109.909 -178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -48.95 -42.94 39.15 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 120.993 -1.067 . . . . 73.11 110.728 -178.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 23.4 tttp -76.24 -58.99 2.96 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.269 -0.895 . . . . 73.02 111.014 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.578 ' HE2' ' CD2' ' A' ' 110' ' ' PHE . 93.6 mmm -71.31 -32.96 69.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.335 -0.853 . . . . 64.51 111.052 -174.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.581 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.5 t -45.99 -56.98 9.0 Favored Pre-proline 0 C--N 1.298 -1.66 0 O-C-N 120.905 -1.122 . . . . 74.4 109.63 -178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.0 Cg_endo -62.86 -26.39 74.59 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.156 1.082 . . . . 74.12 111.016 176.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.665 HG11 ' HG3' ' A' ' 113' ' ' GLU . 85.9 t -62.29 -40.82 89.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.658 -1.276 . . . . 63.33 109.668 178.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.594 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 6.3 mmt -58.71 -43.3 90.06 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.073 -1.017 . . . . 74.03 109.639 176.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 94' ' ' HIS . 42.9 m-85 -75.06 -42.94 55.88 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.789 -1.194 . . . . 75.45 110.971 -178.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.4 t30 -55.69 -42.25 74.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.01 -1.057 . . . . 74.35 109.422 174.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.85 ' HA ' HD12 ' A' ' 96' ' ' LEU . 20.6 tpt180 -60.8 -37.51 82.19 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 121.425 -0.797 . . . . 75.14 109.461 174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.558 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -91.7 -71.38 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.478 -0.764 . . . . 72.45 110.999 -177.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.517 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.6 t60 -62.28 -20.61 64.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.081 -1.012 . . . . 72.44 110.59 -172.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.608 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.53 -70.64 0.79 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.158 -0.964 . . . . 71.11 109.976 -176.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.85 HD12 ' HA ' ' A' ' 92' ' ' ARG . 80.1 mt -61.03 -26.75 67.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.278 -0.889 . . . . 74.4 110.029 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 94.1 mtt-85 58.1 32.82 22.49 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.402 -0.811 . . . . 74.14 110.332 -179.002 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.508 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -126.36 71.51 71.4 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.313 -0.867 . . . . 74.35 109.955 176.576 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.493 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 21.6 Cg_exo -60.15 142.32 98.05 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.957 1.504 . . . . 71.45 110.351 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.573 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.9 Cg_endo -59.44 136.29 70.63 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 123.924 1.486 . . . . 74.43 110.193 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.474 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 19.2 ptmt -95.89 -25.41 16.01 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 72.31 110.5 -178.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.493 ' HA ' ' SD ' ' A' ' 65' ' ' MET . 69.4 m-20 -142.74 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.161 -0.962 . . . . 74.51 109.716 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -58.16 -26.98 63.38 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.064 -1.022 . . . . 71.33 109.532 173.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -69.18 -53.59 19.23 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.256 -0.903 . . . . 74.55 110.899 -176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.474 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.6 mm-40 -60.94 -38.19 85.0 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.993 -1.067 . . . . 65.14 109.003 177.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.023 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.3 tp -59.28 -43.57 92.53 Favored 'General case' 0 C--N 1.3 -1.559 0 O-C-N 121.471 -0.768 . . . . 54.15 110.157 177.115 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 35.5 ttm180 -59.11 -45.65 90.34 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.911 -1.118 . . . . 71.3 110.423 179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.1 tp60 -58.96 -40.53 84.99 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.998 -1.064 . . . . 71.4 110.154 179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.023 HD12 ' HA ' ' A' ' 106' ' ' LEU . 83.4 mt -54.08 -49.0 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.114 -0.991 . . . . 73.2 110.149 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.578 ' CD2' ' HE2' ' A' ' 85' ' ' MET . 33.9 m-85 -58.55 -48.32 81.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.996 -1.065 . . . . 53.42 110.51 177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.886 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.4 mt -59.17 -41.85 89.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.023 -1.048 . . . . 73.51 110.219 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.96 -39.66 75.01 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.096 -1.003 . . . . 73.05 110.441 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.665 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.3 mm-40 -73.06 2.06 7.8 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.197 -0.939 . . . . 73.24 111.189 -175.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.83 6.9 45.59 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.743 -1.343 . . . . 72.31 109.743 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.526 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 30.3 mm -80.85 148.46 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.105 -1.232 . . . . 54.14 109.701 177.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.542 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.8 m-20 -89.31 131.42 35.41 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.031 -1.043 . . . . 71.24 110.175 -179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.886 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -53.66 -41.63 67.01 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.914 -1.116 . . . . 52.22 109.43 -179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.26 -40.22 96.79 Favored 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.316 -0.865 . . . . 63.11 110.014 172.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.871 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -66.17 -49.32 67.79 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.733 0.778 . . . . 72.34 110.43 -176.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.727 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.6 t80 -62.64 -41.77 99.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.259 -0.901 . . . . 70.24 110.154 177.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.409 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.4 m-20 -59.01 -41.8 88.58 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.794 -0.762 . . . . 64.24 109.596 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.75 -40.15 91.38 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.199 -0.938 . . . . 73.33 110.04 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.779 ' CB ' ' HB3' ' A' ' 78' ' ' ALA . . . -72.42 -45.27 60.4 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.262 -0.899 . . . . 73.34 111.003 -176.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.52 ' N ' HG23 ' A' ' 75' ' ' THR . 47.3 t80 -59.48 -31.73 69.6 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.181 -0.949 . . . . 72.34 109.652 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -88.14 6.3 37.19 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.405 -0.809 . . . . 74.35 110.131 -178.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -70.41 130.46 21.09 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.724 -1.351 . . . . 43.32 109.724 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.419 ' CG ' ' N ' ' A' ' 128' ' ' ALA . 51.7 p90 -59.36 -33.54 71.29 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.124 -1.221 . . . . 74.21 109.597 176.005 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.419 ' N ' ' CG ' ' A' ' 127' ' ' PHE . . . -59.97 -43.26 95.2 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.202 -0.936 . . . . 33.5 110.08 177.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.959 ' HA ' ' HE3' ' A' ' 132' ' ' MET . 38.9 t -57.0 -50.36 76.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 120.945 -1.097 . . . . 73.13 110.028 178.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -57.14 -39.77 75.86 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.211 -0.931 . . . . 70.34 109.954 -177.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.548 ' HA ' ' CD ' ' A' ' 134' ' ' ARG . 22.8 t -63.58 -34.73 78.45 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.268 -0.895 . . . . 71.13 110.477 179.386 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.959 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 61.2 mtm -72.56 -39.19 67.65 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.055 -1.028 . . . . 73.34 110.174 -178.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.99 HG21 ' HG2' ' A' ' 71' ' ' LYS . 21.4 t -66.11 -46.6 87.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 121.564 -0.71 . . . . 63.44 110.343 -178.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.548 ' CD ' ' HA ' ' A' ' 131' ' ' SER . 15.6 ptm180 -62.1 -40.67 96.65 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.584 -1.322 . . . . 75.14 109.613 175.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.2 OUTLIER -50.47 -71.45 0.06 Allowed 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.312 -0.868 . . . . 74.12 110.44 179.055 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.2 p90 -47.1 -43.56 20.55 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.955 -1.091 . . . . 65.44 110.648 -172.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.5 t0 -52.97 -49.73 65.53 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.811 -1.18 . . . . 73.15 109.849 -176.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.464 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 8.7 ttpt -61.59 -39.15 90.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.017 -1.052 . . . . 71.52 110.352 175.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.52 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 79.3 mt-30 -58.53 -46.92 85.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.07 -1.019 . . . . 72.23 110.78 -175.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.61 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 50.5 t80 -69.04 -37.71 78.74 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 121.141 -0.974 . . . . 75.42 109.912 -178.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -61.89 -52.06 65.62 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 120.138 -0.625 . . . . 74.43 110.61 -178.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.575 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.24 -35.3 80.06 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.033 -1.042 . . . . 62.21 110.27 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.647 ' OG ' HD12 ' A' ' 145' ' ' LEU . 97.4 p -63.63 -20.96 66.1 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.384 -0.823 . . . . 73.33 110.324 -179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.69 31.36 78.23 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.959 -1.656 . . . . 73.22 108.959 -176.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.055 HD22 ' HB1' ' A' ' 150' ' ' ALA . 30.6 mt -76.37 129.28 36.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.175 -1.191 . . . . 72.43 110.381 -177.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.1 m -65.63 -36.91 85.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.205 -0.935 . . . . 51.32 109.621 175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 178.86 -176.08 47.75 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.408 -1.477 . . . . 51.2 109.408 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.1 m -110.41 165.45 12.66 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.352 -1.087 . . . . 72.02 109.66 178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.542 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 33.5 Cg_endo -70.19 128.9 13.82 Favored 'Cis proline' 0 N--CA 1.491 1.343 0 C-N-CA 122.336 -1.944 . . . . 63.12 111.477 2.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 1.055 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.05 135.6 52.88 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.385 -0.822 . . . . 41.13 109.384 173.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.902 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -111.46 128.38 68.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.004 -1.06 . . . . 63.4 109.846 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.568 HG22 HD22 ' A' ' 158' ' ' LEU . 17.5 t -116.37 132.02 67.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 C-N-CA 119.368 -0.933 . . . . 64.33 110.03 -179.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.715 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.5 t -105.76 129.74 58.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.367 -0.833 . . . . 43.32 109.837 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.502 ' OD1' ' HA ' ' A' ' 20' ' ' PRO . 25.8 m-20 48.3 34.02 4.25 Favored 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.429 -0.794 . . . . 75.34 110.567 -177.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.498 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 1.2 t30 44.12 31.39 0.53 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.331 -0.856 . . . . 72.14 110.256 174.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.677 ' HB2' ' HB2' ' A' ' 16' ' ' ALA . 19.8 tpt180 -141.9 -31.79 0.54 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.201 -0.937 . . . . 73.44 110.316 -177.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.94 ' CE2' HG22 ' A' ' 11' ' ' VAL . 61.7 m-85 -112.66 140.13 47.69 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.909 -1.12 . . . . 62.33 110.315 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.993 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.2 125.94 52.22 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.278 -0.889 . . . . 64.4 109.072 178.002 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.892 HG13 ' CD2' ' A' ' 173' ' ' LEU . 93.8 t -83.35 120.39 34.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.326 -0.859 . . . . 73.54 110.382 -174.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.527 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.7 mt-30 -79.06 -52.18 8.55 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.234 -0.916 . . . . 65.2 109.58 173.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 66.74 8.03 45.17 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.802 -1.319 . . . . 73.33 109.802 177.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -61.87 -36.77 82.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.18 -1.189 . . . . 73.53 110.313 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.454 ' O ' ' OE1' ' A' ' 169' ' ' GLU . 75.7 m -86.45 3.1 45.3 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.31 -0.869 . . . . 60.01 110.547 -178.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -91.9 86.62 5.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.045 -1.034 . . . . 74.42 110.44 -178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 76.8 mttt -61.02 -27.14 68.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.175 -0.953 . . . . 52.44 110.003 176.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 48.5 m -131.98 153.15 50.63 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 74.23 109.987 -178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.621 HD21 HG23 ' A' ' 39' ' ' ILE . 35.9 mt -53.01 -26.64 16.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.068 -1.02 . . . . 62.32 110.787 -179.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -57.93 -41.66 83.2 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.71 -1.244 . . . . 63.42 110.462 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.485 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 81.8 tt0 -79.98 -42.48 23.83 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.907 -1.121 . . . . 70.35 110.39 178.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.902 ' OH ' HG21 ' A' ' 151' ' ' VAL . 77.2 t80 -62.32 -44.88 95.46 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.123 -0.986 . . . . 75.2 110.132 177.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.733 ' CD1' HD12 ' A' ' 43' ' ' LEU . 67.1 t80 -59.35 -46.64 88.08 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.381 -0.824 . . . . 73.33 110.118 176.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.555 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.7 m-20 -56.44 -42.76 78.66 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.214 -0.929 . . . . 62.04 110.475 -178.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.892 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.7 tp -54.11 -54.55 37.93 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.71 -1.244 . . . . 73.13 110.083 175.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -53.55 -43.93 55.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.985 -1.072 . . . . 74.22 109.947 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.565 ' HA ' HD12 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.85 -41.63 87.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.152 -0.967 . . . . 73.11 110.585 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.555 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 29.8 m-85 -67.4 -43.15 82.02 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.112 -0.992 . . . . 71.34 110.156 -179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.878 ' CD1' HG22 ' A' ' 159' ' ' VAL . 79.8 mt -59.81 -36.65 77.2 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.158 -0.964 . . . . 71.12 109.755 177.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.565 HD12 ' HA ' ' A' ' 175' ' ' ASN . 6.0 mt -58.39 -31.02 67.28 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.329 -0.857 . . . . 74.22 109.906 175.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.8 p -90.24 -12.81 36.85 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.318 -0.864 . . . . 72.4 110.321 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 157' ' ' TYR . 20.5 mt -97.5 141.69 30.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.293 -0.879 . . . . 72.13 110.263 -179.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 42.9 tttm . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.019 -0.991 . . . . 62.05 110.245 179.953 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.261 0.553 . . . . 71.14 110.29 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.515 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 37.7 mt-30 -58.78 -34.5 71.52 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.214 -0.929 . . . . 70.15 110.409 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CE1' ' CE2' ' A' ' 176' ' ' TYR . 54.4 p90 -129.75 163.11 26.91 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.244 -0.91 . . . . 73.02 110.669 -174.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.437 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 55.3 tptt -169.86 149.58 3.74 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.478 -0.764 . . . . 73.24 109.606 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 84.3 tt0 -55.51 134.43 50.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.011 -1.056 . . . . 63.31 109.921 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.1 1.25 79.6 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.503 -1.439 . . . . 64.34 109.503 -176.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 96.2 mt-10 -134.35 -60.25 0.8 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.107 -1.231 . . . . 75.41 110.372 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.647 ' HB3' HD22 ' A' ' 173' ' ' LEU . 6.2 m-70 -96.63 -15.3 21.6 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.139 -0.976 . . . . 74.51 109.954 178.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 51.6 p90 -157.49 173.09 17.42 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.467 -0.77 . . . . 52.33 110.548 176.081 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.522 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.8 mt-30 -130.06 158.28 40.07 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.494 -0.754 . . . . 73.01 109.617 175.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.564 HG22 ' CE2' ' A' ' 157' ' ' TYR . 98.2 t -104.75 132.22 51.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.02 -1.05 . . . . 73.31 110.716 -179.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.633 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -99.18 151.19 21.28 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.775 -0.578 . . . . 74.24 110.164 -179.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 17.2 pttm -73.41 -2.04 20.73 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.125 -0.984 . . . . 72.02 109.959 175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.533 ' CG2' ' HB3' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.28 156.81 67.49 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.314 -0.866 . . . . 74.55 110.4 -179.894 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -62.22 142.3 91.12 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.046 1.55 . . . . 45.32 110.458 179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.925 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.95 155.91 18.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.191 -0.943 . . . . 62.43 110.118 177.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 69.3 m -77.85 146.41 35.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.195 -0.941 . . . . 61.05 110.408 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -63.47 -29.93 71.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 74.34 109.821 177.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.463 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.6 OUTLIER -117.59 176.07 1.76 Allowed Pre-proline 0 N--CA 1.488 1.472 0 O-C-N 121.414 -0.804 . . . . 74.11 109.589 176.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.491 ' HB2' HD22 ' A' ' 178' ' ' LEU . 59.1 Cg_endo -71.9 127.46 12.97 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 110.01 -178.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.641 HG21 ' CD ' ' A' ' 54' ' ' GLN . 8.9 p -147.98 139.97 18.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.916 -1.115 . . . . 74.23 109.773 172.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.6 t -117.35 123.2 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 120.945 -1.097 . . . . 63.13 109.575 179.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.476 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 82.4 p -108.96 123.93 49.88 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.586 -1.321 . . . . 65.13 109.933 179.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.606 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.6 tt0 -100.35 125.2 46.57 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.495 -0.753 . . . . 74.51 109.905 179.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CB ' HG12 ' A' ' 148' ' ' VAL . 75.9 m-85 -98.84 122.26 41.85 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.343 -0.848 . . . . 73.45 109.804 178.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.45 ' HA ' ' SG ' ' A' ' 33' ' ' CYS . 52.6 p90 -141.77 168.96 18.52 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.353 0.597 . . . . 70.32 110.903 -178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.62 ' OG ' HG21 ' A' ' 148' ' ' VAL . 1.4 m -133.61 138.44 45.97 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.392 -0.818 . . . . 72.13 110.277 178.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.856 ' O ' HG21 ' A' ' 93' ' ' ILE . 89.1 m-85 -60.37 -15.58 27.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.014 . . . . 73.24 110.088 174.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.614 ' HA ' HG21 ' A' ' 93' ' ' ILE . 34.9 m-85 -104.37 18.84 21.37 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 74.32 110.975 -174.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.7 ' HB2' ' HE3' ' A' ' 61' ' ' MET . 2.5 t -122.83 99.15 41.89 Favored Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 120.875 -1.141 . . . . 34.41 110.391 -176.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.6 Cg_endo -57.52 -42.98 55.33 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.837 1.44 . . . . 74.12 110.033 -179.768 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 85.5 t60 -60.9 -49.16 78.59 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.039 -1.038 . . . . 75.33 110.09 175.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.8 OUTLIER -63.34 -49.94 71.97 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.034 -1.041 . . . . 63.23 110.339 178.932 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 26.1 m-20 -55.18 -37.45 67.06 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.033 -1.042 . . . . 64.23 110.224 -177.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 48.0 m -65.63 -41.75 92.27 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.098 -1.001 . . . . 63.24 110.275 177.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.818 ' CE2' HD11 ' A' ' 40' ' ' ILE . 68.6 t80 -63.53 -33.1 74.83 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.267 -0.896 . . . . 71.51 110.469 -179.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.545 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 11.1 tt0 -39.24 -58.16 1.97 Allowed Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.273 -0.892 . . . . 62.11 111.18 -175.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.553 ' O ' ' HB3' ' A' ' 41' ' ' ALA . 5.4 Cg_endo -52.43 -39.09 74.69 Favored 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.16 1.084 . . . . 75.43 110.523 -179.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.769 HD13 HE21 ' A' ' 42' ' ' GLN . 25.5 mm -55.13 -48.76 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 120.855 -1.153 . . . . 74.02 109.797 176.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.818 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.4 mm -56.63 -40.31 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.016 -1.053 . . . . 72.13 109.927 175.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.82 -38.7 72.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.005 -1.059 . . . . 51.33 109.652 176.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.769 HE21 HD13 ' A' ' 39' ' ' ILE . 40.9 mt-30 -57.7 -43.63 85.32 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.051 -1.031 . . . . 70.1 109.223 176.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.85 HD13 ' CD1' ' A' ' 171' ' ' PHE . 26.4 tp -58.09 -40.76 81.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.207 -0.933 . . . . 74.23 110.232 176.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.8 ' HA ' HD12 ' A' ' 47' ' ' LEU . 22.5 mttp -56.17 -46.69 79.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.205 -0.935 . . . . 73.34 110.242 -179.148 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -60.27 -34.4 73.67 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.306 -0.871 . . . . 62.41 109.358 176.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.518 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 44.8 mt-30 -94.36 1.88 55.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.626 -0.672 . . . . 72.04 110.306 -179.569 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.873 HD23 ' HD2' ' A' ' 48' ' ' PRO . 1.7 mt -73.73 141.58 79.3 Favored Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.258 -0.901 . . . . 64.42 110.249 -177.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.873 ' HD2' HD23 ' A' ' 47' ' ' LEU . 14.9 Cg_exo -64.88 138.77 59.19 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.868 1.457 . . . . 71.22 109.737 176.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -55.93 -34.71 65.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.132 -0.98 . . . . 75.11 109.834 179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.48 -37.32 94.48 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.988 -1.245 . . . . 71.01 109.988 -179.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.472 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -70.61 138.14 50.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.027 -1.278 . . . . 72.11 110.806 -174.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 55.1 mttt -97.56 153.31 18.26 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.551 -0.718 . . . . 74.11 109.614 174.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.639 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -121.68 127.35 50.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.773 -1.205 . . . . 64.12 110.737 -179.802 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.641 ' CD ' HG21 ' A' ' 21' ' ' VAL . 93.8 mt-30 -113.66 160.03 19.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 74.24 110.439 177.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.2 mttm -127.27 148.61 50.22 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.05 -1.031 . . . . 74.21 110.659 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.56 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 11.0 t-20 -136.44 136.63 39.67 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.407 -0.808 . . . . 65.33 110.301 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.677 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -111.07 119.06 37.75 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.038 -1.039 . . . . 75.14 109.403 177.568 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.631 HG23 ' O ' ' A' ' 58' ' ' VAL . 16.1 m -89.14 131.16 37.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 120.79 -1.194 . . . . 64.32 110.851 -177.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.449 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 53.8 p -94.53 -7.84 40.02 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.156 -0.965 . . . . 63.24 109.983 171.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.598 ' HE1' HG21 ' A' ' 58' ' ' VAL . 1.4 p90 -55.51 -28.32 54.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.124 -0.985 . . . . 61.33 110.608 -173.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.7 ' HE3' ' HB2' ' A' ' 30' ' ' CYS . 0.0 OUTLIER -103.25 -23.6 13.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.146 -0.971 . . . . 73.12 110.022 177.691 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.507 ' N ' ' HG3' ' A' ' 61' ' ' MET . . . -56.97 -35.22 67.75 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.517 -1.433 . . . . 64.31 109.517 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.85 -157.57 21.72 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.341 -1.504 . . . . 34.13 109.341 -177.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 24.1 m120 -54.11 -36.57 63.38 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.98 -1.306 . . . . 73.2 110.693 -178.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.549 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 24.3 ttt -84.87 -2.94 58.42 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.164 -0.96 . . . . 71.21 110.725 -177.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.449 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -57.1 -39.41 89.75 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.421 -1.472 . . . . 72.02 109.421 -178.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -59.46 -39.64 84.28 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.162 -1.199 . . . . 62.31 110.104 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.43 -44.46 87.28 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.069 -1.019 . . . . 45.42 110.337 178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.556 ' HG3' ' CE2' ' A' ' 29' ' ' TYR . 97.4 mmm -59.65 -45.28 92.47 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.952 -1.093 . . . . 73.04 110.516 -177.682 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.586 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 20.4 m -61.89 -43.93 97.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.947 -1.096 . . . . 75.43 110.017 177.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.585 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 22.4 tttt -60.02 -35.18 74.53 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.211 -0.93 . . . . 63.13 109.863 177.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.73 -45.2 91.01 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.118 -0.989 . . . . 61.33 110.197 179.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.677 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 21.9 t80 -54.86 -44.5 74.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.772 -1.205 . . . . 54.21 109.411 176.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.019 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.3 -38.94 88.62 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.027 -1.045 . . . . 72.31 109.873 175.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.773 HG23 ' HB3' ' A' ' 123' ' ' ALA . 31.5 m -56.75 -42.93 80.19 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.062 -1.024 . . . . 62.21 109.632 176.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.504 ' HB3' ' HA ' ' A' ' 82' ' ' GLU . 54.8 mtt -53.23 -42.72 66.68 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.019 -1.05 . . . . 71.04 108.947 175.961 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 1.004 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.9 mt -60.76 -44.28 97.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.579 -0.701 . . . . 73.32 110.48 -177.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.51 -36.27 71.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.858 -1.151 . . . . 75.32 110.313 175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.917 HD13 ' CD ' ' A' ' 119' ' ' LYS . 18.8 mt -90.67 6.57 43.42 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.142 -0.974 . . . . 54.3 111.012 -175.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.443 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.1 mt-10 55.39 29.79 13.75 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.82 -1.175 . . . . 73.12 109.965 -176.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.899 HG13 ' O ' ' A' ' 79' ' ' LEU . 13.6 m -118.66 20.51 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.427 -0.796 . . . . 73.32 110.885 -177.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.559 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -58.24 -53.37 59.04 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.882 -1.137 . . . . 71.25 109.888 -178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -50.55 -41.92 54.67 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.093 -1.004 . . . . 73.11 110.578 -178.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.565 ' O ' HG23 ' A' ' 88' ' ' VAL . 25.0 tttp -78.71 -59.14 2.9 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.279 -0.888 . . . . 73.02 110.883 -174.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.595 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 90.3 mmm -70.7 -32.67 69.98 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.481 -0.762 . . . . 64.51 111.266 -174.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 82' ' ' GLU . 5.9 t -46.93 -57.1 9.83 Favored Pre-proline 0 C--N 1.298 -1.654 0 O-C-N 120.844 -1.16 . . . . 74.4 109.683 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.543 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 14.7 Cg_endo -62.96 -26.11 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.256 1.135 . . . . 74.12 110.994 177.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.911 HG11 ' HG3' ' A' ' 113' ' ' GLU . 86.5 t -61.92 -42.04 93.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.639 -1.288 . . . . 63.33 109.498 177.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.606 ' HB3' ' CD1' ' A' ' 28' ' ' PHE . 0.5 OUTLIER -61.83 -42.01 98.49 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.331 -0.948 . . . . 74.03 109.705 178.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.69 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 17.4 m-85 -71.98 -41.91 67.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.651 -1.281 . . . . 75.45 110.639 178.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.523 ' O ' ' HB ' ' A' ' 95' ' ' THR . 36.0 t30 -57.9 -44.78 87.0 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.076 -1.015 . . . . 74.35 109.693 175.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.844 ' HA ' HD12 ' A' ' 96' ' ' LEU . 27.0 tpt180 -59.04 -37.1 76.21 Favored 'General case' 0 C--N 1.293 -1.85 0 O-C-N 121.407 -0.808 . . . . 75.14 109.606 176.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.856 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -93.05 -69.69 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.491 -0.756 . . . . 72.45 110.748 -178.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.511 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.5 t60 -61.97 -21.68 65.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.302 -0.874 . . . . 72.44 110.768 -173.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.6 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -113.68 -70.1 0.82 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.146 -0.971 . . . . 71.11 109.941 -176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.844 HD12 ' HA ' ' A' ' 92' ' ' ARG . 85.7 mt -60.22 -24.9 65.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.303 -0.873 . . . . 74.4 109.971 178.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.466 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 78.3 mtm180 58.05 32.36 21.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.515 -0.741 . . . . 74.14 110.281 -178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 21.9 mttt -122.97 75.18 48.93 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.359 -0.838 . . . . 74.35 109.902 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.61 ' HA ' HD13 ' A' ' 93' ' ' ILE . 13.3 Cg_endo -61.84 142.84 94.83 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.961 1.506 . . . . 71.45 110.478 -177.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.586 ' CG ' HD13 ' A' ' 106' ' ' LEU . 37.8 Cg_exo -55.06 134.36 63.28 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 124.034 1.544 . . . . 74.43 110.182 179.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' HG2' ' HG3' ' A' ' 105' ' ' GLU . 5.1 pttt -100.23 -31.29 11.45 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.28 -0.888 . . . . 72.31 110.251 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 74.2 m-20 -142.78 171.52 13.94 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.173 -0.954 . . . . 74.51 109.872 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.87 -30.34 65.74 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 120.995 -1.066 . . . . 71.33 109.363 173.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -61.21 -56.24 22.92 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.312 -0.867 . . . . 74.55 111.169 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.2 mm-40 -65.07 -38.78 91.9 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.909 -1.119 . . . . 65.14 110.01 -178.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.033 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.4 tp -59.57 -41.38 90.08 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.327 -0.858 . . . . 54.15 109.866 178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 55.7 ttt85 -60.07 -47.28 86.53 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.994 . . . . 71.3 110.437 177.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.79 -39.63 81.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.097 -1.002 . . . . 71.4 110.214 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.033 HD12 ' HA ' ' A' ' 106' ' ' LEU . 75.0 mt -54.5 -49.06 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.131 -0.981 . . . . 73.2 110.007 -179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.679 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 21.2 m-85 -57.58 -52.73 64.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.084 -1.01 . . . . 53.42 110.66 178.31 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.879 HD21 ' HA ' ' A' ' 117' ' ' ALA . 92.7 mt -60.11 -39.79 87.42 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.939 -1.101 . . . . 73.51 110.328 -177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -57.94 -38.69 76.41 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.022 -1.049 . . . . 73.05 110.54 178.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.911 ' HG3' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -74.24 4.27 5.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.268 -0.895 . . . . 73.24 111.226 -175.749 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.95 5.38 50.48 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.602 -1.399 . . . . 72.31 109.602 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 25.8 mm -79.47 147.75 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.215 -1.168 . . . . 54.14 109.649 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.517 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -86.04 141.84 29.17 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.08 -1.012 . . . . 71.24 109.882 176.862 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.879 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -64.54 -32.84 74.66 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 120.888 -1.133 . . . . 52.22 109.416 177.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.95 -50.64 67.84 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.516 -0.74 . . . . 63.11 110.93 179.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.917 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.11 -37.18 64.21 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.832 -1.167 . . . . 72.34 110.458 -176.041 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -60.93 -40.52 93.54 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 120.894 -1.129 . . . . 70.24 109.915 175.211 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 49.1 t0 -60.46 -43.81 96.51 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.29 -0.881 . . . . 64.24 109.627 178.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -63.38 -37.45 87.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.259 -0.901 . . . . 73.33 110.237 178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.773 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.86 -45.55 50.31 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.162 -0.961 . . . . 73.34 110.897 -175.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.585 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 61.0 t80 -60.26 -32.41 71.14 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.17 -0.956 . . . . 72.34 109.435 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -93.35 6.74 47.09 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 74.35 110.264 178.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -68.96 130.15 24.59 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.752 -1.339 . . . . 43.32 109.752 -177.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -56.07 -40.36 73.46 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.116 -1.226 . . . . 74.21 109.745 176.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.85 -43.48 90.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.152 -0.967 . . . . 33.5 110.374 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.019 HG13 ' HB3' ' A' ' 74' ' ' ALA . 40.9 t -58.04 -48.65 83.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 120.863 -1.148 . . . . 73.13 110.139 179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -57.13 -39.55 75.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.153 -0.967 . . . . 70.34 109.95 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.497 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.7 m -62.12 -35.28 78.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.225 -0.922 . . . . 71.13 110.475 179.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.745 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 76.5 mtm -74.81 -34.68 62.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.959 -1.088 . . . . 73.34 110.175 -179.006 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.584 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 56.8 t -64.62 -48.1 86.19 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 O-C-N 121.308 -0.87 . . . . 63.44 110.229 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.497 ' HG2' ' O ' ' A' ' 131' ' ' SER . 16.0 ptm180 -64.22 -41.05 97.2 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.791 -1.193 . . . . 75.14 109.547 175.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.486 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 68.5 ttt180 -48.34 -69.12 0.13 Allowed 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.512 -0.742 . . . . 74.12 110.835 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.633 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.3 p90 -52.03 -41.54 62.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.818 -1.176 . . . . 65.44 110.676 -174.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.633 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.4 t0 -53.0 -48.12 67.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 73.15 109.777 -177.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -62.29 -36.9 83.54 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.027 -1.046 . . . . 71.52 110.642 175.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.53 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 90.6 mt-30 -57.07 -47.46 80.95 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.827 -1.17 . . . . 72.23 110.124 -177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.577 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 61.5 t80 -66.1 -40.7 90.97 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.316 -0.865 . . . . 75.42 110.332 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 67.3 mt-30 -65.0 -52.3 56.87 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.813 -0.755 . . . . 74.43 110.447 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.533 ' HB3' ' CG2' ' A' ' 14' ' ' THR . 90.3 m-20 -60.66 -38.36 84.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.34 -0.85 . . . . 62.21 110.358 -179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.591 ' OG ' HD12 ' A' ' 145' ' ' LEU . 92.2 p -67.37 -21.77 65.6 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.443 -0.785 . . . . 73.33 110.515 -176.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.38 30.06 71.52 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 108.903 -1.679 . . . . 73.22 108.903 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.057 HD22 ' HB1' ' A' ' 150' ' ' ALA . 37.1 mt -75.41 131.68 40.35 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.168 -1.195 . . . . 72.43 110.314 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.7 p -76.48 -23.62 53.82 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.291 -0.881 . . . . 51.32 109.99 177.791 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 173.31 -175.35 46.13 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.848 -1.301 . . . . 51.2 109.848 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.62 HG21 ' OG ' ' A' ' 27' ' ' SER . 11.5 m -116.72 166.41 12.87 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.419 -1.048 . . . . 72.02 109.709 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.554 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 35.4 Cg_endo -70.47 132.82 24.45 Favored 'Cis proline' 0 N--CA 1.49 1.318 0 C-N-CA 122.311 -1.954 . . . . 63.12 111.378 1.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 1.057 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.54 135.24 52.04 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.337 -0.852 . . . . 41.13 109.431 173.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . . . . . . . . . 42.4 t -112.13 126.5 69.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.924 -1.11 . . . . 63.4 110.067 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.461 ' HB ' ' OG ' ' A' ' 23' ' ' SER . 19.7 t -116.54 131.47 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.31 -0.869 . . . . 64.33 109.998 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.8 t -108.77 135.44 47.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.395 -0.816 . . . . 43.32 109.794 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.547 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 50.62 22.63 1.13 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.121 -0.987 . . . . 75.34 110.047 -175.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 2.9 t30 52.42 29.36 6.85 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 72.14 110.776 177.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.925 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 64.4 ttt180 -151.29 -23.43 0.21 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.793 -1.192 . . . . 73.44 111.109 -177.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.804 ' HB3' HD22 ' A' ' 177' ' ' LEU . 18.9 m-85 -108.03 140.28 41.43 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.452 -1.405 . . . . 62.33 109.67 171.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.903 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -110.81 127.58 55.44 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.148 -0.97 . . . . 64.4 109.144 -179.227 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.763 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.8 t -83.57 115.16 25.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 C-N-CA 119.705 -0.798 . . . . 73.54 110.279 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.522 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.6 mt-30 -78.11 -53.41 7.4 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.825 . . . . 65.2 109.556 173.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.538 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 70.72 2.86 47.14 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.135 -1.186 . . . . 73.33 110.135 175.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -62.47 -43.26 99.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.972 -1.31 . . . . 73.53 110.176 -179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.567 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 21.5 m -64.49 -34.41 78.16 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.279 -0.888 . . . . 60.01 110.515 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -71.01 127.81 33.85 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.129 -0.982 . . . . 74.42 110.555 -175.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -101.52 -12.31 18.61 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.327 -0.858 . . . . 52.44 110.216 177.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.494 ' HB2' ' OD1' ' A' ' 168' ' ' ASP . 59.3 m -130.32 145.76 51.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.282 -0.886 . . . . 74.23 109.735 179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.59 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.7 mt -53.48 -31.75 47.14 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.09 -1.006 . . . . 62.32 110.894 -176.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 169' ' ' GLU . 27.3 p-10 -60.1 -37.85 81.22 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.792 -1.192 . . . . 63.42 110.548 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.512 ' N ' ' OD1' ' A' ' 168' ' ' ASP . 80.6 tt0 -77.81 -41.19 38.01 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.858 -1.151 . . . . 70.35 110.248 177.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.538 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 86.3 t80 -60.82 -47.01 88.27 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.223 -0.923 . . . . 75.2 110.471 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.85 ' CD1' HD13 ' A' ' 43' ' ' LEU . 22.0 m-30 -63.74 -42.43 97.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.931 -1.105 . . . . 73.33 110.174 176.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.571 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 86.9 m-20 -53.45 -46.21 69.79 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.947 -1.096 . . . . 62.04 110.25 -178.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD11 HD11 ' A' ' 177' ' ' LEU . 2.4 tp -49.8 -54.94 16.11 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.645 -1.285 . . . . 73.13 109.472 171.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.623 HG22 HG21 ' A' ' 159' ' ' VAL . 54.2 t -50.38 -42.22 20.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.099 -1.001 . . . . 74.22 109.85 -179.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.8 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.7 m120 -59.33 -42.07 90.6 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.174 -0.954 . . . . 73.11 110.742 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CE2' ' CE1' ' A' ' 3' ' ' PHE . 80.1 m-85 -69.7 -38.89 77.14 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.067 -1.02 . . . . 71.34 110.118 -179.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.978 ' HA ' HD12 ' A' ' 180' ' ' LEU . 71.8 mt -60.63 -37.73 82.44 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.897 . . . . 71.12 109.406 176.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 175' ' ' ASN . 8.9 mt -57.96 -33.2 68.6 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.236 -0.915 . . . . 74.22 109.39 172.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.469 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 44.8 m -75.33 -25.53 57.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.476 -0.765 . . . . 72.4 109.975 177.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.978 HD12 ' HA ' ' A' ' 177' ' ' LEU . 12.5 mt -87.79 141.46 28.57 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.361 -0.837 . . . . 72.13 110.313 -176.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.454 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 23.9 tttt . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 118.009 -0.996 . . . . 62.05 110.209 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.268 0.556 . . . . 71.14 110.246 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.512 ' O ' ' NE2' ' A' ' 8' ' ' HIS . 54.5 mt-30 -59.11 -33.01 70.34 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.283 -0.886 . . . . 70.15 110.399 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.9 p90 -122.84 160.4 26.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.17 -0.956 . . . . 73.02 110.719 -174.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 84.8 tttt -169.61 154.15 5.39 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.523 -0.736 . . . . 73.24 109.688 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.626 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 78.1 tt0 -56.26 133.93 52.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.997 -1.064 . . . . 63.31 109.949 179.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.23 3.2 72.93 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.541 -1.424 . . . . 64.34 109.541 -177.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -137.07 -68.1 0.48 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.204 -1.174 . . . . 75.41 110.462 -179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.67 ' HB3' HD22 ' A' ' 173' ' ' LEU . 9.4 m170 -90.07 -18.93 24.99 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.196 -0.94 . . . . 74.51 109.814 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.626 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.8 p90 -150.56 162.95 39.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.325 -0.86 . . . . 52.33 110.604 173.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -120.29 147.12 45.41 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.362 -0.977 . . . . 73.01 108.362 168.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.642 HG21 ' CZ ' ' A' ' 157' ' ' TYR . 11.4 p -117.29 136.49 54.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 120.412 -1.43 . . . . 73.31 111.244 -171.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' NE ' ' A' ' 156' ' ' ARG . 90.3 mt -93.23 154.46 18.01 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-N 115.893 -0.594 . . . . 74.24 110.383 -176.437 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 14.3 pttt -77.01 2.14 15.81 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -0.998 . . . . 72.02 109.792 172.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 13.3 p -47.33 165.59 0.21 Allowed Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.268 -0.895 . . . . 74.55 110.62 -178.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.665 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 25.1 Cg_exo -58.15 -23.47 61.64 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.143 1.602 . . . . 45.32 110.823 -178.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 66.61 177.32 0.23 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.194 -0.941 . . . . 62.43 110.094 -175.052 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.1 t -108.36 138.34 44.82 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.136 -0.978 . . . . 61.05 110.008 176.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 24.9 m -56.97 -36.26 70.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.212 -0.93 . . . . 74.34 109.895 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -115.83 173.63 2.88 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.322 -0.861 . . . . 74.11 109.535 175.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.483 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.2 Cg_endo -69.94 121.12 7.78 Favored 'Trans proline' 0 C--N 1.303 -1.857 0 O-C-N 123.773 1.407 . . . . 73.34 109.95 -179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.437 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.9 p -145.51 135.24 18.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.631 0 O-C-N 120.9 -1.125 . . . . 74.23 109.584 171.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.9 t -114.86 129.86 70.31 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 121.016 -1.052 . . . . 63.13 109.751 -178.004 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 72.1 p -124.76 134.42 52.81 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.146 -0.971 . . . . 65.13 109.915 -177.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.584 ' HG2' HD12 ' A' ' 40' ' ' ILE . 36.2 mp0 -108.57 125.86 52.3 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.195 -0.941 . . . . 74.51 110.403 178.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE2' ' OD1' ' A' ' 56' ' ' ASN . 57.0 m-85 -99.83 123.2 43.83 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.486 -0.759 . . . . 73.45 109.726 -179.37 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.504 ' O ' HG22 ' A' ' 58' ' ' VAL . 46.6 p90 -139.8 166.8 23.66 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.486 -0.759 . . . . 70.32 111.051 -177.046 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 32.5 t -135.09 138.39 43.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.456 -0.778 . . . . 72.13 110.122 178.032 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.955 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.9 m-85 -57.95 -23.06 52.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.066 -1.021 . . . . 73.24 110.305 176.342 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.622 ' CD1' HD12 ' A' ' 93' ' ' ILE . 53.7 m-85 -99.9 18.04 19.35 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.201 -0.937 . . . . 74.32 110.977 -174.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.679 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 19.1 t -118.11 111.04 39.02 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 120.837 -1.164 . . . . 34.41 110.167 -177.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -57.97 -38.26 92.79 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 123.768 1.404 . . . . 74.12 109.695 179.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -58.61 -48.24 81.66 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.219 -0.925 . . . . 75.33 109.971 175.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.49 ' SG ' ' N ' ' A' ' 149' ' ' PRO . 61.8 m -66.72 -43.65 83.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.128 -0.982 . . . . 63.23 110.346 178.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.575 ' OD1' ' CG ' ' A' ' 94' ' ' HIS . 28.7 t-20 -52.61 -40.9 63.2 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.212 -0.93 . . . . 64.23 110.617 -177.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.454 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.2 p -82.11 -38.22 25.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.136 -0.977 . . . . 63.24 110.715 -179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.917 ' CE2' HD11 ' A' ' 40' ' ' ILE . 29.2 t80 -64.7 -30.81 71.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.229 -0.919 . . . . 71.51 110.751 -175.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.528 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -38.38 -60.34 1.07 Allowed Pre-proline 0 N--CA 1.495 1.808 0 O-C-N 121.248 -0.908 . . . . 62.11 111.319 -174.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 6.1 Cg_endo -53.5 -43.53 56.77 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.48 1.252 . . . . 75.43 110.673 -177.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.544 HD12 ' HA ' ' A' ' 36' ' ' PHE . 84.7 mt -54.35 -46.48 69.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 120.928 -1.108 . . . . 74.02 109.9 177.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.917 HD11 ' CE2' ' A' ' 36' ' ' PHE . 31.6 mm -56.18 -44.91 80.5 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 120.914 -1.116 . . . . 72.13 110.261 176.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.448 ' HA ' ' HD2' ' A' ' 44' ' ' LYS . . . -55.33 -37.59 67.63 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.063 -1.023 . . . . 51.33 109.531 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.519 ' NE2' HD11 ' A' ' 167' ' ' LEU . 14.2 mt-30 -59.5 -42.98 93.42 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.174 -0.954 . . . . 70.1 109.728 176.129 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.75 HD12 ' CD1' ' A' ' 171' ' ' PHE . 42.2 tp -62.07 -39.44 92.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.145 -0.972 . . . . 74.23 110.187 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.948 ' HA ' HD12 ' A' ' 47' ' ' LEU . 20.0 mttp -57.43 -49.34 76.55 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.367 -0.833 . . . . 73.34 110.289 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -61.57 -34.57 75.81 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.342 -0.849 . . . . 62.41 109.446 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.626 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 50.3 mt-30 -85.78 -16.24 39.46 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.57 -0.706 . . . . 72.04 110.501 -178.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.948 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.4 mt -53.65 137.92 52.38 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 64.42 110.372 -176.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 37.5 Cg_endo -74.65 144.23 31.36 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.03 1.542 . . . . 71.22 110.104 179.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.7 -34.84 67.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.154 -0.966 . . . . 75.11 109.782 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.32 -35.75 89.14 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.762 -1.335 . . . . 71.01 109.762 178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.532 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -87.08 140.16 29.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.124 -1.221 . . . . 72.11 110.595 -177.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 29.6 mttm -94.38 157.72 15.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.541 -0.724 . . . . 74.11 109.631 175.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.935 ' CD1' HD11 ' A' ' 47' ' ' LEU . 54.1 t80 -126.03 157.1 38.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.816 -1.177 . . . . 64.12 110.795 -179.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 68.5 tp60 -150.4 159.85 44.17 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-O 121.769 0.795 . . . . 74.24 110.47 -176.723 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.504 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 32.3 mttp -125.61 144.75 50.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.959 -1.088 . . . . 74.21 110.3 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.618 ' ND2' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -136.28 137.26 40.54 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.365 -0.834 . . . . 65.33 110.234 -178.059 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.488 ' NE2' ' HB3' ' A' ' 70' ' ' SER . 2.9 p-80 -114.61 129.1 56.63 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.776 -1.203 . . . . 75.14 110.093 175.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.9 m -84.34 137.12 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.353 -0.842 . . . . 64.32 110.707 -176.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.43 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 59.9 p -93.4 -14.73 26.45 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.275 -0.89 . . . . 63.24 110.565 175.445 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.595 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 16.6 p90 -75.68 -30.05 59.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.757 -1.215 . . . . 61.33 110.314 -176.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.679 ' HE2' ' HB2' ' A' ' 30' ' ' CYS . 88.0 mmm -64.08 -39.12 93.36 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.074 -1.016 . . . . 73.12 110.054 174.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.432 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -67.21 -43.95 87.85 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.914 -1.274 . . . . 64.31 109.914 -179.168 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.58 -140.34 14.86 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.145 -1.582 . . . . 34.13 109.145 -175.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.45 -37.15 64.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.059 -1.26 . . . . 73.2 110.592 179.311 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.465 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.6 ttt -90.56 4.74 50.38 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.069 -1.019 . . . . 71.21 110.711 -176.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.43 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.92 -40.27 81.03 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.531 -1.427 . . . . 72.02 109.531 -179.362 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.3 tt0 -58.46 -41.39 85.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.166 -1.196 . . . . 62.31 110.186 178.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.401 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.06 -44.71 95.06 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.128 -0.983 . . . . 45.42 110.205 179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.417 ' CE ' ' CD2' ' A' ' 28' ' ' PHE . 96.5 mmm -59.91 -42.04 93.03 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.039 -1.038 . . . . 73.04 110.417 -178.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.742 ' CB ' HG13 ' A' ' 133' ' ' VAL . 21.1 m -59.69 -47.84 84.03 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.037 -1.04 . . . . 75.43 110.006 178.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 21.8 mttt -59.86 -35.19 74.28 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.038 -1.039 . . . . 63.13 110.4 176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -61.39 -48.19 82.36 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.973 -1.079 . . . . 61.33 110.256 -177.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.468 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.3 t80 -59.58 -42.19 91.93 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.854 -1.154 . . . . 54.21 109.964 177.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.05 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.1 -41.89 97.5 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.083 . . . . 72.31 109.957 177.746 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.937 HG23 ' HB3' ' A' ' 123' ' ' ALA . 24.7 m -61.1 -44.1 97.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.253 -0.905 . . . . 62.21 110.067 178.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 67.6 mtt -47.6 -48.43 28.29 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.201 -0.937 . . . . 71.04 109.079 175.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.693 HD12 ' HA ' ' A' ' 74' ' ' ALA . 95.1 mt -61.35 -46.33 96.82 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 C-N-CA 120.273 -0.571 . . . . 73.32 110.44 -175.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -57.88 -37.96 74.91 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.074 -1.016 . . . . 75.32 110.623 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.99 HD13 ' CD ' ' A' ' 119' ' ' LYS . 22.7 mt -87.97 9.56 21.85 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.138 -0.976 . . . . 54.3 110.573 -177.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 53.14 33.67 15.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.961 -1.087 . . . . 73.12 109.777 -176.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.947 HG13 ' O ' ' A' ' 79' ' ' LEU . 18.5 m -120.78 12.38 6.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.33 -0.856 . . . . 73.32 111.184 -176.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.642 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mm-40 -57.36 -52.73 64.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.624 -1.297 . . . . 71.25 109.765 177.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -54.3 -39.37 66.91 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 120.758 -1.214 . . . . 73.11 110.228 176.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.2 tttp -65.58 -46.7 78.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.301 -0.874 . . . . 73.02 111.732 -171.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.649 ' HA ' HG23 ' A' ' 88' ' ' VAL . 4.3 ppp? -126.22 4.79 7.07 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.805 -1.184 . . . . 64.51 111.558 -170.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -49.78 -57.5 12.12 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 120.571 -1.33 . . . . 74.4 109.121 175.469 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 86' ' ' VAL . 11.7 Cg_endo -63.86 -18.38 63.69 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.59 1.31 . . . . 74.12 111.19 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.704 HG21 ' OE1' ' A' ' 113' ' ' GLU . 87.0 t -64.83 -44.52 96.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.619 -1.3 . . . . 63.33 109.571 175.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.756 ' SD ' HG21 ' A' ' 109' ' ' ILE . 86.7 mmm -62.54 -43.47 98.73 Favored 'General case' 0 C--N 1.301 -1.537 0 C-N-CA 119.074 -1.05 . . . . 74.03 109.691 178.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 21.0 m-85 -69.71 -40.13 76.46 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.723 -1.236 . . . . 75.45 110.738 178.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 29.1 t30 -57.95 -56.46 21.67 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.018 -1.051 . . . . 74.35 109.456 174.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.811 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.6 ttt85 -51.33 -36.08 41.15 Favored 'General case' 0 C--N 1.294 -1.831 0 O-C-N 121.401 -0.812 . . . . 75.14 110.053 -177.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.955 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.2 mm -79.85 -65.02 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.176 -0.952 . . . . 72.45 110.716 176.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.575 ' CG ' ' OD1' ' A' ' 34' ' ' ASN . 85.5 t60 -70.71 -14.78 62.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.249 -0.907 . . . . 72.44 111.16 -171.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.78 -66.36 1.03 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.95 -1.094 . . . . 71.11 110.525 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.811 HD12 ' HA ' ' A' ' 92' ' ' ARG . 67.2 mt -61.82 -24.21 66.74 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.008 -1.058 . . . . 74.4 109.787 178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 95' ' ' THR . 69.5 mtt85 59.25 32.25 21.83 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.529 -0.732 . . . . 74.14 109.878 -176.008 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 17.9 mttt -122.05 72.29 34.29 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.378 -0.826 . . . . 74.35 109.886 177.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -64.61 141.25 72.21 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.123 1.591 . . . . 71.45 110.378 -178.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_endo -61.6 130.6 32.19 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.943 1.496 . . . . 74.43 110.066 178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.466 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 8.6 pttt -98.1 -23.12 15.87 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.993 . . . . 72.31 110.446 -178.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 71.0 m-20 -142.9 170.07 16.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.142 -0.974 . . . . 74.51 109.797 -179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.97 -26.67 62.62 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 120.957 -1.089 . . . . 71.33 109.533 173.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -69.48 -53.7 17.88 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.193 -0.942 . . . . 74.55 110.949 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.419 ' O ' HG13 ' A' ' 109' ' ' ILE . 74.5 mm-40 -61.77 -37.08 83.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.798 -1.189 . . . . 65.14 109.151 177.03 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.0 tp -59.63 -44.06 93.61 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.507 -0.745 . . . . 54.15 110.056 176.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.459 HH21 ' HB1' ' A' ' 117' ' ' ALA . 72.5 ttt180 -58.61 -45.12 89.87 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.891 -1.131 . . . . 71.3 110.393 178.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 63.0 tp60 -58.67 -40.39 83.4 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.076 -1.015 . . . . 71.4 110.297 179.703 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.025 HD12 ' HA ' ' A' ' 106' ' ' LEU . 66.0 mt -55.4 -49.56 72.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.057 -1.027 . . . . 73.2 110.169 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.559 ' CG ' ' CE1' ' A' ' 120' ' ' PHE . 38.8 m-85 -57.88 -49.81 75.44 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.973 -1.079 . . . . 53.42 110.355 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.851 HD21 ' CA ' ' A' ' 117' ' ' ALA . 88.2 mt -60.58 -40.89 93.34 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.051 -1.031 . . . . 73.51 110.258 -177.48 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.5 t0 -58.04 -39.11 77.6 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.008 -1.057 . . . . 73.05 110.414 179.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.704 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.3 mm-40 -70.97 -0.04 8.45 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -0.898 . . . . 73.24 111.217 -175.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 104.86 10.76 31.88 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.867 -1.293 . . . . 72.31 109.867 179.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 80.6 mt -94.04 150.66 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.048 -1.266 . . . . 54.14 110.172 178.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.531 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -85.89 142.65 28.72 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.105 -0.997 . . . . 71.24 110.244 -176.882 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.851 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -65.46 -33.21 75.4 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.107 -0.996 . . . . 52.22 109.367 176.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.84 -49.79 71.4 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.493 -0.754 . . . . 63.11 110.879 -179.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.99 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.86 -36.16 62.33 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.844 -1.16 . . . . 72.34 110.501 -176.395 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.84 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.0 t80 -61.2 -41.84 97.53 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.943 -1.098 . . . . 70.24 110.038 174.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.426 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 91.7 m-20 -61.26 -42.3 98.39 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.207 -0.933 . . . . 64.24 109.77 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.71 -38.12 86.68 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.184 -0.948 . . . . 73.33 110.132 178.432 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.937 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -73.51 -44.97 56.49 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.211 -0.93 . . . . 73.34 110.807 -175.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 63.8 t80 -59.27 -32.73 70.29 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.149 -0.969 . . . . 72.34 109.628 179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -90.24 5.23 47.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.822 . . . . 74.35 110.245 -179.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -79.37 129.61 9.29 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.797 -1.321 . . . . 43.32 109.797 -177.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -58.0 -29.58 65.39 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.058 -1.26 . . . . 74.21 109.565 174.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.62 -47.92 80.86 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.079 -1.013 . . . . 33.5 109.92 178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.05 HG13 ' HB3' ' A' ' 74' ' ' ALA . 25.1 t -57.42 -46.52 85.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 120.797 -1.189 . . . . 73.13 109.714 174.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.5 m-20 -56.42 -40.89 75.45 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.424 -0.797 . . . . 70.34 110.549 -176.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 86.1 p -67.74 -31.6 71.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.22 -0.925 . . . . 71.13 110.461 -179.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.678 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 72.9 mtm -74.4 -39.95 62.33 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.022 -1.049 . . . . 73.34 110.265 -178.93 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.742 HG13 ' CB ' ' A' ' 70' ' ' SER . 79.6 t -64.13 -48.48 85.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 63.44 110.444 179.705 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 29.7 ptt180 -62.85 -41.77 99.48 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.986 -1.071 . . . . 75.14 109.932 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.503 ' O ' ' HG3' ' A' ' 139' ' ' GLN . 0.0 OUTLIER -51.51 -68.53 0.16 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.193 -0.942 . . . . 74.12 110.376 179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.618 ' CD1' ' ND2' ' A' ' 56' ' ' ASN . 7.3 m-30 -53.38 -41.75 66.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.1 -1.0 . . . . 65.44 110.905 -174.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.7 t0 -54.43 -47.46 72.79 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.683 -1.261 . . . . 73.15 109.908 -179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -60.73 -39.1 87.39 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.062 -1.024 . . . . 71.52 110.187 175.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 18.8 mt-30 -57.08 -45.62 83.19 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.137 -0.977 . . . . 72.23 110.26 -177.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.798 ' HA ' HD12 ' A' ' 145' ' ' LEU . 57.6 t80 -64.21 -40.81 96.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.23 -0.919 . . . . 75.42 110.165 179.188 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -62.24 -51.42 67.8 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.511 -0.743 . . . . 74.43 110.456 -179.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.524 ' O ' ' CG2' ' A' ' 14' ' ' THR . 89.3 m-20 -63.12 -37.09 85.84 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.144 -0.972 . . . . 62.21 110.227 178.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.537 ' OG ' HD12 ' A' ' 145' ' ' LEU . 75.3 p -66.91 -18.67 65.49 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.462 -0.774 . . . . 73.33 110.671 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.07 30.69 72.0 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.974 -1.65 . . . . 73.22 108.974 -176.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.936 HD22 ' CB ' ' A' ' 150' ' ' ALA . 51.6 mt -77.55 137.4 38.59 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.288 -1.125 . . . . 72.43 110.099 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 50.3 p -112.81 6.84 18.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.33 -0.856 . . . . 51.32 110.291 -179.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.19 127.87 0.97 Allowed Glycine 0 N--CA 1.488 2.162 0 C-N-CA 119.618 -1.277 . . . . 51.2 110.174 179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.8 m -84.55 163.38 47.28 Favored Pre-proline 0 N--CA 1.495 1.82 0 O-C-N 121.331 -1.099 . . . . 72.02 109.227 172.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.568 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 41.1 Cg_endo -73.44 129.18 17.19 Favored 'Cis proline' 0 N--CA 1.489 1.228 0 C-N-CA 122.306 -1.956 . . . . 63.12 111.411 4.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.936 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -119.6 140.1 51.12 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 41.13 109.383 171.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.978 ' O ' HD13 ' A' ' 158' ' ' LEU . 45.6 t -113.8 125.29 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 120.872 -1.143 . . . . 63.4 109.984 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.688 HG22 HD21 ' A' ' 158' ' ' LEU . 41.4 t -114.04 130.45 68.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.416 -0.802 . . . . 64.33 110.272 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.732 HG11 ' HB2' ' A' ' 177' ' ' LEU . 25.6 t -109.55 130.45 62.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.509 -0.744 . . . . 43.32 109.714 178.062 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 24.9 m-20 48.98 28.76 2.11 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.199 -0.938 . . . . 75.34 110.589 -173.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 3.8 t30 51.83 31.2 7.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.17 -0.956 . . . . 72.14 110.075 175.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.644 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.3 tpt180 -143.94 -39.88 0.29 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.103 -0.998 . . . . 73.44 110.421 -175.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.942 ' HB3' HD22 ' A' ' 177' ' ' LEU . 60.1 m-85 -106.14 148.19 28.12 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.818 -1.177 . . . . 62.33 110.376 178.314 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.978 HD13 ' O ' ' A' ' 151' ' ' VAL . 0.2 OUTLIER -117.51 122.8 44.68 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.408 -0.807 . . . . 64.4 109.275 -179.428 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.721 HG21 HG22 ' A' ' 174' ' ' VAL . 41.3 t -77.02 112.57 15.09 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 O-C-N 121.418 -0.802 . . . . 73.54 110.307 -176.293 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.497 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 68.9 mt-30 -72.49 -49.63 31.7 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.142 -0.974 . . . . 65.2 109.447 173.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 73.74 -1.3 46.45 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.37 -1.092 . . . . 73.33 110.37 173.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -64.41 -42.2 96.19 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.936 -1.331 . . . . 73.53 110.279 -179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.578 ' CB ' ' NE2' ' A' ' 8' ' ' HIS . 24.5 m -66.72 -33.72 76.27 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.36 -0.837 . . . . 60.01 110.641 -179.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.618 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -71.03 97.23 1.42 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.131 -0.98 . . . . 74.42 110.51 -175.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -61.85 -29.54 70.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.306 -0.871 . . . . 52.44 110.299 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 94.7 p -133.73 159.41 40.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.181 -0.95 . . . . 74.23 109.986 -178.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.519 HD11 ' NE2' ' A' ' 42' ' ' GLN . 53.4 mt -52.92 -28.12 21.95 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.132 -0.98 . . . . 62.32 111.028 -177.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.43 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.5 m-20 -57.31 -41.68 80.37 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.623 -1.298 . . . . 63.42 110.369 -179.459 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.511 ' OE2' ' NE2' ' A' ' 2' ' ' GLN . 74.6 mm-40 -79.96 -42.38 24.09 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.903 -1.123 . . . . 70.35 110.564 178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.618 ' N ' ' HB1' ' A' ' 164' ' ' ALA . 75.6 t80 -63.08 -46.17 88.68 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.183 -0.948 . . . . 75.2 110.129 179.44 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.75 ' CD1' HD12 ' A' ' 43' ' ' LEU . 73.0 t80 -60.13 -45.57 92.55 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.385 -0.822 . . . . 73.33 110.262 176.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.517 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.4 m-20 -56.53 -46.99 80.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.015 -1.053 . . . . 62.04 110.441 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.67 HD22 ' HB3' ' A' ' 8' ' ' HIS . 5.0 tp -50.97 -53.21 35.09 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.771 -1.206 . . . . 73.13 110.116 175.356 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.721 HG22 HG21 ' A' ' 159' ' ' VAL . 54.0 t -51.97 -43.19 35.78 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 120.978 -1.076 . . . . 74.22 109.702 -178.758 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.667 ' HA ' HD12 ' A' ' 178' ' ' LEU . 0.9 OUTLIER -58.72 -42.33 88.47 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.18 -0.95 . . . . 73.11 110.926 -179.802 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 76.3 m-85 -69.37 -41.05 77.04 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.023 -1.048 . . . . 71.34 110.193 -179.507 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.03 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.8 mt -58.22 -37.17 74.32 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.142 -0.974 . . . . 71.12 109.435 176.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.667 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -61.01 -29.4 69.68 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.268 -0.895 . . . . 74.22 109.986 174.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 36.4 m -94.92 -14.13 24.76 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.319 -0.863 . . . . 72.4 110.311 -177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.03 HD12 ' HA ' ' A' ' 177' ' ' LEU . 43.4 mt -74.8 -40.57 61.05 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.173 -0.955 . . . . 72.13 110.474 -178.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.46 ' O ' ' O ' ' A' ' 180' ' ' LEU . 56.8 mttt . . . . . 0 N--CA 1.494 1.744 0 CA-C-O 118.098 -0.953 . . . . 62.05 110.561 178.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.301 0.572 . . . . 71.14 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.0 mt-30 -58.91 -32.36 69.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.32 -0.862 . . . . 70.15 110.345 179.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.682 ' CZ ' ' CD2' ' A' ' 176' ' ' TYR . 53.5 p90 -121.65 149.73 42.77 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.166 -0.959 . . . . 73.02 110.65 -175.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.478 ' CG ' ' O ' ' A' ' 3' ' ' PHE . 66.1 mttm -156.68 158.66 37.37 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.424 -0.798 . . . . 73.24 109.449 175.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.598 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 76.2 tt0 -62.08 128.1 34.51 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.937 -1.102 . . . . 63.31 109.942 176.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.91 -2.49 66.46 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.527 -1.429 . . . . 64.34 109.527 -176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.465 ' OE1' ' O ' ' A' ' 5' ' ' GLU . 57.5 mp0 -131.02 -62.94 0.88 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.099 -1.236 . . . . 75.41 110.436 179.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.608 ' HB3' HD22 ' A' ' 173' ' ' LEU . 1.7 m-70 -92.6 -18.09 23.53 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.15 -0.969 . . . . 74.51 109.833 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.598 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 55.7 p90 -156.54 169.91 23.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.554 -0.716 . . . . 52.33 110.672 176.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.526 ' HG3' ' NE2' ' A' ' 160' ' ' GLN . 93.5 mt-30 -128.05 158.26 38.45 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.577 -0.702 . . . . 73.01 109.315 173.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.973 HG22 ' CE1' ' A' ' 157' ' ' TYR . 68.7 t -105.16 131.89 53.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.779 -1.201 . . . . 73.31 110.706 -178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.812 HD11 HD23 ' A' ' 158' ' ' LEU . 81.2 mt -95.19 152.75 18.09 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.734 -0.604 . . . . 74.24 110.267 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.6 mttp -76.2 -1.18 25.06 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.137 -0.977 . . . . 72.02 110.009 176.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.52 ' CG2' ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.62 154.76 78.93 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.279 -0.888 . . . . 74.55 110.182 179.401 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.516 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.8 Cg_endo -63.14 126.85 18.77 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.036 1.545 . . . . 45.32 110.497 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.884 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -78.91 173.36 12.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.01 -1.056 . . . . 62.43 110.002 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 50.4 m -105.18 144.57 31.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.223 -0.923 . . . . 61.05 110.208 -179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.0 p -61.54 -29.32 69.93 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.264 -0.897 . . . . 74.34 110.054 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -115.25 169.81 6.32 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.311 -0.868 . . . . 74.11 109.749 177.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.526 ' HB2' HD22 ' A' ' 178' ' ' LEU . 52.5 Cg_endo -70.36 125.35 11.73 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.884 1.465 . . . . 73.34 109.98 -179.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.612 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.0 p -144.95 137.79 21.71 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 O-C-N 120.808 -1.182 . . . . 74.23 110.212 173.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 54' ' ' GLN . 9.3 t -124.68 124.35 67.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.161 -0.962 . . . . 63.13 109.784 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.2 t -119.27 135.94 54.46 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.889 -1.132 . . . . 65.13 110.375 179.405 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.821 ' CD ' HG21 ' A' ' 40' ' ' ILE . 82.1 tt0 -103.49 126.31 50.57 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.349 -0.844 . . . . 74.51 110.613 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CB ' HG12 ' A' ' 148' ' ' VAL . 69.0 m-85 -98.29 123.96 42.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.287 -0.883 . . . . 73.45 109.642 174.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.544 ' O ' HG22 ' A' ' 58' ' ' VAL . 47.1 p90 -140.29 164.93 28.78 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.523 -0.736 . . . . 70.32 110.678 -176.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.528 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 45.6 t -130.52 132.4 45.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 72.13 110.54 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.695 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.0 m-85 -61.19 -28.41 69.12 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.099 -1.001 . . . . 73.24 110.268 175.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.568 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.6 OUTLIER -88.5 15.72 7.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.379 -0.826 . . . . 74.32 110.883 -174.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.53 ' HB2' ' CE ' ' A' ' 61' ' ' MET . 40.4 t -124.42 95.02 43.93 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 120.969 -1.082 . . . . 34.41 110.299 -177.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.407 ' HB3' ' HA ' ' A' ' 94' ' ' HIS . 31.7 Cg_exo -53.44 -53.05 7.26 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.064 1.56 . . . . 74.12 110.489 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -57.02 -47.26 81.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.892 -1.13 . . . . 75.33 110.241 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.528 ' CB ' ' HD3' ' A' ' 149' ' ' PRO . 25.8 m -64.01 -42.49 97.13 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.974 -1.079 . . . . 63.23 110.163 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' OD1' ' O ' ' A' ' 27' ' ' SER . 45.0 m-20 -57.55 -38.81 75.37 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.121 -0.987 . . . . 64.23 110.117 -179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.3 m -63.36 -42.82 98.9 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.171 -0.955 . . . . 63.24 110.187 178.022 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.711 ' HE2' HD11 ' A' ' 40' ' ' ILE . 70.8 t80 -64.11 -37.75 88.56 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.341 -0.85 . . . . 71.51 110.434 179.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.538 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -41.37 -56.54 4.37 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.133 -0.979 . . . . 62.11 110.453 -176.141 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.538 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 52.7 Cg_exo -42.46 -50.29 5.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.638 1.336 . . . . 75.43 110.494 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.631 HG23 HD21 ' A' ' 167' ' ' LEU . 78.3 mt -54.55 -46.65 72.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 120.913 -1.117 . . . . 74.02 110.163 178.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.821 HG21 ' CD ' ' A' ' 24' ' ' GLU . 35.4 mm -54.63 -41.43 55.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.8 -1.187 . . . . 72.13 109.887 176.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.31 -38.22 73.7 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.122 -0.986 . . . . 51.33 109.543 176.513 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.857 ' NE2' HD11 ' A' ' 167' ' ' LEU . 20.6 mt-30 -58.29 -41.63 84.82 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.225 -0.922 . . . . 70.1 109.291 176.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD12 ' CD1' ' A' ' 171' ' ' PHE . 47.6 tp -63.38 -40.33 96.94 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.408 -0.807 . . . . 74.23 110.247 176.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.759 ' HA ' HD12 ' A' ' 47' ' ' LEU . 35.4 mttt -55.9 -51.23 68.33 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.34 -0.85 . . . . 73.34 110.217 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 54.8 mt-30 -65.14 -36.7 85.08 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-O 121.74 0.781 . . . . 62.41 109.441 179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.559 ' CG ' ' CE1' ' A' ' 171' ' ' PHE . 6.7 tt0 -76.97 -29.08 55.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.741 -0.6 . . . . 72.04 110.323 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.759 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.2 mt -50.11 146.32 8.48 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.325 -0.86 . . . . 64.42 110.271 -175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.34 143.85 94.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.913 1.481 . . . . 71.22 109.923 179.058 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.72 -33.36 71.52 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.096 -1.002 . . . . 75.11 109.707 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.98 -39.62 97.29 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.818 -1.313 . . . . 71.01 109.818 178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.499 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.57 144.21 49.61 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.062 -1.258 . . . . 72.11 110.5 -177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 30.6 mmtp -100.71 152.67 20.19 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.501 -0.749 . . . . 74.11 109.405 174.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.566 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 44.9 t80 -123.79 158.01 32.75 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.678 -1.264 . . . . 64.12 110.823 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.612 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -141.22 161.69 37.28 Favored 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 121.599 0.714 . . . . 74.24 110.226 -177.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.472 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 4.1 pttm -124.93 138.65 54.23 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -0.941 . . . . 74.21 110.575 -178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.495 ' ND2' ' HA ' ' A' ' 136' ' ' PHE . 1.3 m120 -138.74 128.13 24.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.382 -0.824 . . . . 65.33 110.161 -179.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.626 ' NE2' ' CD2' ' A' ' 136' ' ' PHE . 13.7 p-80 -114.47 132.22 56.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.812 -1.18 . . . . 75.14 110.028 176.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.638 HG21 ' HG3' ' A' ' 61' ' ' MET . 34.1 m -92.2 136.12 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.323 -0.86 . . . . 64.32 111.015 -175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.483 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 57.2 p -93.62 -14.3 26.63 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.329 -0.857 . . . . 63.24 110.528 174.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.596 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 9.7 p90 -72.93 -30.28 63.76 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.7 -1.25 . . . . 61.33 110.067 -176.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.638 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -63.15 -38.37 90.89 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.123 -0.985 . . . . 73.12 110.155 173.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.542 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -64.97 -46.03 90.54 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.874 -1.29 . . . . 64.31 109.874 -178.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 102.0 -140.44 14.87 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.398 -1.481 . . . . 34.13 109.398 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.66 -37.92 66.31 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.053 -1.263 . . . . 73.2 110.857 -178.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.516 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.6 ttt -95.33 6.53 48.77 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.049 -1.032 . . . . 71.21 110.405 -178.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.76 -40.73 97.0 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.524 -1.43 . . . . 72.02 109.524 -179.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -57.97 -41.01 82.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -1.169 . . . . 62.31 110.186 179.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.24 -48.31 76.3 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.152 -0.968 . . . . 45.42 110.435 -179.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.568 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 83.4 mtp -60.16 -40.5 90.14 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.993 -1.067 . . . . 73.04 110.425 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 22.9 m -60.51 -49.05 79.11 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.994 -1.066 . . . . 75.43 110.193 179.379 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.018 ' HG2' HG21 ' A' ' 133' ' ' VAL . 53.2 mtpt -60.09 -33.73 72.5 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.937 -1.102 . . . . 63.13 109.933 176.563 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.92 -47.12 86.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.109 -0.994 . . . . 61.33 110.21 -178.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.472 ' OH ' ' HD2' ' A' ' 55' ' ' LYS . 84.1 t80 -58.44 -43.21 88.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.928 -1.108 . . . . 54.21 109.699 176.788 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.024 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -60.95 -38.58 86.38 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.898 -1.127 . . . . 72.31 109.694 176.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.746 HG23 ' HB3' ' A' ' 123' ' ' ALA . 27.4 m -58.08 -42.8 86.32 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.083 -1.011 . . . . 62.21 109.688 175.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.592 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 65.8 mtt -52.54 -43.01 64.9 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.062 -1.024 . . . . 71.04 108.877 176.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -59.78 -44.53 94.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 C-N-CA 119.785 -0.766 . . . . 73.32 110.122 -177.3 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.38 -36.14 73.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.045 -1.035 . . . . 75.32 110.37 175.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.904 HD22 ' HG2' ' A' ' 119' ' ' LYS . 38.7 mt -88.55 5.36 43.08 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.08 -1.012 . . . . 54.3 110.804 -176.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 81.6 tt0 54.49 32.75 17.4 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.874 -1.141 . . . . 73.12 109.777 -175.292 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 79' ' ' LEU . 17.8 m -120.39 10.6 6.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.306 -0.871 . . . . 73.32 111.196 -176.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.578 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.5 mp0 -45.43 -72.17 0.06 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.793 -1.192 . . . . 71.25 109.662 -179.925 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.3 m-20 -53.04 -35.99 60.09 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.879 -1.138 . . . . 73.11 110.616 178.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 42.7 tttt -57.72 -44.29 85.86 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.011 -1.055 . . . . 73.02 111.359 -170.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.668 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.47 -3.2 6.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.001 -1.062 . . . . 64.51 110.779 -176.072 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.578 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -51.16 -44.96 88.83 Favored Pre-proline 0 C--N 1.298 -1.645 0 O-C-N 120.828 -1.17 . . . . 74.4 109.193 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.2 Cg_exo -65.04 -23.33 61.2 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.358 1.188 . . . . 74.12 110.652 175.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.737 HG21 ' OE1' ' A' ' 113' ' ' GLU . 60.3 t -66.64 -41.2 87.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 120.836 -1.165 . . . . 63.33 109.573 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.524 ' CE ' HD11 ' A' ' 106' ' ' LEU . 26.3 mtp -63.81 -42.51 97.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.007 -1.077 . . . . 74.03 109.882 176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.68 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 22.6 m-85 -67.81 -44.18 77.91 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.656 -1.278 . . . . 75.45 110.435 178.174 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.524 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.9 t30 -56.89 -53.25 60.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.101 -1.0 . . . . 74.35 109.543 174.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.876 ' HA ' HD12 ' A' ' 96' ' ' LEU . 46.1 ttt85 -52.52 -33.99 47.67 Favored 'General case' 0 C--N 1.294 -1.811 0 O-C-N 121.373 -0.829 . . . . 75.14 109.892 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.695 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.9 mm -84.37 -67.08 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.284 -0.885 . . . . 72.45 110.565 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.407 ' HA ' ' HB3' ' A' ' 31' ' ' PRO . 48.2 t-80 -64.99 -19.25 65.9 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 72.44 111.227 -172.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.524 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -119.63 -69.02 0.87 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.877 -1.139 . . . . 71.11 110.656 -174.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.876 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.4 mt -60.74 -24.54 65.79 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.088 -1.007 . . . . 74.4 109.72 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 95' ' ' THR . 89.0 mtt180 58.66 32.77 22.52 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.495 -0.753 . . . . 74.14 109.991 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.517 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.2 mtmp? -126.0 73.23 70.93 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.414 -0.804 . . . . 74.35 110.083 178.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.543 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 23.4 Cg_exo -59.43 156.4 36.3 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.913 1.481 . . . . 71.45 110.289 -179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.541 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.4 Cg_exo -54.1 111.19 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.971 1.511 . . . . 74.43 110.226 -179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 9.5 tptt -60.85 -46.56 90.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.333 -0.854 . . . . 72.31 110.291 178.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.471 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -144.2 -173.1 3.92 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.376 -0.828 . . . . 74.51 109.522 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.66 -32.02 70.09 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 120.811 -1.18 . . . . 71.33 109.541 171.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -69.83 -52.26 26.48 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.101 -1.0 . . . . 74.55 111.254 -176.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.432 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.6 tp10 -59.68 -38.19 80.83 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.796 -1.19 . . . . 65.14 109.108 176.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.934 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.1 tp -57.57 -45.16 85.52 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.614 -0.678 . . . . 54.15 110.084 176.213 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -59.83 -45.69 91.59 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.993 -1.067 . . . . 71.3 110.618 179.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.7 tp60 -59.37 -39.68 84.06 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.979 -1.075 . . . . 71.4 110.352 -179.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.934 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.0 mt -54.89 -48.14 74.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.033 -1.042 . . . . 73.2 109.919 -179.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.48 ' O ' ' HB ' ' A' ' 115' ' ' ILE . 29.1 m-85 -57.87 -49.92 75.05 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.118 -0.989 . . . . 53.42 110.231 176.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.859 HD21 ' CA ' ' A' ' 117' ' ' ALA . 93.3 mt -57.51 -42.27 82.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.977 -1.077 . . . . 73.51 110.153 -177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -58.36 -38.38 77.12 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.124 -0.985 . . . . 73.05 110.3 179.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.737 ' OE1' HG21 ' A' ' 88' ' ' VAL . 73.6 mm-40 -73.94 3.08 7.29 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.317 -0.864 . . . . 73.24 111.178 -175.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.99 11.4 37.24 Favored Glycine 0 N--CA 1.492 2.401 0 N-CA-C 109.88 -1.288 . . . . 72.31 109.88 178.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.75 HG23 ' CD ' ' A' ' 119' ' ' LYS . 86.3 mt -95.41 150.75 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.227 -1.161 . . . . 54.14 110.089 178.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.559 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 2.2 m-20 -89.36 138.45 31.44 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 120.852 -1.155 . . . . 71.24 110.257 -174.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.859 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -41.85 91.23 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.03 -1.044 . . . . 52.22 109.462 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.24 -41.32 99.06 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 122.0 0.905 . . . . 63.11 110.009 172.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.904 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.24 -47.96 74.94 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.611 0.72 . . . . 72.34 110.417 -177.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.856 ' HA ' HD11 ' A' ' 79' ' ' LEU . 85.6 t80 -62.02 -43.56 98.58 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.388 -0.82 . . . . 70.24 110.255 175.749 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -57.89 -41.64 83.0 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.748 -0.781 . . . . 64.24 109.588 -178.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.97 -40.35 93.03 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.208 -0.932 . . . . 73.33 109.985 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.746 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.47 -45.63 58.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 73.34 110.979 -176.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.476 ' N ' HG23 ' A' ' 75' ' ' THR . 52.1 t80 -58.82 -32.42 69.37 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.182 -0.948 . . . . 72.34 109.529 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.86 6.02 41.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.399 -0.813 . . . . 74.35 110.124 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.7 128.16 11.0 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.802 -1.319 . . . . 43.32 109.802 -178.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -57.49 -33.79 68.38 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.076 -1.249 . . . . 74.21 109.601 175.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.38 -44.41 92.75 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.249 -0.907 . . . . 33.5 110.269 178.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.024 HG13 ' HB3' ' A' ' 74' ' ' ALA . 30.6 t -58.2 -49.55 81.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 120.793 -1.192 . . . . 73.13 110.035 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.416 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.7 t0 -57.05 -39.85 75.69 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.03 -1.044 . . . . 70.34 110.031 -177.552 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.2 m -60.38 -38.2 83.16 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.187 -0.945 . . . . 71.13 110.218 178.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.688 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.6 mtm -73.35 -34.22 65.51 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.957 -1.09 . . . . 73.34 110.534 -177.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.018 HG21 ' HG2' ' A' ' 71' ' ' LYS . 60.2 t -58.73 -45.26 91.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.815 0 O-C-N 120.963 -1.085 . . . . 63.44 109.409 176.155 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.554 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -60.62 -38.7 85.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.851 -1.156 . . . . 75.14 109.203 172.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.505 ' HB3' ' O ' ' A' ' 132' ' ' MET . 58.3 ttt180 -54.86 -54.41 42.76 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.787 -0.571 . . . . 74.12 110.981 -175.309 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.631 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 3.7 p90 -66.84 -39.53 87.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.879 -1.138 . . . . 65.44 110.449 -176.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.631 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 55.6 t0 -57.45 -48.24 79.7 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.909 -1.119 . . . . 73.15 110.121 -179.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.525 ' HD2' ' NE2' ' A' ' 141' ' ' GLN . 52.0 tptt -60.88 -42.72 98.52 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.102 -0.999 . . . . 71.52 110.407 179.011 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 6.1 mm100 -61.09 -44.02 98.0 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.835 -1.166 . . . . 72.23 110.618 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.574 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 64.7 t80 -65.73 -40.06 91.77 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.106 -0.996 . . . . 75.42 110.867 -176.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.566 ' CG ' ' N ' ' A' ' 142' ' ' ASP . 8.0 pt20 -70.86 -47.21 60.55 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 119.143 -1.023 . . . . 74.43 110.027 -176.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.566 ' N ' ' CG ' ' A' ' 141' ' ' GLN . 89.9 m-20 -61.23 -34.56 75.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.212 -0.93 . . . . 62.21 110.017 175.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.481 ' O ' HD13 ' A' ' 12' ' ' LEU . 67.4 p -71.16 -19.49 62.41 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.463 -0.773 . . . . 73.33 110.646 -177.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.67 30.8 70.54 Favored Glycine 0 N--CA 1.488 2.102 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' HB1' ' A' ' 150' ' ' ALA . 79.5 mt -80.79 135.17 35.92 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.411 -1.052 . . . . 72.43 110.116 -179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.3 p -108.51 5.34 25.09 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.327 -0.858 . . . . 51.32 110.108 179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.1 129.09 1.07 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.013 -1.235 . . . . 51.2 110.013 179.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.4 m -84.58 162.92 49.11 Favored Pre-proline 0 N--CA 1.497 1.88 0 O-C-N 121.448 -1.031 . . . . 72.02 109.223 173.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.564 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 43.2 Cg_endo -73.75 132.86 28.35 Favored 'Cis proline' 0 N--CA 1.49 1.287 0 C-N-CA 122.289 -1.963 . . . . 63.12 111.485 5.412 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.926 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -125.73 131.16 52.6 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.186 -0.946 . . . . 41.13 109.269 171.165 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.485 ' O ' HD13 ' A' ' 158' ' ' LEU . 42.9 t -109.97 129.55 64.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 120.897 -1.127 . . . . 63.4 110.012 -177.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.447 ' O ' ' HA ' ' A' ' 22' ' ' VAL . 11.8 t -113.68 129.81 68.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.194 -0.941 . . . . 64.33 110.218 -178.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.606 HG11 ' HB2' ' A' ' 177' ' ' LEU . 11.6 t -111.41 135.57 50.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.589 -0.695 . . . . 43.32 109.519 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.555 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.1 m-80 52.05 22.69 1.94 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.093 -1.004 . . . . 75.34 110.06 -175.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 3.6 t30 51.0 30.12 5.09 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.192 -0.942 . . . . 72.14 110.64 177.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.884 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.6 ttt180 -151.14 -21.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 120.788 -1.195 . . . . 73.44 111.014 -177.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.973 ' CE1' HG22 ' A' ' 11' ' ' VAL . 58.5 m-85 -111.05 141.77 44.09 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.596 -1.315 . . . . 62.33 110.015 172.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.867 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -112.29 124.91 53.5 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.22 -0.925 . . . . 64.4 109.162 -179.875 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.708 HG22 ' CD1' ' A' ' 177' ' ' LEU . 76.8 t -80.23 114.72 21.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 O-C-N 121.416 -0.802 . . . . 73.54 110.386 -174.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.526 ' NE2' ' HG3' ' A' ' 10' ' ' GLN . 98.3 mt-30 -78.7 -53.12 7.48 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.188 -0.945 . . . . 65.2 109.639 174.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.41 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 60.13 13.51 28.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 109.829 -1.308 . . . . 73.33 109.829 177.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -62.7 -37.59 87.08 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.159 -1.201 . . . . 73.53 110.44 -178.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.512 ' OG ' ' NE2' ' A' ' 8' ' ' HIS . 53.6 p -87.51 -1.54 58.0 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.323 -0.861 . . . . 60.01 110.556 -177.392 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -84.38 106.75 16.21 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.108 -0.995 . . . . 74.42 110.482 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.1 mttt -89.72 -6.12 56.36 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.151 -0.968 . . . . 52.44 110.082 176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -140.09 143.66 36.39 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.36 -0.838 . . . . 74.23 109.901 179.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.857 HD11 ' NE2' ' A' ' 42' ' ' GLN . 49.2 mt -53.57 -29.27 36.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.008 -1.057 . . . . 62.32 111.009 -178.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.418 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.6 m-20 -57.66 -40.34 79.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.711 -1.243 . . . . 63.42 110.397 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.48 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 83.4 tt0 -77.59 -43.83 30.4 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.876 -1.14 . . . . 70.35 110.475 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.41 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 71.6 t80 -62.79 -45.42 92.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.028 -1.045 . . . . 75.2 109.912 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.714 ' CD1' HD12 ' A' ' 43' ' ' LEU . 61.3 t80 -59.34 -45.55 91.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.43 -0.794 . . . . 73.33 110.011 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.563 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.6 m-20 -56.56 -48.47 77.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.161 -0.962 . . . . 62.04 110.461 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.686 HD11 HD11 ' A' ' 177' ' ' LEU . 4.9 tp -51.09 -54.77 21.91 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.758 -1.214 . . . . 73.13 110.018 174.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.517 HG22 HG21 ' A' ' 159' ' ' VAL . 55.8 t -52.49 -43.55 42.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.068 -1.02 . . . . 74.22 109.898 -178.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.67 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.6 m120 -58.55 -42.1 87.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.205 -0.935 . . . . 73.11 110.801 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.682 ' CD2' ' CZ ' ' A' ' 3' ' ' PHE . 67.9 m-85 -70.66 -40.68 72.87 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.006 -1.059 . . . . 71.34 110.356 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.025 ' HA ' HD12 ' A' ' 180' ' ' LEU . 82.4 mt -57.89 -37.06 73.28 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.04 -1.038 . . . . 71.12 109.323 175.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.67 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.0 mt -59.52 -29.8 68.14 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.219 -0.926 . . . . 74.22 109.846 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 72.2 p -94.98 -4.47 46.6 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.259 -0.9 . . . . 72.4 110.611 -177.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.025 HD12 ' HA ' ' A' ' 177' ' ' LEU . 31.4 mt -91.36 141.85 28.32 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.125 -0.984 . . . . 72.13 110.282 178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 29.6 tttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.973 -1.013 . . . . 62.05 110.144 179.869 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 121.237 0.542 . . . . 71.14 110.254 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.572 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.8 tt0 -56.4 -37.75 70.57 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.174 -0.954 . . . . 70.15 110.192 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' A' ' 173' ' ' LEU . 84.2 m-85 -100.35 129.72 46.37 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.231 -0.918 . . . . 73.02 110.194 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.4 tttp -147.86 145.3 28.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.244 -0.91 . . . . 73.24 110.444 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.628 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 61.0 tt0 -55.81 137.49 49.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 63.31 110.162 176.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.438 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 90.96 -3.85 81.13 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.483 -1.447 . . . . 64.34 109.483 179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.437 ' O ' ' NE2' ' A' ' 160' ' ' GLN . 96.0 mt-10 -133.7 -65.1 0.69 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.096 -1.238 . . . . 75.41 110.464 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.574 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 15.2 m-70 -91.2 -22.1 20.8 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.279 -0.888 . . . . 74.51 109.396 177.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.628 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 50.0 p90 -155.55 169.56 24.0 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.549 -0.72 . . . . 52.33 110.532 175.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -119.75 146.9 45.23 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.449 -0.782 . . . . 73.01 109.303 172.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.012 HG22 ' CE2' ' A' ' 157' ' ' TYR . 79.2 t -98.97 132.59 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.882 -1.136 . . . . 73.31 110.892 -176.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.607 HD13 ' O ' ' A' ' 143' ' ' SER . 81.9 mt -102.59 153.83 19.71 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.846 -0.534 . . . . 74.24 110.196 -178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 30.1 mttt -80.01 6.01 12.55 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.22 -0.925 . . . . 72.02 110.076 176.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.567 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -51.44 160.5 0.96 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.302 -0.874 . . . . 74.55 110.577 -178.385 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.681 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 34.8 Cg_exo -57.03 -22.2 45.76 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.227 1.646 . . . . 45.32 110.61 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 67.06 172.32 0.26 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.26 -0.9 . . . . 62.43 110.283 -176.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.494 ' N ' ' O ' ' A' ' 154' ' ' ASN . 29.3 t -107.27 138.53 43.29 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.028 -1.045 . . . . 61.05 110.117 176.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.9 p -60.26 -31.4 70.18 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.168 -0.957 . . . . 74.34 109.9 179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.461 ' O ' ' OD1' ' A' ' 154' ' ' ASN . 0.6 OUTLIER -118.32 172.6 4.01 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 74.11 109.469 174.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.468 ' HA ' ' OD1' ' A' ' 154' ' ' ASN . 53.8 Cg_endo -69.34 120.5 7.33 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 123.733 1.386 . . . . 73.34 109.836 -179.132 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.7 p -144.19 134.83 21.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.645 0 O-C-N 120.789 -1.194 . . . . 74.23 109.721 172.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.579 ' HB ' ' CD1' ' A' ' 53' ' ' PHE . 11.2 t -115.64 127.06 73.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.146 -0.971 . . . . 63.13 109.727 -177.714 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 94.1 p -120.78 138.17 54.15 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.016 -1.052 . . . . 65.13 110.446 -176.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.85 ' CD ' HG21 ' A' ' 40' ' ' ILE . 33.4 mt-10 -96.26 132.34 41.82 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.35 -0.844 . . . . 74.51 109.881 175.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.591 ' CD2' ' ND2' ' A' ' 56' ' ' ASN . 72.6 m-85 -105.59 123.18 47.48 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.881 -1.137 . . . . 73.45 109.721 172.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.578 ' O ' HG22 ' A' ' 58' ' ' VAL . 49.4 p90 -142.14 165.33 27.73 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.613 -0.679 . . . . 70.32 111.184 -176.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.496 ' HB3' ' HB2' ' A' ' 30' ' ' CYS . 36.0 t -127.94 138.17 52.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.473 -0.767 . . . . 72.13 110.077 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.575 ' CG ' ' CE ' ' A' ' 69' ' ' MET . 97.5 m-85 -58.97 -22.13 59.74 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.291 -0.881 . . . . 73.24 110.766 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.533 ' HA ' HG21 ' A' ' 93' ' ' ILE . 58.5 m-85 -105.76 24.23 12.63 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.054 -1.028 . . . . 74.32 110.858 -175.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 21.5 t -122.13 91.79 48.96 Favored Pre-proline 0 N--CA 1.489 1.497 0 O-C-N 120.852 -1.155 . . . . 34.41 110.382 -175.575 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -52.74 -31.08 49.34 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.057 1.556 . . . . 74.12 109.729 177.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 64.6 m170 -62.19 -49.85 74.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.138 -0.976 . . . . 75.33 109.967 174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 1.052 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 28.3 m -62.73 -43.46 98.76 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.125 -0.984 . . . . 63.23 109.907 177.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' ND2' ' HB3' ' A' ' 90' ' ' PHE . 24.3 t-20 -55.61 -40.45 72.12 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.299 -0.875 . . . . 64.23 110.705 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.467 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 51.2 m -68.32 -43.58 77.25 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.104 -0.998 . . . . 63.24 110.69 -178.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.864 ' CE2' HD11 ' A' ' 40' ' ' ILE . 69.0 t80 -69.34 -34.52 74.75 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.187 -0.946 . . . . 71.51 110.846 -176.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.537 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -41.2 -55.13 5.34 Favored Pre-proline 0 N--CA 1.493 1.691 0 O-C-N 121.13 -0.981 . . . . 62.11 110.773 -173.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 45.7 Cg_exo -47.36 -49.79 12.42 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 123.711 1.374 . . . . 75.43 110.624 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.629 HG23 HD21 ' A' ' 167' ' ' LEU . 87.4 mt -54.29 -48.19 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.965 -1.084 . . . . 74.02 110.261 -179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.864 HD11 ' CE2' ' A' ' 36' ' ' PHE . 41.0 mm -58.28 -39.36 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 120.831 -1.168 . . . . 72.13 110.028 177.146 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -55.74 -39.39 71.08 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.045 -1.034 . . . . 51.33 109.44 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 12.2 mt-30 -59.37 -44.8 92.67 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.153 -0.967 . . . . 70.1 109.411 175.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.793 HD12 ' CD2' ' A' ' 171' ' ' PHE . 50.2 tp -57.74 -42.72 84.51 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.269 -0.894 . . . . 74.23 110.533 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.84 ' HA ' HD12 ' A' ' 47' ' ' LEU . 27.6 mtpp -59.59 -45.41 91.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.232 -0.918 . . . . 73.34 110.485 -179.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.7 mt-30 -59.18 -34.86 72.62 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.169 -0.957 . . . . 62.41 109.39 176.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.445 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 40.5 mt-30 -94.6 -4.7 47.32 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.488 -0.757 . . . . 72.04 110.407 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 44' ' ' LYS . 6.7 mt -61.35 145.8 90.04 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.143 -0.973 . . . . 64.42 110.292 -176.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.0 Cg_exo -63.68 141.1 77.9 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.938 1.493 . . . . 71.22 109.993 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.05 -34.44 74.88 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.192 -0.943 . . . . 75.11 109.764 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.34 -39.85 98.28 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.865 -1.294 . . . . 71.01 109.865 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -73.16 142.78 47.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.129 -1.218 . . . . 72.11 110.6 -177.287 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 86.9 mttt -96.98 156.79 16.2 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.4 -0.812 . . . . 74.11 109.593 174.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.579 ' CD1' ' HB ' ' A' ' 22' ' ' VAL . 36.2 t80 -124.92 159.92 30.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.731 -1.23 . . . . 64.12 110.648 177.47 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.508 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -150.35 161.4 42.55 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.24 110.523 -174.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.435 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 76.2 mttt -122.7 143.08 50.03 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.042 -1.036 . . . . 74.21 110.462 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.591 ' ND2' ' CD2' ' A' ' 25' ' ' PHE . 4.7 t30 -136.77 132.12 34.33 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.289 -0.882 . . . . 65.33 110.034 -178.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.9 p-80 -115.17 134.0 55.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.662 -1.274 . . . . 75.14 110.277 175.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.63 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.1 m -95.25 138.45 20.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.941 . . . . 64.32 110.826 -175.407 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.409 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.3 p -93.59 -15.14 25.7 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.284 -0.885 . . . . 63.24 110.758 176.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 15.1 p90 -76.49 -29.53 56.87 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.57 -1.331 . . . . 61.33 110.183 -176.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.63 ' HG3' HG21 ' A' ' 58' ' ' VAL . 71.0 mmm -63.16 -38.42 91.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.11 -0.994 . . . . 73.12 110.089 172.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -68.85 -43.37 74.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.133 -1.187 . . . . 64.31 110.133 -177.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 100.56 -146.9 17.79 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.929 -1.668 . . . . 34.13 108.929 -173.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -54.52 -38.93 67.12 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.955 -1.32 . . . . 73.2 110.408 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.452 ' O ' ' HG3' ' A' ' 65' ' ' MET . 14.7 tpt -74.04 -14.14 60.96 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.202 -0.936 . . . . 71.21 110.514 179.603 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.409 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -55.56 -41.35 81.31 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.81 -1.316 . . . . 72.02 109.81 -175.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -57.01 -41.82 79.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.073 -1.251 . . . . 62.31 109.954 179.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.03 -45.35 89.29 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.228 -0.92 . . . . 45.42 110.346 178.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.575 ' CE ' ' CG ' ' A' ' 28' ' ' PHE . 97.3 mmm -60.51 -41.84 95.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.021 -1.049 . . . . 73.04 110.572 -177.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.806 ' OG ' HG13 ' A' ' 133' ' ' VAL . 97.3 p -61.49 -47.88 83.64 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 75.43 110.044 179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.821 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -60.0 -33.64 72.26 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.14 -0.975 . . . . 63.13 110.359 175.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.8 73.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.076 -1.015 . . . . 61.33 110.439 -176.013 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 72.9 t80 -57.54 -44.38 85.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.759 -1.213 . . . . 54.21 109.615 175.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.812 ' HA ' HD12 ' A' ' 77' ' ' ILE . . . -60.99 -39.91 91.46 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.155 -0.965 . . . . 72.31 109.962 176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.739 HG23 ' HB3' ' A' ' 123' ' ' ALA . 32.3 m -58.74 -43.17 90.18 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.192 -0.942 . . . . 62.21 109.847 177.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.809 ' SD ' HG23 ' A' ' 86' ' ' VAL . 42.3 mtt -53.76 -42.58 68.37 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.059 -1.026 . . . . 71.04 108.946 177.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.812 HD12 ' HA ' ' A' ' 74' ' ' ALA . 84.5 mt -59.32 -43.14 89.37 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.84 -0.744 . . . . 73.32 110.004 -177.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.694 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.07 -36.31 72.63 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.876 -1.14 . . . . 75.32 110.008 173.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.975 ' O ' HG13 ' A' ' 81' ' ' VAL . 32.8 mt -90.05 5.63 45.85 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.306 -0.871 . . . . 54.3 110.764 -177.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.414 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 75.4 mm-40 54.81 31.06 14.83 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.945 -1.097 . . . . 73.12 110.043 -175.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.975 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.3 m -121.37 14.0 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.236 -0.915 . . . . 73.32 111.518 -175.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' HG2' HG12 ' A' ' 77' ' ' ILE . 2.7 mp0 -45.55 -77.06 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.546 -1.346 . . . . 71.25 109.853 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -49.91 -35.44 23.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.759 -1.213 . . . . 73.11 110.631 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 85.7 tttt -57.8 -43.62 85.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 73.02 111.31 -171.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.691 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.9 ppp? -126.42 -3.24 6.78 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.939 -1.101 . . . . 64.51 110.878 -176.573 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.809 HG23 ' SD ' ' A' ' 76' ' ' MET . 1.4 t -53.02 -47.01 97.3 Favored Pre-proline 0 C--N 1.298 -1.64 0 O-C-N 120.596 -1.315 . . . . 74.4 108.953 179.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.542 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 17.3 Cg_exo -60.91 -26.48 83.2 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 123.354 1.186 . . . . 74.12 110.627 174.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.743 HG21 ' CD ' ' A' ' 113' ' ' GLU . 61.9 t -65.69 -40.79 88.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.779 -1.201 . . . . 63.33 109.632 179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.506 ' HE2' HD11 ' A' ' 106' ' ' LEU . 82.1 mmm -58.94 -42.55 90.05 Favored 'General case' 0 C--N 1.299 -1.607 0 C-N-CA 119.062 -1.055 . . . . 74.03 109.252 177.195 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.535 ' CE1' ' HA ' ' A' ' 28' ' ' PHE . 42.7 m-85 -70.18 -46.68 64.13 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.825 -1.172 . . . . 75.45 110.942 178.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.515 ' O ' ' HB ' ' A' ' 95' ' ' THR . 48.0 t30 -56.21 -48.76 75.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.037 -1.039 . . . . 74.35 109.821 177.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.565 ' HA ' HD13 ' A' ' 96' ' ' LEU . 18.5 tpt180 -49.98 -37.57 33.11 Favored 'General case' 0 C--N 1.293 -1.867 0 O-C-N 120.973 -1.079 . . . . 75.14 109.39 174.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.533 HG21 ' HA ' ' A' ' 29' ' ' TYR . 1.9 mm -85.48 -68.23 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.492 -0.755 . . . . 72.45 110.821 178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.463 ' N ' ' O ' ' A' ' 90' ' ' PHE . 85.8 t60 -64.87 -19.4 65.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.199 -0.938 . . . . 72.44 110.995 -172.352 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.565 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -114.95 -71.03 0.76 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.985 -1.072 . . . . 71.11 110.207 -175.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.619 HD12 ' H ' ' A' ' 96' ' ' LEU . 4.9 mp -61.19 -25.49 67.07 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.043 -1.036 . . . . 74.4 109.958 178.177 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.508 ' NH1' ' O ' ' A' ' 95' ' ' THR . 73.9 mtt85 58.47 37.04 25.67 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.412 -0.805 . . . . 74.14 110.138 -177.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.2 mttt -126.96 74.58 76.55 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.337 -0.852 . . . . 74.35 109.884 177.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.45 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.4 Cg_endo -61.76 140.04 83.7 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.074 1.565 . . . . 71.45 110.273 -178.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -59.42 131.03 38.41 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.942 1.496 . . . . 74.43 110.068 179.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.467 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 1.1 ptpm? -96.47 -22.02 17.37 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.144 -0.972 . . . . 72.31 110.493 -178.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.467 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 72.1 m-20 -142.96 170.37 15.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.152 -0.967 . . . . 74.51 109.86 -179.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.26 -26.98 63.58 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.039 -1.038 . . . . 71.33 109.553 173.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -68.95 -53.49 20.55 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.196 -0.94 . . . . 74.55 110.912 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.466 ' HG3' ' HG2' ' A' ' 101' ' ' LYS . 75.3 mm-40 -61.25 -37.99 85.07 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 120.923 -1.111 . . . . 65.14 109.218 177.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.993 ' HA ' HD12 ' A' ' 109' ' ' ILE . 12.8 tp -59.8 -43.1 94.62 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.511 -0.743 . . . . 54.15 110.09 177.018 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.752 ' NH1' HD11 ' A' ' 111' ' ' LEU . 70.5 ttp85 -60.01 -45.97 91.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.939 -1.1 . . . . 71.3 110.47 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.473 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.4 tm0? -58.76 -40.23 83.29 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.067 -1.021 . . . . 71.4 110.123 -179.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.993 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.1 mt -56.43 -49.06 78.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.185 -0.947 . . . . 73.2 110.137 -179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.488 ' CD2' ' CD1' ' A' ' 120' ' ' PHE . 22.6 m-85 -58.16 -46.6 85.44 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 53.42 110.23 177.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.863 HD21 ' CA ' ' A' ' 117' ' ' ALA . 90.9 mt -57.99 -40.96 82.02 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.105 -0.997 . . . . 73.51 110.016 -178.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.473 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 89.4 m-20 -57.81 -39.53 77.8 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.192 -0.943 . . . . 73.05 110.297 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.743 ' CD ' HG21 ' A' ' 88' ' ' VAL . 75.9 mm-40 -75.66 5.97 5.44 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 73.24 111.284 -175.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.29 11.24 42.67 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.962 -1.255 . . . . 72.31 109.962 176.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.746 HG23 ' CD ' ' A' ' 119' ' ' LYS . 84.6 mt -94.61 150.76 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.254 -1.145 . . . . 54.14 109.965 178.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.558 ' HB2' ' CB ' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -90.05 137.76 32.08 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 120.863 -1.148 . . . . 71.24 110.197 -174.284 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.863 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -59.21 -41.53 88.84 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.099 -1.001 . . . . 52.22 109.452 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.41 -41.4 98.72 Favored 'General case' 0 C--N 1.3 -1.583 0 CA-C-O 121.941 0.877 . . . . 63.11 109.956 172.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.902 ' HG2' HD22 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -65.31 -48.13 74.15 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-O 121.69 0.757 . . . . 72.34 110.445 -177.044 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.879 ' HA ' HD11 ' A' ' 79' ' ' LEU . 88.9 t80 -61.35 -43.76 98.33 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.285 -0.884 . . . . 70.24 110.248 175.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.6 t0 -57.56 -41.47 81.12 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 119.731 -0.788 . . . . 64.24 109.637 -179.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.46 94.28 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.31 -0.869 . . . . 73.33 109.984 177.164 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.739 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -71.47 -45.95 61.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.236 -0.915 . . . . 73.34 111.018 -176.526 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.475 ' N ' HG23 ' A' ' 75' ' ' THR . 56.6 t80 -59.08 -32.5 69.84 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.1 -1.0 . . . . 72.34 109.576 179.25 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -89.54 5.51 45.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.322 -0.861 . . . . 74.35 110.102 -179.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.05 130.9 14.42 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.783 -1.327 . . . . 43.32 109.783 -178.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -55.29 -38.58 68.81 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.085 -1.244 . . . . 74.21 109.556 175.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.448 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.29 -46.75 85.51 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.247 -0.908 . . . . 33.5 110.279 179.328 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 0.81 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.3 t -54.13 -50.53 54.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.834 -1.166 . . . . 73.13 110.013 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.475 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.1 t0 -56.58 -43.01 79.62 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.08 -1.012 . . . . 70.34 109.839 -177.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.5 m -59.36 -36.22 75.34 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.235 -0.916 . . . . 71.13 110.427 178.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.481 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -73.52 -38.22 65.38 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.847 -1.158 . . . . 73.34 110.672 -176.046 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.821 HG21 ' HG2' ' A' ' 71' ' ' LYS . 98.2 t -58.83 -44.88 91.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 121.113 -0.992 . . . . 63.44 109.657 177.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 55.9 mtp85 -62.06 -44.27 97.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.127 -0.983 . . . . 75.14 109.641 176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.489 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 23.1 ttm-85 -51.8 -57.28 9.77 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.64 -0.663 . . . . 74.12 111.226 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 55.0 m-85 -65.88 -41.38 91.67 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.717 -1.239 . . . . 65.44 110.812 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -56.39 -45.66 80.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.938 -1.102 . . . . 73.15 110.084 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.401 ' HB3' ' HE2' ' A' ' 138' ' ' LYS . 16.4 mtpt -62.03 -39.54 92.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.995 -1.065 . . . . 71.52 110.689 177.365 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.489 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -56.26 -46.74 79.51 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.029 -1.045 . . . . 72.23 110.134 -177.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.686 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 56.6 t80 -67.49 -38.62 84.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.225 -0.922 . . . . 75.42 110.596 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -65.12 -51.26 62.35 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.243 -0.911 . . . . 74.43 110.19 -179.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.567 ' O ' HG23 ' A' ' 14' ' ' THR . 90.4 m-20 -60.12 -37.79 81.08 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.287 -0.883 . . . . 62.21 110.301 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.607 ' O ' HD13 ' A' ' 12' ' ' LEU . 97.1 p -64.71 -22.21 66.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.348 -0.845 . . . . 73.33 110.393 -178.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.78 28.91 68.14 Favored Glycine 0 N--CA 1.487 2.06 0 N-CA-C 108.951 -1.659 . . . . 73.22 108.951 -176.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.992 HD22 ' HB1' ' A' ' 150' ' ' ALA . 57.9 mt -77.73 121.76 24.46 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.281 -1.129 . . . . 72.43 110.358 -177.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.8 m -67.94 -37.81 82.08 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.277 -0.889 . . . . 51.32 110.093 176.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -166.59 147.1 11.57 Favored Glycine 0 N--CA 1.487 2.097 0 C-N-CA 119.749 -1.215 . . . . 51.2 110.104 -178.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.587 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 11.4 m -84.44 163.54 46.89 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.458 -1.025 . . . . 72.02 109.253 174.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.587 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 42.2 Cg_endo -73.07 132.98 28.41 Favored 'Cis proline' 0 N--CA 1.491 1.329 0 C-N-CA 122.393 -1.919 . . . . 63.12 111.537 6.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.992 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.07 143.5 50.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.252 -0.905 . . . . 41.13 109.513 171.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.466 HG21 ' OH ' ' A' ' 170' ' ' TYR . 40.3 t -115.23 128.6 72.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.021 -1.05 . . . . 63.4 109.9 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.565 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 46.6 t -116.27 132.35 66.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.157 -0.964 . . . . 64.33 110.535 -177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.699 HG11 ' HB2' ' A' ' 177' ' ' LEU . 20.7 t -108.88 130.93 60.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.47 -0.769 . . . . 43.32 109.888 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 35.7 m-80 48.26 27.74 1.4 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.288 -0.882 . . . . 75.34 110.69 -173.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.5 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.2 t30 52.37 30.83 8.65 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.125 -1.03 . . . . 72.14 110.096 175.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.632 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 18.0 tpt180 -144.36 -39.21 0.28 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.128 -0.982 . . . . 73.44 110.584 -175.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 1.012 ' CE2' HG22 ' A' ' 11' ' ' VAL . 57.2 m-85 -104.82 141.32 36.71 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.989 -1.069 . . . . 62.33 110.077 178.447 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.99 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -110.35 125.61 53.37 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.282 -0.886 . . . . 64.4 109.321 -178.21 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.636 HG22 HD12 ' A' ' 177' ' ' LEU . 83.0 t -79.19 119.05 27.71 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.426 -0.796 . . . . 73.54 110.391 -175.061 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 27.5 mt-30 -83.8 -57.54 3.17 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.259 -0.901 . . . . 65.2 109.494 173.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.7 2.02 48.76 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 110.027 -1.229 . . . . 73.33 110.027 176.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -62.92 -40.82 98.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.079 -1.248 . . . . 73.53 110.12 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 43.7 m -64.63 -33.52 76.12 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.371 -0.83 . . . . 60.01 110.315 178.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.521 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -85.61 114.03 22.29 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 74.42 110.79 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttp -92.08 -3.35 55.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 52.44 110.053 175.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.2 t -131.54 144.43 51.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 74.23 109.923 179.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.629 HD21 HG23 ' A' ' 39' ' ' ILE . 43.3 mt -53.03 -29.27 28.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.055 -1.028 . . . . 62.32 111.088 -177.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.37 -40.73 78.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.608 -1.308 . . . . 63.42 110.439 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.521 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 95.7 mt-10 -80.27 -41.43 25.02 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.866 -1.147 . . . . 70.35 110.76 178.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.466 ' OH ' HG21 ' A' ' 151' ' ' VAL . 74.9 t80 -62.96 -45.3 93.09 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.864 -1.147 . . . . 75.2 109.956 177.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.793 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.9 t80 -58.01 -47.03 84.27 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.416 -0.802 . . . . 73.33 110.065 176.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 91.0 m-20 -57.49 -42.87 83.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.141 -0.975 . . . . 62.04 110.47 -179.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.618 HD11 HD11 ' A' ' 177' ' ' LEU . 5.5 tp -54.24 -54.18 43.58 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.656 -1.277 . . . . 73.13 110.165 176.213 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.665 HG11 HD21 ' A' ' 43' ' ' LEU . 54.8 t -53.72 -43.7 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.096 -1.003 . . . . 74.22 109.91 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.566 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.24 -41.3 88.43 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.163 -0.961 . . . . 73.11 110.766 179.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.541 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 33.9 m-85 -67.54 -43.39 80.85 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.977 -1.077 . . . . 71.34 110.144 179.655 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.013 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.5 mt -59.93 -37.46 79.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.266 -0.896 . . . . 71.12 109.979 178.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.566 HD12 ' HA ' ' A' ' 175' ' ' ASN . 12.6 mt -60.33 -28.35 68.07 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.25 -0.906 . . . . 74.22 110.153 177.466 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 59.3 p -97.13 -11.03 24.84 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.926 . . . . 72.4 110.424 -177.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.013 HD12 ' HA ' ' A' ' 177' ' ' LEU . 38.5 mt -77.95 -44.03 28.06 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.199 -0.938 . . . . 72.13 110.632 -178.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' O ' ' HG2' ' A' ' 156' ' ' ARG . 42.8 tttm . . . . . 0 N--CA 1.494 1.737 0 CA-C-O 117.974 -1.013 . . . . 62.05 110.452 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.461 ' O ' ' HE3' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.321 0.581 . . . . 71.14 110.186 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.57 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.5 tt0 -56.36 -37.77 70.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.247 -0.908 . . . . 70.15 110.179 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.688 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 89.6 m-85 -105.41 132.83 51.1 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.303 -0.873 . . . . 73.02 110.127 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.461 ' HE3' ' O ' ' A' ' 1' ' ' ALA . 92.9 mttt -134.34 153.42 51.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.33 -0.856 . . . . 73.24 110.21 -178.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.577 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 82.6 tt0 -71.85 134.69 46.26 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.223 -0.923 . . . . 63.31 110.078 177.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.52 -7.46 68.51 Favored Glycine 0 N--CA 1.488 2.135 0 N-CA-C 109.476 -1.45 . . . . 64.34 109.476 -177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.403 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 96.1 mt-10 -130.99 -55.07 1.05 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.14 -1.212 . . . . 75.41 110.453 179.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.579 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 27.4 m-70 -92.54 -21.28 20.2 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.208 -0.932 . . . . 74.51 109.757 178.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.589 ' CG ' HD21 ' A' ' 177' ' ' LEU . 44.1 p90 -154.27 174.59 14.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.455 -0.778 . . . . 52.33 110.616 175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.482 ' HG2' ' HB3' ' A' ' 158' ' ' LEU . 13.9 pt20 -131.33 157.56 43.04 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.095 -0.706 . . . . 73.01 109.095 174.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.76 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.7 t -104.23 127.89 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 120.733 -1.23 . . . . 73.31 110.711 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 1.052 HD13 ' HA ' ' A' ' 143' ' ' SER . 85.2 mt -86.59 -11.91 50.14 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.795 -0.565 . . . . 74.24 110.499 -178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 12' ' ' LEU . 53.7 mttp 56.95 17.32 3.27 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.153 -0.967 . . . . 72.02 109.665 -171.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.521 HG22 ' HB3' ' A' ' 142' ' ' ASP . 0.2 OUTLIER -70.94 165.65 45.19 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.343 -0.848 . . . . 74.55 110.101 177.789 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_exo -56.22 96.68 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.997 1.525 . . . . 45.32 110.269 178.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.93 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -71.7 160.3 32.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.154 -0.967 . . . . 62.43 110.328 -178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 94.6 p -90.94 148.46 22.42 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.255 -0.903 . . . . 61.05 110.291 -179.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.0 p -64.34 -29.84 70.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.234 -0.916 . . . . 74.34 110.184 179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.403 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.5 OUTLIER -115.96 172.84 3.4 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.336 -0.853 . . . . 74.11 109.796 178.117 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.6 Cg_endo -71.05 123.2 9.46 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.861 1.453 . . . . 73.34 109.979 -179.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.456 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.5 p -145.41 137.77 20.79 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.831 -1.168 . . . . 74.23 109.844 172.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -117.56 128.28 74.82 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 O-C-N 121.116 -0.99 . . . . 63.13 109.73 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 96.1 p -116.77 134.58 54.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.025 -1.047 . . . . 65.13 110.046 -178.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.655 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.3 tt0 -105.38 124.92 50.36 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.542 -0.724 . . . . 74.51 110.41 178.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CB ' HG12 ' A' ' 148' ' ' VAL . 61.1 m-85 -97.6 122.53 40.78 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 73.45 109.72 176.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.478 ' CE1' ' O ' ' A' ' 56' ' ' ASN . 50.2 p90 -139.67 169.03 18.49 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.598 -0.689 . . . . 70.32 110.502 -176.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.501 ' OG ' ' HB3' ' A' ' 61' ' ' MET . 46.8 t -129.93 130.0 44.56 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.294 -0.879 . . . . 72.13 110.607 -179.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 97.7 m-85 -60.38 -24.07 64.82 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.082 -1.011 . . . . 73.24 110.361 175.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.633 ' CE1' ' CD1' ' A' ' 93' ' ' ILE . 88.3 m-85 -103.4 21.14 16.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.197 -0.939 . . . . 74.32 110.727 -174.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.574 ' HB2' ' HE2' ' A' ' 61' ' ' MET . 42.9 t -123.17 106.8 33.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.886 -1.134 . . . . 34.41 110.17 -177.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.425 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.8 Cg_endo -58.0 -49.89 11.61 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.977 1.514 . . . . 74.12 110.403 -176.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -58.31 -45.61 87.7 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.125 -0.984 . . . . 75.33 110.156 178.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 21.4 m -65.73 -45.54 82.3 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.08 -1.013 . . . . 63.23 110.325 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 30' ' ' CYS . 8.4 m-20 -56.01 -38.6 70.71 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 120.973 -1.08 . . . . 64.23 109.995 -178.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.471 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 46.9 m -65.37 -41.24 93.97 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.138 -0.976 . . . . 63.24 110.159 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.859 ' CE2' HD11 ' A' ' 40' ' ' ILE . 80.2 t80 -59.23 -35.61 73.96 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.315 -0.866 . . . . 71.51 110.491 -179.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.564 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -39.67 -62.13 0.91 Allowed Pre-proline 0 N--CA 1.494 1.757 0 O-C-N 121.18 -0.95 . . . . 62.11 111.094 -174.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.6 Cg_endo -51.9 -39.86 67.83 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.527 1.277 . . . . 75.43 110.642 -177.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.937 HG23 HD21 ' A' ' 167' ' ' LEU . 84.9 mt -55.55 -49.07 76.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.897 -1.127 . . . . 74.02 110.021 177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.859 HD11 ' CE2' ' A' ' 36' ' ' PHE . 24.2 mm -57.68 -39.65 71.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.968 -1.082 . . . . 72.13 110.114 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.483 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.17 -37.73 72.54 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.011 -1.056 . . . . 51.33 109.67 176.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.447 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 29.2 mt-30 -58.42 -43.85 88.86 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.077 -1.014 . . . . 70.1 109.194 175.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.934 HD13 ' CD1' ' A' ' 171' ' ' PHE . 47.3 tp -59.63 -42.55 92.95 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.334 -0.854 . . . . 74.23 110.588 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.852 ' HA ' HD12 ' A' ' 47' ' ' LEU . 1.9 mtpm? -59.47 -45.36 91.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.357 -0.839 . . . . 73.34 110.518 -177.419 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.19 -37.84 84.4 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.158 -0.964 . . . . 62.41 109.277 176.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.503 ' NE2' ' CD2' ' A' ' 171' ' ' PHE . 50.3 mt-30 -78.25 -25.73 46.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.582 -0.699 . . . . 72.04 110.487 178.37 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.852 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.5 mt -53.67 148.08 20.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.154 -0.966 . . . . 64.42 110.463 -175.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HG2' ' HB2' ' A' ' 51' ' ' ALA . 27.0 Cg_endo -68.6 142.81 54.57 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.07 1.563 . . . . 71.22 109.966 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -56.91 -34.75 68.25 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.188 -0.945 . . . . 75.11 109.82 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.66 -39.52 97.52 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.874 -1.29 . . . . 71.01 109.874 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.581 ' HB2' ' HG2' ' A' ' 48' ' ' PRO . . . -72.93 140.53 47.52 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.152 -1.205 . . . . 72.11 110.601 -177.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 87.7 mttt -96.93 156.67 16.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.451 -0.78 . . . . 74.11 109.583 174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.575 ' CE2' ' HD2' ' A' ' 44' ' ' LYS . 55.1 t80 -123.34 159.08 29.63 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.663 -1.273 . . . . 64.12 110.64 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.517 ' N ' ' O ' ' A' ' 22' ' ' VAL . 50.8 tt0 -145.69 161.04 40.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.5 -0.75 . . . . 74.24 110.236 -175.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.479 ' HD2' ' OH ' ' A' ' 73' ' ' TYR . 27.9 mttm -123.04 144.17 49.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.077 -1.015 . . . . 74.21 110.533 -179.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.478 ' O ' ' CE1' ' A' ' 26' ' ' PHE . 4.7 m-20 -142.17 133.03 25.73 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.441 -0.787 . . . . 65.33 110.048 -178.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.583 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.0 OUTLIER -116.57 125.88 52.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.916 -1.115 . . . . 75.14 110.144 -178.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.685 HG21 ' HG3' ' A' ' 61' ' ' MET . 35.0 m -73.96 135.36 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.201 -0.937 . . . . 64.32 110.697 179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.477 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 60.5 p -93.34 -14.31 27.06 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.23 -0.918 . . . . 63.24 110.413 175.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.594 ' CD2' ' HB ' ' A' ' 58' ' ' VAL . 11.0 p90 -74.03 -29.99 62.2 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.656 -1.278 . . . . 61.33 110.091 -177.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.685 ' HG3' HG21 ' A' ' 58' ' ' VAL . 92.6 mmm -64.71 -38.48 91.13 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.097 -1.002 . . . . 73.12 110.101 173.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.462 ' HA3' ' HA2' ' A' ' 66' ' ' GLY . . . -62.88 -45.65 95.24 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.704 -1.358 . . . . 64.31 109.704 -178.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 87.69 -126.33 7.98 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.54 -1.424 . . . . 34.13 109.54 -178.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 -55.07 -38.47 68.1 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.088 -1.242 . . . . 73.2 110.748 -178.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.456 ' SD ' ' O ' ' A' ' 100' ' ' PRO . 70.9 mtp -102.41 21.09 15.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.091 -1.006 . . . . 71.21 110.629 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.63 -51.97 55.74 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.497 -1.441 . . . . 72.02 109.497 -178.959 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -60.42 -39.68 88.28 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.174 -1.192 . . . . 62.31 110.33 178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.86 -47.77 81.93 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.077 -1.014 . . . . 45.42 110.59 -177.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.633 ' HE2' ' CE2' ' A' ' 29' ' ' TYR . 3.3 tpp -61.04 -43.18 99.27 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 73.04 110.29 -178.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.6 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 45.3 m -59.6 -47.6 84.95 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.034 -1.041 . . . . 75.43 110.136 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.843 ' HG2' HG21 ' A' ' 133' ' ' VAL . 33.1 mtpt -60.0 -34.31 73.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.088 -1.008 . . . . 63.13 110.035 176.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.414 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -62.63 -47.61 83.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.128 -0.982 . . . . 61.33 110.327 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.571 ' CD2' ' NE2' ' A' ' 57' ' ' HIS . 80.5 t80 -56.74 -44.55 81.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.893 -1.129 . . . . 54.21 109.861 175.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.079 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.74 -38.42 90.45 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.96 -1.088 . . . . 72.31 109.895 177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.83 HG21 ' CE1' ' A' ' 120' ' ' PHE . 25.3 m -57.14 -43.1 82.12 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.116 -0.99 . . . . 62.21 109.508 176.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.549 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 62.9 mtt -53.36 -44.02 68.23 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.111 -0.993 . . . . 71.04 109.043 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.905 HD12 ' HA ' ' A' ' 74' ' ' ALA . 83.5 mt -61.33 -43.33 96.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.906 -0.718 . . . . 73.32 110.452 -176.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.653 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.7 -37.09 72.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.86 -1.15 . . . . 75.32 110.347 175.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.881 HD11 ' HA ' ' A' ' 120' ' ' PHE . 27.4 mt -90.2 5.7 45.89 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.102 -0.998 . . . . 54.3 111.017 -175.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 95.9 mt-10 55.85 29.56 14.27 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.79 -1.194 . . . . 73.12 109.772 -175.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.869 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.9 m -117.84 23.15 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.413 -0.804 . . . . 73.32 110.877 -177.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.626 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -58.96 -43.75 91.37 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.787 -1.196 . . . . 71.25 109.41 178.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -57.31 -40.31 77.61 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.764 -1.21 . . . . 73.11 110.284 175.733 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.617 ' O ' HG23 ' A' ' 88' ' ' VAL . 30.3 mtpp -67.44 -43.62 80.68 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.209 -0.932 . . . . 73.02 111.314 -175.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.559 ' SD ' HD12 ' A' ' 115' ' ' ILE . 79.8 mmm -109.91 -12.36 14.57 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.837 -1.165 . . . . 64.51 111.118 -165.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.626 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.9 t -57.07 -58.72 15.88 Favored Pre-proline 0 C--N 1.297 -1.679 0 O-C-N 121.164 -0.96 . . . . 74.4 109.621 -178.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.555 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 20.6 Cg_endo -66.99 -29.41 40.64 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 123.456 1.24 . . . . 74.12 110.621 175.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.617 HG23 ' O ' ' A' ' 84' ' ' LYS . 55.6 t -53.83 -43.19 55.81 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.794 -1.191 . . . . 63.33 109.54 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.593 ' CE ' HD11 ' A' ' 106' ' ' LEU . 0.0 OUTLIER -67.16 -51.52 52.76 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.1 -1.0 . . . . 74.03 109.825 175.592 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.687 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 24.1 m-85 -62.47 -11.51 16.52 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.723 -1.236 . . . . 75.45 110.5 178.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.493 ' O ' ' HB ' ' A' ' 95' ' ' THR . 26.9 t30 -94.15 -63.94 1.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 122.049 0.928 . . . . 74.35 109.576 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.846 ' HA ' HD12 ' A' ' 96' ' ' LEU . 48.0 ttt85 -46.0 -32.45 2.79 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.661 -0.649 . . . . 75.14 110.564 -175.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.633 ' CD1' ' CE1' ' A' ' 29' ' ' TYR . 0.8 OUTLIER -86.9 -60.37 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.933 -1.104 . . . . 72.45 110.668 176.161 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.5 ' HB3' ' O ' ' A' ' 90' ' ' PHE . 58.4 t-80 -68.71 -19.35 64.36 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.304 -0.873 . . . . 72.44 110.739 -175.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.493 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 2.9 m -118.19 -71.07 0.75 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.017 -1.052 . . . . 71.11 110.711 -173.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.846 HD12 ' HA ' ' A' ' 92' ' ' ARG . 45.1 mt -59.58 -24.51 63.82 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.168 -0.958 . . . . 74.4 109.728 179.137 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.482 ' HB3' ' O ' ' A' ' 96' ' ' LEU . 27.1 ttm180 62.68 29.72 16.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.495 -0.753 . . . . 74.14 109.968 -177.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.512 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 8.6 mttp -125.87 74.95 71.24 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.268 -0.895 . . . . 74.35 109.989 177.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -63.07 152.6 78.72 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.026 1.54 . . . . 71.45 110.347 -179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.747 ' CG ' HD13 ' A' ' 106' ' ' LEU . 35.0 Cg_exo -55.35 118.75 5.53 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.007 1.53 . . . . 74.43 110.258 -179.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 12.8 tptt -64.56 -46.36 83.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.297 -0.877 . . . . 72.31 110.143 176.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 77.1 m-20 -144.29 -171.93 3.68 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.504 -0.747 . . . . 74.51 109.463 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -59.51 -32.09 69.98 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 120.814 -1.179 . . . . 71.33 109.581 170.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -69.39 -51.98 31.35 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.149 -0.969 . . . . 74.55 111.184 -176.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.463 ' O ' HG13 ' A' ' 109' ' ' ILE . 48.4 tp10 -59.97 -37.72 80.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.784 -1.198 . . . . 65.14 109.079 176.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.06 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.7 tp -58.9 -43.6 91.05 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.579 -0.701 . . . . 54.15 110.064 177.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 41.1 ttm180 -59.84 -45.61 91.86 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.022 -1.049 . . . . 71.3 110.414 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.5 tp60 -58.33 -40.5 82.28 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.975 -1.078 . . . . 71.4 110.181 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.06 HD12 ' HA ' ' A' ' 106' ' ' LEU . 79.9 mt -53.63 -48.37 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.086 -1.009 . . . . 73.2 109.989 -179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.523 ' HA ' ' CE ' ' A' ' 85' ' ' MET . 30.0 m-85 -56.71 -49.07 76.27 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.013 -1.054 . . . . 53.42 110.575 177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.96 HD11 ' HB2' ' A' ' 117' ' ' ALA . 21.4 mt -65.11 -36.92 85.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.904 -1.122 . . . . 73.51 110.502 -176.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -57.41 -39.01 75.26 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.918 -1.114 . . . . 73.05 110.086 175.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.514 ' CB ' ' SD ' ' A' ' 85' ' ' MET . 73.1 mm-40 -71.99 0.35 9.58 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.299 -0.876 . . . . 73.24 111.065 -176.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.96 12.26 37.45 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 110.029 -1.228 . . . . 72.31 110.029 178.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.559 HD12 ' SD ' ' A' ' 85' ' ' MET . 86.7 mt -101.1 159.56 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.045 -1.268 . . . . 54.14 110.399 179.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.505 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.22 138.48 32.87 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.883 -1.136 . . . . 71.24 110.663 -172.44 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.96 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.74 -30.12 71.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.097 -1.002 . . . . 52.22 109.595 174.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.49 -51.22 64.12 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.316 -0.865 . . . . 63.11 110.704 179.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.764 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -74.92 -37.78 61.97 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.872 -1.143 . . . . 72.34 110.624 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 89.3 t80 -62.19 -40.65 96.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.894 -1.129 . . . . 70.24 110.219 175.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.411 ' HB2' ' O ' ' A' ' 117' ' ' ALA . 55.9 t0 -60.17 -42.79 95.72 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.147 -0.971 . . . . 64.24 109.711 177.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.78 -39.24 91.0 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.136 -0.978 . . . . 73.33 110.113 178.331 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.653 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -73.01 -44.55 60.82 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.177 -0.952 . . . . 73.34 110.896 -176.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 59.4 t80 -57.38 -34.41 68.82 Favored 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.19 -0.944 . . . . 72.34 109.461 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -91.23 4.78 51.43 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.449 -0.782 . . . . 74.35 110.043 179.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.64 131.06 10.74 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.679 -1.369 . . . . 43.32 109.679 -178.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -57.83 -30.63 65.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.061 -1.258 . . . . 74.21 109.859 176.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -58.08 -49.51 76.68 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.111 -0.993 . . . . 33.5 110.137 179.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.079 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.7 t -58.29 -44.73 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 120.834 -1.166 . . . . 73.13 109.796 175.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -56.2 -40.15 73.56 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.316 -0.865 . . . . 70.34 110.531 -178.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.495 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 85.9 p -67.68 -31.62 71.72 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.16 -0.962 . . . . 71.13 110.441 -178.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.774 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 75.0 mtm -75.18 -36.23 61.49 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.972 -1.08 . . . . 73.34 110.127 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.843 HG21 ' HG2' ' A' ' 71' ' ' LYS . 84.9 t -64.46 -48.6 84.44 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 O-C-N 121.33 -0.856 . . . . 63.44 110.43 179.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 131' ' ' SER . 39.0 ptt85 -64.87 -38.34 90.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.636 -1.29 . . . . 75.14 109.395 176.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.493 ' O ' ' HG2' ' A' ' 139' ' ' GLN . 27.7 ttm180 -51.54 -56.91 10.82 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.619 -0.675 . . . . 74.12 111.327 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.629 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.0 p90 -65.2 -40.66 94.47 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.57 -1.331 . . . . 65.44 110.475 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.629 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 30.2 m-20 -53.5 -47.67 69.67 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.9 -1.125 . . . . 73.15 110.116 -178.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -62.94 -39.72 95.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.959 -1.088 . . . . 71.52 110.713 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 12.8 mm100 -57.37 -46.37 83.46 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.95 -1.094 . . . . 72.23 110.254 -177.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.606 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 64.1 t80 -67.37 -40.23 85.74 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.27 -0.894 . . . . 75.42 110.452 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -64.95 -51.47 61.6 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.497 -0.752 . . . . 74.43 110.384 -178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.521 ' HB3' HG22 ' A' ' 14' ' ' THR . 90.7 m-20 -60.33 -37.61 81.13 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.262 -0.899 . . . . 62.21 110.2 178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 1.052 ' HA ' HD13 ' A' ' 12' ' ' LEU . 98.5 p -66.7 -21.56 66.09 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 73.33 110.666 -177.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 72.35 27.87 68.98 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.916 -1.673 . . . . 73.22 108.916 -175.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.926 HD22 ' CB ' ' A' ' 150' ' ' ALA . 61.5 mt -78.43 139.4 38.74 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.272 -1.134 . . . . 72.43 110.187 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 63.8 p -118.33 7.71 12.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.379 -0.826 . . . . 51.32 110.039 178.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 177.59 125.16 0.89 Allowed Glycine 0 N--CA 1.489 2.193 0 C-N-CA 119.666 -1.254 . . . . 51.2 110.164 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 10.7 m -84.41 164.07 44.65 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 121.34 -1.094 . . . . 72.02 108.981 171.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.575 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 40.0 Cg_endo -72.99 135.22 38.75 Favored 'Cis proline' 0 N--CA 1.489 1.23 0 C-N-CA 122.339 -1.942 . . . . 63.12 111.528 4.214 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.926 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -128.46 139.63 52.24 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.277 -0.89 . . . . 41.13 109.373 171.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.582 HG21 ' OH ' ' A' ' 170' ' ' TYR . 41.0 t -112.61 128.71 69.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 120.952 -1.093 . . . . 63.4 110.032 -179.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.547 HG22 HD22 ' A' ' 158' ' ' LEU . 31.9 t -118.03 133.07 66.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.22 -0.925 . . . . 64.33 110.234 -179.649 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.814 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.2 t -108.86 134.0 52.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.425 -0.797 . . . . 43.32 109.747 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.518 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 2.7 m-80 48.74 29.83 2.37 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.163 -0.961 . . . . 75.34 110.006 -174.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . . . . . . . . . 3.7 t30 46.72 29.12 0.91 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.096 -1.002 . . . . 72.14 110.916 175.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.93 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 77.3 ttt180 -146.96 -26.66 0.4 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.885 -1.134 . . . . 73.44 111.067 -178.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.76 ' CE2' HG22 ' A' ' 11' ' ' VAL . 65.1 m-85 -106.97 139.13 41.87 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.58 -1.325 . . . . 62.33 109.875 173.074 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.3 OUTLIER -109.59 126.84 54.02 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.44 -0.787 . . . . 64.4 109.092 -179.326 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.791 HG13 HD23 ' A' ' 173' ' ' LEU . 90.3 t -81.36 115.78 24.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 O-C-N 121.383 -0.823 . . . . 73.54 110.357 -173.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -76.86 -49.91 14.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.166 -0.959 . . . . 65.2 109.553 173.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 72.53 2.07 54.36 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.903 -1.279 . . . . 73.33 109.903 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -62.63 -40.49 97.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.16 -1.2 . . . . 73.53 110.244 -179.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.573 ' OG ' ' CE1' ' A' ' 8' ' ' HIS . 23.1 t -63.52 -32.25 73.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.295 -0.878 . . . . 60.01 110.247 178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.74 ' HB1' ' HB2' ' A' ' 169' ' ' GLU . . . -77.24 121.89 24.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.322 -0.862 . . . . 74.42 110.579 -176.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 42.4 mttp -90.66 -2.46 57.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.292 -0.88 . . . . 52.44 110.133 176.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.462 ' HB3' ' OE1' ' A' ' 169' ' ' GLU . 25.2 t -151.68 156.45 40.4 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.216 -0.928 . . . . 74.23 109.663 179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.937 HD21 HG23 ' A' ' 39' ' ' ILE . 6.3 mp -51.23 -30.1 16.41 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.909 -1.119 . . . . 62.32 110.865 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 22.0 t70 -57.55 -41.27 80.68 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.733 -1.229 . . . . 63.42 110.631 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.74 ' HB2' ' HB1' ' A' ' 164' ' ' ALA . 61.6 mp0 -76.8 -41.25 45.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.862 -1.149 . . . . 70.35 110.508 177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.582 ' OH ' HG21 ' A' ' 151' ' ' VAL . 27.3 t80 -59.32 -47.04 86.92 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -0.931 . . . . 75.2 110.223 -179.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.934 ' CD1' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -66.6 -41.84 87.83 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.104 -0.998 . . . . 73.33 110.316 177.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.6 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 91.8 m-20 -53.83 -42.82 68.86 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.098 -1.001 . . . . 62.04 110.093 179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.791 HD23 HG13 ' A' ' 159' ' ' VAL . 4.0 tp -53.6 -53.93 44.73 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.748 -1.22 . . . . 73.13 109.93 173.283 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.582 HG22 HG21 ' A' ' 159' ' ' VAL . 52.3 t -50.64 -43.04 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.069 -1.02 . . . . 74.22 109.777 -179.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.792 ' HA ' HD12 ' A' ' 178' ' ' LEU . 65.0 m-80 -58.91 -41.88 88.3 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.195 -0.94 . . . . 73.11 110.982 179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.688 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 72.5 m-85 -68.46 -39.86 81.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.995 -1.066 . . . . 71.34 110.102 179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.071 HD23 HD12 ' A' ' 180' ' ' LEU . 67.5 mt -61.45 -36.43 80.37 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.249 -0.907 . . . . 71.12 109.674 177.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.7 mt -57.53 -33.86 68.53 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.236 -0.915 . . . . 74.22 109.593 174.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 51.0 m -80.37 -25.82 38.96 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 72.4 109.772 175.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.071 HD12 HD23 ' A' ' 177' ' ' LEU . 66.0 mt -74.38 -33.45 63.06 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.469 -0.769 . . . . 72.13 110.542 -177.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.435 ' HA ' ' CG ' ' A' ' 154' ' ' ASN . 20.2 tttt . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.959 -1.019 . . . . 62.05 110.171 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.266 0.555 . . . . 71.14 110.174 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.564 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 62.9 tt0 -56.34 -37.01 69.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -0.908 . . . . 70.15 110.21 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.654 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.3 m-85 -105.15 129.77 53.47 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.26 -0.9 . . . . 73.02 110.22 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.514 ' C ' ' CE1' ' A' ' 9' ' ' TYR . 84.8 tttt -150.21 150.17 31.21 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.333 -0.854 . . . . 73.24 110.42 -176.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.624 ' N ' ' CZ ' ' A' ' 9' ' ' TYR . 75.5 tt0 -60.5 134.03 56.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.164 -0.96 . . . . 63.31 110.256 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.51 -1.61 76.22 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.586 -1.406 . . . . 64.34 109.586 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 75.5 mm-40 -131.17 -67.73 0.69 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.203 -1.175 . . . . 75.41 110.326 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.564 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 41.0 m170 -97.8 -14.03 21.01 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.234 -0.916 . . . . 74.51 109.908 179.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.624 ' CZ ' ' N ' ' A' ' 5' ' ' GLU . 52.4 p90 -157.28 169.9 23.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.339 -0.851 . . . . 52.33 110.544 172.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 68.2 tp60 -123.69 150.38 44.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.517 -0.739 . . . . 73.01 109.432 174.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.984 HG22 ' CE1' ' A' ' 157' ' ' TYR . 95.7 t -101.81 133.92 43.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 120.916 -1.115 . . . . 73.31 110.559 -178.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 84.1 mt -102.29 143.5 31.99 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.601 -0.687 . . . . 74.24 110.37 -176.867 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.7 mttm -58.26 -17.03 16.4 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.174 -0.954 . . . . 72.02 109.688 174.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.521 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.1 OUTLIER -52.28 154.14 4.47 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.336 -0.852 . . . . 74.55 110.655 -176.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 20.1 Cg_exo -59.86 142.95 99.58 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.131 1.595 . . . . 45.32 110.523 -179.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 1.009 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -105.33 149.5 26.0 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.18 -0.95 . . . . 62.43 110.115 176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 52.1 m -72.25 146.41 47.28 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.215 -0.928 . . . . 61.05 110.346 -178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.0 t -61.11 -35.56 77.35 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.21 -0.931 . . . . 74.34 109.934 177.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.525 ' CB ' ' HD2' ' A' ' 20' ' ' PRO . 0.2 OUTLIER -114.6 178.55 0.94 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.389 -0.819 . . . . 74.11 109.804 178.255 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.525 ' HD2' ' CB ' ' A' ' 19' ' ' SER . 56.4 Cg_endo -70.75 124.35 10.6 Favored 'Trans proline' 0 C--N 1.304 -1.799 0 O-C-N 123.829 1.436 . . . . 73.34 110.076 -179.243 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG21 ' NE2' ' A' ' 54' ' ' GLN . 8.8 p -145.16 136.67 20.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 O-C-N 120.829 -1.169 . . . . 74.23 109.954 172.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.565 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.26 128.18 75.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 O-C-N 121.076 -1.015 . . . . 63.13 109.612 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.413 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 77.8 p -122.09 133.98 54.77 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.103 -0.998 . . . . 65.13 109.621 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.787 ' OE2' HG22 ' A' ' 151' ' ' VAL . 38.2 tp10 -105.4 129.57 53.69 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.075 -1.016 . . . . 74.51 110.237 179.18 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.628 ' CE2' ' ND2' ' A' ' 56' ' ' ASN . 66.4 m-85 -100.52 126.68 46.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.435 -0.791 . . . . 73.45 109.902 179.077 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.493 ' CD1' ' O ' ' A' ' 56' ' ' ASN . 54.9 p90 -148.92 165.57 31.16 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.675 -0.641 . . . . 70.32 110.517 -177.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.581 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 23.7 t -135.21 134.37 40.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.136 -0.977 . . . . 72.13 110.409 176.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.679 ' CE1' ' CZ ' ' A' ' 90' ' ' PHE . 97.2 m-85 -59.87 -13.26 9.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.088 -1.008 . . . . 73.24 110.662 177.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.563 ' CD2' ' SD ' ' A' ' 69' ' ' MET . 0.1 OUTLIER -95.63 11.01 34.76 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.118 -0.989 . . . . 74.32 111.618 -171.811 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.517 ' SG ' ' CB ' ' A' ' 33' ' ' CYS . 5.6 p -133.28 113.73 13.43 Favored Pre-proline 0 N--CA 1.494 1.735 0 O-C-N 120.562 -1.336 . . . . 34.41 110.402 179.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.472 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 10.1 Cg_endo -58.05 -37.9 93.92 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.856 1.451 . . . . 74.12 110.44 -178.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.7 m80 -58.33 -51.79 68.31 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.005 -1.06 . . . . 75.33 110.167 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.517 ' CB ' ' SG ' ' A' ' 30' ' ' CYS . 1.4 t -65.22 -45.23 85.55 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.069 -1.019 . . . . 63.23 110.316 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.449 ' HB3' ' HB3' ' A' ' 90' ' ' PHE . 14.8 m-20 -54.76 -38.58 67.36 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.137 -0.977 . . . . 64.23 110.179 -176.395 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.459 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 50.1 m -69.46 -40.88 76.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.14 -0.975 . . . . 63.24 110.381 177.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.689 ' HE2' HD11 ' A' ' 40' ' ' ILE . 74.6 t80 -62.36 -35.92 80.62 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.298 -0.876 . . . . 71.51 110.673 -177.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.566 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 1.1 mm-40 -40.88 -58.22 2.79 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.175 -0.953 . . . . 62.11 110.583 -175.276 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 47.3 Cg_exo -40.99 -51.46 3.76 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 123.797 1.419 . . . . 75.43 110.624 177.334 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.447 HG23 HD21 ' A' ' 167' ' ' LEU . 88.7 mt -53.64 -47.29 61.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 120.93 -1.106 . . . . 74.02 110.15 179.196 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.689 HD11 ' HE2' ' A' ' 36' ' ' PHE . 32.7 mm -55.87 -39.67 57.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.965 -1.084 . . . . 72.13 110.014 176.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.565 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.54 -38.46 74.78 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.2 -0.938 . . . . 51.33 109.616 177.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 14.7 mt-30 -59.61 -43.89 93.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.178 -0.951 . . . . 70.1 109.517 176.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.757 HD12 ' CD1' ' A' ' 171' ' ' PHE . 51.1 tp -59.23 -43.02 92.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.146 -0.971 . . . . 74.23 110.498 178.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.863 ' HA ' HD12 ' A' ' 47' ' ' LEU . 12.7 mtmm -60.39 -46.33 90.38 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.959 . . . . 73.34 110.351 -177.847 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -59.33 -33.24 70.9 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.214 -0.929 . . . . 62.41 109.249 176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.504 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 42.9 mt-30 -92.47 -8.59 44.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.547 -0.721 . . . . 72.04 110.363 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.863 HD12 ' HA ' ' A' ' 44' ' ' LYS . 5.3 mt -64.14 143.23 98.32 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.105 -0.997 . . . . 64.42 110.265 -177.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.488 ' CD ' HD23 ' A' ' 47' ' ' LEU . 18.7 Cg_exo -61.61 141.59 91.7 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.993 1.522 . . . . 71.22 110.057 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -61.0 -34.86 75.47 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.223 -0.923 . . . . 75.11 109.842 178.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.77 -38.4 95.88 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.782 -1.327 . . . . 71.01 109.782 178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.59 140.81 49.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.118 -1.225 . . . . 72.11 110.507 -177.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 74.9 mmtt -96.32 155.09 16.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.452 -0.78 . . . . 74.11 109.615 175.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.611 ' CE2' ' HD3' ' A' ' 44' ' ' LYS . 60.7 t80 -125.58 159.83 31.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.759 -1.213 . . . . 64.12 111.017 -178.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.625 ' NE2' HG21 ' A' ' 21' ' ' VAL . 97.7 mt-30 -145.98 160.35 41.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.575 0.702 . . . . 74.24 110.264 -177.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 16.9 mttp -130.11 142.99 50.54 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.089 -1.007 . . . . 74.21 110.435 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.628 ' ND2' ' CE2' ' A' ' 25' ' ' PHE . 25.1 t-20 -139.24 142.77 37.81 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.86 . . . . 65.33 110.521 -178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.692 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.5 p-80 -120.71 137.22 54.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.806 -1.184 . . . . 75.14 110.067 172.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.616 ' HB ' ' CD1' ' A' ' 60' ' ' PHE . 35.9 m -102.54 134.63 42.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.238 -0.914 . . . . 64.32 110.89 -175.508 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.455 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 84.0 p -94.11 -10.84 32.0 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.41 -0.806 . . . . 63.24 111.223 177.626 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 140' ' ' PHE . 27.8 p90 -71.37 -32.76 68.87 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.364 -1.46 . . . . 61.33 110.698 -171.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.642 ' HE1' ' CG2' ' A' ' 148' ' ' VAL . 38.3 mtm -72.03 -35.19 69.31 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.742 -1.224 . . . . 73.12 109.946 171.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.74 -43.01 86.68 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 109.817 -1.313 . . . . 64.31 109.817 -177.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 99.1 -149.19 18.99 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.469 -1.452 . . . . 34.13 109.469 -178.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.1 m120 -54.09 -37.64 64.46 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.072 -1.252 . . . . 73.2 110.899 -177.113 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.52 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.0 ttt -93.51 5.06 52.85 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.941 -1.1 . . . . 71.21 110.52 -177.918 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.455 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.61 -41.63 95.73 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.302 -1.519 . . . . 72.02 109.302 179.477 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -58.38 -40.59 82.73 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.215 -1.168 . . . . 62.31 110.325 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -63.69 -49.6 72.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.016 -1.053 . . . . 45.42 110.372 -179.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.577 ' HE2' ' HB2' ' A' ' 28' ' ' PHE . 81.0 mtp -60.66 -39.83 89.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.928 -1.108 . . . . 73.04 110.49 -178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.511 ' HB3' ' NE2' ' A' ' 57' ' ' HIS . 25.6 m -59.86 -48.99 79.44 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.97 -1.081 . . . . 75.43 110.156 178.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.879 ' HG2' HG21 ' A' ' 133' ' ' VAL . 19.4 mtpt -59.39 -34.01 71.91 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.024 -1.048 . . . . 63.13 110.188 176.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.474 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.13 -47.52 82.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.14 -0.975 . . . . 61.33 110.332 -177.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.464 ' O ' ' HB2' ' A' ' 76' ' ' MET . 89.7 t80 -57.75 -43.14 85.22 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.749 -1.219 . . . . 54.21 109.739 176.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.011 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.33 -38.2 88.55 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.914 -1.116 . . . . 72.31 109.854 176.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.641 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.8 m -57.17 -43.69 82.81 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.139 -0.975 . . . . 62.21 109.646 175.746 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.591 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 65.8 mtt -53.48 -42.74 67.57 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.103 -0.998 . . . . 71.04 109.165 176.481 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.958 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.0 mt -61.79 -46.58 96.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.536 -0.728 . . . . 73.32 110.301 -176.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.403 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.93 -29.63 70.36 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.824 -1.173 . . . . 75.32 109.703 172.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.017 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.1 tp -90.95 5.33 49.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.496 -0.752 . . . . 54.3 110.538 -176.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.454 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 80.3 tt0 50.79 33.69 8.9 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.001 -1.062 . . . . 73.12 110.214 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.017 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.2 m -125.47 8.85 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.17 -0.956 . . . . 73.32 111.049 -178.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.9 mp0 -42.8 -73.18 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.012 -1.055 . . . . 71.25 110.067 -177.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.8 -37.04 59.27 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.74 -1.225 . . . . 73.11 110.809 -179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 55.4 tttp -58.7 -44.94 90.47 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.02 -1.05 . . . . 73.02 111.374 -169.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.572 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.4 ptm -126.54 1.12 6.89 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.954 -1.091 . . . . 64.51 111.03 -176.075 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -54.07 -45.32 99.1 Favored Pre-proline 0 C--N 1.299 -1.604 0 O-C-N 120.591 -1.318 . . . . 74.4 109.27 177.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 21.2 Cg_exo -58.97 -27.52 85.09 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.368 1.194 . . . . 74.12 110.422 175.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.77 HG21 ' OE1' ' A' ' 113' ' ' GLU . 48.1 t -64.67 -42.06 93.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 120.895 -1.128 . . . . 63.33 109.587 178.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.583 ' CE ' HD11 ' A' ' 106' ' ' LEU . 8.2 mtp -57.7 -41.68 82.17 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.069 -1.052 . . . . 74.03 109.619 178.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.679 ' CZ ' ' CE1' ' A' ' 28' ' ' PHE . 43.7 m-85 -73.56 -45.95 50.3 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 120.722 -1.236 . . . . 75.45 110.738 178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.521 ' O ' ' HB ' ' A' ' 95' ' ' THR . 37.0 t30 -55.74 -43.87 77.03 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.035 -1.041 . . . . 74.35 109.502 175.609 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.868 ' HA ' HD12 ' A' ' 96' ' ' LEU . 28.7 tpt180 -56.43 -37.6 70.45 Favored 'General case' 0 C--N 1.295 -1.797 0 O-C-N 121.3 -0.875 . . . . 75.14 109.361 175.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.581 HG21 ' O ' ' A' ' 28' ' ' PHE . 1.3 mm -90.26 -69.69 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.466 -0.771 . . . . 72.45 110.798 -179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.522 ' N ' ' O ' ' A' ' 90' ' ' PHE . 46.7 t-80 -62.75 -20.77 65.28 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.146 -0.971 . . . . 72.44 110.817 -172.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.604 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.1 m -115.43 -70.31 0.8 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.114 -0.991 . . . . 71.11 110.097 -175.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.868 HD12 ' HA ' ' A' ' 92' ' ' ARG . 73.7 mt -60.61 -25.91 66.62 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.255 -0.903 . . . . 74.4 109.961 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.506 ' NH1' ' O ' ' A' ' 95' ' ' THR . 74.6 mtt85 57.8 33.4 23.17 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.378 -0.826 . . . . 74.14 110.134 -177.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.52 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 10.0 mmmt -127.89 74.58 78.68 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.315 -0.866 . . . . 74.35 109.905 177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.53 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.6 Cg_endo -61.76 152.2 75.83 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.927 1.488 . . . . 71.45 110.396 -178.036 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.742 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.6 Cg_endo -55.13 120.68 8.59 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.004 1.529 . . . . 74.43 109.983 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.463 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 60.4 mmtt -62.75 -46.69 86.9 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.479 -0.763 . . . . 72.31 109.764 179.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.463 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.6 m-20 -145.24 -165.51 2.19 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.679 -0.638 . . . . 74.51 109.721 -179.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.89 -30.84 70.4 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 120.907 -1.12 . . . . 71.33 109.592 169.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -63.81 -58.13 7.77 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.062 -1.024 . . . . 74.55 111.149 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.455 ' O ' HG13 ' A' ' 109' ' ' ILE . 75.4 mm-40 -64.16 -36.96 85.77 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.777 -1.202 . . . . 65.14 109.703 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.014 ' HA ' HD12 ' A' ' 109' ' ' ILE . 10.7 tp -58.37 -43.36 88.42 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.432 -0.793 . . . . 54.15 110.094 178.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.515 ' NH2' ' OD2' ' A' ' 121' ' ' ASP . 78.5 ttt180 -60.69 -45.32 94.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.989 -1.07 . . . . 71.3 110.235 177.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.457 ' OE1' ' OD2' ' A' ' 112' ' ' ASP . 3.0 tm0? -58.16 -40.08 80.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.14 -0.975 . . . . 71.4 110.136 -179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.014 HD12 ' HA ' ' A' ' 106' ' ' LEU . 70.7 mt -55.21 -50.14 66.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.198 -0.938 . . . . 73.2 110.186 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.591 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 26.4 m-85 -57.54 -47.69 81.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.047 -1.033 . . . . 53.42 110.501 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.833 HD21 ' CA ' ' A' ' 117' ' ' ALA . 87.0 mt -60.52 -39.05 86.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.991 -1.068 . . . . 73.51 110.193 -178.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.457 ' OD2' ' OE1' ' A' ' 108' ' ' GLN . 88.1 m-20 -58.39 -38.21 76.87 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.025 -1.047 . . . . 73.05 110.413 177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.77 ' OE1' HG21 ' A' ' 88' ' ' VAL . 65.7 mm-40 -72.48 2.66 5.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 73.24 111.35 -175.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 100.22 7.71 51.65 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.415 -1.474 . . . . 72.31 109.415 -178.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.51 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 20.2 mm -81.9 148.46 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.231 -1.158 . . . . 54.14 109.387 176.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.537 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -89.37 140.01 29.94 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.79 -1.194 . . . . 71.24 109.758 174.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.833 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -64.09 -33.18 75.17 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.86 -1.15 . . . . 52.22 109.16 178.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.31 -50.01 71.74 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.485 -0.759 . . . . 63.11 110.922 179.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.581 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.79 -35.79 59.98 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.775 -1.203 . . . . 72.34 110.47 -175.503 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.641 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.5 t80 -62.91 -40.5 97.79 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.881 -1.137 . . . . 70.24 109.878 176.161 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.515 ' OD2' ' NH2' ' A' ' 107' ' ' ARG . 92.2 m-20 -59.29 -42.96 92.51 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.226 -0.921 . . . . 64.24 109.602 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -61.73 -39.61 92.18 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.222 -0.923 . . . . 73.33 110.31 177.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.715 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -72.57 -45.2 60.33 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.203 -0.935 . . . . 73.34 110.916 -175.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.569 ' N ' HG23 ' A' ' 75' ' ' THR . 74.3 t80 -59.73 -32.26 70.38 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.168 -0.958 . . . . 72.34 109.568 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -88.52 6.78 36.24 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.36 -0.837 . . . . 74.35 110.054 178.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.44 128.33 11.37 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.849 -1.301 . . . . 43.32 109.849 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -55.5 -37.92 68.49 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.165 -1.197 . . . . 74.21 109.572 175.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.453 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.59 -46.22 87.42 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.207 -0.933 . . . . 33.5 110.465 -179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.011 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.6 t -55.81 -48.94 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 120.784 -1.197 . . . . 73.13 109.972 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -56.6 -43.6 80.27 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.133 -0.979 . . . . 70.34 109.997 -177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -58.77 -36.97 75.26 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.134 -0.979 . . . . 71.13 110.245 178.054 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.567 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.0 OUTLIER -68.11 -40.88 82.44 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.969 -1.082 . . . . 73.34 110.558 -177.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.879 HG21 ' HG2' ' A' ' 71' ' ' LYS . 64.3 t -58.33 -43.19 85.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.095 -1.003 . . . . 63.44 109.701 177.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.8 mtp85 -58.9 -48.16 82.41 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 75.14 110.402 -179.712 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.53 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 9.0 mtp180 -58.81 -47.5 84.56 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.172 -0.955 . . . . 74.12 110.789 -177.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.692 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 25.9 m-85 -60.85 -47.37 86.67 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 120.92 -1.113 . . . . 65.44 110.722 -175.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.61 -45.68 91.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.929 -1.107 . . . . 73.15 110.346 -179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 33.1 tptt -62.55 -40.73 97.74 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.011 -1.056 . . . . 71.52 110.395 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.536 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 5.0 mm100 -58.77 -46.24 87.95 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -0.965 . . . . 72.23 110.184 -177.34 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.68 ' CZ ' ' CZ ' ' A' ' 60' ' ' PHE . 55.2 t80 -64.63 -39.47 93.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.308 -0.87 . . . . 75.42 110.155 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -62.07 -51.53 67.6 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.367 -0.833 . . . . 74.43 110.497 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.516 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.5 m-20 -61.55 -37.62 84.47 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -0.976 . . . . 62.21 110.269 178.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.579 ' OG ' HD12 ' A' ' 145' ' ' LEU . 95.5 p -64.99 -21.5 66.86 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.41 -0.806 . . . . 73.33 110.329 -177.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.95 29.57 70.71 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 108.751 -1.739 . . . . 73.22 108.751 -176.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 158' ' ' LEU . 49.6 mt -77.28 123.33 26.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -1.097 . . . . 72.43 110.363 -177.679 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 51.3 m -68.31 -37.36 80.52 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.295 -0.878 . . . . 51.32 110.038 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -170.36 147.6 10.81 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 110.041 -1.223 . . . . 51.2 110.041 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.642 ' CG2' ' HE1' ' A' ' 61' ' ' MET . 10.3 m -84.44 165.02 40.43 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 121.364 -1.08 . . . . 72.02 109.171 174.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.593 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 36.8 Cg_endo -70.7 132.05 22.32 Favored 'Cis proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.74 -1.775 . . . . 63.12 111.738 5.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.903 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -129.58 141.08 51.04 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.153 -0.967 . . . . 41.13 109.443 171.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 17.2 t -113.88 127.88 71.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.004 -1.06 . . . . 63.4 110.023 -177.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.505 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 19.5 t -114.13 130.9 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 119.489 -0.884 . . . . 64.33 110.211 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.77 HG11 ' HB2' ' A' ' 177' ' ' LEU . 26.1 t -112.18 135.68 50.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.485 -0.759 . . . . 43.32 109.589 178.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.545 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 1.8 m-80 50.53 24.98 1.79 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.126 -0.984 . . . . 75.34 109.933 -173.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.438 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 50.17 30.12 4.08 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.163 -0.96 . . . . 72.14 110.826 176.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.009 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 58.5 ttt180 -153.5 -18.86 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.877 -1.139 . . . . 73.44 110.924 -178.078 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.984 ' CE1' HG22 ' A' ' 11' ' ' VAL . 67.3 m-85 -108.85 139.18 44.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.664 -1.273 . . . . 62.33 109.869 172.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.126 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -109.26 122.82 48.16 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.252 -0.905 . . . . 64.4 109.037 179.225 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.712 HG13 HD23 ' A' ' 173' ' ' LEU . 70.9 t -77.58 116.1 20.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.748 -0.781 . . . . 73.54 110.165 -175.063 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.511 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -83.32 -55.14 4.5 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 65.2 109.599 175.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 61.61 11.49 29.33 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.017 -1.233 . . . . 73.33 110.017 175.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -61.6 -41.49 97.52 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.009 -1.289 . . . . 73.53 110.035 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 22.6 t -65.68 -30.98 71.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.324 -0.86 . . . . 60.01 110.148 176.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.465 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -81.59 108.36 15.1 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.205 -0.935 . . . . 74.42 110.688 -175.435 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -90.7 -6.55 54.32 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.241 -0.912 . . . . 52.44 109.93 174.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -126.64 146.29 50.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 74.23 109.943 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.447 HD21 HG23 ' A' ' 39' ' ' ILE . 38.5 mt -53.8 -26.32 23.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.204 -0.935 . . . . 62.32 110.941 -178.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -57.33 -41.86 80.81 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 120.763 -1.211 . . . . 63.42 110.508 -179.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.465 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 94.1 mt-10 -82.5 -40.07 21.57 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.931 -1.105 . . . . 70.35 110.683 179.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 81.8 t80 -63.32 -45.28 92.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.963 -1.086 . . . . 75.2 109.975 177.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.757 ' CD1' HD12 ' A' ' 43' ' ' LEU . 71.5 t80 -58.23 -48.03 81.64 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.461 -0.774 . . . . 73.33 110.193 176.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.525 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 90.9 m-20 -57.58 -43.49 84.61 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.091 -1.006 . . . . 62.04 110.708 -178.535 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.712 HD23 HG13 ' A' ' 159' ' ' VAL . 4.5 tp -53.88 -53.54 51.18 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.645 -1.285 . . . . 73.13 110.151 177.015 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.488 HG11 HD21 ' A' ' 43' ' ' LEU . 57.8 t -53.66 -42.93 53.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.018 -1.051 . . . . 74.22 109.766 -178.231 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.529 ' HA ' HD12 ' A' ' 178' ' ' LEU . 16.1 m-80 -60.08 -40.42 89.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.32 -0.862 . . . . 73.11 111.0 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.654 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 61.4 m-85 -68.45 -42.49 78.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.895 -1.128 . . . . 71.34 110.106 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.006 ' HA ' HD12 ' A' ' 180' ' ' LEU . 80.0 mt -61.16 -37.15 81.84 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.272 -0.892 . . . . 71.12 109.906 178.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.545 ' HA ' ' ND2' ' A' ' 154' ' ' ASN . 10.3 mt -58.77 -29.83 67.08 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.201 -0.937 . . . . 74.22 109.975 175.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.518 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.1 p -90.27 -3.14 57.98 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 72.4 110.191 -179.345 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.006 HD12 ' HA ' ' A' ' 177' ' ' LEU . 18.2 mt -100.17 140.82 33.85 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.314 -0.866 . . . . 72.13 110.222 -179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 1.9 mtpm? . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 118.0 -1.0 . . . . 62.05 110.198 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.225 0.536 . . . . 71.14 110.184 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.565 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.1 tt0 -56.38 -36.48 68.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.268 -0.895 . . . . 70.15 110.307 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.679 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 93.8 m-85 -104.19 132.74 50.12 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.182 -0.949 . . . . 73.02 110.272 -179.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -132.22 153.65 50.39 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.295 -0.878 . . . . 73.24 110.124 -178.67 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.748 ' OE2' HG21 ' A' ' 11' ' ' VAL . 80.8 tt0 -77.81 131.51 37.61 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.124 -0.985 . . . . 63.31 109.991 177.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 93.53 -2.01 69.92 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.358 -1.497 . . . . 64.34 109.358 -175.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.409 ' O ' ' OE1' ' A' ' 160' ' ' GLN . 75.5 mm-40 -129.66 -58.89 1.09 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.159 -1.201 . . . . 75.41 110.432 -179.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.565 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 25.7 m170 -98.35 -14.02 20.39 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.165 -0.959 . . . . 74.51 109.949 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.7 ' CG ' HD21 ' A' ' 177' ' ' LEU . 50.2 p90 -154.75 165.11 37.61 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.217 -0.927 . . . . 52.33 110.589 171.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -122.03 153.73 38.21 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.471 -0.768 . . . . 73.01 109.575 175.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.862 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.1 t -102.22 134.07 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 120.907 -1.121 . . . . 73.31 110.649 -177.423 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.714 HD11 HD23 ' A' ' 158' ' ' LEU . 59.1 mt -102.47 146.03 28.69 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.654 -0.653 . . . . 74.24 110.436 -176.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 27.4 tttt -54.74 -21.0 9.59 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.143 -0.973 . . . . 72.02 109.771 173.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.936 HG22 ' HB3' ' A' ' 142' ' ' ASP . 3.3 p -46.0 148.83 1.34 Allowed Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.318 -0.864 . . . . 74.55 110.609 -176.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -63.2 140.31 77.03 Favored 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 124.133 1.596 . . . . 45.32 110.189 177.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.979 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -100.19 155.54 17.7 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.185 -0.947 . . . . 62.43 110.048 178.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 95.9 p -85.38 145.08 27.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.092 -1.005 . . . . 61.05 110.413 -177.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.7 m -61.67 -36.94 82.3 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.211 -0.931 . . . . 74.34 109.967 178.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.464 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -107.63 171.1 4.9 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.405 -0.81 . . . . 74.11 109.623 177.547 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.467 ' CG ' ' HA ' ' A' ' 51' ' ' ALA . 56.0 Cg_endo -71.03 126.74 12.77 Favored 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.728 1.383 . . . . 73.34 110.214 -178.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.531 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 8.6 p -146.84 138.43 18.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 120.766 -1.209 . . . . 74.23 109.921 171.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.9 t -120.72 129.78 75.27 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 O-C-N 121.174 -0.954 . . . . 63.13 109.588 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 95.9 p -121.35 137.28 54.77 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.09 -1.006 . . . . 65.13 110.105 -177.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.712 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.4 tt0 -110.34 126.29 54.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.304 -0.873 . . . . 74.51 110.419 177.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CD2' ' HB3' ' A' ' 56' ' ' ASN . 92.6 m-85 -98.27 124.88 43.12 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.294 -0.879 . . . . 73.45 109.723 175.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.533 ' O ' HG22 ' A' ' 58' ' ' VAL . 51.5 p90 -139.78 167.51 21.95 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.425 -0.797 . . . . 70.32 111.067 -177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.536 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 38.8 t -133.53 136.32 44.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.427 -0.796 . . . . 72.13 110.515 178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.926 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.6 -22.11 61.34 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.174 -0.953 . . . . 73.24 110.582 176.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.476 ' HA ' HG21 ' A' ' 93' ' ' ILE . 77.2 m-85 -99.4 15.87 24.96 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.157 -0.965 . . . . 74.32 110.923 -173.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 33' ' ' CYS . 7.6 t -118.15 97.78 50.99 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 120.968 -1.083 . . . . 34.41 110.184 -178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.458 ' O ' HG23 ' A' ' 35' ' ' THR . 31.7 Cg_exo -53.15 -44.03 52.21 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.967 1.509 . . . . 74.12 110.059 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.6 m80 -58.46 -47.57 83.61 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.08 -1.013 . . . . 75.33 109.843 175.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.52 ' CB ' ' HB3' ' A' ' 30' ' ' CYS . 0.5 OUTLIER -64.56 -41.66 96.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.089 -1.007 . . . . 63.23 110.303 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 94' ' ' HIS . 1.9 t-20 -53.73 -41.57 67.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.134 -0.978 . . . . 64.23 110.404 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.47 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 53.2 p -73.43 -36.81 66.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.144 -0.973 . . . . 63.24 110.42 179.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.963 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 80.4 t80 -64.25 -38.51 91.3 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.299 -0.875 . . . . 71.51 110.702 -178.391 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.543 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 0.2 OUTLIER -42.24 -57.34 4.5 Favored Pre-proline 0 N--CA 1.493 1.718 0 O-C-N 121.073 -1.017 . . . . 62.11 110.552 -174.56 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 44.9 Cg_exo -46.11 -48.44 12.91 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.628 1.331 . . . . 75.43 110.521 178.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.568 HD12 ' HA ' ' A' ' 36' ' ' PHE . 87.5 mt -54.73 -48.78 72.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.044 -1.035 . . . . 74.02 110.213 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.963 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.6 mm -57.22 -38.87 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 120.953 -1.092 . . . . 72.13 109.962 177.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.48 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -58.34 -39.2 78.85 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.003 -1.061 . . . . 51.33 109.652 176.343 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.563 ' NE2' ' CD1' ' A' ' 167' ' ' LEU . 15.3 mt-30 -59.44 -40.07 85.62 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.134 -0.978 . . . . 70.1 109.393 176.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.975 HD13 ' CG ' ' A' ' 171' ' ' PHE . 47.2 tp -62.98 -39.41 94.65 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 74.23 110.162 176.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.725 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.6 mttt -56.26 -49.8 73.15 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.362 -0.836 . . . . 73.34 110.316 -177.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.513 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 17.0 pt20 -66.16 -35.63 80.99 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 119.415 -0.914 . . . . 62.41 109.383 178.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.513 ' N ' ' HG3' ' A' ' 45' ' ' GLN . 49.8 mt-30 -72.75 -30.38 64.1 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.386 -0.821 . . . . 72.04 110.269 176.59 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.725 HD12 ' HA ' ' A' ' 44' ' ' LYS . 4.9 mt -52.97 141.71 37.65 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.28 -0.888 . . . . 64.42 110.22 -177.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.474 ' HD2' HD23 ' A' ' 47' ' ' LEU . 19.7 Cg_exo -61.56 145.9 97.38 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.953 1.502 . . . . 71.22 109.931 179.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -59.38 -31.18 68.99 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.128 -0.983 . . . . 75.11 109.699 178.595 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.64 -39.02 97.37 Favored Glycine 0 N--CA 1.487 2.099 0 N-CA-C 109.723 -1.351 . . . . 71.01 109.723 178.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.467 ' HA ' ' CG ' ' A' ' 20' ' ' PRO . . . -74.14 139.77 44.74 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.085 -1.244 . . . . 72.11 110.571 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 52.1 mttp -98.14 156.25 16.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.538 -0.726 . . . . 74.11 109.538 174.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.626 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 46.5 t80 -122.52 159.84 26.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.726 -1.233 . . . . 64.12 110.617 178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.59 ' N ' ' O ' ' A' ' 22' ' ' VAL . 98.7 mm-40 -142.57 160.33 40.5 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.47 -0.769 . . . . 74.24 110.338 -174.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -126.68 142.88 51.41 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.102 -0.999 . . . . 74.21 110.402 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.584 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.1 m-20 -140.93 133.84 29.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.307 -0.871 . . . . 65.33 110.236 -178.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.657 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -112.9 126.31 55.33 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.021 -1.049 . . . . 75.14 109.684 -177.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG21 ' HG3' ' A' ' 61' ' ' MET . 33.8 m -81.9 132.29 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 120.972 -1.08 . . . . 64.32 110.63 179.07 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.469 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 21.3 m -93.69 -11.73 30.88 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.261 -0.899 . . . . 63.24 110.499 174.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.588 ' CZ ' ' HG2' ' A' ' 61' ' ' MET . 11.6 p90 -75.53 -30.22 59.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.632 -1.293 . . . . 61.33 110.041 -177.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.656 ' HG3' HG21 ' A' ' 58' ' ' VAL . 85.6 mmm -63.45 -39.42 94.43 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.233 -0.917 . . . . 73.12 110.092 173.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.408 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -66.41 -45.34 86.52 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.895 -1.282 . . . . 64.31 109.895 -178.105 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 107.13 -144.7 15.93 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.248 -1.541 . . . . 34.13 109.248 -176.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 52.0 t30 -54.37 -38.9 66.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.974 -1.31 . . . . 73.2 110.738 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 26.4 ttt -93.66 5.2 52.4 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.055 -1.028 . . . . 71.21 110.406 -178.297 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -59.85 -39.07 94.96 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.284 -1.526 . . . . 72.02 109.284 179.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 50.4 tp60 -57.73 -40.72 80.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.251 -1.147 . . . . 62.31 109.994 179.086 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -65.01 -42.58 94.3 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.107 -0.996 . . . . 45.42 110.218 178.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.474 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 96.7 mmm -58.55 -46.19 87.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.018 -1.051 . . . . 73.04 110.558 -177.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.589 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 42.5 m -62.09 -44.77 95.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.965 -1.085 . . . . 75.43 109.92 177.749 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.586 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 29.5 tttt -59.86 -34.69 73.46 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.276 -0.89 . . . . 63.13 109.957 178.371 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.475 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -64.12 -46.96 81.89 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.127 -0.983 . . . . 61.33 110.244 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.657 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 49.6 t80 -56.51 -43.23 79.58 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.883 -1.136 . . . . 54.21 109.542 177.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.075 ' CB ' HG13 ' A' ' 129' ' ' VAL . . . -60.97 -40.43 93.37 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.981 -1.074 . . . . 72.31 109.853 176.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.863 HG23 ' HB3' ' A' ' 123' ' ' ALA . 38.4 m -56.05 -43.12 77.56 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.097 -1.002 . . . . 62.21 109.734 175.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.599 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.0 mtt -53.26 -43.36 67.33 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.096 -1.002 . . . . 71.04 108.935 176.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.975 HD12 ' HA ' ' A' ' 74' ' ' ALA . 77.0 mt -59.84 -43.61 92.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.951 -0.7 . . . . 73.32 110.118 -177.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.496 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.09 -38.05 72.81 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.008 -1.057 . . . . 75.32 110.327 176.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.958 HD13 ' CD ' ' A' ' 119' ' ' LYS . 20.4 mt -91.19 9.27 31.88 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.109 -0.994 . . . . 54.3 110.816 -176.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.461 ' O ' ' HG3' ' A' ' 80' ' ' GLU . 45.3 tp10 53.83 33.94 18.17 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.909 -1.119 . . . . 73.12 109.901 -176.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 79' ' ' LEU . 19.3 m -119.98 9.51 6.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.279 -0.888 . . . . 73.32 111.047 -176.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 86' ' ' VAL . 5.9 mp0 -44.66 -71.57 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.84 -1.162 . . . . 71.25 109.922 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -53.4 -36.42 61.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.86 -1.15 . . . . 73.11 110.693 -179.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 79.6 tttt -59.02 -43.33 91.55 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.033 -1.042 . . . . 73.02 111.437 -170.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.674 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.7 ppp? -126.02 -2.52 7.08 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.937 -1.102 . . . . 64.51 110.804 -175.397 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -51.82 -46.84 91.91 Favored Pre-proline 0 C--N 1.298 -1.646 0 O-C-N 120.765 -1.21 . . . . 74.4 109.219 -179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HD3' ' HB ' ' A' ' 86' ' ' VAL . 16.7 Cg_exo -61.01 -26.55 83.33 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.265 1.139 . . . . 74.12 110.683 174.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.71 HG11 ' CD ' ' A' ' 113' ' ' GLU . 50.7 t -65.41 -41.58 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 120.843 -1.161 . . . . 63.33 109.722 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.578 ' HE2' HD11 ' A' ' 106' ' ' LEU . 84.3 mmm -60.24 -41.68 93.68 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.908 -1.117 . . . . 74.03 109.389 176.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.685 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 25.8 m-85 -69.04 -45.47 70.34 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.862 -1.149 . . . . 75.45 110.746 178.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.527 ' O ' ' HB ' ' A' ' 95' ' ' THR . 42.5 t30 -57.98 -50.05 74.72 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.076 -1.015 . . . . 74.35 109.85 177.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.849 ' HA ' HD12 ' A' ' 96' ' ' LEU . 18.2 tpt180 -51.14 -37.25 45.09 Favored 'General case' 0 C--N 1.295 -1.802 0 O-C-N 121.223 -0.923 . . . . 75.14 109.497 176.442 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.926 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.3 mm -85.54 -68.02 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.475 -0.765 . . . . 72.45 110.713 178.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.519 ' CB ' ' OD1' ' A' ' 34' ' ' ASN . 84.8 t60 -65.04 -18.81 65.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.229 -0.92 . . . . 72.44 111.025 -172.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.542 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -118.26 -70.63 0.78 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.958 -1.089 . . . . 71.11 110.411 -175.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD12 ' HA ' ' A' ' 92' ' ' ARG . 53.2 mt -60.44 -24.75 65.45 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.92 . . . . 74.4 110.247 -178.709 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 95' ' ' THR . 39.1 mmt180 58.7 35.47 24.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.375 -0.828 . . . . 74.14 110.038 -175.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.533 ' HB3' ' CZ ' ' A' ' 92' ' ' ARG . 2.4 mtpp -120.46 76.64 26.2 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.347 -0.845 . . . . 74.35 110.03 178.098 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 22.1 Cg_exo -60.28 143.25 99.5 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.967 1.509 . . . . 71.45 110.29 -179.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.649 ' CG ' HD13 ' A' ' 106' ' ' LEU . 31.6 Cg_exo -53.46 114.59 1.83 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.959 1.505 . . . . 74.43 110.203 178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.521 ' CB ' ' OE1' ' A' ' 105' ' ' GLU . 17.3 tptt -62.17 -47.31 85.09 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.293 -0.879 . . . . 72.31 110.262 177.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.47 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.3 m-20 -144.76 -173.53 4.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.845 . . . . 74.51 109.737 -179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -59.93 -31.53 69.94 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.778 -1.201 . . . . 71.33 109.5 170.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -62.09 -56.29 20.36 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.255 -0.903 . . . . 74.55 111.169 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.521 ' OE1' ' CB ' ' A' ' 101' ' ' LYS . 86.9 tt0 -64.64 -37.98 89.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.751 -1.218 . . . . 65.14 109.892 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.988 ' HA ' HD12 ' A' ' 109' ' ' ILE . 9.5 tp -56.32 -43.36 78.92 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.418 -0.801 . . . . 54.15 109.759 178.136 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.579 ' HG3' ' CD2' ' A' ' 120' ' ' PHE . 49.2 ttp180 -60.97 -45.5 94.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.98 -1.075 . . . . 71.3 110.424 176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.461 ' NE2' ' OD1' ' A' ' 112' ' ' ASP . 4.8 tm0? -56.64 -40.66 75.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.993 -1.067 . . . . 71.4 110.05 -178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.988 HD12 ' HA ' ' A' ' 106' ' ' LEU . 50.3 mt -55.48 -48.35 77.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.175 -0.953 . . . . 73.2 110.071 179.257 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.496 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 22.1 m-85 -54.29 -47.71 72.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.027 -1.045 . . . . 53.42 110.262 177.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.75 HD11 ' HB2' ' A' ' 117' ' ' ALA . 34.3 mt -63.42 -37.0 85.6 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.085 -1.009 . . . . 73.51 110.443 -177.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . 0.461 ' OD1' ' NE2' ' A' ' 108' ' ' GLN . 88.3 m-20 -57.04 -38.49 73.26 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.861 -1.15 . . . . 73.05 110.04 175.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.71 ' CD ' HG11 ' A' ' 88' ' ' VAL . 71.5 mm-40 -74.43 3.21 7.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.263 -0.898 . . . . 73.24 111.054 -175.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.87 9.7 48.41 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 110.005 -1.238 . . . . 72.31 110.005 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.585 HG23 ' CE ' ' A' ' 119' ' ' LYS . 81.8 mt -94.54 159.37 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.11 -1.229 . . . . 54.14 110.327 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.502 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.34 142.41 27.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.006 -1.059 . . . . 71.24 110.347 -177.046 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.75 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.0 -31.34 72.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.928 -1.107 . . . . 52.22 109.753 174.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.5 -51.5 62.63 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.314 -0.866 . . . . 63.11 110.704 179.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.958 ' CD ' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.94 -36.35 64.64 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.919 -1.113 . . . . 72.34 110.526 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.881 ' HA ' HD11 ' A' ' 79' ' ' LEU . 90.2 t80 -62.26 -41.46 98.46 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 120.909 -1.12 . . . . 70.24 110.029 174.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -59.79 -43.03 94.61 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.183 -0.948 . . . . 64.24 109.638 178.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.14 -39.26 92.01 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.185 -0.947 . . . . 73.33 110.25 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.863 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.95 -45.23 59.19 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.184 -0.948 . . . . 73.34 110.882 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 71' ' ' LYS . 63.9 t80 -58.48 -33.63 70.01 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.126 -0.984 . . . . 72.34 109.337 178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 79.7 m-20 -93.01 6.75 46.82 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.432 -0.793 . . . . 74.35 110.067 177.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.04 130.01 16.11 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.606 -1.398 . . . . 43.32 109.606 -178.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -56.73 -35.93 69.14 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.137 -1.214 . . . . 74.21 109.813 177.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.59 -46.61 89.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.188 -0.945 . . . . 33.5 110.454 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.075 HG13 ' CB ' ' A' ' 74' ' ' ALA . 41.3 t -59.55 -48.91 85.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 120.729 -1.232 . . . . 73.13 110.173 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 57.3 t0 -57.2 -39.79 76.12 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.034 -1.041 . . . . 70.34 109.966 -178.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.3 t -59.84 -38.23 81.46 Favored 'General case' 0 C--N 1.301 -1.5 0 O-C-N 121.149 -0.97 . . . . 71.13 110.282 178.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.741 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 74.9 mtm -72.47 -34.13 67.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.022 -1.049 . . . . 73.34 110.412 -178.707 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.585 ' O ' ' CD2' ' A' ' 136' ' ' PHE . 67.9 t -60.08 -45.51 95.54 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 O-C-N 121.006 -1.059 . . . . 63.44 109.676 177.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.467 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 60.1 mtp180 -62.18 -39.51 92.94 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.938 -1.101 . . . . 75.14 109.326 173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 132' ' ' MET . 51.1 ttt85 -53.43 -53.98 43.46 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.207 0.527 . . . . 74.12 111.002 -176.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.634 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.9 p90 -67.92 -39.95 83.47 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.851 -1.156 . . . . 65.44 110.453 -176.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.634 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 57.0 t0 -54.91 -48.33 73.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.922 -1.111 . . . . 73.15 110.103 -177.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 62.5 tttm -61.58 -41.91 98.09 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.074 -1.016 . . . . 71.52 110.339 176.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.478 ' HG2' ' O ' ' A' ' 135' ' ' ARG . 10.0 mm100 -57.23 -46.22 83.15 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.039 -1.038 . . . . 72.23 110.671 -176.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.643 ' HA ' HD12 ' A' ' 145' ' ' LEU . 59.6 t80 -66.12 -39.69 90.09 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 75.42 110.143 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.403 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 26.6 mt-30 -61.77 -52.03 65.89 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.596 -0.69 . . . . 74.43 110.447 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.936 ' HB3' HG22 ' A' ' 14' ' ' THR . 89.3 m-20 -63.16 -39.19 93.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.161 -0.962 . . . . 62.21 110.151 178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.566 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.9 p -62.95 -20.12 64.93 Favored 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.506 -0.746 . . . . 73.33 110.665 -177.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 69.09 29.91 72.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 108.93 -1.668 . . . . 73.22 108.93 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.945 HD22 ' CB ' ' A' ' 150' ' ' ALA . 55.6 mt -78.05 140.78 39.13 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.361 -1.082 . . . . 72.43 110.099 -179.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 10.2 t -118.57 0.58 11.57 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.323 -0.861 . . . . 51.32 110.075 -179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -179.95 125.15 0.94 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 9.6 m -84.52 163.99 44.74 Favored Pre-proline 0 N--CA 1.497 1.895 0 O-C-N 121.279 -1.13 . . . . 72.02 109.183 172.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.2 Cg_endo -71.92 131.48 21.88 Favored 'Cis proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.508 -1.872 . . . . 63.12 111.736 4.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.945 ' CB ' HD22 ' A' ' 145' ' ' LEU . . . -120.04 138.11 53.71 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.244 -0.91 . . . . 41.13 109.397 170.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.454 ' O ' HD13 ' A' ' 158' ' ' LEU . 24.0 t -112.89 127.09 70.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 120.991 -1.068 . . . . 63.4 110.151 -178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.462 HG22 ' CD2' ' A' ' 158' ' ' LEU . 21.5 t -117.79 132.5 67.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.387 -0.821 . . . . 64.33 110.189 -179.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.856 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.9 t -110.66 135.73 48.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.479 -0.763 . . . . 43.32 109.711 178.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.554 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 49.49 26.82 1.81 Allowed 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.162 -0.961 . . . . 75.34 110.212 -174.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.453 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 50.31 28.62 3.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.008 -1.057 . . . . 72.14 110.968 175.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.979 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 75.1 ttt180 -152.03 -19.87 0.18 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.851 -1.156 . . . . 73.44 111.015 -177.469 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.873 ' HB3' HD22 ' A' ' 177' ' ' LEU . 70.2 m-85 -111.14 137.71 48.49 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.578 -1.326 . . . . 62.33 109.924 172.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.714 HD23 HD11 ' A' ' 12' ' ' LEU . 0.1 OUTLIER -110.01 125.25 52.71 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.359 -0.838 . . . . 64.4 109.157 -179.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.718 HG13 HD23 ' A' ' 173' ' ' LEU . 24.6 t -76.76 110.19 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.744 -0.783 . . . . 73.54 110.265 -175.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.494 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.4 mt-30 -72.04 -47.29 52.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.213 -0.929 . . . . 65.2 109.557 173.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.45 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 63.61 10.95 39.8 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.79 -1.324 . . . . 73.33 109.79 176.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.472 ' HG2' ' HB3' ' A' ' 160' ' ' GLN . 99.3 mm-40 -61.57 -37.42 83.8 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.195 -1.18 . . . . 73.53 110.373 -178.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 74.7 m -87.5 4.82 41.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.214 -0.929 . . . . 60.01 110.4 -179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -86.06 106.95 17.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.096 -1.003 . . . . 74.42 110.435 -178.109 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 16.8 pttm -85.9 -9.74 56.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 52.44 110.093 177.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 82.7 p -151.4 156.41 40.64 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.269 -0.894 . . . . 74.23 109.733 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 38.3 mt -53.46 -31.62 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.052 -1.03 . . . . 62.32 110.644 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.431 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.3 m-20 -55.85 -40.94 73.58 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 120.875 -1.14 . . . . 63.42 110.414 -178.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 88.1 tt0 -78.62 -42.18 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.868 -1.145 . . . . 70.35 110.624 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.45 ' CD1' ' HA3' ' A' ' 161' ' ' GLY . 75.8 t80 -60.88 -46.08 92.04 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.048 -1.032 . . . . 75.2 110.197 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.975 ' CG ' HD13 ' A' ' 43' ' ' LEU . 17.1 m-30 -65.96 -41.1 91.68 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.029 -1.045 . . . . 73.33 110.378 177.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 88.0 m-20 -53.93 -43.36 69.71 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.715 -1.24 . . . . 62.04 110.082 178.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.718 HD23 HG13 ' A' ' 159' ' ' VAL . 5.0 tp -53.14 -53.44 50.45 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.755 -1.216 . . . . 73.13 109.806 173.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.584 HG22 HG21 ' A' ' 159' ' ' VAL . 52.7 t -50.36 -42.71 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.062 -1.024 . . . . 74.22 109.749 179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.671 ' HA ' HD12 ' A' ' 178' ' ' LEU . 11.2 m120 -59.13 -42.58 90.94 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.22 -0.925 . . . . 73.11 110.765 -179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.679 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 76.6 m-85 -68.21 -40.28 82.19 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.054 -1.029 . . . . 71.34 110.095 -179.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.951 ' HA ' HD12 ' A' ' 180' ' ' LEU . 66.8 mt -60.96 -37.04 81.0 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.207 -0.933 . . . . 71.12 109.432 176.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.671 HD12 ' HA ' ' A' ' 175' ' ' ASN . 5.3 mt -58.17 -31.04 66.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.348 -0.845 . . . . 74.22 109.83 174.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 175' ' ' ASN . 43.4 p -90.14 -5.31 56.62 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -0.897 . . . . 72.4 110.296 -179.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.951 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.5 mt -96.6 140.9 30.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.274 -0.891 . . . . 72.13 110.167 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.485 ' O ' ' NH1' ' A' ' 156' ' ' ARG . 83.0 tttt . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.999 -1.001 . . . . 62.05 110.249 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 121.226 0.536 . . . . 71.14 110.19 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.577 ' O ' ' CD2' ' A' ' 8' ' ' HIS . 62.2 tp60 -56.47 -41.18 76.13 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.214 -0.928 . . . . 70.15 110.392 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.685 ' CE2' ' CE2' ' A' ' 176' ' ' TYR . 27.8 p90 -147.51 157.94 43.78 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.254 -0.904 . . . . 73.02 110.606 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.567 ' O ' ' CE1' ' A' ' 9' ' ' TYR . 15.2 mtpt -155.95 -165.34 1.92 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.407 -0.808 . . . . 73.24 109.755 177.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.589 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 95.4 mt-10 -92.73 125.6 37.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.152 -0.968 . . . . 63.31 110.095 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.462 ' HA2' ' HG2' ' A' ' 10' ' ' GLN . . . 88.88 -12.86 64.55 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 108.672 -1.771 . . . . 64.34 108.672 -173.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.468 ' OE1' ' HB2' ' A' ' 4' ' ' LYS . 92.0 mt-10 -104.99 -74.15 0.66 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -1.142 . . . . 75.41 110.65 179.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.577 ' CD2' ' O ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -86.57 -21.73 26.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.202 -0.936 . . . . 74.51 109.743 178.489 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.636 ' CG ' HD21 ' A' ' 177' ' ' LEU . 43.4 p90 -156.98 172.88 17.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.512 -0.743 . . . . 52.33 110.546 176.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.462 ' HG2' ' HA2' ' A' ' 6' ' ' GLY . 95.1 mt-30 -127.82 158.06 38.73 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.42 -0.8 . . . . 73.01 109.601 171.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 1.056 HG22 ' CE2' ' A' ' 157' ' ' TYR . 52.2 t -101.39 133.46 44.68 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.118 -0.989 . . . . 73.31 110.213 -178.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.486 ' HB2' ' OG1' ' A' ' 14' ' ' THR . 60.7 mt -107.33 145.98 32.14 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.549 -0.719 . . . . 74.24 110.579 -173.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 14' ' ' THR . 36.3 tttt -55.72 -20.79 15.73 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.154 -0.966 . . . . 72.02 109.744 172.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.897 HG22 ' HB3' ' A' ' 142' ' ' ASP . 6.9 p -42.46 146.47 0.7 Allowed Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.281 -0.887 . . . . 74.55 110.333 -177.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -61.7 139.73 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.111 1.585 . . . . 45.32 110.127 178.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.994 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -103.45 155.42 18.52 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.119 -0.988 . . . . 62.43 110.444 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 32.1 t -87.25 142.6 27.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.134 -0.979 . . . . 61.05 110.25 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.2 p -61.37 -28.9 69.57 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.31 -0.869 . . . . 74.34 110.059 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.7 170.99 4.69 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.299 -0.876 . . . . 74.11 109.726 177.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.438 ' HB2' ' HA ' ' A' ' 51' ' ' ALA . 57.7 Cg_endo -71.58 124.34 10.21 Favored 'Trans proline' 0 C--N 1.304 -1.801 0 O-C-N 123.811 1.427 . . . . 73.34 110.0 -179.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.618 HG21 ' OE1' ' A' ' 54' ' ' GLN . 9.8 p -146.9 137.52 17.73 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 O-C-N 120.833 -1.167 . . . . 74.23 110.101 173.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.627 ' CG2' HD21 ' A' ' 178' ' ' LEU . 20.6 t -118.47 127.37 75.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.167 -0.958 . . . . 63.13 109.864 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.516 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 96.1 p -117.34 139.68 50.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.047 -1.033 . . . . 65.13 109.647 178.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.905 ' OE1' HG21 ' A' ' 40' ' ' ILE . 4.4 pt-20 -110.37 122.2 47.13 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.064 -1.023 . . . . 74.51 110.456 179.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.61 ' C ' HG11 ' A' ' 148' ' ' VAL . 84.9 m-85 -93.68 127.5 39.41 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.473 -0.767 . . . . 73.45 110.093 179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.585 ' CZ ' ' HB3' ' A' ' 57' ' ' HIS . 55.0 p90 -140.47 168.43 19.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.695 -0.628 . . . . 70.32 110.459 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.465 ' HB2' ' SD ' ' A' ' 61' ' ' MET . 34.5 t -135.06 130.96 36.41 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.144 -0.973 . . . . 72.13 110.478 179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.927 ' O ' HG21 ' A' ' 93' ' ' ILE . 96.8 m-85 -59.02 -23.68 62.17 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.179 -0.95 . . . . 73.24 110.608 178.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.6 ' HA ' HG21 ' A' ' 93' ' ' ILE . 81.3 m-85 -97.82 19.8 13.14 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.185 -0.947 . . . . 74.32 110.878 -173.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.423 ' HB3' ' HB2' ' A' ' 33' ' ' CYS . 47.1 t -126.92 94.74 38.84 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 120.915 -1.116 . . . . 34.41 110.026 -178.477 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.524 ' HB3' ' CD2' ' A' ' 94' ' ' HIS . 37.2 Cg_exo -51.02 -45.01 38.97 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.032 1.543 . . . . 74.12 110.358 -177.263 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -58.19 -46.35 85.93 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.076 -1.015 . . . . 75.33 110.079 176.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.489 ' HA ' ' HG3' ' A' ' 149' ' ' PRO . 19.6 m -66.76 -44.13 82.25 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.045 -1.034 . . . . 63.23 110.297 179.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 21.2 m-20 -56.07 -38.9 71.26 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.131 -0.981 . . . . 64.23 109.951 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.469 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.4 m -67.51 -39.67 85.13 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.194 -0.941 . . . . 63.24 110.339 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.78 ' HE2' HD11 ' A' ' 40' ' ' ILE . 69.9 t80 -62.1 -36.14 80.81 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.319 -0.863 . . . . 71.51 110.674 -177.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.565 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -40.37 -58.04 2.63 Favored Pre-proline 0 N--CA 1.496 1.841 0 O-C-N 121.128 -0.983 . . . . 62.11 110.529 -175.463 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 41.8 Cg_exo -41.67 -50.37 4.89 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.709 1.373 . . . . 75.43 110.573 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.542 HD12 ' HA ' ' A' ' 36' ' ' PHE . 89.6 mt -53.35 -46.79 58.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 120.917 -1.114 . . . . 74.02 110.186 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.905 HG21 ' OE1' ' A' ' 24' ' ' GLU . 27.5 mm -55.23 -41.72 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.834 -1.166 . . . . 72.13 109.948 175.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.78 -37.9 71.76 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.024 -1.047 . . . . 51.33 109.638 176.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.44 ' HG3' ' HA ' ' A' ' 39' ' ' ILE . 36.8 mt-30 -57.8 -43.82 85.9 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.182 -0.949 . . . . 70.1 109.433 176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.917 HD13 ' CD1' ' A' ' 171' ' ' PHE . 33.1 tp -60.65 -40.8 93.36 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.213 -0.929 . . . . 74.23 110.269 177.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.0 mttp -55.47 -47.95 75.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.308 -0.87 . . . . 73.34 109.934 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 55.6 mt-30 -61.65 -34.07 75.06 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.314 -0.866 . . . . 62.41 109.449 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.522 ' NE2' ' CE2' ' A' ' 171' ' ' PHE . 43.1 mt-30 -92.66 -0.49 57.29 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.536 -0.727 . . . . 72.04 110.491 -178.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' HA ' ' A' ' 44' ' ' LYS . 8.3 mt -67.77 143.8 96.9 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.185 -0.947 . . . . 64.42 110.322 -177.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 20.9 Cg_exo -61.34 143.37 97.88 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.949 1.499 . . . . 71.22 109.924 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.423 ' CG ' ' N ' ' A' ' 50' ' ' GLY . 21.3 pt-20 -62.64 -35.38 79.41 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.128 -0.982 . . . . 75.11 109.911 179.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.423 ' N ' ' CG ' ' A' ' 49' ' ' GLU . . . -65.46 -36.94 93.22 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.785 -1.326 . . . . 71.01 109.785 178.403 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.438 ' HA ' ' HB2' ' A' ' 20' ' ' PRO . . . -74.09 138.83 44.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.189 -1.183 . . . . 72.11 110.777 -175.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.427 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 61.9 mttp -94.19 157.32 16.12 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.44 -0.788 . . . . 74.11 109.578 174.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.776 ' CD1' HD11 ' A' ' 47' ' ' LEU . 55.8 t80 -124.31 157.88 33.9 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.747 -1.221 . . . . 64.12 110.802 179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.618 ' OE1' HG21 ' A' ' 21' ' ' VAL . 26.2 mt-30 -146.96 160.87 41.82 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.533 -0.729 . . . . 74.24 110.53 -176.612 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.485 ' HD3' ' OH ' ' A' ' 73' ' ' TYR . 89.0 mttt -118.61 140.01 50.59 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.056 -1.027 . . . . 74.21 110.518 178.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.582 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . 2.7 m-80 -137.4 141.41 41.69 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.438 -0.789 . . . . 65.33 110.033 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.67 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 4.1 p-80 -126.3 141.34 51.95 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.674 -1.266 . . . . 75.14 110.38 175.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.538 HG21 ' SD ' ' A' ' 61' ' ' MET . 34.3 m -91.01 132.1 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.275 -0.891 . . . . 64.32 110.51 -178.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . . . . . . . . . 54.2 p -93.92 -10.42 33.86 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.299 -0.876 . . . . 63.24 110.519 175.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 61' ' ' MET . 3.2 p90 -73.78 -35.81 64.99 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.652 -1.28 . . . . 61.33 110.195 -175.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 60' ' ' PHE . 91.1 mtp -63.66 -37.71 88.36 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.021 -1.049 . . . . 73.12 110.091 172.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.94 -41.3 99.92 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.958 -1.257 . . . . 64.31 109.958 -178.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 97.71 -151.86 19.8 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 108.923 -1.671 . . . . 34.13 108.923 -174.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -53.41 -41.52 66.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.016 -1.285 . . . . 73.2 110.381 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.456 ' O ' ' HG3' ' A' ' 65' ' ' MET . 16.2 tpt -68.34 -16.98 64.14 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.107 -0.996 . . . . 71.21 110.708 179.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -51.73 -40.92 49.67 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.804 -1.319 . . . . 72.02 109.804 -174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -59.7 -40.21 87.18 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.986 -1.302 . . . . 62.31 110.056 179.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.56 86.02 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.129 -0.982 . . . . 45.42 110.383 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.47 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 97.6 mmm -59.97 -41.6 92.31 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.104 -0.997 . . . . 73.04 110.447 -178.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.885 ' CB ' HG13 ' A' ' 133' ' ' VAL . 33.1 m -60.21 -49.08 79.04 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.068 -1.02 . . . . 75.43 110.114 178.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.584 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.3 mttt -59.92 -35.01 73.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.042 -1.036 . . . . 63.13 110.515 177.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.723 ' HB2' HD21 ' A' ' 106' ' ' LEU . . . -63.61 -49.48 73.15 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.003 -1.061 . . . . 61.33 110.329 -176.275 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.485 ' OH ' ' HD3' ' A' ' 55' ' ' LYS . 66.6 t80 -58.79 -43.08 90.37 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.894 -1.129 . . . . 54.21 109.694 177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.105 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.39 -39.33 90.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.848 -1.158 . . . . 72.31 109.837 176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.806 HG21 ' CE1' ' A' ' 120' ' ' PHE . 26.0 m -57.38 -43.69 83.84 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.176 -0.952 . . . . 62.21 109.558 176.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.648 ' HE2' ' CZ ' ' A' ' 110' ' ' PHE . 66.2 mtt -53.04 -42.43 65.74 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.115 -0.991 . . . . 71.04 109.205 176.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.919 HD12 ' HA ' ' A' ' 74' ' ' ALA . 79.5 mt -61.7 -47.17 94.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 C-N-CA 119.819 -0.752 . . . . 73.32 110.332 -177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.55 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.37 -29.67 70.06 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.85 -1.157 . . . . 75.32 109.763 173.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.971 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.5 tp -95.38 9.51 39.66 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.381 -0.824 . . . . 54.3 110.67 -175.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 80' ' ' GLU . 79.7 tt0 49.11 36.69 9.28 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.084 -1.01 . . . . 73.12 110.578 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.971 HG13 ' O ' ' A' ' 79' ' ' LEU . 20.9 m -126.81 9.11 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.1 -1.0 . . . . 73.32 110.975 -179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.584 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -44.22 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.936 -1.102 . . . . 71.25 109.947 -178.098 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -53.65 -36.91 62.6 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.807 -1.183 . . . . 73.11 110.763 -179.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -58.32 -44.41 88.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.108 -0.995 . . . . 73.02 111.356 -170.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.631 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.3 ptm -126.55 -0.61 6.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.974 -1.079 . . . . 64.51 110.876 -174.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.1 t -53.48 -45.22 98.65 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.636 -1.29 . . . . 74.4 109.062 178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.571 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 20.9 Cg_exo -59.68 -27.76 85.72 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.381 1.2 . . . . 74.12 110.381 175.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.805 HG21 ' OE1' ' A' ' 113' ' ' GLU . 49.9 t -64.76 -41.3 91.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.933 -1.104 . . . . 63.33 109.673 179.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.731 ' HE1' HD11 ' A' ' 106' ' ' LEU . 20.9 mtp -59.6 -41.76 91.06 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 118.914 -1.114 . . . . 74.03 109.614 177.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 36.1 m-85 -71.78 -43.53 65.56 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.723 -1.236 . . . . 75.45 110.623 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.533 ' O ' ' HB ' ' A' ' 95' ' ' THR . 41.9 t30 -57.41 -47.36 81.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.08 . . . . 74.35 109.585 174.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.865 ' HA ' HD12 ' A' ' 96' ' ' LEU . 21.3 tpt180 -52.37 -37.07 55.38 Favored 'General case' 0 C--N 1.294 -1.839 0 O-C-N 121.251 -0.905 . . . . 75.14 109.495 175.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.927 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.0 mm -88.41 -68.58 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.476 -0.765 . . . . 72.45 110.627 179.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.524 ' CD2' ' HB3' ' A' ' 31' ' ' PRO . 11.0 t-160 -62.21 -21.23 64.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.289 -0.882 . . . . 72.44 111.042 -173.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.572 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.2 m -115.95 -71.14 0.76 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.98 -1.075 . . . . 71.11 110.224 -176.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD12 ' HA ' ' A' ' 92' ' ' ARG . 43.0 mt -60.52 -25.3 66.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.242 -0.911 . . . . 74.4 109.979 179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 97' ' ' ARG . 35.1 mtm105 58.1 33.05 22.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 74.14 110.276 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.511 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 1.1 mptt -122.71 73.25 43.39 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.296 -0.878 . . . . 74.35 109.998 176.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.501 ' HB3' HD13 ' A' ' 93' ' ' ILE . 13.1 Cg_endo -61.93 142.84 94.44 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.962 1.506 . . . . 71.45 110.305 -178.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.588 ' HG3' HD13 ' A' ' 106' ' ' LEU . 10.8 Cg_endo -59.53 133.83 54.28 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.016 1.535 . . . . 74.43 109.995 178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 2.9 pttt -96.4 -29.29 14.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.25 -0.906 . . . . 72.31 110.408 -178.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.457 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.5 m-20 -143.09 176.17 9.3 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 74.51 109.904 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.24 -30.96 66.95 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 120.953 -1.092 . . . . 71.33 109.377 173.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.82 -56.81 16.75 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.243 -0.911 . . . . 74.55 111.155 179.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -64.29 -39.89 94.85 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.903 -1.123 . . . . 65.14 109.912 -178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.071 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.77 -41.27 86.23 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.389 -0.82 . . . . 54.15 109.891 179.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.44 ' O ' ' HG ' ' A' ' 111' ' ' LEU . 40.7 ttm180 -60.86 -45.8 93.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.04 -1.037 . . . . 71.3 110.355 176.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 60.8 tp60 -57.22 -40.96 78.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.959 -1.088 . . . . 71.4 110.29 -179.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.071 HD12 ' HA ' ' A' ' 106' ' ' LEU . 46.0 mt -55.39 -48.14 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.048 -1.032 . . . . 73.2 109.882 179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.648 ' CZ ' ' HE2' ' A' ' 76' ' ' MET . 20.9 m-85 -57.84 -47.55 82.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.09 -1.006 . . . . 53.42 110.434 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.709 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.3 mt -64.16 -38.05 89.66 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.882 -1.136 . . . . 73.51 110.409 -177.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -56.33 -38.52 71.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.864 -1.148 . . . . 73.05 110.007 174.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.805 ' OE1' HG21 ' A' ' 88' ' ' VAL . 67.1 mm-40 -71.57 0.4 8.64 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.321 -0.862 . . . . 73.24 111.206 -176.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 101.22 10.35 42.27 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.84 -1.304 . . . . 72.31 109.84 179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.531 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 79.9 mt -95.73 159.0 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.187 -1.184 . . . . 54.14 110.26 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.495 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -95.26 141.77 28.46 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.982 -1.074 . . . . 71.24 110.289 -176.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.709 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -64.82 -31.77 73.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.006 -1.059 . . . . 52.22 109.772 175.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -63.4 -52.14 62.85 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.305 -0.872 . . . . 63.11 110.77 179.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.67 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.56 -38.05 65.34 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 120.815 -1.178 . . . . 72.34 110.665 -176.679 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.806 ' CE1' HG21 ' A' ' 75' ' ' THR . 66.4 t80 -62.09 -39.51 92.7 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 120.861 -1.149 . . . . 70.24 109.923 176.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.2 -42.98 96.27 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.127 -0.983 . . . . 64.24 109.632 177.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.468 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.63 -34.75 74.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.297 -0.877 . . . . 73.33 110.199 177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.588 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -82.03 -44.1 17.07 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.12 -0.988 . . . . 73.34 110.976 -175.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.677 ' N ' HG23 ' A' ' 75' ' ' THR . 68.3 t80 -59.48 -32.23 70.07 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.197 -0.939 . . . . 72.34 110.147 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.468 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 30.9 p-10 -94.79 9.02 40.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.228 -0.92 . . . . 74.35 110.151 -177.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.64 133.32 19.18 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.614 -1.395 . . . . 43.32 109.614 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -57.19 -33.83 67.88 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.116 -1.226 . . . . 74.21 109.838 177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -59.49 -46.89 87.52 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.219 -0.926 . . . . 33.5 110.369 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.105 HG13 ' HB3' ' A' ' 74' ' ' ALA . 24.7 t -56.7 -50.63 73.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 120.765 -1.21 . . . . 73.13 109.949 178.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.47 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.8 t0 -57.13 -41.07 78.36 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.116 -0.99 . . . . 70.34 109.952 -176.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 22.8 m -59.91 -37.54 79.73 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.253 -0.905 . . . . 71.13 110.266 178.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.807 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.8 mtm -71.19 -38.34 72.11 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.995 -1.066 . . . . 73.34 110.484 -177.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.885 HG13 ' CB ' ' A' ' 70' ' ' SER . 59.2 t -57.18 -44.76 84.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 O-C-N 121.071 -1.018 . . . . 63.44 109.709 176.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.47 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 53.4 mtp85 -59.29 -47.58 84.84 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.246 -0.909 . . . . 75.14 110.205 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.525 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 5.7 mtp85 -58.7 -49.37 77.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.169 -0.957 . . . . 74.12 110.916 -177.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.67 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 22.0 m-85 -58.46 -51.24 70.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 120.952 -1.092 . . . . 65.44 110.543 -175.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.455 ' O ' ' HG3' ' A' ' 141' ' ' GLN . 56.0 t0 -59.76 -43.99 94.05 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.103 -0.998 . . . . 73.15 110.484 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 26.3 tttt -62.58 -42.49 99.59 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.097 -1.002 . . . . 71.52 110.635 -178.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.525 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 1.8 mm100 -59.3 -45.52 91.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.971 -1.08 . . . . 72.23 109.733 -177.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.832 ' HA ' HD12 ' A' ' 145' ' ' LEU . 56.6 t80 -62.14 -42.92 99.72 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.419 -0.8 . . . . 75.42 110.261 178.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.455 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 95.3 mt-30 -62.09 -50.47 71.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.732 -0.605 . . . . 74.43 110.583 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.897 ' HB3' HG22 ' A' ' 14' ' ' THR . 91.9 m-20 -62.58 -36.69 83.5 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.101 -1.0 . . . . 62.21 109.925 176.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.492 ' CB ' ' HG ' ' A' ' 145' ' ' LEU . 4.7 t -58.79 -27.55 65.13 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.678 -0.639 . . . . 73.33 110.312 -179.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 73.83 20.17 79.75 Favored Glycine 0 N--CA 1.483 1.801 0 N-CA-C 108.531 -1.828 . . . . 73.22 108.531 -170.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 158' ' ' LEU . 39.9 mt -66.18 126.03 27.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.161 -1.199 . . . . 72.43 110.274 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.9 m -68.95 -34.89 76.1 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.127 -0.983 . . . . 51.32 109.53 173.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . -177.53 -173.52 43.08 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.916 -1.274 . . . . 51.2 109.916 179.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.61 HG11 ' C ' ' A' ' 25' ' ' PHE . 4.3 m -113.42 168.85 7.15 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.547 -0.972 . . . . 72.02 109.168 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.603 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 14.0 Cg_exo -66.63 131.7 15.49 Favored 'Cis proline' 0 N--CA 1.494 1.504 0 C-N-CA 123.05 -1.646 . . . . 63.12 111.607 3.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.94 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -130.46 118.64 21.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.289 -0.882 . . . . 41.13 109.512 172.708 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.525 ' CG2' ' OH ' ' A' ' 170' ' ' TYR . 26.9 t -101.69 130.65 51.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.955 -1.091 . . . . 63.4 110.026 -177.186 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 38.7 t -116.26 132.2 66.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.359 -0.838 . . . . 64.33 110.322 -176.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.7 HG11 ' HB2' ' A' ' 177' ' ' LEU . 17.6 t -109.39 134.44 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.444 -0.785 . . . . 43.32 109.592 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.557 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.2 m-80 50.0 28.16 2.79 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.117 -0.99 . . . . 75.34 110.031 -174.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.548 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 5.2 t30 45.94 31.24 1.04 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.253 -0.905 . . . . 72.14 110.917 177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.994 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 71.9 ttt180 -151.9 -19.78 0.19 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.891 -1.131 . . . . 73.44 111.062 -178.011 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 1.056 ' CE2' HG22 ' A' ' 11' ' ' VAL . 51.5 m-85 -109.48 138.38 45.92 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.474 -1.392 . . . . 62.33 109.796 171.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.087 HD21 HD21 ' A' ' 145' ' ' LEU . 0.2 OUTLIER -109.27 125.18 52.02 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.292 -0.88 . . . . 64.4 109.436 -178.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.789 HG21 HG22 ' A' ' 174' ' ' VAL . 87.1 t -77.85 112.36 15.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 C-N-CA 119.901 -0.72 . . . . 73.54 109.992 -177.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.509 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.8 mm-40 -79.81 -50.13 10.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.377 -0.827 . . . . 65.2 109.98 176.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 67.35 7.9 48.14 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.753 -1.339 . . . . 73.33 109.753 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -61.07 -37.74 83.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -1.166 . . . . 73.53 110.344 -178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.575 ' OG ' ' CD2' ' A' ' 8' ' ' HIS . 61.9 p -88.01 -6.36 58.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.231 -0.918 . . . . 60.01 110.649 -178.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -88.86 126.78 35.52 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.086 -1.009 . . . . 74.42 110.313 -178.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 165' ' ' LYS . 24.9 tttt -100.18 -2.5 33.84 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.244 -0.91 . . . . 52.44 110.577 -178.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 83.6 p -148.2 153.82 39.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.033 -1.042 . . . . 74.23 110.171 -179.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.596 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 28.3 mt -54.32 -31.34 53.97 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.085 -1.01 . . . . 62.32 110.66 -178.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.7 m-20 -56.94 -40.84 77.16 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.871 -1.143 . . . . 63.42 110.551 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.49 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 99.1 mt-10 -76.45 -41.75 46.33 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.888 -1.132 . . . . 70.35 110.578 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.634 ' CE1' HG12 ' A' ' 159' ' ' VAL . 87.4 t80 -62.89 -46.31 88.43 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.155 -0.966 . . . . 75.2 110.334 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.917 ' CD1' HD13 ' A' ' 43' ' ' LEU . 18.9 m-30 -65.96 -41.06 91.73 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.063 -1.023 . . . . 73.33 110.421 178.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.499 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 93.0 m-20 -56.61 -46.32 80.96 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.78 -1.2 . . . . 62.04 110.043 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.713 HD23 HG13 ' A' ' 159' ' ' VAL . 3.6 tp -49.32 -56.08 10.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.805 -1.185 . . . . 73.13 109.664 172.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.789 HG22 HG21 ' A' ' 159' ' ' VAL . 52.0 t -49.42 -43.07 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.525 0 O-C-N 121.099 -1.001 . . . . 74.22 109.804 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.988 ' HA ' HD12 ' A' ' 178' ' ' LEU . 12.2 m120 -58.29 -43.1 87.89 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.119 -0.988 . . . . 73.11 110.641 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.685 ' CE2' ' CE2' ' A' ' 3' ' ' PHE . 79.5 m-85 -70.81 -38.72 73.3 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.051 . . . . 71.34 110.133 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.896 ' HA ' HD12 ' A' ' 180' ' ' LEU . 79.4 mt -59.49 -35.85 74.9 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.111 -0.993 . . . . 71.12 109.707 176.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.988 HD12 ' HA ' ' A' ' 175' ' ' ASN . 18.6 mt -56.31 -31.01 63.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.226 -0.921 . . . . 74.22 109.864 176.034 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . . . . . . . . . 45.0 p -90.9 -4.37 56.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.325 -0.859 . . . . 72.4 110.179 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.896 HD12 ' HA ' ' A' ' 177' ' ' LEU . 30.4 mt -99.95 141.12 33.2 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.31 -0.869 . . . . 72.13 110.256 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.458 ' HG2' ' OXT' ' A' ' 181' ' ' LYS . 28.5 tttt . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.018 -0.991 . . . . 62.05 110.249 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.677 0 CA-C-O 121.238 0.542 . . . . 71.14 110.237 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' NE2' ' HG3' ' A' ' 169' ' ' GLU . 59.5 tt0 -56.38 -35.91 68.25 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.346 -0.846 . . . . 70.15 110.175 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.683 ' CZ ' ' CE2' ' A' ' 176' ' ' TYR . 52.0 p90 -130.51 164.07 25.64 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.317 -0.865 . . . . 73.02 110.178 178.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.49 ' HB3' ' OE1' ' A' ' 7' ' ' GLU . 19.5 tttt -172.83 167.02 5.24 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.137 -0.977 . . . . 73.24 110.286 -177.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 96.4 mt-10 -65.71 131.47 46.42 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.274 -0.891 . . . . 63.31 110.54 -177.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 85.14 -11.34 60.79 Favored Glycine 0 N--CA 1.484 1.873 0 N-CA-C 108.928 -1.669 . . . . 64.34 108.928 -176.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.49 ' OE1' ' HB3' ' A' ' 4' ' ' LYS . 93.5 mt-10 -107.57 -70.6 0.79 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.185 -1.185 . . . . 75.41 110.605 179.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.772 ' HB3' HD22 ' A' ' 173' ' ' LEU . 5.0 m-70 -89.39 -22.1 22.73 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.289 -0.882 . . . . 74.51 109.605 178.528 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.693 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.6 p90 -155.98 170.64 21.67 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.393 -0.817 . . . . 52.33 110.642 175.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -130.7 158.03 41.19 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.487 -0.758 . . . . 73.01 109.361 173.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.906 HG22 ' CE2' ' A' ' 157' ' ' TYR . 46.2 t -101.5 132.0 48.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.007 -1.058 . . . . 73.31 110.69 -175.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.667 HD11 HD23 ' A' ' 158' ' ' LEU . 84.3 mt -95.34 150.55 20.14 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.711 -0.618 . . . . 74.24 110.241 -179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 4.2 pttm -73.12 -2.5 21.72 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.129 -0.982 . . . . 72.02 109.923 175.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.503 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -63.42 155.84 73.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.313 -0.867 . . . . 74.55 110.339 179.832 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.512 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.7 Cg_endo -63.55 131.16 30.57 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.149 1.605 . . . . 45.32 110.554 -179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.971 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -84.02 173.87 10.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.092 -1.005 . . . . 62.43 109.905 175.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.478 ' O ' ' HD2' ' A' ' 181' ' ' LYS . 29.3 t -99.57 141.29 32.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.109 -0.995 . . . . 61.05 110.143 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 87.1 p -58.5 -29.74 66.49 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.181 -0.95 . . . . 74.34 109.778 179.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.402 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.7 OUTLIER -116.83 168.04 9.57 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.367 -0.833 . . . . 74.11 109.513 174.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.529 ' HB2' HD22 ' A' ' 178' ' ' LEU . 55.7 Cg_endo -70.76 125.2 11.38 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 123.817 1.43 . . . . 73.34 110.017 -178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.588 ' CG2' ' CG ' ' A' ' 54' ' ' GLN . 7.4 p -144.84 135.94 20.35 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.621 0 O-C-N 120.91 -1.119 . . . . 74.23 109.823 172.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.559 ' O ' ' N ' ' A' ' 54' ' ' GLN . 10.4 t -117.24 127.01 74.86 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 121.024 -1.047 . . . . 63.13 109.77 -178.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.427 ' HG ' ' HE1' ' A' ' 25' ' ' PHE . 88.9 p -116.73 134.42 54.82 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.011 -1.056 . . . . 65.13 110.23 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.804 ' OE1' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.38 129.06 48.74 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.38 -0.825 . . . . 74.51 110.151 177.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.52 ' O ' ' CG1' ' A' ' 148' ' ' VAL . 76.3 m-85 -104.21 124.72 49.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.199 -0.938 . . . . 73.45 109.941 177.236 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.537 ' CE1' ' HE3' ' A' ' 55' ' ' LYS . 46.4 p90 -139.38 167.2 22.61 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.713 -0.617 . . . . 70.32 110.744 -178.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.544 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 25.5 t -134.89 134.57 40.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.291 -0.881 . . . . 72.13 110.493 179.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.689 ' CD1' ' CE1' ' A' ' 90' ' ' PHE . 95.1 m-85 -57.12 -20.62 26.73 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.28 -0.887 . . . . 73.24 110.59 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.505 ' HA ' HG21 ' A' ' 93' ' ' ILE . 82.5 m-85 -102.72 17.78 23.0 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.127 -0.983 . . . . 74.32 111.06 -172.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 41.9 t -124.7 101.4 33.31 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 120.97 -1.081 . . . . 34.41 110.2 -178.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.534 ' O ' HG23 ' A' ' 35' ' ' THR . 9.1 Cg_endo -56.04 -39.88 88.41 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 O-C-N 123.891 1.469 . . . . 74.12 109.999 -178.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.5 m80 -58.31 -47.76 82.67 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.966 -1.084 . . . . 75.33 109.879 174.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.99 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 34.3 m -64.72 -41.74 95.74 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.103 -0.998 . . . . 63.23 110.223 177.82 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.44 ' CG ' ' HB3' ' A' ' 90' ' ' PHE . 62.1 t-20 -54.66 -40.67 69.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.24 -0.913 . . . . 64.23 110.537 -179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 31' ' ' PRO . 52.1 p -73.1 -40.01 65.33 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.104 -0.997 . . . . 63.24 110.494 -179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.985 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.0 t80 -63.14 -35.72 81.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.242 -0.911 . . . . 71.51 110.622 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.541 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.7 tt0 -40.18 -58.9 2.07 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.154 -0.966 . . . . 62.11 111.084 -174.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 5.8 Cg_endo -53.08 -43.96 52.78 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.232 1.122 . . . . 75.43 110.51 -177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.562 HD12 ' HA ' ' A' ' 36' ' ' PHE . 95.6 mt -54.25 -48.05 67.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 74.02 110.106 178.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.985 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 25.5 mm -57.44 -39.51 69.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 120.994 -1.066 . . . . 72.13 110.087 177.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -56.71 -39.37 73.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.819 -1.175 . . . . 51.33 109.526 175.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.646 ' NE2' HD11 ' A' ' 167' ' ' LEU . 15.8 mt-30 -60.1 -41.26 92.17 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 70.1 109.449 176.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.741 HD12 ' CD1' ' A' ' 171' ' ' PHE . 36.2 tp -61.37 -39.9 92.34 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.359 -0.838 . . . . 74.23 110.233 176.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.685 ' HA ' HD12 ' A' ' 47' ' ' LEU . 31.4 mttt -55.48 -51.66 66.25 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.304 -0.872 . . . . 73.34 110.09 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -64.93 -36.61 84.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.505 -0.747 . . . . 62.41 109.48 179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.572 ' HG2' ' CZ ' ' A' ' 171' ' ' PHE . 6.8 tt0 -76.66 -31.88 57.59 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.744 -0.598 . . . . 72.04 110.375 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 44' ' ' LYS . 12.6 mt -50.88 150.63 5.09 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.322 -0.861 . . . . 64.42 110.326 -176.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.524 ' HG2' ' CB ' ' A' ' 51' ' ' ALA . 20.4 Cg_endo -66.76 144.68 72.49 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.05 1.553 . . . . 71.22 110.047 -179.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -60.06 -34.02 72.85 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.199 -0.938 . . . . 75.11 109.814 178.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -39.47 97.02 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.687 -1.365 . . . . 71.01 109.687 178.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.524 ' CB ' ' HG2' ' A' ' 48' ' ' PRO . . . -75.57 142.76 42.67 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -1.232 . . . . 72.11 110.519 -178.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 33.1 mttt -97.76 157.65 15.95 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.512 -0.743 . . . . 74.11 109.641 175.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.553 ' CE2' ' HE2' ' A' ' 44' ' ' LYS . 51.1 t80 -124.16 159.74 29.39 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.734 -1.229 . . . . 64.12 110.859 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.588 ' CG ' ' CG2' ' A' ' 21' ' ' VAL . 99.1 mm-40 -142.76 160.91 39.42 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.419 -0.8 . . . . 74.24 110.302 -176.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.537 ' HE3' ' CE1' ' A' ' 26' ' ' PHE . 12.6 tptt -129.06 133.67 47.79 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.17 -0.956 . . . . 74.21 110.198 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.485 ' OD1' ' HA ' ' A' ' 136' ' ' PHE . 0.5 OUTLIER -136.51 138.77 41.7 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.222 -0.924 . . . . 65.33 110.595 -176.796 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.678 ' CE1' ' CD1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -109.78 131.67 54.85 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 121.055 -1.028 . . . . 75.14 109.351 177.463 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.1 m -94.8 131.28 42.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 120.923 -1.111 . . . . 64.32 110.431 179.479 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.458 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 63.9 p -94.28 -8.18 39.79 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.332 -0.855 . . . . 63.24 110.365 175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.62 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.3 OUTLIER -62.27 -38.72 90.39 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.887 -1.133 . . . . 61.33 110.239 -172.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.62 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 10.9 mtm -71.46 -34.69 70.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.839 -1.163 . . . . 73.12 110.11 172.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -56.3 -40.91 86.23 Favored Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.961 -1.256 . . . . 64.31 109.961 -176.099 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.46 -150.47 19.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.38 -1.488 . . . . 34.13 109.38 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -53.82 -36.82 62.91 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.111 -1.229 . . . . 73.2 110.981 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 100' ' ' PRO . 25.5 ttt -88.68 2.53 53.11 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.918 -1.114 . . . . 71.21 110.768 -176.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.458 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.05 -41.23 84.83 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.607 -1.397 . . . . 72.02 109.607 -178.723 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -59.95 -39.97 87.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.092 -1.24 . . . . 62.31 110.214 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.41 -46.46 83.15 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.119 -0.988 . . . . 45.42 110.302 179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.465 ' HG3' ' OH ' ' A' ' 29' ' ' TYR . 94.9 mmm -60.38 -41.84 94.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.142 -0.974 . . . . 73.04 110.567 -177.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.593 ' HB2' ' CE2' ' A' ' 136' ' ' PHE . 97.3 p -62.21 -46.05 90.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.965 -1.085 . . . . 75.43 110.228 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 1.039 ' HG2' HG21 ' A' ' 133' ' ' VAL . 18.4 mttt -59.58 -34.55 72.87 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.936 -1.103 . . . . 63.13 110.18 175.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -61.73 -47.07 86.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.103 -0.998 . . . . 61.33 110.175 -178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.678 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 33.4 t80 -57.55 -44.48 85.23 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.933 -1.104 . . . . 54.21 109.608 176.324 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.052 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.08 -38.03 87.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.0 -1.062 . . . . 72.31 109.802 177.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.689 HG23 ' HB3' ' A' ' 123' ' ' ALA . 29.2 m -57.73 -43.48 85.34 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.139 -0.976 . . . . 62.21 109.579 176.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.535 ' HA ' ' CG2' ' A' ' 81' ' ' VAL . 59.4 mtt -53.03 -43.81 66.86 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.091 -1.006 . . . . 71.04 109.071 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.976 HD12 ' HA ' ' A' ' 74' ' ' ALA . 82.1 mt -60.42 -44.18 95.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 C-N-CA 119.938 -0.705 . . . . 73.32 110.392 -176.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.672 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -57.92 -36.55 72.62 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.057 -1.027 . . . . 75.32 110.313 176.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.866 ' O ' HG13 ' A' ' 81' ' ' VAL . 31.3 mt -89.67 5.8 44.21 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.102 -0.999 . . . . 54.3 110.97 -176.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 79' ' ' LEU . 96.0 mt-10 55.98 28.8 13.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.804 -1.185 . . . . 73.12 109.811 -174.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.866 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.5 m -117.62 23.13 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.383 -0.823 . . . . 73.32 110.881 -177.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.6 mp0 -58.34 -45.62 87.78 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.652 -1.28 . . . . 71.25 109.391 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 91.8 m-20 -58.25 -40.42 81.74 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 120.79 -1.193 . . . . 73.11 110.242 175.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.639 ' O ' HG23 ' A' ' 88' ' ' VAL . 63.3 mttp -66.96 -42.1 85.74 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.114 -0.991 . . . . 73.02 111.356 -175.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.717 ' HE1' ' HA ' ' A' ' 110' ' ' PHE . 80.0 mmm -109.8 -14.95 14.22 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.903 -1.123 . . . . 64.51 110.911 -167.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.591 HG23 ' O ' ' A' ' 82' ' ' GLU . 3.5 t -58.67 -57.73 24.48 Favored Pre-proline 0 C--N 1.297 -1.695 0 O-C-N 121.112 -0.992 . . . . 74.4 109.486 -179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.547 ' CD ' ' HB ' ' A' ' 86' ' ' VAL . 18.8 Cg_endo -66.05 -26.46 50.62 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.352 1.185 . . . . 74.12 110.936 175.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.698 HG11 ' HG3' ' A' ' 113' ' ' GLU . 79.3 t -58.84 -45.48 91.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 120.678 -1.264 . . . . 63.33 109.542 177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.651 ' HE1' HD11 ' A' ' 106' ' ' LEU . 1.9 mtp -65.07 -43.13 93.2 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.291 -0.88 . . . . 74.03 109.94 178.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.689 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 19.7 m-85 -68.27 -34.68 76.63 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.896 -1.128 . . . . 75.45 110.355 178.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.54 ' O ' ' N ' ' A' ' 95' ' ' THR . 65.8 t30 -63.63 -66.49 0.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.179 -0.95 . . . . 74.35 109.713 174.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.855 ' HA ' HD12 ' A' ' 96' ' ' LEU . 52.8 ttt85 -47.75 -36.12 10.97 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.407 -0.808 . . . . 75.14 110.82 -173.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.513 HG21 ' O ' ' A' ' 28' ' ' PHE . 3.5 mm -70.88 -58.71 4.6 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.909 -1.119 . . . . 72.45 111.029 178.489 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 85.9 t60 -84.05 -10.97 57.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.284 -0.885 . . . . 72.44 110.295 -174.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.54 ' N ' ' O ' ' A' ' 91' ' ' ASN . 27.2 m -112.98 -71.63 0.74 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.316 -0.865 . . . . 71.11 110.191 -175.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.855 HD12 ' HA ' ' A' ' 92' ' ' ARG . 8.9 mt -66.81 -21.05 66.05 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.281 -0.887 . . . . 74.4 109.581 175.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.523 ' N ' ' O ' ' A' ' 92' ' ' ARG . 98.0 mtt180 57.09 32.14 21.17 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.447 -0.783 . . . . 74.14 109.941 -178.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.514 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 9.1 mmtt -124.63 72.92 61.42 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.25 -0.906 . . . . 74.35 110.164 179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD3' ' C ' ' A' ' 97' ' ' ARG . 21.3 Cg_exo -60.37 143.13 99.47 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.9 1.474 . . . . 71.45 110.149 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.545 ' HB2' ' CE ' ' A' ' 65' ' ' MET . 35.5 Cg_exo -54.37 135.72 66.58 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.009 1.531 . . . . 74.43 110.346 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 29.8 pttt -102.06 -32.29 10.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.399 -0.813 . . . . 72.31 110.111 179.459 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.452 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 73.7 m-20 -142.74 173.66 11.34 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.366 -0.834 . . . . 74.51 109.716 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.469 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 97.0 mt-10 -57.56 -32.07 66.76 Favored 'General case' 0 C--N 1.301 -1.508 0 O-C-N 120.981 -1.075 . . . . 71.33 109.36 173.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.4 tt0 -58.81 -54.94 41.39 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.262 -0.899 . . . . 74.55 111.219 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.448 ' O ' HG13 ' A' ' 109' ' ' ILE . 83.9 tt0 -66.08 -38.79 89.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.907 -1.121 . . . . 65.14 109.885 -178.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.882 ' HA ' HD12 ' A' ' 109' ' ' ILE . 11.3 tp -58.3 -41.51 84.61 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.416 -0.802 . . . . 54.15 109.941 -179.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 70.5 mtm180 -64.31 -44.53 91.29 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.954 -1.091 . . . . 71.3 110.485 177.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.51 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.6 mm100 -59.46 -39.11 82.59 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.963 -1.086 . . . . 71.4 110.615 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.882 HD12 ' HA ' ' A' ' 106' ' ' LEU . 74.0 mt -55.6 -49.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.028 -1.045 . . . . 73.2 109.984 178.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.717 ' HA ' ' HE1' ' A' ' 85' ' ' MET . 19.6 m-85 -58.38 -51.0 71.64 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.064 -1.022 . . . . 53.42 110.795 179.686 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD11 ' HB2' ' A' ' 117' ' ' ALA . 41.0 mt -62.01 -37.73 85.96 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.929 -1.107 . . . . 73.51 110.356 -176.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -56.94 -38.84 73.48 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.935 -1.103 . . . . 73.05 110.197 175.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.698 ' HG3' HG11 ' A' ' 88' ' ' VAL . 75.2 mm-40 -75.86 6.04 5.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.357 -0.84 . . . . 73.24 111.273 -175.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.64 4.95 56.92 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.761 -1.336 . . . . 72.31 109.761 179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.49 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.9 mm -81.62 155.7 4.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.135 -1.215 . . . . 54.14 109.78 177.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.557 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 0.9 OUTLIER -95.9 139.54 31.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.991 -1.068 . . . . 71.24 110.001 178.369 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.613 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -63.42 -31.58 72.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.842 -1.161 . . . . 52.22 109.42 173.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.26 -51.37 63.93 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.438 -0.788 . . . . 63.11 110.867 179.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.817 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -75.78 -36.71 59.7 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.792 -1.192 . . . . 72.34 110.607 -175.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.775 ' HA ' HD11 ' A' ' 79' ' ' LEU . 75.8 t80 -60.92 -41.64 96.57 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 120.837 -1.164 . . . . 70.24 109.933 175.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.87 -43.59 94.62 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.204 -0.935 . . . . 64.24 109.691 177.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -62.07 -38.49 89.01 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 73.33 110.309 178.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -72.99 -44.1 61.44 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.155 -0.966 . . . . 73.34 110.851 -175.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -58.34 -33.91 70.06 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.15 -0.969 . . . . 72.34 109.454 178.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -88.38 6.63 36.44 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.414 -0.803 . . . . 74.35 109.999 178.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -72.93 130.48 14.19 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.685 -1.366 . . . . 43.32 109.685 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.27 -34.99 69.22 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.13 -1.218 . . . . 74.21 109.706 176.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.46 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -58.9 -48.49 81.26 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.165 -0.959 . . . . 33.5 110.306 179.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.052 HG13 ' HB3' ' A' ' 74' ' ' ALA . 36.8 t -55.38 -50.02 68.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 120.822 -1.174 . . . . 73.13 110.074 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 50.9 t0 -56.79 -38.65 72.82 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.131 -0.981 . . . . 70.34 109.995 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.458 ' O ' ' HG2' ' A' ' 134' ' ' ARG . 23.6 m -62.6 -36.07 81.57 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.177 -0.952 . . . . 71.13 110.455 179.357 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.48 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.6 mpp? -73.3 -36.67 66.3 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.06 -1.025 . . . . 73.34 110.06 -179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 1.039 HG21 ' HG2' ' A' ' 71' ' ' LYS . 47.2 t -64.46 -47.3 89.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 O-C-N 121.426 -0.796 . . . . 63.44 110.232 -178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.532 ' HG3' ' N ' ' A' ' 135' ' ' ARG . 19.3 ptp180 -64.76 -40.65 95.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.762 -1.211 . . . . 75.14 109.491 174.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.532 ' N ' ' HG3' ' A' ' 134' ' ' ARG . 58.7 ttt180 -50.1 -60.31 3.07 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.669 -0.644 . . . . 74.12 111.058 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.624 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 1.9 p90 -61.97 -41.32 97.88 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.866 -1.146 . . . . 65.44 110.685 -175.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.624 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 36.2 m-20 -50.95 -47.33 61.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.728 -1.232 . . . . 73.15 109.818 -178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.453 ' O ' ' OD1' ' A' ' 142' ' ' ASP . 42.6 mttt -63.32 -40.27 96.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.934 -1.104 . . . . 71.52 110.594 175.408 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 135' ' ' ARG . 9.6 mt-30 -58.2 -42.49 86.29 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.94 -1.1 . . . . 72.23 110.611 -175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.689 ' HA ' HD12 ' A' ' 145' ' ' LEU . 61.9 t80 -74.76 -37.7 62.39 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 120.871 -1.143 . . . . 75.42 110.264 -179.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 137' ' ' ASP . 96.1 mt-30 -65.84 -53.14 43.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.596 -0.69 . . . . 74.43 110.631 -177.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.503 ' HB2' HG22 ' A' ' 14' ' ' THR . 22.4 p-10 -69.36 -33.08 72.54 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.145 -0.972 . . . . 62.21 110.193 -179.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.578 ' OG ' HD12 ' A' ' 145' ' ' LEU . 87.4 p -62.45 -21.26 65.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.222 -0.924 . . . . 73.33 110.416 178.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 66.83 32.94 82.59 Favored Glycine 0 N--CA 1.487 2.097 0 N-CA-C 109.026 -1.63 . . . . 73.22 109.026 -176.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.0 HD22 ' HB1' ' A' ' 150' ' ' ALA . 40.1 mt -79.13 131.11 36.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.175 -1.191 . . . . 72.43 110.367 -178.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 52.9 p -75.79 -23.98 55.94 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.256 -0.903 . . . . 51.32 109.837 176.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.594 ' HA2' ' CE2' ' A' ' 60' ' ' PHE . . . 172.16 -177.35 44.89 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.862 -1.295 . . . . 51.2 109.862 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 5.0 m -112.07 165.09 13.64 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.514 -0.992 . . . . 72.02 109.618 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.553 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 38.6 Cg_endo -71.8 129.27 16.16 Favored 'Cis proline' 0 N--CA 1.49 1.307 0 C-N-CA 122.313 -1.953 . . . . 63.12 111.325 3.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 1.0 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -121.71 135.37 54.95 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.354 -0.841 . . . . 41.13 109.316 172.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.868 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.4 t -112.89 126.99 70.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.952 -1.092 . . . . 63.4 109.924 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.456 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 13.4 t -115.69 130.97 69.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 C-N-CA 119.551 -0.86 . . . . 64.33 110.105 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.726 HG11 ' HB2' ' A' ' 177' ' ' LEU . 16.6 t -110.38 132.65 58.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.431 -0.793 . . . . 43.32 109.76 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.504 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 18.2 m-20 47.35 31.95 2.04 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.227 -0.92 . . . . 75.34 110.337 -175.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.512 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.7 t30 48.9 30.17 2.62 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.133 -0.979 . . . . 72.14 110.845 173.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.971 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 76.5 ttt180 -151.9 -26.56 0.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.854 -1.153 . . . . 73.44 111.306 -177.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.945 ' HB3' HD22 ' A' ' 177' ' ' LEU . 55.6 m-85 -106.78 137.04 45.56 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.535 -1.353 . . . . 62.33 109.941 172.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.957 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -111.27 124.96 53.28 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.238 -0.913 . . . . 64.4 109.352 -179.035 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.493 HG13 HD23 ' A' ' 173' ' ' LEU . 52.9 t -76.04 108.4 8.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 C-N-CA 119.718 -0.793 . . . . 73.54 109.991 -176.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.508 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.6 mt-30 -66.54 -39.74 88.73 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.314 -0.866 . . . . 65.2 109.724 174.364 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.401 ' C ' ' O ' ' A' ' 160' ' ' GLN . . . 43.61 50.12 7.05 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.348 -1.501 . . . . 73.33 109.348 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.473 ' O ' ' HB2' ' A' ' 163' ' ' SER . 67.5 tp60 -52.89 -39.74 62.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.246 -1.15 . . . . 73.53 110.129 -177.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.473 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 29.8 t 179.75 71.37 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.248 -0.907 . . . . 60.01 110.37 178.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 169' ' ' GLU . . . -68.94 132.28 46.45 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.091 -1.006 . . . . 74.42 109.715 176.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 24.2 mttm -59.11 -34.95 72.62 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.238 -0.913 . . . . 52.44 110.387 -177.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 50.9 m -150.79 164.74 35.49 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.154 -0.966 . . . . 74.23 109.837 -179.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.646 HD11 ' NE2' ' A' ' 42' ' ' GLN . 45.8 mt -53.39 -25.6 16.23 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 120.969 -1.082 . . . . 62.32 110.397 178.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.426 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 91.3 m-20 -58.92 -41.53 87.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.802 -1.186 . . . . 63.42 110.418 178.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 164' ' ' ALA . 85.1 tt0 -75.84 -46.01 32.66 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.882 -1.137 . . . . 70.35 110.587 177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.868 ' OH ' HG21 ' A' ' 151' ' ' VAL . 83.2 t80 -62.05 -44.72 96.08 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.951 . . . . 75.2 110.005 179.274 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.741 ' CD1' HD12 ' A' ' 43' ' ' LEU . 57.3 t80 -60.11 -44.66 94.7 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.392 -0.817 . . . . 73.33 110.16 176.61 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.533 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 89.9 m-20 -56.61 -48.42 77.51 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.078 -1.014 . . . . 62.04 110.475 -177.769 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.772 HD22 ' HB3' ' A' ' 8' ' ' HIS . 4.9 tp -51.54 -55.35 19.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.687 -1.258 . . . . 73.13 109.988 175.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 55.7 t -51.59 -43.29 31.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.024 -1.047 . . . . 74.22 109.896 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.722 ' HA ' HD12 ' A' ' 178' ' ' LEU . 2.7 m120 -58.52 -43.0 89.01 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.202 -0.936 . . . . 73.11 110.565 179.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.683 ' CE2' ' CZ ' ' A' ' 3' ' ' PHE . 66.4 m-85 -68.62 -41.4 79.55 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.033 -1.042 . . . . 71.34 110.303 -179.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.945 HD22 ' HB3' ' A' ' 157' ' ' TYR . 75.6 mt -57.41 -37.34 72.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.094 -1.004 . . . . 71.12 109.385 176.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.722 HD12 ' HA ' ' A' ' 175' ' ' ASN . 10.4 mt -60.54 -28.97 68.85 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.2 -0.938 . . . . 74.22 110.127 175.434 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.523 HG23 ' O ' ' A' ' 175' ' ' ASN . 44.3 p -98.34 -4.26 35.31 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.119 -0.988 . . . . 72.4 110.677 -175.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.754 HD12 ' HA ' ' A' ' 177' ' ' LEU . 33.9 mt -91.77 5.78 48.53 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.124 -0.985 . . . . 72.13 110.382 179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.478 ' HD2' ' O ' ' A' ' 17' ' ' SER . 8.0 ttpt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.963 -1.017 . . . . 62.05 110.328 179.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 121.344 0.593 . . . . 71.14 110.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -56.65 -35.73 68.71 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 70.15 110.266 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.647 ' CD2' ' CE2' ' A' ' 176' ' ' TYR . 22.9 m-85 -104.29 137.36 42.31 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.221 -0.925 . . . . 73.02 109.647 -178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.576 ' H ' ' CD2' ' A' ' 8' ' ' HIS . 32.6 tttt -162.56 133.24 4.81 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.009 -1.057 . . . . 73.24 110.943 -170.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.546 ' HB2' ' CZ ' ' A' ' 9' ' ' TYR . 74.7 tt0 -49.51 134.52 19.31 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.09 -1.006 . . . . 63.31 110.62 176.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.23 -13.42 57.15 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.959 -1.656 . . . . 64.34 108.959 -178.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -119.41 -78.8 0.59 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.451 -1.029 . . . . 75.41 109.669 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 1.135 ' ND1' HD13 ' A' ' 173' ' ' LEU . 0.3 OUTLIER -79.41 -16.87 55.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.443 -0.786 . . . . 74.51 111.807 -176.259 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 1.122 ' CD2' HD21 ' A' ' 177' ' ' LEU . 2.3 p90 -151.61 174.17 13.78 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.45 -1.406 . . . . 52.33 111.764 173.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.64 155.57 44.78 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 115.216 -0.902 . . . . 73.01 109.165 171.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.939 HG22 ' CE2' ' A' ' 157' ' ' TYR . 61.9 t -103.99 133.83 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.864 -1.147 . . . . 73.31 111.023 -175.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.708 HD13 ' O ' ' A' ' 143' ' ' SER . 86.5 mt -100.15 155.46 17.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.789 -0.569 . . . . 74.24 110.211 -179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -75.99 1.6 14.93 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 72.02 110.062 175.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.833 HG23 ' O ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -44.49 160.33 0.24 Allowed Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.258 -0.901 . . . . 74.55 110.647 -178.434 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.578 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 19.3 Cg_endo -63.22 -21.87 72.35 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.189 1.626 . . . . 45.32 110.33 178.048 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 15' ' ' PRO . . . 63.39 165.52 0.13 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.367 -0.833 . . . . 62.43 110.397 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 30.2 t -107.93 139.86 41.92 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.128 -0.983 . . . . 61.05 110.224 178.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.1 t -58.15 -35.61 71.8 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -0.937 . . . . 74.34 110.17 -179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -109.0 172.4 3.68 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.338 -0.851 . . . . 74.11 109.862 178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.425 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.4 Cg_endo -71.65 121.31 7.56 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.842 1.443 . . . . 73.34 109.971 -179.156 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 8.6 p -143.11 137.2 26.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 O-C-N 120.774 -1.203 . . . . 74.23 109.926 172.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.512 ' O ' ' N ' ' A' ' 54' ' ' GLN . 12.0 t -118.42 125.53 74.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 121.098 -1.002 . . . . 63.13 109.709 -179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 92.0 p -118.16 135.84 53.98 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.06 -1.025 . . . . 65.13 110.191 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.799 ' OE1' HG21 ' A' ' 40' ' ' ILE . 83.1 tt0 -103.65 128.41 50.96 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.35 -0.844 . . . . 74.51 110.185 177.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CD2' ' CG ' ' A' ' 56' ' ' ASN . 76.1 m-85 -102.27 124.6 48.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.131 -0.98 . . . . 73.45 109.975 178.108 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.617 ' O ' HG22 ' A' ' 58' ' ' VAL . 40.9 p90 -143.4 167.15 22.87 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.627 -0.67 . . . . 70.32 111.214 -177.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.521 ' OG ' ' CB ' ' A' ' 61' ' ' MET . 46.4 t -134.15 138.92 45.53 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.429 -0.794 . . . . 72.13 110.523 178.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.958 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.2 m-85 -59.43 -28.44 66.95 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.239 -0.913 . . . . 73.24 110.639 177.387 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.47 ' HA ' HG21 ' A' ' 93' ' ' ILE . 51.9 m-85 -96.93 21.7 9.32 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.287 -0.883 . . . . 74.32 111.034 -174.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 22.8 t -123.03 94.75 46.9 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 120.843 -1.161 . . . . 34.41 110.249 -178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -52.36 -37.87 72.35 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.007 1.53 . . . . 74.12 109.967 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 77.4 m80 -58.52 -47.43 84.17 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.075 -1.016 . . . . 75.33 109.816 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.969 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 37.5 m -65.67 -40.79 92.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.142 -0.974 . . . . 63.23 110.146 177.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.577 ' ND2' ' CB ' ' A' ' 94' ' ' HIS . 15.6 t-20 -53.33 -42.58 66.88 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.112 -0.992 . . . . 64.23 110.365 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.458 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 50.4 m -71.09 -43.71 67.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.174 -0.954 . . . . 63.24 110.558 179.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.973 ' CZ ' HD11 ' A' ' 40' ' ' ILE . 66.3 t80 -60.85 -34.78 75.11 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.342 -0.848 . . . . 71.51 110.706 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.547 ' CB ' ' CD ' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -39.72 -61.89 0.97 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.211 -0.931 . . . . 62.11 111.114 -175.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.547 ' CD ' ' CB ' ' A' ' 37' ' ' GLU . 4.2 Cg_endo -51.59 -43.34 51.17 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.499 1.263 . . . . 75.43 110.719 -176.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.572 HD12 ' HA ' ' A' ' 36' ' ' PHE . 85.7 mt -55.17 -49.11 74.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 120.855 -1.153 . . . . 74.02 110.067 178.601 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.973 HD11 ' CZ ' ' A' ' 36' ' ' PHE . 26.8 mm -58.67 -38.63 72.74 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 120.977 -1.077 . . . . 72.13 110.179 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.96 75.91 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.887 -1.133 . . . . 51.33 109.571 176.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.488 ' O ' ' HG2' ' A' ' 45' ' ' GLN . 16.4 mt-30 -59.95 -40.96 90.78 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.15 -0.968 . . . . 70.1 109.41 176.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.716 HD12 ' CD1' ' A' ' 171' ' ' PHE . 61.6 tp -61.99 -39.01 90.75 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 74.23 110.157 176.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.692 ' HA ' HD12 ' A' ' 47' ' ' LEU . 17.1 mttp -57.21 -50.81 71.69 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.452 -0.78 . . . . 73.34 110.463 -178.497 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.522 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 19.7 pt20 -68.39 -35.06 77.13 Favored 'General case' 0 N--CA 1.491 1.582 0 C-N-CA 119.526 -0.87 . . . . 62.41 109.61 -179.382 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.602 ' CB ' ' CE1' ' A' ' 171' ' ' PHE . 46.4 mt-30 -75.67 -31.07 59.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.537 -0.727 . . . . 72.04 110.335 178.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.692 HD12 ' HA ' ' A' ' 44' ' ' LYS . 9.3 mt -51.03 145.22 12.65 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.257 -0.902 . . . . 64.42 110.359 -175.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.7 Cg_exo -63.04 145.07 93.96 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.996 1.524 . . . . 71.22 109.988 179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 75.3 mm-40 -60.37 -33.67 72.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.152 -0.968 . . . . 75.11 109.806 177.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -60.93 -40.02 97.8 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.869 -1.292 . . . . 71.01 109.869 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -72.73 143.11 48.13 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.01 -1.288 . . . . 72.11 110.435 -178.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 50.6 mttp -97.21 153.49 17.97 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.484 -0.76 . . . . 74.11 109.581 175.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.609 ' CE2' ' CE ' ' A' ' 44' ' ' LYS . 52.7 t80 -123.62 158.58 31.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.74 -1.225 . . . . 64.12 110.686 178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.512 ' N ' ' O ' ' A' ' 22' ' ' VAL . 51.0 tt0 -147.5 160.96 42.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.481 -0.762 . . . . 74.24 110.182 -176.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.443 ' HE3' ' HE2' ' A' ' 44' ' ' LYS . 36.2 mttp -126.26 143.55 51.11 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.075 -1.015 . . . . 74.21 110.512 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' CG ' ' CD2' ' A' ' 25' ' ' PHE . 13.1 t-20 -133.46 130.48 38.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.355 -0.841 . . . . 65.33 110.301 -179.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.576 ' O ' ' CD1' ' A' ' 136' ' ' PHE . 0.7 OUTLIER -110.27 120.11 41.39 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.961 -1.087 . . . . 75.14 109.797 174.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.647 HG21 ' HG3' ' A' ' 61' ' ' MET . 31.7 m -85.2 137.38 20.93 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.253 -0.904 . . . . 64.32 110.808 -176.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.48 ' O ' ' HA3' ' A' ' 66' ' ' GLY . 89.8 p -93.57 -14.52 26.45 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.311 -0.868 . . . . 63.24 110.783 176.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' CD1' ' HB ' ' A' ' 58' ' ' VAL . 18.9 p90 -75.5 -29.75 59.63 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.635 -1.29 . . . . 61.33 109.962 -177.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.647 ' HG3' HG21 ' A' ' 58' ' ' VAL . 73.3 mmm -65.24 -38.43 90.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.126 -0.984 . . . . 73.12 110.041 171.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -62.14 -45.67 95.57 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.823 -1.311 . . . . 64.31 109.823 -177.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 103.15 -143.13 15.69 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.344 -1.503 . . . . 34.13 109.344 -177.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.3 m-20 -54.73 -37.73 66.26 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.063 -1.257 . . . . 73.2 110.887 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.55 ' HE2' HD22 ' A' ' 106' ' ' LEU . 24.0 ttt -97.85 9.53 42.46 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.97 -1.081 . . . . 71.21 110.381 -178.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 59' ' ' SER . . . -58.38 -40.51 94.26 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 109.42 -1.472 . . . . 72.02 109.42 179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.446 HE21 HG11 ' A' ' 133' ' ' VAL . 64.0 tp60 -58.85 -40.56 84.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.198 . . . . 62.31 110.259 179.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.473 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.27 -46.44 86.82 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.125 -0.984 . . . . 45.42 110.236 179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.459 ' SD ' ' HG2' ' A' ' 100' ' ' PRO . 94.7 mmm -58.71 -41.6 86.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.054 -1.029 . . . . 73.04 110.417 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' A' ' 136' ' ' PHE . 29.7 m -60.48 -49.22 78.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.107 -0.996 . . . . 75.43 110.332 -179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.832 ' HG2' HG21 ' A' ' 133' ' ' VAL . 56.2 mtpt -59.99 -34.88 73.91 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.923 -1.111 . . . . 63.13 110.103 177.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 76' ' ' MET . . . -62.17 -48.29 80.74 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.078 -1.014 . . . . 61.33 110.3 -177.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.498 ' CD2' ' CD2' ' A' ' 57' ' ' HIS . 71.1 t80 -58.56 -43.23 89.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.94 -1.1 . . . . 54.21 109.716 177.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.058 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.25 -39.7 91.31 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.083 -1.01 . . . . 72.31 109.8 177.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.797 HG23 ' HB3' ' A' ' 123' ' ' ALA . 35.2 m -57.33 -43.74 83.65 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.112 -0.992 . . . . 62.21 109.571 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.639 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.6 mtt -52.74 -43.34 65.68 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.082 -1.011 . . . . 71.04 109.08 176.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.996 HD12 ' HA ' ' A' ' 74' ' ' ALA . 80.5 mt -59.82 -44.21 93.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 121.532 -0.73 . . . . 73.32 110.207 -177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.468 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -58.17 -36.37 72.95 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.997 -1.065 . . . . 75.32 110.215 175.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.981 ' O ' HG13 ' A' ' 81' ' ' VAL . 22.7 mt -88.06 6.78 34.53 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.21 -0.931 . . . . 54.3 110.739 -177.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 53.74 30.85 11.83 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.922 -1.111 . . . . 73.12 109.944 -176.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.981 HG13 ' O ' ' A' ' 79' ' ' LEU . 15.1 m -119.99 11.59 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.344 -0.847 . . . . 73.32 111.201 -176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.582 ' O ' HG23 ' A' ' 86' ' ' VAL . 6.6 mp0 -44.38 -71.72 0.07 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.887 -1.133 . . . . 71.25 109.883 -179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -52.47 -37.0 56.14 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.916 -1.115 . . . . 73.11 110.909 -179.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 71.2 tttt -58.58 -44.8 89.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.968 -1.083 . . . . 73.02 111.265 -169.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.639 ' SD ' ' HE2' ' A' ' 76' ' ' MET . 4.6 ppp? -126.49 0.83 6.92 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.963 -1.086 . . . . 64.51 110.997 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 82' ' ' GLU . 1.9 t -52.81 -45.45 97.18 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 120.657 -1.277 . . . . 74.4 109.26 178.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 15.7 Cg_exo -62.26 -24.23 75.88 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.406 1.214 . . . . 74.12 110.614 176.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.611 HG11 ' CG ' ' A' ' 113' ' ' GLU . 61.2 t -65.53 -43.34 94.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 120.747 -1.221 . . . . 63.33 109.497 178.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.533 ' HE1' ' CD1' ' A' ' 106' ' ' LEU . 81.3 mmm -60.83 -42.11 97.11 Favored 'General case' 0 C--N 1.298 -1.644 0 C-N-CA 119.107 -1.037 . . . . 74.03 109.533 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.677 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.0 m-85 -70.58 -42.28 71.28 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.836 -1.165 . . . . 75.45 110.798 178.739 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.532 ' O ' ' HB ' ' A' ' 95' ' ' THR . 43.2 t30 -57.34 -55.52 33.65 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 74.35 109.679 175.158 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.867 ' HA ' HD12 ' A' ' 96' ' ' LEU . 47.0 ttt85 -51.84 -35.94 46.39 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 121.343 -0.848 . . . . 75.14 109.983 -178.85 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.958 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.7 mm -81.56 -66.29 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.187 -0.946 . . . . 72.45 110.592 175.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.577 ' CB ' ' ND2' ' A' ' 34' ' ' ASN . 51.7 t-80 -67.52 -17.19 64.57 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.205 -0.934 . . . . 72.44 111.217 -171.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.532 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.3 m -120.79 -68.94 0.87 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 120.865 -1.147 . . . . 71.11 110.553 -175.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.867 HD12 ' HA ' ' A' ' 92' ' ' ARG . 48.5 mt -60.29 -24.13 64.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.052 -1.03 . . . . 74.4 109.747 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 95' ' ' THR . 97.2 mtt180 58.38 33.01 22.75 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.456 -0.778 . . . . 74.14 109.847 -176.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.518 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 2.3 tptt -125.5 74.64 69.15 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.381 -0.824 . . . . 74.35 109.97 178.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.467 ' HB3' HD13 ' A' ' 93' ' ' ILE . 17.5 Cg_endo -63.29 155.42 61.9 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 123.968 1.51 . . . . 71.45 110.316 -178.697 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.701 ' CG ' HD13 ' A' ' 106' ' ' LEU . 32.3 Cg_exo -53.97 118.73 5.28 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.026 1.54 . . . . 74.43 110.095 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.465 ' O ' ' OD1' ' A' ' 102' ' ' ASP . 65.2 mmtt -62.59 -46.69 87.14 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.364 -0.835 . . . . 72.31 109.705 177.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.465 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 78.8 m-20 -144.89 -166.89 2.52 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 109.131 -0.692 . . . . 74.51 109.131 179.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.477 ' O ' ' HG3' ' A' ' 107' ' ' ARG . 96.9 mt-10 -59.82 -32.93 71.11 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 120.795 -1.191 . . . . 71.33 109.606 169.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -68.1 -52.26 37.01 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.008 -1.058 . . . . 74.55 111.48 -175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . . . . . . . . . 48.8 tp10 -59.39 -36.76 76.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.6 -1.312 . . . . 65.14 108.938 176.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.957 ' HA ' HD12 ' A' ' 109' ' ' ILE . 7.6 tp -59.33 -43.53 92.72 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.545 -0.722 . . . . 54.15 110.16 177.531 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.477 ' HG3' ' O ' ' A' ' 103' ' ' GLU . 97.6 mtt180 -60.59 -43.77 97.01 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.824 -1.172 . . . . 71.3 110.625 177.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . 0.484 ' NE2' ' HA ' ' A' ' 108' ' ' GLN . 5.8 mm100 -60.73 -38.84 86.51 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.924 -1.11 . . . . 71.4 110.612 -179.346 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.957 HD12 ' HA ' ' A' ' 106' ' ' LEU . 61.9 mt -55.51 -48.71 76.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.047 -1.033 . . . . 73.2 109.905 178.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.481 ' O ' HG12 ' A' ' 115' ' ' ILE . 24.1 m-85 -57.44 -54.11 50.59 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.071 -1.018 . . . . 53.42 110.738 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.558 HD21 ' CA ' ' A' ' 117' ' ' ALA . 62.5 mt -61.9 -36.65 81.93 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.868 -1.145 . . . . 73.51 110.507 -175.328 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -56.62 -39.04 72.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.851 -1.155 . . . . 73.05 110.17 175.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.611 ' CG ' HG11 ' A' ' 88' ' ' VAL . 76.2 mm-40 -76.32 6.46 5.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 73.24 111.233 -175.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 99.64 3.19 56.29 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.729 -1.348 . . . . 72.31 109.729 -179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 30.3 mm -77.06 153.37 5.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.083 -1.245 . . . . 54.14 109.711 177.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.525 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.1 OUTLIER -96.91 139.41 32.98 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.913 -1.117 . . . . 71.24 109.9 177.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.558 ' CA ' HD21 ' A' ' 111' ' ' LEU . . . -62.56 -32.51 73.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.934 -1.104 . . . . 52.22 109.548 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -62.82 -51.57 66.55 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.288 -0.883 . . . . 63.11 110.897 179.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.79 ' HD3' HD13 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.22 -36.47 58.54 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.788 -1.195 . . . . 72.34 110.722 -175.7 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.724 ' HA ' HD11 ' A' ' 79' ' ' LEU . 82.4 t80 -60.57 -41.49 94.71 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.758 -1.214 . . . . 70.24 109.892 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.2 m-20 -61.52 -42.7 99.2 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.207 -0.933 . . . . 64.24 109.792 178.137 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.458 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -61.38 -33.6 73.93 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.242 -0.911 . . . . 73.33 110.074 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.797 ' HB3' HG23 ' A' ' 75' ' ' THR . . . -81.69 -44.57 16.93 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.167 -0.958 . . . . 73.34 110.99 -175.488 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . . . . . . . . . 73.0 t80 -59.48 -32.76 70.56 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.179 -0.951 . . . . 72.34 109.785 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.458 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.9 p-10 -99.1 8.87 44.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.885 . . . . 74.35 110.011 179.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.53 135.32 18.07 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.631 -1.388 . . . . 43.32 109.631 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -56.72 -34.13 67.2 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.116 -1.226 . . . . 74.21 109.773 177.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -60.08 -47.64 85.03 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.176 -0.952 . . . . 33.5 110.554 -179.032 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.058 HG13 ' HB3' ' A' ' 74' ' ' ALA . 39.5 t -58.43 -49.82 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 120.855 -1.153 . . . . 73.13 110.154 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.452 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 55.7 t0 -57.25 -40.41 77.57 Favored 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.069 -1.02 . . . . 70.34 109.983 -177.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.2 t -60.78 -37.29 81.39 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.169 -0.957 . . . . 71.13 110.364 178.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.792 ' HE3' ' HB1' ' A' ' 74' ' ' ALA . 73.7 mtm -73.9 -34.72 64.52 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.918 -1.114 . . . . 73.34 110.53 -176.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.832 HG21 ' HG2' ' A' ' 71' ' ' LYS . 70.5 t -60.09 -45.93 95.03 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.779 0 O-C-N 121.115 -0.991 . . . . 63.44 109.457 176.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.546 ' HB3' ' NH1' ' A' ' 134' ' ' ARG . 18.5 mtp-105 -59.65 -40.61 88.24 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.078 -1.014 . . . . 75.14 109.069 173.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 132' ' ' MET . 59.0 ttt180 -51.79 -70.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.736 -0.603 . . . . 74.12 110.667 -178.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.628 ' CD1' ' N ' ' A' ' 137' ' ' ASP . 2.1 p90 -51.75 -42.29 62.21 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.964 -1.085 . . . . 65.44 110.829 -176.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.628 ' N ' ' CD1' ' A' ' 136' ' ' PHE . 56.5 t0 -53.57 -47.88 69.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.777 -1.202 . . . . 73.15 109.8 -178.567 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -60.83 -39.39 88.86 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.109 -0.994 . . . . 71.52 110.366 175.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.531 ' HB2' ' ND2' ' A' ' 56' ' ' ASN . 88.6 mt-30 -57.11 -47.81 80.18 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.038 -1.039 . . . . 72.23 110.26 -176.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.631 ' CE1' ' CB ' ' A' ' 145' ' ' LEU . 63.5 t80 -65.6 -39.37 91.49 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.291 -0.881 . . . . 75.42 110.168 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 95.2 mt-30 -62.34 -51.4 67.79 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 119.805 -0.758 . . . . 74.43 110.47 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.833 ' O ' HG23 ' A' ' 14' ' ' THR . 88.2 m-20 -62.19 -37.82 86.76 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.232 -0.917 . . . . 62.21 110.25 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.708 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.2 p -64.78 -21.04 66.69 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.448 -0.783 . . . . 73.33 110.494 -177.557 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 70.29 28.88 70.76 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 108.837 -1.705 . . . . 73.22 108.837 -175.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 158' ' ' LEU . 55.5 mt -79.5 141.76 36.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.301 -1.117 . . . . 72.43 110.292 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 55.9 p -108.33 3.92 23.97 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.327 -0.858 . . . . 51.32 109.949 177.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . . . . . . . . . . . 170.01 158.31 13.7 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 110.031 -1.228 . . . . 51.2 110.031 178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.566 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 2.9 m -108.99 166.1 11.42 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.551 -0.97 . . . . 72.02 109.231 176.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.598 ' HB2' ' CD2' ' A' ' 36' ' ' PHE . 38.0 Cg_endo -71.57 136.8 44.07 Favored 'Cis proline' 0 N--CA 1.489 1.222 0 C-N-CA 122.469 -1.888 . . . . 63.12 111.511 3.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.952 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -131.17 140.34 49.92 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.254 -0.903 . . . . 41.13 109.306 171.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 0.808 HG21 ' OH ' ' A' ' 170' ' ' TYR . 44.9 t -113.25 127.92 70.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 120.977 -1.077 . . . . 63.4 110.065 -178.365 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.52 ' CG1' ' HA ' ' A' ' 155' ' ' ASN . 22.0 t -114.42 130.88 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.289 -0.882 . . . . 64.33 110.241 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.821 HG11 ' HB2' ' A' ' 177' ' ' LEU . 18.3 t -111.5 133.11 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.434 -0.791 . . . . 43.32 109.737 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.528 ' O ' ' HA ' ' A' ' 16' ' ' ALA . 1.8 m-80 52.07 23.24 2.16 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.175 -0.953 . . . . 75.34 110.022 -173.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.52 ' HA ' ' CG1' ' A' ' 152' ' ' VAL . 4.6 t30 49.11 33.5 4.92 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.119 -0.988 . . . . 72.14 110.122 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.561 ' HD3' ' HB2' ' A' ' 16' ' ' ALA . 15.0 tpt180 -145.34 -37.48 0.27 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -0.993 . . . . 73.44 110.597 -176.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.939 ' CE2' HG22 ' A' ' 11' ' ' VAL . 62.6 m-85 -103.18 142.49 34.06 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.844 -1.16 . . . . 62.33 110.083 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 1.101 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.78 124.91 51.33 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.387 -0.821 . . . . 64.4 109.102 179.167 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.744 HG22 ' CD1' ' A' ' 177' ' ' LEU . 79.7 t -80.49 107.05 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 73.54 110.139 -175.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.503 ' HG2' ' HA ' ' A' ' 9' ' ' TYR . 99.9 mm-40 -70.5 -45.13 66.25 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.309 -0.869 . . . . 65.2 109.738 174.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 71.65 2.16 49.05 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 110.081 -1.207 . . . . 73.33 110.081 176.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -62.99 -40.56 98.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.256 . . . . 73.53 110.241 -179.66 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 84.9 p -69.31 -23.42 63.8 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.341 -0.849 . . . . 60.01 110.523 -178.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.663 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -84.23 101.38 11.85 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.095 -1.003 . . . . 74.42 110.66 -175.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 52.7 mttm -63.23 -30.92 71.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.271 -0.893 . . . . 52.44 110.276 176.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 86.3 p -137.99 164.43 29.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.275 -0.891 . . . . 74.23 109.955 -178.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.553 HD21 HG23 ' A' ' 39' ' ' ILE . 44.8 mt -52.47 -27.69 17.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.943 -1.098 . . . . 62.32 111.104 -176.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -58.7 -41.14 85.6 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.616 -1.302 . . . . 63.42 110.511 179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.524 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 73.8 mm-40 -80.15 -41.97 24.36 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.841 -1.162 . . . . 70.35 110.562 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.808 ' OH ' HG21 ' A' ' 151' ' ' VAL . 80.0 t80 -63.41 -43.95 96.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.164 -0.96 . . . . 75.2 109.948 178.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.716 ' CD1' HD12 ' A' ' 43' ' ' LEU . 70.9 t80 -59.99 -47.21 86.76 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.392 -0.817 . . . . 73.33 110.113 176.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.575 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 92.2 m-20 -57.17 -43.39 82.51 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.142 -0.974 . . . . 62.04 110.315 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 1.135 HD13 ' ND1' ' A' ' 8' ' ' HIS . 3.9 tp -54.78 -50.42 68.52 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.91 -1.118 . . . . 73.13 110.262 175.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 53.2 t -55.3 -41.95 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 74.22 109.656 -179.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.535 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.08 -41.13 87.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.198 -0.939 . . . . 73.11 110.721 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.647 ' CE2' ' CD2' ' A' ' 3' ' ' PHE . 69.8 m-85 -67.39 -43.42 81.39 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.957 -1.089 . . . . 71.34 110.118 179.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 1.122 HD21 ' CD2' ' A' ' 9' ' ' TYR . 84.0 mt -59.93 -38.35 82.13 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.206 -0.934 . . . . 71.12 109.885 177.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.1 mt -58.12 -29.38 65.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.228 -0.92 . . . . 74.22 109.862 176.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 175' ' ' ASN . 45.6 p -91.76 -1.06 57.55 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.239 -0.913 . . . . 72.4 110.235 -179.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.998 HD12 ' HA ' ' A' ' 177' ' ' LEU . 20.3 mt -101.44 140.8 35.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.283 -0.886 . . . . 72.13 110.274 179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 67.0 mttm . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 118.037 -0.982 . . . . 62.05 110.213 179.974 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.686 ' HB1' ' HE2' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.212 0.53 . . . . 71.14 110.153 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.569 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 63.2 tt0 -56.21 -37.35 69.54 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.181 -0.949 . . . . 70.15 110.259 -179.997 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.545 ' HA ' ' CG ' ' A' ' 8' ' ' HIS . 48.6 m-85 -103.08 131.65 49.92 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.263 -0.898 . . . . 73.02 109.948 -178.778 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.686 ' HE2' ' HB1' ' A' ' 1' ' ' ALA . 53.5 mttt -144.69 167.21 23.12 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.212 -0.93 . . . . 73.24 110.586 -177.506 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.587 ' HG2' ' CE2' ' A' ' 9' ' ' TYR . 84.9 mt-10 -79.8 131.9 36.01 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.338 -0.851 . . . . 63.31 110.393 -177.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 9' ' ' TYR . . . 86.43 -12.96 59.45 Favored Glycine 0 N--CA 1.485 1.905 0 N-CA-C 108.881 -1.688 . . . . 64.34 108.881 -175.306 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.472 ' OE1' ' HD2' ' A' ' 4' ' ' LYS . 90.7 mt-10 -107.67 -70.64 0.79 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -1.128 . . . . 75.41 110.681 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.569 ' CE1' ' O ' ' A' ' 2' ' ' GLN . 13.1 m-70 -90.4 -21.14 22.09 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.244 -0.91 . . . . 74.51 109.487 179.057 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.639 ' CG ' HD21 ' A' ' 177' ' ' LEU . 51.8 p90 -158.72 171.77 19.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.579 -0.701 . . . . 52.33 110.369 174.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -124.76 153.98 41.6 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.361 -0.837 . . . . 73.01 109.472 172.906 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.908 HG22 ' CE1' ' A' ' 157' ' ' TYR . 39.6 t -103.16 134.4 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 120.962 -1.086 . . . . 73.31 110.601 -176.421 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' CB ' ' OG1' ' A' ' 14' ' ' THR . 76.7 mt -102.57 143.33 32.4 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.635 -0.666 . . . . 74.24 110.382 -176.599 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -58.74 -16.79 18.27 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.194 -0.942 . . . . 72.02 109.666 173.371 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.527 ' OG1' ' CB ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -53.15 151.76 8.81 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.359 -0.838 . . . . 74.55 110.492 -177.258 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 18.4 Cg_endo -63.04 136.17 55.1 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 124.121 1.59 . . . . 45.32 110.583 -179.064 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.951 ' HB2' ' HD2' ' A' ' 156' ' ' ARG . . . -89.65 175.11 7.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.186 -0.946 . . . . 62.43 109.993 175.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 29.1 t -99.84 140.9 33.37 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.276 -0.89 . . . . 61.05 110.18 179.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 23.3 m -56.01 -35.49 66.88 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.218 -0.926 . . . . 74.34 109.783 179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.428 ' HB2' ' NZ ' ' A' ' 52' ' ' LYS . 0.1 OUTLIER -113.41 168.39 7.87 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.295 -0.878 . . . . 74.11 109.601 175.393 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.501 ' HG2' ' HA ' ' A' ' 51' ' ' ALA . 52.7 Cg_endo -70.09 125.93 12.53 Favored 'Trans proline' 0 C--N 1.303 -1.848 0 O-C-N 123.824 1.433 . . . . 73.34 110.049 -178.819 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.43 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 9.7 p -144.87 135.08 19.36 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.761 -1.212 . . . . 74.23 109.551 171.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.59 ' CG2' HD21 ' A' ' 178' ' ' LEU . 7.0 t -117.04 129.52 73.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 O-C-N 120.972 -1.08 . . . . 63.13 109.592 -178.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.504 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 35.3 t -122.98 134.38 54.33 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.007 -1.058 . . . . 65.13 110.334 -178.532 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 1.037 ' OE1' HG22 ' A' ' 151' ' ' VAL . 74.1 mm-40 -103.53 126.3 50.6 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.395 -0.816 . . . . 74.51 110.196 178.368 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.599 ' CE1' ' CG2' ' A' ' 152' ' ' VAL . 55.3 m-85 -98.59 125.36 43.81 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.356 -0.84 . . . . 73.45 109.797 -179.377 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.509 ' HB2' ' HB3' ' A' ' 33' ' ' CYS . 55.2 p90 -143.47 167.06 23.1 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.522 -0.736 . . . . 70.32 110.99 -178.631 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.552 ' HB3' ' CE ' ' A' ' 61' ' ' MET . 11.4 t -135.35 138.23 43.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.805 . . . . 72.13 110.189 176.37 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.737 ' O ' HG21 ' A' ' 93' ' ' ILE . 95.1 m-85 -57.76 -15.27 7.56 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.032 -1.043 . . . . 73.24 110.434 176.195 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.497 ' HA ' HG21 ' A' ' 93' ' ' ILE . 85.0 m-85 -103.44 16.48 26.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.031 -1.043 . . . . 74.32 111.293 -172.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 26.6 p -132.81 110.7 13.29 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 120.847 -1.158 . . . . 34.41 110.152 179.399 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -56.84 -26.96 69.65 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.86 1.453 . . . . 74.12 110.172 -178.55 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -59.7 -51.48 69.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.093 -1.005 . . . . 75.33 110.192 178.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.882 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 21.9 m -66.86 -42.5 85.58 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.029 -1.044 . . . . 63.23 110.31 178.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 62.9 t-20 -55.15 -40.89 71.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.165 -0.959 . . . . 64.23 110.369 179.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.484 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 48.8 m -70.1 -38.57 75.68 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.162 -0.961 . . . . 63.24 110.528 178.317 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.809 ' CE2' HD11 ' A' ' 40' ' ' ILE . 35.0 t80 -68.19 -31.69 71.4 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.334 -0.853 . . . . 71.51 110.717 -175.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.536 ' CB ' ' HD3' ' A' ' 38' ' ' PRO . 1.7 mt-10 -38.69 -55.79 2.55 Favored Pre-proline 0 N--CA 1.497 1.909 0 O-C-N 121.202 -0.936 . . . . 62.11 111.015 -173.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD3' ' CB ' ' A' ' 37' ' ' GLU . 40.6 Cg_exo -47.11 -44.29 23.76 Favored 'Trans proline' 0 C--N 1.301 -1.963 0 O-C-N 123.438 1.23 . . . . 75.43 110.451 177.179 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.7 HD12 ' CD1' ' A' ' 36' ' ' PHE . 68.5 mt -63.26 -29.2 46.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.973 -1.08 . . . . 74.02 109.942 177.776 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.809 HD11 ' CE2' ' A' ' 36' ' ' PHE . 49.1 mm -65.72 -45.51 91.7 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.718 0 O-C-N 120.38 -1.45 . . . . 72.13 110.011 175.157 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.472 ' HA ' ' HD3' ' A' ' 44' ' ' LYS . . . -59.85 -42.01 92.69 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.145 -0.972 . . . . 51.33 110.051 -175.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.684 ' CD ' HD13 ' A' ' 167' ' ' LEU . 4.4 pp0? -71.03 -30.43 66.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.89 -1.131 . . . . 70.1 110.423 177.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.657 HD12 ' CD2' ' A' ' 171' ' ' PHE . 54.0 tp -65.02 -40.48 94.93 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.547 -1.346 . . . . 74.23 110.078 174.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.792 ' HA ' HD12 ' A' ' 47' ' ' LEU . 25.9 mtpp -61.5 -53.06 61.4 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.468 -0.77 . . . . 73.34 110.568 -179.595 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -60.54 -37.44 81.21 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.334 -0.854 . . . . 62.41 109.525 -179.559 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.471 ' CB ' ' CE2' ' A' ' 171' ' ' PHE . 26.9 mt-30 -76.93 -32.74 57.57 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.632 -0.668 . . . . 72.04 110.206 178.313 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD12 ' HA ' ' A' ' 44' ' ' LYS . 7.5 mt -47.22 147.26 2.65 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.315 -0.866 . . . . 64.42 110.378 -177.387 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 16.5 Cg_exo -63.31 141.81 83.3 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.973 1.512 . . . . 71.22 109.953 179.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.96 -34.75 75.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.136 -0.978 . . . . 75.11 109.814 178.051 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -62.59 -39.57 98.04 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.771 -1.332 . . . . 71.01 109.771 179.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.501 ' HA ' ' HG2' ' A' ' 20' ' ' PRO . . . -71.96 142.5 49.41 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.066 -1.255 . . . . 72.11 110.569 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 54.0 mttp -95.58 156.6 16.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.476 -0.765 . . . . 74.11 109.68 175.99 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -124.57 154.96 39.85 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.907 -1.121 . . . . 64.12 110.497 179.873 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.557 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.2 tt0 -144.55 162.15 37.33 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.292 -0.88 . . . . 74.24 110.56 -174.462 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.464 ' NZ ' ' OH ' ' A' ' 73' ' ' TYR . 39.4 mtpt -126.82 140.8 52.09 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.066 -1.021 . . . . 74.21 110.118 178.204 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.562 ' OD1' ' CE2' ' A' ' 25' ' ' PHE . 0.4 OUTLIER -135.4 136.6 41.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 65.33 110.386 -178.076 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.674 ' CE1' ' CE2' ' A' ' 136' ' ' PHE . 1.0 OUTLIER -110.27 133.4 53.28 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.16 -0.963 . . . . 75.14 109.64 -179.57 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 58' ' ' VAL . 33.6 m -102.57 130.81 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.904 -1.122 . . . . 64.32 110.352 176.757 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.456 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 59.1 p -94.65 -8.01 39.17 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.282 -0.887 . . . . 63.24 110.319 175.227 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.637 ' CE1' ' CG ' ' A' ' 61' ' ' MET . 0.3 OUTLIER -63.12 -34.51 77.75 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.815 -1.178 . . . . 61.33 110.3 -172.282 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.637 ' CG ' ' CE1' ' A' ' 60' ' ' PHE . 20.9 mtm -77.17 -33.51 56.5 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.845 -1.159 . . . . 73.12 109.984 171.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.443 ' HA2' ' CD2' ' A' ' 29' ' ' TYR . . . -56.15 -39.94 82.18 Favored Glycine 0 N--CA 1.493 2.45 0 N-CA-C 109.921 -1.272 . . . . 64.31 109.921 -176.26 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 94.76 -151.82 20.27 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.303 -1.519 . . . . 34.13 109.303 -176.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -54.08 -36.8 63.55 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.138 -1.213 . . . . 73.2 111.032 -176.872 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.469 ' HG2' ' O ' ' A' ' 65' ' ' MET . 24.0 ttt -91.78 5.64 49.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.93 -1.106 . . . . 71.21 110.793 -176.265 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.456 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -56.06 -40.9 84.21 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.399 -1.48 . . . . 72.02 109.399 179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 94.4 mt-30 -60.49 -39.5 87.9 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.092 -1.24 . . . . 62.31 110.322 179.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.454 ' HB3' ' HG2' ' A' ' 65' ' ' MET . . . -63.7 -45.95 87.66 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.092 -1.005 . . . . 45.42 110.226 179.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.64 ' CG ' ' CD1' ' A' ' 28' ' ' PHE . 29.2 tpp -59.34 -43.74 92.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.057 -1.027 . . . . 73.04 110.409 -178.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.502 ' HB2' HG13 ' A' ' 133' ' ' VAL . 20.3 m -59.67 -48.33 82.11 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.946 -1.096 . . . . 75.43 110.214 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.777 ' HG2' HG21 ' A' ' 133' ' ' VAL . 47.6 mtpt -59.89 -34.82 73.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.016 -1.053 . . . . 63.13 110.197 177.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.471 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.58 -48.4 77.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.068 -1.02 . . . . 61.33 110.43 -177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.547 ' CD1' ' CE1' ' A' ' 57' ' ' HIS . 59.4 t80 -58.59 -43.05 89.37 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 120.859 -1.15 . . . . 54.21 109.643 177.513 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.077 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -61.22 -38.84 88.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.835 -1.165 . . . . 72.31 109.665 176.919 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.746 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.91 -43.38 81.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.162 -0.961 . . . . 62.21 109.587 175.219 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.633 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 64.5 mtt -52.73 -42.82 65.24 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.165 -0.959 . . . . 71.04 108.903 176.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.953 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.9 mt -61.39 -46.93 95.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 120.018 -0.673 . . . . 73.32 110.426 -176.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.527 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -60.91 -30.93 70.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.834 -1.167 . . . . 75.32 109.758 173.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.035 ' O ' HG13 ' A' ' 81' ' ' VAL . 4.7 tp -93.62 9.66 35.91 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.477 -0.764 . . . . 54.3 110.577 -176.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 49.2 34.1 5.73 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.131 -0.981 . . . . 73.12 110.581 179.422 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.035 HG13 ' O ' ' A' ' 79' ' ' LEU . 16.5 m -123.18 8.7 5.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.183 -0.948 . . . . 73.32 110.96 -179.078 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.595 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.8 mp0 -43.26 -73.01 0.05 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.976 -1.078 . . . . 71.25 110.051 -177.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 -53.54 -36.4 61.79 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.845 -1.159 . . . . 73.11 110.736 -179.398 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 16.3 tttt -58.74 -43.12 90.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.011 -1.056 . . . . 73.02 111.362 -170.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.702 ' HA ' HG23 ' A' ' 88' ' ' VAL . 3.4 ppp? -126.19 -3.16 6.93 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.033 -1.042 . . . . 64.51 110.751 -175.817 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 82' ' ' GLU . 2.0 t -51.25 -44.72 88.71 Favored Pre-proline 0 C--N 1.299 -1.622 0 O-C-N 120.76 -1.213 . . . . 74.4 109.173 179.834 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 11.4 Cg_exo -65.28 -22.97 59.87 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.382 1.201 . . . . 74.12 110.703 175.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.731 HG11 ' CD ' ' A' ' 113' ' ' GLU . 60.9 t -65.73 -41.84 91.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 120.838 -1.164 . . . . 63.33 109.511 178.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.799 ' HE1' HD11 ' A' ' 106' ' ' LEU . 26.8 mtp -65.25 -43.11 92.4 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.055 -1.058 . . . . 74.03 109.938 177.232 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.684 ' CE1' ' CD2' ' A' ' 28' ' ' PHE . 24.0 m-85 -67.11 -41.25 86.54 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.693 -1.254 . . . . 75.45 110.463 178.353 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.53 ' O ' ' HB ' ' A' ' 95' ' ' THR . 39.5 t30 -57.32 -54.57 45.26 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.027 -1.046 . . . . 74.35 109.412 172.652 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.791 ' HA ' HD12 ' A' ' 96' ' ' LEU . 50.8 ttm-85 -51.45 -35.37 39.36 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.374 -0.829 . . . . 75.14 110.356 -177.005 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.737 HG21 ' O ' ' A' ' 28' ' ' PHE . 4.1 mm -80.19 -63.13 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.207 -0.933 . . . . 72.45 110.894 177.333 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 72.5 t60 -75.85 -11.47 59.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.134 -0.978 . . . . 72.44 111.23 -171.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.53 ' HB ' ' O ' ' A' ' 91' ' ' ASN . 1.4 m -122.81 -66.12 1.05 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.837 -1.165 . . . . 71.11 110.489 -176.899 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.791 HD12 ' HA ' ' A' ' 92' ' ' ARG . 64.5 mt -62.29 -24.98 67.6 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.018 -1.051 . . . . 74.4 109.624 177.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LEU . 82.6 mtm180 58.31 33.08 22.81 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.458 -0.776 . . . . 74.14 109.9 -175.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -127.66 70.58 77.05 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.216 -0.928 . . . . 74.35 110.103 177.732 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.507 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . 19.4 Cg_exo -61.64 145.48 97.54 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.006 1.53 . . . . 71.45 110.23 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.477 ' CB ' HD13 ' A' ' 106' ' ' LEU . 11.5 Cg_endo -60.62 137.27 72.38 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.11 1.584 . . . . 74.43 109.973 178.867 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.524 ' CE ' ' OE2' ' A' ' 105' ' ' GLU . 7.0 pttp -104.51 -28.7 11.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.187 -0.946 . . . . 72.31 110.142 -179.021 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.454 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 76.3 m-20 -142.48 172.06 13.2 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.325 -0.859 . . . . 74.51 109.88 -179.139 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -57.15 -29.92 64.01 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.103 -0.998 . . . . 71.33 109.408 174.083 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -58.54 -59.75 4.89 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 74.55 111.208 179.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.524 ' OE2' ' CE ' ' A' ' 101' ' ' LYS . 94.9 mt-10 -67.05 -37.12 83.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.882 -1.137 . . . . 65.14 110.163 -177.676 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.017 ' HA ' HD12 ' A' ' 109' ' ' ILE . 13.7 tp -57.73 -41.99 82.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.264 -0.898 . . . . 54.15 109.704 178.794 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.724 ' NH2' ' HB1' ' A' ' 117' ' ' ALA . 75.9 ttt180 -62.09 -46.01 90.96 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.066 -1.022 . . . . 71.3 110.32 176.69 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.6 tp60 -57.56 -40.15 78.29 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.039 -1.038 . . . . 71.4 110.334 179.996 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.017 HD12 ' HA ' ' A' ' 106' ' ' LEU . 69.2 mt -54.3 -48.71 67.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.173 -0.954 . . . . 73.2 109.763 179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.609 ' CE2' ' CE1' ' A' ' 120' ' ' PHE . 16.2 m-85 -56.11 -50.35 71.33 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.139 -0.976 . . . . 53.42 110.572 177.081 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.871 HD11 ' HB2' ' A' ' 117' ' ' ALA . 30.2 mt -64.98 -36.36 84.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.873 -1.142 . . . . 73.51 110.462 -175.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -57.54 -39.46 76.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.932 -1.105 . . . . 73.05 110.119 175.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.731 ' CD ' HG11 ' A' ' 88' ' ' VAL . 72.4 mm-40 -69.44 -2.86 12.23 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.265 -0.897 . . . . 73.24 110.977 -177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 103.12 10.52 36.49 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.934 -1.267 . . . . 72.31 109.934 -179.988 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.521 ' CG2' ' HD2' ' A' ' 119' ' ' LYS . 78.3 mt -95.54 159.83 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.07 -1.253 . . . . 54.14 110.176 179.214 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.511 ' HB2' ' HG2' ' A' ' 119' ' ' LYS . 0.3 OUTLIER -95.38 141.38 29.02 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.0 -1.062 . . . . 71.24 110.493 -176.992 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.871 ' HB2' HD11 ' A' ' 111' ' ' LEU . . . -65.21 -31.11 72.12 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.029 -1.044 . . . . 52.22 109.694 175.267 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.42 -51.6 62.34 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.334 -0.854 . . . . 63.11 110.77 179.734 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.681 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -73.27 -37.55 66.25 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 120.945 -1.097 . . . . 72.34 110.481 -176.74 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.746 ' CE1' HG21 ' A' ' 75' ' ' THR . 81.8 t80 -63.12 -40.76 98.56 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.944 -1.098 . . . . 70.24 109.836 176.288 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.448 ' O ' ' OD1' ' A' ' 125' ' ' ASN . 56.0 t0 -57.16 -42.97 82.07 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.149 -0.969 . . . . 64.24 109.446 178.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -60.79 -40.79 93.95 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.11 -0.994 . . . . 73.33 110.194 177.293 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.619 ' HB2' HD13 ' A' ' 79' ' ' LEU . . . -70.82 -44.96 65.46 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.221 -0.924 . . . . 73.34 110.96 -176.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.667 ' N ' HG23 ' A' ' 75' ' ' THR . 74.2 t80 -58.66 -32.32 68.99 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.14 -0.975 . . . . 72.34 109.647 178.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 21.7 m120 -84.55 8.09 17.84 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.339 -0.851 . . . . 74.35 110.058 179.759 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -73.04 126.78 10.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.87 -1.292 . . . . 43.32 109.87 -177.618 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -56.12 -37.89 70.05 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.121 -1.223 . . . . 74.21 109.6 175.009 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . . . . . . . . . . . -57.98 -42.89 86.06 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.15 -0.968 . . . . 33.5 110.289 179.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.077 HG13 ' HB3' ' A' ' 74' ' ' ALA . 37.5 t -57.37 -48.43 82.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 120.784 -1.198 . . . . 73.13 110.077 178.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.92 -40.63 76.69 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 70.34 110.06 -178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . 0.529 ' HA ' ' NE ' ' A' ' 134' ' ' ARG . 22.8 t -62.15 -34.78 77.04 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.27 -0.894 . . . . 71.13 110.565 179.458 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.895 ' HE3' ' HA ' ' A' ' 129' ' ' VAL . 68.1 mtm -71.97 -41.41 67.72 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.894 -1.129 . . . . 73.34 110.218 -178.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.777 HG21 ' HG2' ' A' ' 71' ' ' LYS . 86.1 t -63.5 -46.02 96.24 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.305 -0.872 . . . . 63.44 110.613 -179.099 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.529 ' NE ' ' HA ' ' A' ' 131' ' ' SER . 36.4 ptt180 -64.94 -43.94 91.08 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.925 -1.109 . . . . 75.14 110.279 -178.128 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.523 ' O ' ' CG ' ' A' ' 139' ' ' GLN . 6.2 mtt180 -57.1 -46.66 82.41 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.055 -1.028 . . . . 74.12 110.561 178.786 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.674 ' CE2' ' CE1' ' A' ' 57' ' ' HIS . 18.5 m-30 -59.57 -48.47 81.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.962 -1.086 . . . . 65.44 110.594 -176.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.5 -46.38 83.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.925 -1.109 . . . . 73.15 110.237 -178.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 21.0 tttm -62.4 -39.99 95.05 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.052 -1.03 . . . . 71.52 110.323 178.815 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.523 ' CG ' ' O ' ' A' ' 135' ' ' ARG . 6.8 mm-40 -58.37 -45.91 87.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.077 -1.015 . . . . 72.23 110.15 -177.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.576 ' CZ ' ' O ' ' A' ' 145' ' ' LEU . 65.8 t80 -61.86 -42.23 98.8 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.388 -0.82 . . . . 75.42 110.244 178.667 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -62.05 -52.0 65.71 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.618 -0.676 . . . . 74.43 110.667 179.575 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.527 ' O ' ' CG2' ' A' ' 14' ' ' THR . 90.2 m-20 -61.66 -38.13 86.62 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.227 -0.921 . . . . 62.21 110.453 -178.697 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.602 ' OG ' HD12 ' A' ' 145' ' ' LEU . 85.3 p -65.16 -23.85 67.23 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.422 -0.799 . . . . 73.33 110.285 -177.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.81 29.24 67.61 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.889 -1.684 . . . . 73.22 108.889 -174.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 158' ' ' LEU . 32.5 mt -75.16 128.35 35.29 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.307 -1.113 . . . . 72.43 110.297 -178.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 46.7 m -64.15 -36.34 83.73 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.106 -0.996 . . . . 51.32 109.479 173.283 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.597 ' HA2' ' CE1' ' A' ' 60' ' ' PHE . . . 179.42 -174.09 45.94 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.735 -1.346 . . . . 51.2 109.735 177.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.6 m -108.88 162.99 18.0 Favored Pre-proline 0 N--CA 1.493 1.681 0 O-C-N 121.394 -1.062 . . . . 72.02 109.306 178.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.569 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 5.9 Cg_exo -73.06 132.26 25.86 Favored 'Cis proline' 0 N--CA 1.488 1.202 0 C-N-CA 122.674 -1.803 . . . . 63.12 111.504 9.123 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.964 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -132.23 130.6 41.18 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 41.13 109.54 173.67 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.037 HG22 ' OE1' ' A' ' 24' ' ' GLU . 28.5 t -108.48 129.22 63.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 120.924 -1.11 . . . . 63.4 109.977 -178.133 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 10.8 t -116.21 130.48 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.126 -0.984 . . . . 64.33 110.022 179.542 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.95 HG11 ' HB2' ' A' ' 177' ' ' LEU . 33.9 t -109.69 132.69 57.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.337 -0.852 . . . . 43.32 109.742 179.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.562 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 14.4 m-20 46.68 32.47 1.72 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.208 -0.933 . . . . 75.34 110.317 -175.0 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.485 ' ND2' ' O ' ' A' ' 15' ' ' PRO . 1.8 t30 49.09 29.8 2.64 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.255 -0.903 . . . . 72.14 110.983 172.679 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.951 ' HD2' ' HB2' ' A' ' 16' ' ' ALA . 72.6 ttt180 -152.38 -23.73 0.17 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.822 -1.173 . . . . 73.44 111.145 -178.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.908 ' CE1' HG22 ' A' ' 11' ' ' VAL . 60.7 m-85 -107.96 139.38 42.66 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.554 -1.341 . . . . 62.33 109.99 173.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.981 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.68 124.73 50.99 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.3 -0.875 . . . . 64.4 108.982 178.833 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.728 HG22 ' CD1' ' A' ' 177' ' ' LEU . 95.2 t -80.98 118.69 29.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.343 -0.848 . . . . 73.54 110.333 -174.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.489 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 94.5 mt-30 -80.99 -53.86 6.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.269 -0.894 . . . . 65.2 109.489 173.503 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . 0.433 ' HA3' ' CD1' ' A' ' 170' ' ' TYR . . . 68.51 5.18 42.43 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.102 -1.199 . . . . 73.33 110.102 175.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -62.61 -40.33 96.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.063 -1.257 . . . . 73.53 110.124 -179.877 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.4 m -64.33 -31.73 73.05 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.361 -0.837 . . . . 60.01 110.383 178.688 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.458 ' HA ' ' OE1' ' A' ' 169' ' ' GLU . . . -79.53 111.24 15.61 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.118 -0.988 . . . . 74.42 110.846 -174.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 4.6 mtmp? -90.06 -7.06 54.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.249 -0.907 . . . . 52.44 109.868 173.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 29.4 t -134.99 147.3 49.68 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.34 -0.85 . . . . 74.23 109.834 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.684 HD13 ' CD ' ' A' ' 42' ' ' GLN . 39.1 mt -52.5 -29.7 26.39 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.984 -1.072 . . . . 62.32 111.041 -176.783 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.427 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.1 m-20 -56.71 -40.75 76.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.666 -1.271 . . . . 63.42 110.366 -178.91 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.458 ' OE1' ' HA ' ' A' ' 164' ' ' ALA . 84.1 tt0 -81.44 -41.84 21.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.834 -1.166 . . . . 70.35 110.668 179.203 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 0.706 ' OH ' HG21 ' A' ' 151' ' ' VAL . 69.9 t80 -62.2 -45.65 92.4 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.942 -1.099 . . . . 75.2 109.738 177.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.657 ' CD2' HD12 ' A' ' 43' ' ' LEU . 60.1 t80 -59.19 -46.98 87.01 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.393 -0.817 . . . . 73.33 110.258 176.171 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.566 ' O ' ' CD2' ' A' ' 176' ' ' TYR . 90.9 m-20 -55.78 -43.48 76.82 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.192 -0.942 . . . . 62.04 110.532 -178.118 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.642 ' CD2' HG13 ' A' ' 159' ' ' VAL . 5.6 tp -54.34 -54.24 43.06 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.734 -1.229 . . . . 73.13 110.147 175.735 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . . . . . . . . . 56.0 t -52.71 -44.64 47.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.093 -1.004 . . . . 74.22 109.861 -178.164 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.696 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.7 m-80 -58.16 -42.25 85.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.206 -0.934 . . . . 73.11 110.789 179.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' CD2' ' O ' ' A' ' 172' ' ' ASP . 56.0 m-85 -66.86 -43.34 83.83 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.929 -1.107 . . . . 71.34 110.221 -179.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.955 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.7 mt -57.39 -38.18 73.85 Favored 'General case' 0 N--CA 1.487 1.388 0 O-C-N 121.196 -0.94 . . . . 71.12 109.536 177.117 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.696 HD12 ' HA ' ' A' ' 175' ' ' ASN . 9.5 mt -61.49 -30.02 70.34 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.271 -0.893 . . . . 74.22 109.955 174.393 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.598 HG23 ' O ' ' A' ' 175' ' ' ASN . 55.9 p -93.58 -14.71 26.21 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.325 -0.86 . . . . 72.4 110.163 -178.852 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.955 HD12 ' HA ' ' A' ' 177' ' ' LEU . 48.1 mt -73.79 -33.54 64.27 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.259 -0.901 . . . . 72.13 110.462 179.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 180' ' ' LEU . 46.3 tttt . . . . . 0 N--CA 1.493 1.702 0 CA-C-O 117.951 -1.023 . . . . 62.05 110.464 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.527 ' O ' ' CE ' ' A' ' 4' ' ' LYS . . . . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.337 0.589 . . . . 71.14 110.226 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.554 ' O ' ' CE1' ' A' ' 8' ' ' HIS . 60.6 tt0 -58.36 -33.5 69.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.282 -0.886 . . . . 70.15 110.369 179.714 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PHE . . . . . 0.659 ' CD1' ' CE2' ' A' ' 176' ' ' TYR . 80.4 m-85 -100.22 131.53 46.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.199 -0.938 . . . . 73.02 110.242 -177.678 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.527 ' CE ' ' O ' ' A' ' 1' ' ' ALA . 9.5 mmtt -135.62 154.8 51.2 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 73.24 110.251 -179.205 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.585 ' CA ' ' CZ ' ' A' ' 9' ' ' TYR . 83.2 tt0 -70.72 135.14 48.06 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.203 -0.935 . . . . 63.31 110.128 176.395 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.85 -9.0 68.34 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.54 -1.424 . . . . 64.34 109.54 -179.084 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -129.17 -54.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.178 -1.189 . . . . 75.41 110.368 179.522 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.583 ' CG ' ' HA ' ' A' ' 3' ' ' PHE . 25.1 m-70 -93.31 -20.88 19.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.229 -0.919 . . . . 74.51 109.733 177.902 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.655 ' CG ' HD21 ' A' ' 177' ' ' LEU . 53.5 p90 -157.96 172.97 17.48 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.544 -0.723 . . . . 52.33 110.495 177.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -128.21 155.83 43.9 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.492 -0.755 . . . . 73.01 109.78 175.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.525 ' CG2' ' OE2' ' A' ' 5' ' ' GLU . 69.6 t -102.73 134.84 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 120.98 -1.075 . . . . 73.31 110.645 -179.532 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.65 HD11 HD23 ' A' ' 158' ' ' LEU . 78.7 mt -103.47 144.66 31.11 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.688 -0.633 . . . . 74.24 110.281 -177.511 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -55.25 -20.32 10.71 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.084 -1.01 . . . . 72.02 109.683 174.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.535 HG22 ' HB2' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -50.39 150.9 4.22 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.319 -0.863 . . . . 74.55 110.488 -176.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.459 ' O ' ' ND2' ' A' ' 155' ' ' ASN . 19.4 Cg_endo -63.41 141.0 79.34 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.184 1.623 . . . . 45.32 110.485 179.311 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.874 ' HB2' ' CD ' ' A' ' 156' ' ' ARG . . . -99.31 168.76 9.82 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 62.43 109.983 177.271 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 49.7 m -99.54 144.57 28.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.072 -1.017 . . . . 61.05 110.29 -178.514 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.6 p -62.52 -29.35 70.49 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.367 -0.833 . . . . 74.34 110.11 -179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.403 ' HB3' ' HD2' ' A' ' 20' ' ' PRO . 0.8 OUTLIER -113.48 170.88 4.84 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.351 -0.843 . . . . 74.11 109.788 177.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' PRO . . . . . 0.589 ' HB2' HD22 ' A' ' 178' ' ' LEU . 57.9 Cg_endo -71.81 122.8 8.83 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.881 1.464 . . . . 73.34 110.035 -179.068 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 7.3 p -144.07 137.68 23.98 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.814 -1.179 . . . . 74.23 109.988 172.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.537 ' O ' ' N ' ' A' ' 54' ' ' GLN . 11.3 t -118.65 127.19 75.64 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 O-C-N 121.231 -0.918 . . . . 63.13 109.635 -179.593 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' GLN . 88.2 p -117.26 134.75 54.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.961 -1.087 . . . . 65.13 110.188 -179.478 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.858 ' CD ' HG21 ' A' ' 40' ' ' ILE . 81.8 tt0 -102.04 129.09 48.27 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -0.86 . . . . 74.51 110.059 176.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.535 ' CE2' ' CG ' ' A' ' 56' ' ' ASN . 67.6 m-85 -100.53 125.3 46.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.164 -0.96 . . . . 73.45 109.785 176.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.419 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 55.1 p90 -144.18 165.58 27.45 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.802 -0.561 . . . . 70.32 110.617 -178.201 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . 0.587 ' CB ' ' CE ' ' A' ' 61' ' ' MET . 22.7 t -135.7 135.69 40.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.259 -0.901 . . . . 72.13 110.398 177.082 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.765 ' O ' HG21 ' A' ' 93' ' ' ILE . 97.3 m-85 -57.37 -24.38 54.94 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.033 -1.042 . . . . 73.24 110.325 175.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.564 ' CE2' ' SD ' ' A' ' 69' ' ' MET . 0.4 OUTLIER -89.67 13.97 12.85 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 74.32 111.152 -173.438 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 31' ' ' PRO . 36.7 t -126.67 89.91 51.0 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 120.836 -1.165 . . . . 34.41 110.079 -178.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.452 ' HD2' ' HA ' ' A' ' 30' ' ' CYS . 9.5 Cg_endo -55.38 -44.03 52.67 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.103 1.58 . . . . 74.12 110.347 -176.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -60.38 -45.91 91.86 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.983 -1.073 . . . . 75.33 109.929 176.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.459 ' SG ' ' O ' ' A' ' 148' ' ' VAL . 24.7 m -62.3 -41.06 98.19 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.106 -0.996 . . . . 63.23 109.879 177.481 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.472 ' O ' ' HB2' ' A' ' 37' ' ' GLU . 49.2 t30 -56.08 -40.96 74.39 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.176 -0.953 . . . . 64.23 110.439 178.669 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.457 ' O ' ' HD2' ' A' ' 38' ' ' PRO . 45.5 m -60.64 -42.02 96.07 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.171 -0.955 . . . . 63.24 110.16 178.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.748 ' HE2' HD11 ' A' ' 40' ' ' ILE . 71.1 t80 -65.83 -38.06 87.87 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.236 -0.915 . . . . 71.51 110.528 179.639 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 7.1 mt-10 -41.44 -55.02 5.78 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.104 -0.998 . . . . 62.11 110.593 -175.556 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' GLU . 51.7 Cg_exo -43.48 -48.63 8.32 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.657 1.346 . . . . 75.43 110.432 177.377 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.452 ' O ' ' HB2' ' A' ' 42' ' ' GLN . 81.4 mt -54.64 -46.64 73.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 120.937 -1.102 . . . . 74.02 110.093 177.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.858 HG21 ' CD ' ' A' ' 24' ' ' GLU . 32.1 mm -55.08 -41.54 60.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 120.912 -1.117 . . . . 72.13 110.046 176.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 38' ' ' PRO . . . -57.64 -38.66 75.41 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.012 -1.055 . . . . 51.33 109.613 176.581 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.485 ' HG3' ' O ' ' A' ' 38' ' ' PRO . 19.0 mt-30 -57.91 -40.74 81.1 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.295 -0.878 . . . . 70.1 109.34 176.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.731 HD12 ' CD2' ' A' ' 171' ' ' PHE . 48.1 tp -63.88 -38.62 91.78 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.259 -0.9 . . . . 74.23 110.294 175.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.767 ' HA ' HD12 ' A' ' 47' ' ' LEU . 45.9 mttt -56.11 -50.67 70.42 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.351 -0.843 . . . . 73.34 110.368 -177.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLN . . . . . 0.532 ' HG3' ' N ' ' A' ' 46' ' ' GLN . 22.6 pt20 -69.63 -35.51 75.31 Favored 'General case' 0 N--CA 1.49 1.531 0 C-N-CA 119.62 -0.832 . . . . 62.41 109.514 179.783 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.592 ' HB3' ' CE2' ' A' ' 171' ' ' PHE . 27.7 mt-30 -72.27 -33.13 67.25 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.578 -0.701 . . . . 72.04 110.383 178.014 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.767 HD12 ' HA ' ' A' ' 44' ' ' LYS . 10.9 mt -49.41 147.36 5.7 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.355 -0.841 . . . . 64.42 110.335 -176.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 47' ' ' LEU . 17.3 Cg_exo -62.41 142.44 90.71 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.916 1.482 . . . . 71.22 110.052 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -57.07 -35.64 69.6 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.196 -0.94 . . . . 75.11 109.83 178.181 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -61.59 -39.02 96.8 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.779 -1.329 . . . . 71.01 109.779 179.291 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -71.78 143.15 49.65 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.068 -1.254 . . . . 72.11 110.51 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 21' ' ' VAL . 11.1 mmtp -99.16 154.52 18.07 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.802 . . . . 74.11 109.628 175.316 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.574 ' CZ ' ' HE2' ' A' ' 44' ' ' LYS . 50.7 t80 -122.1 159.74 26.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.784 -1.197 . . . . 64.12 110.639 178.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.537 ' N ' ' O ' ' A' ' 22' ' ' VAL . 63.6 tt0 -146.36 161.29 40.68 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.458 -0.776 . . . . 74.24 110.182 -175.189 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LYS . . . . . 0.535 ' O ' ' CE1' ' A' ' 136' ' ' PHE . 26.9 mttp -124.29 143.14 50.73 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.1 -1.0 . . . . 74.21 110.567 -178.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 136' ' ' PHE . 0.6 OUTLIER -137.36 141.84 41.78 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.434 -0.791 . . . . 65.33 110.142 179.364 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' HIS . . . . . 0.691 ' CE1' ' CD2' ' A' ' 136' ' ' PHE . 3.0 p-80 -118.92 136.59 53.98 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.837 -1.164 . . . . 75.14 110.184 175.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 58' ' ' VAL . 34.2 m -102.85 132.15 49.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.259 -0.901 . . . . 64.32 110.522 -178.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' SER . . . . . 0.443 ' HB2' ' C ' ' A' ' 66' ' ' GLY . 82.9 p -93.89 -9.4 37.33 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.275 -0.89 . . . . 63.24 110.347 174.649 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.619 ' CE2' ' HG3' ' A' ' 61' ' ' MET . 0.2 OUTLIER -62.72 -39.32 93.67 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.867 -1.146 . . . . 61.33 110.431 -173.179 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' MET . . . . . 0.619 ' HG3' ' CE2' ' A' ' 60' ' ' PHE . 54.7 mtm -72.33 -35.12 68.51 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.807 -1.183 . . . . 73.12 110.16 172.707 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -55.28 -40.01 74.11 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.908 -1.277 . . . . 64.31 109.908 -175.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.45 -153.24 20.41 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.413 -1.475 . . . . 34.13 109.413 -177.528 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 86.8 m-20 -54.16 -37.23 64.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.111 -1.229 . . . . 73.2 110.996 -176.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' MET . . . . . 0.475 ' HG2' ' O ' ' A' ' 65' ' ' MET . 25.4 ttt -91.07 3.74 53.95 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.982 -1.073 . . . . 71.21 110.606 -177.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.443 ' C ' ' HB2' ' A' ' 59' ' ' SER . . . -58.47 -41.29 95.26 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.39 -1.484 . . . . 72.02 109.39 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -58.07 -40.4 80.92 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.14 -1.212 . . . . 62.31 110.276 179.581 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.58 -48.27 75.59 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.037 -1.039 . . . . 45.42 110.395 -179.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' MET . . . . . 0.564 ' SD ' ' CE2' ' A' ' 29' ' ' TYR . 82.3 mtp -60.41 -41.95 94.97 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.978 -1.076 . . . . 73.04 110.522 -177.865 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.573 ' HB3' ' CD2' ' A' ' 57' ' ' HIS . 49.2 m -60.18 -45.17 94.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.975 -1.078 . . . . 75.43 109.924 177.34 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.579 ' HD3' ' CZ ' ' A' ' 124' ' ' TYR . 15.9 tttt -59.79 -35.28 74.33 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.172 -0.955 . . . . 63.13 109.829 177.385 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.483 ' O ' ' HB ' ' A' ' 75' ' ' THR . . . -63.37 -45.34 91.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.306 -0.871 . . . . 61.33 110.266 -179.104 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.469 ' HA ' ' SD ' ' A' ' 76' ' ' MET . 88.5 t80 -57.55 -43.22 84.26 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.743 -1.223 . . . . 54.21 109.653 176.62 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.043 ' HB3' HG13 ' A' ' 129' ' ' VAL . . . -62.12 -38.7 89.94 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.906 -1.121 . . . . 72.31 109.812 176.167 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.682 HG21 ' CE1' ' A' ' 120' ' ' PHE . 30.3 m -56.55 -43.62 80.1 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.12 -0.988 . . . . 62.21 109.673 175.485 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' MET . . . . . 0.61 ' HE2' ' SD ' ' A' ' 85' ' ' MET . 63.2 mtt -52.73 -43.69 65.87 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.137 -0.977 . . . . 71.04 109.1 176.531 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.909 HD12 ' HA ' ' A' ' 74' ' ' ALA . 78.7 mt -62.18 -45.8 97.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 C-N-CA 119.852 -0.739 . . . . 73.32 110.286 -175.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.543 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . . . -61.83 -29.18 70.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.763 -1.211 . . . . 75.32 109.55 172.211 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 1.018 ' O ' HG13 ' A' ' 81' ' ' VAL . 3.7 tp -90.15 3.43 53.42 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.605 -0.685 . . . . 54.3 110.639 -176.326 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 52.2 31.24 8.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.027 -1.045 . . . . 73.12 110.339 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.018 HG13 ' O ' ' A' ' 79' ' ' LEU . 14.8 m -124.46 10.45 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.252 -0.905 . . . . 73.32 111.152 -177.618 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.572 ' O ' HG23 ' A' ' 86' ' ' VAL . 1.7 mp0 -42.94 -72.31 0.06 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.937 -1.102 . . . . 71.25 110.0 -178.158 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -52.42 -38.41 59.04 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 120.85 -1.156 . . . . 73.11 110.836 179.688 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 15.5 tttp -59.56 -43.89 93.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.998 -1.064 . . . . 73.02 111.453 -169.052 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . 0.686 ' HA ' HG23 ' A' ' 88' ' ' VAL . 5.6 ppp? -126.54 0.5 6.88 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.95 -1.094 . . . . 64.51 110.982 -176.039 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.573 ' N ' ' CD ' ' A' ' 87' ' ' PRO . 2.0 t -52.13 -45.09 93.9 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 120.617 -1.302 . . . . 74.4 109.02 177.06 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' N ' ' A' ' 86' ' ' VAL . 16.3 Cg_exo -61.78 -24.23 77.15 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.382 1.201 . . . . 74.12 110.658 175.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' VAL . . . . . 0.774 HG11 ' CG ' ' A' ' 113' ' ' GLU . 60.0 t -65.84 -43.47 93.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.823 -1.173 . . . . 63.33 109.646 179.321 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' MET . . . . . 0.647 ' CE ' HD11 ' A' ' 106' ' ' LEU . 16.2 mtp -60.52 -41.82 95.17 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 118.905 -1.118 . . . . 74.03 109.573 177.26 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.686 ' CE1' ' CD1' ' A' ' 28' ' ' PHE . 23.7 m-85 -68.57 -44.51 74.26 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.821 -1.174 . . . . 75.45 110.657 177.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASN . . . . . 0.505 ' O ' ' HB ' ' A' ' 95' ' ' THR . 40.9 t30 -58.71 -50.59 73.32 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.096 -1.002 . . . . 74.35 109.784 176.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.857 ' HA ' HD12 ' A' ' 96' ' ' LEU . 24.7 tpt180 -50.66 -36.1 34.03 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.336 -0.852 . . . . 75.14 109.364 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.765 HG21 ' O ' ' A' ' 28' ' ' PHE . 2.2 mm -87.48 -67.79 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.453 -0.779 . . . . 72.45 110.592 177.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.442 ' N ' ' O ' ' A' ' 90' ' ' PHE . 84.8 t60 -62.07 -21.66 65.13 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.308 -0.87 . . . . 72.44 111.12 -173.295 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.555 HG22 ' N ' ' A' ' 96' ' ' LEU . 1.3 m -117.02 -71.04 0.76 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.974 -1.079 . . . . 71.11 110.308 -174.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.857 HD12 ' HA ' ' A' ' 92' ' ' ARG . 38.2 mt -60.7 -24.07 65.35 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.209 -0.932 . . . . 74.4 109.999 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . 0.469 ' HG3' ' O ' ' A' ' 95' ' ' THR . 92.8 mtt-85 58.04 32.84 22.51 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.406 -0.809 . . . . 74.14 110.053 -177.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.499 ' O ' ' NE ' ' A' ' 92' ' ' ARG . 0.1 OUTLIER -124.52 74.23 61.82 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.359 -0.838 . . . . 74.35 110.035 178.122 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' CB ' ' CE1' ' A' ' 29' ' ' TYR . 12.5 Cg_endo -61.26 147.02 96.69 Favored 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.889 1.468 . . . . 71.45 110.154 -179.753 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' PRO . . . . . 0.736 ' HG3' HD13 ' A' ' 106' ' ' LEU . 8.0 Cg_endo -55.3 114.47 1.89 Allowed 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.976 1.514 . . . . 74.43 110.19 -179.206 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HB3' ' HG3' ' A' ' 105' ' ' GLU . 13.5 tptt -60.23 -45.69 92.37 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.448 -0.783 . . . . 72.31 110.518 179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 101' ' ' LYS . 79.1 m-20 -144.64 -169.33 3.13 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.448 -0.782 . . . . 74.51 109.752 -178.273 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -60.15 -31.16 69.83 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.957 -1.089 . . . . 71.33 109.552 170.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 51.7 tt0 -63.63 -56.71 13.69 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.228 -0.92 . . . . 74.55 111.105 -178.763 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' GLU . . . . . 0.469 ' HG3' ' HB3' ' A' ' 101' ' ' LYS . 75.5 mm-40 -64.5 -38.11 89.89 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.749 -1.219 . . . . 65.14 109.746 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 1.016 ' HA ' HD12 ' A' ' 109' ' ' ILE . 8.9 tp -58.07 -43.64 87.08 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.394 -0.816 . . . . 54.15 109.991 178.139 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 58.3 ttp180 -60.21 -45.51 92.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.033 -1.042 . . . . 71.3 110.411 178.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' GLN . . . . . . . . . . . . . 61.4 tp60 -58.0 -40.29 80.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.061 -1.025 . . . . 71.4 110.236 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.016 HD12 ' HA ' ' A' ' 106' ' ' LEU . 63.9 mt -54.6 -49.61 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.107 -0.996 . . . . 73.2 110.05 -179.464 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.557 ' CD2' ' CE1' ' A' ' 120' ' ' PHE . 37.9 m-85 -58.26 -50.86 72.11 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.042 -1.036 . . . . 53.42 110.511 178.472 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.832 HD21 ' HA ' ' A' ' 117' ' ' ALA . 89.4 mt -60.16 -39.96 88.24 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.007 -1.058 . . . . 73.51 110.278 -177.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ASP . . . . . . . . . . . . . 91.1 m-20 -58.01 -38.66 76.57 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.056 -1.027 . . . . 73.05 110.518 178.14 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.774 ' CG ' HG11 ' A' ' 88' ' ' VAL . 72.3 mm-40 -70.0 -0.39 7.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.201 -0.937 . . . . 73.24 111.293 -176.179 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 102.65 5.73 47.8 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.429 -1.468 . . . . 72.31 109.429 -176.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' ILE . . . . . 0.506 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 28.8 mm -78.83 146.3 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.417 0 O-C-N 121.172 -1.193 . . . . 54.14 109.532 176.709 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . 0.559 ' CB ' ' HG2' ' A' ' 119' ' ' LYS . 1.0 OUTLIER -84.97 140.0 31.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.92 -1.112 . . . . 71.24 109.575 175.692 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.832 ' HA ' HD21 ' A' ' 111' ' ' LEU . . . -62.78 -33.24 74.78 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.76 -1.213 . . . . 52.22 109.079 175.823 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ALA . . . . . . . . . . . . . . . -64.4 -49.62 70.86 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.402 -0.811 . . . . 63.11 111.119 -179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.697 ' HD3' HD11 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -76.02 -35.03 59.67 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.663 -1.273 . . . . 72.34 110.53 -175.615 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' PHE . . . . . 0.682 ' CE1' HG21 ' A' ' 75' ' ' THR . 70.0 t80 -63.4 -40.01 96.05 Favored 'General case' 0 C--N 1.301 -1.541 0 O-C-N 120.863 -1.148 . . . . 70.24 109.873 175.953 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' CG ' ' O ' ' A' ' 117' ' ' ALA . 92.3 m-20 -60.57 -43.02 97.76 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.17 -0.956 . . . . 64.24 109.668 177.661 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.474 ' O ' ' OD1' ' A' ' 125' ' ' ASN . . . -60.02 -35.67 75.58 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.249 -0.907 . . . . 73.33 110.145 177.768 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.543 ' HB1' ' HB3' ' A' ' 78' ' ' ALA . . . -80.64 -44.43 18.86 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.147 -0.971 . . . . 73.34 110.927 -175.763 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' TYR . . . . . 0.599 ' N ' HG23 ' A' ' 75' ' ' THR . 77.7 t80 -61.2 -30.54 70.48 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.138 -0.976 . . . . 72.34 109.969 -178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' ASN . . . . . 0.474 ' OD1' ' O ' ' A' ' 122' ' ' ALA . 32.0 p-10 -98.66 9.58 42.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.169 -0.957 . . . . 74.35 110.187 -179.623 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.88 133.36 20.72 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.591 -1.404 . . . . 43.32 109.591 -179.543 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -57.01 -36.02 69.91 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.077 -1.249 . . . . 74.21 109.849 177.702 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ALA . . . . . 0.456 ' O ' ' SD ' ' A' ' 132' ' ' MET . . . -59.64 -48.59 81.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.122 -0.987 . . . . 33.5 110.364 -179.674 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' VAL . . . . . 1.043 HG13 ' HB3' ' A' ' 74' ' ' ALA . 38.3 t -56.18 -49.06 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.837 -1.164 . . . . 73.13 110.168 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 134' ' ' ARG . 56.8 t0 -56.62 -41.32 76.87 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.979 -1.076 . . . . 70.34 110.061 -178.241 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' SER . . . . . . . . . . . . . 23.1 t -59.48 -37.07 77.28 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.222 -0.924 . . . . 71.13 110.312 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.664 ' HE1' ' HA ' ' A' ' 129' ' ' VAL . 1.2 mpp? -71.77 -36.53 70.41 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.014 -1.054 . . . . 73.34 110.487 -178.195 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 71' ' ' LYS . 59.5 t -58.39 -45.98 89.47 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.691 0 O-C-N 121.206 -0.934 . . . . 63.44 109.547 177.075 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 130' ' ' ASP . 62.5 mtm180 -61.51 -45.74 92.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.358 -0.839 . . . . 75.14 109.659 177.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 136' ' ' PHE . 23.4 ttm180 -47.6 -68.24 0.21 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.678 -0.639 . . . . 74.12 110.901 179.152 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' PHE . . . . . 0.691 ' CD2' ' CE1' ' A' ' 57' ' ' HIS . 60.5 m-85 -62.24 -37.87 87.05 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.826 -1.171 . . . . 65.44 111.368 -172.553 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -56.91 -51.29 69.71 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.467 -1.396 . . . . 73.15 110.0 -179.067 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.417 ' O ' ' OD2' ' A' ' 142' ' ' ASP . 27.5 tttt -63.22 -35.7 81.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.922 -1.111 . . . . 71.52 109.703 173.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.517 ' HA ' ' OD2' ' A' ' 142' ' ' ASP . 4.0 tp60 -54.11 -48.83 70.31 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.469 -0.769 . . . . 72.23 110.549 -177.207 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 140' ' ' PHE . . . . . 0.6 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 61.7 t80 -68.25 -37.75 81.09 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 121.301 -0.874 . . . . 75.42 110.404 -179.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 141' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -63.43 -50.68 68.83 Favored 'General case' 0 C--N 1.301 -1.531 0 C-N-CA 119.593 -0.843 . . . . 74.43 110.503 -178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.535 ' HB2' HG22 ' A' ' 14' ' ' THR . 2.7 p30 -66.47 -34.15 77.28 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.169 -0.957 . . . . 62.21 110.278 179.906 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.614 ' O ' HD13 ' A' ' 12' ' ' LEU . 99.7 p -62.51 -22.29 66.17 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.307 -0.871 . . . . 73.33 110.0 179.477 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 144' ' ' GLY . . . . . . . . . . . . . . . 71.87 28.14 69.37 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 108.877 -1.689 . . . . 73.22 108.877 -177.784 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 158' ' ' LEU . 57.9 mt -78.99 126.73 31.07 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.27 -1.135 . . . . 72.43 110.235 -178.69 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 146' ' ' THR . . . . . . . . . . . . . 47.4 m -68.2 -35.43 77.98 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.153 -0.967 . . . . 51.32 109.574 174.159 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 147' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 60' ' ' PHE . . . -174.57 -179.57 45.25 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.945 -1.262 . . . . 51.2 109.945 178.492 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 149' ' ' PRO . 4.0 m -111.37 167.09 9.58 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.665 -0.903 . . . . 72.02 109.296 178.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 149' ' ' PRO . . . . . 0.577 ' HA ' ' HB ' ' A' ' 148' ' ' VAL . 7.8 Cg_exo -69.94 133.83 27.47 Favored 'Cis proline' 0 N--CA 1.489 1.243 0 C-N-CA 122.757 -1.768 . . . . 63.12 111.469 3.023 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 150' ' ' ALA . . . . . 0.892 ' HB1' HD22 ' A' ' 145' ' ' LEU . . . -126.35 141.52 51.87 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.254 -0.904 . . . . 41.13 109.441 171.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 151' ' ' VAL . . . . . 1.004 HG21 ' OH ' ' A' ' 170' ' ' TYR . 30.3 t -114.28 126.96 71.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 120.892 -1.13 . . . . 63.4 110.093 -178.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.491 ' CG2' ' CE1' ' A' ' 25' ' ' PHE . 21.2 t -116.03 132.12 66.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.352 -0.843 . . . . 64.33 110.202 179.941 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 153' ' ' VAL . . . . . 0.922 HG11 ' HB2' ' A' ' 177' ' ' LEU . 15.8 t -109.83 135.9 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.528 -0.732 . . . . 43.32 109.656 179.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 154' ' ' ASN . . . . . 0.539 ' ND2' ' HA ' ' A' ' 178' ' ' LEU . 2.0 m-80 50.51 24.26 1.55 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.155 -0.966 . . . . 75.34 110.09 -175.926 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 155' ' ' ASN . . . . . 0.473 ' ND2' ' O ' ' A' ' 155' ' ' ASN . 3.1 t30 51.83 28.33 4.94 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.144 -0.972 . . . . 72.14 110.931 176.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.874 ' CD ' ' HB2' ' A' ' 16' ' ' ALA . 76.1 ttt180 -152.33 -18.98 0.17 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.935 -1.103 . . . . 73.44 111.077 -178.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 157' ' ' TYR . . . . . 0.782 ' HB3' HD22 ' A' ' 177' ' ' LEU . 10.5 m-85 -111.69 138.28 48.46 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.59 -1.319 . . . . 62.33 109.965 173.545 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 158' ' ' LEU . . . . . 0.924 HD21 HD21 ' A' ' 145' ' ' LEU . 0.1 OUTLIER -108.84 127.89 54.43 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.213 -0.929 . . . . 64.4 109.199 -179.496 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.644 HG13 HD23 ' A' ' 173' ' ' LEU . 25.4 t -80.72 109.47 15.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 O-C-N 121.438 -0.789 . . . . 73.54 110.321 -175.013 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 160' ' ' GLN . . . . . 0.496 ' HG3' ' HA ' ' A' ' 9' ' ' TYR . 95.7 mt-30 -72.25 -47.15 52.42 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.272 -0.892 . . . . 65.2 109.563 173.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 161' ' ' GLY . . . . . . . . . . . . . . . 62.56 11.77 36.89 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.816 -1.314 . . . . 73.33 109.816 177.024 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -61.51 -36.84 81.66 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.097 -1.237 . . . . 73.53 110.407 -178.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 53.9 p -85.53 -4.25 59.1 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.178 -0.951 . . . . 60.01 110.567 -177.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.573 ' HB1' ' N ' ' A' ' 170' ' ' TYR . . . -88.84 95.0 10.12 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -0.966 . . . . 74.42 110.519 -177.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 165' ' ' LYS . . . . . . . . . . . . . 21.9 tttm -61.32 -32.2 72.06 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.364 -0.835 . . . . 52.44 110.236 176.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . . . . . . . . . 49.1 m -134.96 160.26 38.84 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.294 -0.879 . . . . 74.23 109.905 -177.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 167' ' ' LEU . . . . . 0.462 ' O ' ' CB ' ' A' ' 171' ' ' PHE . 4.5 mp -51.12 -23.94 3.63 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.052 -1.03 . . . . 62.32 110.899 -177.961 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 168' ' ' ASP . . . . . 0.423 ' O ' ' CG ' ' A' ' 172' ' ' ASP . 92.2 m-20 -58.87 -42.52 89.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.677 -1.264 . . . . 63.42 110.29 179.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 169' ' ' GLU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 164' ' ' ALA . 77.4 mm-40 -79.66 -44.09 21.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.02 -1.05 . . . . 70.35 110.459 176.839 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 170' ' ' TYR . . . . . 1.004 ' OH ' HG21 ' A' ' 151' ' ' VAL . 88.7 t80 -61.03 -45.7 93.71 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.287 -0.883 . . . . 75.2 110.048 178.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . 0.731 ' CD2' HD12 ' A' ' 43' ' ' LEU . 61.8 t80 -59.49 -46.78 87.83 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 73.33 110.222 175.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 172' ' ' ASP . . . . . 0.619 ' HB2' ' CZ ' ' A' ' 3' ' ' PHE . 92.3 m-20 -57.15 -43.66 82.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.182 -0.949 . . . . 62.04 110.656 -177.706 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.644 HD23 HG13 ' A' ' 159' ' ' VAL . 4.4 tp -54.67 -51.78 64.42 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.736 -1.228 . . . . 73.13 109.995 176.405 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 174' ' ' VAL . . . . . 0.56 HG22 HG21 ' A' ' 159' ' ' VAL . 56.0 t -52.46 -43.19 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.937 -1.102 . . . . 74.22 109.847 -179.866 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 175' ' ' ASN . . . . . 0.856 ' HA ' HD12 ' A' ' 178' ' ' LEU . 1.8 m-80 -59.67 -41.65 91.09 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.154 -0.966 . . . . 73.11 110.802 179.528 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.659 ' CE2' ' CD1' ' A' ' 3' ' ' PHE . 67.8 m-85 -67.12 -42.14 84.98 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.995 -1.066 . . . . 71.34 110.12 179.671 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.96 ' HA ' HD12 ' A' ' 180' ' ' LEU . 77.5 mt -60.78 -37.51 82.13 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.283 -0.885 . . . . 71.12 109.772 178.496 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 178' ' ' LEU . . . . . 0.856 HD12 ' HA ' ' A' ' 175' ' ' ASN . 13.5 mt -56.95 -33.88 67.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.195 -0.94 . . . . 74.22 109.334 173.409 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 179' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 176' ' ' TYR . 40.7 m -74.49 -27.39 60.54 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.451 -0.78 . . . . 72.4 109.834 174.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.96 HD12 ' HA ' ' A' ' 177' ' ' LEU . 17.8 mt -85.59 142.41 29.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.481 -0.762 . . . . 72.13 110.318 -176.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.481 ' OXT' ' HD3' ' A' ' 156' ' ' ARG . 84.8 tttt . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 118.029 -0.986 . . . . 62.05 110.205 -179.849 . . . . . . . . 1 1 . 1 stop_ save_